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LETTERS TO THE EDITOR
YSM in W.W. II
To the editor:
I enjoyed reading Dr. Fred Collier's
humorous account in the Summer 1990
Yale Medicine of the change in the
Yale medical students’ education
during World War 11. I would like to
mention another change that was
effected by the war: the composition of
classes at the Yale School of Medicine.
During these years, the percentage of
women rose dramatically from about 6
percent to over 11 percent. In fact, in
1948, 15 percent of the entering class
were women, but this figure dropped to
5 percent two years later. It was not
until 1971 that the number of women at
the School of Medicine reached the
same proportion. These trends are also
reflected in national statistics on the
admission of women to medical
schools.
Susan Baserga, M.D., Ph.D. '88
Lecturer, MB&B
Yale School of Medicine

To the editor:
Dr. Collier’s article, “Yale Medical
Students March to War,’’ was on target
even if we student-soliders rarely were.
The war changed all American
communities, but the Yale School of
Medicine was changed in special ways.
Medical students were allowed to
continue their studies, but most went off
to the military. They were replaced by
all sorts of trainees from the armed
services, American and otherwise. My
roommate, a public health student
named Ray Chan, organized a big
dance for a contingent from Chiang
Kai-shek’s air force, busing in Chinese
girls from nearby colleges.
We lost faculty to the regular
services and to the Yale unit. We gained
faculty in the form of refugees from
Hitler and Mussolini. We learned to
pronounce “necrosis” with a rolled “R”
and a “Z” sound. Arturo Castiglioni,
who had just published his History of
Medicine, gave an elective to a small
group before the big fireplace in the
historical library. The setting, plus the
intensity and passion of his
presentations, rose above our
differences in language. Other refugee
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physicians were not as fortunate and
worked in the area at menial jobs.
I can still find the little scar on my
arm where Professor Harold S. Burr
burned me with mustard gas. While
studying the toxic effects of the
mustards, faculty of the department of
pharmacology discovered the anti¬
tumor activities of these compounds. As
a part-time worker in that department, I
witnessed Dr. Burr’s research, which
included measuring the electrical
potential across a blister raised by
liquefied mustard gas. He had no
trouble recruiting volunteers; long
before institutional review boards, we
just walked in and rolled up our sleeves.
Far more unpleasant, hazardous —
and ultimately important to science —
were the studies on conscientious
objectors. Then as later there was a
strong virology unit at Yale. Hepatitis
A, then called catarrhal jaundice, was
prevalent among the troops, and an
outbreak of hepatitis B followed the
introduction of a yellow fever vaccine.
With transmission modes unknown,
potentially infectious materials were
administered to the volunteers through
several routes. I don’t recall any deaths,
but these young men who were often
scorned because they were unwilling to
“risk their livers” in war certainly risked
them in another way.
Charles A. Hall, M.D. ’44
Veterans Affairs Medical Center
Albany, New York

Insurance Benefits
To the editor:
Though not a School of Medicine
alumnus, I did graduate from another
Yale professional school, and that
occasionally brings me into contact
with Yale Medicine.
As a consultant to large employers
regarding their employee health
insurance benefits, I found the Spring
1990 issue of Yale Medicine to be
especially helpful. The question of solid
organ transplantation is one of vital
interest to the nation’s employers who
are paying the bulk of the cost for these
procedures. Gregory R. Huth’s
interview with Dr. Levine regarding the
ethical challenges of transplantation

was well done and proved of interest to
one of our clients who is considering
whether or not her company should pay
for certain types of solid organ
transpkints.
Keep up the good work and please
understand that your impact extends
well beyond the medical community.
Tho.se of us in the health care financing
area also profit from what we learn in

Yale Medicine.
Scott J. Fruchter, M.Div. '76
Chief operating officer
Costeffex
Cleveland, Ohio

Fetal Transplant
Researchers
To the editor:
I read with interest and not a little
disappointment the recent article by
Susan Okula in the Spring 1990 Yale
Medicine. While page 16 gave good
general coverage to the fetal neural
transplant program, it failed to reflect
the singular efforts of the department of
obstetrics and gynecology and Drs.
Richard Robbins and Csaba Leranth,
without whom the project would never
have progressed. Of course, I know that
this was an innocent error. It does not
detract from my appreciation of the
general excellence and style of the
Bulletin. However, it is sad that those
who have worked so hard on behalf of
the program should have missed their
chance to be included in this exposure
to the Yale audience.
Frederick Naftolin, M.D., D.Phil.
Professor and Chairman, OBIGYN
Yale School of Medicine

Clarification
In a photo caption on page 39 of the
Summer 1990 Yale Medicine,
Matthew F. Lopes Jr., M.P.H. ’77, was
listed as director of the medical school’s
Health Careers Opportunity Program
(HCOP). More precisely, HCOP is a
program of the department of
epidemiology and public health.
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THE CREATIVE LEAP
hy Dr. Allen C. Steere, Post-doctoral fellow '75-’77
Members of the Yale medical school Class of 1990, I have
decided to speak today about artistic qualities in medicine,
about the importance of intuitive, creative thinking, and about
feeling and empathy for patients. We generally devote little
time to thinking or teaching about such things, but 1 believe
that they form an important framework for our lives in
medicine. Besides, today is a day for reflection, and more
importantly, a day of dreaming about what is to come, so it
seems appropriate to think about and highlight the importance
of intuitive thinking.
Let me state emphatically that I am in no way
downgrading the importance of science or the scientific
method. This is an age of incredible, unbelievable scientific
accomplishment of which we are all in awe. It still amazes me
to think that DNA was described only in the 1950s. I was in
high school. We are the first generation ever to know that the
same four nucleic acids — adenine, thymidine, guanine and
cytosine — code for all life fomis, for all the diversity around
us. It is almost unfathomable how much this discovery has
changed medicine and medical research in only 30 years. This
is the molecular biologic revolution. It is an incredibly
exciting time to be involved with the biologic sciences.
However, it is important for us to recognize that intuitive
thinking and dreaming, what 1 am calling today a part of the
art of medicine, had to come first. There were people
previously who knew or felt that all life was interrelated.
Charles Darwin theorized that all life had evolved from the
simplest to the most complex fomis. This kind of thinking had
to come first and had to guide the scientific accomplishment.
In the same way, dreaming about your future career in
medicine, as we do today, has to come first, and these dreams
will play a role in shaping your career. To say it in another
way, both the right and left brain must work together to get a
creative result; both creative and analytical thought are
necessary. To say it more metaphorically, both masculine and
teminine qualities are important in creativity; to have a baby,
both a man and a women are necessary. Whether man or
woman is more important is an absurd question. Neither can
do it alone.
Lessons from Ixodes dammini Ticks
■As a way of illustrating these points, 1 would like to share
with you a story about ticks. Back a few years ago, we were
trying to find the agent of Lyme disease in ticks. Each
summer. 1 hired two students, often from the forestry school,
to collect ticks for study.
On several occasions, to show solidarity, 1 went with them.
I'lagging lor ticks involves dressing up in a white jump suit
and dragging a blanket through the forest. On an average day,
you may collect a couple of ticks per hour. It is one of the
Dr. .Alien ( '. Steere. professor of medicine at Tufts Universitx
Si hoot oj .Medicine, and chief, rheumatolot’ylimnuinoloyx at
New T.n^land Medical Center, delivered the first School of
MediiHie Class Day address on Max 27. This article is ati
' lilted version of that address.

more tedious things that I have done. However, the people
that you are with make a big difference. I particularly enjoyed
one student from the forestry school who had a tremendous
respect and reverence for nature. Reuben spoke at length
about how the entire system in the forest was delicately
balanced and every life forni had its role.
Well, what good are ticks, I thought. Andy Speilman, an
entomologist at Harvard who is always a provocative thinker,
has subsequently told me that the purpose of ticks is to keep
the visitors out. The animals that have lived with the ticks for
eons, like mice and deer, are completely tolerant to infection
with the tick-transmitted spirochete that causes Lyme disease.
These animals do not become sick when infected. In contrast,
the strangers in the forest, the new predator or you and I, do
become ill when exposed to the tick-transmitted spirochete.
At the time, 1 had no such insight and instead thought
about how ironic it was that my life’s journey had taken me
down this road where my life had become inextricably linked
with ticks, detestable creatures about which I had no previous
interest whatsoever. I was trying to learn about and
understand the complex life cycle of Ixodes dammini ticks.
These insects feed only three times in their usual two-year
life cycle. A larval tick climbs a blade of grass or a twig in the
morning or evening during summer and waits for a host,
preferably a mouse. If none comes by, the tick drops back
down to the ground. This process is repeated over and over.
Many larval ticks never find a suitable host and die. Others
may find the wrong host, such as my blanket, and end up
being dissected in the laboratory.
However, if an appropriate animal brushes by, preferably a
mouse, the tick leaps and attaches, sucking blood for three to
four days. The tick then falls to the ground, so engorged that it
is unable to move. The blood meal is then processed and
eventually the tick molts to the next stage, a nymph. The next
summer, the nymphal tick goes through this same process,
and that fall, the adult ticks must go through the process
again. While feeding as adults, the ticks mate, and then the
male tick falls off and dies. The female tick falls to the
ground, lays thousands of eggs and then dies. What a life, I
thought. What a useless life.
Then 1 realized to my amazement, to my horror, that my
life was like that of the ticks. I suppose now you may be
wondering what kind of life I’ve had. Let me tell you
something about it. My DNA is lined up in such a way that I
am very interested in music. Before medicine, I played the
violin; I practiced hours each day. When it was time to go to
college, I went to New York. I was a student at Columbia and
took private lessons from Ivan Galamian, who was head of
the violin department at Juilliard. Important qualities that
were stressed included the communication of feeling through
music, listening carefully, and practicing long hours in an
attempt to refine and perfect one’s message.
It is the same person who now does medical research on
Lyme disease. 1 consider myself to be an artist within the
scientific field of medical research. The feeling person in
music has become the intuitive thinker and listener in my
current life, and long hours of practicing violin have become
the persistent effort over a period of years to determine
whether one’s intuitive ideas are correct.
Yale
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Pfizer Pharmaceuticals

Let me explain more of what I mean by the intuitive,
creative leap. One of the most famous examples of this sort of
thinking was manifested by the observation of Sir Alexander
Fleming, the father of the antibiotic age. You know the story.
He noticed that bread mold, a fungus, which had fallen onto a
culture plate, inhibited the growth of bacteria near the fungus.
With this seemingly simple and obvious observation, he saw
the world in a completely new way; he saw with clarity what
others had not seen. As you know, this observation led to the
development of penicillin, which remains the wonder drug of
our century.
Although creative leaps of genius are rare, all of us must
make several creative leaps in the course of our lives. Such an
event happened in my life several months after beginning a
rheumatology fellowship at Yale in 1975. I learned of a
cluster of children in Lyme, Connecticut, who were thought to
have juvenile rheumatoid arthritis, a puzzling illness of
unknown cause. Soon after beginning work on this problem,
there was the intuitive realization that this illness was
something new, something different, and that it was probably
a tick-transmitted infection.
Our thinking is often formed or at least influenced by
listening to others and hearing what they have to say. In this
particular case, it was two mothers from Lyme who brought
this situation to my attention. Both suspected that the children
with apparent juvenile rheumatoid arthritis had an infection
because so many children that they knew were affected.
Because of the tremendous explosion of ticks in the area, both
had even wondered if ticks were transmitting the illness.
Many subsequent experiences have reinforced for me that
reasonable patients often have an intuitive sense of what is
happening to them, and being able to listen and hear what
they .say is an important part of the art of medicine. Even if
we do not understand the disease process, the sense that you
have listened, and stood with the patient, can influence the
healing process.

The Long Run
Of course, if one stops here, one is left only with intuition, a
guess, and empathy. It is here that science steps in to test the
reality of the intuition, and to go, step by step, through the
laborious process of determining whether the intuitive idea is
correct. For me, the Yale medical school environment was a
place where such work could flourish; I was fortunate to be in
the fellowship program directed at that time by Dr. Stephen
Malawista, who was a supportive mentor.
Still, it often requires one's intuitive vision to help one stay
the course through all of the negative experiments. Over the
next several years, we were able to put together clinical and
epidemiologic evidence that strongly implicated a particular
Ixodes tick in transmitting the disease. We also learned that
the illness responded to penicillin therapy, which suggested
that a bacterial agent was the cause. However, all of our
efforts to find an infectious agent in ticks were negative.
The actual causative agent, a spirochete, was not found
until seven years after the initial observation in Lyme,
Connecticut. People have subsequently told me that seven
years is no time at all to wait for a major breakthrough. And,
as you may know, we were not the ones who made the
breakthrough. We did not have the special expertise required;
Willy Burgdorfer at the Rocky Mountain Laboratory did.
Burgdorfer, an entomologist, had spent years dissecting ticks
and working with a type of tick-transmitted spirochete called
Borrelia.
Tick Ixodes Dammini
Yale Medicine FallAVinter 1990-91

3

Dr. Allen C. Steere, Postdoc ’75-’77:
Lyme Disease Pioneer
Before Dr. Allen C. Steere came to Yale in 1975 for a twoyear post-doctoral fellowship in rheumatology, he had spent
eight years in and around Columbia University gamering his
undergraduate degree and medical education; a 1965 B.A.
degree from Columbia College was followed by an M.D.
degree in 1969 from the College of Physicians and Surgeons.
The next four years featured internship and residency in
medicine at St. Luke’s Hospital in New York City, including
a year as chief resident in medicine. From 1973 to 1975, he
served in Atlanta at the Centers for Disease Control as an
epidemiologist for the U.S. Public Health Service.
It was Dr. Steere’s subsequent work at Yale, however, that
established him as one the nation’s preeminent medical
researchers. As a fellow in the rheumatology program then
directed by Dr. Stephen E. Malawista, professor of medicine,
Dr. Steere played a leading role on the team of biomedical
.scientists that identified Lyme disease. The researchers did so
by studying a group of children from Lyme, Connecticut, who
had arthritis. With the help of colleagues at the department of
epidemiology and public health, the researchers also
implicated the tick Ixodes dammini as the Lyme disease
vector.
Dr. Steere continued his investigations into the disease as
an assistant and associate professor at the medical school
from 1977 to 1987. His contributions to the study and
treatment of Lyme di.sea.se have won him numerous citations
and awards, including the Ciba-Geiga Rheumatology Prize,
which he shared with Dr. Malawista in 1985. Most recently,
he received the Zucker Prize from Tufts University School of
Medicine, where he has served since 1987 as professor of
medicine and chief, rheumatology/immunology at New
England Medical Center.
Dr. Allen C. Steere

.•\t times, it was difficult for him to get support for this
work since its purpose seemed obscure. But then the day
came for his creative leap, the day when his special expertise
allowed him to see what no one else had seen, a previously
unrccogni/ed spirochete, now called Bonelia burgdorferi, in
the midgut of an Ixodes daniniini tick. My role, as it turned
out. was to help articulate a vision that this tick carried an
infectious agent which caused Lyme disease. To articulate a
vision is one of the roles of the artist in medical research or in
any other field.
.So how is my life like the ticks? While they climb a blade
of grass each day, I come to work, take out my papers, or set
up my test tubes, or perhaps even drag a blanket through the
lorest. At the end of the average day, I clo.se up and go home;
nothing too enlightening has happened. However, at the
appropriate time, a time of searching, I must be poised and
reatly for the intuitive leap.
< >ne cannot decide to make a scientific discovery any more
than a tick can make a mouse come by its blade of grass.
Rather, wc- must dream about what we want first, prepare
I'urselves lor those dreams, position ourselves appropriately,
and wait, rtien. when the opportunity presents itself, we must
lake .an mtuitise leap, just as the tick leaps to its host, ’fhough
do not know at the time where our leaps will take us, a

successful intuitive leap will introduce us to new realms that
will make possible the next stage of our lives.
You are about to enter into a new period in your life. For
most of you, the demanding years of internship and residency
training will still be a period of putting in place the
knowledge that will allow you to make creative leaps in
medicine. Some of you will make important scientific
discoveries; some of you will be exceptional healers; some of
you will be gifted leaders; and some of you will be
extraordinary teachers. We know that all of you have been
given exceptional talents and abilities, and therefore you will
have much to give in these roles.
Along the way, it is likely that you, like the ticks, will take
several creative leaps which will take you into new realms
that are difficult to imagine today. You will see incredible
new discoveries and treatments, and because of this, learning
will be a part of your everyday life. As graduating medical
students, you carry our hopes and aspirations for progress in
medicine and for making this a better world. You are both the
greatest resource of the Yale School of Medicine and its most
important accomplishment. Congratulations and may God
bless you in your journey and give you courage in your
creative leaps.
YM
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PUBLIC POLICY IN THE AGE OF AIDS
by Stephen C. Joseph, M.D. ’63, M.P.H.
All major public health issues have significant social and
political parameters. AIDS represents the first major public
health issue, at least in modem times, in which the political
and social contexts have been defined (one might even say
“fixed”) before the critical elements of clinical and
biomedical knowledge were available. “And that,” as the poet
said, “has made all the difference.”
All through this first decade of the epidemic, we have been
playing catch-up defense: charting the epidemic by cases of
illness rather than by rates of infection — working with a
snapshot in time, five years or more delayed. Thus, we have
been identifying new risk groups and foci of infection years
too late to be able to cut the virus off before it gained a solid
foothold.
The human immunodeficiency virus is extraordinarily
well-adapted for survival; its epidemic will smolder on for
decades even after the explosive outbreaks of the 1980s and
early 1990s are behind us. Transmitted by sexual, bloodborne, or materno-fetal routes, the virus turns the DNA of
infected cells into factories to produce more virus.
In adults, it then, with no specific clinical signs at the time
of infection, enters a long (usually three-to-five year) period
of clinical latency. During the months of the so-called
“window period” between infection and first appearance of
HIV-antibodies, no currently applicable technology can
diagnose the infected individual.
Once infected, a person becomes infectious to others and
remains so for life. With a median time from infection to full¬
blown AIDS of some eight-to-10 years, and a post-diagnosis
survival period of more than two years, that leaves a very long
interval for continued transmission and infection of others.
Moreover, with rapid advances in treating opportunistic
infections and palliating viral replication, it may soon be
possible to characterize AIDS as a “chronic treatable disease,
though incurable.”
In New York City, we have had approximately 26,000
cases of AIDS to date as defined by the Centers for Disease
Control (CDC). An estimated three-to-four times that many
people are affected by HIV-related illness, and some 200,000
persons in the city are infected with the virus.
To understand where the epidemic is going, and what
would constitute appropriate public policy to combat it, one
needs to look at three major trends that constitute the present
and future course of the epidemic in New York. These trends
will also be increasingly reflected nationwide, especially in
the other cities of high-prevalence HIV infection.

The Imploding Epidemic
The first trend is what I call the “Great Epidemiologic Shift.”
AIDS is increasingly a family, neighborhood, poverty,
minority, drug-abuse associated epidemic. In 1988, the

number of newly diagnosed AIDS cases in New York among
intravenous drug users surpassed cases newly diagnosed
among men who have sex with men. Substance abusers
continue to account for an increasing proportion of HIV
transmission, to each other through the use of contaminated
injection equipment, and to their sexual partners and unborn
children through heterosexual transmission.
Women, who comprised less than 11 percent of AIDS
cases in New York during the first five years of the epidemic,
now account for over 15 percent of the cases occurring
annually; we expect this to rise to 20 percent in the next year
or two. Two-thirds of these women have been infected by
their own drug use. But increasingly, heterosexual
transmission from an infected drug-using sex partner is the
route of infection to non-drug injecting women. Often these
women are unaware of the risk posed by current or past
partners.
We have had almost 3,500 cases of AIDS among females
in New York City, and there is little doubt that there are
thousands of asymptomatic infected women and women in
early stages of clinical immuno-incompetence as yet
undiagnosed. State health department surveys have shown
that one in 61 women giving birth in New York City is HIVinfected, compared to one in 489 in the rest of the state.
The association with drug abuse has meant that AIDS is
increasingly concentrated in minority and poverty
populations, and this trend is accentuated as drug use becomes
a gateway to heterosexual transmission. Of the more than 600
cases of children with AIDS diagnosed in New York, over 90
percent have been black or Hispanic. In short, the epidemic is
not “exploding” across the entire landscape; there is no reason
to predict the formerly feared “heterosexual break-out” in
epidemic proportions across white middle-class America.
Rather, the virus is imploding, in poverty and minority
neighborhoods, where rates of intravenous transmission have
been high and unmodified since the beginning of the
epidemic, and where heterosexual transmission is
accelerating. These localized pockets of high endemicity are
the future of the epidemic, as the virus adds to the burdens of
social and health problems — not to mention the
discrimination — that these poverty and minority
communities already bear.
A recent CDC study showed at one sentinel hospital in the
Bronx, almost one in four emergency room patients are HIVinfected, the great majority unaware of their infection. It is
reasonable to assume that in some parts of New York City,
five-to-10 percent of childbearing-age women are currently
infected.
Intravenous drug use has been the common denominator of
this penetration of the virus into poverty and minority
communities, but it is no longer the only drug-AIDS
connection. Increasingly, the crack epidemic is a powerful
channel for the virus. The reasons are multiple:
• the increase in cocaine injectors, who “shoot up” more
frequently and share more needles than heroin injectors;

This article was adapted from an address, “Public Health and
Public Policy in the Age of AIDS," which Dr. Joseph
delivered at Medical Alumni Weekend on Friday, June 8.
Yale Medicine Fall/Winter 1990-91

• the hypersexual behavior associated with cocaine, and
especially crack addiction;
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• the vast increase in sex-for-drugs transactions among
crack-addicted women;
• the greater proportion of women and young persons in
general addicted to crack as compared to heroin;
• the phenomenon of the “crack house,” which plays a
role in rapid multiple partner transmission comparable
to the gay bath house/sex club and the heroin shooting
gallery;
• the very probable association of sexually transmitted
diseases, especially genital ulcer disease, with
potentiation of HIV transmission.
The incidence of primary and .secondary syphilis doubled
in New York between 1988 and 1989, and more new cases
were reported among women than among men, a distinctly
unusual trend. In a recent study of men attending a sexually
transmitted disease clinic in the Bronx, all of whom were
heavy crack users, and all of whom denied intravenous drug
injection and sex with other men, 30 percent tested HIV
positive.
Among gay men in New York and San Francisco, where
educational levels are high and where outstanding community
action and rnobili/ation took place, risk-avoiding behavior
was mirrored by rates of decrease in sexually transmitted
diseases and reduced rates of new HIV infections. By
contrast, there is little rea.son to hope that similar phenomena
will take place in the “imploding” communities. Both
minority leadership and the rank-and-file have to date been
more notably focused on denying the problem rather than on
rnobili/ing against it, though this has started to change,
especially in New York's black community.
Kducational efforts and other preventive programs aimed at
drug injectors have shown no outstanding success. Infection
rates among intravenous drug users in New York City are
reliably estimated at between 50 and 60 percent, much higher
if one focuses on those who frequent the shooting galleries,
and are probably reaching functional saturation. And
increasingly, onwards hetero.sexual transmission to black and
Hispanic women and their children cannot be predicted by the
standard categories of risk groups or risk behavior; The virus
has dived below the surface of our scanning categories.
Palliation, Not Cure
The second major trend of critical importance to the future of
the epidemic is the rapidly broadening treatment horizon,
riiough v\e can offer neither a long-term effective
chemotherapeutic agent nor chemoprophylaxis, we can
palliate with anti-virals on a rapidly increasing scale.
Our ability to combat the sequelae of immunodeficiency
— the opportunistic and other infections — has increased
even more dramatically, and here we already have solid
instances of chemoprophylaxis that can bring proven survival
benetits to asymptomatic and early-stage HIV-ill patients as
well as to those with categorical AIDS.
I hese advances, extraordinary as to how much has been
learned ami applied to a new disease process in less than a
decade, have important itnplications for patient care, for
^iirvi\al and quality of life. They also have daunting
implications tor access, availability atid costs of tnedical care.
But I wisli to locus here oti their implications for public health
pi'lies.
N"v., lur the first time, early identification of the HIV■ '
. i individual is in the clear best interests of that

individual, as well as in the interests of society. Medical
benefits of early identification of the asymptomatic individual
mean that greatly expanded efforts need to be placed upon
identifying and alerting that individual, and on making
accessible an appropriate system of care. There is no longer
any credibility to the old argument, “Why be tested? They
can’t do anything about it anyway....” Nor can it be said that
widespread antibody testing would serve more as a tool of
social repression than of public health and individual
protection.
I predict that history will view our collective failure to use
the HIV-antibody test more vigorously as one of the major
missed opportunities of the AIDS tragedy. We have displayed
an unwillingness to rapidly expand counseling and testing.
We have not matched the technical power of the testing
instrument with strong protective legislation and practice to
preserve voluntary consent and confidentiality.
Thus, we have lost an opportunity to develop timely
understanding of the patterns of infection within populations;
neither have we developed effective systems of partner
notification that would have warned many thousands of
unsuspecting partners-at-risk. As a result, we have failed in
our medical responsibilities to provide asymptomatic infected
individuals with early access to clinical support and,
increasingly, effective disease management.
The strident politics of AIDS has led to a view of the
antibody test as a “necessary evil” only to be employed within
the narrowest of conditions, rather than as a significant public
health tool. With careful safeguards against potential abuse,
wider use of this test could have given us a much more
effective approach to both the prevention and treatment
dilemmas of the epidemic.
Strident Voices
The third major trend, along with the epidemiologic shift and
the broadening treatment horizon, has been the growth of the
politics of conflict. AIDS, being about sex and about drugs, is
impossible to address without engendering controversy and
social conflict.
From the earliest issues of homophobia and stigmatism,
through the current bitter struggle over providing clean
needles and syringes to drug addicts, the history of the
epidemic has been one of harsh criticism and counter¬
criticism, of conflicts over social policy that sometimes led to
threats and violence. The politics of sexual and racial conflict
have influenced, and at times dominated, the scientific as well
as the social response to the epidemic.
More recently, the rise of militant AIDS activism,
especially on the part of gay advocacy groups such as ACTUP, has taken the controversies over public health policy, the
availability of care, and the appropriate course of drug
research, development and distribution to new heights of
visibility — and to new depths of rancor.
In the early years of the epidemic, most of the threats to
reasoned debate and unbiased development of public health
policy came from the right. Conservative religious and
political groups sought to bar explicit health education,
condom availability and needle exchange. These days, the
clamor comes more from the left, as protesters demand that
only their perspective be considered, and that something,
everything, be done immediately, successfully, and no matter
what the feasibility, cost or competing priority.
My chief concern is that both the scientific community and
the public will grow tired of the shrill demands, and move on
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Dr. Stephen C. Joseph, ^63:
Battling the Dragon
Before assuming the office of New York City Commissioner
of Health in 1986, Dr. Stephen C. Joseph’s public health
career had taken him around the world, from the developing
nations of Nepal and Cameroon to the wilds of Wyoming and
Newfoundland.
A New York City native. Dr. Joseph earned his degree
from Harvard before entering the School of Medicine in
1959. He received an M.P.H. degree from the Johns Hopkins
University in 1968, and did his internship and residency in
pediatrics at Boston Children’s Hospital.
He was the special coordinator for Child Health and
Survival for the United Nations Children’s Fund (UNICEF)
in New York from 1983 until 1986. During a five-year term
as a commissioned officer in the U.S. Public Health Service
in the mid-1960s, he served as a Peace Corps physician in
Nepal.
Dr. Joseph has worked at the Children’s Hospital Center of
the District of Columbia and was chief of pediatrics at
Grenfell Regional Health Services in Newfoundland. He has
taught at Harvard University, the University for Health
Sciences in Cameroon and Memorial University of
Newfoundland. He prepared a plan for a community-based
medical school for the University of Wyoming.
During two stints with the Agency for International
Development, Dr. Joseph worked in Cameroon helping
establish a medical school and in Washington, D.C.,
overseeing health, population and education programs. He
has also served as special assistant to the assistant secretary
for health and scientific affairs of the U.S. Department of
Health, Education and Welfare and as director of the
Neighborhood Health Centers Program of the Office of
Economic Opportunity.

to other concerns, leaving us less with which to combat the
very real and growing needs of the epidemic than we might
otherwise have had. To scream “genocide” at the Centers for
Disease Control or the National Institutes of Health, the only
two federal agencies that have met their responsibilities —
and met them with excellence in this epidemic — is not likely
to generate additional political, scientific, medical or popular
support.
It would be foolish to think that the politics of conflict will
lessen as we move into the second decade of the epidemic.
We are witnessing a tightening knot composed of a worsening
fiscal situation and a rapidly expanding need for ever more
expensive care.
The increasingly ugly racial climate of the 1990s and the
epidemiologic shift of AIDS will exacerbate each other. Our
best measures as health professionals for meeting these
conflicts will be the ones that have always served us well:
working from our best current data, not being afraid to change
our positions as the data give us new insights; providing the
public with a full and honest account of what the science
reveals, not being afraid to convey either bad news or good;
and seeking a balance between the rights of the individual and
the protection of society.
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Dr. Joseph is a member of the Institute of Medicine, a
fellow and former chairman of the executive board of the
American Public Health Association, and a fellow of the
American Academy of Pediatrics.
Currently, he is writing a book about his experiences
confronting the AIDS epidemic while New York City’s top
health official from 1986 until 1990. The working title is
Dragon Within the Gates: The Once and Future AIDS
Epidemic.

Dr. Stephen C. Joseph

New Initiatives
As the great epidemiologic shift, the broadening therapeutic
horizon and the politics of conflict form the future of the
epidemic, how should public policy respond? Let me suggest
an outline of four principles:
• continued maximal efforts in biomedical and socio¬
medical research;
• rapid expansion of clinical and social services;
• a serious approach to the national drug abuse epidemic;
and
• a mobilization of effective public health action.
I can’t imagine that anyone can be found who is opposed
to continued investment at the highest feasible level in HIV
biomedical research. Since HIV infection represents the
convergence of two critical facets of contemporary
biomedicine, immunology and virology, the long-term
benefits of AIDS research will include an immense payoff for
a wide spectrum of diseases.
We have been fortunate in one sense; Had the AIDS
epidemic burst upon us even a decade earlier, we would not
have possessed the basic tools with which to define and study
7

the virus as we have. Nevertheless, we have barely tapped the
knowledge we need to gain from AIDS regarding the
behavioral, social and cultural aspects of epidemic infectious
disease.
The critical importance of both areas, biomedical and
sociomedical research, transcends this epidemic, for if AIDS
has taught us anything, it should be that we are not, as we had
mistakenly thought, immune from mass infectious disease.
There will be a next time, and perhaps this next virus to come
out of the forest and catch hold will be one that is more
casually transmissible.
With regard to expanding clinical and social services for
people with MIV illness, there is an urgent need for a federal
strategy to support high-prevalence areas. New York City is
spending more than $400 million dollars annually on the
epidemic, half of that from the city tax levy. Over the first
five years of this decade the direct costs of the epidemic in the
city will be $7 billion, and we cannot continue to bear so
much of the costs with only moderate state support. The same
phenomenon is occurring in San Francisco and in other highprevalence areas.
There are many more service delivery issues that are not
being adequately addressed, too many to mention here. The
major problems in HIV clinical care are the same as those that
plague our entire health care system: access, equity, quality
and quality assurance, evaluation and cost. It may just be that
if we find .some roads to improvement with AIDS, we may
find some answers applicable on a wider scale.
fhere will be no effective prevention of AIDS until or
unless we solve the primary problems of the substance abuse
epidemic. Our prevention and treatment efforts to date,
beyond sloganeering, have been half-hearted, our law
enforcement efforts have been inadequate. Clearly neither
approach by itself provides the answer.
We need much broader sanctions on the enforcement side,
especially measures that will provide a credible deterrent to
street dealers. Only this will provide a buffer within which
vastly expanded education and treatment can work. We need
to understand much more about why people use drugs, and
especially about the pharmacology and sociology of what is
clearly the future of drug abuse: smokable purified
derivatives, of which crack is only the harbinger.
Instead of decriminalizing hard drugs, we need to
effectively criminalize the supply side with harsh and
believable sanctions, while at the same time providing
preventive education and accessible treatment. All this will be
incredibly expensive on a national .scale, perhaps $4 billion a
year on education and treatment, perhaps another billion or
more annually for research — and who can estimate? — $10
billion or more in military, local law enforcement. Judicial
and corrections systems costs.
Are we willing to pay for it? Tm not optimistic, but I can
see no order-of-magnitude progress on either epidemic front
without that kind of commitment.
Public Health Planning
I w'ant to close by focusing briefly on specific public health
initiatives that are necessary at this stage of the epidemic, and
that have so far not been adequately taken in New York or
■ ■F.lw here,
Thr first has to do with providing clean injection
equip; i‘ III to intravenous drug users. It is in my view
'
■ ’ ..ble that w'c would withhold this measure on the
r: and unproven platitudes of “encouraging drug
I'ding mixed messages." These same tired

arguments have been used to oppose family planning — with
just as little supporting data.
On the contrary, the data, including those from our own
constrained program in New York, all point to the same
conclusion: no evidence of harm and many indicators of
benefit. This is one of the very few direct measures of primary
prevention we can take to slow HIV transmission, not only
among intravenous drug users, but also to their (largely
female and largely minority) sexual partners and children.
Simply changing state laws to permit needle possession
without prescription is not enough. Proactive public health
programs of needle exchange should be vigorously
undertaken so that other prevention and treatment initiatives
can be coupled with them.
We must have many-fold expansion of counseling and
HIV antibody testing programs, with voluntary confidential
testing available and aggressively pursued at every clinical
point of contact. Anonymous testing must be preserved as an
option for those who will refuse under any other
circumstances, but voluntary confidential testing in a medical
and health service context is the key to massive expansion.
Even in New York City, where the resistance to testing has
been greatest, and where we have opened eight city-funded
and -operated anonymous counseling and testing sites, the
volume of confidential testing outweighs anonymous testing
by more than two to one. Expanded testing must, of course, be
buttressed by strong legal protection of confidentiality and
anti-discrimination measures, as well as by maximal efforts to
expand services.
More extensive efforts in contact tracing and partner
notification are essential, especially now that the virus has
“submerged” in minority communities and risk cannot be
correlated with traditional risk groups. Obviously, partner
notification must remain voluntary and be focused where it
will be most effective. Arguments that “tracing everyone’s
sex partners for the past 10 years would be expensive and
futile” are spurious diversions from what is both a medical
and a public health obligation: the duty to warn where
possible the unsuspecting person of the risk of a fatal and
sexually transmissible disease.
The effective implementation of both expanded testing and
partner notification requires that all states should have
mandatory confidential public health reporting of HIV
infection. Physicians and hospitals should be required to
report, under strict conditions of confidentiality, the names of
infected persons, as is currently the case in 32 (mostly lowprevalence) states.
We have an excellent record in public health of using this
kind of information well and sensitively. In New York City,
where AIDS but not HIV infection has been reportable since
the beginning of the epidemic, we now have a list of 26,000
names which has been invaluable in tracking the epidemic.
Guarded with the utmost care, there has never been a leak
from this list, even when we were threatened with legal
action.
Particularly because of the epidemiologic shift and the
broadening therapeutic horizon, there is an urgent need now
to employ the traditional tools of prevention and disease
control. The hour is late, and the largest opportunities for
stopping transmission are long behind us. But there is much
that we can still salvage for the welfare of individuals at risk,
for those already infected and for the welfare of the entire
community. I believe that future generations of medicine and
public health will look back with a measure of contempt for
tho.se who understood this equation but failed to act.
YM

Yale Mhdicine

FallAVinier 1990-91

EPH CELEBRATES
ITS FIRST 75 YEARS
Photos bv Harry Bishop

by Gregory R. Hath, M.P.H. ’84

^
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In the winter of 1915, as the cannons of
World War I roared an ocean away, a little
known singer named A1 Jolson faced a far
friendlier din in downtown New Haven.
Applause thundered in Jolson’s ears as he
concluded his performance in “Sinbad,” a
musical at the newly opened Shubert
Theater. In that same city, 1915 would
prove auspicious for another young man
who would touch many lives — though in a
field that would offer far less fame, fortune
and applause — Charles-Edward Amory
Winslow, one of the first biomedical
scientists with training in public health.
\
Winslow had earned his M.S. degree
)
from M.I.T., where he had been a student,
and later a colleague, of William T.
Sedgwick. Sedgwick, 1877S, had left a
teaching position at Yale Medical School to
found the nation’s first department of public
health at M.I.T. C.-E.A. Winslow, bearing
the torch that his mentor had lighted, was
bringing it to Yale, inaugurating a
professorship in public health endowed by
the estate of Anna M.R. Lauder, an heiress
to the Andrew Carnegie fortune. Thus
Yale’s department of public health was bom.
Three-quarters of century later, the
department, known as epidemiology and
public health (EPH) since 1960, has
Dr. Burton H. Singer
emerged from a recent time of uncertainty.
This period ended in the summer of 1989, when a University
Comments today’s Lauder professor, 22-year faculty member
committee headed by Provost Frank M. Turner affirmed
Adrian M. Ostfeld, M.D.: “A feeling of optimism has arisen
Yale’s commitment to the program, while recommending
in this department since the Turner report was released, and
much of that feeling is directly attributable to Burt Singer’s
some key changes. University President Benno C. Schmidt Jr.
leadership.”
and medical school Dean Leon E. Rosenberg endorsed the
Turner report without amendment.
After only a year with Dr. Singer at the helm, the results go
At that time, the dean commented, “Our country must see a
far beyond boosting faculty and staff morale. For example,
closer bond forged between those scientists, educators, care
the incoming M.P.H. Class of 1992 comprises 66 students, a
third smaller than previous classes due to tighter screening of
givers and administrators concerned with the health of groups
and those concerned with the health of individuals.’’ He
applicants. And these students have begun the fall semester
added, “The ties between our School of Medicine and its
challenged by a new, more rigorous curriculum.
department of public health must be stronger. I will do all I
In one way, EPH’s renaissance represents the department’s
can to see that Yale’s educational, service and research
coming full circle, a return to its founder’s emphasis on how
activities aimed at improving the health of the public will
medicine and public health must work together. Even as
continue to be strengthened.”
Winslow required the department’s first public health students
This support, along with the take-charge style of the
to study biochemistry, he also taught medical students about
department’s new chairman and associate dean. Burton H.
the public health perspective. Similarly, this year’s incoming
Singer, Ph.D., has helped renew EPH’s sense of purpose.
M.P.H. students will be encouraged (and next year’s class
required) to take a course covering the basic ideas of
molecular biology and its implications for epidemiology and
Gregory R. Huth is publications editor at the Yale University
health policy. In addition, more classes will be offered jointly
School of Medicine Office of Public Information.
between the medical school and EPH.
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Taking this a step further. Dr. Singer has begun to build
bridges between his department and those with a primary
focus other than health care, especially Yale’s forestry and
law schools. In addition to fostering ties with other fields and
modernizing the curriculum, the plan to strengthen EPH
includes:
• recruiting eight more faculty members, in accordance
with the Turner report;
• bolstering the environmental health division by
recruiting some of these full-time faculty members for
primary appointment with the division;
• putting a greater emphasis on international health;
• repairing and modernizing the Laboratory of
Epidemiology and Public Health (LEPH), the
department’s headquarters and primary research facility.
Toward a 21st-century M.P.H. Curriculum
EPH was undergoing a thorough self-examination even as the
Turner committee convened. In July 1989, as the provost’s
committee concluded its work, an EPH faculty and staff
committee also issued a report, about how to strengthen the
M.P.H. curriculum. This panel was chaired by Michael B.
Bracken. M.P.H., Ph.D., professor of research in
epidemiology and obstetrics and gynecology.
Perhaps the most dramatic changes to grow out of the
Bracken report have to do with the “core curriculum,” the
series of lectures and discussions designed to provide M.P.H.
students with an overview of the most serious public health
problems — and w ith approaches for dealing with them. Until
this year, lectures would feature faculty members from each
division giving one or more presentations as part of a single,
massive overview course.

Observes Dr. Singer: “We came to the conclusion that by
attempting to offer so much breadth, we erred on the side of
not offering enough depth.”
To remedy the situation, key faculty from each division
have been more involved in planning and teaching core
courses than ever before. Just as importantly, the format of the
courses has changed, with each now taught as a discrete,
separately graded class, or module, lasting several weeks,
similar to medical students’ rotations. Reflecting the increased
rigor of the courses and the addition of a second required
biostatistics course, credit for the core curriculum has been
increased by several credit hours, to a total of 30.
The final three semesters of the master’s core program
resemble those of previous years. The community project is
still required in the second .semester, and the praxis (renamed
“internship”) and master’s essay (now called the “master’s
thesis”) round out the third and fourth semesters, along with
divisional requirements and electives.
Eor many M.P.H. graduates, the most intriguing core
curriculum addition may be the new course, “Concepts of
Molecular Biology in Public Health.” What does the
submicroscopic focus of molecular biology have to offer
tomorrow’s public health professionals?
Dr. Singer replies: “The tools of tomorrow’s epidemiology
will be molecular diagnostic tools. These will serve as a kind
of early warning system, making it possible to assess who is
susceptible to the onset of any number of chronic diseases. If
our students are unfamiliar with these technologies, they will
be basically illiterate as public health professionals.”
His words echo those of the Bracken report: “The
development of AIDS policy cannot be understood without an
appreciation of the molecular behavior and microbiology of
the virus, or the epidemiology of viral transmission. Similarly,
the impact of genetic engineering, DNA probes and other new
technologies on the health care system cannot be assessed
without understanding [these] fundamental concepts.”
Hands-on Education Continues
Dr. Bracken’s committee strongly endorsed the community
project requirement in which teams of students undertake
health care research and evaluation projects for a wide range
of organizations, most of them within the state. The
community project concept represents one of EPH’s great
contributions to the training of public health professionals in
this country. Pioneered at Yale in the 1950s by the late Ira
Hiscock, M.P.H., community projects have received national
recognition for combining community service, practical
experience and the application of academic techniques. [See
“Community Projects at Yale: Central to an M.P.H.
Education.”]
Yet even this part of the core program has undergone fine
tuning:
• Like all parts of the master’s program, community
projects are now overseen by Lorraine V. Klerman,
Dr.P.H., professor of public health, in her new role as
M.P.H. program director.
• After the traditional review process by faculty and
students, final review of projects will be made by the
newly fonned EPH curriculum committee.
• Each project will involve smaller groups of students —
numbering four or five. In recent years, some projects
included up to seven students.

/ ’;
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Community Projects at Yale:
Central to an M.P.H. Education
By offering students hands-on experience in doing research
and evaluation for health care and social service
organizations, community projects have played a major role
in the M.P.H. program for more than 40 years. Community
projects are among the most acclaimed facets of the M.P.H.
curriculum at Yale. In fact, a recent report on graduate level
public health education by the National Academy of Sciences’
Institute of Medicine cited EPH’s community projects as a
model.
Since 1980, community projects have been coordinated by
Elaine Anderson, M.P.H. ’76, director of the EPH resource
center. She can present a litany of projects that have had a
lasting impact locally, some even nationally. For instance, a
1974 community project focused on the dangers of second¬
hand smoking to non-smokers. It resulted in the commuter
railroad between New Haven and New York limiting smoking
passengers to designated cars. This set a national precedent
that helped launch the increasingly successful movement to
ban smoking on public transportation.

• Projects will be graded with a full range of grades and
not on a pass/fail basis as in recent years.
• Public and non-profit sector projects will be encouraged
even more strongly than in the past.
The Bracken committee also made suggestions regarding
the final two requirements of the core program, now known as
the internship and the master’s thesis. Like the community
project, the internship allows students to gain work or
research experience in their area of interest. The internship,
however, involves the placement of a single student in a
sponsoring organization that may be located locally or
anywhere in the world.
In the past, students were encouraged to begin their praxis
in the summer after their first year and if possible to continue
their work through the third semester. The department even
offered the incentive of up to 13 or 14 extra credits for some
praxis experiences.
The rationale behind encouraging an extended praxis was
dual: The added experience one gained from a longer
placement, the thinking went, would make the praxis more
valuable as a job reference. An extended placement might
also increase the chances for students finding full-time work
at their sponsoring agency after graduation.
Now the emphasis has shifted to maximizing M.P.H.
students’ exposure to Yale’s academic resources during their
concentrated, two-year training period. Comments Dr.
Bracken, “While the internship is very important, this
experience does not make up for the knowledge students gain
in their third semester courses.”
Beginning this year, students are being encouraged to
pursue internship placements that last only the summer. As
part of this revised approach, one of the incentives for
undertaking an extended internship has been removed; a
maximum three credit hours can be accrued for the internship.
Moreover, to increase the opportunities for students
looking for experience using statistics, epidemiology and data
management, faculty members who are pursuing research that
Yale Medicine
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A more recent community project conducted a survey of
New Haven neighborhoods in an effort to help the Hill Health
Center plan for expanding its services; another provided the
city of West Haven with data about infant mortality rates in
various neighborhoods. An evaluation of the LIFESTAR
emergency services program of Hartford Hospital helped
administrators decide to continue the program, which they
had considered closing. And this year a team of M.P.H.
students will continue a project that is assisting New Haven
department of health Director William P. Quinn, M.P.H. ’75,
determine how well the city is meeting its health goals for the
year 2000.
Almost every year some of the written reports that
conclude community projects lead to articles that are
published in scholarly journals. Such was the case of a recent
project that documented the misconceptions many
Connecticut secondary school school students hold regarding
transmission of the AIDS virus. This project, advised by
Steven D. Helgerson, M.D., M.P.H., a former faculty
member, was published in the journal Pediatrics, and was
presented at the 1990 national meeting of the American
Public Health Association in Washington, D.C.

involves these disciplines are being asked to consider
sponsoring an internship.
Rounding out its review of the core program for the
M.P.H. degree, the Bracken committee strongly endorsed
continuing the master’s thesis requirement. As before, two
readers will review each thesis, with one reader coming from
a division other than the student’s concentration.
In addition to these core program changes, beginning this
year, M.P.H. candidates will be given the opportunity to
graduate with honors. Students will be so rewarded if they
receive an honors grade from both their readers on the
master’s essay and if their course work ranks within the top
20 percent of their class.
Faculty Mobilizes
EPH’s reorganization will have a marked effect on the
department’s faculty, as well. To start. Chairman Singer
expects that the eight additional faculty members called for in
the Turner report should be in place within five years.
Currently EPH is recruiting for two professors at the
assistant or associate level in health economics and in
outcome and technology assessment. Another two junior
faculty members will be hired to bolster environmental health,
and soon the department will begin a search for a senior
person to serve as this division’s director.
Finally, EPH has advertised for a senior level faculty
person for the Harold H. Hines Jr. Professor of Health Care
Management, a position that is moving to the department
from the School of Organization and Management (SOM).
(The professorship is filled alternately by the YSM and SOM.)
The promise of reinforcements, however, has not kept the
work load of many current faculty members from
intensifying. Dr. Singer has undertaken the EPH
reorganization in close consultation with the faculty; this has
translated into hundreds of hours spent on myriad committees.
Moreover, institution of the core course modules has
demanded more teaching time.
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that Yale was one of 15 institutions which had received grants
to submit a plan for developing a community-based center for
education, research and service in primary health care. The
University’s partner in this endeavor is the nearby Hill Health
Center, which has had a close working relationship with the
School of Medicine since its founding in 1968.
Heading up this effort is Dr. Ralph 1. Horwitz, professor of
medicine and epidemiology. He has assembled a team of
faculty members from EPH and other medical school
departments, the School of Nursing, and staff members from
the Hill Health Center. The proposal they will submit will
allow for health professionals in training to increase the care
offered to the most underserved people of greater New Haven.
In the summer of 1992, the foundation will announce which
of a maximum of six institutions will receive funding to
establish such a program. Grants will range from $4 million to
$6 million.
Foreign Attachments

Dr. Lorraine \ '. Klernian

Neither is this heightened faculty involvement a temporary
state of affairs. Take for example the new M.P.H. curriculum
committee chaired by Dr. Lorraine V. Klemian. She leads the
committee by virtue of her role as director of the M.P.H.
program, a newly created position assumed in addition to her
other responsibilities.
Other committee members include eight lead faculty from
the core courses, the community project coordinator and a
member each from the M.P.H. admissions and academic
progress committees; three second-year M.P.H. candidates
will represent students.
.‘\ look at the steering committee charged with
strengthening the environmental health division illustrates
how liPH is working closer with other departments and Yale
protessional schools. In fact, the steering committee is led by
someone from outside the medical school, Garry D. Brewer,
Ph.I)., a professor with joint appointments at SOM and the
forestry school.
('ommittee member Dr. Mark R. Cullen, associate
prolessor ol medicine and epidemiology, points out that “in
aildition to recruiting new faculty members and a division
head, we have been charged with strengthening El^H’s
alliances with other Yale professional schools, the Pierce
Laboratory and the occupational and environmental health
program m internal medicine." The John B. Pierce
Laboratory, alliliated with the medical school, conducts basic
rt-search into environmental effects on the human body.
Stutlenis already are taking advantage of these new links;
ihi-. V'.-ar. Id’ll has ofiered several new environmental health
; uiist V thanks 1(1 cross-listings with forestry, law' and internal
Mj.-dk IIUV

I '
'

' '.v spirit of inter-departmental and inter-school
(i I may also help lead the way to a deeper
;
It in the New Haven community. In July, the W.K.
s u aii'in ol Battle Creek, Michigan, announced

To complement the department’s efforts to help its neighbors,
EPH has gotten the backing to expand its service to the
international community. Since the early 1960s the
department has provided a home for the Yale-World Health
Organization (WHO) Collaborating Centre for Arbovirus
Research and Reference. [See “EPH Scientists Lead in Wide
Range of Research.’’]
In November, the department’s expertise in policy
planning and evaluation will be spotlighted as the medical
school dedicates the Yale-WHO Collaborating Centre for
Health Promotion, Policy and Research. Center Director
Lowell S. Levin, Ed.D., M.P.H., professor of public health,
explains that the new program will use a space-age computer
network to make sophisticated data bases available to improve
the health of even the poorest countries. He says that the
system “is designed to allow practitioners, scholars, and
policy makers and analysts worldwide develop and evaluate
public policies and health promotion programs.” Beginning in
1991, scholars from around the world will visit EPH to learn
continued on page 14

EPH Divisions and Division Heads
Biostatistics
Theodore R. Holford, Ph.D., professor of public health
Chronic Disease Epidemiology
Adrian M. Ostfeld, M.D., the Anna M.R. Lauder
Professor of Epidemiology and Public Health
Environmental Health
Burton H. Singer, Ph.D., associate dean, chairman and
professor of public health and statistics (acting head)
Health Policy and Resources
Lisa E. Berkman, Ph.D., associate professor of
epidemiology
Infectious Disease Epidemiology
Robert E. Shope, Ph.D., professor of epidemiology
Microbiology*
Nancy H. Ruddle, Ph.D., associate professor of
epidemiology and biology
*Division introduced in fall 1990
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EPH Scientists Lead in
Wide Array of Research

Dr. Robert B. Tesh
Throughout the discussions about EPH’s future, the
excellence of one major aspect of the department was
underscored: its research program. Currently, 25 faculty
scientists serve as principal investigators of projects supported
by $7.5 million in grants and contracts. Their studies range
from molecular science and “wet” laboratory research to
demographic, epidemiological and other social studies.
The researchers whose work is briefly described here
undertake their investigations in such fields as tropical
diseases, nutrition, genetic disorders and environmental
health. They represent but a small sampling of the cornucopia
of interests pursued by EPH scientists.
One of the oldest research groups at EPH is the worldrenowned Yale Arbovirus Research Unit (YARU), which is
directed by Robert E. Shope, M.D., professor of
epidemiology. YARU was originally established by the
Rockefeller Foundation to study diseases which are
transmitted by biting insects and ticks and which affect people
and their domestic animals throughout the world. The unit
also serves as the World Health Organization Reference
Center for Arboviruses.
Dr. Shope and other researchers at YARU study how
diseases such as dengue, yellow fever, eastern equine
encephalomyelitis and leishmaniasis are transmitted by
insects to people. The arbovirus unit. Dr. Shope explains, is
devoted to studying how the infectious agents which cause
these diseases are maintained in nature, usually through a
cycle of biting insects and wild animals. “Man is sort of an
incidental host,” he explains. “If we can better understand this
cycle of the disease, then we can better figure out where the
cycle can be best interrupted.”
One of Dr. Shope’s colleagues, Robert B. Tesh, M.D.,
professor of epidemiology, has traveled to tropical regions
around the globe to collect the mosquitoes, sand flies and
triatomines (“kissing bugs”) that he breeds in the warm, most
chambers of the YARU insectary on the 6th floor of LEPH.
Dr. Tesh is particularly interested in the epidemiology of
leishmaniasis, a sometimes fatal parasitic disease which can
also cause ulcerations of the skin and mucous membranes. For
the past seven years, he has captured sand flies and other
potential insect vectors of the disease in the coffee fields and
jungles of Colombia, where leishmaniasis is highly endemic.
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Also collaborating with Dr. Tesh is Diane McMahon-Pratt,
Ph.D., associate professor of epidemiology. She studies more
basic questions such as the molecular mechanisms by which
the leishmania develop in the sand fly’s gut and the immune
response of animals and people to infection with these
parasites. A better understanding of these questions, she says,
may enable researchers to develop vaccines or to genetically
engineer antibodies that would protect people from infection.
While tropical diseases as a rule do not plague Western
nations, the First World faces its own set of health problems,
many associated with the unsound eating habits of affluence,
such as a high-fat, low-vegetable diet. Evidence that beta
carotene, a vitamin A precursor, may prevent lung cancer has
influenced the research of Susan T. Mayne, Ph.D., assistant
professor of epidemiology and public health. She is exploring
whether the diets of non-smoking lung cancer patients lack
this nutrient. Dr. Mayne also has begun enrolling head and
neck cancer patients in a seven-year clinical study to test
whether beta-carotene — found in carrots and other leafy
vegetables — can prevent second primary tumors and local
recurrences.
Our modern way of living also presents its share of
environmental hazards. This reminder comes from Brian P.
Leaderer, M.P.H. ’71, Ph.D. ’75, associate professor of
epidemiology, head of the division of environmental health
sciences at EPH and associate fellow at the John B. Pierce
Laboratory. He specializes in indoor air quality, passive
smoking and environmental risk assessment.
Dr. Leaderer’s research indicates that even staying indoors
doesn’t necessarily help in eluding air pollution. Chemical
solvents, air fresheners, new carpets, cleaning fluids and
foundation soils release fumes or gases that can cause “sick
building syndrome,” a chronic case of unhealthy indoor air.
Dr. Leaderer also has documented how other people’s
cigarette smoke can affect non-smokers’ health. In one study
he and colleagues found that in buildings where smoking is
permitted, three to five times greater ventilation is needed to
maintain healthy air quality than in smoke-free buildings.
Neil Risch, Ph.D., associate professor of public health and
human genetics, thinks many common chronic disorders may
be due to a complex combination of genes and environmental
influences. He looking for possible genetic links to illnesses
such as schizophrenia and depression.
Dr. Risch devises mathematical strategies in efforts to
detect and map genes associated with such disorders, which
tend to run in families. In addition to the diseases mentioned
above, he studies breast, ovarian and endometrial cancers,
autoimmune diseases such as insulin-dependent diabetes
mellitus and multiple sclerosis, psychiatric disorders,
cardiovascular disease, epilepsy and dystonia, a neurological
disorder prevalent in Ashkenazi Jews.
Recently, Dr. Risch and colleagues studied a controversial
aspect of genetic screening: DNA fingerprinting. This
technique attempts to single out individuals by identifying
gene segments extracted from samples of blood, hair, semen
and other tissue. The Risch team found that one problem
attributed to DNA fingerprinting resulted from technicians
misinterpreting the DNA pattern rather than unexpected
genetic similarity among unrelated individuals due to
population subgrouping.
“The objections that some people raised to DNA
fingerprinting aren’t valid reasons for excluding these
techniques from the forensic setting,” Dr. Risch concludes.
—

Diane Loupe and Gregory R. Hath
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how they can apply the system in their home countries.
Dr. Singer adds that many of the center’s environmental
policy efforts will focus on Eastern Europe, where the
democracy movement has brought to light some ot the most
severe pollution problems ever documented. An economist
with expertise in the epidemiology of malaria. Dr. Singer has
promoted even further EPH involvement in developing lands.
Under his leadership, the infectious diseases division is
forging new ties with the forestry school’s Tropical Resource
Institute. Dr. Singer himself is participating in
epidemiological studies of malaria in Brazil and Chagas’
disease in Argentina.

LEPH, designed by noted architect Phillip Johnson, is
widely regarded as one of the jewels in the medical school’s
architectural crown. Still, the edifice has not aged gracefully,
requiring a “face-lift” after only 26 years. For some months
now, those entering or leaving through the main entrance have
done so under the protection of scaffolding, lest one of the
limestone slabs that makes up the outer walls succumbs to
gravity. The building’s foundation needs work as well.
Inside, the original ventilation system has to be
modernized to meet new building codes, and to more easily
accommodate increasing numbers of “P-3” laboratories, those
equipped for the most noxious or infectious agents. Such
laboratories must adhere to the strictest federal ventilation
standards.

Renovating LEPH: .A $.VIulti-million Challenge

A Healthy Future

In addition to restructuring the department. Dr. Singer also
has initiated an ambitious plan to rebuild LEPH, located at 60
College St. Years of neglect to the building had passed due to
a combination of circumstances. As a result ot ditticult
financial times in the 197()s. Yale pursued a University-wide
policy of deferring maintenance on its physical plant. Later,
when the medical school undertook its capital campaign,
EPlEs uncertain tuture further delayed renovation plans.
Now, given the long-term commitment of the University
and medical school to EPH, Dr. Singer has submitted a multimillion dollar plan for inclusion in the University’s upcoming
capital campaign. His plans detail the need for a
comprehensive fix-up.

EPH’s renaissance, as reflected in its building plans,
program improvements and expanding faculty, is based on a
proud heritage. In the spirit of the public health ethos, over
the years EPH has made its mark through the dramatic
contributions of basic researchers such as Drs. Dorothy
Horstmann and John Rodman Paul, whose work paved the
way for the polio vaccine. Its policy experts, such as John
Thompson, have revolutionized the health care field with such
cost-control measures as DRGs, or diagnostic-related groups,
even as current faculty members such as Drs. Ostfeld and
Berkman, along with Stanislav Kastl, Ph.D., are exploring
new vistas in the study of aging. Moreover, EPH’s graduates
are serving in key health care positions from Washington,
D.C., to some of the most remote areas of the world.
From these many contributions emerges a picture of a
medical school department which for 75 years has fulfilled its
mission of education, research and public service by helping
to improve the health of people worldwide. Yale’s efforts to
strengthen EPH too reaffirm a tradition: the University’s
commitment to academic excellence and to serving its local,
national and international communities.
When asked about the time and effort it has taken to
implement the new EPH program. Dr. Singer replies at first
with only a smile and a shrug. Then he concludes with
characteristic aplomb, “Of course, it’s a lot of work, but that’s
what it takes to make exciting things happen.”
YM
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REFLECTIONS ON PUBLIC HEALTH
As part of the 75th anniversary celebration of the medical
school's department of epidemiology and public health, Yale
Medicine prondlv presents the essays of nine distinguished
EPH graduates who have agreed to reflect on their
professional education and to share their thoughts about the
many public health challenges facing humanity today.

Shan Cretin
Ph.D., M.RH. ’70

Frederick G.
Adams
D.D.S., M.P.H. ’70
Health Services
Commissioner
State of Connecticut
Hartford, Conn.

In my travels around the country I meet with people from all
segments of society. 1 have found, to my dismay, that
Americans in general are more aware of and concerned about
public health concerns than their leaders, especially their
elected officials. This is particularly true of officials at the
highest levels of national government. Although America’s
leaders express concern in speeches and other forms of public
communication, a national policy on public health has yet to
be articulated.
To be sure, certain issues have captured the national
attention — for example, AIDS, abortion and drug abuse —
but the broader aspects of public health have not. My sense is
that we as a nation still regard health care as primarily
reactive or “curative” rather than comprehensive and
preventive; concentration is on the individual rather than on
the community.
One distressing result of this approach: Although the
United States spends more per capita on health care than other
industrialized countries, we seem to benefit less from these
services. Our infant mortality rate is higher than that of all but
a handful of Western European nations and our life
expectancy statistics are not much better. Even more
deplorable, America’s health care shortcomings affect
minority peoples disproportionately.
If the public health approach of prevention, education and
empowerment represents what is needed to address the health
crisis of developing nations, it also offers the United States’
best hope for improving the health of its poor and minority
communities — the burgeoning Third World within our own
borders.
Yale Medicine FallAVinter 1990-91

Professor
UCLA department of
health services
Los Angeles, Calif.

During the past decade the most urgent public policy
questions have involved public health. AIDS and the
environment have become front-page news, along with the
problems of drug addiction, health care financing and
abortion. Despite the demonstrable importance of public
health education and research, Yale’s department of
epidemiology and public health and other schools of public
health have recently had their position in the academic milieu
questioned. What explains the uneasy relationship between
public health and the rest of academia?
Public health offers a shared, societal perspective, in
contrast to the majority of more parochial academic
disciplines. Eaculty in schools of public health come from a
variety of backgrounds, including social sciences, biological
sciences and physical sciences, and address a wide range of
problems, from health financing to toxic waste. What unifies
this apparently disparate field is an interest in applying
disciplinary training to the solution of health problems at a
population, rather than at an individual level. This unifying
principle is, unfortunately, also the source of the friction
between public health and other faculties of the university.
The focus on applications leads colleagues from the “pure”
disciplines to view public health research with suspicion. We
do not work at the “cutting edge” of theory, but rather see
whether established theory can lead to better solutions for
practical problems. In this sense, we are engineers more than
scientists. When our work is judged by academics from such
fields as economics or biochemistry, it may be dismissed as
“too applied” to qualify as “real” research.
Public health differs with medicine, as well, over its
emphasis on the health of populations rather than individuals.
What is good for the health of one individual may benefit the
entire community, as in the case of immunizations against
infectious diseases. However, costly life support for a
terminally ill patient may contribute less to the community’s
health than such non-medical approaches as subsidized school
lunches or better occupational safety standards. Advances in
medical technology have improved our collective health, but
15

have also complicated the delivery and financing of medical
care. The United States spends 12 percent of its gross national
product on medical care, yet our health as a nation lags behind
that of countries spending far less. We clearly need to
complement our biomedical research with health policy
research focusing on the health of the society.
In the dialogue between advocates for individual patients
and advocates for society, there are no “good guys” or “bad
guys.” A fundamental problem for a free society is balancing
the rights of the individual and the needs of society. This
same balance is needed in developing national health policies.
It is important for there to be both schools of medicine, with
physicians who are working to improve the diagnosis and
treatment of diseases for individual patients, and schools of
public health, with economists, sociologists, behavioral
scientists, environmental scientists and epidemiologists
working to improve the health of populations.
In providing a home for public health, the university
fulfills its obligation to address societal as well as intellectual
problems. As an alumna. 1 am pleased and proud that the
tradition of public health education will continue at Yale.

Debra W. Haffner
M.RH. ’79
Executive director
Sex Information and
Education Council
of the United States
New York, N.Y.

fhough I received my degree from the department of
epidemiology and public health 11 years ago, to this day I
often use information from my epidemiology, management,
and maternal and child health courses. My work has been
particularly influenced by the principles 1 learned from Jim
Jekel. Lorraine Klerman and Lowell Levin. But 1 also daily
call upon a set of skills which were not addressed during my
student days at LBII: the political skills that we as leaders in
public health require to educate others as to the need for
public health programs.
.•\s the executive director of SIECUS, the Sex Information
anil liducation Council of the United States, 1 lead an
organi/ation dedicated to affirm sexuality as a natural and
healthy part of living and to advocate for the right of
individuals to make responsible sexual choices. Sexuality is
clearly a public health issue, although 1 do not remember it
b. mg addressed in any of my classes.
I' ah the sexual diseases (sexually transmitted diseases,
III'
' ction, infertility, etc.) and the rampant sexual “dis■ ur culture (as reflected in sexism, homophobia,
c, etc.) require public health approaches to reduce

their prevalence. Many of today’s public health problems are
rooted in the culture's lack of understanding about — and
acceptance of — sexuality.
Nowhere is this more evident than in the response to the
HIV epidemic, where moralism is being presented by some
political leaders as a public health imperative. Much of the
funding for HIV prevention has been used to promote efforts
to restrict sexual behaviors and lifestyles.
For example, almost all HIV education programs for teen¬
agers concentrate on abstinence, while ignoring the needs of
millions of teen-agers for “safer sex” education. Regulations
promulgated by the Centers for Disease Control at the
directive of Congress forbid the use of public monies to
produce explicit materials on heterosexual and homosexual
safer sex practices. Many of us have worked vigorously to
blunt the effects of these misguided political/moral agendas
that have dominated public health practice.
Almost all of us in public health need to work in a political
context; political decisions affect public health priorities.
During the last decade, political considerations have affected
regulations and funding for maternal and child health
programs, community health centers, abortion, family
planning, fetal research, environmental health and
occupational health, to name only a few. The acceptance of a
national health service or insurance program, first proposed
by Yale professors more than 50 years ago, is clearly
dependent on building political support.
1 believe that it is vital to prepare public health students for
their role in the political arena. We need to teach these new
professionals how to lobby, work with the media and
articulate their vision. Understanding and developing these
skills are as important as developing those in research,
administration and fund-raising. It is incumbent on all of us in
public health to provide the leadership to assure that everyone
has the right to affordable and quality health care services and
education.

William L. Kissick
M.D. ’57
Dr.P.H. ’61
G.S. Pepper Professor
of Public Health
and Preventive
Medicine
University of Pennsylvania
Philadelphia, Pa.

When I left the wards of Yale-New Haven Hospital in the
summer of 1958 to matriculate for the study of public health, 1
cros.sed the Rubicon of health affairs. Visits as a fourth-year
clinical clerk to chronically ill patients in their homes with my
wife, a staff nurse with the New Haven Visiting Nurse
Association, had convinced me that the School of Public
Health needed the School of Medicine. Three decades later, 1
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recognize the reverse as imperative. Society spent
approximately $600 billion for health and medical care last
year, almost 12 percent of the gross national product. That is
twice the defense budget and two-and-one-half times the
revenues of America’s automotive industry. Some claim the
United States has thus bought the finest health services in the
world. This statement is true, if you mean that our finest is
unexcelled. If one includes the dimension of equity and the
highest health status, the claim is not valid.
The U.S. Health Care Financing Administration forecasts
medical expenditures reaching 15 percent of GNP in the year
2000. Some economists reason that the health care sector’s
marginal growth will balance out at 18 percent of GNP; an
extrapolation of growth over the past three decades, however,
would carry it to 100 percent of GNP in 2057.
Kissick’s Second Law states, “No society has sufficient
resources to provide all of the health services its population
would utilize.” I am convinced that this law would be valid at
100 percent GNP. This frames the dilemma for medicine in
the 21st century. Enter public health.
Public health is based on principles that can be
incorporated into medicine in a variety of ways. Medical
practice is predominantly reactive; the physician stands ready
to provide the fullest spectrum of quality care. By contrast,
public health is anticipatory, proactively identifying and
targeting opportunities for health promotion, disease
prevention and comprehensive care. Medicine, quite properly,
focuses on advocacy for the individual patient; public health
has a population priority. The golden age of American
medicine was fueled by fee-for-service, with the physician
determining both price and volume. Retrospective cost-based
reimbursement financed hospitals and added to an open-ended
philosophy. Public health, by contrast, requires resource
allocation in closed budgets.
Population basis, closed budgets and anticipatory strategies
help determine our priorities. Who Shall Live? asks Victor
Fuchs, the distinguished economist. The derivative question is
“Who shall decide?” We in medicine are uncomfortable with
these decisions and often make them almost by default.
Though we may decline to address priorities in medicine, rest
assured, the decisions will be made, explicitly or implicitly,
overtly or covertly, with or without medicine’s participation.
The main lesson of public health is accountability. As
physicians we are accountable to the individual patient. Public
health is accountable to society through its representatives.
As I view the evolution of health affairs over the past three
decades, it is my conviction that medicine in collaboration
with public health can achieve excellence as well as equity for
250 million Americans. The department of epidemiology and
public health in its 75 years stands ready for the joint venture.
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Peter J. Levin
M.RH. ’65, Sc.D.
Dean, College of
Public Health
University of South
Florida
Tampa, Fla.

In 1963, jobs in hospital administration were not yet the highprestige executive positions that they sometimes are today.
These were the pre-Medicare days, just before a flood of
federal funds would transform the health care system. I was
attracted to Yale because it offered the master of public health
degree, not a master's in business administration. I viewed
hospital care as part of a much wider public health system.
Happily, EPH saw it this way, too, which led to my most
exciting academic years being spent under John Thompson’s
tutelage.
The old building on Cedar Street smelled of formaldehyde
from the pathology laboratories with which we shared a floor.
Smoke from cigars and pipes — then an acceptable part of the
academic scene — also made their atmospheric contribution.
As they do today, M.P.H. students attended core course
lectures together and represented a wide variety of points of
view and academic and ethnic backgrounds. What made EPH
exceptional for me, however, was the overall positive outlook
of the faculty; along with knowledge, they transmitted hope to
their students. They believed that what they were doing was
important and what we would do in our careers in public
health would be important.
Society as a whole certainly was not impressed with our
importance. People did not go into public health to become
rich. HMOs, disease prevention and health promotion were
not yet accepted as replicable concepts. We were people who
were prepared to accept modest material success in exchange
for knowing that we were doing good for society. We were
the inheritors of the expertise and, hopefully, the values of C.E.A. Winslow.
In the case of hospital administration, we had John D.
Thompson leading the way, prodding and pushing, to have us
embrace scientific methods to analyze situations and develop
methods for change. He was constantly experimenting with
hospital data to improve care through management. He
believed that the administrator could make a difference even
if the doctors and the trustees did not think so. He taught us to
keep one eye on the big picture while you “got the laundry
sorted out.” Politics as well as statistics were part of the game,
and you had better be sure that you had the votes, as well as
the numbers, all added up ahead of time.
Another appealing feature of EPH was its future
orientation. We were all working to make a better world for
everyone. We believed that things would change. My M.P.H.
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graduation year, 1965, saw the passage of Medicare and
Medicaid. Since then, massive infusions of money have gone
into health care delivery, and there is now much wider
government involvement in all aspects of health care and the
environment. Unfortunately, we have not seen improvement
in health status for all of the population that we might have
hoped for, given the amount of money we have invested.
The belief that components of health care delivery can be
analyzed, studied and integrated into a measurably better
system still is not widely accepted. This approach is
sometimes threatening to medical schools, physicians,
hospitals and those who do not believe that we are our
brothers’ and sisters' keepers. Yale EPH gave me more than
tools; it provided me with a framework to approach and solve
problems, and supported my conviction that we can and
should make a difference.

Capt. Patricia D.
Mail, M.P.H. ’67,
C.H.E.S.

^

I

V

Chief, professional
education
Alcohol, Drug Abuse and
Mental Health
Administration
Rockville, Md.

What, you might ask, do the following have in common: the
U.S. Surgeon General, medicine men, puberty ceremonies,
alcoholism prevention and treatment, food handlers' courses,
project officers, clinic managers, HIV services, coalition
building, community outreach workers, health manpower
shortage areas, and military protocol. These are but a few of
the strands that have been woven into the colorful tapestry of
my career in the U.S. Public Health Service.
A combination of field placement with a Western Apache
tribe coupled with a request to develop a community drinking
profile led to a career in public health which has spanned the
continent and provided significant opportunities for
professional growth and contribution. The core curriculum
required during my Yale training laid the foundation for
multidisciplinary activities with an emphasis on the
importance of wider professional affiliation with peers and
colleagues.
My thesis research in alcoholism began a lifelong interest
and resulted in the publication of an annotated bibliography
on North American Intlian alcohol use and abuse (1980), to
say nothing about a basement full of reference material
collected over 20 years.
OI greatest value in my professional preparation was the
emphasis on ileveloping an appreciation of other public health
disi iplines. I'roin statistics and epidemiology through
b I Mistration and basic research, to disease prevention and
'^e.ilth services in the community, my Yale education

provided a coordinated overview that enabled me to approach
all my professional activities as parts of a single discipline.
My greatest concern is that public health is being
increasingly fragmented, destroying the community and
professional integration so important to the delivery and
maintenance of public health services. I have found that
professionals lack a generic frame of reference. Even that
frontline provider, the public health nurse, has disappeared
into the linguistic limbo of “community health nursing.” The
basic environmental health sciences so artfully integrated into
the disease-prevention model seem to have shifted toward
public works and land conservation, and away from simply
protecting people’s health. And health promotion seems more
closely associated with aerobic exercise than with personal
responsibility for positive health behavior.
The finest training in public health was mine in the 1960s.
I do not see this same meaningful integration in the 1990s.
Education for public health practice seems to have shifted
from a community-based model to a more fragmented, single¬
issue approach characteristic of the “congressional disease
syndrome” in which health care priorities are too often set in
reaction to the most vocal or most inOuential special interest
groups.
Public health — as distinct from medical care — is the one
system equipped to address the nation’s health at its core: the
family, community and culture, where health and disease have
their origins. Moreover, public health works with and
understands the needs of the nation’s indigent peoples. My
professional preparation readied me to work in the front lines
of health service delivery. I hope that those of us trained in
the 196()s do not represent the last of the generic public health
professionals.

Michael H. Owens
M.D., M.P.H. ’78
Executive vice president
and chief health officer
Watts Health Foundation
Los Angeles, Calif.

The shadow of 21st-century health care challenges is already
casting a nebulous cloak about us. Our health care system is
undergoing nothing short of a revolution in its definition,
control and economy. Advancing technology is outpacing our
grasp of its liabilities, raising questions of our ability to
incorporate modern medicine into society within ethical let
alone rational constraints. We are concomitantly faced with
the reality that much of the United States’ minority population
is confronting a health care crisis rivaling that of so-called
“Third-World” countries, as evidenced by the current measles
outbreak and by minority infant mortality rates.
Yale Medicine
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The perverse interplay of new technology and the life
challenges of the poor is evidenced when we view the
problem of runaway teenage pregnancy in terms of the debate
about fetal research; poor minority women produce ample
potential raw material for such research. Similar parallels can
be seen between the potential linkages between homicide as
the number one cause of mortality in inner-city youth and the
coincidental location of many large teaching hospitals with
organ transplant centers for everything from cornea to heartlung transplants.
The failure of leadership and communication from the
cognoscente to the ever-burgeoning numbers of functionally
illiterate in our society does not argue well for a true national
resolve to understand — let alone address — the problems of
a society in decay. Our schools of public health must move
beyond their current status as bastions of training researchers
and bureaucratic information gatherers and users, to become
institutions of creative learning, outreach and
experimentation. The World Health Organization includes the
psychological and spiritual along with the physical as
principal tenets of health.
Schools such as Yale must focus more outwardly for the
common good. They must aggressively network with minority
and non-traditional institutions of higher learning; they must
forge links with health care organizations and civic
organizations that reflect our poly-cultural and poly-ethnic
citizenry. The social responsibilities of our premier schools of
public health of course do not stop at our shores. International
health needs are also ever-increasing. How better to begin
meeting our global responsibility than by rededicating
ourselves to creatively bringing forth the potential of our own
multicultural/multiethnic population as the cultural bridge
between ourselves and those on distant shores. The mission is
the same, the timing not yet impossible, the imperative
compelling, the risk of avoidance incontrovertibly evident in
human misery and suffering. The indefatigable spirit of
humanity will prevail only if we get out of our own way.

Karl A. Smith
M.D., Dr.P.H. ’71
Deputy director, division
of health sciences
International Development
Research Centre
Ottawa, Canada

knowledge was important in my subsequent work for the
Dr.P.H., which, in turn, added greater depth to my teaching,
research and service activities back at the University of the
West Indies. Some of my former students now bear witness to
the indirect influence EPH has exerted on their own career
choices, especially those who embraced the once new and
suspect discipline of epidemiology. My Yale exposure also
convinced me that my own career choice in public health was
the correct one.
I was later drawn to international health as a second career;
for more than a decade I have worked for an organization that
encourages and supports research in the developing world. In
this role I have discovered that every country needs a rational
mix of personal and community health services; that health
status results from the interplay of many factors, including
genetics, environment, economics, health systems and
services, personal and community behavior — and public
policies.
There is a tendency in many developed countries to regard
basic research and the provision of biomedical and clinical
high-technology packages as the answer to health problems.
Public health receives little attention. Yet, while many
developing countries for reasons of prestige will try to follow
this high-technology model, most of them will find it an
unaffordable and inappropriate use of scarce resources.
Greater emphasis must be placed on “the public health,”
including preventive measures and health promotion.
Learning institutions like Yale, with their tremendous
prestige, must assume even greater leadership in assisting the
developing world meet its public health challenges. The world
is increasingly becoming a global village with shared needs,
concerns and consequences for each other’s actions. In this
context, Yale has an obligation to make major contributions
as one of the world’s leaders in medical and public health
education and research.
How many developing country scientists are being trained
in public health at Yale? Do they return to their own countries
to work? What continuing support do they receive? Are there
ongoing networks with Yale faculty?
Yale must exercise greater influence, nationally and
internationally, in culturally sensitive ways, in research,
training and advocacy regarding the public health. While, for
example, the EPH chairman’s advisory role to WHO is
laudable, and other professors engage in international
activities, will EPH enhance its corporate international
stature? Let me close by quoting the late Arthur J. Viseltear,
Ph.D., from his graduation address to the EPH Class of 1989;
“The world is changing rapidly; will you do your share to
influence the future? Will you remember and hold dear the
public health ethos?”

In studying for my M.P.H. at Yale, while the tools of
epidemiology and biostatistics and the know-how to
administer health services were imperatives, equally exciting
were the qualitative approaches and methodologies for
understanding people’s motivation and behavior. I remain
grateful to all my teachers in these various domains.This
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Stevens
M.P.H. ^63
Ph.D. ’68

one is talking about Medicare costs, AIDS, pollution, or the
absence of health insurance. Managers of health care
institutions need to have a strong background in epidemiology
and social statistics as well as in the arcane details of capital
finance; they certainly need an appreciation of history and
politics. As I write about the history and policies of health
care, I feel particularly grateful for my background in health
statistics. (Thank you, Colin White!)
And yes, the lecture on privies has proved useful on at
least three occasions.

UPS Foundation
Professor in the
Social Sciences
Uni versify of Pennsylvania
Philadelphia, Pa.

In 1961, the year I entered EPH as a student, the department
was housed on Cedar Street. Public health was a collection of
disciplines which were assumed to fit naturally together as
they had done in the days, not too far distant, when the field
was a matter of controlling infectious diseases and was
concerned with measurement, sanitation, education,
progressive social policies and the stark realities of practical
politics. Federal funding for public health was in its prime,
both for education and research — I was one of the fortunate
recipients.
Medical care and hospital administration, then two
separate fields, were taught within this framework, although it
was not always clear how the newer problems of institutional
management, private health insurance arrangements and
proposals for government intervention (this was before
Medicare) meshed with some of the other fields. Eric Mood’s
lecture on how to build a rural sanitation system for a
dwelling, made graphic by the large model of a privy he
hefted to class, contrasted with Isidore Falk’s discussions of
w ho was backing what major piece of health legislation in the
L'..S. Congress, or John Thompson’s concerns about hospitalhospital and hospital-medical staff relations.
1 was fortunate to be able to combine hospital
administration and medical care in the M.P.H. curriculum and
then to go on for a Ph.D. in epidemiology, focusing my
dissertation on specialization in medicine with Dr. Falk as my
advisor. My dissertation fields, epidemiology, sociology,
health administration, have stood me in good stead over the
\ears. How much more versatile than doing three fields of
management!
Being a student of health care institutions within a public
health conte.xt also has been of continuing practical value. Dr.
i-alk. like others of his generation of activists, saw
government involvement in medical care as the next logical
step in the broad history of public health. John Thompson,
presenting the hospital as a force for potential good in the
community, expected the administrator to do more than keep
the institution going along established lines. Managers were
agents ol change, with the opportunity to create better
services to local communities through cooperation across
institutions.
1 n. .ili/e no" how much I have internalized these views. I
b i"
. ■ li'o l\ accepted the public health perspective —
'
I'js io d in the 199()s as the “new way” to look
i n < - ilv.ilth is a collective concern, whether

Preventive medicine must come through a fundamental
change in the attitude of the physician and in the attitude of
the medical school where he is trained. It is to a new
generation of medical students, imbued with a new spirit of
prevention, that we look forward with hope. At Yale, it is our
special duty and opportunity to make this new spirit prevail;
and we believe that in the working of such a revolution our
medical school can make its most unique contribution to
human progress.
To state that the death rate of New York City has been
reduced from 25 per 1,000 in 1890 to 13 per 1,000 in 1920
may perhaps leave one unmoved; but think for a moment
what such statistics mean in temis of human life and human
happiness. Today (1923) in that great city, there are 201
deaths every 24 hours. If the death rate of 30 years ago were
still in force there would be 384 — a saving of 183 lives with
each revolution of the Earth. If death be the wage of sanitary
sin, nearly one-half the debt has been remitted in a period of
30 years.
If we had but the gift of second sight to transmute abstract
figures into tlesh and blood, so that as we walk along the
street we could say, “That man would be dead of typhoid
fever,” “That woman would have succumbed to tuberculosis,”
“That rosy infant would be in its coffin” — then only should
we have a faint conception of the silent victories of public
health. For such achievements we may thank God and take
courage for the future, bearing on our banners that eternal
phrase of Cicero: “In no single thing do men approach the
gods more nearly than in the giving of safety to mankind.”
The Evolution and Significance of the Modern Public Health
Campaign, C.-E.A. Winslow. Yale University Press, 1984,
pp. 64-65.
YM
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THE CHANGING FACE
OF PUBLIC HEALTH
by Dr. Myron E. Wegman, ’32, ’32-’36 HS
From the perspective of 1990, the status of public health in
1915 appears not very different from the turn of the century.
By the time Yale established its department of public health,
life expectancy in the United States had improved to age 52,
from 47 in 1900; figures as low as these are seen today only
in a few developing countries. Yet profound changes in
thinking were taking place. Understanding of infectious
diseases was expanding rapidly, even though newly
developed specific treatments, like serotherapy, were not
terribly effective.
This concern with contagion may have influenced the
choice of Charles-Edward Amory Winslow as the first EPH
department head; his own studies with William T. Sedgwick
at MIT had been in sanitary science and biology. Two earlier
efforts to develop a broadly based. University-wide
department at Yale had been shelved, which may have moved
Winslow to focus on teaching prevention to undergraduate
medical students and “to capture a few for public health.” In
his comprehensive 1988 article in the Yale Journal of Biology
and Medicine, the late Arthur J. Viseltear reports that
Winslow failed in the latter goal; a parallel effort to develop
an Institute of Human Relations to bring medicine into closer
relationship with non-medical aspects of health and disease
also failed, “as the medical curriculum returned to traditional
concerns” with the patient, sickness and cure.
Since my own medical school education overlapped some
of these developments, I propose to comment on the history
from both a personal and conceptual point of view. How a
person such as myself — focused on a clinical area in student
and residency days — wound up in public health, may be
instructive for others. Moreover, a look at how public health
has changed in 75 years may help achieve a better perspective
on today’s problems.

Illustrious Professors
As I think back to 1928-1932, Winslow was hardly a failure.
His lectures, and those of Professor Ira Hiscock, were great
intellectual exercises for us medical students, even though
they did not lead me or, as I recall, any of my classmates
directly to a public health career. More importantly, there
must have been considerable influence on faculty members
like Leo Rettger and George Smith in bacteriology and the
Yale greats in infectious diseases — Francis Blake and John
Paul in medicine and James Trask in pediatrics. We certainly
learned from them of the community implications of the
spread of disease.
Winslow’s regard for medical students was revealed
outside the classroom as well as inside it. Once each year he
invited the entire senior class for dinner at his home after
which, with most of us sitting on the floor, he talked of the
social function of medicine, reading to us selections from
medical, public health and English literature. I remember it as
an inspiring evening although, again, it did little for
recruitment to public health.
Yale Medicine
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Dr. Myron E. Wegman

Dr. Myron Wegman ^32, ’32-’36 HS:
A Half-century in Public Health
After completing his residency in pediatrics at New Haven
Hospital in 1936, Dr. Myron Wegman headed South to
become a pediatric consultant in the Maryland
Department of Health. At the urging of Dr. Grover Powers
and another of his former professors at Yale, Dr. Martha
Eliot, he also completed an M.P.H. degree at the Johns
Hopkins School of Public Health. The advice of these two
great teachers had a profound effect on his professional life.
Dr. Wegman’s subsequent career in public health led
him to Puerto Rico for a teaching post at the School of
Tropical Medicine, to New York City and work with the
bureau of child hygiene, and to medical school teaching
positions at Cornell, Columbia and Johns Hopkins.
In 1946, he returned to his original field, becoming
professor and head of pediatrics at Louisiana State
University Medical School in New Orleans. Here Dr.
Wegman maintained his involvement in public health
through volunteer work and by chairing the city’s health
council. A series of international consultancies for the
World Health Organization led him to join the Pan
American Health Organization (the WHO Regional Office
for the Americas) in Washington, D.C.; for his last four
years there, he served as its secretary-general.
In 1960, Dr. Wegman returned to academe as dean and
professor of public health at the University of Michigan
School of Public Health and Searle Professor of Pediatrics
in the medical school. He was named dean emeritus in
1974 and Searle Professor emeritus in 1978.
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Lowell Reed’s exciting clas.ses in biostatistics and had contact
with public health giants like Wade Hampton Frost and Abel
Wolman. Being a graduate student in public health proved to
be an intellectually stimulating and rewarding experience.
At the same time, as 1 tried to teach modem pediatrics to
rural Maryland practitioners — some the product of the preFlexner diploma mills — I encountered public health “in the
raw.” In addition to primitive environmental conditions and
dreadful maternal and infant mortality rates, I had to deal with
a variety of infectious diseases. This included a family
outbreak of tularemia, diagnosed not by my clinical acumen
but through the astuteness of the state bacteriology laboratory.
It was a powerful exposure and a great learning experience,
even though there were times when I wondered whether my
training on a sophisticated clinical and research service was
being frittered away.
Then came a major break; I was asked to teach the sixweek maternal and child health course at Hopkins. I accepted
and continued at this position as a commuter during my next
two jobs. In the second of these, incidentally, I had the good
luck to work under another remarkable Yalie, Leona
Baumgartner, then head of the Bureau of Child Hygiene; her
extraordinary career included eight years as one of New York
City’s greatest health commissioners. Subsequently, my
various posts have given me opportunity to take part in city,
state and international public health activities, as well as
teaching and academic administration in two large state
universities.

My own path to a career in public health was anything but
straight and narrow. After a three-week substitute internship
in surger) demonstrated to my discomfiture that technical
de.xterit) was not my forte. 1 became more and more attracted
to pediatrics, chiefly through increasing admiration for Grover
Powers and his colleagues. Internship and residency in
pediatrics v\ere glorious years; when 1 became chief residenf,
I had reached the top. In fact, although 1 have since held high
administratise and academic positions. 1 have never felt so
important as 1 did in 19.15-19.16.
Pediatrics is in many ways public health in action, so upon
finishing my residency. 1 jumped at the opportunity to work
as a pediatric consultant in the Maryland Department of
Health. I here I helped educate rural practitioners in better
care of children. Not surprisingly. Dr. Powers’ urging that 1
become involved in the community was crucial to my
decision. I also benefited from knowing another faculty
member, Martha liliot, whose sophisticated research on
\itamin D and rickets led her almost inevitably to child
health. Later, as associate chief and chief of the U.S.
Children's Bureau, she had a lasting impact on public health
in the United .States.
Martha Idiot urged me not only to accept the Maryland
post but to insist that 1 do my .Master's in Public Health at
Johns Hopkins at the same time. At first 1 resisted the latter
suggestion, largely out of a Yale-induced conceit. After four
years of medical school and four years of pediatric residency
at d ale, I didn’t see how Johns Hopkins could teach me
an>thing! This attitude was shattered quickly as I sat in

Table 1.

.\ge-adjusted death rates. United States, selected causes, three five-year periods.

Age-adjusted death rate per 100,000

.Ml causes
Selected infectious diseases
Tuberculosis
Innuen/a and pneumonia
Measles
Whooping cough
Typhoid fever
Gastritis and enteritis
Syphilis

1

2

3

1900-04

1940-44

1980-84

1698.1

1017.1

560.8

188.5

43.0

0.6

190.9

60.3
1.1
2.0

12.0

8.1
8.0
26.8
91.6

0.7

16.6

12.3

437.2
83.9

469.1
118.4

240.7

83.1

71.6

37.8

-

20.3
17.5

12.1

22.6
49.0
11.7

1.2

5.7

8.9

Selected chronic diseases
Major cardiova.scular disease
M.iligntint net)plasms
\ iolence
,\ccidcnls
(Motor vehicle)
(All v)ther)
Suicide
1 himieide

83.1

132.6

9.3
9.6
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Figure 1.

Trends in neonataS and total infant mortality rates, United States, 1915-1987.

Public Health Then and Now
I have gone on at some length about my personal history to
set the stage for contrasting the state of public health 75 years
ago with today. How to measure the change? Since “health”
can’t be quantified and morbidity data are incomplete, we
often look at absence of mortality as an indicator of health.
We certainly live longer — life expectancy in the United
States has increased since 1915 to almost 75, a gain of almost
50 percent.
One way to look at the components of this improvement is
to study age-adjusted mortality rates for various disease
groups. Age-adjustment is a standard technique that
compensates for the inevitably higher mortality rates in older
people. By applying actual age-specific rates at different
times or in different communities to a single standard
population, one can calculate a hypothetical total rate that is
more meaningful for comparative purposes.
In Table 1, age-adjusted death rates from major cause
groups are shown for three five-year periods, 1900-1904,
1940-1944 and 1980-1984. The decline in deaths from
communicable diseases has been little short of spectacular. In
our present, well-justified concern over the physical and
chemical pollution of our environment, it is easy to forget the
lethal biological pollution that was so pervasive in the early
decades of this century.
Tuberculosis was everywhere — three-quarters of my
medical school class tested positive when we entered, and all
of us were positive when we graduated. At least two of my
classmates had to drop out of medical school because of
tuberculosis. Typhoid fever was so prevalent that in 1920 the
Boy Scout’s handbook advised: “Scouts must be careful when
Yale Medicine
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out in the country never to drink water from a stream just
because it looks clean and pure; it may well be contaminated
with typhoid bacilli.”
Most of the decline in infectious disease deaths, however,
took place prior to 1940. During this period there had been
considerable expansion of public health activities, particularly
as to the environment, as well as great improvement in
general clinical management of the ill, especially regarding
their fluids and electrolytes. Since 1940, of course, the
influence of specific therapy has been substantial; for
example, deaths from tuberculosis have declined more rapidly
since 1940 than before.
Syphilis is a striking exception to this infectious disease
trend; almost no change in death rates took place in the pre1940 era, when therapy was ineffective and public health
focus on venereal diseases was just beginning. It was a
curious coincidence that the discovery of penicillin as
effective therapy for syphilis came only after the 1936
appointment of an innovative surgeon general, Thomas
Parran, who had made an attack on syphilis one of his
priorities.
Among chronic diseases, the remarkable decline in deaths
from cardiovascular disease since 1940 is more likely
attributable to improvements in therapy than to effectiveness
of prevention. By contrast, the steady increase in deaths from
malignant neoplasms is dire evidence of the gaps in our
knowledge as well as our failure to apply what we do know
about prevention and therapy. We are doing better with some
cancers, but the seemingly inexorable increase in cancer of
the lung in women is disheartening.
One explanation is failure to combat the advertising skills
of the tobacco companies, who while claiming piously that
23

their only goal is to get people to change brands, nevertheless
target the young. Yet it seems obvious that as older smokers
die oft' the young must be recruited it sales are to be
maintained.
■American tobacco's other market, of course, is outside our
borders. Here the situation is a national disgrace. While the
Public Health Service has made a decrease in smoking a
national priority, the President's trade representative promotes
the sale of American cigarettes abroad. It seems to me
obscene to threaten Thailand — in the midst of its national
anti-smoking campaign — with U.S. trade sanctions it it
resists importation of American cigarettes and won't allow
American cigarette advertising.
Death rates from non-motor vehicle accidents have
declined by almost 80 percent, but we can glean only small
satisfaction from the stabilization of motor vehicle death
rates. There is still a long way to go.
Curiously, the age-adjusted rate of deaths from suicide has
shown little variation throughout the century although there
have been changes in the rates for individual age groups. A
recent increase in suicide among teen-agers and young adults
has been paralleled by declines in older age groups. One
might hypothesize some genetic predisposition to suicide
which becomes manifest at different ages, depending upon the
social stress of particular time periods. Finally, the awful
increase in deaths from homicide reflects deep-rooted social
and economic ills in our society not easily susceptible to
public health interventions.
Let me supplement the data on the general population with
two selected observations on infant mortality, a subject I have
worked on for 60 years. Figure 1, taken from an annual paper
I do on vital statistics for the journal Pediatrics, illustrates a
pervasive problem in our society; far poorer health status in
some population groups. The widening discrepancy between
white and black infant mortality rates runs counter to the
e.xpectation that, other things being equal, higher rates ought
to come down more rapidly than rates that have already
reached lower levels. But all things are not equal. Differences
in environmental conditions and access to quality health care
for .Afro-Americans persist, and the results are obvious.
Infant mortality is also a useful measure of our status
internationally. Figure 2 compares the U.S. with four other
countries, reasonably representative of the rest of the
developed world. The scale is logarithmic, permitting direct
comparison of speed of decline, irrespective of absolute
differences in rates.
Relative slowing of the U.S. decline has been a cause for
serious national concern and can by no means be explained by
the size ol our minority problem. It seems intolerable that the
richest and most powerful nation in the world should have
slipped from having the sixth lowest rate in 19.^0, when we
were bettered by only a few small countries, to being 22nd in
l‘‘H/. And the total population of the countries with rates
better than ours now exceeds 500 million.
Remaining \ igilant
I his briel re\iew ol the past leads me now to speculate on
luture public health priorities. Since I cannot hope to be
exhaustive. I shall limit m\self to three general areas:
• atteiitiiiii to the traditional aspects of public health;
• publk health ellorts in ileveloping countries;
• medu.il

e.ire

in the United States.

First off, all the evidence indicates that concern with the
more traditional aspects of public health must not slacken.
Infectious diseases have not gone away. True, the World
Health Organization (WHO) had unique success in
eradicating smallpox, a disease with a centuries-long legacy
of cutting down “princes and peasants.” But the microbial
world is resourceful. The appearance of AIDS as a worldwide
phenomenon of devastating proportions is but one example.
The size of the problem and the way this disease has robbed
us of some of our brightest minds worldwide illustrate why
we must make a concerted and adequately financed attack an
urgent priority.
Thinking in quantitative terms, however, diseases of longer
standing must not be forgotten. Measles and tuberculosis also
are on the rise, though still on a relatively minor scale. These
are portents; maintenance of adequate immunization levels in
all sectors of the population must be a national priority.
Targeting immunization programs for budget cutting is highly
misguided.
Having controlled bacterial and parasitic “pollution,” the
developed countries must now turn to problems in the
chemical and physical environment; such dangers occupy
enough space in the media to obviate discussion here. But the
media seem to pay less attention to the health danger of
ionizing radiation. There is now general recognition that
whoever starts a nuclear war signals the suicide of mankind.
How then can anyone justify continuing testing of nuclear
weapons and the resultant increase in environmental danger?
Secondly, the vast majority of the world’s 5,000 million
people live in countries with what we would consider
unacceptable health resources and environmental conditions.
It is naive to assume that in the 20th, let alone the 21st
century, we in the West can isolate ourselves and not be
affected by health conditions abroad. Nor is this a question
solely of infectious diseases. The cycle of ill health and
poverty exaggerates international tensions, threatening the
“haves” as well as the “have-nots” and leading too often to
armed conflicts that may spread like any other epidemic.
Our country has been a leader in international health
cooperation. The Agency for International Development,
within its limits as an arm of our State Department, has a
distinguished history in helping many countries in crucial
health areas. Furthermore, the United States took the lead in
establishing and supporting the Pan American Health
Organization in 1902 and was a potent force in later starting
the World Health Organization and encouraging its growth.
Yet WHO’s accomplishments, while considerable, are far less
than its potential.
Is it not a national scandal that our country is crippling
WHO’s programs by being in serious arrears since 1985, in
effect welshing on the dues we accepted as a formal
obligation? As of this writing, WHO puts the sum of our
arrears and current assessment at $111.2 million. Yet this is
not because of any disagreement with WHO health policies;
the United States has, in fact, praised WHO fiscal
management. Even countries as poor as Haiti and Bangladesh
pay their dues regularly!
Finally, I come to medical care. Although I believe that
continued attention to preventive activities must be a priority,
the data 1 have shown emphasize that high quality medical
care is central to better health for all. Inequities and
unevenness in medical care must be overcome if the United
States is to reach its national potential and catch up to the rest
of the world. It is simply not enough to say that the United
States provides the finest care available anywhere—if one can
afford it.
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Figure 2.

Trends in infant mortality rates, five countries, 1930-1987.

During my early years in public health, many of my
colleagues believed that medical care should not be a concern
of government. In 1948, the American Public Health
Association almost split before adopting a mild statement
supporting the principle of health insurance for all Americans.
Now, at least, there is growing consensus that assurance of
available, accessible and acceptable medical care to
everybody is a national responsibility. Many argue that a
national plan would be too expensive, yet with our current,
chaotic approach, few can suggest that we are getting our
money’s worth.
It is a bit sad that warnings from decades ago about
escalating medical costs are just now hitting home. Secretary
of Health and Human Services Louis J. Sullivan predicts that
our health care costs will reach $1.5 trillion by the year 2000.
Personally, that figure, incomprehensible as it is, doesn’t
frighten me. We could afford it — if only we were to receive
the full value of every dollar we shall spend. As it stands,
absurd fragmentation has led to huge waste and billions of
dollars squandered in needless duplication and administrative
complexity. Individuals have their costs paid by multiple
units, some public and some private. Highly trained
physicians waste increasing amounts of time in paperwork
instead of caring for patients; doctors are very expensive
clerks.
More than 20 years ago, I chaired the Comprehensive
Health Planning Council of Southeast Michigan, seeking
public and private cooperation for an area of 5 million people.
Interestingly, the push to do something about rational
planning came primarily from the big auto companies and the
unions, working together. Objections and foot-dragging came
from the organized medical profession. In the end, the
initiative failed. Now, as evidence of waste and unnecessary
Yale Medicine
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expense mounts, business and labor are bringing renewed
pressure.
Canada, our neighbor, with better health indices and lower
costs, presents an example that merits serious study. But
Canada does not have all the answers. Persistence of fee-forservice remuneration reflects serious problems. Industry long
ago demonstrated that productivity does not depend on piece
work.
Yale people were early leaders in trying to reform medical
care. In the 1930s, during my house staff years. Dr. John
Punnett Peters, the John Slade Ely Professor of Internal
Medicine, formed the “Committee of 430,’’ one of the earliest
groups from within the medical profession that called for
reform in health care organization. It is no reflection on Dr.
Peters or his many successors among medical leaders that a
rational plan has not yet been achieved.
Yale’s EPH department has a distinguished record in
health services research over the years, as well. There is
plenty of “room at the top” for Yale once again to take a
national leadership role; the department’s current
reorganization appears to be a major step toward achieving
this end.
I’d like to close on an aspect of public health I have
referred to only indirectly thus far — the quality of life. It is
easy in the desire to quantify health status and progress to
concentrate too much on just reducing mortality rates. But
clearly, keeping people alive is not enough. One pundit put it
well: “The basic objective of public health is to help everyone
die young — as late as possible.” Society needs to provide the
environment, in the broadest sense, that permits every person
to enjoy life to the extent of his or her capacity. That’s a goal
every health worker can accept gladly.
YM

25

STUDENT RESEARCH DAY 1990

At the poster session. Dr. Robert //. Gifford confers with Sonya Ei ickson, '90. about her historical research.

Opening Remarks
The tradition of inedical student research at Yale goes back
about ]s() years. We remain one of the few, if not the only
medical school that requires a completed, bound thesis as a
requirement for graduation. Thus, the thesis project stands as
one of the cornerstones of the Yale System of medical
education.
'fhis important exercise graphically illustrates to each
student how difficult it is to implement and to write up quality
research. It fosters an appreciation of the scientific literature
and a more critical appraisal of published results. It often, but
not always, leads to new infomiation.
However, in many ways, the student research process is
more important than the results, especially the experience
uith sophisticated research techniques and the one-on-one
relationship uith a faculty advisor. Many students become so
engrossed in their projects that they decide to spend an
aiklitional year in medical school to pursue their investigation
111 greater depth.
In nH-ent \ears, thanks to the efforts of the office of student
ri-si-areh anti its tlirector. Dr. John N. Forrest Jr., a number of
• m. M t-r lellowships have been made available to support
*
l Uerestetl m a fifth year devoted to research. Many of
ih:-s. [-r..;:Tts liave been tir will be published in the near
iUiie
si man\ have been presented at national meetings.
■ ; s' ulents sDinmence their thesis work in the summer
s■■ eu ir first year of medical school. They choose a

thesis advisor and a topic that interests them. The topic does
not have to involve “wet bench” research. Some students
select clinical projects involving patients or chart reviews.
Some opt for projects in public health. Some tackle subjects
in medical ethics or medical history. Whatever the subject, it
is essential that there be a hypothesis; the student must ask a
question and figure out how best to answer it or to prove the
hypothesis using the scientific method.
During that first summer, many choose a faculty sponsor
and begin a long, close student-faculty collaboration that
extends into the senior year. The final written thesis must be
approved by the sponsor and read and approved by a
departmental thesis committee. Some theses are later
designated by the various departments for honors and these
are forwarded to members of the Medical School Thesis
Committee where they are read and discussed. That group
decides on the five theses that merit presentation here and
identifies those to be awarded prizes at graduation.
I would like to express my appreciation to all who worked
so hard to make Student Research Day a success, especially
the students who have participated, their faculty sponsors,
Mrs. Virginia Simon and biomedical communications.
Assistant Dean Betsy Winters and Ms. Nancy Dometios in the
office of student research.
Dr. Robert //. Gifford
Associate dean for education and student affairs
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Abstracts
Identification for RNA splicing errors resulting in human
ornithine transcarbamylase deficiency
Russ P. Carstens
Faculty advisor: Lean E. Rosenberg, M.D., the C.N.H. Long
Professor of Human Genetics, Medicine and Pediatrics
Ornithine transcarbamylase (OTC) is an X-linked, liver
specific enzyme which catalyzes the second step of the urea
cycle. In humans, inherited deficiency of OTC in hemizygous
affected males usually results in severe ammonia intoxication
and early death. In order to characterize mutations responsible
for OTC deficiency, we used the polymerase chain reaction to
amplify cDNAs prepared from patient livers, obtained at
autopsy, which demonstrated no OTC enzyme activity. Of 11
livers tested, it was possible to produce amplifiable cDNA
from seven. In three of these seven cases, smaller than normal
products were observed. Sequencing of the cDNAs revealed
that two were missing exon 7 of the OTC gene and that the
other was missing the first 12 base pairs of exon 5.
Sequencing of genomic DNA from these patients revealed

that one mutant missing exon 7 had a point mutation causing
a T to C substitution in the 5’ splice donor site of intron 7.
The other mutant missing exon 7 had an A to G change in the
third position of intron 7. Interestingly, both of these
mutations resulted in skipping the preceeding exon, rather
than inclusion of some or all of the affected intron 4. Here, the
cryptic splice acceptor site within exon 5 was used. Although
each of the deletions was in frame. Western blotting of liver
homogenates from these patients with anti-OTC antiserum
showed no immunoreactive material. Northern blotting of
liver RNA from these patients demonstrated reduced but
significant amounts of OTC mRNA in one of the patients with
a deleted exon, but dramatic reduction in OTC mRNA in the
other two. We propose that these point mutations, which
result in abberant splicing of the OTC pre-mRNAs, lead to
OTC deficiency through either decreased efficiency of mRNA
export from the nucleus to the cytosol or synthesis of enzyme
subunits that are unstable and rapidly degraded. These are the
first examples of human OTC deficiency resulting from
mutations that cause production of abnormally spliced
mRNAs and may represent a common mechanism involved in
the pathogenesis of this disease.

Dean Leon E. Rosenberg congratulates those who made oral thesis presentations: (from left) Sanjoy
Sundaresan, Russ P. Carstens, Mark A. Dettelbach, Guy M. McKhann and Beverly J. Stoute.
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Intraperitoneal delivery of free fatty acids induces severe
h\pocalcemia in rats; a model for hypocalcemia of
pancreatitis
Mark Dettelharfi
f ill i(lt\ advisor: Andrew F. Stewart. M.D.. associate
professor oj me die me
Hypocalcemia is a regular feature of severe pancreatitis.
Indirect evidence suggests a causative role for intraperitoneal
free fatty acids generated by the action of pancreatic lipase on
peritoneal and retroperitoneal fat. We therefore examined the
effects of direct intraperitoneal injections of free fatty acids
on serum calcium in rats. Four free fatty acids were selected
based on their natural abundance in animal fat. Two saturated
free fatty acids, stearate and palmitate, induced little or no
hypocalcemia. In contrast, the two unsaturated free fatty
acids, oleate and linoleate, which together account for the
majority of free fatty acids in animal fat, caused dramatic
hypocalcemia in treated versus control rats (6.3 ± 1.4 and 5.3
± 0.7 mg/dl, respectively, versus 10.1 ± 0.5). Dose-response
studies demonstrated that even minute quantities of oleate
(3(K) and KM) p per 250 gm rat) caused marked hypocalcemia
(7.2 ± O.S and 7.2 ± 0.3 mg/dl, respectively). Studies of
treated versus control rats also revealed a decrease in ionized
calcium (3.15 ± 0.2 versus 5.6 ± 0.05. p < .001) and
magnesium (1.4 ± 0.15 versus 2.0 ± 0.10, p < .001), an
appropriate increase in PTll levels (1670 ± 451 versus 296 ±
142 pg/dl, p < .001), and a fall in calcitonin levels (70.4 ±
16.4 pg/ml, p < .002) but no change in albumin or phosphate
levels. In vitro, the Ksp of calcium dioleate was shown to be
5.3 X 10 -S M 3/L 3: thus at physiologic levels of calcium and
free fatty acid. 100 p of oleate binds 7.2 mg of calcium, or
approximately twice the total ECF ionized calcium in the rat.
.Amounts of intraperitoneal free fatty acids which can
easily be achieved in pancreatitis find pathophysiologically
significant amounts of calcium and can lead to severe
hy pocalcemia. This model strongly suggests a role for free
fatty acids in the etiology of pancreatitis-associated
h\ pocalcemia.

Neurochemical changes in the hippocampus in human
temporal lobe epilepsy
Sanjoy Sundaresan
Faculty advisor: Nahal DeLenerolle, D.Phil., associate
professor of surgery (neurosurgery)
Medically intractable temporal lobe epilepsy (TLE) is
commonly treated surgically by antero-medical temporal
lobectomy, which includes removal of the hippocampus. In
patients with temporal lobe epilepsy of unknown etiology
(CTLE), such surgery results in seizure control, implying the
presence of a seizure focus within this tissue. The hippocampi
from such patients; from patients with TLE resulting from a
lesion (TTLE); and from autopsy controls were examined by
autoradiographic techniques for the localization of receptors
(glutamate, GABA A, adenosine Al, muscarinic, NPY,
opiate); second messengers (adenylate cyclase, protein kinase
C); and sodium-potassium ATPase. The distribution of the
opioid
peptide
dynorphin
was
studied
by
immunocytochemistry and in situ hybridization. These studies
show that TTLE hippocampi are similar to those of autopsy
controls. The CTLE hippocampi displayed changes in the
above substances which are consistent with mechanisms that
may increase the excitability of hippocampal principal
neurons. The pattern of distribution of glutamate receptor
subtypes provides insight as to the selective vulnerability of
neurons in the hippocampus due to excitotoxic injury: CAl
and CA4 neurons which show upregulation of NMDA and
QA receptors are in areas most affected, while granule cells
which do not show these changes are least affected. The
development of a seizure focus and hippocampal injury in
epilepsy thus seems to be related to cellular and biochemical
reorganization of the hippocampus.

Robin Hornung's research into
AIDS prevalence among
pregnant women and their
children in Tanzania attracted
the attention of Dr. Anthony S.
Fauci, who delivered the third
annual Lee E. Farr, M.D.,
Lecture. Dr. Fauci is director of
the National Institute of Allergy
and Infectious Diseases.
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Russ Carstens and Beverly Stoute
share a lighter moment with
Dr. Farr, ’33, and his wife Miriam.

Effect of low temperature on the trafficking of 215 kD
mannose-6-phosphate/IGF-ll receptors in rat clone 9
hepatocytes

Isolation and characterization of human T-cell
lymphotropic virus type-1 from patients with tropical
spastic paraparesis

Beverly J. Stoute
Faculty advisor: Marilyn Farquhar, Ph.D., Sterling Professor
of Cell Biology and Pathology

Guy M. McKhann II
Faculty advisor: Gueh-Djen Edith Hsiung, Ph.D., professor
emeritus of laboratory medicine

Reduction in temperature has been used extensively as a tool
for disrupting membrane and intracellular protein traffic at
defined stations along both the endocytic and exocytic
pathways. In the present study, the effect of low temperature
on the intracellular trafficking of mannose-6-phosphate
(Man6P) receptors in rat Clone 9 hepatocytes was
investigrced using indirect immunofluorescence (IF) and
immunoperoxidase (IP) localization of receptors at the
electron microscopic level. Clone 9 hepatocytes were treated
with ammonium chloride (NH 4 Cl) or chloroquine for 1 hour,
2 hours, and 3 hours at 37°C and at 20°C to follow receptors
as they became progressively trapped in endosomes. The
percentage of cells with “Golgi,” “Mixed Endosomal-Golgi,”
and pure “Endosomal” immunofluorescence signals was
determined at each time point. The presence of
immunodetectable Man6P receptor in each intracellular locale
at the IE level was confirmed by diaminobenzidine
localization at the electron microscopic level. To follow
receptors as they recycled back to the Golgi complex. Clone 9
hepatocytes were first treated with NH 4 Cl or chloroquine for
3.5 hours at 37°C to trap receptors in endosomes, then
incubated in weak base-free media at 37°C and at 20°C to
allow receptors to travel back to the Golgi complex. Results
reported in this study demonstrate that the trafficking of
Man6P receptors from the Golgi complex (receptor sorting
site) to endosomes (receptor delivery site) proceeds at a
slower rate, but is not disrupted at 20°C. The results obtained
using NH 4 Cl and chloroquine are identical except that the
recycling of Man6P receptors back to the Golgi complex after
chloroquine removal is slower than recycling after NH 4 Cl
removal. We conclude that movement of intracellular Man6P
receptors from the Golgi complex to endosomes and recycling
from endosomes back to the Golgi complex proceeds at 20°C,
indicating that Man6P receptor traffic is not sensitive at this
temperature.

Endemic tropical spastic paraparesis/HTLV-1 associated
myelopathy (TSP/HAM) is a slowly progressive chronic
neurological disorder that is manifested clinically by spastic
paraparesis frequently in association with bowel and bladder
dysfunction. It is one of the most common chronic neurologic
disorders in many endemic foci around the world. Human Tlymphotropic virus type 1 (HTLV-1) has been etiologically
associated with TSP/HAM based primarily on the high
prevalence of antibodies to HTLV-1 in the serum and CSF of
affected patients. We report here the isolation of HTLV-1
from peripheral blood lymphocytes and cerebrospinal fluid
derived mononuclear cells of TSP/HAM patients by
stimulation with interleukin-2 and cocultivation with
umbilical cord blood mononuclear cells. Established cell lines
contained HTLV-1 antigen as demonstrated by
immunofluorescence and cell-associated virus particles as
observed by electron microscopy; low-level reverse
transcriptase activity was detected in cultures expressing viral
antigens. Virus infected cultures were transformed in vitro as
determined by their loss of contact inhibition and their
continuous growth in the absence of exogenous IL-2. Of
particular significance was our isolation of HTLV-1 from
three family members with TSP/HAM of varying duration
and clinical severity.
This study resulted in the first isolation of virus from a
cluster of TSP/HAM patients within the same family, the first
isolation of virus from a childhood case of TSP/HAM, and the
first in vitro transfromed HTLV-l-infected cells from
TSP/HAM patients. In addition, the methodology applied in
this investigation subsequently has been used to consistently
isolate virus from HTLV-1 infected persons from widely
separated geographic locations. This work supports a
causative role from HTLV-1 in the pathogenesis of
TSP/HAM and helps to extend the spectrum of disease that
may result from HTLV-1 infection.
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GALLERY
''Portrait of Bernardino RamazzinV^ by Johann Georg Seilla
Bernardino Ramazzini (1633-1714)
ua.s born in Carpi, a town in north
central Italy a few miles north of
Modena. He studied both medicine
and law at Pamia and received his
doctorate in medicine in 1959.
In 17()(). Ramazzini's work
entitled De morhis artificum
diatriha was published; five years
later, the Latin work was translated
into English (although not
adequately until 1940) as Diseases
of Tradesmen. This was the first
treatise to address comprehensively
the infirmities provoked by the
hazards of one's livelihood, that is,
occupational health.
Ramazzini deals with a variety
of trades people, such as miners of
metals, wet-nurses, corpse-bearers
and fishermen. He also offers
advice for workers who stand,
sedentary workers and those who
strain their eyes over fine work. A
dissertation on "Diseases of
Learned Men" is included as well,
lest it be thought that only those
involved with physical labor were
subject to health hazards.
Ramazzini
discusses
occupational health and hygiene in
a practical yet poetic manner,
combining
quotations
from
classical verse with his own erudite
prose. In the 1713 supplement,
vshich augments the original edition
by 12 entries. Ramazzini muses on
the nature of weaving;
How useful or rather how’ necessary is the
w eaver's art we can decide from the fact that
every livini; soul covers his nakedness with some
sort oj woven stuff. Nor should we j’rumhle at
Nature for having bestowed plumage on birds and
on every animal a hairy coverini>, while man
(do/ie she has left naked. Lor man has inventive
lalent.s and hands with which to weave for himself
many difjerent kinds of clothin}’. not merelv as a
(in crim; but also to adorn and beautify himself.

This benevolent portrait of Ramazzini appears in his
posthumous Opera Omnia (Geneva, 1717) as the
frontispiece. The print is a copper plate engraving with its
characteristic sharply cut lines, which is the most common
fomi of book illustration at the time. Johann Georg Seiller
of Schaffhausen was a painter and engraver primarily of
portraits, including one in 1705, of Joseph I, Emperor of
the Holy Roman Empire, and another with the tantalizing
title, “A monk attempting to kiss a girl.”
Janice Braun
Medical Historical Library
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Joining in Yale-New Haven Hospital’s groundbreaking (from left): Deputy Dean
Donald M. Donaldson; Dr. Gary Friedlaender, chairman and chief, orthopaedics
and rehabilitation: Dr. Paul G. Barash, chairman and chief, anesthesiology;
M. Patricia Gibbons, R.N., YNHH’s vice president of nursing: and Dr. Joseph
Warshaw, chairman and chief, pediatrics.

YNHH Breaks Ground
For New Building
After months of preparations, on
Sept. 26, Yale-New Haven Hospital
(YNHH) broke ground for an 11-story
building — which includes a
children’s hospital — and the
renovation of its Memorial Unit. In
August, YNHH received approval
from the state Commission on
Hospitals and Health Care (CHHC)
for the construction, which is
scheduled for completion in 1993.
Key points of the facilities renewal
project include: construction of the new
patient care building with all private
rooms; renovation of the Memorial Unit
and elimination of three- and four-bed
rooms; expansion of emergency room,
operating room, diagnostic imaging and
radiation therapy facilities.
The CHHC granted a bed increase of
25, bringing the hospital’s licensed bed
capacity up to 900; this will allow
YNHH to increase its number of beds
and bassinets by 68. The total capital
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expenditure approved was $153 million
for 445,0(X) square feet of new
constmction and 300,0(X) square feet of
renovation.
In anticipation of the YNHH
building project, the nursing school has
moved into temporary quarters in the
Grace Building. The University has
commissioned the New York
architectural firm of Williams and Tsien
to design and oversee the constmction
of a new School of Nursing on the
medical center campus.

Maternal HIV
Transmission
Less than 20 Percent
More than 80 percent of babies bom to
women infected with the AIDS vims
are free from infection and symptoms
three years after birth, according to a
study by School of Medicine
researchers.
Dr. Warren A. Andiman, associate
professor of pediatrics and epidemi¬
ology and medical director of the AIDS

Care Program at Yale-New Haven
Hospital (YNHH), directed the study
which examined 116 babies bom to
women infected with the Human
Immunodeficiency Vims, or HIV, the
vims responsible for AIDS. The
researchers reported their results in the
July issue of the American Journal of
Diseases of Children.
Since babies acquire antibodies to
many diseases from their mothers,
infants of HIV-infected mothers will
test positive for HIV antibodies at birth,
says Dr. Andiman. But most infants
lose their HIV antibodies after birth and
will not exhibit signs of infection during
the first years of life. Other studies have
estimated the matemo-fetal
transmission rate at 24 to 33 percent.
Co-authors of the article are B. Joyce
Simpson, R.N., YNHH; Betty Olson,
A.A.S., research associate, Yale; Dr.
Laura Dember, ’88, the Hospital of the
University of Pennsylvania; Dr.
Thomas J. Silva, ’90, Children’s
Hospital, Boston; and Dr. George
Miller, the John F. Enders Professor of
Pediatrics and professor of
epidemiology and of molecular
biophysics and biochemistry. Dr. Miller
is also chief of the section of pediatric
infectious diseases at YNHH.

Secondhand Smoke
Puts Youth at Risk
Nearly 17 percent of lung cancer deaths
among nonsmokers can be traced to
secondhand cigarette smoke they
inhaled as children or adolescents from
their smoking parents. A Yale research
team led by Dr. Dwight T. Janerich,
professor of epidemiology and in the
Cancer Center, reported the findings in
the Sept. 5 edition of the New England
Journal of Medicine.
The study involved almost 400
pieople throughout upstate New York. It
found that the risk of lung cancer was
double that of other nonsmokers. If
these figures are confirmed, annually
1,7(X) deaths in the United States are
caused by childhood exposure to other
people’s cigarette smoke.
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Researchers Join
National Infant Study
I'he Sch(K)l of Medicine, Yale-New
Haven Hospital (YNHH) and
Quinnipiac College collaborated with
resetirchers at seven other sites across
the country in the Infant Health and
Development Program, a national study
of u hether intervention programs
improve the development of premature,
low-birth-weight infants.
David T. .Scott, Ph.D., an associate
professor of pediatrics and a
developmental psychologist at YNHH
directed the New Haven segment of the
study. Results for the national study,
which involved more than 1,(KK)
infants, uere reported in the June 13
issue of the Journal ofllic American
Medical Association.
'Hie Neu 1 laven researchers studied
126 premature babies, most from New
Haven County. 'I’he babies, weighing
5.3 pounds or less, were bom at YNHH
in 19X4 and I9S5, and were cared for at
the Newborn Special Care Unit.
"All t)f the children in the trials
received high quality follow-up services
that included physical examinations,
developmental evaluations and referral
sen. ices," notes Dr. .Scott.
Researchers randomly chose which
babies would receive extra sen ices.
including weekly home visits during
their first three years of life. During
their second and third years, these
children also attended a special child
development program h)r premature
babies run by the Quinnipiac College
Day-Care Center.
bivalualions at age three showed
significant IQ score improvements for
children who received the extra
educational sen ices. In a second phase
of the study, researchers are tracking the
children's progress after completing the
specitil intenention program.

Hoys Often Mistaken
For Reading Disabled
fhe "snips and snails and puppy dog
tails" little boys are made of may result
in their teachers misclassifying them as
reading disabled, as revealed by a study
led by Dr, .Sally If Shaywit/, asscK’iate
.irolessoi of (v.xiiatrics and in the Child
: :dy ^ ^-liter.
I" : !‘neral, 'i-aehers rate Niys as

: . lnil•^ more aetive, more

inattentive and less dextrous and as
having more problems in behavior,
kinguage and academics than their
female peers,” reports Dr. Shay witz and
colleagues in the August 22 Journal of
the American Medical Association. Yet,
despite teacher reports of difficulties in
the classroom, the researchers’
measures of the overall ability and
achievement of boys turned out to be
comparable to that of girls.
The authors studied reading levels in
445 children from six geographic
regions in Connecticut. The 235 girls
and 210 boys were followed from
kindergarten through the third grade.
Co-authors on the study include:
Bennett A. Shaywitz, M.D., professor
of pediatrics, neurology and in the Child
Study Center; Jack M. Fletcher, Ph.D.,
department of ptediatrics, the University
of Texas, and Michael D. Escobar,
Ph.D., associate research scientist in
public health (biostatistics).

Foundation Funds
Sexual Abuse Program
The New Haven Foundation has
awarded a $.54,(KX) grant to the
depiulment of pediatrics to expand its
Sexual Abu.se Evaluation Program and
enhance the program’s affiliations with
local organizations concerned with
children at risk.“We want to make sure
that a child with a complicated case
doesn’t get lost between the cracks in
the system,” says Dr. John M.
Leventhal, medical director of the
program and associate professor of
pediatrics. “The grant will enable us to
follow through more thoroughly with
such cases.”
The funding also will help establish
outreach with hard-to-contact families
in which children have been suspected
of being sexually abused and with
sexually abu.sed children who are more
comfortable talking about their situation
in their own home.
Julia P. Hamilton, M.S.W., the
program’s co-director, adds, “We also
hojx’ to start a one-day training program
for members of the state Department of
Children and Youth Services, along
with members of community and health
care agencies, to better educate them
about the problem of sexual abuse.”
Ms. Hamiliton also is chief social
worker for ambulatory care at YaleNew 1 laven 1 lospital and assistant
clinical professor of pediatrics.

The program began in 1985 in
response to a dramatic increase in
reports of sexual abuse among children.
Dr. Leventhal reports: “We see between
180 and 200 children per year suspected
of being sexually abused, with an
average age of 7.”
Tlie program is a collaborative effort
of the School of Medicine’s department
of pediatrics, the YNHH department of
.social work, the School of Nursing
Pediatric Nurse Practitioner Program
and YNHH Primary Care Center. The
evaluation team includes a medical
director, co-director, two nurse
practitioners and two social workers.

Gene Mutation Linked
To SIDS Symptoms
An enzyme deficiency that sometimes
masquerades as sudden infant death
syndrome (SIDS) can be traced to a
single genetic mutation in most cases,
paving the way for genetic screening
for the disorder, report researchers at
Yale and the University of
Pennsylvania.
The disorder results from a
deficiency of the enzyme MCAD, or
medium chain acyl-CoA dehydro¬
genase. MCAD helps the body use its
stored fat to generate energy. People
who lack a normally functioning
MCAD gene have a problem breaking
down fatty acids and are susceptible
to sudden drops in blood glucose levels,
leading to lethargy, vomiting and coma.
Babies and children who lack the
enzyme can suddenly lapse into a
coma and die, says Dr. Kay Tanaka,
professor of human genetics at Yale.
Since such symptoms occur in SIDS,
researchers think some babies who
apparently died of SIDS probably had
MCAD deficiency, he adds.
The disease appears to be most
common among people of northern
European descent. Studies done in
England have estimated that as many
as one in 100 people carry the gene,
meaning that approximately one in
10,000 people will have the di.sorder.
Dr. 'Tanaka, Paul M. Coates, Ph.D.,
professor of pediatrics at the
University of Pennsylvania and a
researcher at the Children’s Hospital
of Philadelphia, and their colleagues
report in the September issue of the
Journal of Clinical Investigation that
MCAD deficiency is apparently due
to a single genetic mutation in 8 out
of 9 cases.
Yale Medicine FallAVinter 1990-91

In his commencement address to the EPH Class of 1990, Dr. Benjamin Spock said, “The major problems facing our
children today include over-competitiveness; physical punishment; violence on television.... The problems are a lack of
daycare and the need for more inspiring schools.” He added, “There’s no reason why we in the United States shouldn’t
have a good health care system. . . It’s horrible, it’s indecent, it’s immoral that people by the hundreds of thousands are
wandering the streets without any place to live in the richest country the world has ever known, even as trillions of dollars
are being wasted adding to our nuclear arsenal despite the improvement in our relationship with the Soviet Union.”

Protein May Lead
To Diabetes Test
A protein that plays a key role in the
development of insulin-dependent
diabetes has been identified by a team
of researchers from Yale and
University of California at San
Francisco (UCSF) medical schools.
The finding could lead to a test to
screen for people likely to develop
insulin-dependent, or Type I, diabetes
mellitus. Often called juvenile-onset
diabetes, it is the most severe form of
diabetes, afflicting nearly a million
Americans who come to require daily
insulin injections.
The discovery may make it
possible to diagnose those prone to
developing Type I diabetes as early as
eight years before symptoms appear,
and could lead to preventive therapy.
The researchers report their findings
in the Sept. 13 issue of Nature.
Pietro De Camilli, M.D., associate
professor of cell biology at Yale,
Steinunn Baekkeskov, Ph.D., assistant
professor of microbiology/immunology
and medicine at UCSF, and their
colleagues established that the
enzyme glutamic acid decarboxylase
(GAD), is the protein that stimulates
the production of antibodies in the
blood of many people who eventually
Yale Medicine

Fall/Winter 1990-91

develop diabetes — often years
before symptoms appear. These
antibodies were first discovered in
diabetics eight years ago, but the
identity of the protein that stimulated
them remained a mystery. GAD is
found in insulin-secreting cells of the
pancreas and in many neurons.

Medical Education
Project to Begin
Yale University is one of 12 U.S.
medical schools selected to participate
in the Robert Wood Johnson
Foundation’s major initiative to reform
medical education. The foundation’s
planning grant of up to $150,(XX) will
enable the school to “chart a strategy for
adapting its educational programs to
prepare students to become physicians
able to serve the health care needs of
both the individual and the public.’’
Medical school Dean Leon E.
Rosenberg comments: “These national
foundation funds will help support the
school’s efforts to review our
curriculum and to implement
recommendations made in 1988 by a
special task force that evaluated our
curriculum. Since then, we have been
moving in directions parallel to the
foundation’s initiative.”

A year ago. Dean Rosenberg
appointed Dr. Emile L. Boulpaep,
former chairman of the cellular and
molecular physiology department, as
the first chairman of a 12-member
Educational Policy and Curriculum
Committee to carry out its broad
mandate to change, integrate or manage
the curriculum to adapt it to emerging
needs.
Three main program areas that
complement the foundation’s objectives
were identified. They include:
• Finding new sites for clinical
education, especially ambulatory,
out-patient care settings such as
health maintenance organizations.
These settings reflect current shifts
in the modes of delivering health
care services.
• Better integrating the teaching of
basic sciences into clinical medicine
programs, taking a physiological
system- or disease-related approach.
In addition, the school will
encourage integrated programs
between medical students and other
health professional students through
new curriculum initiatives, including
shared teaching experiences.
• Centralizing educational policy and
curriculum governance.
A cornerstone of the curriculum
review is that the unique “Yale System”
of medical education shall be preserved.
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Cocaine Withdrawal Tied
To Dopamine Metabolism
School ot Medicine researchers report
that the brain chemical responsible for
cocaine's euphoria may also contribute
to the intense craving addicts feel w hen
they stop taking the drug.
.A month-long study of six ccx'aineaddicted men. most of v\ horn smoked
freebase ccxaine, revealed that after
they stopped using the drug, their brains
prtxessed less dopamine, a
neurotransmitter responsible for the
cwaine high. That craving helps keep
addicts kxked in ctxaine’s potentially
deadl) embrace.
Researchers at the Clinical
Neuroscience Research Lhiit of the
Connecticut .Mental Health Center
noted that during their subjects’ early
withdrawal stage, the men exhibited
increased dopamine metabolism, a
development vv hich nomialized later in
the stud)'.
Dr. Christopher McDougle, a
postd(K'toral research fellow in
psychiatn,. presented his findings May
16 at the annual meeting of the
.American Psychiatric .Association.
(i)ther authors include Drs. Lawrence H.
Price, asscx'iate professor of psychiatry;
Joseph Palumbo, fomierly a
postdtx'toral fellow in psychiatry and
now in private practice; Thomas R.
Kosten, asscxiate professor of
psychiatry; and Herbert D. Kleber and
Ceorge R. Heninger, both professors of
psychiatry. Dr. Kleber is on leave from
'I'ale to sen. e as deputy director for
demand reduction for the Office of
National Drug Control Policy.

C^)caine Prices Parallel
Those of 1908 Epidemic
Ixgali/ing dmgs won't necessarily
remove profits from dmg trafficking,
accortling to a comparison of cxxaine
pricing undertaken by a School of
Medicine physician-historian.
('omparing prices to average wages,
the current street price of ctxaine is
similar to or even lower than cixaine's
price during an epidemic of drug abuse
that empted after the turn of the century
I hen.: i raine was legally available in
till- I s
xplains Dr, David F, Musto.
' • ■ ■ >i psychiatry and the history
' 1 >r. Musto compared the

price of cocaine during two periods of
drug abuse: 1908 to 1914 and 1982
to 1989.
“In terms of buying power, the cost
of illicit cocaine in the early and the
recent eras studied was similar,” notes
Dr. Musto.
His findings, published in the June
issue of Connecticut Medicine, seem to
negate the argument that drug
legalization would reduce the crime
associated with drug sales by
undercutting black market profits.
“Today’s advocates of the
legalization of cocaine may be surprised
to find out that the United States was
the only major Western nation to allow
unlimited distribution, sale and
promotion of narcotics during the 19th
century," says Dr. Musto.
Anti-drug laws were passed in
reaction to public experience with legal
drugs. Dr. Musto adds.

Lyme Organism Present
A Half-century Ago
Sophisticated genetic tests indicate
that ticks carried the organism
responsible for Lyme disease as long
as 44 years ago. three decades before
the disease was identified.
The finding suggests that Lyme
disease could have appeared in the
1940s in eastern Long Island, where it
may have been diagnosed as
“Montauk knee" or “Montauk spider
bite," says David Persing. M.D..
Ph.D., who directed the study while a
researcher at the School of Medicine.
Dr. Persing. now a staff clinical
pathologist at the Mayo Foundation,
and colleagues describe their research
in the Sept. 21 issue of Science. Dr.
Persing's Yale co-authors are Stephen
E. Malawista, M.D., professor of
medicine, and Paul N. Rys. a
laboratory research scientist.
Lyme disease, named for the
Connecticut town where it was first
identified in 1975 by Yale
rheumatologists including Dr.
Malawista, is caused by a spiral¬
shaped bacterium, or spirochete,
called Borrelia burgdorferi. It is
transmitted by the tick Ixodes
dammini. In their research, the
scientists employed an advanced
genetic procedure called polymerase
chain reaction, or PCR. The PCR test
permitted them to look for the Lyme
organism in museum tick specimens,
often dried or preserv ed in alcohol.

Traumatic Stress Causes
Brain Chemistry Changes
Traumatic events may substantially
alter the chemistry of the brain,
sensitizing victims to adrenaline surges
decades later. This may account for
symptoms of post-traumatic stress
disorder (PTSD) and panic disorder, say
researchers at the Department of
Veterans Affairs Medical Center in
West Haven and at the School of
Medicine. Dr. Dennis S. Chamey,
associate professor of psychiatry and
director of the National Center for
PTSD neuroscience division, presented
the findings at a May 19 symposium at
the annual meeting of the American
Psychiatric Association in New York.
People with PTSD typically have
endured severe trauma such as military
combat, child abuse, rape, torture or a
natural disaster. Years later PTSD
sufferers can exhibit “fight or flight”
reactions in the absence of real danger.
Other symptoms include flashbacks of
the traumatic event, jumpiness,
irritability, disturbed sleep, depression
or feelings of guilt.
Researchers at the National PTSD
Center at West Haven have found that
yohimbine — a drug commonly used to
elevate blood pressure and treat
impotence — triggers panic attacks and
flashbacks in PTSD patients. On two
occasions, the researchers administered
either the drug or a placebo to 15 PTSD
patients who are Vietnam veterans.
Yohimbine induced panic attacks in
60 percent of the subjects and triggered
flashbacks in about half of them. In
earlier studies, the drug brought about
panic attacks in about 60 percent of
more than 100 patients with panic
disorder.
Because yohimbine blocks the
action of the alpha 2 receptor, a protein
that stimulates the sympathetic nerv'ous
system, the results support the
hypothesis that trauma may alter brain
chemistry in PTSD patients, sensitizing
them to adrenaline surges.
Dr. Chamey's co-authors include Dr.
Steven M. Southw ick, director of FTSD
programs at West Haven, and Dr. John
H. Kry'sUil. chief of the center's
Laboratory of Clinical Psychopharma¬
cology. Drs. Krystal and Southwick are
assistant professors of psychiatry.
The West Haven center is the only
U.S. institution devoted to studying the
biology iind psychopharmacology
of PTSD.
Yai.e Medicine
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Fetal Neural Cells
Survive Transplantation
Cryopreserved fetal brain cells
implanted into the brain of a human
patient have survived transplantation,
report members of the Yale
University Neural Transplant
Program in the Sept. 29 issue of
Lancet.
Comments D. Eugene Redmond
Jr., M.D., professor of psychiatry,
“The grafted tissue demonstrated the
capacity to survive, adapt, develop
and mature in the adult human brain,
as well as in the brains of monkeys.
Grafts were recovered after the
patient died of continuing
complications of Parkinsonism which
the team believes were unrelated to
the transplant procedure.
“Although this patient did not
appear to benefit from the graft, the
team remains optimistic about the
success of the procedure and looks
forward to determining the outcome
from a current study involving 20
patients,” Dr. Redmond adds.
The clinical research procedure is
based on fundamental scientific work
and laboratory animal studies
conducted for many years by School
of Medicine biomedical scientists, in
conjunction with colleagues at the
University of Rochester. Private funds
support this clinical research study.

Study Offers Clues
To OCD Physiology
Researchers at the School of Medicine
and at Brown University have found
that fluvoxamine, an antidepressant,
effectively relieves symptoms of
obsessive compulsive disorder (OCD)
in many patients. Besides providing
doctors with another dmg to treat OCD,
the research findings, described in the
June Archives of General Psychiatry,
strongly suggest that serotonin, a brain
chemical important in transmitting
nerve impulses between nerve cells,
plays a major role in the disorder.
Simple tasks often tyrannize people
suffering from OCD. Some are
obsessed with recurring and disturbing
thoughts, ideas or images. Others feel
compelled to perform repetitive tasks,
such as washing their hands. Some
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At a reception following the Yale physician associates’ commencement on
Aug. 28, graduates Jeffrey R. Smith and B. Sarah Schiefer converse with state
Rep. Benjamin V. DeZinno Jr. Mr. DeZinno wrote a recently passed law
allowing Connecticut P.A.s to write prescriptions, given a physician's approval
within 24 hours.

people have both obsessions and
compulsions. An estimated 1 to 3
percent of Americans will suffer from
some form of OCD during their
lifetime.
“Our findings indicate that only
those antidepressants which possess the
ability to inhibit the transport of
serotonin into nerve terminals are also
effective against OCD,” says Dr.
Goodman, assistant professor of
psychiatry and director of the study.
Serotonin is a multipurpose protein
found in many places in the body, and
is thought to be involved in controlling
states of consciousness and mood.
Dr. Goodman also chairs the
Scientific Advisory Board to the New
Haven-based Obsessive Compulsive
Foundation, Inc., an organization that
he co-founded with an OCD patient.
Study co-authors from Yale include;
Drs. Lawrence H. Price and Dennis S.
Chamey, associate professors of
psychiatry; Pedro L. Delgado, John H.
Krystal and Linda Nagy, all assistant
professors of psychiatry; Joseph
Palumbo, a former postdoctoral fellow
at Yale; and George R. Heninger,
professor of psychiatry. Co-author
Steven A. Rasmussen is with the Brown
University School of Medicine.

NEW BOOKS
Diagnostic Dysmorphology, by Dr. Jon
M. Aase ’62. Plenum Publishing (New
York) 1990.
Spinal Cord Compression: Diagnosis
and Principles of Management, by Drs.
Thomas N. Byrne, associate clinical
professor of neurology, and Stephen G.
Waxman, professor and chairman of
neurology. F.A. Davis Co.
(Philadelphia) 1990.
Scientific Foundations of Sports
Medicine, ed. by Dr. Carol C. Teitz,
’74. B.C. Decker (Toronto) 1989.
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HARVEY CUSHING/JOHN HAY WHITNEY
MEDICAL LIBRARY

(Left) A new information room is included in
35,000 square feet of additional medical library
space. This augments the previously available
50,000 square feet, much of which was renovated.
Total cost of the project: $10 million.

(Right) At the dedication ceremony held on .lune
7, Yale President Benno C. Schmidt ,lr. presents a
framed architectural rendering of the medical
library addition to Betsey Cushing Whitney as
daughter Kate \\ hitney looks on. Mrs. Whitney
and her family donated $S million to the project.
/\.v a tribute to their generosity, the medical
library has been renamed to honor two illustrious
Yale College graduates. Mrs. Whitney's father.
Dr. Harvey Cushing. IS91, and her husband, the
laie.lohn Hay Whitney. 192b.
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t) Daylight streams into the information
Architect Alexander Piirves, associate
:sor of architectural design at Yale,
led the renovated and expanded areas with
Dehar Associates of New Haven.

(Left) Students prepare for classes in one of the
libraiy's new study areas. Also included in the
e.xpanded space is a computer system which
connects to the University's fiber optics computer
netvi’ork and which makes available more than
400 electronic databases.

(Right) Renovation of the periodical room was
made possible by a $1 million gift by Mrs. Belle
Morse. The space was renamed the Morse
Periodical Room to honor the memory of Mrs.
Morse's husband, Stephen I. Morse, a 1925
Sheffield Scientific School graduate, and her son,
Stephen /. Morse, '51 M.D., Ph.D.
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FACULTY NEWS
Dr. Stephen Aryian, professor of
surgerv', was recognized with a
Distinguished Service Auard from the
Society ot } lead tind Neck Surgeons for
his outstanding contributions to the
educational activities of the society.
Mark D. Biggin, Ph.D., assistant
professor ol molecular biophysics and
bicKhemistry, was named a Pew
Scholar in the Biomedical Sciences by
the Pew Chiiritable Trusts of
Philadelphia. He will receive a
S2(K).(K)0 aw ard during the next four
years to help support his research on
detennining how proteins control the
complex patterns of gene expression in
tin orgtuiism.
Dr. .Arthur E. Broadus, professor
of medicine and head of the division of
endcK'rinology, was awarded the annual
Prederic C. FTirtter Award from the
American StK'iety for Bone tind Mineral
Research. I'he international award
recognizes Dr. Broadus leading work
on disorders asscK'iated with
hypercalcemia, abnonnally high levels
of bkxKl calcium.
Dr. Lawrence S. Cohen, the
Ebenezer K. Hunt Professor of
Medicine, is president-elect of the
■AsscK'iation of University Cardiologists.
He will assume the presidency of the
national orgtuiization in January 1991.
Dr. Michael L. Dewar, assistant
professor of cardiothoracic surgery, and
Dr. .lohn A. Klefteriades, asstxtiate
professor of surgery', have received a
S16,9(X) grant from the American Heart
.Ass(x'iation, Connecticut affiliate, to
support an ex{x;rimental surgery project
that uses skeletal muscle in an attempt
to assist a failing heart.
Dr. Rocko M. Fasanella, associate
clinical professor of ophthalmology and
visual science, received tin honorary
degree from Sacred 1 leart University
lor his research into eye surgery' and his
pioneering Easanella-Sers at Operation,
vshich corrects dnxrping eyelids.
Oene K. (Jindi, Ph D., assixiate
prolessor of ditignosiic radiology, has
tx-en awtirdeil a ,^-year, $3.J5,(KK) grant
from the Air 1-orce Office of Scientific
Resetirch for basic research in the
.ipplicalion of neural networks to image
prik Ning and analysis.

The 1990 Francis Gilman Blake Award for the most outstanding teacher in the
medical arts was shared by G. Morris Dillard, M.D., Ph.D., associate professor
of medicine (left), and Peter A. Grannnm, M.B.B.S., associate professor of
obstetrics and gynecology.

Susan Hockfield, Ph D., associate
professor of neuroanatomy, has been
named by Yale President Benno C.
Schmidt Jr. to the University-wide
faculty committee instituted to monitor
the University's affinnative action
efforts concerning faculty recruitment
and retention of women, members of
minority groups and handicapped
IKTsons.

Dr. Dorothy M. Horstmann, the
John R. Paul Professor Emeritus of
Epidemiology and Pediatrics and senior
research scientist, received the 1990
Alumnus of the Year Award for
outstanding achievement from the
Alumni-Eaculty Association of the
University of California San Francisco
School of Medicine.
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Dr. Robert A. King, assistant
professor in the Child Study Center,
was the first recipient of the B’nai
B’rith Women’s National Scholars
Award for his contributions toward
advances in children’s emotional health.
He received the award in April during a
special session of the organization’s
biannual convention.
Dr. Michael Lerner, associate
professor of internal medicine, was
awarded the Burroughs Wellcome
Fund’s 1990 George Herbert Hitchings
Award for Innovative Methods in Dmg
Design for his research endeavors to
harness the chemical reactions that
enable frogs to change from green to
brown. The $300,000 gift will support
Dr. Lemer’s studies for five years,
which he hopes will lead to a way for
drug developers to rapidly screen
experimental drugs for their potential
efficacy.
Drs. Robert A. Levine and Stephen
C. Wardlaw, both clinical professors of
laboratory medicine, received the “R &
D 100” award, recognizing their design
of the QBC Malaria Test as one of the
most significant technical products of
the past year. The QBC Malaria Test,
which represents the most advanced
malaria diagnostic method, was a joint
effort with Becton Dickinson Tropical
Disease Diagnostics. Also recognized
was Dr. R. Rodion Rathbone, director
of biomedical instrumentation and
assistant clinieal professor of laboratory
medicine, for the development of the
light beam-splitting microscope adapter.
Dr. Richard A. Matthay, professor
of medicine, has been elected chairman
of the Medical School Council for a
two-year term beginning Sept. 1, 1990.
Dr. Leonard M. Milstone, associate
professor of dermatology, was the
Dozor Visiting Professor at the Ben
Gurion University Medical School in
Beer Sheva, Israel, during the month of
June.
Dr. Eva-Pia Reich, associate
research scientist in immunobiology,
received the Juvenile Diabetes
Foundation International Career
Development Award and the Greenwall
Foundation Award for her research on
insulin-dependent diabetes mellitus.
Judith S. Rodin, Ph.D., chairman
and the Philip R. Allen Professor of
Psychology, and Thomas A. Steitz,
Ph.D., professor of molecular
biophysics and biochemistry, have been
elected fellows of the American
Yale Medicine FallAVinter 1990-91

Academy of Arts and Sciences.
Professor Rodin is chairman of the John
D. and Catherine T. MacArthur
Foundation Research Network on
Health-Promoting and HealthDamaging Behavior. Professor Steitz’s
research involves the use of X-ray
crystallography to determine the threedimensional molecular stmcture of
proteins and nucleic acids.

President Benno C. Schmidt in May,
took effect July 1. Dr. Spangler had
been serving as acting medical director
of UHSC since 1989.
Dr. John S. Strauss, profes.sor of
psychiatry, participated in Clark
University’s conference entitled “What
is Schizophrenia?” The conference,
held in Worcester, Mass., brought
together scholars and clinicians from all
over the world to discuss questions
relating to the identification and
treatment of the debilitating mental
illness.
Dr. Joseph B. Warshaw, chairman
and professor of pediatrics, has been
elected to the Institute of Medicine. Dr.
Warshaw’s research has led to a better
understanding of normal fetal
development, how babies adapt
biologically to life after birth and other
problems newborns have in an intensive
care unit. He has also been a leading
proponent for the development of a
children’s hospital at Yale-New Haven
Hospital.

Dr. Eva-Pia Reich
Dr. John M. Sedivy, assistant
professor of molecular biophysics and
biochemistry, received a Presidential
Young Investigator Award from the
National Science Foundation to support
his research on the normal functions of
genes that control cell growth and
development. He studies ways to halt
mutant cancer genes without upsetting
normal body function.
Dr. Robert E. Shope, professor of
epidemiology, has been appointed
chairman of the steering committee of
Dengue and Japanese Encephalitis
Vaccine Development of the World
Health Organization “Programme for
Vaccine Development and Transdisease
Vaccinology.”
Dr. Norman J. Siegel, professor of
pediatrics and medicine and director of
pediatric nephrology, was appointed in
April to the National Board of Medical
Examiners Part II Pediatrics Test
Committee.
Dr. Stephanie S. Spangler,
assistant clinical professor of obstetrics
and gynecology, has been named
director of the University Health
Services Center (UHSC). The five-year
appointment, announced by Yale

In November 1991, Dr. Barry L.
Zaret, the Robert W. Berliner Professor
of Medicine and Diagnostic Radiology,
will assume the presidency of the newly
formed Association of Professors of
Cardiology. The organization of
directors comprises cardiology sections
at U.S. medical schools.
Several faculty members have been
named fellows of the American
Association for the Advancement of
Science: Lawrence B. Cohen, Ph.D.,
professor of cellular and molecular
biology; Michael Davis, Ph.D.,
professor of psychiatry and psychology;
Alan C. Sartorelli, Ph.D., director of
the Comprehensive Cancer Center and
the Alfred Gilman Professor of
Pharmacology; and Dieter Gerhard
Soil, Ph.D., professor of molecuku
biophysics and biochemistry.
Five members of the School of
Medicine have been designated
“Emeritus” by the Yale Corporation:
Franklin Hutchinson, Ph.D., professor
of molecular biophysics and
biochemistry; William H. Prusoff,
Ph.D., professor of pharmacology;
Morton F. Reiser, M.D., the Albert E.
Kent Professor of Psychiatry; Daniel S.
Rowe, M.D., professor of pediatrics and
public health; and Albert J. Solnit,
M.D., Sterling Professor in the Child
Study Center, Pediatrics and Psychiatry.
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ALUMNI REPORT
My asscK'iation with the School of
Medicine began when 1 enrolled as a
freshman in 1950. My classmates and 1
were enthusiastic but concerned about
u hat w as ahead of us. Our journey
through medical school was guided by a
superb faculty who taught us to be
ctiring physicitms in the broadest sense
of the temi. My training sustained me
through my years of clinical practice in
urology.
Now, 40 years later. 1 am once again
a freshman of sorts. I am honored to
accept this appointment as director of
alumni affairs and eager to represent the
alumni/ae of our school. My new
journey w ill be guided by Nick Spinelli,
w ho has given new life to alumni affairs
vsith his enthusiasm and perception. He
w ill be a hard act to follow but has
agreed to serve as a consultant for as
long as necessar)'.
Physically, the medical center has
changed dramatically from the time I
was a student. 'Hie Memorial Unit has
been e.xpanded to iticlude the sites of
the fomier church, convent and the
How ard .Avenue donnitories. Plans call
for a new children's hospital to replace
the old .St. John's parochial school,
vshich later housed the School of
Nursing. The old dental building has
been converted into lecture halls with
direct access to the anatomy w ing and
renamed the Jane Ellen Hope Building.
The driveway at the Howard Avenue
entrance to the New Haven unit was
removed to e.xpand the hospital to the
sidewalk on 1 loward Avenue, and the
Yale Physicians Building replaced part
ol the parking lot and residents' housing
across the street.
The new '^'ale Psychiatric Institute
now operates ticross from the I lope
Building, and our new Center for
Molecular Medicine on College Street
and Congress Avenue is nearing
completion. Phis beautiful facility is
architecturally striking and will
contribute profoundly to the medical
sch(H)l research mission. The library' too
has undergone a major renovation; the
llar\e\ Cushing/John Hay Whitney
Mvdical Library' offers much expanded
Stacks, exciting new computer
ctipahilitii's ;ind other improvements
well li' l:i\ ing altered the beauty of the
re I. ing riKim or the reference

Remarkable progress has occurred
since many of us left New Haven. But
with all the change, the sense of
continuity remains. The students I have
met are intelligent, eager and appear
happy. The Yale System — including
the thesis requirement — remains in
place and is endorsed by the students
and faculty. A major concern is the
current cost of attending medical school
and the severe debt burden a large
percentage of the students must assume.
It is hoped that we can find means to
support these future Yale graduates
with increasing alumni support. The
students are very much part of the
medical school family and continue to
represent our legacy.
Alumni Weekend in June was once
again well planned and executed.
Stephen C. Joseph, M.D. '63, M.P.H.,
was the keynote speaker and presented
an excellent address titled “Public
Health and Public Policy in the Age of
AIDS.” Dr. Joseph also participated in a
symposium moderated by William L.
Kissick, M.D. '57, M.P.H. '59, Dr.P.H.
'61, which discussed the weekend's
theme, the “Ethos of Public Health: A
Challenge for Medicine in the TwentyFirst Century.” Susan Addiss, M.P.H.
'69, and Lawrence Crowley, M.D. '44,
added significantly to the panel.
Dr. Thomas Kugelman, '60,
president of the Ass(x:iation of Yale
Alumni in Medicine (AYAM), presided
at the annual meeting. A plaque for
record alumni giving to the medical
school campaign was accepted on
behalf of alumni donors by Dr. John
Ogilvie, '34, chairman. Medical School
Alumni Campaign. A special
presentation to Jack was made by Dean
Leon E. Rosenberg. The AYAM by¬
laws amendments were approved.
Nominees for the AYAM executive
committee for 1990 included Drs.
Sanfurd G. Bluestein, '46, (renominated
for a second temi); Bennett L. Blitzer,
'73; Harold D. Bomstein, '53; Michael
Kashgarian, ’5S; Forrester A. Lee, '79;
and William A. Whalen Jr., '53.
Class reunion seminars were again
well attended and provcKative. Tlie
Class of 1965 discussion, “Twenty-Five
Years l^ater: Yale and Beyond,” was
chaired and nKxierated by Dr. John
Seashore; the Class of 1960 presented
“Medicine in the Public Arena,”

moderated by Dr. Jerrold R. Post. The
Class of 1945 appointed Dr. Richard
Breck to lead a discussion of “Wine,
Women and War.” Class dinners
arranged by individual classes offered
the opportunity to renew old
friendships, reminisce about old times
and plan for future meetings. A dinner
at the Graduates Club honoring the
Classes of 1940, 1935 and 1985
climaxed a busy and stimulating
weekend.
Dr. Kugelman will continue to serve
as president of our alumni association.
He has been an active and assertive
leader of our executive committee. It
will be a privilege to work with him.
Students and residency candidates
have been welcomed and hosted by
alumni during their out-of-state
interviews. We keep a 'host' list of
those of you who can help. Let us know
if you are available. We will continue to
support Dr. Leonard Kemler, alumni
fund chairman, and Dr. Samuel
Kushlan, co-chairman, bequests and
endowments, in their efforts. Student
loan funds must be increa.sed to
encourage a continuing active alumni
association.
The office of alumni affairs
represents all Yale medical school
alumni. We welcome your suggestions,
concurrence and criticism. Please
communicate your ideas to us,
especially regarding alumni weekend,
regarding both format and scheduling.
While our office is based in New
Haven, we hope to involve alumni from
beyond the Connecticut, New York and
Massachusetts areas.
I look forward to assuming my
responsibility as director of alumni
affairs.
Dr. Arthur C. Crovatto, '54
Director of Alumni Affairs
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ALUMNI NEWS
Dr. Alice Whittier, ’25, of Portland,
Maine, retired from pediatric practice in
1978 at the age of 80. She is a past
president of the New England Pediatric
Society and served through the 1950s as
Maine Medical Center’s chief of
pediatrics.
Dr. Samuel Albert, ’30, has been
practicing medicine for the past 45
years for Americans who have served in
the armed services. He has an outpatient
practice in Manhattan where he is
affiliated with the U.S. Department of
Veterans Affairs.
Dr. Arnold S. Reiman, ’46-’49 HS,
editor-in-chief of the New England
Journal of Medicine, will retire in June
1991. Dr. Reiman was appointed editor
in 1977 and became editor-in-chief in
1988. He plans to devote more time to
writing, teaching and public policy
debates on American health care.
Dr. Cecil G. Sheps, ’47 M.P.H,
professor emeritus at the schools of
medicine and public health at the
University of North Carolina at Chapel
Hill, was awarded the American Public
Health Association’s 1990 Sedgwick
Memorial Medal for Distinguished
Service in Public Health.
Dr. James M.A. Weiss, ’51 M.P.H,
’50-’53 HS, the first professor of
psychiatry at the University of Missouri
and founding chairman of the
department at the University Health
Sciences Center in Columbia, will retire
Dec. 31, 1990. He will continue as a
full-time research professor at Missouri
in the medical school.
Drs. Paul Calabresi, ’55, physicianin-chief in the department of medicine
at Brown University, and David J.
Kupfer ’65, professor and chairman of
psychiatry at the University of
Pittsburgh Medical School, are newly
elected members to the Institute of
Medicine.
Dr. Eiji Yanagisawa, ’56-’59 HS,
clinical professor of otolaryngology at
Yale, won the World Festival of
Cinematography and Videography
Silver Medal at the September meeting
of the 14th World Congress of OtoRhino-Laryngology and Head and Neck
Surgery held in Madrid, Spain. His
winning videotape demonstrated the
contribution of aryepiglottic
constriction to ringing voice quality
Yale Medicine FallAVinter 1990-91

During Alumni Weekend 1990, John B. Ogilvie, M.D. ’34, received a
framed drawing of the Sterling Hall of Medicine and the thanks of Dean
Leon E. Rosenberg for serving as medical alumni chairman of the school’s
successful capita! campaign.

using videolaryngoscopic
documentation with acoustic analysis.
Dr. Robert W. Wroblewski, ’58,
after serving as director of oncology at
Akron General Center and Medina
General Hospital in Ohio, is now
director of medical oncology at Good
Samaritan Hospital in Vincennes, Ind.
Dr. Robert C. Wallach, ’60, has
left his position as departmental director
of obstetrics and gynecology at the Beth
Israel Medical Center to become the
director of gynecologic oncology at the
New York University School of
Medicine. He also is a professorial
lecturer at the University of Puerto Rico
School of Medicine.
Dr. Thomas B. Kirsch, ’61, clinical
associate professor of psychiatry at
Stanford University, is president of the
International Association for Analytical
Psychology, the professional
organization of Jungian psychoanalysis.
Dr. Robert L. Johnson, ’63-’64
HS, associate clinical professor at the
University of California San Francisco
and chief of otolaryngology at the
Children’s Hospital, is a lieutenant
colonel in the U.S. Army Reserve and a
consultant at Fetterman Hospital in San
Francisco. He also guest lectures at the
University at Jodpur in Rajaston, India.
Dr. Anthony Robbins, ’66,
professor of public health at Boston
University, directs the International

Commission of Physicians and
Environmentalists to Investigate the
Health and Environmental
Consequences of Nuclear Weapons
Production. The commission plans a
comprehensive review of the 1957
Kyshtym accident in the Soviet Union,
where a high-level waste storage tank
exploded. He also is treasurer of the
International Physicians for the
Prevention of Nuclear War.
Dr. Joan L. Venes, ’67 HS,
professor of surgery (neurosurgery) and
pediatrics at the University of
Michigan, was awarded a 1990-1991
Robert Wood Johnson Foundation
Fellowship in Health Policy to serve as
part of a one-year orientation and work
experience program in Washington,
D.C.
Dr. John J. Kelly Jr., ’69, ’69-’70
HS, professor of neurology at Tufts
Medical School, is senior neurologist
and director of neuromuscular service
and the electromyography laboratory at
New England Medical Center in
Boston.
Frederick G. Adams, D.D.S., ’70
M.P.H, Connecticut state health
commissioner, has been chosen to
advise federal expenditures in dental
research. He serves on the 17-member
panel of the National Institute of Dental
Research’s National Advisory Dental
Research Council.
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Ur. .John C. Lee, ’70-’72 HS. has
been appointed associate dean for
research and graduate studies at the
Virginia-Mar>'land Regional College of
VeterintuA' Medicine.
Ur. .John A. Daelev, '71
retired from the federal .seiA'ice in
JanuaiA 1990 to Arlington, Te.x.. after
42 years of combined military and civil
service. He .served as director for Region
VI, department of health and human
seiA'ices since 1981. Dr. Daeley received
the Federal Emergency Management
Agency’s Outstanding Public Service
Award in recognition of exemplary
serv ice as a regional emergency
management team director.
Ur. .John P. Fulkerson, '72,
professor of orthopaedic surgery' at the
University of Connecticut School of
Medicine, was named director of sports
medicine at the UConn Health Center
and as a physician for the Hartford
Whalers litK'key team. He is secretaryelect of the Arthroscopy Association of
North America, and is a member of the
American Orthopaedic Srx'iety of Sports
Medicine and the Sports Medicine
Committee of the American Academy
of Orthpaedic Surgeons. He received the
Bantam Award of Trinity College in
1 lartford for his care of athletes.
Matthew A. Kurs, 75 M.P.H.,
received the American Medical
International (AMI) 1989 Special
Achievement .Award. He is president
and chief executive officer of AMI St.
Joseph Hospital at Creighton University
in Omaha, Neb. He was previously
chief operating officer of AMFs Florida
region and AMFs central region in
Denver.
Ur. Mary I.ake Polan, '75, fomier
asscK'iate professor of obstetrics and
gynecology at Yale, has been appointed
chair of the department of gynecology
and obstetrics at Stanford University
Sch(H)l of Medicine and as chief of
gynecology and obstetrics services at
Stanford University Hospital.
Ur. (’arol I>. Kpstein, '76, was
appointed vice president of medical
affairs and chief medical officer of
ImmunoCien. Inc., a biotechnology
company based in Cambridge, Mass.,
s[X‘c'iali/ing in the treatment of cancer.
Prior to this ap|X)inlment, Dr. Epstein
'.' is vice president and director of
■ linicui affairs for Imnuinex Corp. and
■s c .(ant clirectDr of anti-inflammatory
' i.'l'niism and cardiovascular
'
Ayersi Laboratories.

Dr. O’dell M. Owens, '16, a
member of the University of Cincinnati
board of trustees, visited hospitals in
Moscow, Leningrad, Kharkov and
TTilisi during two weeks in July and
August in a program to evaluate laser
surgery in the Soviet Union.
Dr. Dennis U’Arcy Banks, 'll,
teaches freshman composition at the
University of Arizona while pursuing a
Ph.D. in English, with a concentration
in Native American Indian literature
and poetry. He also has received a law
degree and was a visiting scholar at
Harvard Law School.

Dr. Edwin Trevathan, ’82-’84 HS,
recently left his position at the Centers
for Disease Control to become medical
director for the department of
neurophysiology and director of the
pediatric epilepsy program at Scottish
Rite Children’s Medical Center in
Atlanta.

Dr. Stephen E. Levick, ’77-’82 HS,
began full-time private practice in
August 1989 at the Institute of
Pennsylvania Hospital where he also is
medical director of outpatient
evaluation services.
Dr, Richard D. Bey, '19, clinical
assistant professor of neurology at
Bowman Gray School of Medicine and
managing partner of Southeastern
Medical Imaging, has a private neurol¬
ogy practice in Winston-Salem, N.C.
Dr. Duncan K. Fischer
Robert V. Levine, '80 M.P.H, has
been appointed a member of the board
of directors of the Queens, New York,
chapter of the American Lung
Association.
Dr. David S. Weiss, '81, has been
named orthopaedic consultant to the
Juilliard School dance division. In
April, he delivered Grand Rounds at
Yale to the department of orthopaedics
and rehabilitation entitled “Scientific
and Practical Aspects of Knee
Rehabilitation Following Anterior
Cruciate Ligament Reconstruction."
Dr. David P. Norton, '83, is part of
a pediatrics group practice in Marin
County, Calif., and attends and teaches
at San Franci.sco General Hospital. He
also is a clinical faculty member at the
University of California San Francisco.

Dr, Charles M. Zacks, '84, has an
ophthalmology practice with a sub¬
specialty in cornea and external disease
at the Maine Eye Center in Portland.
Dr. Greg A. Sachs, '85, is assistant
professor of medicine at the University
of Chicago after finishing fellowships in
geriatrics and medical ethics.
Dr. Duncan K. Fischer, '86, a
neurosurgery resident at Baylor College
of Medicine, has won a $30,0(X)
American College of Surgeons
Scholarship for his research on human
brain tumor antigens and the production
of monoclonal antibodies.
Michael P. Krusch, '86 PA, is
pursuing an M.D. degree at the
University of Chicago Medical School.

.leannee P. Martin, '83 M.P.H, is
the executive director of the Hospice
Programs of Visiting Nurses and
Hospice of San Francisco, which have
been widely recognized for their costeffective and innovative care to persons
with HIV disea.se.

Dr. Glenn Isaacson, '88, has been
appointed director of pediatric
otolaryngology at St. Christopher’s
Hospital for Children in Philadelphia
and assistant professor of
otolaryngology and pediatrics at
Temple University School of Medicine.

(Jary F. Spinner, '83 PA, physician
assistant at the Hill Health Center in
New Haven, received the American
Academy of Physician Assistants'
Outstanding Physician Assistant of the
Year Award at its June annual
conference in New Orleans.

Drs. .loni Hansson, '89, an intern in
the department of medicine, and
Kathleen Stewart, '88-'90 HS, junior
assistant resident in the department of
medicine, received Samuel D. Kushlan
Awards for their contributions to patient
care during rotation through the
community medical .service.
Yale Medicine Fal IAVinter 1990-91

STUDENT NEWS
Second-year students May Chen and
Marlene Corujo were selected by their
classmates to receive the CIBA-GEIGY
Award for outstanding community
service. The students co-direct the Yale
chapter of Students Teaching AIDS to
Students, a national group of medical
students who teach high school pupils
about preventing the disease.
Sonya Erickson, a fifth-year
medical student, has been selected as
the student member of the American
Association of Medical Colleges’
Liaison Committee on Medical
Education for the 1990-1991 academic
year. As a member of the committee,
Ms. Erickson will participate in the
review and discussion of medical
school accreditation survey reports and
will take part in survey visits to medical
schools each year.
Terence L, Geiger, an M.D., Ph.D.
graduate student in the section of
immunobiology, has been named the
second recipient of the Miles Scholar
Award. Dr. Geiger’s research centers on
how the immune system learns to
distinguish foreign bodies, such as
bacteria and viruses, from its own
organism. The award covers tuition,
supplies and other costs, as well as a
two-year stipend.

(Above, from left) Madeline Cordero, Amy Freeman and Marisol Pagan were
among 16 minority high school students from New Haven who spent most of July
and August doing laboratory research at the side of some of the nation’s leading
scientists. The School of Medicine’s 11th annual Summer Research Apprenticeship
Program offered stipends to 13 students thanks to the National Institutes of
Health! Public Health Service Division of Research Resources: the medical school
itself funded three stipends. Researchers from the School of Medicine, epidemiology
and public health, and the John B. Pierce Laboratory took part in the program.
Class of 1992 medical students William Rodriguez and Adetokunbo “Toki”
Ayelese coordinated the weekly lecture series attended by the high school students.

(Below) Matthew Lemer, ’91, was one of eight Wilbur G. Downs Fellows from the
medical school and EPH to pursue research outside the United States during 1990.
Mr. Lemer gathered data on the relationship between malaria and anemia in a
pediatric population in Kenya, the subject of his M.D. thesis.

Hughes Institute
Funds Scholarships

^

The Howard Hughes Medical Institute
(HHMI) has awarded nearly $400,000
to the School of Medicine for graduate
training in the biomedical sciences. The
school will distribute money from the
grant, determined by the excellence of
graduate students working with HHMIsupported researchers, into three
programs to nature graduate research.
The HHMI grant will contribute
$122,400 to establish six new graduate
student fellowships, including three for
the new Neuroscience Graduate
Program; $265,400 will go to raising
biomedical graduate student stipends to
$12,900; and approximately $10,000
will help develop and support
computer-based facilities to promote
communication among graduate
students at scattered campus locations.
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COMMENCEMENT 1990

Four generations husk in the joy of Mark Miller's graduation.

.lennifer Mark and her proud father.
Richard Mark.

Dr. Charles A. Jane way Jr., professor of
inununohiology, biology and in the
Cancer Center, received the 1990
Bohmfalk Prize for teaching basic
science; Dr. Margaret J. Bia, associate
professor of medicine, won the Bohmfalk
Prize for clinical instruction.
YaleMkdicine
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Stacy Wills (left) and Christina
Wypijewski share in the anticipation of
receiving their M.P.H. degrees.

M.D. graduate Ron Ennis poses with his
son, Ariel, a candidate for the School of
Medicine Class of 2013.

AH Uhmed Ajani leads a contingent of graduating EPH students up the stairs of the Yale Repertory
Theater. Mohammad Zahid Ansari follows a step behind.
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DEVELOPMENT REPORT
The Kresge Foundation
Challenges YSM Alumns
rtic Kresge Foundation of Troy,
Mich., has awarded a $1 million
challenge grant to the School of
Medicine to support construction of
the Center for Molecular Medicine
(CMM). The award is contingent on
1) "b ale’s ability to raise the
remaining S5.45 million needed to
complete the S35.4 million project; 2)
an increase in the percentage of YSM
alumni/ae donors to the School of
Medicine Alumni Fund to 55 percent,
from the current 43 percent.
When the CMM opens next year, it
will represent (me of Yale's most
significant investments in basic
scientific research. More than 40
laboratories will help sustain
leadership in molecular genetics and
expand the scientific horizons in such
fields as neurobiology, oncology and
cardiovascular research. Biomedical
scientists at the center w ill explore
new directions in research outlined in
the work of Drs. Leon F. Rosenberg,
(ieorge Iftlade and other pioneers in
molecular and cell biology.
file School of Medicine has
launched a campaign of intensive
fundraising to meet the goals .set by
the foundation's grant. Over the next
year, the school will seek the support
from its alumni and friends, as well as
from corporations and foundations in
an effort to complete funding for the
( \FVL Already, progress has been
made toward increasing the
percentage of contributions from
alumni/ae; at least 50 corporations
and foundations have been contacted
as potential donors, as well.
I'he Kresge l-'oundation joins an
arra\ ol (irgani/ations which have
supported Yale in this venture. The
W .\f Keck Foundation, the Ira W.
DeCamp Foundation, the Lucille B.
Markey Charitable 'I'rust and the
Ihw-ard Hughes Medical Institute
h.i\e (ommitled funds for the center's
coiisiMkiiDn and its research programs.
I ' :i iishcd in 1024, the foundation
' [ident, private foundation
• personal gifts of

Sebastian S. Kresge. The foundation
supports institutions of higher
education, health and long-term care,
arts and humanities, social service,
science and environment, and public
affairs. Its grants fund projects
involving construction or renovation
of facilities and purchase of major
capital equipment or real estate.

The Gesell Institute
Endows Professorship
Dr. Arnold Gesell, founder of child
development at Yale and the creator
of the institution which became the
Child Study Center, has been honored
by the creation of the Arnold Gesell
endowed professorship for an
assistant or associate professor in the
Child Study Center. The chair is made
possible by a major gift from the
Gesell Institute and marks the
reintegration of the work of Arnold
Gesell and his collaborators into the
Child Study Center and Yale
University.
Arnold Gesell came to Yale in
1911 after earning his Ph.D. degree at
Clark University and starting medical
school at the University of Wisconsin.
His first appointment was as assistant
professor of education. In 1915 he
earned his M.D. degree from Yale and
was rapidly launched on creating a
new discipline, spanning the
emerging fields of child psychology,
pediatrics and mental hygiene.
For the next four decades, he and
his closest collaborators, including
Frances L. Ilg, M.D., and Louise
Bates Ames, Ph.D.. laid the
foundations for the scientific study of
the maturation of behavior, through
their rigorous testing of normal and
developmentally impaired infants and
children. Their pathbreaking work
was reported in a series of books and
reports translated into many
languages for professionals, parents
and social policy planners. The Gesell
method became the framework for all
subsequent approaches to
developmental assessments.
Dr. Gesell and his collaborators
left Yale at the time of his retirement

in 1948 and organized the Gesell
Institute for Human Development in
New Haven. The Gesell Institute
began providing a range of services,
primarily for younger children,
including a nursery school and
developmental clinics. In addition, the
institute offered a national lecture
series and psychological consultation
to schools throughout the United
States. This work continued after Dr.
GeselFs death in 1961.
Over the last two years, the board
of the Gesell Institute, chaired by
Howard Kahn, Ph.D., and with the
scientific guidance of Dr. Louise
Bates Ames, conducted a review of
the institute's policy. This led to the
decision to emphasize the national
lecture series, and to scale back
clinical programs in New Haven.
Toward these ends, the Gesell
Institute has sold its two buildings to
Yale, where the institute retains
offices. Some proceeds from the sale
have gone to create the Gesell
professorship, to assure the long-term
continuation of the academic and
clinical work in the spirit of Dr.
Arnold Gesell.

Fulton Book Fund
Established at Yale
The Lucia P. Fulton Book Fund, an
endowed book fund in memory of Mrs.
John F. Fulton, has recently been
established at the Harvey Cushing/John
Hay Whitney Medical Library. Mrs.
Fulton, who died in April 1989, was the
widow of Dr. John F. Fulton. She was a
devoted supporter of the Medical
Library and the History of Medicine at
Yale.
Following Dr. Fulton’s death in 1960,
she continued for three decades to
extend her hospitality to faculty and
students at Mill Rock, her home in
Hamden. Contributions to this book
fund may be send to Ms. Bella Berson,
director, Harvey Cushing/John Hay
Whitney Medical Library, 333 Cedar
St., P.O. Box 3333, New Haven, CT
06510.
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Samuel P.W. Black
Samuel P.W. Black, M.D., one of the
founders of the University of Missouri
Medical School, died of a heart attack
on June 9 at his home in Cornwall,
Conn. He was 73.
Dr. Black, professor of neurosurgery
at the University of Michigan from
1955 until his retirement in 1982,
continued his research and writing
about aneurysms as professor emeritus.
A native of Barbourville, Ky., Dr.
Black graduated from Choate School in
1936, Yale University in 1940 and
Johns Hopkins School of Medicine in
1943. After active duty in the Pacific
during World War II, he returned to
Yale for his residency in neurosurgery
and joined the Yale faculty in 1950.
Five years later he helped found the
University of Missouri Medical School.
He authored and co-authored more
than 40 journal articles and was a past
president of the Missouri State
Neurological Society. Among his
medical society memberships were the
American College of Surgeons and the
American Association of Neurological
Surgeons.
A skillful mountaineer, Dr. Black
had been on climbing expeditions all
over the world.
He is predeceased by his wife, Betty
Lohman Black. He leaves two
daughters, Susan Norling and Nancy
Montgomery; two sons, John and
Samuel; and six grandchildren.
Contributions may be sent to the
University of Missouri Medical School,
1 Hospital Dr., Columbia, MO 65212.

OBITUARIES
National Academy of Sciences and the
World Health Organization.
During his career he served as
chairman of the New York State Drug
Abuse Advisory Commission and
president of the American College of
Neuropsychopharmacology. Dr. Brill
repeatedly warned of the hazards of
marijuana and opposed its legalization.
A native of Bridgeport, Conn., Dr.
Brill earned his bachelor’s and medical
degrees at Yale, in 1928 and 1932. He
interned at Pilgrim State Mental
Institution and was its clinical director
for eight years before his promotion to
director.
He is survived by his wife, Wenonah
Beale Brill; a son, Michael; two
daughters, Helen Broxmeyer and Jean
Hough; and four grandchildren.

Ward J. McFarland

Henry Brill
Henry Brill, M.D., former director of
the Pilgrim State Psychiatric Center in
West Brentwood, Long Island, died of
cancer on June 17 at the Good
Samaritan Hospital in West Islip, Long
Island. He was 83.
A psychiatrist and authority on drug
addiction. Dr. Bril! helped introduce the
use of tranquilizers in New York State
mental hospitals to foster the early
release of patients. He was the first
deputy commissioner of the state’s
Department of Mental Hygiene, its
regional commissioner for Long Island
and later a consultant.
He was a clinical professor at the
Downstate Medical Center in Stony
Brook, Long Island, and for decades
served as a drug consultant for many
state and federal agencies, including the
American Medical Association, the

Yale Medicine
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Pennsylvania and from 1957 to 1961
served as professor of surgical
pathology at the University of Alabama
Medical Center. He went on to become
a clinical professor of pathology at New
York Medical College; director of
clinical laboratories in Ramsey, N.J.;
corporate medical director of Becton
Dickinson and Co. in Rutherford, N.J.;
and adjunct professor of pathology at
Farleigh Dickin.son University in
Teaneck, N.J.
Dr. Collier was a member of the
American Association of Pathologists
and Bacteriologists, the International
Academy of Pathology, American
Society of Clinical Pathologists, and the
United States and Canadian Academy
of Pathology, Inc. He also was a
member of the Pathology Advisory
Committee of the Southeastern Cancer
Chemotherapy Study Group; the board
of directors for the Harkins Medical
Research Foundation and the
subcommittee on neonatal
hypothyroidism of the National
Committee for Clinical Laboratory
Standards.
Dr. Collier retired in July 1989 to
pursue his interests in writing, sailing
and traveling.
He is survived by his wife, Rosalie;
two sons, Wade and Fred; and one
daughter, R. Samantha Collier.

Dr. Fred Collier

Fred Collier
Fred Collier, M.D., died April 19 at the
age of 66.
A native of Topeka, Kan., Dr.
Collier earned a B.S. degree from
Sheffield Scientific School of Yale
University in 1944 and an M.D. degree
from Yale School of Medicine in 1946.
He interned at the Medical College of
Virginia and served pathology
residencies at Yale, New Britain
General Hospital and the Cleveland
Clinic. He was a private first class in the
medical administrative corps during
World War II.
In 1956, he was associate pathologist
at the Hospital of the University of

Ward J. McFarland, M.D., an
orthopaedic surgeon, died April 6 at
Lawrence and Memorial Hospital in
New London, Conn. He was 75.
A native of Caspian, Mich., Dr.
McFarland graduated from Yale
College in 1936 and from the School of
Medicine in 1939. He interned at New
Haven Hospital and served residencies
at Newington Children’s Hospital and
Grace-New Haven Hospital. He was a
captain in the Army Air Force during
World Wai- II.
Dr. McFarland was chief of the
medical staff and orthopedic surgery at
Lawrence and Memorial Hospital in
New London for more than 20 years
and was in private practice from 1949
until his death. He also was a consultant
for Uncas-on-Thames Hospital in
Norwich, Conn., and the U.S. Coast
Guard Academy Hospital in New
London.
A diplomate of the American Board
of Orthopaedic Surgery and a fellow of
the American Academy of Orthopaedic
Surgery, Dr. McFarland was honored
with the American Medical
Association’s Physician’s Recognition
47

Award in 1973 and 1976. He wa.s a
member of the .American Medical
A.ssociation and the Alumni
.Asstx;ialion of Newington Children's
Hospital.
1 le was predecea.sed by his wife,
.Mar\ Luise Heniy', iind is surv ived by a
son. Dr. Ward J. .McFarland Jr.; a
daughter. Natalie .M. Black; and three
grandchildren.
.Memorial contributions may be
made to 1 lospice of Southeastern
Connecticut, c/o Utwrence and
Memorial Hospital, 325 Montauk Ave.,
New London, CT 06320.

OBITUARIES

Arnold B. Rilance
.Arnold B. Rilance, M.D., died of ciuicer
on .May 13 at the Potomac Valley
Nursing Home in Main land. He was 82.
.-\ native of Montreal, Dr. Rilance
became a U.S. citizen in 1942 and was
a practicing physician in New Haven
from 1944 until his retirement in 1986.
1 le also was an attending physician at
Yale-New Haven Hospital and the
Hospital of St. Raphael. .A 1931
graduate of McGill University Medical
Sclux)l, Dr. Rilance worked as an
assistant resident at Trudeau Sanitarium
and as a senior physician at Laurel
Heights Sanitarium until 19-44.
During his career. Dr. Rilance served
as asscK'iate clinical professor of
metlicine at Yale University luid acting
director at the Bureau of Tuberculosis
Control. Department of Health, New
1 Liven. 1 le was a fellow and governor
for Connecticut’s American College of
Chest Ph> sicians; past president of the
.American Trudeau ScK'iety; and a
member of the American, New Haven
and Connecticut medical siK'ieties. In
1963, he w as the first recipient of the
David Russell Lyman Memorial
frophy. presented annually by the
fuberculosis and Health Association of
the New 1 Liven Area Inc.
1 le was predeceased by his wife,
Ldith Marshall Rilance. He leaves three
daughtcl^. Jane Keefer. Nancy Rilance
and Janet Rilance; anti a granddaughter.

Lewis A. Scheuer
Lew is A. Scheuer. M.D.. tiled of colon
cancer May 26. 1 le was 87.
I )r. Scheuer. a 1928 graduate of the
.St hix)l ot Metlicine. completed an
inlemship at (irace 1 lospital and a
[vtlialric resitlency at the New York
I'oundling Hospital, where he remained
as a staff memlvr. I le maintaineti a
prat lice in New 'I’ork lor more than 50
years.
■4 is

physician at Grace-New Haven
Community Hospital, where he served
as f)ediatrician-in-chief for nine years.
He was the author of more than 70
scientific publications and two books.
In 1964, the American Academy of
Pediatrics bestowed on Dr. Senn the
first C. Anderson Aldrich Award in
Child Development and in 1970 the
American Psychiatric Association
honored him with its Agnes Purcell
McGavin Award for his outstanding
contributions to the prevention of
emotional disorders in children.
He is survived by a daughter, the
Rev. Corelyn Senn, and two
grandchildren.
Contributions may be made to the
Children’s Defense Fund, the Nature
Conservancy or Connecticut Hospice.

Rudolph E. Vandeveer
Dr. Milton J.E. Senn

Milton J.E. Senn
Milton J.E. Senn, M.D., an expert in
child psychiatry, died on June 8 of
bladder cancer at the Connecticut
Hospice. He was 88.
Dr. Senn was chainnan of the Yale
pediatrics department from 1951 to
1964 and director of the Child Study
Center from 1948 to 1966. After
retiretiient in 1970, he remained as
Sterling Professor Emeritus of
Pediatrics and Psychiatry at Yale and
became vice president for child studies
of the Eield Eoundation of New York
City.
An activist for children’s issues, he
helped found the Children’s Defense
Eund and traveled extensively to gather
firsthand evidence of child hunger and
ill health for Congress and compiled an
oral history of the child development
movement for the National Library of
Medicine.
A native of Milwaukee, Wis., Dr.
Senn was a 1925 B.A. degree graduate
of the University of Wisconsin and a
1927 graduate of its medical school. He
became a fellow in pediatrics at
Washington University in St. Louis luid
in 1939 was named professor of
pediatrics and psychiatry at Cornell
University Medical College and
director of the Institute for Child
Development at New York Hospital.
Eight years later he became attending
[K'diatrician at New York Hospital and
the follow ing year became attending

Rudolph E. Vandeveer, M.D., died June
25, 1989, in the Health Science Center
in Syracuse, N.Y. Dr. Vandeveer, who
died of injuries suffered in an
automobile accident, was 83.
A native of Detroit, Mich., and
resident of Winter Park, Ela., Dr.
Vandeveer was a graduate of Staunton
Military Academy, the University of
Michigan and a 1932 graduate of the
Yale School of Medicine. He served his
internship at Haiper and Children’s
Hospital in Detroit, pediatric residence
at Eord Hospital and Keifer Contagious
Children’s Hospital and his allergy
residency at New York Ho.spital of
Cornell University. He became a fellow
of the American Academy of Pediatrics
in 1943 and of the American College of
Allergists in 1944.
Prior to his retirement in 1981, Dr.
Vandeveer was a pediatrician/allergist
associated with Dr. John Hoes in Rome,
N.J. He was affiliated with Rome
Hospital, past president of the Oneida
County Medical Society and the Central
New York Academy of Medicine, and a
member of the Central New York
Pediatric Club and the America Medical
Association. Dr. Vandeveer also was a
member of the Rome Board of
Education, on which he served as
president for two years.
He is predeceased by his wife, Ellen.
He leaves three sons, Lauren, Peter and
James; luid eight grandchildren.

Yale Mkdicine FallAVinter 1990-91

Harold T. Vogel

Memorials

Harold T. Vogel, M.D., a retired
pediatrician from Queens, N.Y., died
May 19 of a heart attack at South
Nassau Community Hospital in
Rockville Centre, Long Island. He was
90 years old.
Dr. Vogel graduated from Yale
School of Medicine in 1924 and was a
charter member of the Queens Medical
Society. He joined the Flushing
Hospital staff in 1930 and served as
director of pediatrics from 1946 to
1966. He also was a board member of
the hospital. He retired at 78.
He was predeceased by his wife,
Madeleine Bauer. He leaves two
daughters, Karen Vorhees and Carla
Leon; seven grandchildren, and a great¬
grandchild.

Deceased medical alumni and friends
may be memorialized by a gift to the
School of Medicine Alumni Fund
endowment in the name and class of
the person so honored. The next-ofkin of a deceased medical alumnus/a
is advised about this In Memoriam
Program by mail sometime after the
School of Medicine receives
notification of the death. The letter of
information includes a copy of the
Testament of Remembrance in which
the names of all persons so
memorialized are listed in the medical
section by class, thus establishing a
lasting memorial. Donors receive a
personally penned note of
appreciation from the In Memoriam
Program director.
Deceased alumni and friends so
honored in 1989-1990 were:

John J. Wolfe
John J. Wolfe, M.D., died April 21 at
the age of 86.
A native of Dublin, Ireland, Dr.
Wolfe practiced in Louisville, Ky., as a
maxillofacial plastic surgeon from 1946
until his retirement. A graduate of the
Royal Dental Academy in London, he
also attended Columbia Lfniversity
Dental School and taught at New York
University Dental School. He graduated
from Yale School of Medicine in 1933.
In 1933, Dr. Wolfe began work for
the Rockefeller Foundation’s School of
Medical Nursing and Research and in
1939, practiced and taught in
missionary hospitals throughout South
India and served on the staff of the
BiJay Singh Hospital in Bikaner,
Rajasthan. During World War II, Dr.
Wolfe joined the 10th Air Force and
was instrumental in bringing Chinese
troops to India. Upon his discharge as a
colonel, he was awarded U.S.
citizenship.
He served as head of the department
of plastic surgery at the University of
Louisville Medical School, and was a
member of the American Board of
Plastic Surgery, the American College
of Surgeons, the American Society of
Maxillofacial Surgeons, the American
Society of Plastic and Reconstructive
Surgery and the Kentucky Medical
Association.
He is survived by his wife, Jill, and a
daughter, Julia.
Memorial contributions may be
made to the Yale University School of
Medicine, Office of Development,
Parkinson’s Disease Research, P.O.
Box 3333, 350 Congress Ave., New
Haven, CT06519.
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Donato Anthony D’Esopo, ’24
Albert Jablonsky, ’27
Grillwork at the Yale Medical
Historical Library

Robert I. Rubinstein, ’28
Vincent A. Doroszka, ’30
Robert Watkinson Huntington Jr., ’33
Francis P. Guida, ’34

IN MEMORIAM

Ward J. McFarland, ’39
Arthur S. Tucker, ’39

Howard A. Wood
November 22, 1989

’25 M.D.

Joseph P. Kriss, ’43
Paul E. Molumphy, ’44

Samuel J. Stabins
January 27, 1989

’26 HS

Charles Sheldon Judd Jr., ’46
Richard G. Britton, ’47

Robert I. Rubinstein
May 1, 1990

’28 M.D.

Lewis A. Scheuer
May 26, 1990

’28 M.D.

Harold E. Harrison
October 2, 1989

’31 M.D.

Paul E. Huston
November 21, 1988

’39 M.D.

Ward J. McFarland
April 6, 1990

’39 M.D., ’49 HS

Edward Foord, ’47
Lawrence C. Perry, ’47
Russell J. Barmett, ’48
Boy Frame, ’48
Class of 1950 Scholarship Fund
John Currier Gallagher, ’58
Robert Joseph Polackwich, ’73
David J. Kreis Jr., ’77
Hans Graichen (faculty)
Mrs. Bieggi (friend)

Lawrence P. Shea
February 13, 1990
Ame G. Haavik
January 1, 1990

’47 M.D.

’56 M.D.

Richard G.Jordan
Director, In Memoriam Program

Douglas W. Johnston ’64 M.D., ’66 HS
November 30, 1989
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ALUMNI WEEKEND

An Alumni Weekend panel on the "Ethos of Public Health" included (from left} Drs.
Burton //. Singer. Lawrence Crowley, Stephen Joseph, and Susan Addiss. M.P.H.
This )ear Medical Alumni Weekend
attracted nearly 4(X) alumni/ae. A most
extraordinary dedication ceremony of
the new Harvey Cushing/John Hay
Whitney Medical Library ushered in the
weekend on Tliursday afternoon. June
7. The ingeniously expanded space
contains the technology for the most
sophisticated computer systems for
medical infomiatics. It deserxes
inspection by everx' alumnus/a.
The reunion ke) note speaker. Dr.
Stephen C. Joseph. '63, commissioner
of health for New York City from 1986
to Hf-X), drew a record attendance on
I riday. fhe detailed description of his
attempts to moxe public policy to
control the rapidly proliferating AIDS
epidemic in New '^'ork City provoked
lively audience questions and dialogue.
I le explained the shifting character of
the epidemic, which is affecting more
women and children as a consequence
of increasing dmg abuse. [See "Public
Policy in the Age of AIDS," page 5|
Reunion 1990 celebrated the 75th
litniversarx of the .Sch(X)l of Medicine's
di ■ irtment of epidemiology and public
h-'.ilt! 1 PPl I) and saluted the Univer■ i '. ; oinmitment to strengthening
io.i in tills field. Dr. Joseph's talk
■ d ihe political, economic and
hich are crucial to

function in the field, and are thereby
required as elements in the curriculum.
Dr. Joseph joined the panel on the
follow ing morning to discuss the theme:
"The Ethos of Public Health: A
Challenge for Medicine in the 21st
Century.” Also on the panel was Dr.
Burton H. Singer, recently appointed
EPH chainnan, who described newly
articulated plans for broadening and
integrating training in medicine, nursing
and public health to meet the challenges
of a new centurv'.
Dr. William L. Kissick '57, as
moderator, presented the dramatic
history of his three decades as a
physician in public health. The revival
of the ethos of public health is crucial if
medicine is to fulfill its promise as a
profession.
Ms. Susan Addiss. M.P.H. '69.
reviewed the distinguished history of
public health at Yale. As a working
professional in the field, she described
her own role as "continuously defining
the unacceptable"; she added that her
hofie for the years ahead in community
health, was to be able to conquer the
“unacceptable."
Dr. Joseph, in de.scribing the
harrow ing "second epidemic" of drug
abuse complicating HIV infection,
detailed the politics of poverty, w ith

special emphasis on women and
children. He painted an intriguing
picture of public health challenges
which are global and ecological,
including not only infections (HIV,
malaria) but also environmental
pollution (global warming), problems
which require professionals whose
vision has no boundaries.
Dr. Lawrence Crowley, '44, former
chancellor and dean of medicine at
Stanford University, outlined the
emerging need for settings other than
tertiary care hospitals for training
tomorrow's physician. Ambulatory
settings of varied character are needed
to address many of the issues posed by
the other speakers, and in a setting
where nurses, public health workers, as
well as physicians, work together in
improving the health of patients. He
presented as examples the University of
Washington School of Medicine and
the pediatrics program at North
Carolina at Chapel Hill. This was a
sobering and thought-provoking hour.
The faculty lectures on Saturday
morning presented varied subject
matter. Best attended was the seminar
in psychiatry. Dr. Eric J. Nestler
described the ways in which molecular
chemistry and physics are entering the
arena of clinical medicine and
psychiatry', including treatment for drug
addiction. Dr. Robert B. Innis also gave
a fascinating presentation about how
new imaging techniques are helping
redefine the function and malfunction
of the living brain. His laboratory team
is paying special attention to the
molecular chemistry' and genetics of
schizophrenia.
Presentations by Drs. Henry R.
Black and Barry L. Zaret outlined major
research in the treatment and prevention
of heart disease. Dr. Black summarized
the identification and modification of
cardiovascular risk factors; his talk
featured investigations of hypertension
and hyperlipidemias w hich have led to
effective preventive measures.
Dr. Zaret described a projected
cardiovascular rehabilitation hotel, with
construction planned to begin in 1991.
This 4(X)-unit facility, known as the
Vivatat Pavilion, should provide
scientifically based behavior
modification programs with attention to
both nutrition and exercise. This center
Yale Medicine

FallAVinter 1990-91

will combine the medical center’s
scientific expertise with private
enterprise resources to offer preventive
measures to individuals who manifest
risk factors for future disease.
The session moderated by Ms. Merle
Waxman, director of the Office for
Women in Medicine, was attended by a
capacity audience. Alumnae who spoke
included: Drs. Alice Shepard Cary, '43,
(35 years of primary care practice in
Kyoto, Japan); Margretta Seashore, ’65,
(20 years in academic practice of
pediatrics and genetics at Yale); and
Jane Carter, ’85, assistant professor,
department of anesthesiology.
Reflections on their medical education
and subsequent careers provoked lively
dialogue among members of the
audience. The issue of integrating
successful marriage and parenting with
practice and teaching dominated the
discussion. The problem of ascending
the promotional ladder in academic
medicine was also a major topic. Susan
Baserga, M.D., Ph.D., ’88, presented a
history of coeducation at the medical
school. The popularity of this
presentation suggests it might warrant
repetition at future reunions.
Dean Rosenberg’s “State of the
School” report at the A YAM annual
meeting on Saturday described the
spiectacular and moving dedication of
the recently completed Harvey
Cushing/John Hay Whitney Medical
Library. Dedication of the Yale
Psychiatric Institute took place this past
winter; and progress on construction of
the Center for Molecular Medicine
continues, with its dedication scheduled
for June 6, immediately prior to next
year’s reunion. The architects
responsible for each of these three
facilities are of international renown,
and the buildings will become
landmarks in American architecture.
Major expansion of Yale-New
Haven Hospital is planned and will
include a new children’s hospital
facility. The involvement of a
distinguished commercial urban
developer in the community contiguous
to our medical center promises to
change the face of our campus and to
provide an attractive, unified
architectural plan.
Recent ambitious and crucial
investments in the future of the School
of Medicine have required the support
of its friends and family as never before.
To date it has received such assistance
in record fashion. Dr. John B. Ogilvie,
’34, chairman of alumni contributions
for the Campaign for the Yale School of
Medicine, reported that 65 percent of
Yale Medicine FallAVinter 1990-91

our graduates contributed, providing
more than $15 million of the total $155
million raised. Dr. Ogilvie unveiled a
bronze plaque recording names of
major alumni donors; this will be placed
at the entrance of the newly completed
medical library. For his dedicated
perfomiance as chairman. Dr. Ogilvie
was presented a framed painting of the
Sterling Hall of Medicine.
Dr. Martin Gordon, chairman of the
nominating committee, presented the
nominees for appointment to the
executive committee of A YAM, and as
delegates to AYA. They were
unanimously elected by the assembly
and include: Executive committee:
Bennett L. Blitzer, M.D., ’73; Harold D.
Bomstein, M.D., ’53; Michael
Kashgarian, M.D., ’58; Forrester A.
Lee, M.D., ’79, HS ’81; William A.
Whalen Jr., M.D., ’53, HS ’59; AYA:
Martin E. Gordon, M.D., ’46; MarieLouise T. Johnson, M.D., ’56.
The second annual reunion dialogue
and tea held in the historical library was
particularly engaging this year. The
speakers, Drs. Howard Spiro and
Shirley McCarthy, with Dr. Arthur
Ebbert as moderator, skillfully
established the intended dialogue and
engaged the audience in discussion. The
topic, “Humanism in an Era of High
Technology,” evoked wide-ranging
comments about the apparent erosion of
the doctor-patient relationship in an age
of increasingly complex knowledge.
The difficulties in teaching “humanism”
in any era were also discussed.
The reunion dinners, in various
locations, were well received,
particularly the Eriends of the 50th
dinner for the Class of 1940; the classes
of 1935, 1930 and 1985 were honored
at this party as well. With more than
100 guests at the Graduates Club, the
group was greeted by Dean Rosenberg.
A record 12 members of the 50th
reunion class attended. Also present
were Dr. John Mendillo and Dr. Knox
Einley, celebrating their 60th reunion;
and Dr. Samuel Kushlan, celebrating
his 55th. Toastmaster Lawrence Pickett,
’44, paid special tribute to Dr. Lee
Sannella of the 50th-reunion class,
whose family had presented a
scholarship fund honoring his late
father. Dr. Salvatore Sannella, of
Springfield, Mass. Dr. Lee Sannella’s
mother, Mrs. Susan Sannella, age 94,
was present and was saluted by all those
assembled. Representing his Class of
1985, Dr. Ered Santoro, the class agent,
extended greetings from the 30 guests
assembled at their fifth reunion.

While overall attendance this year
averaged that of 1989, attendance at
each scheduled event was nearly double
that of past years. The reunion class
programs were exceptionally well
structured and the panel discussions
superlative. Efforts to improve certain
factors, such as faculty attendance, will
continue to be pursued. Eoremost,
because almost all participants seemed
to enjoy basking in nostalgic
reminiscence, the primary goal of the
weekend was achieved.
Dr. Nicholas P.R. Spinelli, '44
Former Director, Alumni Affairs

Association of
Yale Alumni in Medicine
Thomas P. Kugelman, M.D. ’60,
President
Muriel D. Wolf, M.D. ’59,
Vice President
Gilbert E. Hogan, M.D. ’57,
Secretary
Dwight E. Miller, M.D. ’56,
Past President
Executive Committee
Bennett L. Blitzer, M.D. ’73
Sharon L. Bonney, M.D. ’76
Harold D. Bomstein, M.D. ’53
Jay H. Hoofnagle, M.D. ’70
Michael Kashgarian, M.D. ’58,
HS ’63
Forrester A. Lee, M.D. ’79, HS
’81
Nicholas M. Passarelli, M.D. ’59
Dorothea R. Peck, M.D. ’43
William A. Whalen Jr., M.D.
’53, HS ’59
Representatives to the
Association of Yale Alumni
Fredric K. Cantor, M.D. ’62
Lycurgus M. Davey, M.D. ’43
Martin E. Gordon, M.D. ’46
Marie-Louise Johnson, M.D. ’56
Kristaps J. Keggi, M.D. ’59
Gioacchino S. Parrella, M.D. ’41
R. Leonard Kemler, M.D. ’43
Chairman
Medical School Alumni Fund
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DISTINGUISHED SERVICE AWARDS
Louis J. Kaplan
The faithful and dedicated service you rendered to the
graduates of the School of Medicine as associate dean for
alumni affairs during the years 1971 through 1985 is warmly
and gratefully remembered today.
You skillfully and wisely guided the leadership of our
Association and helped to build an organization which has
become an important source of support for the school, its
students, and alumni/ae. In a brief decade, you earned the
affection and respect of our alumni throughout the country.
Many came to know you especially well at their annual
reunions. They responded in 1985 by electing you an
honorary member of the Association of Yale Alumni in
Medicine for your lifetime.
With the passage of time, the value of your directorship
grows ever more apparent as our Association continues to
mature. For your enduring counsel and contributions to this
process we honor you.

Harry M. Zimmerman, M.D.
Class of 1927

Dr. A. John Anlxan

A. John Anlyan, M.D.
Class of 1945
Ir is 50 years since you were transplanted fron] Ale.xandria,
liyypt. to Yale and to its medical school for your education.
You have been a devoted alumnus of Yale for half a century.
You graced the medical Class of 1945 with your
individualistic and continental wit and manner for which you
were famous on campus. Completing medical school as an
AOA graduate, you commenced practice as a thoracic
surgeon in San Francisco after educational pauses at the
Memorial Sloan-Kettering Institute in New York. Ohio State
University and the U.S. Navy.
W ith your beloved wife. Betty Ann. you have been active
among our California alumni contingent since the 1950s.
Your loyalty and generosity to our school has been constant
and e.xtraordinary. The Aniyans have repeatedly hosted social
rvi-nts in the Bay area of California as gracious ambassadors
■ the Yale School of Medicine. You have been a role model of
th di'.tant alumnus leader who provides a regional and
naii.iiud identity for our medical center.
It i - inr your unwavering and always positive response to
/ •“
your school has made of you. and for your wise
//■
• ounsri (o leaders of the School of Medicine, that
aion honors you.

Drs. Harvey Cushing and Milton Winternitz were your
teachers and mentors at Yale over 60 years ago, and you
proceeded to forge a brilliant career as a pioneer in the field
of neuropathology. Your extraordinary talent as a teacher of
pathology was to make you a legend among the graduates of
Yale Medical School during the two decades you seiwed as a
faculty member. Although your career brought you
distinguished posts at tw'o prestigious medical schools
thereafter, the affection and respect of your Yale students has
brought you back to New Haven and to your students’
reunions almost annually as their guest. You have continued
to be our teacher and school historian.
As you approach your ninth decade of life, you continue to
teach with the same energy, charisma and wonder of your
youth. Your former students now number in the thousands
throughout the world. September 1990 will find you lecturing
to some of them in Kyoto, Japan.
For your abiding love and service to Yale and her alumni
we thank you.
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Louis J. Kaplan (left) with Dr. Nicholas P.R. Spinelli, a 1988 Distinguished Service Award recipient.
Dr. Spinelli received a plaque at this year s award ceremony, citing his service as YSM director of
alumni affairs. He retired in October.

Dr. Harry M. Zimmerman (center) flanked by his wife, Miriam, and Dr. Kno.x H. Finley, '30.

Yale Medicine

FallAVinter 1990-91

53

REUNION REPORTS
Photos by Harry Bishop

Dr. Ia’c Sunnclla.'4(), (center) pauses from his conversation with classmates Richard
Durmont and John Halew

1940
5()th-year reunion
hy Dr. Donald C. Johnson
It is a great pleasure to have the
opportunity to report to you all on the
5()th reunion of our class. In spite of the
losses in our class roster, illness, and
other reasons for not attending, there
were 16 menibers of our class who
w ere able to make it. Of these, 14 came
to the "Friends of the .“iOth” dinner held
at the Graduates Club on Elm .Street in
New Haven.
It was awesome to see how New
I laven has grown — not always as
some might have liked it to — but grow
it has. And so has the medical school
area. It was a thrill to see the new
CushingAVhitney labrary', which was
dedicated on I'hursday, June 7th.
'I'wo individuals in our class came to
a reunion for the first time — Dick
Dormont, recently retired, from Minot,
N.D.. and Ike Eefevre, who left his
general medicine practice in Coeymans,
N.Y.. Just outside Albany. It w'as good
til see them both after .SO years. Ike's
channing w ife. Helen, came with him.
The dinner the medical school gave
111 luir honor also was attended by
I'lMiii trom classes before us — and I
I. .. to >how what .SO years w ill do for

and to you — the Class of 198S was
also in attendance. How young they
seem! The highlight of the evening was
the recognition of Lee Sannella's
family for their contribution of $S0.(XX).
Lee, of course, was present and so was
his 92-year-old mother, who seemed to
be having a ball! It is a great thing that
the Sannella family has done, and I am
sure the entire class joins me in
expressing our gratitude.
The following came to the dinner on
Saturday evening: Ron Beckett, still
active at Hartford Hospital, brought
Eunie Wells, who reports on Jack in a
nursing home with Alzheimer’s. Dick
Domiont also attended. Jack and
Rosemary Haley, who now live in
Wallingford, Conn., semi-retired (Jack
does some office gynecology); both
look great and have changed ever so
little since our last encounter. Hank and
Ellen Humphrey are just fine; he loves
retirement, both have time to do what
they want, which includes visiting
grandchildren. Henry is better since
surgery for the spinal problem. Stu
Irons came from Florida. He’s doing
well in retirement; his wife died some
time back.
It was good to see Bill Lee again,
who has retired to Bath, Maine. He still
plays a mean game of tennis. I’m told.
Ike Lefevre has not as yet completely

retired but is heading rapidly in that
direction, he says. Jack MacAllister
came, and it was good to renew contact
with him. He and I drove back to
Portsmouth, N.H., where he now lives
in the Strawberry Banke area in a
charming old restored house. Pat
Emerson is now remarried to a Yale
graduate, Sheffield, and medical school
Class of 1943. Pat and Wes now live in
Cotuit on Capte Cod. It was just great to
see Helen Haury Woods again. Dick
has been laid low with his chronic
hepatitis and seems a bit frail. Helen
also has been having trouble with the
spinal stenosis problem. Although Dick
didn’t make the dinner, both came to
Jim’s brunch on Sunday.
It was great to see Eddie and Martie
Martin. Eddie is still practicing in New
Britain. Both look wonderful and have
changed little, if at all, in the past 10
years. Jim and Iz Ferguson, both their
usual selves, were hosts for the Sunday
quiche brunch, and delicious it was. We
all had a marvelous time. “Old Ferg”
seems to be doing well, although his
back is a bit troublesome and he has had
to curtail his strenuous athletic
endeavors. The honorary member of
our class, (ilene Fitzpatrick, and his
wife came to the brunch and it was
great to see them both again.
As for me, your class amanuensis, I
continue my volunteer jobs with the
Red Cross, with local AIDS education
endeavors, and have finished a tour of
duty on a committee to advise the
commissioner of human services in
Maine regarding AIDS. Despite some
prostatic surgery, I manage to get
around, bogged down by excess weight
and the attendant dietary indiscretions.
1 am planning to send to all members
of the Class of 1940 an update of things
I could not include in this column
because of lack of space; so bear with
me. Best Wishes.

1945
45th-year reunion
by Dr. Frederic M. Blodgett
The School of Medicine held its 45th
reunion June 8th and 9th. We began on
Friday, the 8th by attending the class
seminar in the Beaumont Room. There
we heard from Drs. Atwood. Breck,
Yale Mcdicine
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Gardam, Reiner, Laupus and Alice
Shepard Cary, and were reminded that
our class has come to play a significant
role in today’s world-wide medical care
system. We toured the fine, amply
expanded Cushing/Whitney Library.
We sat in on many other seminars and
grand rounds in the Hope Building and
the hospital. A highlight was the alumni
association meeting, where John
Aniyan was awarded a Distinguished
Service Award for his generous support
of the school. Making this meeting all
the more special was the same award
for Professor Harry Zimmerman, one
of our most respected teachers.
Our banquet was held at the Colony
Inn. Topped off with John Anlyan’s
keen humor and enriched by George
Naumburg’s gift of Seyval Blanc table
wine from his Hudson River region
vineyard. George was unanimously
voted Honored Vintner of the Yale
School of Medicine. The deaths of
John Flynn and Ray Lesser were
recognized and deeply regretted. Bobbi
Morin, widow of Larry Morin, was
the guest of Dick and Natalie Dyer and
made the reunion more complete.
Some of the class were absent
because of prior commitments, but sent
regards. Mark and Margaret Lindsey
were traveling in Europe. Ken and
Nicki Steele were at Dartmouth for
Ken's 50th-year reunion; Bob and
Rutbie Easton were in California for
grandchildren’s celebration and other
reasons. All of our absent classmates
were missed. Those who did attend
were: John and Betty Aniyan; Fred
and Phyllis Blodgett; Louise Burr;
Sandy and Claudene Cockerell; Dick
and Natalie Dyer; Alice Dershimer
and Joseph; Jim and Dorothy
Gardam; Herb and Jean Harned Jr,;
Bill and Majorie Jenny; Mike Lau;
George and Michelle Naumburg Jr.;
Sam May; Joe and Mary Stanton; AI
Atwood; Dick Breck; Alice Shepard
Cary; Edward and Hadassah Daniels;
Sid Feuerstein; Ray and Pat
Gagliardi; Phil Good; Roger (Tex)
Hollan; Lee and Barbara Jones; Bill
Laupus; Tim Reiner; and Chick
Sherwood.
Don’t forget about the Big 50, 1995!
Put it on the calendar now.
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Class of 1950 graduates reminisce (from left): Drs. William Bucher, Margaret Lyman
and Claude Delia.

1950
40th-year reunion
hy Dr. Claude W. Delia
I am very pleased to report the activities
of the Class of 1950 at the alumni
reunion in New Haven in this our 40th
year. There was a remarkable turnout
for this occasion despite the fact that we
are spread out from coast to coast. Our
class has 43 members, and 23 were
present at the 4 p.m. welcoming
speeches. In all, 53 percent of our class
attended the reunion.
In addition to the scheduled events,
there were several impromptu dinners
on Thursday evening which ended in
the early morning hours in our class
hospitality suite in the Colony Inn. Our
dinner on Saturday night was preceded
by a reception in the same suite. Here
the classmates came together with
spouses and friends to renew old
acquaintances and forge new
friendships.
Our dinner at Paolo’s restaurant was
made very enjoyable by the good food
and wine, the efficient service, the large
attendance, and the presence of our
special guest from the faculty. Dr.
Rocko Fasanella. There were 42 of us
who sat at six round tables, an
arrangement that allowed family-style
service and conversation.
Those present were: Russell and
Joan Anderson; Lyal and Bonnie
Asay; Jane (Baldwin) and Clare
Shumway; Bill and Ida Bucher; Bill
and Jeanne Delia; Kent Ellis; Lloyd

and Peg Felmly; Daniel and Anita
Fine; Lawrence and Rina Friedman;
Carl and Marjorie Gagliardi; Naomi
and Sara (iolden; Sidney and Karen
(Pat) and Amy Lee; John Leroy;
Sylvia (Levine) and Robert Axelrod;
Margaret Lyman; Harold and Julia
March; Orlando and Dorothy Miller;
Harry and Sheila McClelland;
Charles and Margaret Nugent;
Robert and Ruth Sturman; Robert
and Phoebe Sceery; and Myra Tyler.
The banquet lasted four hours,
during which time there was a serious
interlude when we remembered our
deceased classmates. Sid Lee reminded
us of our class commitment to the
memorial fund as well as our needed
support of the Yale endowment. Many
of those who were not present sent
messages by mail, telephone and we
were even “faxed” once. In fact, there
were only five classmates whom we did
not hear from. Finally, Jane Baldwin
Shumway was elected by acclamation
as class secretary and correspondent for
the next five years.
We trooped back across the street to
our hospitality suite to regroup and plan
for the final event, which was a
delightful Sunday brunch at Margaret
Lyman’s brand new country home in
Middlefield. Here many of us bid
farewell to our best reunion so far.
On our way back to South Carolina,
Jeanne and I learned that we were the
grandparents of an 8 pound, 9 ounce
girl — Carson Mackenzie Diltz, bom
early evening on the 11th of June. She
is our reunion baby!
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1955
35th-year reunion
h\' Dr. William E. Lattanzi
The medical school Class ot 1955 held
a class dinner at the Quinnipiack Club
in New Haven on June 9. To those of
you who did not attend, I extend my
condolences; a marvelous time was had
by all.
A few of us have now retired and
those in that category who attended
were the Petersons (Florida), Dave
Kessler (S;ui Francisco) and the
Atwaters (Michigan). The
Bravermans, the Landaus, the
Camilleris, the Peters and the
Lattanzis are all .still in New Haven.
Paul (lOnick is still in practice of
urology but spends time being a parttime bicycle tourist. Ed Brennan
practices psychiatry in Greenwich when
he is not scuba-diving. Bob Kramer
has left the medical directorship of the
Newington Children's Hospital and is
now a fund-raiser for the proposed
Children’s Hospital in Hartford. Paddy
Burns is practicing psychiatry in
Boston. .Jay Bobruff is in
gastrcKmterology, practicing in New
l.ondon and announced his upcoming
marriage to his channing fiancee. Dave
Nelligan is also in New London in the
pathology department at Lawrence and
Memorial Hospital. At this 35th class
reunion, conversation has changed from
what we are all doing in our busy
careers to the status of our
grandchildren.
It was sadly noted that four of our
class members are deceased: Bill
Powell, (lill Leib, Ed Coppola and
.lim Miles. After this wonderful
evening, we are all looking forward to
our 4()th.

a Decline in Research Ethics?” In
addition to Class of '60 attendees there
were a large number of attendees from
other classes.
On Friday evening, there was a
lovely supper at Vic Altshufs graceful
Victorian home, which the class was
reluctant to leave. After the traditional
Saturday reunion seminars and
luncheon, Saturday evening the class
continued their celebration at the New
Haven Lawn Club, with a cocktail
reception and dinner. Songs from our
1958 class skit were resurrected by Vic
and Jerry, and as has become their
tradition. Bob Wallach and Al Ross
once again regaled us with their off-beat
senses of humor. Several members of
the class have retired or are
contemplating retirement in the near
future, a staggering concept.
In attendance were: Vic and Laura
Altsbul, Donna and (Jerry (recently
retired) Cimmino, Paul and Clare
Friedman, Gene Gaenslen, Jim
(lilman, Dan (recently retired from the
military) and Carolyn Jones, Rick and
Marilyn Kindwall, Sue Kleeman,
Tom and Alice Kugelman, Al and
Barbara New-comb, Fred and Ruth
Palace, Jerry and Carolyn Post,
Nancy Rolick Pow'er and Orlo Power,
Al Ross, Dan Rubin and Lina
Swisher, John and Ann Schrogie,
Fred and Ann Stargardter, Gus
Voyagis and Bob Wallach.

1965
25th-year reunion
by Dr. John El. Seashore
Believe it or not, our class celebrated its
25th reunion. Since Phil Manfredi was
unable to attend, he asked me to write a
summary of this historic occasion. We
gathered on Friday afternoon for the
class seminar to hear talks by
Mohandas Kini, John Parrish, Dave
Williams, Carl Hunt, Greta Reed
Seashore and John Seashore. That
evening we had dinner at the Seashores’
and on Saturday night the class dinner
was held at the New Haven Medical
Association building. Twenty-four
classmates (about one-third of the class)
attended one or both dinners: John and
Nancy Austin, Phil Askenase, Paul
and Susan Balter, Phyllis Hurwitz
Duvdevani and Ban, Bob Finkel,
Frank and Donna (Jrady, Gary and
Betsy Gross, Bob (Jryboski, Reid and
Ellie Heftner, Dave and Gretchen
Hill, Carl Hunt, Ginny Burnham
Johnson, Ron and Jane Karpick,
Mohandas and Joanne Kini, Walter
and Joyce Noll, Larry and Linda
Ossias, John and Joan Parrish, Bob
and Mary Pickens, John and Greta
Seashore, Alan and Jeri Stone, John
Titus, Bob and Sue Weiner, and Dave
and Carol Williams.
For entertainment on Saturday we
enjoyed (or suffered through) a tape and
slides of that timeless classic, our senior
show, thanks to the foresight of John
Austin, who has saved these

1960
30th-year reunion
by Dr. .lerrold M. Post
fhe 3()th reunion of the Cla.ss of 1960
w as a splendid affair. The troika of Vic
Altsbul, l orn Kugelman and Jerry
Post planned a very full weekend, and
some 34 classmates and significant
others were in attendance. On Friday
our class sponsored a reunion seminar
;)n "Medicine in the Public Arena.”
1 iT\ I'ost presented a paper on “The
ii' 1' King: Filfects of 111 Health and
! >e ibih:' on Political Leadership,” and
: ' ei 'lman addressed “Is The
i I null Degrading Because of

Dr. Paul Eriedman and I960 classmates celebrate 30 years in the healing arts.
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memorabilia all these years. Everyone
agreed that we all look exactly the
same! We all had a grand time
renewing friendships and recalling our
glory days at 333 Cedar St. I think we
would have had even a bigger turnout
except that many of our classmates had
children graduating from high school or
college that weekend. A good many
also live in California and apparently
felt it was too long a trip, but they were
put to shame by Dave Williams who
came all the way from Alaska, mainly, I
think, to play a round at the Yale golf
course with Alan Stone. Frank Grady
won the prize for the youngest child —
his wife Donna arrived with their 5month-old in arms. Frank must still be
searching for the fountain of youth.
All in all it was a great weekend. We
missed those of you who couldn’t come
and hope to see you all at our 30th.
Graduates of the decades meet: Dr. Margaret Delano. '70, (left) converses with Dr.
Leon Sweer, '80, and his wife Karen Sweer.

1970
20th-year reunion
by Dr. Robert M. Rosa
Our 20th reunion was held at Mory’s
and was a delightful evening of
conversation and reminiscence. In
addition to spouses and guests, those
present included Scott Peterson, who
made the dinner arrangements and who
directs a large private practice of
ophthalmology out of Waterbury,
Conn.; Anne Curtis, chief of chest
radiology at Yale and professor of
radiology; Rick Edelson, recently
appointed chairman of dermatology at
Yale; Jay Hoofnagle, who is at the
NIH and directs the division of
digestive diseases; Norm Coleman,
professor and chairman of the joint
center for radiation therapy at Harvard;
Jonathan Katz, who practices
anesthesia in Bridgeport, Conn.;
Michael Danzig, a cardiologist in Fort
Meyers, Fla.; Jim O’Brien, a plastic
surgeon in Norwood, Mass.; Karl
Wustrack, who came all the way from
Oregon where he is engaged in plastic
surgery; John Blanton, still in New
Haven, where he is a pediatrician; Rick
Solomon, who is moving to the New
England Deaconess Hospital as chief of
clinical nephrology; Jonathan Ecker, a
psychiatrist in Syracuse; Lynn
Whisnant Reiser, a psychiatrist in New
Haven; Paul Hessler, a radiologist in
Rhode Island; Mark Korsten, who is at
Mt. Sinai in New York and is also an
accomplished guitarist and sailor; Meg
DeLano, now a stepgrandmother; and
Bob Rosa, your class secretary, who is
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at the Harvard Medical School, where
he is associate director of the clinical
research center at the Beth Israel
Hospital.
During the evening, letters were read
from Bob Janco (Vanderbilt), Dave
Dueker (University of MissouriColumbia), Bill Mueller (Ohio), Ken
Khoury (California), Phil Steeves
(Massachusetts), Joe Chosid
(Milwaukee), Henry Chessin
(Wisconsin), and Stuart Shorr
(Washington). In addition, Harvey
Fernbach called during the dinner to
extend his best to everyone and to
apologize for his absence, which was
unavoidable. We sincerely hope that
everyone will congregate for our 25th
reunion.

1975
15th-year reunion
by Dr. Mary Jane Minkin
Our 15th reunion may not have been the
best attended, but we all did have fun. It
was wonderful seeing Vivian Reznick,
and her husband Andy Ries, ’74 —
Andy was able to pass on lots of gossip
about his class, too. Vivian is on the
faculty in pediatric nephrology at UC
San Diego (Andy is there in adult
pulmonary medicine). They were also
able to share exploits of their three kids
with Henry Cabin and Florence
Comite, ’76, who have two kids in the

same age group. Henry is still an adult
cardiologist at Yale, and Florence holds
a joint appointment in pediatrics, obgyn and medicine. Your reporter is still
in private practice, ob-gyn, in New
Haven, and on the clinical faculty for
the medical school (and eagerly await¬
ing the birtli of her and mathematician
husband Steve’s second kid).
We did receive a few updates from
class members in the mail. Lana
Holstein and Dave Taylor are in
Arizona, doing family practice and
caring for their family of two kids.
Dave London is in San Francisco,
enjoying private practice radiology.
Doug Zusman is in California as well,
as a cardiac surgeon. Fred Rosenfelt is
an oncologist in Los Angeles, and
unfortunately couldn’t make the
reunion because of an adventure travel
trip.
All of us at the reunion were sorry
that more of our classmates didn’t
attend. Vivian and I had a particularly
good time laughing at our first-year
pictures outside the pathology offices (a
good locale) in Brady. Hopefully, you
all will try for the 20th.
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1985
5th-year reunion
hy Dr. Fred E. Santoro

Classmates catch up on each other's news from the five short years since graduation.

1980
lOth-year reunion
hy Dr. Patricia C. Brown
The YSM Class ot 1980 enjoyed its
iOth reunion with good food and cheer
at Bruxelles restaurant in the heart of
downtown New Haven. ITie turnout
was good with a tr)tal of 29 attending,
including 17 classmates and 12 spouses
and companions. A summary of their
activities follows.
Claudia Dinan is practicing
pulmonary' medicine and living in
Orange, Conn., with her husband
.\ttilio (iranata, '77, and their son,
V ince. Larry Young, cardiology
faculty at Yale, is married to Lynn
Tanoue, '82. Kric Nestler, Yale faculty
in psychiatr>’ and phamiacology, and
his w ife Sue have two children, David
and Matthew, and are expecting a third.
.-\lso kK'al arc Deborah Desir,
rheumatologist at the Community
I lealth Care Plan, and (lary Desir,
nephrologist at Yale. They have three
sons: Carl, Matthew and Christopher.
Nearly liK'al are Mare (iliekstein,
director of MRI at Hartford Hospital,
and wife, Sylvie, w'ho live in
(ilastonbur)’. Conn., and have a baby
bt)'., Sam,
\ numt-HT of [X'ople drop;x'd in from
'\ev, York City, including Carl .SchifT
! :d
' iara, C 'arl practices
'
T Brooklyn. .Alan
■ ' I : . director of
s .ilogy at St. Vincent's

Hospital, joined the reunion with
girlfriend Jill Nathanson. John
Jacobs, Cornell faculty and medical
director of their clinical AIDS program,
is married to Carolyn Douglas and
they are expecting in August. Also from
New York, but the other end of the
state, is Patricia Brown, who has
finished a residency in dermatology
after training in pathology.
Massachusetts is home to many
attendees including David Adelberg,
married to Linda Britto and busily
engaged in private practice orthopedics
in South Dartmouth. Judy Garber,
cancer epidemiologist and clinical
oncologist at Dana Farber, is married to
Myles Brown with whom she has a
girl, Jenifer. Marty Silverstein,
business consultant in health care, is
married to Andy Haas with whom he
has a baby girl, Amy. Etban Lerner,
dennatology faculty at Brighimi and
Women's, and wife Lisa have a baby
boy. Max.
Leon Sweer arrived from Hershey.
Penn., where he is finishing a
pulmonary fellowship. Leon is married
to Karen and they have two children,
Ryan and Kevin. Steve Rosenfeld raid
wife Lisa fiew in from Boca Raton,
Fla., where he practices ophthalmology.
They have two children, Michael and
.lulie. Todd (larvin, urology faculty at
University of New Mexico, travelled
farthest, from Albuquerque, where he
lives w ith wife Dianne and their three
children, Samantha, Marissa and
Alayna.

Members of the Class of 1985 attended
the “Friends of the 5()th’’ dinner hosted
by the Class of 1940 at the Graduates
Club. Michael Gilbert and Susan
McClintic came to New Haven
accompanied by their children, Megan
and Kevin. Mike is a family practice
physician in Irvine, Calif. Brian
Lombardo, whose wife Tracy was
unable to attend, took some time off
from his busy family practice clinic in
Minneapolis. Guy Fish, along with his
wife Kim and children Nicole and
James came from Delaware, where
Guy is in solo practice in internal
medicine. JoAnne Burger has
continued her training at Yale where
she is a developmental pediatrics
fellow. Her husband, Michael Kaplan,
and daughter, Rebecca, also
participated in the weekend activities.
Ted and Joyce Love drove down from
Boston, where Ted is a cardiology
fellow at the Massachusetts General
Hospital. Carol Farver, now a
pathology fellow at Brigham and
Women's Hospital, and Robert
Neediman, who is developmental
pediatrics fellow at Boston City
Hospital, also made the trip down the
coast. They are the proud parents of a
daughter, Grace.
Peter Rubin is completing an
ophthalmology fellowship and will be
joining the staff at the Massachusetts
Eye and Ear Hospital. Fred Santoro,
after completing a one-year fellowship
in adolescent medicine, joined another
pediatrician in private practice in
Groton, Conn. His wife. Anne, and son.
Thomas, have settled down in East
Lyme. Also in Connecticut are Susan
Moore and Albert Gobel and their son
Wade. Susan has been continuing her
training, now with the department of
laboratory medicine at Yale. Kimball
and Janet Woodward have settled in
Westport where they have a one-year
old .son, Richmond. Kim is just
completing a one-year fellowship in
vitreo-retinal surgery at Manhattan Eye,
Ear and Throat Hospital, where he plans
on staying as a resident instructor and to
work in the private practice of retinal
surgery. Marnin Merrick joined us
from Philadelphia where he is a
hematology-oncology fellow at the
University of Pennsylvania.
We are all looking forward to the
lOth, where hopefully more of us can
catch up with each other.
Yale Medicine
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1989-1990 ALUMNI FUND REPORT
Message from the Dean
Today’s students become tomorrow’s
alumni/ae; no one understands this
better than Dr. Nicholas P.R. Spinelli,
’44, the school’s immediate past
director of alumni affairs. During the
past five years, he has worked closely
with our students, encouraging them
to recognize just how vital they are to
the future of their alma mater.
As a tribute to Dr. Spinelli’s
success, many of these students and
recent graduates have displayed their
dedication to Yale in charitable
giving. By doing so, these new and
future physicians, biomedical
scientists and public health
professionals — most of them of
modest means — have provided much
needed financial support to Yale
medical and public health students as
the cost of higher education continues
to climb.
The medical school Class of 1990
provides a good example of this spirit
of generosity. More than 90 percent
contributed to the School of Medicine
Alumni Fund. Class members also
conceived of, and provided initial
funding for, the new student lounge in
Edward S. Flarkness Hall. At their
request, we have dedicated this
handsome space to Dr. Spinelli.
The spirit of generosity also
manifests itself as your school gives
of itself as an institution. We continue
to give the highest quality education
to our students; our students, faculty
and staff still volunteer countless
hours to support the New Haven
community, including many not-forprofit organizations that require our
help more than ever during these
unsettled economic times.
Last year, the School of Medicine
received richly, too, including major
gifts from Belle Morse, the Mathers
Foundation, the Sanella family and
the Kresge Foundation challenge.
Finally, we are most grateful for the
record donations of $656,000 from
medical alumni/ae and $135,500 from
our EPH graduates.
I urge you as medical and EPH
alumni/ae to continue in this great
Yale heritage of generosity. Your
gifts support the education of a
generation of young people who
Yale Medicine FallAVinter 1990-91

through their scholarship, idealism
and dedication to community service
are already helping to build a
healthier future for humanity.
Leon E. Rosenberg, M.D.
Dean

Dr. Leonard Kemler, ’43, addresses
the 1990 AYAM assembly.

From the YSM
Alumni Fund Chairman
The train of alumni giving is back on
track. We had set a goal of $650,000
for the academic year 1989-1990.
Thanks to the efforts of our loyal
class agents and to Drs. Sam Kushlan
and William Collins (representing
house staff and bequest and
endowments), we not only achieved
our goal, but surpassed it. A record
$656,000 was pledged or given to the
School of Medicine Alumni Fund this
past academic year. We congratulate
our class agents and thank all our
alumni donors.
During the 1989-1990 fiscal year,
our percentage of participation
remained the same—43 percent—but
this will have to increase during the
current year if we are to meet a
challenge from the Kresge
Foundation. If we raise our

percentage of participation to 55
percent, the foundation has agreed to
donate $1 million toward the
completion of the Center for
Molecular Medicine. If those of you
who have not given recently make
even a small contribution this year,
the School of Medicine will benefit
forever. The size of your contribution
is not as important as you
participation. All gifts, large or small,
will be gratefully accepted. We can
do it.
We are also planning special
programs for reunion classes
beginning this year. Dean Rosenberg
is particularly interested in this
project. Those of you who will have a
1991 reunion will hear from your
reunion chairperson during the course
of the year. Any suggestions or ideas
will be welcomed by the reunion
committee, and volunteers to work on
this nostalgic event are encouraged to
come forth.
No report would be complete
without heartfelt thanks to our alumni
fund Director, Monica Robinson, and
her staff. This year’s success would
not have been possible without their
consistent efforts and help. Also,
special thanks to those agents whose
classes achieved a 75 percent or
greater alumni fund participation, as
listed below.
We look forward with enthusiasm
to our coming campaign. Best wishes
for a happy and healthy year.
Dr. R. Leonard Kemler, '43
Chairman

%

CLASS

100

1923

William Cohen

100

1924

David Raskind

91

1931

Michael D’Amico

75

1934

John Ogilvie

76

1941

Charles Cheney

75

1946

Thomas Whelan

78

1947

George Barnes

CLASS AtJENT
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School of Medicine Alumni Fund Class Participation
1988-1989
CLASS
1922 and prior
1923
1924
1925
1926
1927
1928
1929
1930
1931
1932
1933
1934
1935
1936
1937
1938
1939
1940
1941
1942
1943A
1943B

ACENT

William Cohen
David Raskind
Alice Whittier
Maxwell Bogin
Harry' Zimmerman
Lewis Scheuer
Paul McAlenney
Michael D'Amico
Franklin Foote
John Ogilvie
James Haralambie
Wilbur Johnston
Nelson Ordway
Rebecca Solomon
James Ferguson
Charles Cheney
Walter Burdette
Dorothea Peck
S. Brownlee Brinkley

TOTAL

1989-1990
% PART.

$ 1.811
642
10,284
531
542
1,038
53,518
1,358
12,957
4.494
5,865
1,607
4,389
6,454
23,677
1,904
2,136
19,301
9,178
4,702
3,829
4,232
3.399
7,631
46,770
3,850
9,196

100
100
100
56
60
67
60
67
53
79
63
57
62
57
23
50
56
71
58
66
56
67
5
59
73
53
52

7.764

57

1944
1945
1946
1947A
1947B

Nicholas Spinelli
Richard Breck
Thomas Whelan
George Barnes
W. Roy Breg

1948
1949
1950
1951
1952
1953
1954
1955
1956A
1956B

Paul Koehler
Daniel Elliot
Margaret Lyman
Lowell Goodman
Harvey Young
Vincent Gott
John Rose
Robert Kramer
John Gardner
Donald Dalessio

7,288
5.951
12,523
8,479
5,770
6,355
8,237
6,405
10..346

46
70
64
45
40
51
70
63
54

1957A
1957B

Harry Briggs
Howard Minners

1958A
1958B

Andrew McGowan
Paul Rudnick

1959 A
1959B

Asa Barnes
Muriel Wolf

1960A
1960B

Eugene Gaenslen
Thomas Kugelman

1961A
1961 B

Robert S. Briggs
Warren Widmann

1962 A
1962B

A.R. Pschirrer
Frederic Cantor

l'»(:3
I'lWA
H

Craig Llewellyn
William J. Houghton
Robert Lyons

i v-r.

David Hill
Mary Alice Houghton
Gar- I'ownsend

2,975
3,515
6,490
7,414
3.985
11.399
7,094
5,798
12,892
3,536
4.275
7,811
3,575
3,925
7,500
1,580
2,527
4.107
7,971
4,360
9,800
14,160
5.544
2,775
1.885
4.660
4,204
5,935
10,139

59
61
60
68
58
63
64
59
62
50
52
51
54
54
54
34
38
36
35
51
71
61
47
51
42
47
57
76
67

\

J. i -. Dowaliby
nth 'O', Lo\ell

TOTAL
2,011
686
11,334
5,473
1,720
1,136
3,580
1,376
147,690
3,426
2,339
2,103
4,652
6,780
3,991
2.289
1,346
4,131
16,441
4,593
3,600
6,743
5.930
12.673
10,131
10.573
8,800
6,834
2.653
9,487
7,675
3,930
74,952
10,581
4,275
8,710
6,034
6.932
4,862
3.235
8,097
3,575
4.575
8,150
9.702
4.820
14.522
7,222
4.474
11.696
5.333
6.500
11.833
3,305
4.610
7.915
4,090
3.051
7,141
6,984
2.185
10.6.50
12.835
13,299
2.975
3,400
6,375
3,428
5.715
9,143
Yale Medicine

% PART.
100
100
100
50
60
63
60
67
71
91
50
69
75
52
34
64
72
69
65
76
64
74
54
64
65
67
70
78
64
71
56
60
71
59
42
55
60
58
47
53
50
57
64
61
53
52
53
61
57
59
57
57
57
51
57
54
60
39
50
32
41
68
55
50
57
52
55
54
74
64
FallAVinter 1990-91

1988-1989
CLASS

AGENT

1968A
1968B

Frank Lucente
Donald Lyman

1969
1970
I971A
1971B

Adrian Schnall
James Missett
John Cieply
Barbara Kinder

1972
1973A
1973B
1973C

Harry Malech
Lee Goldman
John McQuade
Jerrold Rosenbaum

1974A
1974B

Amy Schechter
Robert Schechter

1975A
1975B

Daniel Passed
Mary Jane Minkin

I976A
1976B

William Levy
Glenn Gorlitsky

1977A
1977B

Attilio Granata
Ronald Vender

1978A
1978B
1978C

Duke Cameron
Seth Powsner
Thomas Smith

1979A
1979B

Jeffrey Kaine
Cynthia Sherman

1980A
1980B

Eduardo Alfonso
Steven Rosenfeld

1981
1982A
1982B
1982C

Anthony Urbano
Muriel Cyrus
Jed Gorlin
S. Wolf-Rosenblum

1983A
1983B

Michael Tom
David Schwartz

1984A
1984B

Hingge Hsu
Jay Kostman

1985A
1985B

Greg Sachs
Fred Santoro

1986A
1986B
1986C

Eric Bernstein
Clinton Lindo
Eric Suan

1987A
1987B
1987C
1987D

Barry Weinstock
Subba Gollamudi
Mindy Schuster
Mark Widmann

1988A
1988B
1988C

Michael Mockovak
Susan Valley
Hedi Zaghi

1989A
1989B
1989C
1989D

Stephen Bharucha
Lewis Lipsey
Melissa Myers
Roger Widmann

TOTAL
3,627
3.852
7,480
11,088
4,922
3,438
4,175
7,613
10,108
1,425
3,740
1.725
6,890
1.955
1.385
3,340
1,410
1.304
2,714
2,540
2.275
4,815
610
1.205
1,815
2,325
415
280
3,020
1,190
1.245
2,435
1,020
725
1,745
1,125
95
330
335
760
324
205
529
675
385
1,060

43
64
53
63
38
52
57
44
47
39
39
46
40
49
32
40
23
18
20
32
46
36
24
44
34
26
33
50
30
40
31
35
29
30
30
23
7
44
29
23
16
26
20
32
18
25

786
786
95
220
60
375
237
2,070
175

32
32
7
7
14
9
26
22
23

2,552
59
90
149
298
110
245
50

21
26
17
16
20
20
20
10
10
15

440

Yale Medicine

FallAVinter 1990-91

1989-1990
% PART.

TOTAL

% PART.

9,053
4.830
13,883
7,602
5,823
3,468
5.725
9,193
9,835
1,766
2,015
1.691
5,472
1,755
3.800
5,555
1,570
1.179
2,749
3,000
1.260
4,260
2,420
2.527
4,947
1,770
325
115
2.210
685
1.900
2,585
2,375
1.056
3,431
1,645
650
300
470
1.420
276
330
606
485
500
985
695
190
885
230
95
35
360
261
50
100
70
411
57
145
20
222
110
245
50
35
440

45
58
52
52
46
43
44
44
47
48
39
43
43
49
37
43
31
20
26
35
36
36
24
47
36
22
27
25
25
34
24
29
35
27
31
20
12
35
38
28
9
30
20
26
19
23
26
23
25
16
11
7
12
20
17
14
11
17
19
17
8
15
13
24
11
13
15

61

CONTRIBUTORS 1990-1991
The names and data included on the following pages were provided by the
Yale School of Medicine Alumni Fund and reflect contributions made
between Julx 1. 1989 and June 30. 1990.
MKDK Al. SCHOOL
AIT MM
1906
Charles R. Mitchell*
1908
Michael A. Parlalo*
1912
Waller Clark Tiklen*
1913
Ralph Emerson Taylor*
1916
Ernest Russell*
1919
Willys M. MonrcK'*
1920
Oscar Brenner*
1922
Maurice Gro/in*
Chester E. Hurwit/*
Helen P, Langner
1923
William Cohen
lulius Anthony Olean*
Hyman W. Weinstein*
1924
John J. Batchelor
Donato Anthony D'Esopo'
David M. Raskind
Myron A. Sallick*
Harold 1'. Vogel*
1925
Dorence S. Cowles
Waldo F. Desmond*
Wdliam E. Hall
Samuel Reback
Eli Hyman Rubin*
Alice A. S. Whittier
Howard Asa Wood*
1926
Stanton T. Allison*
Louise Baker
Maxwell Bogin
Wdliam 11 Hahn*
Joseph L. 1 let/el*
Joseph 1'. Matteis
1927
\S’allace Robert Boslssick"
llenrs Irwin l ineberg
John Martin I reiheil'
I ;-'nald F t nbson
AM

1929
James Rae Ameill Jr.*
John M. Bailey*
John W. Cass Jr.
Olive Gates
George S. Goldman
Alexander O. Half*
John A. Hangen
Paul F. .McAlenney
Tony Liebman Rakieten*
William Frederick Roth Jr.*
Russell B. Scobie
Robert Tennant
Newell Raymond
Washburn*
Julius G. Weiner*
Mabel Wilson
1930
Samuel .Alpert
Daniel N. Beers*
Frederick Fit/herbert Boyce
Charles A. Breck*
Lewis Dickar*
Vincent A. Doroszka*
Knox H. Finley
J. Roswell Gallagher
Leonard Greenburg
Amy H. Hunter-Wilson
Edmund L. Kitzmeyer
Paul H. Lavietes
Moses D. Lischner*
James Merriman Lynch*
John C. Mendillo
Paul Watson*
Charles L. Wood

1931
Henry H. Briggs Jr.
Benjamin Castleman*
.Michael D'Amico
Helen R. Gilmore
Paul A. Harper
Morris Heller*
Thomas C. Jaleski
Rhoda M. Mickey
Nelson Newmark
Abraham J. Schechter
James .A. Stringham
Max Tal'I'el

rt Jablonsky

'' i'

I i-\, v'

■

‘ - i‘ I
■ I

Meredith
i - I ;■

■ ^
' '

1928
Max Alpert*
Sheldon A. Jacobson
Edw ard P J Kearney
Ralph E. Knutti
R. Harold Lockhan
Edward W. Ludw ig*
Nathan E. Ross
Robert 1. Rubinstein*
John M. Russell*
Alvin A. Schaye*
Lew is A. Scheuer*

' ;iC
Vi

- iiKin

1932
Louis K. Alpert
Reginald V. Berry
Frank Carroll
Clement C. Clarke
Hester B. Curtis
Joseph P. Donnelly
Lee E. Farr
Thomas FI. Farthing*

Conrad R. Lam
Elizabeth M. Ramsey
Benjamin N. Tager
Myron E. Wegman
Roland T. Wehger*

1933
Myron J. Adams*
Fred W. Buse
Warren P. Cordes
Franklin M. Foote
Jack Greenberg
Daniel Foster Harvey*
George K. Hirst
Robert Watkinson
Huntington Jr.*
John G. Martin
Raymond E. Miller
Ashley Pond 111*
Edwin B. Seelye*
Sidney Stringer*
John J. Wolfe
Francis M. Woods

1934
Frederick Beck
Joseph Budnitz
Francis P. Guida*
Derick Algernon January*
Knowles B. Lawrence
Herbert C. Miller
Edward Thomas O'Donnell*
John B. Ogilvie
Lucien M. Pascucci
Harry Sherman
Wedgwood P. Webber
William R. Willard
George Zalkan*

1935
Walter E. Barney
George A. Carden Jr.
Edgar S. Childs
H. Hoffman Groskloss
James Quintin Haralambie
W. Howard Homer
Mildred Hartshorn January
Samuel D. Kushlan
Donald P. Morris*
Norman E. Peatfield
Milton Rose*
Clark P. Searle
Walter A.L. Thompson
1935 Classmates

Wilbur D. Johnston
Alfred E. King
Dunham Kirkham
Julia Mehlman
James P. Morrill
T. Dennie Pratt
Alan A. Rozen
Morgan Sargent
Edward J. Shaw
Albert D. Spicer
John M. Thomas
Jean Wells

Theodore W. Steege
Lester J. Wallman

1939
Stephen W. Collins Jr.*
Harold H. Coppersmith
Noiman L. Cressy
William H. Druckemiller
Robert Goodfellow Ernst*
John P. Ferguson Jr.
S. Jerome Greenfield
Arthur E. Laidlaw
Margaret A. Lennox
Ward J. McFarland*
James Peter Murphy
Russell Nahigian*
Douglas S. Riggs
Roger N. Ryley
Ernest L. Sarason
Rebecca Z. Solomon
John D. Tobin
Darrell G. Voorhees
Douglass W. Walker
John H. Wentworth
Malvin F. White

1938
Roy N. Barnett
Henry L. Carideo
S. Charles Kasdon
Benjamin E. Lyons
John J. McGillicuddy
Edward Nichols
Nelson K. Ordway
Charles J. Petrillo
Edward W. Pinkham Jr.
James Radcliffe Jr.
George E. Roberge

SCHOOL OF MEDICINE
ALUMNI EUND BOARD
David Raskind, M.D. '24
J. Roswell Gallagher, M.D. '30
Franklin M. Foote, M.D. '33
Samuel D. Kushlan, M.D. '35
Malvin White, M.D. '39
R. Leonard Kemler, M.D. '43
Nicholas P.R. Spinelli, M.D. '44
William McClelland, M.D. '47
Paul Koehler, M.D. '48
Lowell I. Goodman, M.D. '51
Harold Bomstein Jr., M.D. '53
Herbert Hurwitz, M.D. '54
Robert Kramer, M.D. '55
Robert Donahue, M.D. '58
William Waskowitz, M.D. '57
Nicholas Passarelli, M.D. '59
David Hill, M.D. '65
John Foster, M.D. '71
Sharon Bonney, M.D. '76
FUND OFFICERS 1989-1990
Medical School Alumni Fund

1936
Lester W. Burket
Albert W. Diddle
Margaret C. L. Gildea
George A. Hahn*
Louise G. Hutchins
Philip M. LeCompte
Donald F. Marshall
Stephen F. Nagyfy
Frederick A. Post
Margaret Sommers
Morris Tager

R. Leonard Kemler, M.D. '43
Chairman
J. Roswell Gallagher, M.D. '30
Bequest & Endowment Co-chairman
Samuel D. Kushlan, M.D. '35
Bequest & Endowment Co-chairman
Former House Staff Chairman
EPH Alumni Fund

1937
Edmund R. Blower
William G. Cooper Jr.
David A. Dolowitz
D. Crosby Greene

* Deceased

Stephen Skorcz, M.P.H. '70
Chairman
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1940

1943A

Theodore E. Allen
Joseph V. Baldwin
Ronald S. Beckett
Jack S. Blaisdell
Philip S. Brezina
David Crocker*
Wynant Dean
Richard E. Dormont
Robert M. Dunlap
James E. Eerguson Jr.
Eugene J. Fitzpatrick Jr.
Henry D. Humphrey
H. Stuart Irons
Donald G. Johnson
Ira D. LeFevre Jr.
John D. MacAllister
Paul D. MacLean
Edward Martin
Maurice Ross*
W. Norman Sears*
Joseph E. Sokal*
J. Champneys Taylor
Patricia E. Wanning
Helen H. Woods

Ralph D. Alley
John R. Brobeck
Lycurgus M. Davey
Donal L. Dunphy
R. M. Fasanella
Gerard Fountain
Edward Douglas Homing*
R. Leonard Kemler
Jonathan Trumbull Lanman*
Douglas Lindsey
J. Philip Loge
Henry E. Markley
Walter J.J. Nero
Dorothea R. Peck
Earl J. Rhoades
Henry A. Riedel
Bernard R. Rowen
Marcus E. Sanford
Robert A. Sears*
Edward Hersey Soule
Hilliard Spitz
Nicholas M. Stahl
Robert J. Staub
Sophie Trent Stevens
Oliver G. Stonington
Frederick A. Waldron
John J. Weber
Robert H. Wyatt

1941
Robert H. Alway
Robert H. Areson
W. Randal Bell
Knute E. Berger
William A. Carey
Joseph P. Carson Jr.
Charles B. Cheney
Herbert W. Diefendorf
Robert F. Dine*
Peter A. Duncan
Lloyd D. Flint
John Franklin
Robert L. Gilbert
Frederick P. Glike
Sidney L. Lasell
William Lee
Bjorn Lih
F. Eugene Martin
John R. McDermott*
Willys M. Monroe
Malcolm C. Murfitt
Jean E. Neighbor
Edward B. O’Connell
Robert W. Ollayos
Gioacchino S. Parrella
David V. Pecora
Edwin D. Rogers
Leslie Simmonds

1943B
Richard N. Abbott
John R. Almklov
David G. Borden
James L. Bradley*
S. Brownlee Brinkley
Henry B. Bruyn Jr.
Thomas L. Bucky
Jane B. Cadbury
Philip B. Chase
Hunter H. Comly
Norman I. Condit
Ronald W. Cooke
Joseph I. Epstein
Robert H. Furman
Victor C. Hackney
Frank R. Hurlbutt Jr.
Henry H. Jones
Joseph F. Kell
Sawyer E. Medbury
Hoyt B. Miles Jr.
Benjamin R. Robinson Jr.
Donald W. Seldin
Francis A. Spellman*

1944
1942
William E. Bloomer
James M. Bunce
Walter J. Burdette
Robert E. Carroll
Donald S. Childs Jr.
Vincent J. Collins
Eugene M. de Hostos
David G. Decker*
Hendrik DeKruif
Davitt Felder
Elihu Friedmann
Allan V.N. Goodyer*
William Harrison Jr.
Wilson E. Hughes
Leo Kellerman
John R. Lincoln
Patrick S. Mullins*
Dean Nichols*
Charles F. Scholhamer
Richmond W. Smith Jr.
Carter Stilson
Edgar B. Taft,
Maurice Tulin
Francis P. Vose*
Irving Norman Wolfson
1942 Classmates*

Yale Medicine

Carl E. Andrews
Joseph Ciola*
Edward J. Conway
John C. Coolidge
George B. Corcoran Jr.
Frank W. Countryman
Charles H. Crothers
Lawrence G. Crowley
John H. Doherty
Robert W. Frelick
Carol Goldenthal
Charles A. Hall
Howard B. Hamilton
Robert I. Hinkiey
Ward S. Jenkins
Edith M. Jurka
John Weaver King
Frederick F. Krauskopf
Elias J. Marsh
Katharine Hawley Martin
Joseph Massaro
A. Reese Matteson
Paul E. Molumphy*
Russell R. Monroe
Lawrence K. Pickett
Haynes W. Sheppard
Sarah P. Sherwood
Nicholas P.R. Spinelli
Mrs. Gertrude Spinelli*

Fall/Winter 1990-1991

Roy B. Sauberman celebrates his graduation with grandfather Nathan
Sauberman, a retired engineer. (Commencement photographs throughout
this section offer a reminder that contributions to the School of Medicine
and EPH alumni funds, unless otherwise directed by the donor, support
student financial aid. }
Priscilla Dienes Taft
Anthony Varjabedian
Calvin Watts Woodruff*
Reuben Zucker*

1945
George Howard Allison
Albert S. Atwood
Frederic M. Blodgett
Richard W. Breck
Louise H. Burr
Alice Shepard Cary
Sanford F. Cockerell
Jay B. Cohn
Thomas P. Cotter
Edward M. Daniels
Richard R. Dyer
Robert S. Easton
Sidney S. Feuerstein
Alice Dershimer Friedman
Raymond A. Gagliardi
Philip S. Good
Herbert S. Hamed Jr.
Paul W. Hoffert
O. Roger Hollan
Hans R. Huessy
Leland W. Jones
Michael W. Lau
William E. Laupus
Raymond E. Lesser*
Mark McD Lindsey
* Deceased

James R. Mason
Charles E. McLean
George W. Naumburg Jr.
Fitzhugh C. Pannill
Richard M. Peters
Elliot R. Reiner
Charles E. Sherwood
Joseph R. Stanton

1946
Margaret J. Albrink
William G. Banfield Jr.
Franklin C. Behrle
Sanfurd G. Bluestein
Linus W. Cave
'Thomas J. Coleman
James F. Cooney*
George C. Cusick
Thomas A. Doe
Edward F. Edinger
Gregory E. Flynn
Martin E. Gordon
Charles Sheldon Judd Jr.*
Ruth S. Kempe
Benjamin F. Kitchen Jr.
James A. Kleeman
Vincent J. Longo
Richard Hess Mann*
Thomas J. Mathieu
Hugh J. McLane
Joe D. Morris

John H. Morton
John F. Neville Jr.
Laura W. Neville
Harry Dickson Patton
Vincent Pepe
Francis G. Reilly*
David H. Riege
Phillips E. Roth
Julian A. Sachs
Donald P. Shedd
Richard G. Sisson
Colby S. Steams
Robert R. Wagner
William J. Wedemeyer Jr.
Thomas J. Whelan Jr.
Hugh R. Williams*
Elihu S. Wing Jr.

1947
George R. Barnes Jr.
Albert W. Bostrom Jr.
John E. Bowers
W. Roy Breg Jr.
Richard G. Britton*
David L. Brook
Rocco A. Calandruccio
John C. Carpenter
Charles R. Cavanagh Jr.
Roland G. Chambers
Arthur Harry Chapman
Robert A. Chase

63

William R. Chaffee
Allen Chetrick
Rex B. Conn
James P. Dunn
Donnell Dencil Etzwiler
Vincent Lynn Gott
A. Daniel Hauser
George L. Hoffmann
Peter Biggs Hukill
Richard Robert Knowles III
Preston Lee Leslie
Hildegard Mueller Leslie
John Dutch Lord
Robert N. Melnick
Harvey Martin Peck
Warwick Potter Jr.
Paul G. Quie
Jose Ramirez-Rivera
Irwin K. Rosenberg
Barbara F. Rosenberg
Virginia C. Saft
Richard Andrew Sinnott Jr.
Ora K. Smith
Howard Willis Smith
Lynn Cortland Stoker
William Junior Vandervort
William August Wilson
James Frederic Young

1954

(From left) Beverly Stoiite enjoys the afternoon with Tracy Nelson and Laurie-Ann Nesseralla.

1947 (cont.)
Amo/, I. ChemofT
William r. Collins Jr.
Bradford S. Colwell
Robert P. Darrow
Archie L. Dean Jr.
Jean H. Dougherty
Owen W. Doyle
Franklin Harold Epstein
Edward Eoord*
Richard K. Friedlander
Frank L. Golbranson
Frank 11. Horton
Robert J. Kerin
Don F. Kimmerling
Richard P. Levy
Brock Lynch
Victor A. .Machcinski
Charles L. .Mache Jr.
William K. .McClelland
Robert F. Newton
Myron K. Nobil
Lawrence C. Perry*
Philip H. Philbin
Olive E. Pitkin
Irv ing Rudman
■Alvin Somberg
Igor Tamm
Patricia B. Fudbury
Fdlis J. Van Slyck
M. Henry Williams Jr.
I94H
Russell J. Barmelt
■ leorge F Batten
F.dith M Beck
Jonathan S. Bishop
Allyn (i. Bridge
Rithard Steele Buker Jr,
Aiiliui 1. Coleman Jr.
Ruth F . Corlell
■-1 Robi-rl Downie
Victor A Drill
Fli/aFcih Fuller Fdsner
■ tv n A

l isi^

Frame
1

Emil Frei III
Julian Frieden
Paul S. Goldstein
Allan Green*
B. Herold Griffith
Sylvia Preston Griffiths
Richard M. Hannah
Ross R. Harcus
Paul B. Koehler
Patrick J. McLaughlin Jr,
C. Arden Miller
Lewis P. Rowland
Benjamin F. Rush Jr.
Gabriel A. Saviano*
Jerome H. Shapiro
Jessie Parkinson Spear
Anne G. St. Goar
Paul Talalay
Wallace W. Turner
Paul Woodbury Weld
1949
William G. Aniyan
Jonathan S. Bishop
Mary Pucci Couchman
Phillip G. Couchman
N. Joel Ehrenkran/
Daniel W. Elliott
Gunnar O. Eng
Albert A. Fisk
Eleanora C. Gordon
Frederic W. Gray
Jackson Harris
Frederick R. Hine
Halsted R. Holman
Benjamin A. Johnson
Orval 1, McKay
Timothy F. Nolan Jr.
Julian I. Pichel
Edmund L. Piper
Charles L. Rennell Jr.
Murray /.. Rosenberg
Daniel Rudman
Lawrence E. Shulman
Martha Vaughan
Vernon T. Watley
Mary-Agnes P. Wine

1950
Russell N. Anderson
Sylvia L. Axelrod
Malcolm A. Bagshaw
John E. Borowy
William H. Bucher
Alvin Davis
Claude W. Delia
Marie C. Duncan
Kent Ellis
Thomas J. Ferraro Jr.
Daniel Fine
Lawrence R. Freedman
Carl A. Gagliardi
Archie James Golden*
Melvin H. Kaplan
Sidney S. Lee
Janus C. Lindner
Margaret S. Lyman
Harold March
Harry L. McClelland
Marina P. Meyers*
John H. Meyers
Robert Edward Quinn*
Robert T. Sceery
Cynia B. Shimm
Jane B. Shumway
Martin E. Smith*
John S. Strauss
Robert H. Sturman
B. Lionel Truscott
Myra D. Tyler
Frederick Edward Vultee*
1950 Classmates

1951
Karel Bedrich Absolon
W. Robert Adams
Frank R. Allen
Thomas T. Amatruda Jr.
Stanley D. Ardell
Eleanor Clay Bigley
John J. Egan
Lawrence R. Freedman
Sidney S. Furst
Joseph M, Garland
'Decea.sed

Lowell 1. Goodman
John T. Groel
Robert N. Hamburger
Carrold K. Iverson
William Kiekhofer
Jocelyn S. Malkin
Francis L. Merritt
Paul D. Millikin
Walter S. Morgan
Albert R. Mowlem
Richard S. Munford
Ismail Nik Nevin
Charles A. Nugent Jr.
Gerard B. Odell
Jose Felix Patino
Arthur A. Pava
Majic S. Potsaid
Robert G. Small
Bradley R. Straatsma
William A. Taylor*

1952
Siegried A. Centerwall
Willard R. Centerwall
Frank R. Coughlin Jr.
Robert P. Gerety
Arthur P. Hustead
James Kent Luce
N. Karle Mottet
Robert L. Nolan
Sidney Nathan Paly
Robert G. Petersdorf
Leonard Rush
Elizabeth M. Rush
Mary Wheatland Schley
Donald H. Schultz
Robert B. Schultz
John H. Wagner Jr.
John L. Wolff
Harvey L. Young
Robert Zeppa

1953
Jonathan Barry*
Claude Bloch
Harold D. Bomstein Jr.

Frank P. Berg
Richard J. Bouchard
George N. Bowers Jr.
Ralph K. Campbell
John R. Cole
Arthur C. Crovatto
Donald D. Davis
Walter J. Freeman
John A. Gariepy
Edward J. Gerety
Samuel T.J. Giammona
Frank L. Gruskay
Robert P. Hatch
Walker R. Heap Jr.
Eva H. Henriksen
Herbert S. Hurwitz
Robert F. Hustead
Robert J. T. Joy
Donald S. Komfeld
Richard Lamb
Harry C. Miller Jr.
Paul N. Neufeld
James J. Nora
Lowell E. Olson
Anthony V. Piccirillo
Richard D. Pullen
Jacques M. Quen
John Keith Rose
Elihu M. Schimmel
Leonard M. Silverman
Robert L. Stein
Martin B. Vita

1955
John B. Atwater
John C. Bailar III
George E. Becker
E. Edward Bittar
Joseph 1. Boylan Jr.
Irwin M. Braverman
Edward Noel Brennan
Padraic Bums
Nicholas A. Coassin
Edward D. Coppola*
Milton Com
Pasquale James Costa
Robert G. Crounse
John G. Daley
Fred Wendell Doyle
Leroy Engel
F. Robert Fekety Jr.
Edwin G. Fernand
Mahlon V.R. Freeman
James Conway Garlington
Paul Gonick
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Ion Gresser
John H. Hodge
D. Franklin Johnson Jr.
Harry O. Kendall
David R. Kessler
Robert A. Kramer
James Lum
Joseph S. McGuire Jr.
Robert C. Nodine
James P. Nolan Jr.
Gloria C. Onque
Edward J. Ottenheimer Jr.
John C. Pace Jr.
Robert H. Peters Jr.
Gregory Peterson Jr.
Robert A. Reich
Paul J. Robinson
F. Brantley Scott Jr.
Clement B. Sledge
Alan A. Stone

1956
Alan E. Apfel
Peter Bios Jr.
Levon Z. Boyajian
Thomas M. Brown
Rosalie A. Bums
Donald J. Dalessio
Chandler Dawson
S. Evans Downing
Gilbert M. Eisner
Thomas F. Ferris
John H. Gardner III
Sumner Gochberg
Joan Marasco Hardenbergh
John Herd Hart
Robert L. Hill
William H. Hindle
George T. Kammerer
Jerome O. Klein
William V. Lewit
Preston C. Manning
Elmer T. Mitchell Jr.
Norman F. Moon
Donald J. Nalebuff
A. Frederick North Jr.
David A. Page
George W. Paulson
Stewart E. Pursel
Robert Lee Scheig
Edward C. Senay
Benjamin A. Shaver Jr.
Donald William Sherrick
Daniel R. Silbert
Donald R. Sperling

1957
F. Calvin Bigler
Jack Norman Blechner
Richard I. Breuer
Harry C. Briggs
Carl A. Brinkman
John P. Carey
Louis Z. Cooper
Harold Dick Cross
Thomas H. Danaher

James R. Dorr
Salvatore Falbo
Harold J. Fallon Jr.
Robert E. Eishbein
Ronald H. Eishbein
James R. Eitzgerald
Anthony L. Fons 111
Elizabeth H. Forsyth
Robert H. Glass
Anne H. Good
Jack Peter Green
Gilbert F. Hogan
Warren R. Johnson
Richard Lee Kahler
Stanley E. Kilty
William L. Kissick
Willard A. Krehl
Jack Levin
Bennett F. Markel
Mark D. Marshall
Howard A. Minners
Robert K. Modlin
George Albert Nelson Jr.
Herbert A. Newman
Thomas Francis O’Brien Jr.
Raymond E. Phillips
Clifford B. Reifler
Melville P. Roberts Jr.
Arnold Schoolman
Kenneth A. Simon
Gilbert B. Solitare
Donald C. Stahl
William J. Waskowitz
Herbert Winston
James G. Zimmer

1958
George K. Aghajanian
Don P. Amren
Joseph E. Angelo
Gerard N. Burrow
Benjamin Bursten
John A. Carlston
Robert J. Donohue Jr.
Donald A. Duncan
Joel C. Eberlin
Michael E. Fishman
John Currier Gallagher*
Marcia Kraft Goin
William M. Gould
James Greenwald
Charles A. Hall Jr.
Stanley Harris
Michael Kashgarian
Haskins K. Kashima
Jay Ward Kislak
Theodore W. Lieberman
Myron Lotz
Andrew Joseph McGowan Jr.
Richard Charles Miller
Albert Muggia
Robert S. Neuwirth
Carol F. Phillips
William B. Radcliffe
Paul A. Rudnick
Thomas R. Shea

Bruce H. Sklarew
Edward Lloyd Socolow
Raymond W. Turner
Margaret Smith Wenzel
Joseph P. Wierzbinski III
John Patrick Wood
Pauline B. Wood

1959
Scott Ingram Allen
Robert M. Amick
Asa Barnes Jr.
Francis A. Beer
Jack F. Bowers
Edwin M. Clayton
Sidney M. Cohen
Ronald C. De Conti
Gerald Fenichel
Robert L. Fisher
Paul Jay Friedman
Robert J. Gonyea
Gerald B. Gordon
W. Keith Hadley
H. Rodney Hartmann
William H. Heydom
C. Richard Hinckley
Leonard Inker
John J. Jasaitis
Edvardas Kaminskas
Herbert J. Kaufmann
David W. Kingsbury
Myron S.S. Lee
Kathryn Huxtable Lewis
Brian J. McGrath
James A. O’Neill Jr.
Robert H. Ostberg
Nicholas M. Passarelli
Charles A. Phillips
Lincoln T. Potter
James D. Prokop
James R. Ralph
Joseph D. Saccio
Constantine J. Sakles
Marc D. Schwartz
Richard M. Senfield
Owen A. Shteir
Sanford P. Solomon
Gene W. Spector
James J. Stagnone
John S. Strauss
Lois W. Tice*
Leo H. Von Euler
Muriel D. Wolf

1960
Victor Altshul
Jack D. Barchas
Stuart P. Bowne
Ormond V. Brody
Donald P. Buebendorf
Stanley M. K. Chung
Gerald N. Cimmino
Jon E. Courtney
John M. Davis
Malin Dollinger
David Paul Dunn*

Caldwell B. Esselstyn Jr.
Warren H. Eisher
Paul Jay Friedman
Eugene C. Gaenslen Jr.
James I. Gilman
Roland H. Ingram Jr.
Daniel M. Jones
William S. Kaden
Eric P. Kindwall
Frank J. Kleeman
Susan T. Kleeman
Thomas P. Kugelman
Edward R. Lang
Thomas Lau
Eugene G. McCarthy Jr.
Donald L. Miller
Allan W. Newcomb
Buford L. Nichols Jr.
Fred Palace
Nancy Rolick Powell
Albert Matthew Ross
Daniel J. Rubin
John J. Schrogie
Fred Stargardter
Constantine M. Voyagis
Robert C. Wallach
May Yung-Fun Woo Wang
Ronald A. Yankee
1960 Classmates

1961
Kenneth A. Arndt
Earl L. Baker
Frank H. Baker
Albert A. Bechtoldt Jr.
Robert S. Briggs
Orson R. Dee
Paul David Deiter
Ronald A. Dierwechter
Jon Dudley Dorman
T. Wayne Downey
John E. Fenn
Norbert Fleisig
Edward C. Gilbert
Robert Sterling Gillcash
Louis D. Hunt
Richard L. Keefe
Robert Isaac Levy
George M. Lordi
Hugh James Lurie
Joseph Richard Lusby
Sally Lockwood Marches!
Vincent T. Marches!
David B. Matloff
Joseph W. McDaniel
Anoush Miridjanian
Richard Allen Moore
Norman 1. Moss
John Curtis Parker
Elaine Pitt
Roy E. Ronke Jr.
Thomas H. Sakoda
Stanley G. Schade
Robert N. Taub
Hugh C. Thompson III
Eranklin H. Top Jr.

1988-1989
NUMBER
SOLICITED

NUMBER
CONTRIBUTED

David E. Weaver
Warren D. Widmann
John R. Woodward

1962
Charles B. Anderson
Frederic P. Anderson
Spencer J. Brody
Fredric K. Cantor
Thomas Newell Chase
Richard N. Collins
Oliver Townsend Dann
Arnold Joel Eisenfeld
I. Bruce Elfenbein
John W. Foreman
Anthony V. Furano
John N. German
David H. Groth
Patricia C. Hassakis
Gary Jacobson
Glenn L. Kelly
David E. Knoop
Manuel J. Lipson
John P. Lynch
Malcolm A. Martin
Allan L. Mattem
Stanley E. Matyszewski
David J. McConnell
William A. Miller
Malcolm S. Mitchell
David D. Nicholas
A. Richard Pschirrer
Joseph Ross
Edward L. Spencer Jr.
James A E Spencer
Larry Lee Stewart
Seth Thaler
Sherwood Waldron Jr.
William Eamsworth Weber
Stewart R. Wright

1963
Miguel R. Alonso
John E. Conte Jr.
Andrew Edin
John P. Eliopoulos
William T. Friedewald
Alexander R. Gaudio
Lee D. Goldberg
Peter B. Gregory
Benjamin Keith Harris
Harold P. Kaplan
Constantine D. Kyropoulos
William B. Lehmann
Peter B. Livingston*
Craig H. Llewellyn
Herbert Meltzer
Robert E. Mueller
Sheldon R. Pinnell
Jay M. Pomerantz
Lee Bland Talner
Peter V. Tishler
Lawrence Tremonti
Peter G. Weiner
Jerome Allen Winer

1989-1990

PERCENT
PARTICIRATION

TOTAL

NUMBER
SOLICITED

NUMBER
CONTRIBUTED

PERCENT
PARTICIRATION

TOTAL

Alumni

3,687

1,609

46

$ 484,848

3,735

1,630

44

$ 607,960

Former House Staff

1,002

276

28

31,436

2,112

221

10

28,932

432

88

20

12,256

432

69

16

7,946

—

—

—

11,558

—

—

—

11,337

5,121

1,973

39

$ 522,698

6,279

1,920

31

$ 656,175

Parents/ Friends
Interest/Miscellaneous
TOTAL
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1964
William A. Alonso
Benon W, Ashman
Leland S. Berger
Philip Blume
Robert M. Briggs
Thomas A. Cardella
Joseph F.J. Curi
Anthony Ferranle
Norman C. Fosi
John F.B. Haney
Gene 1. Higashi
l.awrence Horwiiz
William J. Houghton
Lewis Landsberg
Richard V. Lee
Thomas L. Lentz
David B. Leof
James S. Levine
Richard Murray Linburg
Robert W. Lyons
Andrew E. MacMahon
William F. Matchett
Robert L. Mitchell
Alan H. Morris
James J. Murphy
Donald A. O'Kieft'e Jr.
William B. Pratt
Jack S. Rice Jr.
Norman Seller
Robert L. Shelton
Donald G. Skinner
A. Thomas Snoke
Lyall C. Stilp 11
Lee Van Lenten
Charles Vogel
Stephen Waltman
Oscar Wand
1965
Susan A. Aoki
Thomas T. Aoki
John H..M. Austin
Paul Balter
Thomas B. Caldwell 111
David G. Campbell
Robert M. Cohn
.Michael J. Cummings
David S. Fedson
Robert I. Finkel
Christopher C. Gates
Frank J. Grady
Robert Andre Gryboski
James K. Ciude
Reid R. Helt'ner Jr.
David A. Hill
Carl E. Hunt
Ronald J. Karpick
Mohandas M. Kini
Sandra Chook Levine
Mark W. Lischner
Philip D. .ManTredi
Walter W. Noll
A. Lawrence Ossias
John .A. Parrish
Robert L. Pickens
William A. Renert
Ciene A. Robinson
George B. Row land
John 11. Seashore
Margretta Ann Reed
Seashore
David .M. Shames
David P. Simmons
Harlan Spitz
Man Vk'illiam Stone
R iS. ;i (i. Weiner
I’. l Vuan Shu Wong

Philip Bernstein
James Edward Brown
Eugene Patrick Cassidy
Joseph A. Donadio
Marvin A. Eisengart
Peter M. Fitzer
Robert N. Frank
Robert C. George
Peter D. Gibbons
J. McLeod Griffiss
Robert A. Gunn
Stuart T. Hauser
Jay G. Hayden
Mary Alice Houghton
Bruce W. Jackson
Gordon R. Kelly
Stuart M. Kotler
Wilbur L. Kukes
David C. Law
Lynne L. Levitsky
John Stephens Melish
Harold Mellin
Eli H. Newberger
Edward J. O'Keefe
Neil J. Peterson
William D. Peterson
James D. Slavin Jr.
Parker J. Staples
Gary L. Townsend
Jon S. Way I and
Joan T. Wayland
Arne S. Youngberg
Richard B. Yules

1967
Daniel L. Arons
Arthur L. Beaudet
Daniel J. Booser
Gary C. Burget
Mary Williams Clark
Kenneth F. Crumley
Cynthia Rapp Curry
Marian C. Davidson
James J. Dineen
James M. Dowaliby II
John A. Drews
Peter R. Egbert
Dennis Grant Egnatz
Herbert W. Felsenfeld
Richard J. Hart Jr.
Richard L. Heppner
George P. Herr
David L. Ingram
Anthony P. Lovell
Laura Kirchman Manuelidis
Stephen W. Miller
William J. Mitchell
Joseph L. Morris
Jennifer Robinson Niebyl
John Northup Jr.
John O. Pastore
William E. Perkins
Brian F. Rigney
Robert I. Roy
Jonathan L. Saveli
Alfred Q. Scheuer
Stephen C. Schimpff
Sidney C. Smith Jr.
Lewis S. Solomon
Robert S. Steinberg
Richard B. Swett
M. David Tilson 111
Robert A. Vogel
Robert A. Vollero
Joseph F. Walter
.Martin Wand
Robert J. Winer
Robert S. K. Young
Peter M. Zeman

William Catalona
Donald R. Coustan
Rutledge W. Currie
Barbara Mayer Egbert
Alan G. Finesilver
Richard A. Getnick
Mark Gilbert Grand
Leonard Grauer
Ralph S. Greco
Kevin N. Hennessey
John R. Hill II
Peter Jokl
Jeffrey S. Lee
Marc E. Lippman
Frank E. Lucente
Donald O. Lyman
Stephen I. Marglin
Rodrigo Martinez
David P. Millett
Richard P. Mills
Richard M. Morehead Jr.
John A. Ogden
James W. Ogilvie
Jackson B.E. Pickett 111
Ralph Jerome Rauch
Joseph L. Renda
Gordon H. Sasaki
Jacob J. Schlesinger
Bruce Stuart Schoenberg*
Frederick C. Sherman
Elizabeth M. Short
Howard W. Siegel
Gerald L. Springer
Lee H. Strohl
Per Henrik Wickstrom
Creed W. Wood

1969
Charles S. Angell
David G. Ansel
David W. Barry
Robert E. Belliveau
Donald H. Buchholz
Richard J. Daly
Charles A. Dinarello
Douglass T. Domoto
Ralph J. Falkenstein
Gary S. Famham
Steven A. Frankel
William H. Frazier
Anna S. Gail
Royal J. Gay
Sander G. Genser
Robert O. Gordon
Thomas C. Howard
Lee M. Jampol
Joel Mark Kaufman
Paul H. Kelker
Lynn G. Lagerquist Jr.
Elliot M. Livstone
Robert L. Marier
Arnold F. Mazur
Ellen B. Milstone
Bruce K. Nagle
Lionel M. Nelson
Nancy Olmsted
Deborah A. Putnam
N. Burgess Record Jr.
Joseph M. Rochford
David J. Sahn
Lutz H. Schlicke
Adrian M. Schnall
David J. Schulak
Gerald J. Smallberg
Michael S. Toren
David L. Upton
Robert J. Walat
Stephen R. Webb

1970
1968
Philip L. Barry
Daniel 1. Becker
Grace Jordison Boxer

Richard A. Charlat
Henry Chessin
Michael J. Chusid
C. Norman Coleman

♦Deceased

James E. De Lano Jr.
Margaret W. DeLano
W. Montague Downs
Jonathan Ecker
Richard L. Edelson
Robert Alan Epstein
Bruce A. Fabric
Thomas H. Gouge
Paul C. Hessler
Jay H. Hoofnagle
Jonathan D. Katz
Mark A. Korsten
Thomas L. Lewis
Robert B. Litman
Anne W. Lucky
Roger A. Mason
James R. Missett
William K. Mueller
W. Scott Peterson
Bruce A. Reitz
Robert M. Rosa
Dennis E. Shield
Stuart S. Shorr
Richard A. St. Onge
Daniel A. Symonds
Ray W. Tripp III
Brian Weiss
C. Bruce Wenger
Joellen Weme
Daniel Wuensch
Karl O. Wustrack

Robert B. Geehr
Robert D. Glassman
Robert F. Goodman
Bruce B. Haak
Andrew E. Hoover
Thomas L. Horn
Vernon H. Humbert Jr.
Fred Hyde
Anthony H. Jackson
Jesse B. Jupiter
Philip W. Lebowitz
Theodore M. Levin
Paul A. Lucky
Harry L. Malech
Jeffrey S. Menkes
David B. Moyer Jr.
James A. Nathanson
John P. O’Grady
Edward J. Olinger
William L. Risser
David H. Romond
Philip M. Rothfeld
John S. Smolowe
Frederick D. Stockwell
Lawrence P. Temkin
Philip J. Weyman
Michael W. Yogman

1973
David A. Adler
David Nelson Bailey
Clement R. Boland
Mary Ann BrunstetterShafer
Robert W. Bucholz
James N. Campbell
Marvin M. Chassin
F. Sessions Cole III
Joseph M. Connors
Christopher M. Doran
Jane H. Ferguson
Richard J. Fingeroth
Robert A. Florin
Lee Goldman
Gary V. Gordon
Gary T. Grimes
Howard S. Honig
Andrew G. Kadar
Lynne M. Liptay
Mark G.F. McCormick
John F. McQuade III
Jerry Nagler
John Frederick Neil*
Claes M. Nilsson
David E. Peach
David Pickar
Robert Joseph Polackwich*
Charles F. Reynolds 111
James S. Robertson
Thomas J. Romano
Jerrold F. Rosenbaum
Robert A. Sirota
John R. Stratton
James F. Sullivan
Thomas F. Sweeney
Robert J. Ursano
Richard S.K. Young
Randall M. Zusman

1971
Judith L. Bader
Laurie J. Bleicher
Bruce Block
Willard Cates Jr.
John L. Cieply
Frederick L. Cohn
Andrew D. Cook
Michael Cynamon
Leonard I. Eisenfeld
Harvey Fembach
Fred Finkelman
John W. Foster Jr.
Jerold Alan Haber
Michael J. Hart
William W. Hay Jr.
N. Timothy Jette
Robert M. Kessler
Barbara K. Kinder
William L. Krinsky
Gary M. Lande
David H. Lippman
Richard Albert Moggio
Martin Paris
John A. Patti
Barry Bruce Perlman
Michael C. Piercey
Anthony V. Proto
Barry S. Rand
Irving G. Raphael
Douglas R. Schmidt
John Smiarowski
James P. Southwick
Daniel R. Synkowski
Richard D. Travers
Paul A. Vignola
Robert B. Vranian
Albert Carl Weihl
Daniel G. Wright

1974

1972
Robert D. Arbeit
R. Michael Buckley Jr.
Michael A. Catalano
Leonard H. Cohen
Philip L. Cohen
Gloria Cummings*
Robert F. DeBlasi
Norman M. Dinerman
William H. Druckemiller Jr.
M. Felix Freshwater
John P. Fulkerson

Stephen B. Arnold
Irving M. Asher
Leonard I. Banco
Douglas A. Berv
Bruce David Blumberg
Neil Blumberg
Peter J. Buchin
Bert D. Collier Jr.
Paul David
Vincent A. Di Maria
Roger H. Emerson Jr.
Irl L. Extein
Allan B. Fried land
Michael A. Gerber
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Hillel D. Skoff
Kim R. Swartz
Marcia R. Taylor
Lawrence H. Young
1981
Cynthia B. Aten
Robert B. Bailey Jr.
Alicia Barela
Sherri L. Brown
Susan Burdette
Stephen Wilson Burgos
Patricia A. Burke
Marc D. Coltrera
Paula M. Fracasso
Laurie J. Gordon
Neil D. Gross
Scott A. Hundahl
Elliot Each
Robert M. Milstein
Richard L. Mogemian
David A. Paly
Barbara A. Roach
Dovelet Shashou
Anthony M. Urbano
Nancy E. Vinton

Spirits are running high for Gary DiLiso and Mark Dettelhach.
David Grant
Robert F. Flempton
Robert C. Jimerson
Ancil A. Jones
Robert M. Kolodner
Saul Lande
Olusegun O. Lawoyin
Edward L. Marut
James R. McMonagle
Marjorie A. S. Oda
Richard C. Pasternak
Andrew L. Ries
David Z. Ritvo
Amy S. Schechter
Robert J. Schechter
James A. Strom
George H. Talbot
Carol C. Teitz
Edward M. Wolin
1975
Ralph E. Binder
Sharon L. Bonney
William S. Bush
Rodney J. Butch
James P. Grabman
Carol L. Kandall
Kevin Kane
Bernhard H. Lisker*
Richard J. Loewenstein
Yvonne E. Lomax Burnett
Hyman J. Milstein
Mary Jane Minkin
Robert G. Nankin
Andrew B. Newman
Edwin G. Olson
George J. Pardos
Vivian Reznik
Philip J. Rich
James E. Robertson III
Salvatore V. Romano Jr.
Robert S. Sandler
Steven A. Schwartz
Barbara J. Stoll
David J. Taylor
David W. Wiltse
Douglas R. Zusman

1976
Sarah S. Auchincloss
Alfredo L. Axtmayer
John C. Bartlett
Peter B. Bitterman
Alan B. Bloch
Randall D. Cebul
Pauline Y. Chao
Richard S. Childs Jr.
John D. Clemens
Kenneth J. Dobuler
John A. Elefteriades
Geoffrey Etherington
Leonard Firestone
Ira H. Gewolb
Glenn A. Gorlitsky
Joel Kabak
Norman V. Kohn
William K. Levy
Douglas G. Mann
Jon S. Morrow
Daniel W. Rahn
Paul R. Ramirez
Susan H.K. Ryu
Richard S. Schottenfeld
John T. Sladky
Bonita F. Stanton
Charles R. Swenson
Jacob E. Tauber
Peter M. Ting
John C. Wiles
Jerome B. Zeldis
1977
Michael G. Adelberg
John J. Boronow
Stuart Brian Dubin
Sybil E. Duchin
Susan Firestone
James A. Fox
Julia B. Frank
Robert W. Hand
Bruce L. Innis
Howard K. Koh
David J. Kreis Jr.*
Margaret S. McKenna
Robert J. Mitchell
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R. Andrew Packard
Alan S. Penziner
Richard E. Peschel
Theodore M. Pitts
Jordan S. Pober
Steven J. Scheinman
Susan Bromberg Schneider
Ricky M. Schneider
Simeon A. Schwartz
Ronald J. Vender
Steven L. Warsof
Sharon R. Weinstein
John E. Whitcomb
Daniel Wohlgelemter
Richard N.W. Wohns
1978
Thomas T. Amatruda
Booker T. Bush Jr.
Duke E. Cameron
Jesse M. Cedarbaum
Emily A. Fine
Stuart M. Forman
Arthur M. Gershkoff
Linda J. Hall
Jeffrey Neal Hausfeld
Alexandra N. Helper
Robert Hershfield
Anne A. Knowlton
Sanford D. Markowitz
Barbara H. Pober
Seth M. Powsner
Sally Rudicel
Donald C. Simonson
Caroline R. Taylor
Stanley J. Tillinghast
Marcia J. Wade
David L. Wessel
Susan Wong
1979
Nancy Berliner
J. Kenneth Burkus
Jeffrey Neil Dombusch
Joel I. Franck
John Jay Gargus
*Deceased

David E. Golan
Bruce Halperin
Edward C. Halperin
Marc Hellerstein
Heather L. Johnson
Jeffrey L. Kaine
Leslie Jay Katz
Helen H. Kay
Anne A. Knowlton
Forrester A. Lee Jr.
Michael K. Lindsay
Shirley McCarthy
David E. Ness
Jean Rosenthal
Lynn K. Rudich
Gary L. Schaer
Cynthia Anne Sherman
Jeffrey Work
Gary Zeevi
1980
David E. Adelberg
Eduardo Alfonso
Seth Leo Alper
Frederick R. Aronson
Alan B. Astrow
David Allen August
Patricia Church Brown
Daryl F. Browne
Michael W. Champeau
Michael M. Chang
Thomas F. Deering
Forrest John Doud
Todd J. Garvin
Marc F. Glickstein
David Jay Goldberg
Gary I. Greenwald
Maria White Greenwald
Jonathan L. Jacobs
Mary Polly McKinstry
Cesar R. Molina
Eric J. Nestler
Mark J. Ratain
Neal L. Rosen*
Steven I. Rosenfeld
John A. Selling

1982
Sylvia R. Beck
Thomas J. Brennan
Keith L. Gladstien
Jed B. Gorlin
Daphne Hsu
Laurie B. Komreich Katz
Michael E. Katz
Patricia Kellner
Kathleen Anne Nolan
Joyce A. O’Shaughnessy
Dan B. Odenheimer
Carrie A. Redlich
Robert J. Rizzo
Lewis P. Rubin
William M. Sikov
Henry J. Stern
Lynn T. Tanoue
Patrick Toth
Albert L. Ungricht
David A. White
Stephanie Wolf-Rosenblum
1983
John Taylor Adams*
Robert E. Bookstein
Elena Citkowitz
William Kadish
Laurie Margolies
Lois A. Morton
David P. Norton
Dan A. Oren
Harlan A. Pinto
Augusta S. Roth
Moshe Rubin
Daniel Paul Sabbeth
David E. Schwartz
Daniel M. Sosin
Philip M. Spiro
Kenichi Takeshita
1984
Martha Ray Arden
Robert W. Arnold
David I. Astrachan
John E. Babich
Leonard Bell
Troyen A. Brennan
Barbara Ann Coda
David J. Fillmore
David A. Frank
Kim A. Gutner
Bruce G. Haffty
Jeffrey N. Katz
Jay R. Kostman
John H. Krystal
Richard L. Leff

67

Lewis Lipsey
Melissa Terry Myers
Lisa Ragen
Andrew TTiomas Walker
Roger F. Widmann

Loretla Rubens
Saul Sadka
David A. Shrier
Mark Stein
Susan P. Tredwell

1985

FORMER HOUSE
OFFICERS

Alice S.Y. Chi
Guy Fried
Richard Bruce Garber
Angela Grant
Daniel Greenwald
Barbara Guillette
Jacqueline Gutmann
Marie Hobart
Stuan Neal Isaacs
Susan Korrick
Shirley J. Lee
Jeffrey A. Lowell
Gail Mattson-Gates
Robert D. Needlman
Anne Regenstein
Ellen C. Rieur
Greg A. Sachs
Fred Santoro
Edward B. Savage
Gary L. Shapira
Timothy Alan Shapiro
Louis J. Tesoro
1985 Classmates*

1986
Catharine Ann Arnold
\V. Lee Bailey
Eric F. Bernstein
John A. Detre
Jay Gates
Michael Grossbard
Clinton L. Lindo
Brian P, Lombardo
Elizabeth A. Plotkin
Andrew W. Steele
Steven VVaisbren
John J. Wysolmerski

1987
Andrew Ba/.os
Subba R. Gollamudi
Amy Caroline Justice
Rebecca E. Radish
Joseph Thomas King Jr.
Theresa L. McGuinness
Seth A. Rosenthal
Mindy G. Schuster
Richard P. Tierney
Robert C. Urban Jr.
David H. Weingold
Barry Weinstock
1987 Classmates

1988
Joi Barrett
Kathleen Camey-Godley
Joshua E. Freedman
Robert Kim
Frederick Long
Peter .Alexander Merkel
Theodore Miclau
Michael Emeric Mockovak
John Robert Nienow
Michael A. Rothschild
Steven Slovic
Walter Michael Stadler
Susan \ alley
I ledasatollaii /.aghl
1989
K.itherine Ann Albert
III t er l-ranklin Bock
'■
■ ;
inv.cll
■ c.iil

Phillip R. Aaron
Robert A. Achtel
William R. Adams
N. Erick Albert
John L. Albrigo
Neil S. Alex
Arthur Ames
C. E. Anagnostopoulos
Angela Anderson
Renato Armas
John P. Amst
John M. Aversa
Adel H. Ayoub
Ronald J. Bailey
Arnold M. Baskin
Carl Bennett Bean
Gerald A. Belkin
Gregory Kent Bergey
Michael Richard Berman
Larry Berte
Ralph Daniel Bien
Richard A. Blasband
Paula McFadden Bortnichak
Christine Brahney
Ronald W. Braun
Steven A. Brody
Kenneth Burke
Dennis J. Card
Richard S. Casden
J. Richard Casuccio
Whei C. Chang
Richard Allen Chase
Martin S. Chattman
Ryszard Chetkowski
Chang Song Choi
Michael Chun
Jane R. Clark
Gary M. Cohen
Ian M. Cohen
Burton H. Cohen
David L. Copen
Leandro Cordero
Susan Covey
Sidney L. Cramer
Robert E. Crootof
F. Mitchell Cummins
Michael Martin Deren
Daniel M. Divack
Donald S. Dock
William R. Drucker
Frank H. Duffy
Edward Dunn
Marlene R. Eckstein
Stephen A. Edelstein
Lawrence B. Eisenberg
Malcolm Mitchell Ellison
Walter Ettinger
Richard B. Everson
Jeffrey C. Femyhough
Richard Webster Finner
Bruce T. Fletcher
John N. Forrest Jr.
l.awrence Z. Freedman
George J. Friou
Norman H. Gahm
Jose L. Garcia-Oller
Phillip 11. Gates
George O. Gclinas Jr.
Jonathan Gertler
V. Philip Glassman
Barry Goldberg
Nelson U. Goldberg
Joel S. Golden
John W. Goidkrand

Isaac Goodrich
Richard Reed Gramse
Gordon W. Grundy
Joseph Guaraldo
Alberto R. Guinazu
Kenneth Gwirtz
Seymour Haber
Hedda Ann Litowitz Haning
Ray V. Haning Jr.
Richard B. Harvey
Richard U. Hausknecht
Richard U. Hausnecht
Michael D. Heafner
Mary M. Herman
William H. Heydom
Judith Hochstadt
Gregory L. Holmes
David Smith Hubbell
Eric A. Hyson
Raymond J. Ippolito
Henry G. Jarecki
Robert Orville Jensen
Rollin M. Johnson
Clifford Joseph
John P. Judson
Sheila Moriber Katz
Douglas Key
Stephen King
Samuel C. Klagsbrun
Lawrence E. Klein
Richard Knobelman
Arthur H. Knowiton
Thomas J. Koontz
Boonsri Kosarussavadi
Joseph A. Kovarik
Eugene Kuchner
Joel C. Labow
W. Clark Lambert
Muriel A. Lambert
Emmanuel Landau
Randi Leavitt
Vincent Leung
Douglas M. Levin
Arthur L. Levy
John D. Lewis
Luke K. Licalzi
Walter S. Lockhart
Steven Macht
Bennett Marcus
Stephen Mariani
Frank Masino
Richard J. Maunder
Randolph M. McConnie
John P. McGovern
Pamela M. McKenzie
Janet Meegan
Thalia Mesologites
Anthony B. Minnefor
George Mizner
John H. Monroe
Phyllis R. Monroe
Yasmeen A. Moody
Alan Morelli
Patrick E. Moriarty
L-ewis B. Morrow
Seymour Cy Nash
Donald Natibuff
Gwendolyn B. Nichols
George Nichols
Sheldon Nova
Joseph Manuel Ortiz
Edgardo Ortiz
Raymond L. Osborne Jr.
Robert L. Paltzik
Pradip M. Pathare
Edward W. Powers
Kusum Prabhakar
Gilbert A. Ratcliff
Robert R. Rickert
Jeffrey P. Robbins
Claude Roge
Fred M. Rosenbloom
Robert L. Rowley*
David R. Rubinow

*Deceased

Julia Sabetta
James R. Sabetta
Arthur W. Samuelson
Mary Sanders
Michael Saruk
A S Hasan Sarwar
Mark Scharf
Ronnie G. Schlesinger
Jonathan Schreiber
Doug Schulman
Louis N. Scotti
James Thomas Sehn
Richard Alan Selzer
Howard Senter
Carlton C. Sexton
Thomas E. Shaffer
Daniel W. Shapiro
Vernon H. Sharp
Nathan T. Sidley
Gary R. Siegel
Joel Silidker
Frederic N. Silverman
Robert E. Silverman
Paul I. Silverstein
Earl J. Simburg
Leon G. Smith
Thomas J. Spackman
Stephanie S. Spangler
Richard I. Staiman
John G. Steciw
Judit Stenn
Fred Leslie Strieker
Herbert Suesserman
Craig Summers
Herbert Tabor
Marc J. Taylor
Lee Lawrence Thibodeau
James W. Thompson
Troy L. Thompson II
James S. Touloukian
Bernard Tsai
L. Newton Turk III
Daniel W. VanHeeckeren
Romulo L. Villar
Robert S. Waldman
Gary R. Wanerka
Thomas A. Warthin
James E. Watson
Herbert Allan Wenner
George Wharton
Robert R. White III
Princess Williams
Robert J. Williamson
Stephen Winter
Philip Witorsch
Suna E. Woods
Eiji Yanagisawa
Robert C. Young
Steven M. Zamore
Leonard H. Zamore
Marvin Paul Zimmerman
Richard Walter Zimmerman
Lawrence H. Zingesser

PARENTS AND FRIENDS
Mr. Irving Abelow
Mr. Lawrence David
Ackman
Nancy Andreoni
Bryan Birch
Mr. Harold Burg
Mr. Paul W. Carstens
Mr. & Mrs. Abe Cazen
Mr. Howard Chin
George Sr. Winther Cole
Mr. Fred C. Colin
Willibald H. Conzen
Mrs. Judy Coppola
Mr. Edward J. Dilisio
Frederick H. Dill
William Dee Dockery Jr.
Mr. Arthur E. Dolnansky
Mr. & Mrs. Kenneth T.
Doran
Dorothy Marie Ference
Mr. Max Finkelman
Mr. Maurice Joseph
Fitzgerald
Gerald Wilfred Friedland
William & Isabel Goodrich
Mrs. Harold Grant
Mrs. Barbara J. Guillette
Frederick W. Heilman
Mrs. Gloria F. Holmes
Jacques Hussussian
Irving I. Kaplin
Joseph T. King
Kenneth P. Kinney
Mr. Boris Kliot
Carolyn Leehy
John Joseph Ixy
Edward G. Lund Jr.
Mrs. Virginia G. Mannick
Mortimer Bennett Marcus
Mr. Shizuo Matsui
Mr. Arthur P. Miller
Mary Elizabeth Mintum
Mr. & Mrs. Lewis Nankin
Elbert John Thomas Nelson
Mr. & Mrs. Victor M.
Newman
Mr. Marshall D. Newton
Dr. William G. O'Donnell
Mr. Jon Ogland
Dr. Richard D. Otis
Mr. & Mrs. Louis Parent
Mr. Samuel Perlman
Dr. & Mrs. Levi V. Perry
Ann D'Esopo Phillips
Mr. Leonard Portney
R. Donald Reich
Richard J. Roddy
Mr. Joel G. Roth
Harold & Frances Sampson
Henry S. Sanematsu
Dr. Joseph Schlesinger
Leon G. Smith
Naomi Goldfarb Solomon
Kenneth Alan Stein
Prof. & Mr. Lubert Stryer
Mrs. Leo Teitz
Richard Tjoan-Thay TTiio
Thomas M. Tierney
Jeanne Carol Weaver
Mr. & Mrs. Milton
Weinberg
Mr. Harold Weinberg
Jack Weingold
Michael Frederick Weiss
Mr. & Mrs. Herman H.
Zusman
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STERLING ASSOCIATION
LIFETIME BENEFACTOR
J. Roswell Gallagher ’30
Amy H. Hunter-Wilson '30
Myra D. Tyler ’50

SPONSOR
Myron A. Sallick '24*
Howard Asa Wood ’25*
Theodore E. Allen ’40
Lowell I. Goodman ’51
John Currier Gallagher ’58*
Leonard Grauer ’68
M. Felix Freshwater ’72

PATRON
John B. Ogilvie ’34
Donald P. Morris ’35*
Henry D. Humphrey ’40
Thomas P. Cotter ’45
Charles E. Sherwood ’45
Martin E. Gordon ’46
Sidney S. Lee ’50
Harold D. Bomstein Jr. ’53
William H, Hindle ’56
Robert M, Amick ’59
A. Thomas Snoke ’64
Thomas B. Caldwell III ’65
James W. Ogilvie ’68

Former House Officers
Richard Allen Chase

FELLOW
Louise Baker ’26
Sheldon A, Jacobson ’28
Nathan E. Ross ’28
Lewis A. Scheuer ’28*
Vincent A. Doroszka ’30*
Henry H. Briggs Jr. ’31
Nelson Newmark ’31
Harry Sherman ’34
Margaret C. L. Gildea ’36
Frederick A. Post ’36
Alfred E. King ’37
Robert M. Dunlap ’40
Edward Martin ’40
David V. Pecora ’41
Ralph D. Alley ’43 March
R. M. Fasanella ’43 March
Ronald W. Cooke ’43
December
Robert H. Furman ’43
December
Lawrence G. Crowley ’44
Howard B. Hamilton ’44
Frederick F. Krauskopf ’44
A. Reese Matteson ’44
Paul E. Molumphy ’44*
Nicholas P.R. Spinelli ’44
Franklin C. Behrle ’46
Sanfurd G. Bluestein ’46
Thomas J. Coleman ’46
George R. Barnes Jr. ’47
Owen W. Doyle ’47
Paul B. Koehler ’48
Jerome H. Shapiro ’48
Anne G. St. Goar ’48
Sylvia L. Axelrod ’50
William H. Bucher ’50
Claude W. Delia ’50
Kent Ellis ’50
Harry L. McClelland ’50
Gerard B. Odell ’51
Mary Wheatland Schley ’52
Preston Lee Leslie ’53
Ora K. Smith ’53

Yale Medicine

James Frederic Young ’53
James J. Nora ’54
James Conway Garlington ’55
F. Calvin Bigler ’57
William L. Kissick ’57
Donald C. Stahl ’57
Gerard N. Burrow ’58
Robert J. Donohue Jr. ’58
Paul A. Rudnick ’58
Raymond W. Turner ’58
Paul Jay Friedman '59
James R. Ralph ’59
Leo H. Von Euler ’59
Ormond V. Brody, PhD ’60
Paul Jay Friedman ’60
Thomas P. Kugelman ’60
John J. Schrogie ’60
Constantine M. Voyagis ’60
Anoush Miridjanian ’61
Warren D. Widmann ’61
John P. Lynch ’62
Seth Thaler ’62
Robert E. Mueller ’63
Lawrence Tremonti ’63
Peter G. Weiner ’63
Richard Murray Linburg ’64
Robert W. Lyons ’64
Robert L. Mitchell ’64
Donald G. Skinner ’64
Robert Andre Gryboski ’65
Mohandas M. Kini ’65
Philip D. Manfredi ’65
Jay G. Hayden ’66
Wilbur L. Kukes ’66
Gary L. Townsend ’66
Kenneth F. Crumley ’67
Robert 1. Roy ’67
Joseph F. Walter ’67
William Catalona ’68
Joseph M. Rochford ’69
Adrian M. Schnall ’69
Thomas H. Gouge ’70
Laurie J. Bleicher ’71
John W. Foster Jr. ’71
Richard Albert Moggio ’71
Robert F. DeBlasi ’72
Marjorie A. S. Oda ’74
Michael G. Adelberg ’77
Richard N. W. Wohns ’77
David Jay Goldberg ’80

Former House Officers
Ronald W. Braun
Samuel C. Klagsbrun
Walter S. Lockhart

Parents and Friends
Mr. Lawrence David Ackman
Frederick W. Heilman

ASSOCIATE
Michael A. Parlato ’08*
Walter Clark Tilden ’ 12*
David M. Raskind ’24
Maxwell Bogin ’26
Knox H. Finley ’30
Thomas C. Jaleski ’31
Lee E. Farr ’32
Jack Greenberg ’33
Edgar S. Childs ’35
Norman E. Peatfield ’35
Stephen W. Collins Jr. ’39*
Harold H. Coppersmith ’39
William H. Druckemiller ’39
John P. Ferguson Jr. ’39
Wynant Dean ’40
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The School of Medicine Alumni Fund’s Sterling Association recognizes
donors who have made gifts at the following levels:
Lifetime Benefactor

$5(),()0{) and above

Sponsor

H. Stuart Irons ’40
Patricia E. Wanning ’40
Robert H. Areson ’41
Robert W. Ollayos ’41
James M. Bunce ’42
William Harrison Jr. ’42
R. Leonard Kemler ’43 March
Jonathan Trumbull Lanman
’43 March*
Robert H. Wyatt ’43 March
Hunter H. Comly ’43
December
Henry H. Jones ’43 December
Hoyt B. Miles Jr. ’43
December
Carol Goldenthal ’44
Elias J. Marsh ’44
Jay B. Cohn ’45
Edward M. Daniels ’45
Sidney S. Feuerstein ’45
William J. Wedemeyer Jr. ’46
W. Roy Breg Jr. ’47
David L. Brook ’47
Rocco A. Calandruccio ’47
Robert A. Chase ’47
William F. Collins Jr. ’47
Robert J. Kerin ’47
Edith M. Beck ’48
Allyn G. Bridge ’48
Richard Steele Buker Jr. ’48
G. Robert Downie ’48
N. Joel Ehrenkranz ’49
Charles L. Rennell Jr. ’49
Daniel Fine ’50
Janus C. Lindner’50
Fund 1950 Medical ’50*
Thomas T. Amatruda Jr. ’51
Arthur P. Hustead ’52
Sidney Nathan Paly ’52
Robert G. Petersdorf ’52
Richard Andrew Sinnott Jr.
’53
Howard Willis Smith ’53
Arthur C. Crovatto ’54
Lowell E. Olson ’54
Leonard M. Silverman ’54
Leroy Engel ’55
David R. Kessler ’55
Clement B. Sledge '55
Chandler Dawson ’56
Preston C. Manning ’56
Stewart E. Pursel ’56
William M. Gould ’58
Richard Charles Miller ’58
Robert L. Fisher ’59
Herbert J. Kaufmann ’59
Victor Altshul ’60
Eugene C. Gaenslen Jr. ’60
Eugene G. McCarthy Jr. ’60

*Deceased

5,000 - 49,999

Patron

2,000 - 4,999

Fellow

1,000- 1,999

Associate

500 - 999

Member

200 - 499

Albert A. Bechtoldt Jr. ’61
Jon Dudley Dorman ’61
Thomas H. Sakoda ’61
Stewart R. Wright ’62
Alexander R. Gaudio ’63
Leland S. Berger ’64
Donald A. O’Kieffe Jr. ’64
Stephen Waltman ’64
Oscar Wand ’64
Susan A. Aoki ’65
Paul Balter ’65
Michael J. Cummings ’65
David A. Hill ’65
Ronald J. Karpick ’65
Mark W. Lischner ’65
Robert L. Pickens ’65
Robert G. Weiner ’65
John A. Drews ’67
Rutledge W. Currie ’68
Ralph S. Greco ’68
Kevin N. Hennessey ’68
Per Henrik Wickstrom ’68
Ralph J. Falkenstein ’69
Richard L. Edelson ’70
Frederick L. Cohn ’71
Barbara K. Kinder ’71
John A. Patti ’71
Michael C. Piercey ’71
William H. Druckemiller Jr.
’72
Gary T. Grimes '73
Lynne M. Liptay ’73
James S. Robertson ’73
Saul Lande ’74
Olusegun O. Lawoyin ’74
Edward L. Marut ’74
Douglas R. Zusman ’75
Alfredo L. Axtmayer ’76
Leonard Firestone ’76
Michael K. Lindsay ’79
Gary Zeevi ’79
Scott A. Hundahl ’81

Former House Officers
John L. Albrigo
Clifford Joseph
John P. Judson
John P. McGovern
Robert L. Rowley*
James S. Touloukian
Anonymous

Parents and Friends
Edward G. Lund Jr.
R. Donald Reich

Member
Charles R. Mitchell '06*
William Cohen ’23

Julius Anthony Olean ’23*
Harold T. Vogel ’24*
Alice A. S. Whittier ’25
John Martin Freiheit ’27*
Ralph E. Knutti ’28
Tony Liebman Rakieten ’29*
Robert Tennant '29
Frederick Fitzherbert Boyce
’30
Paul H. Lavietes ’30
John C. Mendillo ’30
Charles L. Wood ’30
Michael D'Amico ’31
Paul A. Harper ’31
Joseph P. Donnelly ’32
Conrad R. Lam '32
Elizabeth M. Ramsey ’32
Benjamin N. Tager ’32
Myron E. Wegman ’32
Ashley Pond III ’33*
Sidney Stringer ’33*
Walter E. Barney ’35
George A. Carden Jr. ’35
James Quintin Haralambie ’35
W. Howard Homer ’35
Samuel D. Kushlan ’35
Walter A.L. Thompson ’35
Morris Tager ’36
David A. Dolowitz ’37
Jean Wells ’37
Benjamin E. Lyons ’38
Edward Nichols ’38
Rebecca Z. Solomon ’39
Malvin F. White ’39
Richard E. Dormont ’40
William A. Carey ’41
Herbert W. Diefendorf ’41
Peter A. Duncan ’41
Robert L. Gilbert ’41
William E. Bloomer ’42
Davitt Felder ’42
Wilson E. Hughes ’42
Leo Kellemian ’42
Dean Nichols ’42*
Maurice Tulin ’42
Irving Norman Wolfson '42
John R. Brobeck ’43 March
Lycurgus M. Davey ’43
March
J. Philip Loge ’43 March
Henry A. Riedel ’43 March
Edward Hersey Soule '43
March
Oliver G. Stonington ’43
March
John J. Weber ’43 March
Norman 1. Condit ’43
December
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Sterling Association (Continued)
Victor C. Hackney ’43
December
Donald W. Seldin ’43
December
John C. Coolidge ’44
Charles A. Hall ’44
Ward S. Jenkins ’44
Russell R. Monroe '44
Lawrence K. Pickett ’44
George Howard Allison ’45
Albert S. Atwood ’45
Alice Shepard Cary ’45
Sanford F. Cockerell ’45
Richard R. Dyer ’45
Robert S. Easton ’45
Alice Dershimer Friedman
’45
O. Roger Hollan ’45
Mark McD Lindsey ’45
James R. Mason ’45
George W. Naumburg Jr. ’45
Fitzhugh C. Pannill ’45
Richard M. Peters ’45
Linus W. Cave ’46
Gregory E. Flynn ’46
Charles Sheldon Judd Jr.
’46*
Thomas J. Mathieu ’46
Joe D. Morris ’46
Thomas J. Whelan Jr. ’46
Charles R. Cavanagh Jr. ’47
Roland G. Chambers ’47
Richard K. Friedlander ’47
Brock Lynch ’47
Charles L. Mache Jr. ’47
William K. McClelland ’47
Myron K. Nobil ’47
Olive E. Pitkin ’47
Irving Rudman ’47
Igor Tamm ’47
Patricia B. Tudbury ’47
Jonathan S. Bishop ’48
Ruth E. Cortell ’48
Elizabeth Fuller Eisner ’48
Boy Frame ’48*
Ross R. Harcus ’48
Paul Talalay ’48
William G. Anlyan '49
Daniel W. Elliott ’49
Eleanora C. Gordon ’49
Jackson Harris ’49
Frederick R. Hine ’49
Benjamin A. Johnson ’49
Timothy F. Nolan Jr. ’49
Julian 1. Pichel ’49
Martha Vaughan ’49
Russell N. Anderson ’50
John E. Borowy ’50
Alvin Davis ’50
Carl A. Gagliardi ’50
Cynia B. Shimm ’50
Jane B. Shumway ’50
John S. Strauss ’50
Robert H. Sturman ’50
B. Lionel Truscott ’50
Stanley D. Ardell ’51
Eleanor Clay Bigley ’51
Sidney S. Furst ’51
Joseph M. Garland ’51
Carrold K. Iverson '51
Jocelyn S. Malkin ’51
Albert R. Mowlem ’51
Ismail Nik Nevin ’51
Arthur A. Pava ’51
Majic S. Potsaid ’51
Donald H. Schultz ’52
John H. Wagner Jr. ’52
John L. Wolff ’52
Robert Zeppa ’52
William R. Chaffee ’53
A. Daniel Hauser ’53
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Richard Robert Knowles III
’53
Hildegard Mueller Leslie ’53
Jose Ramirez-Rivera ’53
Richard J. Bouchard ’54
Donald D. Davis ’54
John A. Gariepy ’54
Edward J. Gerety ’54
Eva H. Henriksen ’54
Herbert S. Hurwitz ’54
Robert J. T. Joy ’54
Paul N. Neufeld ’54
Richard D. Pullen ’54
Jacques M. Quen ’54
George E. Becker ’55
Padraic Bums ’55
Milton Com ’55
Robert A. Kramer ’55
James Lum ’55
Joseph S. McGuire Jr. ’55
Robert H. Peters Jr. ’55
F. Brantley Scott Jr. ’55
Alan A. Stone ’55
Levon Z. Boyajian ’56
Thomas M. Brown ’56
Rosalie A. Bums ’56
Donald J. Dalessio ’56
Thomas F. Ferris ’56
John H. Gardner III ’56
Sumner Gochberg ’56
Joan Marasco Hardenbergh
’56
John Herd Hart ’56
George T. Kammerer ’56
Jerome O. Klein ’56
William V. Lewit ’56
Donald J. Nalebuff ’56
George W. Paulson ’56
Robert Lee Scheig '56
John P. Carey ’57
Louis Z. Cooper ’57
Anthony L. Fons III ’57
Anne H. Good ’57
Richard Lee Kahler ’57
Jack Levin ’57
Bennett F. Markel ’57
Robert K. Modlin ’57
Thomas Francis O’Brien Jr.
’57
Clifford B. Reifler ’57
George K. Aghajanian ’58
Joseph E. Angelo ’58
John A. Carlston '58
Stanley Harris ’58
Michael Kashgarian ’58
Jay Ward Kislak ’58
Theodore W. Lieberman ’58
Thomas R. Shea ’58
Edward Lloyd Socolow ’58
Asa Barnes Jr. ’59
Francis A. Beer ’59
Sidney M. Cohen ’59
Gerald Fenichel ’59
Robert J. Gonyea ’59
H. Rodney Hartmann ’59
William H. Heydom ’59
C. Richard Hinckley ’59
Leonard Inker ’59
John J. Jasaitis ’59
Myron S.S. Lee ’59
James A. O’Neill Jr. ’59
Sanford P. Solomon ’59
Muriel D. Wolf ’59
Jack D. Barchas ’60
Stuart P. Bowne ’60
Donald P. Buebendorf ’60
Jon E. Courtney ’60
Malin Dollinger ’60
Roland H. Ingram Jr. ’60
Daniel M. Jones ’60
Frank J. Kleeman ’60
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Edward R. Lang ’60
Donald L. Miller ’60
Allan W. Newcomb ’60
Fred Palace ’60
Nancy Rolick Powell ’60
Daniel J. Rubin ’60
Fred Stargardter ’60
Robert C. Wallach ’60
May Yung-Fun Woo Wang
’60
Ronald A. Yankee ’60
Earl L. Baker ’61
Robert S. Briggs ’61
Orson R. Dee ’61
Ronald A. Dierwechter ’61
John E. Fenn ’61
Richard L. Keefe ’61
George M. Lordi ’61
Joseph Richard Lusby ’61
John Curtis Parker ’61
Elaine Pitt ’61
Stanley G. Schade ’61
Hugh C. Thompson III ’61
Charles B. Anderson ’62
Fredric K. Cantor ’62
Thomas Newell Chase ’62
Oliver Townsend Dann ’62
I. Bruce Elfenbein '62
John W. Foreman ’62
Anthony V. Furano ’62
David E. Knoop ’62
Allan L. Mattem ’62
Stanley E. Matyszewski ’62
William A. Miller ’62
Edward L. Spencer Jr. ’62
Larry Lee Stewart ’62
Miguel R. .Alonso ’63
Andrew Edin '63
John P. Eliopoulos ’63
Peter B. Gregory ’63
Benjamin Keith Harris ’63
Harold P. Kaplan ’63
Peter B. Livingston '63*
Lee Bland Talner '63
Peter V. Tishler ’63
William A. Alonso ’64
Berton W. Ashman ’64
Thomas A. Cardella ’64
Anthony Ferrante ’64
Lawrence Horwitz ’64
Lewis Landsberg ’64
Richard V. Lee ’64
David B. Leof ’64
James S. Levine ’64
William F. Matchett ’64
William B. Pratt ’64
Robert L. Shelton ’64
John H.M. Austin ’65
Robert M. Cohn ’65
Robert I. Finkel ’65
James K. Gude ’65
Carl E. Hunt ’65
Sandra Chook Levine '65
A. Lawrence Ossias ’65
John A. Parrish ’65
Gene A. Robinson ’65
John H. Seashore ’65
Margretta Ann Reed
Seashore ’65
David M. Shames ’65
Eugene Patrick Cassidy ’66
Robert N. Frank ’66
J. McLeod Griffiss ’66
Stuart T. Hauser ’66
Lynne L. Levitsky ’66
John Stephens Melish ’66
Richard B. Yules ’66
Daniel L. Arons ’67
Arthur L. Beaudet ’67
Mary Williams Clark ’67
Herbert W. Felsenfeld ’67
Joseph L. Morris ’67
John Northup Jr. ’67
John O. Pastore ’67

*Deceased

Stephen C. Schimpff ’67
Sidney C. Smith Jr. ’67
Robert S. Steinberg ’67
Richard B. Swett ’67
Robert A. Vogel ’67
Martin Wand ’67
Robert J. Winer ’67
Philip L. Barry ’68
Richard A. Getnick ’68
Peter Jokl ’68
Jeffrey S. Lee ’68
John A. Ogden ’68
Gordon H. Sasaki ’68
Frederick C. Sherman ’68
Creed W. Wood ’68
Richard J. Daly ’69
Anna S. Gail ’69
Royal J. Gay '69
Sander G. Genser ’69
Thomas C. Howard ’69
Lionel M. Nelson ’69
Nancy Olmsted "69
Deborah A. Putnam ’69
David J. Sahn ’69
Lutz H. Schlicke ’69
Gerald J. Smallberg ’69
Michael S. Toren ’69
Stephen R, Webb ’69
C. Norman Coleman ’70
James E. De Lano Jr. ’70
Jonathan Ecker ’70
Jay H. Hoofnagle ’70
Robert B. Litman ’70
William K. Mueller ’70
W. Scott Peterson ’70
Bruce A. Reitz ’70
Robert M. Rosa ’70
Richard A. St. Onge ’70
Brian Weiss '70
Karl O. Wustrack ’70
Judith L. Bader ’71
Bruce Block '71
Andrew D. Cook ’71
William W. Hay Jr. ’71
Martin Paris ’71
Barry S. Rand ’71
Irving G. Raphael ’71
Douglas R. Schmidt ’71
John Smiarowski ’71
Richard D. Travers ’71
Paul A. Vignola ’71
Robert B. Vranian ’71
Albert Carl Weihl ’71
Michael A. Catalano ’72
Bruce B. Haak ’72
Thomas L. Horn ’72
Vernon H. Humbert Jr. ’72
Fred Hyde ’72
Jesse B. Jupiter ’72
David Nelson Bailey ’73
Robert W. Bucholz ’73
James N. Campbell ’73
John F. McQuade III ’73
Jerry Nagler ’73
David Pickar ’73
Randall M. Zusman ’73
Stephen B. Arnold ’74
Irving M. Asher ’74
Bruce David Blumberg ’74
Ancil A. Jones ’74
Amy S. Schechter ’74
Robert J. Schechter ’74
James A. Strom ’74
Carol C. Teitz ’74
Edward M. Wolin ’74
Sharon L. Bonney ’75
William S. Bush ’75
Rodney J. Butch ’75
Mary Jane Minkin ’75
Robert G. Nankin ’75
Pauline Y. Chao ’76
John A. Elefteriades ’76
Glenn A. Gorlitsky ’76
Norman V. Kohn ’76

William K. Levy ’76
Jon S. Morrow ’76
Susan H.K. Ryu ’76
Charles R. Swenson ’76
Susan Firestone ’77
R. Andrew Packard ’77
Alan S. Penziner ’77
Richard E. Peschel '77
Ronald J. Vender 'll
Emily A. Fine ’78
Caroline R. Taylor ’78
Marcia J. Wade ’78
David E. Ness ’79
Cynthia Anne Sherman ’79
David E. Adelberg ’80
Michael W. Champeau ’80
Michael M. Chang ’80
Todd J. Garvin '80
Mark J. Ratain ’80
Hillel D. Skoff ’80
Sherri L. Brown ’81
Thomas J. Brennan ’82
Keith L. Gladstien ’82
Saul Sadka ’84
Angela Grant ’85
Jennifer Franklin Bock ’89

Former House Officers
Phillip R. Aaron
Renato Armas
Adel H. Ayoub
Larry Berte
Christine Brahney
Dennis J. Card
Edward Dunn
Lawrence B. Eisenberg
Richard Webster Finner
Alberto R. Guinazu
Richard U. Hausknecht
Richard U. Hausnecht
Michael D. Heafner
William H. Heydom
Eric A. Hyson
Henry G. Jarecki
Douglas Key
Boonsri Kosarussavadi
Joseph A. Kovarik
Eugene Kuchner
Donald Natibuff
Ronnie G. Schlesinger
Daniel W. Shapiro
Thomas J. Spackman
Stephanie S. Spangler
James W. Thompson
Bernard Tsai
George Wharton
Steven M. Zamore

Parents and Friends
Willibald H. Conzen
Frederick H. Dill
Gerald Wilfred Friedland
Mr. Boris Kliot
Henry S. Sanematsu
Naomi Goldfarb Solomon
Prof. & Mr. Lubert Stryer

PUBLIC HEALTH ALUMNI FUND
1921
Ira V, Hiscock*
1926
John J. Batchelor
1930
Ruth E. Grout
1933
Miriam M, Campbell
Eunice Nickerson Tyler
19.14
Amy H. Hunter-Wilson
Iwao M. Moriyama
19.35
Franklin M, Foote
Almeda King
19.36
M. Allen Pond

From the Public Health Alumni Fund Chairman
The 1989-1990 campaign has been a
resounding success! We reached 298
percent of our goal — raising $ 135,523 —
the most successful public health campaign
ever. This was made possible in no small
measure by the impressive sum of nearly
$101,000 raised by the Class of 1948 and its
class agent, Sam Herman.
Of course, 1 am pleased to acknowledge
the contributions made by all 597 of our
alumni/ae donors, 27 percent of those
solicited. While proud of our
accomplishments, I would like our percent
of participation to increase. Almost 10 years

19.37
Lidie V. Dyer
Howard West
William R. Willard

ago, we achieved a participation of 37
percent of alumni/ae. That will be our goal
for next year!
The meaning is simple — we can’t rest
on our laurels. Please try to emulate those
classes who passed our target goal of
$1,000 per class. Special thanks to the
classes of ’59, ’78, ’79 and ’86, who have
been added to this list since last year.
Thanks again to all of our donors.
Without you we would have no fund at all!
Stephen Skorez, M.P.H. ’70
Chairman

AMOUNT

CLASS

$100,885

1948

Samuel S. Herman

1,680

1967

James M. Malloy

1,670

1976

Elaine P. Anderson

1,570

1979

Catherine Norton/

AGENT(S)

19.3X
Willard H. Boynton
Richard K.C. Lee
Katharine Hawley Martin
Lucy S. Morgan
19.39
Carl I. Cohen
Frances S. Miller

Ralph Tartaglione

1941
Roslyn L. MacNish
Margaret Hyde Moore
Marion Redmond
Alexander Witkow*
1942
Henry F. Canby
Leonard Parcnte
Arthur B. Robins
Charles D, Spangler
194.3
Carolyn S. Koffler
Eric W. Mood
Muriel Bliss Wilbur*
1944
Massimo Calabresi*
Jean F. Heston
Jane Y, Parker
1945
Roslyn R. Bilford
Naomi Barer Golden
JiK' Bales Graber
Lois M. Jund
1946
Doroiliy B. Hamilion
; Paintla Nelson
1947
• : hies S ( hipinan
Xi'iic 7 -::l|on
, . 1 ; . :j1 1
.J , .. 1
. .1 ,

•

1,540

1971

John Bihldorff

1,340

1969

Robert L. Young

1,330

1973

Gary Dean Sax

1,2.50

1959

Dorothy M. Wilson

1,235

1970

Susan W. Balter

1,210

1978

Ann T. Freedman

1,177

1975

Linda K. Broker

1,135

1986

Indu B. Ahluwalia/
Aric T. Wilt

Stephen Skorez, M.P.H.

1948
John B. Dibeler
Mary Margaret Filzgerald
Joseph Hanford Gerber
.Samuel S. Hemian
Barbara L. Holman
Richard E. Johnson
Beatrice H. Kaasch
Dorothea S. LaBelle
Hiram Sibley

1950
Dorothy Reese Bloomfild
Henry G. Brickman
Ida M. Bucher
Helen P. Cleary
Austin J. Evans
Jerome M. Glassman
Martha P. Jayne
Frances K. Reynolds
Nathan M. Simon

1949
Edgar L. Geibel
Eleanor P. Kostant
Hilda 11. Kroeger
Christine R. Owre
Elizabeth D. Robinton
Matilda Rudnick
l-mcst M. Sable

1951
Clarissa E. Boyd
Nonon G. Chaucer
Joanne E. Finley
Homer P. Hopkins Jr.
Robert L. Johnson
Leonard F. Menezer
Jessie Parkinson Spear
♦Deceased

1,085

1968

Francis J. Greaney

Laurence K. Rainsford
Milton H. Sisselman

James M A Weiss
Walter Wenkert
John J. Zugich
1952
Mary 0. Gabrielson
Joanna Adele Henry
Malcolm C. Hope
Charles Holway Lawrance
Sidney S. Lee
Helen Kardys Loria
Yolande F. Lyon
Hannah Eileen MacHenry
Jeanne Ellen Paty

1954
Calvin P. Hatcher
Ruth M. Taber
1955
Amy L. Cawley
Evelyn S. Farnsworth
Morris London
Mary Me C. Mogan
Helen K. Moore*
Frances R. Ogasawara
Gerald Rosenblatt

1953
Jeanette Averill
Abraham Cutcher
William H. Hermann
Yale Medicine
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1956
David D. Boyd
Kathleen H. Howe
John E. Ives
Paul C. Kaufman
John F. Mullett
Julia R. Nole
Mary K. Ochiai
Alice M. Wagner

1957
Janet Beach
Lee De Cady Jr.
William A. Clermont
Edward R. DeLouise
Gaston Jules Deslouches
Sheldon Selig King
Edna May Klutas
Shirley T. Steidel
Patricia A. Viscosi

1958
Edward Bronstein
Helen H. Davenport
Thomas T. Flynn
Normand E. Girard
Mary K. Spiker
Thomas P. Weil

Elliot A. Segal
Viola J. Spinelli
Sttrah L. Turner
David S. Weiner

1966
Barbara L. Brody
Allen Cohen
Patricia R. Colenback
Robert C. Lowrie Jr.
Nancy Alfred Persily
Raul Walder

1967
Carlos E. Alvarez Herrera
Gerard M. Barber
Caroline Fong-Cheng
Ann Gomez
Steven Jonas
Joel Kavet
Patricia D. Mail
James M. Malloy
Nancy Ruth Phillips
Brigitte Prusoff
Bruce J. Steinhardt
Beth M. Whelan
Irma Willner, R.N.
Robert L. Woodward
Peter T. Wotton

1959
William L. Kissick
Marvin A. Lavenhar
Hugh J. Maher
Lee J. Podolin
Ellwyn D. Spiker
Mattie Lee D. Wade

1960
Gyla E. Brooks
Kathryn L. D’Amico
Wouter Ekker
Maxine Geeslin
Rose A. lannotta
Katharine Anna Keppel
John J. Kwasnowski
R. John C Pearson
Hannah Clark Russell

1968
Sonia M. Colon
Joseph L. Dorsey
Robert R. Everett
L. Carol Femow
Michael J. Geaney Jr.
Francis J. Greaney
William D. Harkins
Chester H. Johnson
R. Elizabeth Leif
Jean C. MacCorison
Robert F. Morisse
Arnold R. Saslow
Elizabeth Schwartz SmallElliot
Martha F. Steel
Sheila W. Wellington

1969
Susan S. Addiss
Janet A. Albrecht
James M. Dawson Jr.
Catherine E. Hanley
Gerald R. Harpel
Sylvia N. Holtzberg
Samuel P. Korper
Suchitra Nimmannitya
Samuel D. Rowley
Marva Serotkin
Wanda Vierthaler
Robert L. Young
Chester W. Zamoch Jr.

1970
Susan W. Balter
Arthur A. Berarducci
Michael B. Bracken
Ruth C. Edelson
Walter M. Gawlak
Robert S. Gureasko
Martin James Kandes
Shirley O. Labrum
Scott W. Lite
C. P. Noel McCarthy
Andrea W. Nevins
Saro Palmeri
William L. Pedersen
Charlotte F. Schwartz
Stephen Skorcz
Joseph A. Zaccagnino

1971
John Bihldorff
Evelyn J. Bromet
Willard Cates Jr.
Katrina H. Clark
Karen S. Cohen
John A. Daeley
Harvey Fembach
Anne-Marie A. Foltz
Wanda J. Hatmaker
Mohamed Ismail Johnson
William P. Koughan
Mark J. Magenheim
Joan L. Martinez

Eugene S. Mayer
Nancy P. Mogielnicki
William C. Okulicz
Wan Hin Ooi
David A. Osgood
Carol L. Paul
Jane Silver
Walter O. Spitzer
Robert E. Steele
Barbara R. Stoloff
Judith Whitcomb

1972
David P. Barone
Catherine A. Connolly
Daphne deJ. Gemmill
Dorothy N. Lewis
Steven M. Lipsius
Sergio Ruschel
Jo Ann K. Silverstein
Laurence A. Tanner
Joyce R. Waksman

1973
Emily M. Barclay
Eva Danielsson Cohen
Bernice E. Coleman
A.R. Taylor Denues
Ellen B. Doft
Helen B. Hubert
James L. Mason
Dennis P. May
Dwight N. McNeill
Marjorie E. Nelson
Gary Dean Sax
Janet B. Schoenberg
Alice S. Stark
Thomas J. Stranova
Irene Trowell-Harris
Bonnie C. Yankaskas
Carl J. Zack

1974
Rose Salisbury Beer
Thomas A. Benoit
Ian B. Berger
Olga Brown-Vanderpool

Carl A. Cappello
Beth G. Crocker
J. Breckenridge Eagle
Roberta Lawrence
Evelyn B. Mostow
Deborah Rose
Shelley S. Shanok
Abigail L. Smith
Myma M. Weissman

1975
Edith N. Baum
Ralph E. Binder
Gerald E. Bisbee Jr.
Linda K. Broker
Linda K. Demlo
Jack A. Eiferman
Gerard R. Goulet
William J. Grego Jr.
Rosemary M. Johnson
Barbara R. Unterman Jones
Philip D. Kennedy
James E. Knoben
Stuart L. Lefkowich
Laurence F. McMahon Jr.
Mary W. Palshaw
Dale P. Sandler
Nancy E. Stroup
Raymond Chiu-Ping Tang
Thomas J. Trudell
Franziska U. Ulrich
Vera B. Walline
Pat Boylston Whitt

1976
Elaine P. Anderson
William F. Appicelli
Frances L. de Peyster
Joanna M. Erikson
Paul H. Etkind
Robert H. Frazier
Annette B. Garofalo
Gail lies Genvert
Karen A. Gordon
Janet Heinrich
Robert T. Kauer
Cleve Lee Killingsworth

1961
Gordon R. Beem
Martin Donabedian
Helen M. O’Connell
Margaret P. Parker
Angela M. Russo
William R. Slivka
Harold W. Wicks

Instant rapport: Dr. Burton Singer welcomes home New Haven native Dr. Benjamin Spock.

1963
Raul R. Cuadrado
David Dolins
C. DuVe Florey
Edward M. Kenney
Jean M. Maynard
Samuel B. Webb Jr.

1964
Katherine Maria Detre
John S. T. Gallagher
Linda F. George
Neal L. Maslan
Theodore Rosenberg
Estelle Siker
Monroe W. Spero
Claudewell Sidney Thomas

1965
Robert M. Edwards
Edgar W. Francisco III
H. Patterson Harris Jr.
William C. Harvey
James F. Jekel
Michael E. Kove
Peter J. Levin
Francia M. Pagano
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73

1979

1982

1986

Bruce S. Anderson
Virginia P. Bainbridge
Gertrud S. Berkowitz
Marianne Berwick
Mama P. Borgstrom
Ralph J. Cobum
Susan De Renzo
Frances D. Dwyer
Elizabeth Feuer
Lynn Fielden-Smith
Judith B. Gancher
Debra Haffner
Candice C. Haslegrave
Bruce H. Heckman
Shelley Helfer-Amira
Joseph D. Henn-DeMayo
Phillip S. Katz
Karen Kmetzo
Paul Anthony Kowalski
Benjamin Krevsky
Renee S. L^ary
Mary Elisabeth Lorenzi
Osvaldo Marrero
Patricia J. Moore-Pastides
Marcia C. Richardson
Lisa K. Rosenfeld
George B. Rowland
William E. Schweizer
Ralph Tartaglione Jr.
Elizabeth Tedder
Ilene B. Wachs
Jonas Zucker

Jamie L. Amaral
Gretchen Dieck
Biemesderfer
Martha Livingston Bruce
Francis L. Crowley
Kathleen K. Devine
Denise Heinemann
Ann Storms Kloter
Linda F. Me Caig
William F. McKeon
Susan G. Rice
Lisa E. Stone
Carol L. Vander Wal
Nancy K. Wander
Sandra Michaelson Warren
Maud Helen White
Alvin C. White
Jill Okrent Zaheer

Indu B. Ahluwalia
Clare F. Averbach
Andrea Lee Boissevain
Louise M. Brenner
Debra Jean Brown
Marijane L. Carey
Marie Irene Ciacco
Reid M. Davis
Joe Tom Easley
James R. Ferguson
Nancy E. Fithian
Stephen B. Gruber
Roxanne Kapikian
William J. Malone
Catherine McQuilkin
Daphne M. Nielsen
Joseph M. Pajor
Elizabeth G. Pelz
Philip O. Renzullo
Denise Amy Riedel
Eric Triffin
Tracey E. Virgin
Virginia M. Westra
Lynn D. Wilson

1980

A graduate focuses on Dr. Benjamin Spock’s
EPH commencement address.

Robert A. Knauf
Janina Levy
Robert C. Marquarclt
Gino A. Nalli
Janies B. Rokos
Robert Risdon Schwarz
Mao' Jo Shepard
Marcia A. Testa
Thomas S. Wingardner Jr.
1977
Ldward A. Bortnichak
Richard B. Burt'ord Jr.
Patrick i-. Carone
Terry IJwyer
fierard J. I'oley
Travis K. Hedrick
Idlen I). Jaslow
Rh-ma Kantor Kershnar
Ronald I-. LtilVnsee
V‘. endv K. LelT owich
T'. W.
till K. ' VC'onnor
' Pastidc'
iuiidclsohn Pottern
.'\. Riie

■ itT

hild

Carroll Schilling
Gail M. Sullivan
Virginia R. Towle
Marian Troyer-Merkel

Phillip R. Aaron
Gary J. Aboff
Frederick R. Aronson
Diane Denis Aye
Antoinette M. Brooke
Richard L. Buck
Gary L. Busack
Barbara H. Granger
Ellen B. Greif
Irwin J. Halperin
Samuel S. Hamilton
Virginia S. Humphrey
Helen E. Kelly
Yee-Lean Lee
LeRoy F. Ludwig
James S. Marks
Jane Ungate O’Connor
Ann L. Prestipino
Nancy Maguire Rhodes
Norman M. Schlossberger
Lydia A. Selling
Marsha L. Silverman
Carolyn K. Wells

1981
1978
Vijaya V. Bapat
Kathleen M. Berman
Robert J. Fensterheim
Ann T. Freedman
Janice F. Gold
Cynthia R. Gross
Jane E. Hill
David W. Houck
Christopher M. Maylahn
H. James Myers
Marguerite Nelligan
Peter F. O'Connor
David W. Osborne
Ellen J. Reitler
Ellen D. Rothberg
Robert E. Schwartz
Roberta Jo Shapiro
Marie Stoeckel
Bernadette S. Vissani
R. Bradford Walker
Lucy Ellen Weiger

Harold J. Burdo Jr.
Rebecca L. Calderon
Rollin C. Chew
Angelo J. De Vita
Brian J. Foley
Richard T. Forsley
Ellen M. Gallagher
Peggy A. Gallup
Marie F. Gavula
Joan Urquhart Goodman
Diane E. Goren
Cindy F. Kleiman
William J. McLaughlin
Blackford Middleton
Mtulee D. Mooney
Barbara Gaugler Pennebaker
Frederick V. Peterson Jr.
Maureen T. Power
Gerald W. Robinson Jr.
Elizabeth N. Shapiro
Susan M. Stoecker
Karin Swanson
Keith D. Tait

* Deceased

1983
Barbara W. Abraham
Dean S. Archibald
Dalia Castillo-Aguilar
Mark L. Dembert
Robert A. Duncan
Susan Paris
James N. Gaito
Ellen M. Ginzler
Virginia C. Hiland
Margaret M. Kolb
Allen F. Levy
Cynthia M. Meyer
Scott K. Mock
Shinsuke Morio
Jeannee Parker-Martin
Keith A. Radcliffe
Nano G. Rush
Paul M. Schur
Elizabeth C.H. Stevenson
Patricia C. Weber

1984
Jean L. Freeman
Carolyn H. GranthamMillman
Penny H. Hausser
Marcia Lipkind Hirsch
Sarah M. Horwitz
Gregory R. Huth
Mehrdad Jalali
Georgia Jennings
Jean G. Larson
Cathy Nager
Grael M. O'Brien
Julie A. Russem
Stephen Marc Schwartz
Dennis G. Shrauger
Gerald L. Springer
Marie Ann Tobin

1987
Maureen E. Brady
Hilda C. Chaski
Woan-Ru Chen
Bridgid M. Garrison
Sara A. Holdcroft
Timothy A. Jacobs
Michael T. Koff Jr.
Catherine A. Leda
Barbara J. Moggio
Joseph J. Napolitano
Judith Ann Natale
Pamela Fitzgerald
Pomputius
Anita A, Roth
Mubashar R. Sheikh
Joel A. Wasserman

1988
Ellen Elizabeth Banach
Elaine P. Berger
Sylvia Hillary Blackburn
Francesca Marie Cook
Ellen Lucy Kraftsow
Mark William Legnini
Paul Alan Lindia
Saifuddin Taiyeb Mama
Virginia Alicia PittmanWaller
Carrie A. Redlich
Lawrence Vincent Silvia
Carol Ann Strycharz
Darlene Uten Zimmermann

1989
1985
Rene S. Cabral
Joan M. Cleary
Susan M. Coakley
Suzanne Mary Cooney
Jerald A. Fagliano
Katherine Santella
Fitzpatrick
Barbara K. Gottlieb-Ware
Shirley J. Lee
P. Douglas McConatha
Rona Janis Mogil
Adrian J. Pinsince
Eric Scalettar
Marcia Shapiro
Shirley J. Tirrell
Terry Martin Zingman

Judy Gardner Audette
Daniella Duke
Mary Beth Durkin
Elizabeth Harrison Hadley
Marcella Perez Jones
Mary Jo McGinley
Mary D. H. Miller
Deena Beth Myers
David Dean Peete
Elizabeth Ann Platz
Marie V. Roberto
Robert P. Sbriglio
Joy Misako St. Germain
Joseph Thevenin Jr.
Sophie Helene Tworkowski
Maureen McBride
Whitehurst

FRIENDS
U. Robert Merikangas
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EPH Alumni Fund Class Participation
1988-1989
CLASS
1941 and prior
1942
1943
1944
1945
1946
1947
1948
1949
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974A
1974B

TOTAL

AGENT

Allen Cohen
James Malloy
Francis Greaney
Robert Young
Susan Balter
John Bihldorff
Dorothy Lewis
Gary Sax
Thomas Benoit

1975
1976
1977
1978
1979A
1979B

Linda Broker
Elaine Anderson
Dorothy Rice
Ann Freedman
Catherine Norton
Ralph Tartaglione

1980
1981A
1981B

Christina Quinn
Angelo DeVita
Barbara Pennebaker

1982A
1982B

Constance Jarowey
Jean Milton

1983A
1983B

Jeffrey Hughes
Marybeth McNemey

1984A
1984B

Anthony Alberg
Leslie Balch

1985A
1985B

Joan Cleary
Katherine Fitzpatrick

1986A
1986B

Indu Ahluwalia
Aric Wilt

1987A
1987B

Hilda Chaski
Elizabeth Wennar

1988
1989

Joseph Della Puca
Joy St. Germain

NUMBER
SOLICITED
EPH Alumni
Interest/Miscellaneous
TOTAL

Yale Medicine
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2,499
60
45
50
54
29
35
50
25
52
32
37
25
14
50
47
40
41
30
39
47
20
30
27
38
15
36
33
38
27
48
24
25
26
32
29
26
24
19
21
28
36
32
24
24
29
25
22
37
28
23
23
23
11
16
13
5
26
14
14
33
24
25
16
21
22

$ 1,829
260
396
790
25
75
140
1,185
360
765
460
1,010
280
50
360
365
395
955
725
515
660
80
795
590
780
145
1,545
1,505
1,305
1,245
2,015
415
1,120
435
510
945
1,952
1,020
735
815
960
550
1,510
830
640
260
900
380
495
875
475
230
705
105
180
285
40
330
3~70'
365
720
1,085
620
180
800
321

Eric Mood
Eric Mood
Eric Mood
Stephen Skorcz
Stephen Skorcz
Stephen Skorcz
Samuel Herman
Edgar Geibel
Eric Mood
Robert Johnson
Yolande Lyon
Milton Sisselman
Eric Mood
Frances Ogasawara
David Boyd
Edward DeLouise
Philip Hallen
Dorothy Wilson
Gyla Brooks
Joseph Prekup
Thomas Mayhugh
David Dolins
Estelle Siker

1988-1989
PERCENT
NUMBER
CONTRIPARTICIRATION
BUTORS

1989-1990
% PART.

TOTAL

NUMBER
SOLICITED

TOTAL

% PART.

62
525
301
226
125
75
145
100,885
480
590
590
445
185
45
370
520
520
350
1,250
350
425
0
650
760
725
135
1,680
1,185
1,340
1,235
1,540
395
1,330
350
275
625
1,178
1,670
740
1,210
1,010
560
1,570
820
485
255
740
265
470
735
475
245
720
235
205
440
205
305
510
625
510
1,135
458
300
758
425
370

80
18
33
33
29
30
56
35
43
40
33
25
14
47
42
45
22
22
39
41
0
30
36
41
23
38
36
33
32
44
21
30
30
20
25
27
30
24
24
34
36
35
22
21
33
27
12
26
19
22
20
21
18
17
18
13
21
17
25
24
25
15
8
12
15
21

1989-1990
NUMBER
PERCENT
CONTRIPARTICIBUTORS
RATION

TOTAL

2,161

598

28

$36,388

2,267

597

26

$135,523

—

—

—

3,125

—

—

—

869

2,161

598

28

$ 39,513

2,267

597

26

$136,392

75

THE LAST WORD

Dr. Thomas P. OuJf\'. professor of medicine, delivered the 1990 medical school commencement address. An excerpt follows:
"UV are now poised to unlock the mysteries of life, and as scientists, have entered a grove where it has become literally
possible to alter the very nature of nature. No restraints will completely stifle this quest; what has been thought cannot now
be unthought. But someone must take responsibility for the manner in which society utilizes the knowledge which will be
uncovered. That someone includes people such as yourselves, individuals trained as physicians — scientists with knowledge
encompassing the vast terrain of the molecular and the patient. You must be the stewards who will guarantee that science is
applied in the service of humanity and not humanity in the service of science."
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CONTINUING MEDICAL
EDUCATION AT YALE
Friday
Nov. 9, 1990

UPDATE IN CEREBROVASCULAR DISEASES

(A)

Director: Lawrence M. Brass. M.D.
For practicing neurologists, internists and surgeons. Will focus on the latest advances in
stroke diagnosis, prevention and treatment.

Saturday
Nov. 10, 1990

SOFT TISSUE WORKSHOP EOR THE DERMATOLOGIST
TO IMPROVE OEEICE SURGICAL SKILLS

(H)

Director: David.J. Leff'ell, M.D.
For the practicing physician and the dermatology resident who anticipate a surgically
oriented practice. Designed to meet the needs of the office-based demiatologists and
structured to address a broad range of skills and interests.

Friday-Saturday
Nov. 16-17, 1990

VISITING LECTURE SERIES IN OPHTHALMOLOGY

(C)

Director: David E. Silverstone. M.D.
Speaker: Jerry A. Shields, M.D.
Ocular tumor update.

Friday-Saturday
Nov. 30-Dec. 1, 1990

VISITING LECTURE SERIES IN OPHTHALMOLOGY

(D)

Director: David E. Silverstone, M.D.
Speaker: Marshall M. Parks, M.D.
Pediatric ophthalmology and strabismus update.

Wednesday
Dec. 5, 1990

HOT BABIES: HOW MUCH OE A WORK-UP?

(E)

Director: John M. Leventhal. M.D.
Recent advances in pediatries.

Monday-Thursday
Dec. 10-13,1990
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Yalk Medicine Interview: Are Living Wills Necessary?
What should physicians do to fulfill the wishes of patients regarding
life support when patients cannot speak for themselves? For an informed
opinion, Yale Medicine turns to Angela R. Holder, clinical professor of
pediatrics (law).
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LETTERS TO THE EDITOR
Thanks to
Elizabeth Morgan
To the editor:
This letter represents my second
attempt to thank you for publishing Dr.
Morgan’s article deploring the medical
profession’s long-standing denial of the
incidence and impact of child abuse
(“My Perspective on Child Abuse,”
Summer 1990). Because her article
moved me deeply for personal reasons,
my first attempt grew too long, too
revealing, and perhaps too painful, for
me to share in a professional journal.
But I did finish that letter for myself
because I needed to finish the work of
my heart which Dr. Morgan’s article
had begun within me — grieving again
for my lost mother, once a creative and
intelligent but unhappy young woman
who received prescriptions for
amphetamines and barbiturates from
physicians rather than appropriate
treatment for the adult sequelae of
severe abuse she had suffered as a
child; experiencing again the terror,
rage and shame engendered by her
physical and sexual abuse of me,
abuse that was certainly exacerbated
by the addiction physicians eased
her toward; longing painfully again for
the physician-father whose selfless
dedication to his patients was
admirable but who left his own children
without much protection against
violence.
In this second letter I would like to
emphasize that my own life has turned
out much happier than my mother’s
primarily because increased awareness
of child abuse has made successful
treatment available to me. I have not
had to revisit my own abuse on my
children, as my mother did; on the
contrary, I enjoy parenting immensely
and my children seem to be thriving
emotionally. I also know the deep
pleasure of a long and honest marriage
because my husband’s love for me has
encompassed a willingness to learn
about child abuse since our student
days together at Yale medical school.
What we have learned has changed the
way we both practice medicine and has
definitely helped out patients. Like Dr.
Morgan, we are convinced that child
abuse causes or prolongs many
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illnesses later in life. Since much child
abuse is preventable and many adult
sequelae are now treatable, a physician
who cannot recognize child abuse and
its sequelae today and refer these
problems appropriately is, in essence,
denying treatment to patients and may
even be exacerbating the problem, as
happened in my own family. Dr.
Morgan rightly insists that all
physicians, whatever their specialties,
need to educate themselves about child
abuse. Thank you again for publishing
her excellent article.
Elizaheth Michel, M.D. ’75
Encinitas, Calif.

Kudos
To the editor:
Congratulations on the EPH 75th
anniversary edition of Yale Medicine
— This is a nicely balanced and very
readable issue.
Patricia D. Mail, M.P.H. ’67
Rockville, Md.

To the editor:
Congratulations on the Fall/Winter
issue of Yale Medicine. The whole
issue is excellent.
Rosemary A. Stevens
M.P.H. '63, Ph.D. '68
Philadelphia, Penn.
I

Harry Bishop

The close ties that have developed
between the Pierce laboratory and
EPH in recent years are partly
responsible for the renewed vitality of
the department. The department’s vigor
insures that it will continue to
contribute to the field of public
health and to the health of the School
of Medicine.
Ethan R. Nadel. Ph D.
Director. John B. Pierce Laboratory
Professor of Epidemiology
(Environmental Health) and
Cellular and Molecular Physiology

Fhilaiithropist John B. Pierce

Winslow Inaugurated
Pierce Laboratory

RISON LIBRARY

To the editor:
Your recent article about EPH
celebrating its first 75 years was
inlomiative and thorough, emphasizing
appropriately the medical school's
renewed attention to the integration of
clinical medicine and public health.
I wish to expand upon your
description of the important role that
the John B. Pierce Laboratory has
played in the department since the
founding of the laboratory in 1933. C.E.A. Winslow, the father of public
health at Yale, was also the first
director of the Pierce laboratory. Some
of his best known and most often cited
research was done at the Pierce
laboratory. Professor Winslow initiated
at the Pierce laboratory a unique
interdisciplinary basic science approach
to the study of responses to different
environmental
stimuli.
Pierce
laboratory research over the years has
provided important information on such
public health and environmental issues
as new means to assess indoor air
quality and the details of biological
responses
to
various
airborne
contaminants. Basic environmental
variables currently under study at the
Pierce laboratory include microwave
radiation, temperature, humidity,
oxidants in general and a number of
air pollutants.
Today nearly all of the Pierce
laboratory’s scientific staff participate
in the teaching program of the EPfTs
division of environmental health
science. I'hrough this symbiotic
relationship, we are able to bring
specialized knowledge to new
generations of researchers and public
health practitioners.

Harold E. Harrison
M.D. '31. '31-'35 HS

Harold Harrison
Remembered
To the editor:
It wasn’t long after Harold Harrison
and I first met, more than 60 years ago,
that we learned we’d been born on the
same day. The symbolism was right
on target, for the friendship that
followed had many parallels and
many intersections.
Harold was a year ahead of me in
medical school, and 1 quickly learned
to look with awe on his towering
intellect. Like him, 1 did internship in
pediatrics with Grover Powers, whom
we both revered, and 1 quickly
discovered that Harold was a tough
taskmaster. But what I learned from
him stuck with me. In fact, Harold’s
extraordinary clinical acumen meant
more to me in those years than his
scientific and re.search brilliance that I
later learned to appreciate.
We did so many things together
while we worked on the same .service:
our first trip “abroad,” to eastern
Canada, eating dust in an open roadster

owned by a mutual friend; double
dating with our future wives whom
we’d both met at Yale. Our marriages
took place less than a month apart, and
we kept in touch as we went our
separate ways. It was while I was
staying with Harold and his wife Helen,
when I came to New York from Puerto
Rico during the war, that I was able to
find the sublet that made it possible for
me to reunite our young family.
When, just a few years later, we
both came to head pediatric services,
his advice helped me over some rough
spots. And in 1951 we had a
memorable week in New Orleans with
Harold as a visiting professor. There
he showed his teaching skills to
Louisiana practitioners and demon¬
strated to them and the pediatric faculty
the logic and potential of oral
rehydration long before it achieved
international recognition.
What a thrill it was to watch the
steadily increasing recognition of
Harold
Harrison’s
scientific
preeminence and, particularly, to be
among the cheering multitude present
at the crowning glory of the joint
Howland Award to Helen and Harold
— an extraordinary couple. Despite all
this praise and appreciation of his
talent, Harold never lost his humility or
his likelihood to deprecate the relative
significance of his own contribution.
Harold’s was a marvelously
productive life; he was still remarkably
active after so-called retirement,
making it seem even more unfair that
he was cut off prematurely. In fact,
however, Harold’s major contribution
has not been stopped at all. Important
as the new knowledge, the new ideas,
the new approaches have been, his
major legacy is the corps of younger
persons whom he developed and
nurtured. It will be the succeeding
generations that will make Harold
Harrison’s influence truly enduring.
I am proud to have been his friend.
Myron E. Wegman
M.D. '32. '32-'36 HS
Ann Arbor. Mich.

Correction
The inside cover of the Eall/Winter
1990-1991 Yale Medicine incorrectly
listed Stephen C. Joseph M.D., M.P.H.,
as a graduate of the department of
epidemiology and public health. While
not an EPH graduate. Dr. Joseph did
receive his M.D. degree from the
School of Medicine in 1963.
Yale Medicine
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YALE MEDICINE INTERVIEW:
ARE LIVING WILLS NECESSARY?
.lames Anderson

Editor’s note: Last summer, the U.S. Supreme Court issued
one of its more controversial decisions of recent years in the
case of Nancy Cruzan vs. William Webster. The court ruled
that neither family nor physician could terminate life support
for a comatose patient without written documentation of the
patient's intent. As a result of this decision, incpdries have
drastically increased to organizations such as Concern For
Dying, which offers "living wills” to specify such intent.
In a related development, administrators of hospitals, nursing
homes and other health care institutions have welcomed a
recently passed federal law which, as of Jan. 1, 1991,
requires such institutions to read patients a medical
"Miranda warning” of their right-to-die options. In response
to these developments, Rosalind D'Eugenio, staff assistant at
the School of Medicine Office of Public Information,
interviewed Angela R. Holder, LL.M., clinical professor of
pediatrics (law) at Yale and past president of the American
Society of Law and Medicine.

In light of the Cruzan vs. Webster decision, do you feel a
living will is necessary to uphold a patient's wishes?
Some form of written instruction may be required in some
states, but a formal living will is much too complicated. You
can’t ask somebody who’s not sick to decide under what
circumstances he or she would not want treatment. From the
legal perspective, two things ought to happen about advance
directives. First, instead of having people fill out forms,
doctors ought to realize that they have the responsibility to
talk to patients in general terms about how they feel about
life-saving interventions. Second, if they’re treating a person
for a disease that’s terminal, they ought to get concrete about
what the patient wants while the patient can still speak up.

Is a document needed to represent a patient's intent in court?
Not a single state in the country requires any specific form of
documentation of somebody’s wishes. A note from a doctor’s
office chart saying “I talked to the patient about these issues,
and this is what the patient reported that she or he would
want,” is good enough for the courts in any state. The other
thing that most lawyers advise people to do is to sign a
durable power of attorney, which appoints a given person to
make the decision in a real situation.

Would that be a family member?
Or a friend. It should not ever be the doctor who’s taking care
of the patient. States vary about how formal these have to be,
but in all states, they need evidence of intent. Some states
now have statutes that say that the next of kin can make these
decisions without having to go to court. It’s just appalling that
one of the saddest parts of a family’s life has been made into a
Yale Medicine Spring 1991

Angela R. Holder: "Talk to patients in general terms about
how they feel about life-saving interventions.”
legal circus. I can’t imagine anything worse than having to go
to court to let a loved one in my family die. There may be
times when there’s serious conflict within a family that no
amount of negotiation can solve, and in very rare instances it
makes sense to go to court, but I’ve never encountered one.

Is there a living will that would apply in all states, or would it
be different from state to state and country to country?
From country to country there are wide variations. For
example, there’s no such thing in France as the law of
informed consent. You can’t sue a physician for not telling
you something; the whole professional patient or client
relationship is different. But within the United States,
although each state may have a statute saying a living will or
a durable power of attorney has to have three witnesses, you
merely need to demonstrate the intention of the person who
signs it. People have been dying since before lawyers were
invented, and it’s not necessary to make a legal maneuver of
this. Doctors and patients and families can work these things
3

out by talking before the crisis occurs. Of course, there are
situations where that just can't happen. If I take off in my car
and have an accident in a place where nobody’s ever seen me
before, then you can't fault somebody for not having talked to
me. And 1 certainly am not going to carry my living will in
my overnight bag, either. But, if I have a relationship with a
physician, then it strikes me that he or she has an ethical
obligation at appropriate times to bring up this subject.

\\ hat do von think about the new law that requires medieal
institutions to advise prospective patients about living wills at
or before admission?

Therefore, a durable power of attorney is more important
than a living will?
The most important thing is for doctors to encourage patients
to express themselves about what they want in general, since
no one knows about particulars. Then doctors should help
patients figure out who they want to make the medical
decisions and then document these wishes in some way. The
main thing the doctor must know is exactly how the patient
wants to be treated and if he or she isn't able to speak, who
should speak for the patient.

What if a relative contests the decison of the patient?
The law is a good idea for nursing homes, but how many
hospital admissions clerks are capable of explaining the
consequences of a durable power of attorney to a patient? It's
absurd. There are probably not a lot of doctors that know
enough about it themselves. If a state wants to do living wills
on a mass basis, they ought to do it like they do organ
donations, with driver's licenses. That takes it out of the
medical context so the person who's going to the hospital to
have a healthy baby doesn't think somebody knows
something she doesn't when she gets a living will in the mail.

\\ hen is the right time to write a living will?
.\s far as 1 know, the patient can write out on a piece of
stationery. "If 1 can't speak up. ask my friend Jane,” sign it,
date it and give it to the doctor to put in the doctor’s office
chart, and that will solve 99 percent of the problems that may
come up later. The "clear and convincing evidence” a court
requires doesn't necessarily mean a fomial legal document.

If a daughter comes in after her mother can’t speak up and
says, “I want my mother treated,” when the mother has made
it clear up to this point that she doesn’t want treatment, the
physician might feel that he has to go get a court order. But
that’s the reason to have the patient's wishes documented. A
doctor is perfectly legally correct in saying, “This is what
your mother wanted. We discussed it. I have this note in my
chart that your mother countersigned, and I’m going to do
what my patient wants even though she can’t speak up at this
point.” That’s absolutely legally correct. The problem is that
the unconscious patient can't sue, and the daughter can, so
most doctors would pay more attention to the daughter than
they’re legally required to.

This brings us back to the issue of a living will or some other
document regarding the patient's wishes.
In the best of all worlds, you go to a lawyer and either get the
lawyer to draft a statement for you or tell you what the state’s
requirements are so you can comply with them. A lot of bar
associations do volunteer work in nursing homes and
retirement homes helping people with these documents.

For More Information
Information about living wills and on durable power of
attorney may be obtained through the following:
Concern for Dying
250 West 57th St.
New York. NY 10107
(212) 246-6962
“The Medical Directive”
Harvard Medical School Health Letter
164 Longwood Ave.
Boston, MA 02115
($5 for tvv'o; $ 10 for five;
bulk order prices available)
American Bar Association
“Health Care Powers of Attorney”
stock #D-13895
c/o AARP Fulfillment
1909 K St.. NW
Washington, DC 20049
(202) 3.31-2200.
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Have you seen any particular outline for a living will that you
would recommend?
Concern for Dying, an organization in New York which
actually started the living wills, has the best. It’s very short
and just says "If I’m terminally ill, I don’t want heroic
treatment.” There is a problem defining those terms though.
What is a "terminal illness?” And I have no idea what "heroic
treatment” is. It’s hard to say whether you want something or
not when you don’t know in what circumstances you’ll ever
need it. That’s why it’s better to say. "I don’t know what’s
going to happen to me. but I trust ‘X.’ And I want ‘X’ to
decide on the facts that occur at the time.”

You clearly recommend assigning a power of attorney rather
than writing a living will?
Yes. Don’t try to figure out what you will want in a situation;
try to figure out some person that you trust to make decisions
for you. It’s not that your values change, it’s that your life
changes. Some things become more important, while others
become less important. To say that for all time you can fill out
a form about when you want invasive diagnostic tests is just
ludicrous. It makes the whole process too complicated.
YM
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BLUEPRINT FOR THE ’90S
THE DEAN’S ADDRESS
Editor’s note: On December 17, 1990, as he addressed
members of the School of Medicine's faculty and
administration. Dr. Leon E. Rosenberg commented on the
medical school’s acadenuc plan and outlined plans for his
second term as dean. An edited version of his address follows.
When I last addressed you in 1984, I assessed the state of our
school. I reminded you of our proud institutional heritage and
of the prowess of our distinguished faculty. 1 described our
scale and scope, speaking of such things as the size of our
faculty, our national standing in NIH grant awards, our
growth in clinical earnings. I forecast changes of many sorts
and said that these changes represented a challenge we must
accept, for in the challenge of change lies the opportunity to
soar and to excel. I exhorted you to do more and do it better.
You — and I genuinely mean all of you — have responded
magnificently. You have done more of everything —
teaching, research and service — and you’ve done it better.
My admiration for your collective efforts is equalled only by
my pride in your personal achievements.
You have responded so magnificently to the call of your
dean, your chair, your school and your profession that I have
brought you together today to ask for still more. During the
past three years we have responded to a request from
President Schmidt and provosts Nordhaus and Turner to
develop an academic plan for the School of Medicine in the
1990s. This plan and its counterparts from the Faculty of Arts
and Sciences and from each of the other professional schools
are currently being molded into an academic plan for the
entire University. In turn, this academic blueprint will serve to
define and direct the upcoming $1.5 billion capital campaign
for Yale.
The School of Medicine's planning effort has been multi¬
focal and iterative. It has included five-year plans from all
departments, autonomous sections and centers; digestion and
discussion of those plans at a retreat of deans and chairs;
further appraisal of the departmental plans and a presentation
of a related institutional vision by the dean’s operating group,
consisting of the school’s deans and other key administrators;
and finally a draft text prepared by our marvelous deputy
dean. Bob Donaldson, and myself with the valuable input of
key faculty members. The draft was then read by the Provost,
the President, the Yale Corporation and the chairs of the
school. You now have the revised final plan as submitted to
the corporation in November 1990.
Academic Leadership
The introduction to our school’s plan sets the tone and
presents the vision. The words are largely those of Bob
Donaldson. The spirit, I hope, is all of ours.
This plan charts a strategic course for the School of
Medicine in the 1990s: to establish Yale as the unquestioned
academic leader in making science-based and humane
Yale Medicine Spring 1991

medicine responsive to the needs of society as a whole, not
Just the needs of individuals.
Since World War 11, the technological advances of
biomedical research have revolutionized the care of seriously
ill patients. Thousands of people now survive ailments which
in the past were uniformly fatal. At the same time, the
vineyards of academic medicine have yielded vintage after
vintage of highly specialized physicians skilled in the use of
sophisticated methods for diagnosing and treating diseases.
Despite all this success — and in some instances because
of it — the consequences of disease and its treatment have
come to impose a growing economic burden on the public.
The nation finds itself confronting burgeoning epidemics of
costly disorders rooted in substance abuse and poverty, in
the special needs of a rapidly aging population, and in the
major fiscal commitments required by technology-intensive
medical care.
Instead of the praise and appreciation it used to hear,
medicine now finds itself the target of constant complaints:
It's too impersonal: it’s unevenly distributed: it neglects
minorities and the poor: it’s too concerned with dramatic,
occasional cures and not concerned enough with prevention:
it doesn’t worry enough about maternal and infant survival:
and most of all, it costs too much. U.S. Sen. Albert Gore
recently summarized the public’ a frustration as follows: “We
are the richest nation in the world, our medical e.vpertise and
accomplishments are the envy of the world, and yet our
inability to meet the basic health needs of our citizens is an
embarrassment.’’
Too often, medical schools and academic health centers
have tended to set themselves apart from society’s needs and
dissatisfactions by limiting the size of medicine’s playing
field. Medicine, according to this argument, cannot make
people happy, eliminate slums or feed the hungry: it can only
apply its increasingly powerful tools to those individuals
whose afflictions are definable in biological terms.
This academic plan for the Yale School of Medicine asserts
that these limits are too narrow and that the school, together
with Yale-New Haven Hospital, West Haven Veterans Affairs
Medical Center and its other partners, must take advantage of
its highly developed research and educational programs, not
only to cope with complicated illnesses in individual patients,
hut also to address broadly the urgent health care needs of
the public. We agree that medicine cannot keep drunks from
driving cars, crack dealers from entering school yards,
addicts from sharing needles or cheats from operating
Medicare mills.
However, academic medicine can and should assign a high
priority to research and educational efforts directed at the
fundamental causes, prevention and treatment of alcoholism,
addiction, AIDS, afflictions of the elderly and other diseases
of increasing public conceim. Moreover, academic health
centers must increasingly bring their resources to bear upon
pressing policy issues, including the costs of medical care,
strategies for disease prevention, access to primary care and
quality assurance.
5

Yale School of Medicine is ideally positioned for a leading
role in meeting these difficult challenges this decade. It is
situated in a city large enough to provide the variety of
settings necessary to e.xamine the nation's complex ills, yet
small enough not to he overwhelmed hy them. Moreover, the
school is most fortunate in having Yale-New Haven Hospital
as its academic partner. This modern, multi-faceted health
care facility with its busy emergency room, trauma center and
H25 beds not only provides dedicated and outstanding
medical care to the community but also commits itself to
excellence in clinical research and education. The West
Haven V’/A Medical Center provides similar partnership
opportunities for research and education concerned with the
special health care needs of our rapidly aging population
(f veterans.
Other affiliates of the School of Medicine provide diverse
health care "laboratories" in which Yale can develop
innovative approaches to diseases and health issues of
escalating national concern. These affiliates include two
communitv-based atnbulatoiy clinics for indigent patients and
10 community hospitals in southern Connecticut. The School
of Medicine is able to take full advantage of these diverse
settings, thanks to its major program in public health and a
strong, academically oriented School of Nursing, a key
component of Yale-New Haven Medical Center.
Building upon the school's many strengths, this academic
plan envisions new investigative. educational and service
initiatives. It recognizes the social, legal, economic and
ethic al implications of health and disease. But it goes further.
This plan also articulates the school's unicpie opportunity at
this point in its history to produce physicians and scientists
who will be prepared to solve the myriad health maladies of
our society which will only worsen without soundly conceived
and aggressive intervention.
To Better Serve Society
I want to return to the first sentence which defines the
strategic course of the plan: “to establish Yale as the
unquestioned academic leader in making science-based and
humane medicine responsive to the needs of society as a
whole, not just the needs of individuals."
1 doubt that anyone would see this vision as trivial. 1 hope
all will mark it as bold. As importantly, I hope you agree with
me that it is realistic for our school to aspire to be the
unquestioned leader in the coming decades. The foundation
for leadership is here:
•

a great university led by a president who cares deeply
about medicine and who says repeatedly that he is
energized by the health field because of its significance
in today’s world;

•

a city which has. in microcosm, all of our nation’s
social, political and health problems and which looks to
our University for model answers to major problems;

•

excellent health care facilities in which to perfect
our attempts to prevent, diagnose, cure and under¬
stand illness and. thereby, promote health and
reduce suffering;

•

a faculty and staff of sufficient size, quality, diversity,
energy and dedication to accomplish almost any
reasonable goals.

I his mission statement is worthy of all of us because we
are worthy of it.

The plan then expands on this vision in the form of 10
major goals [see “Goals,” page 7] and a considerably larger
number of specific aims. Taken together, the goals amplify
and buttress the key words in the plan’s first sentence;
academic, science, humane, society, individuals. Concerning
the ordering of these goals, the plan’s first three goals are of
the highest priority because they are the most general and,
therefore, of the broadest significance to the plan as a whole
and to the faculty as a group. Goals 4 through 10 are not
arranged in any order of importance. Each is significant in its
own right; each reflects an institutional need to build on
strength and to correct weakness. Now, I’d like to comment in
some detail on the first three central goals.
Goal 1: Reaffirm our central mission as an educational
institution.
This goal is placed where it belongs — at the very top of
the list. We are, first and foremost, a medical school, and our
central mission is and must continue to be the education of
those who will succeed us — those who will be our
professional heirs. Parenthetically, the recent birth of my first
grandson makes this metaphor particularly gratifying to me.
Three years ago, I asked Dr. Edward Benz to chair a
faculty task force that would evaluate our medical school
curriculum.
That group made many
important
recommendations which have been incorporated into the plan.
Its central message was that we must “find ways to elevate
the status of teaching as a treasured activity within the
medical school.’’ We must place it higher on the marquee, the
task force said.
Some of you might question the validity of this conclusion
because there is abundant evidence that we have done rather
well as an educational institution over the years. We continue
to attract many of the most able students in the country. They
come here because of you, a superb faculty providing them
with exceptional instruction, exciting research opportunities,
personal attention and clinical excellence. They come, as
well, because of the “Yale System” of education which holds
that self-education is the best education when it is guided by
small group seminars and conferences, when it allows
progress at an individual’s own pace, when it stresses learning
principles rather than memorization of facts, when it
eliminates competition for grades, when examinations are
mainly for the student’s benefit, and when close personal
relationships between faculty and student are emphasized.
Thanks to Bob Gifford, our splendid associate dean for
education and student affairs, and his fine staff, the superb
students we attract are also among the happiest and most
satisfied in the nation.
Rewards for Teaching
And yet, a number of forces, some external, some internal,
threaten our commitment and performance in medical
education. One is the perception — the all too common
perception — among our faculty that good teaching is not
appropriately recognized or rewarded here, that our coin and
kudos go to those who produce income for the school through
research grants or clinical activities. We must rid our school
of this perception because it threatens us at our very core.
How to do this?
First, we must make teaching performance a significant
prerequisite for appointment or promotion to senior rank in
our school. The appointments and promotions committee has
already begun to make this point by obtaining much more
information from candidates for promotion about teaching
Yale Medicmne

Spring 1991

2. All directors of required clinical clerkships must now
responsibilities and by pressing department chairs for a
provide students with a syllabus which identifies a core
detailed appraisal of teaching performance. But we need a
body of knowledge and skills that students are expected
more objective system of teaching performance based on
to master;
input from students and peers, and serious efforts in this
regard are underway.
3. In recognition of the changing demographics of clinical
Second, we must convince the chairs, and they in turn
practice, each required clerkship must now contain an
must convince their faculties, that the institutional funds
ambulatory component;
they receive each year recognize their teaching
4. Eleven interdepart¬
responsibilities. I have
mental,
systemschanged the name for this
institutional allocation from
oriented
faculty/student
Goals of the 1990 Academic Plan
“general appropriations,” or
study
groups
are
For the Yale School of Medicine
meeting regularly to
GA, to “educational appro¬
analyze the curriculum
priations,”
or
EA,
to
1.
Reaffirm our central mission as an educational
emphasize this point. I urge
of the first two years,
institution.
to seek greater integra¬
and expect chairs and section
tion and coordination
chiefs to use these funds
2.
Strengthen Yale’s position of leadership in basic
and
to
minimize
explicitly in support of the
biomedical research.
teaching time and respons¬
unwanted redundancy
3.
Integrate the complementary disciplines of
and duplication; and,
ibilities of their faculty
clinical medicine and public health.
members.
5. Yale is one of 12
Third, we must reward our
4.
Lead a University-wide initiative toward
schools in the country
truly outstanding teachers.
prevention and cure of disabling diseases of the
(out of more than 70
Through the generosity of the
brain.
which applied) to be
Bohmfalk bequest, we have
awarded an 18-month
5.
Strengthen
and
broaden
programs
aimed
at
recently established two new
planning grant from
understanding, controlling and eradicating
teaching prizes of $5,000
the
Robert Wood
infectious diseases.
each. These are awarded
Johnson Eoundation as
annually to one member of
6.
Secure a leading role in the prevention, detection
part of its program to
the faculty in the basic
and cure of cancer by strengthening Yale’s
catalyze change in
science departments and
Comprehensive Cancer Center.
medical education in
another in the clinical
our
country. We hope
7.
Expand academic programs devoted to maternal
departments whose teaching
to
be
among the six to
health and the well-being of children.
performance
has
been
eight schools that will
deemed
stellar
by
a
8.
Develop novel approaches to the prevention and
receive larger, longercommittee composed of
treatment of vascular diseases affecting the heart,
term support next year.
students and faculty. More
brain and kidney.
A third powerful force
such accolades are needed.
9.
Make curative transplantation strategies safer
affecting medical educa¬
A second force which
and more available.
tion concerns the shifting
impinges on our educational
ecology and sociology of
purpose is the dramatic
10.
Integrate and strengthen programs aimed at the
increase in our knowledge
clinical practice and of
prevention, treatment and rehabilitation of
base concerning both basic
health
care
needs.
musculoskeletal disorders.
biology and its application to
Medical
practice
is
moving increasingly to
health and disease. The
ambulatory
settings.
explosion of new information
Moreover, the locus of unmet health needs of our poor, our
in medical science is so great that neither our faculty nor our
students can organize or absorb it all. Equally dramatic
disadvantaged minorities, our homeless resides in our cities
and our neighborhoods. The hospital, then, can no longer he
changes have occurred in clinical practice. The capacity of
the only — or even the preferred — site for clinical
physicians and surgeons to intervene on behalf of sick people
instruction. Yet our required clerkships are almost entirely
has burgeoned in a sometimes breathtaking way. The Benz
inpatient-oriented, focusing on the most seriously ill patients
task force said that we needed a new way to respond to these
who require high-technology and intensive care. It is.
dramatic changes — that our structure for curriculum
therefore, possible for a student to complete medical school
evaluation and modification was inadequate.
with a distorted, myopic view of the clinical arena.
Hence, two years ago we established the educational
If we are to prepare our students to grapple with the
policy and curriculum committee (EPCC) as a standing
societal ills that are so much the antecedents of poor health; if
committee of the school reporting directly to the Board of
Permanent Officers (BPO). This committee, under the strong
we are to encourage more of our graduates to follow career
paths in primary care; if we are to prepare our students for the
leadership of Emile Boulpaep, has already accomplished
kind of medicine they will practice after leaving us, we must
much, thereby convincing me and others that medical
education is not as mired in maintaining the status quo as
identify and use new teaching settings and new teachers.
many in our country proclaim.
Such settings must include the Yale Physicians Building, the
Yale Health Services Center, the Hill and Eair Haven health
Let me recount the progress;
centers, our affiliated community hospitals, and the offices
1. A three-week required clerkship in clinical neuroscience
of our voluntary faculty members.
has been inserted into the curriculum for third-year
students;
7

This will not be easy to do. HMOs are under great
financial pressure to be efficient, and teaching is inefficient.
Community health centers must be responsive to the concern
that they not be places for students to “experiment” on those
groups who already feel discriminated against. Our practicing
physicians feel the pinch of competition, the threat of
litigation and the heavy hand of regulation. Nonetheless, we
must meet this challenge, and I must ask you — full-time and
part-time faculty alike — to recognize your responsibilities to
take students into your clinical settings.
Being a faculty member at this school is a privilege earned
by individuals in recognition of their commitment to enhance
our academic programs. It is not a right conferred by
membership on a hospital staff, inclusion in a directory of
alumni or alumnae, or geographic proximity to our institution.
Willing participation in teaching is a necessary but not
sufficient condition of achieving and retaining faculty status.
(Joal 2: Strengthen Yale’s position of leadership in basic
biomedical research.
Here. 1 can be brief because none of you doubt either my
personal or our institutional commitment to this central
mission. This faculty excels in basic research. Very few
institutions match either our breadth or our strength. Our
basic science departments are second to none, but they are
not the only sites at which outstanding fundamental
research is conducted. Our clinical departments have superb
programs as well.
Further, as evidenced by our soon-to-be-completed
Yale Center for Molecular Medicine, we are neither limited
to departmental organization of science nor to artificial
and often simplistic designations of research as being either
fundamental or applied, basic or clinical. It is, in fact, from
the purposeful blurring of these designations that exciting
progress toward understanding disease mechanisms will
continue to come.

other, interdepartmental programs. Only by doing this can we
both expand and decompress internal medicine space and,
thereby, the other clinical departments in which research
aimed at ferreting out basic .secrets of pathobiology is carried
out. Planning for this new building began in September.
Hopefully, construction will begin in less than two years.
Other re.search facilities needs will be noted in relationship to
their respective goals.
Our faculty has been very successful in competing for
federal research funds, particularly from the National
Institutes of Health. Your entrepreneurial spirit in this regard
is to be applauded and appreciated. Moreover, you’ve become
increasingly effective at securing funds from the for-profit
sector to supplement and complement dollars from federal
and non-federal, not-for-profit agencies.
Our capabilities in research will be influenced by our
national climate for research, which has been unusually
stormy during the past year, warranting a brief digression. I
feel compelled to clarify my own position about the current
state of biomedical research because I’m afraid I'm being
misunderstood. The United States has and will, for the
foreseeable future, continue to have the pre-eminent
biomedical research program in the world. It has achieved this
enviable position during the past 40 years through the
following actions:
•

a generous, sustained investment of public funds;

•

distribution of the vast majority of those funds to
investigators at academic institutions;

•

a nationally accepted and supported mechanism for
awarding funds through peer review;

•

appreciation of the value of a mixed support program
composed of individual project grants, center grants and
training funds;
•

Student Enrollment
1983-84

1990-91

% Change

M.D. candidates

417

478

Ph.D. candidates
M.D., Ph.D. candidates

208

300

+ 15
+44

47
206
7

55
149

+ 17

M.P.H. candidates
Dr.P.H. candidates

18

P.A. candidates
House officers

360

43
407

+ 157
.2

Postdoctoral fellows

437

504

1,726

1,954

Total

44

1 o retain our position as leader, we must continue to
provide resources in the form of people, space and money.
We can compete for the best people if we have adequate
space and the required funds. The space must come from a
combination of new construction and renovation. We've done
a lot of both in the past six years, but we must do more.
iipport for Research
■o • .,rding new facilities, the top priority in our plan calls for
i ' .
clinical sciences building to house the fine research
■ .o:' .i'll of our department of internal medicine, as well as

-28

vesting considerable leadership authority
in the director of NIH. If we are to retain
our position of pre-eminence, these facets
of our system must be recognized and
reaffirmed. Although we are currently
experiencing serious problems in the
leadership at the federal level and in the
management of federal funds, I have no
hesitation in saying to you, “Press on and
be resolute.”

I remain convinced that our country will
continue to invest in health-related research
because it is the most cost-effective
+ 13
investment in health that we have. I remain
+ 15
certain that a stable, rewarding career in
+13
science is achievable here and will continue to
be. I remain committed to this School of
Medicine retaining its unified stance in
support of research and not succumbing to the we-they
dissonance of scientist versus institution, or Ph.D. versus
M.D.. or “working” scientist versus Washington-based
organizations that has characterized recent discourse.
(loal 3: Integrate the complementary disciplines of clinical
medicine and public health.
American medicine and public health are each
experiencing fundamental pressures to change. The
aspirations of the American people to enhance the public’s
health and to enrich their personal lives through improved
functioning have become compelling considerations for the
Y.m.e Mhdicine
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health policies we develop as a nation and for the health
practices we follow as individuals. These aspirations have
also challenged the health professions to broaden their
traditional biomedical paradigm by incorporating into it the
socio-cultural and behavioral influences on health and human
functioning.
Although Yale has developed programs of international
distinction in these areas, neither we nor the other great
universities have created the interdisciplinary approaches of
research and education that are needed. Accordingly, we
propose the following objectives to enable Yale University to
provide national and international leadership in crucial
decisions concerning the health of both the public and its
individual members:

Objective 1. Infuse the ethos of public health into the teaching
programs of the medical school and integrate biomedical
knowledge into the teaching programs in the School of Public
Health.
This objective must be viewed as
encompassing the full scope of medical
education and public health. It can only be
accomplished with the full participation of
our clinical, basic science and public health
faculty. Educational content must emphasize
previously neglected areas such as nutrition,
health promotion and disease prevention,
screening for cancer and other chronic
disorders, and deciding when treatment does
more harm than good. These programs must
be merged and fully integrated among
participating groups throughout Yale.

Objective 2. Acquire new knowledge about
the bio-behavioral interactions which
determine good health and optimal outcomes
of illness.
In developing this knowledge, we need to
learn how psychosocial, economic and
behavioral conditions, as well as large-scale
environmental conditions, influence health.
Much work still needs to be done in
understanding the role these factors play in
health outcomes.

of poverty on health, the role of genes in the expression
of disease, the importance of nutritional principles on
health, and the problems of substance abuse and teen-age
pregnancy cut across the arbitrary boundaries that tend to
separate the disciplines.
The Kellogg Foundation has recently decided to fund a
major program combining such health professions’
educational partnerships with a second partnership — namely,
between an academic institution and a community health
center. Yale is one of 15 institutions to have received a highly
competitive planning grant for this endeavor. Large-scale
funding for six or more of these institutions will be announced
in a few months. I hope that our proposal, prepared by a team
led by Ralph Horwitz of the department of internal medicine
and including Burton Singer, chair of EPH, and Judy Krauss,
dean of the School of Nursing, will be found meritorious.

Facilities Highlights: 1984-Present
Research
•

80,600 nsf of incremental laboratory space through new building
construction (Magnetic Resonance Center, Yale Psychiatric Institute,
Yale Center for Molecular Medicine)

•

61,000 nsf of incremental laboratory space through renovation and
modification of existing buildings (Fitkin, Tompkins, Winchester,
Sterling Hall of Medicine)

•

Three-fold increase in funds expended annually for renovation and
infrastructure improvement ($3.0 million in 1983-1984; $10.8 million
in 1989-1990)

Education
•

33,000 nsf expansion/renovation of CushingAVhitney medical library

•

Renovation of Fitkin Amphitheater

Clinical Service
•

Construction of 39,400 nsf Yale Physicians Building

•

Construction of 41,000 nsf Yale Psychiatric Institute

•

Construction/renovation of 13,000 nsf Yale Eye Center

Objective 3. Acquire new knowledge about
vulnerable populations.
In bringing together the research and educational
approaches of traditional biology and clinical medicine with
those of public health, our focus must be on the needs of
special groups across the life span, including not only the very
young and the very old, but also adolescents and those who
have reached mid-life. Studies of vulnerable populations
cannot be complete, of course, unless we continually integrate
the special considerations of those disadvantaged by race,
poverty, social class or by exposure to occupational hazards.

Objective 4. Construct interdisciplinary educational curricula
involving students and faculty in the schools of medicine,
nursing and public health.
Such curricula are urgently required because we cannot
hope to enhance the health of the public unless we broaden
the educational scope of the conventional biomedical
curriculum. Students in all of these disciplines need to
understand the ethos, concepts and evidence that guide
research and influence clinical decisions and health policy.
Moreover, major health-related topics such as the influence
Yale Medicine
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Objective 5. Provide objective foundations for policy
decisions affecting the health of society and the individual.
Through the forcefulness of its science and the
persuasiveness of its faculty, Yale can achieve leadership in
health policy by developing exciting new programs of
research and education that become models for the nation.
The integrated efforts of Yale’s traditional biomedical and
public health programs must be designed to:
•

improve clinical care in all of the health services at
Yale and throughout the country, by basing decisions
firmly on valid scientific evidence;

•

take into account important demographic changes,
particularly the rapid aging of the population in
developed countries;

•

promote national health care policies which trumpet the
crucial goal of universal access and which address
quality and cost by providing the evidence and
intellectual framework to guide public policy makers;
9

•

integrate into a comprehensive health policy agenda
those elements of economic social policies that
influence health.

Goals 4 through 10 are. though less general than goals I
through 3, surely no less important to the school and to groups
among you. 1 will comment briefly on them.
Goal 4; Lead a Lniversity-wide initiative toward
prevention and cure of disabling diseases of the brain.
Yale is blessed with a very large and excellent group of
neuroscientists. Most of them are on the faculty of our school.
Our challenge is to integrate, to coalesce, to cohere. This must
be done in research, education and service.
The vehicles for such integration are being put in place.
They include: a University-wide graduate program overseen
ably by Bill Agnew from cellular and molecular physiology
and .Martha Baton from biology: a neuroscience steering
committee chaired by Basko Rakic; and a commitment on the
part of the school to erect a new facility — a Yale Brain
Center — which will house key components of the program
and community. Yale must respond aggressively during this
Congressionally designated "Decade of the Brain."

Faculty Profile
Category

Number
1983-84
1990-91

Full-time
Academic track
Tenure
Temi
Clinical track
Continuing
Temt
Research track
Total full-time
Voluntary

(irand total

171
230

188
337

34

60

88

92

169
692

247
924

1,492

1,672

2,184

2,596

(ioal 5: Strengthen and broaden programs aimed
at understanding, controlling and eradicating
infectious diseases.
Blagues continue to befall humankind. Yale scientists have
contributed much in such areas as poliomyelitis, infectious
mononucleosis and Lyme disease. We have not been among
the leaders in AIDS, at least in part because of a decision 20
years ago to dismantle the department of microbiology. We
badly need a basic science unit in this field and have
requested from the Yale Corporation approval to reinstitute an
autonomous section of microbiology as of July 1991.
.Although this is not an easy time either in terms of finances or
of available space, to add new academic organizations, we
must do so when necessary. A free-standing section of
microbiology will act in synergy with our increasingly strong
section of immunobiology and with programs in EBH,
internal medicine, laboratory medicine and pediatrics. We
shall all prosper as an outcome.
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Goal 6: Secure a leading role in the prevention, detection
and cure of cancer by strengthening Yale’s
Comprehensive Cancer Center.
We are most fortunate to have one of 24 National Cancer
Institute-designated comprehensive cancer centers in the
United States. We are fortunate, too, that it is remarkably well
led by Alan Sartorelli. It is time to take the next step and build
a facility which will house the center’s offices, its ambulatory
care programs and some research activities. This construction
is necessary if we are to be an effective referral center for
patients with malignancies still responsible for more than
500,()0() deaths in this country annually.
Goal 7: Expand academic programs devoted to maternal
health and the well-being of children.
Because children don't vote, they are regularly overlooked
by politicians. We must be advocates for and champions of
children and their families. Yale has a proud tradition through
its Child Study Center, its department of pediatrics and other
programs aimed at protecting and improving child health. As
our partner, Yale-New Haven Hospital, erects its new
Children’s Hospital, so we must join in promoting laboratory,
clinical, epidemiologic and psychosocial
research aimed at understanding the
vulnerable child — whether that child be
the premature infant of a drug-abusing
teen-age mother or a baby destined to a
life of chronic illness due to cystic
% Increase
fibrosis.
Goal 8: Develop novel approaches to
the prevention and treatment of
10
vascular diseases affecting the heart,
47
brain and kidney.
Cardiovascular disease remains the
number
one killer of American adults.
76
We
are
on the verge of making truly
5
dramatic strides toward prevention of
46
disease resulting from our identification
34
of such major risk factors as smoking and
12
hypercholesterolemia. We have much to
contribute here already. We will do more
19
when we initiate our cardiobiology
program in the Center for Molecular
Medicine and as we expand our vascular
biology research efforts and our clinical care efforts in
internal medicine, surgery, neurology, diagnostic radiology
and elsewhere.
Goal 9: Make curative transplantation strategies safer and
more available.
Among the clinical marvels of our age, organ and tissue
transplantations stand out because of their proven capability
to cure disease. Barenthetically, this essence of hightechnology care is consonant with our emphasis on public
health: first, because transplants are unquestionably costeffective; second, because they depend on public support
through organ and tissue donors.
In the past decade we have assembled a superb group of
surgeons and physicians, basic scientists and clinical
investigators, who now enable us to offer transplants of heart,
lungs, pancreas, liver, kidney, cornea, bone and bone marrow.
We must provide these clinicians and scientists with the
hospital and associated resources they need to make us a true
center of transplant excellence.
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Goal 10: Integrate and strengthen programs aimed
at prevention, treatment and rehabilitation of
musculoskeletal disorders.
About 20 percent of all Americans have their quality
of life impaired by significant and chronic dysfunction
of the musculoskeletal system. As our population ages,
lost productivity resulting from these conditions will
increase as will monetary and human costs. Our research
and clinical programs aimed at arthritis, metabolic bone
disease, skeletal trauma and sports injuries are both multidepartmental and strong. To them must be added a focus
on rehabilitation, which is currently underdeveloped.
Hopefully, this can be accomplished by establishing a major
partnership with Gaylord Hospital and by asking our
department of orthopaedics and rehabilitation to be a lead
agency in our programs.
That outlines this academic vision for our school in the
decade ahead. It cannot be accomplished unless every one
of us plays a part in it. Consider it a working document
which will change with time and circumstances; none of it
is carved in stone.
Yale Medicine
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Some may wonder whether this plan is achievable and
whether it’s realistic given today’s tough economic climate.
Of course, it will not be easy to meet the many goals and aims
I’ve articulated. But being a great institution is never easy. It
requires courage, character, discipline, integrity, leadership
and lots of good luck. Before any of you begin to worry about
whether we’ve overreached, let me remind you that it is
during the toughest economic times — not the easiest ones —
that the soundest and most creative institutions outdistance the
competition. Yale University built more buildings, added
more endowment and launched more programs during the
Great Depression than during any other decade in the
University’s history.
Recent Accomplishments
Furthermore, our own recent history should make us
optimistic about our future. In the short 6 1/2 years that I've
served as dean, this institution has accomplished a great deal.
Since 1984, more than 400 people have been added to our
faculty, largely due to growth in the full-time ranks where
11

we’ve experienced a 34 percent increase in all components:
tenure, continuing, term; and in all three ladders: academic,
clinical and research. [See "Faculty Profile,” page 10,] The
largest fractional increase has occurred among those with
continuing appointments in the clinical track — attesting to
our commitment to greater clinical excellence. The voluntary
faculty has grown less. This reflects a widespread view that
this segment of the faculty is too large, and that its very size
tends to diminish the significance of carrying the Yale name.
1 am particularly pleased to note that the number of tenured
women on our faculty has more than doubled since 1984 —
from 10 to 21. Women with term appointments have also
increased nearly two-fold. This positive step toward equitable
diversity among us has, disappointingly, not yet been
achieved for members of disadvantaged minorities. They
remain distinctly underrepresented, and there has been no
fractional increase in their presence in our tenured or term
faculty ranks. Clearly, there is more to be done here.
Our student body, too, has increased significantly in size
— now numbering 1,954. [See "Student Enrollment,” page 8.)
We educate no fewer than eight categories of students. To
those of you who express concern regularly about our
numbers of graduate students and postdoctoral fellows, I ask
you to be cognizant of the robust growth in these categories.
Further, and of greatest importance, there is every reason to
believe that the quality of our students in all categories has
been sustained or even improved.

•

61,000 nsf of incremental laboratory space through
renovation and modification of existing buildings
(Fitkin, Tompkins, Winchester, Sterling Hall
of Medicine)

•

a more than three-fold increase in funds expended
annually for renovation and infrastructure improvement
($3 million in 1984; $10.8 million in 1990.) These data
clearly reflect our commitment to and capability for
providing the physical resources commensurate with
our missions and vision. They are a symbol of vigor.

Fet me conclude this brief survey of resources by saying
something about money. [See “Financial Highlights.”] Since
1984 the total operating budget of the school has more than
doubled in actual dollars, corresponding to a 53 percent
increase in constant dollars. This denotes a 7.3 percent
compounded annual real growth — a most impressive figure.
Since nearly 90 percent of our income is earned from research
grants and contracts and from clinical programs, it follows
from what Fve just said that those programs would have to
grow, and they have: 37 percent real growth in grants; 64
percent real growth in clinical earnings. Tuition income has
increased too, though not nearly as much. That is as it should
be if you’re as worried as I am about the increased
indebtedness that our M.D.s carry with them upon graduation.
Please take note of the impressive growth in the school’s
endowment base, from $70 million in 1984 to $194 million in
1990. This financial underpinning is
enormously important to us; its growth
reflects both generous philanthropy
Financial Highlights: 1983-1984 to 1989-1990
and excellent management of the
(Dollars in millions)
portfolio. Finally, Td like to mention
that corporate support for our research
% Compound
programs has increased markedly. It is
% Increase Annual Growth
Dollars
still small compared to our federally
derived support, but it is now
Parameter
1983-84 1989-90 Actual Real
Actual Real
respectable. That’s a good omen.
12.8
7.3
Operating budget
143.6
295.6
105.8
52.8
Finally, a word about fund-raising.
5.4
37.4
10.8
Grants/contracts
76.5
141.6
85.1
Thanks to Sue Dorn and now Will
8.6
53.2
121.4
14.2
Clinical programs
117.8
64.3
Melton and an excellent staff, we’re
8.0
2.8
Tuition
7.0
11.1
58.6
17.7
raising more than twice as much
146.4
16.2
10.6
Endowment income
6.9
82.9
2.8
private money each year now than we
69.7
18.6
12.9
Endowment principle
194.0
178.6 106.6
did in 1984. This increase has been
24.5
18.5
Corporate support
1.8
6.7
272.2 176.2
seen in gifts as well as in grants.
In this connection, I am truly
delighted to announce a very special,
New Facilities, Financial (Jrowth
recent financial commitment to the school: a $10 million
naming construction gift for the Center for Molecular
Next, some remarks on facilities. [See "Facilities Highlights,”
Medicine (CMM) from Professor and Mrs. Herb Boyer of $an
page 9.1 We've made remarkable strides in improving the
Francisco. Herb was a postdoctoral fellow in Ed Adelberg’s
quality and quantity of our educational, clinical and re.search
laboratory many years ago. He is a member of the National
space: Of the now nearly 7()().()()() net square feet (nsf)
Academy of Sciences and one of three people ever to win
devoted to our three missions, nearly 3()().()()() — 42 percent
both the National Medal of Science and the National Medal of
have been built since 1984.
Technology. Many of you know him as the co-discoverer of
Highlights of this facilities expansion and improvement
recombinant DNA technology and the co-founder of
program include:
Genentech. This magnificent gift is the largest single
contribution by an individual in this .school’s history.
• a 33.()()() nsf expansion and renovation of the
If you believe as 1 do that the best way to project the future
Cushing/Whitney medical library;
of
a
person, group or institution is to assess the recent past,
• construction of the 41,()()() nsf Yale Psychiatric Institute;
then we have every right to address our future and our
• construction and renovation of the 13,()()() nsf Yale
innovative academic plan with confidence; confidence
Fiye Center;
strengthened by knowing that what we want to do is in the
public interest.
YM
• 8(),b()() nsf of incremental laboratory space through new
building construction in the Magnetic Resonance
Center, 't ale Psychiatrie Institute and \'ale Center for
Molecular Medicine;
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YALE IMMUNOBIOLOGISTS
GET DOWN TO BASICS
Photographs by James Anderson

Using a Fluorescence Activated Cell Sorter (FACS), /. Nicholas Crispe, Ph.D., can monitor 2,000 cells per second. The $200,000
machine can sort with 99 percent accuracy using six different parameters, including four fluorescing signals and tv^'o cell sizes.
by Diane E. Loupe and Gregory R. Hath, M.P.H. ’84
A laser beam’s ethereal blue light cuts through what appears
to be a strand of monofilament fishing line. A microscope,
however, reveals the line to be a fine stream of drops
whizzing by.
Some of the drops contain T cells, specialized white blood
cells that form the front line of defense in the human immune
system. I. Nicholas Crispe, Ph.D., assistant professor of
immunobiology, has chemically labeled some of those cells
with fluorescing molecules and is sorting them with a
Fluorescence Activated Cell Sorter (FACS). When the FACS
laser beam hits a drop bearing a labeled cell, an electric
charge deflects the cell into a test tube. Unlabeled cells drop
into another tube. A video monitor nearby glows with a
computer count of the labeled cells.
This article was written by Diane E. Loupe, staff writer at the
medical school office of public information (OPl), with the
assistance of Gregory R. Huth, OPI publications editor.
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Using FACS, Dr. Crispe can sift through 2,000 cells a
second with 99 percent accuracy, an impressive feat
considering that 20,000 such cells could fit on a pinhead.
FACS exemplifies the powerful tools of molecular, cellular
and genetic research that Dr. Crispe and other faculty in the
medical school's section of immunobiology use to understand
better the human immune system.
Ever since Louis Pasteur introduced the germ theory in the
late 1800s, medical researchers have sought to understand
how the body defends itself against the relentless invasion of
microscopic agents that can cause disease. Richard A. Flavell,
Ph.D., professor and section head of immunobiology, says that
every day, discoveries in his field are providing more answers.
Immunobiology, as Dr. Flavell explains with a British
accent flattened by his years in the United States, "interfaces
with the study of infectious diseases, autoimmunity and
transplantation. Some of the key unsolved problems in all of
the.se areas are related to the immune system.”
When Dr. Flavell arrived in July 1988 to launch the
section, he fulfilled the dream of the late Richard Gershon,
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Richard A. FlavelL Ph D.
M.I3.. a noted researcher in imimine response regulation. As a
professor of pathology. Dr. Gershon's broad-based approach
helped shape immunology research at Yale. He also
advocated forming an autonomous .section of immunobiology.
The fruits of Dr. Gershon's advocacy can be seen in the
growing section's laboratory space on the fourth floor of the
Pitkin .Memorial Building. Here immunobiology’s five
primary faculty members work in conjunction with
approximately 20 graduate students, 40 post-doctoral fellows,
four faculty members with joint departmental appointments
and other faculty collaborators. The quality of the section’s
research attracted support from the Howard Hughes Medical
Institute (HHMl), which largely underwrote laboratory
renovations and the purchase of equipment. Four of the
section’s faculty members, including Drs. Flavell, Bottomly,
Janeway and Bothwell, share appointments with HHMl and
the University.
Immunobiologists study how the immune system develops
and how it is marshalled to destroy pathogens, the viruses,
bacteria and other microorganisms that can make us ill. Some
of the scientists focus on why the immune system sometimes
induces autoimmunity — an assault on the body it is supposed
to protect — causing such diseases as diabetes, multiple
sclerosis and lupus.
(’onslanf Kngagement
Key to the immune system’s ongoing vigil against
microscopic invaders are white blood cells called
F, mphix yies. Like immunological sentries, lymphocytes
•J.ister in the body’s checkpoints, the lymph nodes. As lymph
piidi -. Idter fluids flowing from the body’s tissues, white
- 1;: :d : ells mouitor for pathogens.

Each lymphocyte is a specialist, trained to
recognize and kill a single infiltrator called an
antigen — usually a protein from a pathogen,
foreign to the body. Lymphocytes recognize
antigens by using cell surface molecules called
receptors that fit to an antigenic molecule like a
key fits a lock.
Only when a lymphocyte’s receptor key fits
into an antigen’s lock does it swing into action to
destroy that antigen. Since each lymphocyte reacts
to only one kind of invader, the body develops a
repertoire of such cells with different receptors to
battle a wide array of antigens.
Lymphocytes come in two varieties: T cells, so
named because they form in the thymus, and B
cells, which are formed in bone marrow. B cells
are responsible for eliminating pathogens, such as
bacteria and other microorganisms, that appear
outside cell walls; T cells fight other pathogens,
such as viruses, that hide inside cells.
Like immunological arms factories, B cells
manufacture antibodies, Y-shaped molecules that
circulate in the blood. Antibodies are “trained” to
kill antigen. Some attack and kill pathogens by
binding to them and punching lethal holes in the
invading cell’s surface. Other antibodies bind a
pathogen and introduce it to the surface of macro¬
phages, large cells which then engulf and devour
the invader.
The mission of T cells is even more subtle than
that of their B cell counterparts. Since T cells
attack pathogens that lurk inside cells, these
immunological defenders must identify infected
cells without entering them, a process that would destroy
healthy cells.
Enter the “spies,” major histocompatibility complex
(MHC) proteins, to help T cells with their task. An MHC
molecule comprises a chain of amino acids folded into what
in graphic renderings resembles an intricate wire sculpture. In
one of its tangles, the MHC molecule has formed a deep cleft
in which it can clutch a bit of antigen.
Once it snares some antigenic prey, the MHC protein
brings it to the cell surface, where T cells can chemically
sense the antigen. Upon detecting antigen, T cells punch holes
in the surface of the infected cell, causing an influx of water
that bursts the cell, thus killing the invading pathogen.
At the Microscopic Ramparts
When the elaborate defenses of the immune system
malfunction and begin attacking a person’s own, or “self,”
cells, a wide range of autoimmune diseases can result. Yale’s
immunobiologists are undertaking the basic research that may
lead to better treatments for these diseases and others with
autoimmune components, including AIDS.
Some of the .section’s researchers are learning more about
how cells communicate with each other to signal destruction
of infected cells; their studies could lead to more effective
bone marrow transplants. Still other Yale immunobiologists
are experimenting with new recombinant — genetically
engineered — vaccines against Lyme disease.
The molecular research of Adrian C. Hayday, Ph.D.,
associate professor of biology and immunobiology, touches
on one of medicine’s most debated issues; how stress may be
related to immune response. Dr. Hayday and his team study
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gamma delta T cells, many of which are located on the body’s
barrier surfaces, such as the skin, intestines, mouth and genitals.
Dr. Hayday thinks that gamma delta T cells may
sometimes start killing self cells because of an unfortunate
coincidence. Gamma delta T cells can respond to proteins
switched on during physical or immunological stress, what
Dr. Hayday calls the “molecular equivalent of cries for help.”
These proteins include ones that resemble proteins expressed
by mycobacteria which cause tuberculosis and other di,seases,
a likeness which may trigger an autoimmune attack.
“This raises the question of whether there’s a relationship
between various types of stress and susceptibility to disease,”
affirms Dr. Hayday. To explore this, he plans to test genet¬
ically whether molecules in the brain known to be affected by
mental and emotional stress will disrupt immune function.
Section scientists, in addition to addressing questions of
general autoimmunity, also study individual autoimmune
diseases. For example, the laboratory of Charles A. Janeway
Jr., M.D., is researching the role of T cells in such diseases as
insulin-dependent diabetes, multiple sclerosis and systemic
lupus erythmatosus. Using strains of mice bred to exhibit
symptoms of these diseases. Dr. Janeway, a professor of
immunobiology and HHMI investigator, is trying to discover
how T and B cells communicate with other cells.
Toward this end, his laboratory was one of the first to
clone T cells. Dr. Janeway and his colleagues are focusing on
how these cellular soldiers recognize antigen, how they
distinguish between self and non-self cells, and what spurs the
T cells to action.
Dr. Janeway’s T cell research may contribute to the fight
against the Human Immunodeficiency Virus (HIV), the
AIDS virus. HIV disables the immune system by infecting
and killing T cells which bear molecules called CD4 on their
cell surfaces. Dr. Janeway’s team discovered why T cells
which bear CD4 molecules recognize one of two major forms
of MHC, class 11. T cells link to an antigen-bearing
MHC molecule through both a surface receptor and a
CD4 molecule.
“CD4 binding to MHC class II makes the cell a hundred to
a thousand times more sensitive to antigen, enabling the T cell
to respond efficiently to very low amounts of antigen,” Dr.
Janeway explains.
Dr. Flavell’s research team is also accumulating evidence
that HIV infection may be linked to autoimmunity. HIVinfected cells may shed the protein gpl20, which binds to
the CD4 molecule. Shedding gpl20 renders the cell a target
for killer T cells, says Dr. Flavell, who is studying
this interaction.
Another aspect of Dr. Flavell’s work, his decade-long
research into MHC genes, may help determine why some
people are susceptible to diabetes and other autoimmune
diseases. To pursue this question, his team fashions transgenic
mice by inserting foreign — in this case human — genes into
embryonic animals which then express the genes.
“People who have a certain type of MHC II gene have a
likelihood that they’re going to get diabetes. People who have
a protective kind of gene, which is an MHC class II gene in
mice, are likely not to get disease,” notes Dr. Flavell.
There also may be an autoimmune component to Lyme
disease. Dr. Flavell suggests. Lyme disease is caused by a
spirochete, a spiral-shaped bacterium. Patients displaying
neurological symptoms of the disease have antibodies in their
cerebrospinal fluid that cross-react with an antigen of the
spirochete. Dr. Flavell speculates that “if this antibody binds
to neurons, that might be part of the cause of the damage.”
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Delving into Diabetes
Four years ago. Professor of Medicine Robert S. Sherwin,
M.D., a blood sugar metabolism researcher, took an unusual
sabbatical. Passing up a chance to study in Denmark, he
stayed at home to work in the laboratory of another Yale
researcher, immunobiologist Charles A. Janeway Jr., M.D.
Their collaboration has led to a major research project
regarding the immunological progression of insulindependent diabetes mellitus. The $6 million project,
supported by the National Institutes of Health, began Sept. 1.
It involves 10 Yale
medical
school
researchers who are
studying the cell
biology, immunology
and
molecular
biology of diabetes.
The scientists plan to
conduct
clinical
studies, as well.
Scientists believe
diabetes develops after
T cells make a serious
mistake — they attack
and
destroy
the
insulin-producing beta
cells of the pancreas
Robert S. Sherwin. M.D.
until
insulin
production slows or
stops. Researchers think this error occurs because beta cells
cloak themselves with an antigen that T cells may mistake for
an invading organism.
Dr. Sherwin, together with associate research scientist EvaPia Reich, Ph.D., and Dr. Janeway, identified T cell cloned
lines that could induce diabetes in experimental mice. With
this discovery, the scientists had developed an animal model
that could help them pursue answers to some of the most
basic questions about the disease.
For example, does MHC interact with antigens that attack
beta cells? To find out, Dr. Richard Flavell’s laboratory
fashioned a gene that will be inserted into diabetic mice. He
hopes the gene will induce production of MHC II molecules
targeted by T cells. If this gene hastens the disease’s
progression. Dr. Flavell will have evidence that MHC II plays
a role in diabetes etiology.
Another question involves identifying which antigens on
beta cell surfaces are targets of autoimmune attack. Should
the laboratories of Drs. Janeway and Flavell succeed in
identifying these antigens, it might lead to immunotherapies
for diabetes.
Do cytokines, which often initiate immune responses, play
a role in the disease? To find out. Dr. Nancy Ruddle is
examining the impact of cytokines on insulin-producing cells.
And Dr. Adrian Hayday wants to elucidate the interaction
between the T cells and the pancreatic tissues that they
destroy. His team is trying to clone the genes for T cell
receptors and then insert them into cells that don’t recognize
beta cells. This will help test whether these receptors trigger
an autoimmune attack.
For his part. Dr. Sherwin is working to understand how T
cell clones attack beta cells and whether beta cell activity
influences the attack. Pleased with his ongoing collaboration
with the immunobiologists, he calls their section “a lively,
energetic place where there’s a lot of learning going on.”
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Sounding the Battle Cry

Paula Kavathas, Fh.D., discusses with Dr. Flavell about
recent findings from her research involving CDS molecules.

Yale Scientists Progress
In Cracking the Genetic Code
Immiinobiological research at Yale reflects a growing
emphasis on understanding genes. With ramifications for a
wide range of biomedical issues, genetic research benefits
from an interdisciplinary approach, as reflected in the work of
three of the section's researchers:
•

Paula Kavathas, Ph.D., assistant professor of laboratory
medicine, human genetics and immunobiology. She works
with mutant CD8 molecules on the surfaces of some T
cells. By studying the mutant CD8 cells, she hopes to learn
how they bind to MHC class I molecules on nearby cells
and signal T cells to destroy pathogenic cells. She also is
studying a chemical secreted by the immune system which
appears to interact with both immune and nervous system
cells. This chemical interaction may be responsible in part
for nervous system changes during illness.

•

Nancy Ruddle, Ph.D., associate professor of epidemiology,
biology and immunobiology. She works with genes cloned
for two related cytokines called lymphotoxin and tumor
necrosis factor (TNF). Manufactured by T cells, cytokines
can kill some cells while spurring replication of others. Dr.
Ruddle thinks TNF and lymphotoxin may contribute to the
myelin destruction and interrupted nerve transmission
characteristic of multiple sclerosis. HIV-infected T cells
also appear to be much more sensitive to these cytokines
than non-infected cells. “It’s becoming more and more
clear that TNF and lymphotoxin are important co-factors in
AIDS, in stimulating virus replication and in killing cells,"
she says.

•

David Schat/., Ph.D., a Massachusetts Institute of
Technology researcher who will join the section as the
sixth primary faculty member in July. He studies two
genes important in the assembly of T cell receptor and
antibody genes. Dr. Schat/ cloned the genes called RAG-1
and RAG-2 which appear to produce an enzyme that
shuffles genes around to recombine and produce the
body’s vast repertoire of antibodies and T cell receptors.
But Dr. Schat/ has also found evidence that the genes
aj')pear in the nerve cells of the brain, which may lead to
further insights into brain function.
lb

As some section .scientists look into newly discovered Lyme
disease, others' research may help manage a parasitic scourge
known for millennia, what modern medicine calls
leishmaniasis. This sandtJy-borne disease affects 12 million
people worldwide. Experiments by Kim Bottomly, Ph.D.,
associate professor of immunobiology and associate
investigator with HHMI, are focusing on how the body
eliminates various pathogens, such as those leading to
leishmaniasis and other diseases.
She notes that the mode of defense the immune system
deploys might make the difference between resistance or
susceptibility to Leishmania. If one hand, CD4 T cells
activate antibodies to fight the Leishmania parasite, this
paradoxically is associated with susceptibility and leads to
leishmaniasis, often characterized by fever, fatigue and
secondary infections. If, on the other hand, T cells activate
macrophages, then the body is better able to resist
the parasite.
Dr. Bottomly’s laboratory has identified two kinds of CD4
T cells: helper T cells, which help B cells secrete antibody,
and inflammatory T cells, which activate macrophages.
Hence, the type of helper cell that responds may influence the
severity of leprosy and other diseases. Concludes Dr.
Bottomly: “If we understood the mechanisms that detemiine
the type of cellular response, we might be able to switch on or
trigger the more favorable response.”
In their work with vaccines. Yale immunobiologists
employ yet another strategy to strengthen immune defenses.
Vaccines induce a protective immunity which works like the
natural, lifetime defenses one develops after conquering such
childhood diseases as measles or chicken pox. In effect,
vaccines train the body to defend against a disease without
having to suffer its effects.
Most vaccines stimulate antibody production by using
disease-causing agents that have been killed or greatly
weakened. In a small number of cases, however, such
vaccines actually cause disease. Such is the drawback of the
currently available Lyme disease vaccine for animals, which
uses killed bacteria.
In an attempt to produce a safer result. Dr. Flavell’s team
has developed an experimental recombinant vaccine using a
mouse model developed by Stephen W. Barthold, D.V.M.,
Ph.D., professor of comparative medicine. Dr. Flavell and
Erol Fikrig, M.D., a post-doctoral fellow in infectious
diseases, created the vaccine in collaboration with Ered S.
Kantor, M.D., the Paul B. Beeson Professor of Medicine, by
splicing the gene for a protein from the surface of the Lyme
disease bacterium into a hanniess, common bacterium. Their
vaccine protected mice from an experimentally induced fomi
of the disease.
Eventually, this research may lead to a better diagnostictest for Lyme disease, a more useful animal vaccine, and
perhaps even a human vaccine. Dr. Flavell’s work also could
help efforts to develop a vaccine for syphilis, which is caused
by a spirochete, as well.
Complementing such research into protective immunity,
the scientists in Dr. Bottomly’s laboratory are helping to
define the mechanism of immunological memory, the way
one’s body can recognize and fight diseases which previously
ran their course, sometimes many years earlier. In 1988, Dr.
Bottomly’s team was the first to identify markers for naive
cells, T cells which have not encountered antigen, and
memory cells. T cells which have.

Yai.e Meuic INE Spring 1991

She has evidence that receptors on the surface of memory
T cells are better organized and are located closer together
than those on naive cells. This better organization apparently
leads to more efficient signalling. Now Dr. Bottomly is trying
to find out which genetic signal orders reorganization of those
receptors.
Knowledge of T cells is advancing as well in the
laboratories of Alfred L. Bothwell, Ph.D., an associate
professor and associate HHMI investigator. With Dr.
Bothwell as his advisor, third-year graduate student Alfred
Slanetz has developed a water soluble T cell receptor.
Researchers hope to deduce this protein’s molecular structure
using x-ray crystallography.
Dr. Bothwell also is leading research into how B cell
memory strengthens immunity after a second encounter with a
microorganism — the effect induced by a booster vaccination.
Dr. Bothwell and colleagues are using certain mutations in B
cells to trace the development of immunologic memory.
Welcoming the Ally
Basic research by Yale immunologists may improve the
outlook for the growing number of bone marrow transplant
patients. In this area, the challenge is to help patients rebuild
their compromised immune systems.
A physician who transplants bone marrow to treat a
leukemia patient presents two windows of opportunity for
pathogenic invaders. The first is opened by drugs which
suppress the immune system to counter rejection, the second
by the destruction of the patient’s own bone marrow. Since
marrow generates lymphocytes, its destruction leaves patients
even more vulnerable to infection.
Dr. Crispe's studies of stem cells may lead to better
methods of bone marrow transplantation by offering insights
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into lymphocyte development. Adult bone marrow and the
fetal liver produce stem cells, which eventually become T and
B cells, red and white blood cells and macrophages.
Preliminary work in his laboratory suggests that stem cells
develop into T cells after they enter the thymus.
Refining such knowledge may even allow physicians to
develop treatments for leukemia that would obviate the need
for marrow transplants. Observes Dr. Crispe: “Knowing how
stem cells get their orders to become T cells may help in the
understanding of diseases where T or B cell development
goes wrong, such as some types of leukemia or lymphoma.”
Given the enomious clinical implications of this and other
research pursued by the section. Dr. Flavell sees possible
commercial applications on the horizon. This potential will
benefit from his experience in private industry as the former
president and chief scientific officer of Biogen Research
Corporation in Cambridge, Mass.
Dr. Flavell comments: “It behooves us to make sure that
transfers of technology occur smoothly from academia to
industry, to make sure that our society benefits from
innovation in basic science. This can reward the University
financially and help the development of important new
products in the private sector.”
He adds, on a cautionary note: “It is, however, important to
remember that while industry concerns itself with product
development, our role in the University is to teach and
advance knowledge through basic research.”
YM

Working under a sterile hood, Kim Bottomly, Ph.D., separates
memory from virgin CD4 cells using a specific antibody
developed in her lab. She coats a petri dish with antibodies
that bind strongly to naive cells; memory cells do not bind
strongly to the antibody and can be washed from the dish.
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CENTER FOR MOLECULAR MEDICINE
THE 21 ST CENTURY DEBUTS
Harry Bishop

Adding dO.OOO net square feet of laboratory space to the School of Medicine, the Center for Molecular Medicine will hear the
family name of Herbert W. and Marigrace Boyer to recognise their $10 million gift to the center, the largest-ever family donation
to the School of Medicine.

by Gregory R. Hath. M.P.H. '84. and Diane E. Loupe
From its conception seven years ago through the completion
of its $38 million edifice this year, Yale's Center for
Molecular Medicine (CMM) has displayed the momentum of
an idea whose time has come. CMM’s June 6 dedication,
scheduled to coincide with Alumni Weekend, culminates an
effort that has transformed a vision for modern medical
science into programs that promise to usher Yale into the next
century at the vanguard of biomedical research.
CM M's story begins in the summer of 1984. As Dr. Leon
F£. Rosenberg exchanged the mantle of department chair of
human genetics for that of medical school dean, he presented
the CMM concept to Dean Fimeritus Robert W. Berliner and

In this article. Gregory R. Hath, publications editor at the
School of Medicine's office of public information (OPl).
reported and wrote about historical and programmatic
developments regarding the Center for Molecular Medicine:
Diane /.. Loupe. OP! staff writer, reported and wrote about
scientific issues.
IX

other respected faculty members such as Drs, George E.
Palade and Samuel O. Thier.
Dr. Rosenberg, the first scientist to describe patients with a
genetic defect in vitamin B-12 metabolism, realized how the
cooperation of colleagues from other disciplines had
strengthened his own research. He also was aware of how the
human genetics department speeded the delivery of scientific
discovery to patients by encouraging its basic scientists to
work closely with clinical researchers.
Why not apply these principles on a grand scale, he
reasoned, and do so employing the most advanced tools
modern biomedical science had to offer? Notes Dr.
Rosenberg: “As the fields of cell and molecular biology,
genetics and immunology had burgeoned in the last decade, it
seemed that the opportunities for understanding disease in
molecular temis were enonnous.”
FJis faculty advisors agreed. Enthusiastically. So the dean
proceeded to form a planning committee comprising .some of
the medical .school’s leading basic and clinical researchers.
[See “Steering Committee Governs CMM,” page 23.] The
quest had begun to transform a dream into steel, brick
and mortar.
Yale Medicine
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During CMM’s planning stage, a development in the
not-for-profit sector provided an invaluable boost. In March
1986, the Howard Hughes Medical Institute (HHMI)
embarked on a major reorganization in which it dramatically
increased research funding in five areas: genetics,
immunology, cell biology and regulation, neuroscience and
structural biology. This emphasis so closely meshed with the
one envisioned by CMM’s planners that they wasted no time
in contacting HHMI.
The outcome of subsequent talks exceeded the committee’s
hopes; HHMI committed itself to pay for the construction of
roughly half the center’s research space. Furthermore, the
institute agreed to appoint investigators in two of CMM’s four
research programs, molecular neurobiology and molecular
genetics, from among faculty nominated by the University.
HHMI’s support initiated an avalanche of fund-raising
success. A major gift from the Lucille P. Markey Charitable
Trust established CMM’s third research program, molecular
oncology and development. Molecular cardiobiology emerged
as CMM’s fourth and final program; the medical school is
negotiating with a major pharmaceutical company as a
possible sole corporate sponsor for this Poor.
Meanwhile, other organizations committed to biomedical
research and education added major support for construction
and program. These included the W.M. Keck Foundation, the
Ira W. DeCamp Foundation, and the Walter J. and Lillie A.
Berbecker Scholarship Fund.
One potential funding source, the S.S. Kresge Foundation,
offered a $1 million challenge grant, with the proviso that the
medical school; 1) match this gift with $5 million in
subsequent fund raising; and 2) increase the level of
alumni/ae giving to the School of Medicine Alumni Fund to
$450,000 and achieve 53 percent participation.
At the close of 1990, in dramatic fashion, Herbert W.
Boyer, Ph.D., and his wife, Marigrace, met the first part of the
Kresge Foundation challenge. A 1966 post-doctoral fellow in
the laboratory of Professor Ed Adelberg, Dr. Boyer had gone

on to invent recombinant DNA technology and then develop
it commercially by founding Genentech, Inc., in California.
The magnitude of his success — and of his gratitude to Yale
— was reflected in his family’s $10 million donation to
CMM. In recognition of this gift, the largest ever bestowed on
the School of Medicine by individuals, the CMM will bear the
Boyer family name. [See the Development Report, page 43.1
Building on Experience, Nurturing Innovation
The medical school’s success in gamering support for CMM
not only testifies to careful planning; it also reflects Yale’s
strength in human genetics and in cellular and molecular
research. Dean Rosenberg himself proved to be an important
asset. His leadership in genetic research had earned him
membership in the National Academy of Sciences and the
Institute of Medicine — important credentials when seeking
support in the tens of millions of dollars. Moreover, this
former president of the American Society of Human Genetics
had proven himself in molecular research through studies
which have helped advance understanding of and treatments
for several metabolic diseases characterized by selective
deficiency of mitochondrial enzymes.
Yale’s case was bolstered as well by the distinguished
faculty members who will administer the center. In July 1989,
the Yale Corporation named Vincent T. Marchesi, M.D. ’63,
Ph.D., the Anthony N. Brady Professor of Pathology, Cell
Biology and Biology, as CMM’s first director. A National
Academy of Sciences member and former president of the
American Association of Pathologists, Dr. Marchesi has
conducted pathbreaking studies into the structure of
membrane proteins in red blood cells.
CMM’s program heads also presented impressive
credentials. Joan A. Steitz, Ph.D., professor of molecular
biophysics and biochemistry (MB&B), an HHMI investigator,
had been chosen to head molecular genetics. In addition to her
membership in the National Academy of Sciences,

National Academy of Sciences member Vincent T. Marchesi, M.D. '63, Ph.D., serves as CMM’s director.
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Herhert U . Boyer. Ph D., completed his post-doctoral
fellowship at Yale in 1966 and went on to found (lenentech
hu .. thus helping to launch the hiotechnoloyy industry.

Dr. Steilz's laurels include the National Medal of Science
and the Warren Prize, which more than once has presaged
the Nobel Prize. Her basic research involving RNA function
and her discovery of at least six new essential cellular
components have clinical implications for the treatment
of lupus and cancer.
At the helm in molecular oncology and development is
Sherman M. Weissman, M.D., Sterling Professor of Human
Cienetics, Medicine and MB&B. Dr. Weissman also has an
appointment in the Yale Comprehensive Cancer Center,
bdected to the National Academy of Sciences by virtue of his
leadership in gene structure analysis, he also has developed
new appro’aches for studying the organization of DNA.
Spyridon Artavanis-Tsakonas, Ph.D., at age 44, repre.sents
the youngest of CMM’s program heads. This professor of cell
biology and biology, an HHMI investigator, will move from
Yale’s Science Hill to oversee molecular neurobiology. I4r.
Artavanis-Tsakonas' research has led scientists to identify a
key group of genes which allows embryonic tissue to
segregate neural from epidermal cells.
.‘Mthough a head for molecular cardiobiology — the last of
the four programs to be identified — has not yet been
announced, the program’s focus has been determined. 4’his
ihi-r's researchers will study endothelial cells, which line the
h,;i]i ud blood vessels, learning more about these cells is
\ital to improve treatments for heart disease, stroke and other
\ .!‘>cular diseases.
< Jn, e the full complement of scientists is aboard, the center
V. r! house 2.‘s to .^0 faculty researchers, with six to eight on
'
' -'i ilN lour floors. Dr. Marchesi reports that CMM’s

eight-member faculty steering committee, which he chairs, is
recruiting the center’s junior faculty from candidates with
several years of post-doctoral or residency experience.
In addition to the Yale faculty’s leadership in genetic
research, funding sources were attracted to CMM’s unique,
interdepartmental approach, designed to encourage
collaboration. Moreover, clinically oriented basic researchers
were mandated to play key roles in each program, to speed the
discoveries of basic science to the bedside.
In fact, the entire CMM has been carefully integrated
into the mainstream of medical school. As Dr. Marchesi
explains: “The center idea outside New Haven is often one in
which an elaborate structure is created within a medical
center. Usually it’s isolated and reserved, a province for a
small number of people. That’s not what we’re trying to
achieve here. CMM researchers will be Yale faculty who
happen to work in that location.”
Every CMM researcher will have a primary departmental
appointment at the School of Medicine; Dr. Marchesi says
that he hopes to establish as wide a distribution among
departments as possible. He emphasizes that though “the
center is neither a department, nor a kind of ‘mega¬
department’, nor four departments, one for each tloor. . . its
re.searchers are in every way members of the Yale faculty.”
In addition to their research responsibilities, the center’s
faculty will play an important teaching role. As in CMM
research programs, training at the center will be designed to
foster connections within the medical school.
Hence, trainees will not be limited to graduate-level
fellows assigned to the center. Intramural programs will fund
medical students, residents and clinical fellows who may wish
to rotate in CMM for periods ranging from three months to
several years. Small grants also will be available to support
collaborative research projects between CMM and University
research groups based outside the center.
The medical school’s emphasis on intra.school cooperation
also is evident in the pains planners took in making CMM
accessible. To facilitate pedestrian traffic between CMM and
the rest of the medical school, a pedestrian bridge connects
the center with the Jane Ellen Hope Building. Easy access
from across Cedar Street is assured by a second bridge, which
has been constructed between the second Boors of the Hope
building and Brady Memorial Laboratory.
Cracking the Code
Walking from the Hope building into CMM. one enters the
head space, or shared facility, where a small auditorium and a
common room will serve the entire medical school. CMM
administrators will occupy the first Boor.
The top two floors of the head space will house the W.M.
Keck Foundation Biotechnology Resource Laboratory. This
core service will consolidate the six labs of the Yale Protein
and Nucleic Acid Chemistry Facility, which have been
dispersed among the departments of MB&B, human genetics,
cell biology and in the Membrane Center.
With a full-time staff of 12, the Keck Foundation
laboratory will put $1.6 million worth of high-technology
instruments to work analyzing protein and DNA samples and
providing such sophisticated products as custom-designed
peptides as well as DNA and RNA oligonucleotides. Kenneth
R. Williams, Ph.D., an adjunct professor in MB&B and senior
associate of HHMI, serves as the laboratory’s director. He
reports. “In 1990, we .served 132 re.searchers at Yale, and I 14
others from the National Institutes of Health and 64
institutions around the world.”
Yale MfiDiciNK
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Complementing the laboratory’s broad clientele is a wide
base of support, which reflects the pervasive effect molecular
science is having on modern medicine. In addition to the
Keck Foundation and the departments listed above, the
laboratory has received funds from the National Institutes of
Health, the National Science Foundation, HHMI and the Yale
Comprehensive Cancer Cente,r among other sources.
Moving from CMM’s headpiece into the graceful curve of
the building which sweeps along where Congress Avenue
meets College Street, one encounters the laboratories for the
center’s four programs; each program has been assigned its
own floor. Programs will share a common interest in DNA’s
double helix and its key component, genes. All CMM
researchers will work on some aspect of these minute building
blocks of life.
In the molecular genetics program, located on CMM’s
ground floor, scientists will study how genes produce proteins
and how they sometimes trigger disease — knowledge
essential to all the center’s researchers. Investigators on other
floors will study specific gene functions. Molecular
oncologists, for example, will study the genetics of normal
cell development, in hopes of understanding what goes wrong
to cause the growth and spread of cancers. Molecular
neurobiologists will investigate how genes affect nervous
system development, while cardiobiologists will study
developmental aspects of the cardiovascular system.
For faculty in the HHMI-sponsored molecular genetics
program, research questions arise from the fundamental steps
leading to protein synthesis; stated simply: DNA makes RNA,
which in turn manufactures proteins.
“These basic steps go on in every cell in order to get the
information out of the genome and into the various proteins
that make one kind of cell different from another,”
comments Dr. Steitz. “Everybody who’s involved in the
program is doing research that’s targeted at some aspect of
this basic pathway.”

Dr. Steitz studies an early part of the molecular path: how
DNA assembles messenger RNA (mRNA). In gene
expression, DNA unzips its strands and constructs a mirror
image of itself. This copy — mRNA — directs the production
of proteins.
A key aspect of Dr. Steitz’s work dates back to when
Associate Professor and Assistant HHMI Investigator Michael
R. Lerner, M.D. ’81, Ph.D., ’81, was a graduate student doing
research in her laboratory. It was then that she and Dr. Lerner
di.scovered subcellular particles involved in mRNA synthesis.
They dubbed the particles small nuclear ribonucleoproteins,
snRNPs, and nicknamed them “snurps.” Later research
revealed that snRNPs perform many vital cell functions; Dr.
Steitz aims to discover the individual tasks of the
approximately 15 snRNPs that have been identified.
Some snRNPs appear to be crucial in rearranging the gene
segments that make up mRNA. Dr. Steitz explains that the
DNA of higher organisms contains large regions of “junk,”
called introns, which do not produce proteins. Introns’
protein-producing counterparts are called exons. Some
snRNPs identify boundaries between introns and exons. Other
snRNPs then aid in chopping out the introns and reconnecting
exons so that these protein-making genes can organize
sequences of amino acids into mRNA.
Once the DNA and snRNPs create mRNA, the latter leaves
the nucleus and enters the cytoplasm. With this exodus begins
the research of Sandra L. Wolin, M.D., Ph.D., assistant
professor of cell biology, an associate HHMI investigator. Dr.
Wolin works with ribosomes, complexes of RNA and protein
in the cytoplasm that interact with mRNA to assemble amino
acids into proteins.
Strands of mRNA comprise sequences of three nucleotide
bases, and each of the.se triplets codes for a particular amino
acid. Ribosomes roll along mRNA, both decoding it and
stringing together amino acids, which later become proteins.
.Itimes Anderson

Joan A. Steitz. Ph.D., and Michael R. Lerner. M.D. '81. Ph.D. '81, have been collaborating on research
into small nuclear ribonucleoproteins — snRNPs — since Dr. Lerner was a graduate student working in
Dr. Steitz’s laboratory.
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Dr. Wolin studies the features of inRNA that affect
ribosomes' ability to do this job.
Studies led by Arthur Horwich, M.D.. begin at the home
stretch of the pathway of protein synthesis. Dr. Horwich is
associate professor of human genetics and pediatrics, and an
associate HHMI investigator. He is discovering how newly
made strings of amino acids are folded into complex threedimensional structures. These structures are the functional
forms of proteins.
Dr. Horwich has identified a specialized protein that serves
as a folding "machine” that can recognize the unfolded strings
of amino acids and carry out the origami-like steps that turn
them into folded proteins. Understanding how such machinery
works may allow better methods of producing biologically
important proteins, or might allow genetically altered proteins
that don't fold properly to be corrected.
Another aspect of Dr. Horwich's work may have
implications for babies born with defective hearts. He is
analyzing a strain of mice in which a defect in a single gene
causes the visceral organs to become exactly reversed in their
left-right position. Included is the heart, which becomes

positioned on the right instead of the left, and is often
abnormal in structure. This mouse model of congenital heart
disease resembles many types of human disease, and
understanding how this gene works may offer new avenues of
diagnosis or treatment of the human di.seases. In addition, the
model may help solve one of the body’s fundamental riddles
— how it knows its right from its left.
The research of Stephen T. Reeders, M.D., assistant
professor of medicine and human genetics, further illustrates
the clinical potential of CMM’s basic research. This assistant
HHMI inv estigator seeks to pinpoint genes that cause
inherited kidney diseases, the most common of which is
polycystic kidney disease (PKD). One in 1,000 Americans
suffers from PKD, in which tluid-filled cysts replace healthy
kidney tissue, often leading to renal failure.
Dr. Reeders and his colleagues are studying large numbers
of patients and their families in order to track the diseaseproducing mutations. Their goal is to identify the PKD gene
and a means to characterize and match each mutation with the
pattern of disease it produces.

HHMI: Modern Medicine’s Medicis
A Washington Post writer recently drew a parallel between
what the Howard Hughes Medical Institute (HHMI) is doing
for today's medical research and what the Medici family of
Florence, Italy, did for 15th-century art. Just as the Medicis
used their wealth to nurture the genius of Michelangelo,
da Vinci and Botticelli, the writer suggests, HHMI is
putting to work its $6 billion endowment to advance the
biomedical sciences.
Founded by the late aviator-industrialist in 1953, the
Howard Hughes Medical Institute has become one of the
world’s wealthiest philanthropies and the largest private
supporter of biomedical science in the United States. It
conducts research at some 52 medical centers, hospitals,
universities and other research institutions around the country.
Yale has been an HHMI beneficiary since the institute’s
founding, and has received generous support for both capital
and program development. Most recently, HHMI announced
that it will help Yale construct a new molecular biology and
biophysics building on the central campus next to Kline
Biology Tower, where four HHMI investigators now work.
HHMI agreed to appoint investigators in two of CMM’s
research programs, molecular neurobiology and molecular
genetics. This includes paying their salaries and funding the
research in their laboratories. HHMI also supports four
investigators in the immunobiology section [see “Yale
Immunobiologists Get Back to Basics,” page 13|.
Yale’s 15 HHMI researchers are among approximately 200
HHMI investigators who work at more than 50 sites
nationwide. Unlike many biomedical funding sources, the
Bethesda, Md.-based institute is an independent medical
research organization, employing scientists rather than giving
them grants — a distinction crucial to HHMI’s organizational
struc ture and tax status. HHMI investigators do, however,
hold faculty posts at their universities.
Hughes institute support at Yale extends beyond salaries
and capital improvements. Some Yale medical students and
graduate students in the biomedical sciences have received
fc-llciwships through HIlMI’s grants program. And each year
s'le v I9SX, the institute has made awards to the University to

Purnell W. Choppin, M.D.
recognize the support HHMI investigators receive from
graduate students working in the laboratories of the HHMI
scientists. To link researchers and students across campus,
HHMI underwrites a computer bulletin board, electronic mail
and the “Bio-Med Express,” a bus that shuttles between the
medical school and Science Hill.
Of the CMM, HHMI President Purnell W. Choppin, M.D.,
says he is “confident that from this multidisciplinary center
we shall see the emergence of important new insights into
fundamental biological processes and disease mechanisms,
and the application of that knowledge to the treatment and
prevention of serious diseases.” He adds, “We at HHMI are
pleased and proud to be collaborating with Yale University in
this magnificent new endeavor.”
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In another project. Dr. Reeders has cloned the gene for
one of the collagen molecules that are critical structural
components of glomerular basement membrane — an
extracellular membrane in the kidney that divides the blood
from the urine. This collagen molecule is frequently absent
in the basement membranes of patients with Alport syndrome,
a sex-linked degenerative kidney disease. The gene product
is also the target of autoantibodies in Goodpasture’s
syndrome, a rare autoimmune cause of acute kidney failure
and lung hemorrhage. Dr. Reeders hopes that knowledge of
the molecular structure of the target of Goodpasture
antibodies will shed light on the mechanism of autoimmunity
in this disease.
A vital complement to the floor’s — and the center’s —
research will be provided by Paul B. Sigler, M.D., Ph.D.,
professor of MB&B, and his skills in protein crystallography.
In this process. Dr. Sigler, an HHMI investigator, targets a
section of DNA, binds protein molecules to it and crystallizes
the protein. He then creates an atomic blueprint of the
protein’s molecular structure by interpreting how the crystal
scatters x-rays.
Dr. Sigler comments, “These aren’t wiring diagrams, these
are detailed molecular structures that indicate how the
molecule works in chemical terms. That’s exciting to me.”
Some of Dr. Sigler’s research is based on x-ray
crystallography analysis of the “trp” repressor-operator
complex, which regulates the genes in bacteria that produce
tryptophan, an amino acid essential in human nutrition.
He’s also working to describe how DNA interacts with steroid
hormone receptors and with the proteins of human papilloma
virus, a virus implicated in cervical cancer.

Spyridon Artavanis-Tsakonas, Ph.D., joins the other program
heads on the CMM steering committee. At full complement,
the committee will include 10 members.

Steering Committee Governs CMM
Members of CMM’s steering committee serve for overlapping
three-year terms. Current members include:

Cellular Communication Sans Satellite

Spyridon Artavanis-Tsakonas, Ph.D., professor of cell
biology and biology, an HHMI investigator

In neurobiology, the HHMI-sponsored program on the second
floor. Dr. Artavanis-Tsakonas and his colleagues will work
with genes that control the development and function of the
nervous system. Among the issues these scientists will
explore are those of cellular long-distance communication.
Dr. Artavanis-Tsakonas explains; “Nerve cells have to
communicate with other cells that are far away. One is in your
head and the other is in your toe, and they are in constant
communication. That poses a number of very specific
problems that other cells may not be facing.”
He cites, for example, the question of how nerve cells
“wire” the body. How do embryonic nerve cells lengthen,
follow their elaborate path and connect in a pattern that is
virtually identical within species? Surprisingly, for answers.
Dr. Artavanis-Tsakonas turns not to the human genome but to
that of an insect that is barely visible to the naked eye.
His diminutive subject is Drosophila melanogaster — the
humble fruit fly. Scientists study fruit fly genes that affect
nerve cell development. Because the animal kingdom displays
dramatic similarities at the genetic level, understanding how
nerves develop in these tiny insects may one day help
researchers learn to regenerate nerves in human patients with
spinal cord injuries.
“There’s an incredible conservation of basic biological
mechanisms that essentially transcends species barriers,” says
Dr. Artavanis-Tsakonas. “So, there’s an enormous overlap in
things that we’re looking at in flies or in mice or in humans.”
These biological similarities will help CMM programs
transcend disciplinary boundaries, both within the center and
with the rest of the medical school.

Edward J. Benz Jr., M.D., professor of medicine, human
genetics and in the Cancer Center
Richard A. Flavell, Ph.D. professor and chairman of
immunobiology, an HHMI investigator
*Gerhard H. Giebisch, Sterling Professor of Cellular
and Molecular Physiology
*Vincent T. Marches!, M.D., Ph.D., Anthony N. Brady
Professor of Pathology, Cell Biology and Biology
(committee chairman)
*Joan A. Steitz, Ph.D., professor of molecular
biophysics and biochemistry, an HHMI investigator
*Joseph B. Warshaw, M.D., professor and chairman
of pediatrics
*Sherman M. Weissman, M.D., Sterling Professor of
Human Genetics, Medicine, and Molecular Biology and
Biochemistry and in the Cancer Center.

* Asterisks denote those w’ho served on the CMM planning
committee. Other current faculty members who worked on the
planning committee include:
Emile L. Boulpaep, M.D., professor of cellular and
molecular physiology
Edwin C. Cadman, M.D., Ensign Professor of Medicine
and in the Cancer Center, chairman of internal medicine
Bernard G. Forget, M.D., professor of medicine and
human genetics.

Continued on page 25
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CMM Design Embodies Integration
Cesar Pelli’s Center for Molecular Medicine (CMM) joins
Frank Gehry’s Yale Psychiatric Institute (YPI) and Philip
Johnson’s Laboratory of Epidemiology and Public Health
(LEPH) in the medical school’s — and the University’s —
tradition of commissioning projects by leading architects.
Argentine-born Pelli’s CMM design incorporates a
dramatic curve, evident not only in the building’s exterior, but
also inside, in its main corridors. These hallways separate
CMM’s 40 research laboratories facing the street or “south”
side, from the interior, which includes faculty and fellows’
offices, and support facilities such as controlled-temperature
rooms and tissue culture laboratories. Each south-side
laboratory offers 750 square feet of space. In hallways and
stairwells, built-in oak benches invite researchers to converse
and exchange ideas.

A (liaiii uni of the headpiece’s second floor. CMM’s architect,
( ■' -.ar Pelli. served as dean of the Yale School of Architecture
h 'ini l‘)77 to I9H4. General contractor for the project is
■

Even as CMM’s exterior commands a dominating
presence, the elegance and strength of its curve complements
the center’s urban environment. By defining the intersection
of College Street and Congress Avenue, the building’s bold
sweep completes the gateway to the medical center heralded
by LEPH on the Oak Street connector.
The Center for Molecular Medicine offers a contemporary
interpretation of the styles exhibited by two of its venerable
neighbors — the Jane Ellen Hope Building and the Brady
Memorial Laboratory — to which CMM is linked via
pedestrian bridges. The center’s red brick also evokes
industrial buildings from New Haven’s manufacturing era.
Such considerations, too, are reflected in Mr. Pelli’s other
recent projects: the World Einancial Center, Carnegie Hall
Tower and the Museum of Modem Art addition, all in New
York City.
Because of the sophisticated, rapidly evolving research that
Yale and HHMl scientists will conduct at the center, CMM’s
services, including electricity, heating and cooling, plumbing
and ventilation, have been designed with an eye to meeting
the needs of 21st-century science. These mechanical elements
represent approximately one third of the $38 million cost of
the 125,000 gross-square-foot building, which itself has been
likened to a finely tuned, high-technology instrument.
In some instances, addressing CMM’s mechanical needs
required form to serve function in inventive ways. For
example, Mr. Pelli’s associate, project manager Bruce W.
Sielaff, ’59 M.ARCH., points out that the flared, coppercovered pillars which frame the main entrance on Congress
Avenue do more than support a canopy to protect the porch
below. Though the pillars may recall Egyptian revival style,
their hollow interiors serve as intake shafts for an advanced
ventilation system which draws fresh air into the sub¬
basement for delivery throughout the building. The pillars’
flare is also functional: to reduce turbulence and noise.
Walking between the pillars one enters CMM's headpiece,
or shared facility. On the headpiece’s third and fourth floors,
core laboratories for protein chemistry, protein synthesis, and
DNA synthesis and sequencing will centralize facilities now
scattered throughout the medical center. The headpiece offers
different kinds of shared facilities on the second floor, with a
seminar room and a comfortably furnished common room.
Located in the headpiece and elsewhere in the center are three
conference rooms, plus lunch/break rooms for each of the four
program’s floors.
A subtle emphasis on integration comes from the secondand third-floor outdoor terraces, from which one can view the
weathered copper dome of Sterling Hall of Medicine and the
new arc-shaped information room of the CushingAVhitney
medical library. Another recent architectural project, the
library renovation and addition, was designed by Alexander
Purves with New Haven architect Allan Debar, who also
collaborated on YPI.
Finally, architect Pelli has integrated the Center for
Molecular Medicine by including the two pedestrian bridges
which unite CMM with teaching and research facilities
located in the rest of the medical school. The first, a bi-level
bridge, connects the center’s headpiece with the Hope
building. The second, a single-story structure, overarches
Cedar Street to link Hope and Brady. Through this bridge’s
series of square windows, the School of Medicine unfolds
before the observer’s eye —just as will the mysteries of DNA
in the mind’s eye of scientists who soon will animate the
newest addition to Yale’s architectural treasures.

in ner i onstniction Co. of New York Cit\.
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Continued from page 23
Dr. Artavanis-Tsakonas observes: “We’re all using
different experimental approaches, but in many ways, this is
breaking down the traditional barriers between the various
disciplines: molecular biology, developmental biology,
neurobiology and cell biology. Our people in neurobiology
will have a lot in common with the molecular genetics floor,
with the oncology and development floor, and even with the
cardiobiology floor.”
He points out, for example, that cardiobiologists won’t be
the only scientists with a stake in understanding angiogenesis,
how cells develop into blood vessels. This process may also
interest molecular oncologists, since a cancer can survive only
if nourished by blood. If one could stop the blood vessel from
reaching the cancer, the tumor should starve.
Similarly, CMM cardiobiologists will want to know how
cells communicate to fuse extracellular material and create a
blood vessel. Such knowledge could help treat some forms of
heart disease as well as aneurysm, stroke and other vascular
diseases.
The work of one CMM neurobiologist further illustrates
the potential for inter-program collaboration. Building on his
earlier work with Dr. Steitz, Dr. Michael R. Lerner, associate
professor of molecular neurobiology and associate HHMI
investigator, studies how scientists might employ one
particular snRNP in splicing new forms of mRNA.
In other research. Dr. Lerner, like his colleagues in
neurobiology, turns to a perhaps surprising branch of the
animal kingdom to benefit human health — in this case,
amphibians. He uses frog pigment cells to screen new drugs
for efficacy.
Current screening methods lack quick, simple ways to
evaluate chemicals that trigger production of cyclic adenosine
monophosphate, (cAMP), which helps regulate heart rate,
blood sugar levels and air flow in the lungs. Since cAMP also
allows certain frogs to adapt their skin color to changing
environments. Dr. Lerner is trying to use frog pigment cells to
identify chemicals that trigger cAMP production.
“The beauty of this test is that it would harness a naturally
operating system already in place,” says Dr. Lerner.
Genes of still other animals, including chickens, will guide
many scientists in the molecular oncology program on the
third floor. Dr. Weissman is recruiting researchers who will
study the genetics of normal cellular growth and development,
hoping that this will help explain how tumors form and grow.
“We recognize that the genes involved in controlling
growth during differentiation are a significant portion of the
genes that may be involved in cancer,” reports Dr. Weissman.
Here researchers will compare the varying effects that the
same gene can produce in humans and other organisms. For
example, they will study how the “rel” oncogene, which
directs immunoglobulin production in humans, can mutate to
cause cancer in chickens, and how this same gene controls
body development in the fruit fly. Scientists will move even
further down the evolutionary scale to investigate the human
neurofibromatosis gene, an analog of a yeast gene that helps
regulate cAMP.
The first faculty member recruited for the floor, Michael J.
Stern, Ph.D., currently a postdoctoral fellow at the
Massachusetts Institute of Technology, studies the
development of Caenorhahditis elegans, a roundwonn as tiny
as a comma. Specifically, he studies how a pair of cells in the
developing worm migrate to their final positions.
Understanding this may lead to approaches to control the
abnormal migrations of metastatic tumor cells in humans.
Yale Medicine
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To spur such research. Dr. Weissman’s laboratory is
improving methods for mapping genomes, whether human or
those of other organisms. Dr. Weissman already has
introduced several such techniques, including chromosome
jumping, in which one cuts a length of chromosome, loops it
and joins its ends. By sequencing the ends, researchers save
many hours in identifying genes. He and colleagues now are
attempting to sequence large pieces of DNA by quickly
identifying all of the mRNA that the DNA encodes.
Dr. Weissman also studies the processes by which the
body switches from producing fetal hemoglobin to adult
hemoglobin. His work may advance treatments for such blood
disorders as sickle cell anemia, thalassemia and leukemia.
Fulfilling the Dream
Dean Rosenberg is confident that CMM’s interdisciplinary
structure will nurture such crucial research in all four of the
center’s programs and throughout the medical school. He afso
points out the CMM’s strategic importance to the School of
Medicine’s ongoing quest to maintain a leading faculty in
basic research.
Comments the dean: “You can’t get the best people
without facilities that are good enough to attract the best. Bart
Giamatti once said that if you’re going to be the best, you
have to be able to afford it. Part of affording the best in
science has to do with the facilities.”
Citing the state-of-the-art CMM laboratories which soon
will come to life, he adds: “This is a project about which I’m
extraordinarily excited, proud and hopeful.”
YM

Sherman M. Weissman. M.D.
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Symposia Honoring the Dedication of the
Boyer Center for Molecular Medicine
June 6,1:30 p.m.
Constructing a National Agenda for Biomedical Research
Mary S. Harkness Memorial Auditorium
Yale University School of Medicine
The Honorable Lowell P. Weicker, Jr.
Governor. State of Connecticut
Leon E. Rosenberg, M.D.
C.N.H. Long Professor of Human Genetics. Medicine, and Pediatrics
Dean, Yale University School of Medicine
P. Roy Vagelos, M.D.
Chairman and C.E.O., Merck & Company, Inc.
Dick Thompson
Chief Science and Medicine Correspondent
Washington Bureau, TIME Magazine

June 7, 9:00 a.m.
Perspectives in Molecular Medicine
Commemorating the Four Programs in the
Boyer Center for Molecular Medicine:
Molecular Genetics, Molecular and Developmental
Neurobiology, Molecular Oncology and Development,
and Molecular Cardiobiology
Mary S. Harkness Memorial Auditorium
Yale University School of Medicine
Introduction: Vincent T. Marchesi, M.D., Ph.D.
Anthony N. Brady Professor of Pathology, Cell Biology, and Biology
Director, Boyer Center for Molecular Medicine
“Ribonucleoproteins in the Amphibian Oocyte Nucleus”
Joseph G. Gall, Ph.D.
Department of Embryology
Carnegie Institution of Washington
“The Accumulation of Chemoreceptors at Developing Synapses”
(ierald D. Fischbach, M.D.
Nathan Marsh Pusey Professor and Chairman of Neurobiology
Department of Neurobiology
Harvard Medical School
“Regulating the Transcriptional Regulators”
David Baltimore, Ph.D.
President
The Rockefeller University
“How Cells Control Cholesterol”
Joseph L. Goldstein, M.D.
Professor and Chairman
Department of Molecular Genetics
University of Texas
Southwestern Medical Center at Dallas
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Photograph © 1969 Irving Geis

“Hemoglobin Molecule^’ by Irving Geis
This graphic depiction is based on a photograph derived
from x-ray crystallography — a technique widely used by
Yale biomedical researchers. This technique involves
mathematically reconstructing submicroscopic structures
using data from x-ray diffraction — scattering x-rays off
minute crystals and recording the resulting patterns. In this
drawing, American artist Irving Geis uses such an image to
create a three-dimensional tubular form with peculiar¬
looking bends which represents the myoglobin fold
(hemoglobin is comprised of four myoglobins). In 1957,
myoglobin was the first protein molecule to be visualized
using x-ray crystallography.
The hemoglobin molecule consists of four chains of
amino acids and comprises 10,000 atoms. Oxygenated
blood is red due to four iron atoms located at the center of
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a cluster of atoms called heme. These are depicted here as
the four hovering spheres embedded in rectangular plates.
The width of the molecule is 64 angstrom units — 100
million angstrom units make up a centimeter.
Irving Geis has been a scientific illustrator for more
than five decades. He has illustrated and authored
numerous textbooks, exhibited widely and lectured on
molecular structure. He combines a knowledge of science
with artistic acumen in his conception and execution of
structures that normally elude the human eye. His
rendering of hemoglobin exemplifies the evolving
association between the advancements of medicine and art.
Janice Braun, Historical Library
Harvey CushinglJohn Hay Whitney Medical Library

27

MARTIN LUTHER KING JR. DAY. 1991

John Dow Jr., Ph.D., superintendent of the New Haven public schools (left) joins
Warren A. Andiman, associate professor of pediatrics, epidemiology and
laboratory medicine, and Linda Mayes, M.D., the Arnold Gesell Associate
Professor of Child Development, in exploring “Drug Abuse as it Affects Children.”

fj

Maxine Whitehead, director of minority affairs, is flanked by
Therman E. Evans, M.D.. corporate medicine director and
vice president, CIGNA Corp., and Olivia Cole, stage, screen
and television actor. Dr. Evans and Ms. Cole made presenta¬
tions that drew standing ovations at Harkness auditorium.

M.P.Il. Y)(S’, director of the Hill Health Center,
■j the afternoon’s many discussion groups.

'a-‘It.
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The Youth Department Connecticut Mass Choir of New Haven performs in Harkness auditorium.

Phyllis Harris, a second-year M.P.H. student, led one of the
discussions held in the Hope building's Ebbert lounge.

William King Jr. (left) and Dee Dockery demonstrate a roleplaying technicjue used with New Haven public school
students in the Adolescent Substance Abuse Prevention
(ASAP) program. Mr. King coordinates ASAP with Joanna
Rosen, also a second-year medical student.
29
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SCOPE
New MB&B Building
To (irace Science Hill
Construction has started for a new
building on Science Hill that will house
the department of molecular biophysics
and biochemistry. The four-story.
9(),()()()-square-foot structure, scheduled
for completion in 1993, marks the first
new construction on Science Hill since

neurology, radiology, laboratory
medicine and anesthesiology.
These specialists offer a wide array
of non-invasive vascular diagnostic
studies, sophisticated lipid profiling,
nutrition counseling, ambulatory blood
pressure monitoring, magnetic resonance
imaging and complete angiographic
capabilities. These services augment,
and do not replace, care provided by a
patient's personal physician. Dr. Black
emphasizes.

I96.S.
The estimated S22.2 million
construction project is partially funded
by a S4.5 million contribution from the
Howard Hughes Medical Institute. The
building, designed by Kallmann.
McKinnell & Wood .Architects Inc. of
Boston, will connect with the Sterling
Chemistry Lab and the Josiah Williard
Gibbs Research Laboratories, and will
be adjacent to the Kline Biology Tower.

Linda Berganzi

Pulsed Dye Laser
Removes Birthmarks

Vascular Center
Debuts at Yale
The new \'ale Vascular Center taps into
the medical school's knowledge in a
variety of disciplines to provide high
quality, convenient care targeted at
atherosclerosis and other diseases
affecting blood vessels. The center is
located in the Yale Physicians Building.
‘‘.Atherosclerotic cardiovascular
disease and its complications will kill
or disable the majority of our
population." states Dr. Henry R. Black,
professor of internal medicine, director
of the Preventive Cardiology Program
and co-director of the center.
Lxplains co-director Dr. Richard J.
Gusberg. professor and chief of vascular
surgery. "As our aging population
increasingly confronts the complications
of atherosclerosis, advances in knowledge
and technology have made the manage¬
ment of vascular disease both more
effective and more complicated."
Drs. Gusberg and Black established
the center to keep pace with such
medical advances and to insure that
patients benefit from them in a
:,-nemeni ua\. fhe center's multi■ as'- iplinary team includes specialists
lr;im internal medicine, vascular
.me-Ty. neurosurgery, plastic surgery.

the new centre. He comments. "By
collaborating with the WHO and other
global- and country-level institutions on
programs of education, research,
information exchange and consultation,
the centre will help formulate and
implement health-promotion policies
and research."
Key to this effort will be establishing
a global information/problem-solving
netw ork, using teleconferencing to link
23 Yale experts w ith scholars in WHOmember states throughout the world.
Economists, environmentalists,
epidemiologists and planners in fields
as diverse as agronomy and virology
will contribute their expertise.
Also, through the centre, visiting
scholars w ill collaborate in research
w ith Yale faculty and learn how to
apply teleconferencing methods in
graduate education.

W HO official Ilona S. Kickhnsch. Ph.D..
at the coUahorating centre dedication.

WHO Centre Focuses
On Health Promotion
The World Health Organization (WHO)
has designated the department of
epidemiology and public health as a
WHO Collaborating Centre for Health
Promotion Policy and Research, the
first such WHO-sponsored organization.
Burton H. Singer, Ph.D., professor
and chaimian of epidemiology and
public health, explains that the new
centre melds research, service and
teaching. "EPH faculty members, with
the help of other Yale faculty, will
foster cooperation in research between
health policy experts, epidemiologists,
environmentalists and biostatisticians,
says Dr. Singer.
Lowell S. Levin, Ed.D., M.P.H.,
professor of public health, will direct

Both adults and children can now be
treated at Yale for vascular tumors of
the skin, thanks to the new pulsed dye
laser acquired by the School of Medicine
and Yale-New Haven Hospital.
This laser — the only one of its kind
in the region — treats port-w ine stains
as well as other blood vessel tumors
and broken blood vessels. Port-w ine
stains, like the purplish-red birthmark
on the forehead of Soviet President
Mikhail S. Gorbachev, occur in three
out of every 1,000 new borns.
David J. Leffell. M.D.. assistant
professor of dermatology, explains that
the highly sophisticated laser emits
yellow light, a complementary color to
the red blood vessels that make up the
tumors. Because the laser's heat is
absorbed only by the blood vessels,
w hich are destroyed, and not by the
surrounding tissue, scarring is rare.
The laser unit, about the size of a
small washing machine, uses fiber-optic
cable to conduct the laser energy.
Patients require no anesthesia for the
treatment, which feels like the snap of
an elastic band. In most cases. va.scular
tumors can be permanently removed,
although several treatments may be
required.
Yale Medicine Spring 1991
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Yale Clinic Begins
Genetic Counseling
For Kidney Disorders
People with a relatively common
hereditary disorder that fills their
kidneys with cysts — often leading to
kidney failure — can now receive
genetic testing and counseling, thanks
to a new clinic at the Yale Physicians
Building. The Hereditary Renal Disease
Clinic, which opened in February, is the
first of its kind to offer genetic testing
and coun.seling specifically for people
with such renal diseases as polycystic
kidney disease (PKD), notes Gregory
G. Gemiino, M.D., instructor of
medicine.
Counseling helps people with a
family history of PKD to make
informed choices about health care,
childbearing and the possibility of
receiving a donated organ, explains Dr.
Germino, who co-directs the clinic with
Margretta R. Seashore, M.D., professor
of human genetics and pediatrics.
Although no therapy can prevent PKD,
some of its symptoms, like
hypertension and recurrent kidney
infections, can be managed.
Notes one of the clinic’s scientific
advisors, Stephen T. Reeders, M.D.,
“PKD is one of the most common
genetic diseases in Caucasians.” Dr.
Reeders, assistant professor of medicine
and human genetics, and an assistant
investigator of the Howard Hughes
Medical Institute, estimates that one in
1,000 Americans suffers from PKD.

Perry L. Miller. M.D.. Ph.D.

Dr. Miller comments: “Medical
knowledge is in constant flux as new
drugs and diagnostic tests are
developed, new studies perfonned, new
scientific research published. The
computer has the potential to make this
infomiation available in an up-to-date
fomi to practitioners, researchers and
students anywhere.”
From its office at 350 Congress
Ave., the new center will:
•

•

•

Medical Informatics
Center Opens at YSM
To keep itself at the forefront of the
computer age, the School of Medicine
has established a Center for Medical
Informatics. Perry L. Miller, M.D.,
Ph.D., associate professor of anesthesi¬
ology, has been named its first director.
In announcing this new multidisci¬
plinary center, Dean Leon E. Rosenberg,
states: “The center will provide
intellectual leadership in the creative
application of computers in biomedicine.
Through Dr. Miller’s efforts, the center
will focus on the emerging field of
biomedical information technology,
incorporating patient care, research,
medical education, scholarly information,
and computing and communications.”
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Focus on basic research into the
creative use of computers to support
clinical medicine, molecular
biology, biomedical research and
medical education.
Support and coordinate collaborative
research projects involving medical
school faculty, as well as faculty in
computer science and other
departments at Yale.
Serve as a focal point for training
the next generation of researchers in
this field.

New Center To Research
Child Development
The School of Medicine will establish a
Child Health Research Center where
pediatricians and scientists will advance
the understanding of normal and
abnormal child development.
The Yale center is one of seven new
Child Health Research Centers funded
by the National Institute of Child
Health and Human Development, part
of the National Institutes of Health.
Each center will receive a maximum of
$400,000 annually for five years and
will then compete for additional funds.

Dr. Joseph B. Warshaw, chairman of
the department of pediatrics, serves as
the center’s program director. He
explains: “Senior pediatricians,
scientists, cellular and molecular
biologists, neuroscientists and
geneticists will teach basic science to
pediatric researchers in training. These
young scientists will bring fresh ideas
to the technology of modern basic
science. Their innovative thinking will
improve our understanding of normal
development and the abnormalities that
result in injury, handicaps and death to
children.”
Eight pediatric faculty, including
Dr. Warshaw, will train four young
faculty researchers yet to be selected. In
addition, Yale medical faculty members
in several departments, including
internal medicine, human genetics, cell
biology, pathology, and molecular
biophysics and biochemistry, and the
sections of anatomy and immuno¬
biology, will provide support and
resources for the young faculty.

CMHC Celebrates
25 Years of Service
The Connecticut Mental Health Center,
(CMHC) a collaborative program of the
State Department of Mental Health and
Yale University, will hold a 25th anni¬
versary celebration on Sept. 20 and 21.
Speakers will include former and
current faculty who will highlight the
center’s role as a model mental health
care system for the public and as a
liaison in clinical programs, research
and education. They also will discuss
various challenges facing mental health
professionals today.
“We hope that all former faculty and
staff, especially those who trained at
CMHC, will return to New Haven to
participate in this celebration and to see
our growth and accomplishments in
mental health care,” says Dr. Ezra E.H.
Griffith, CMHC director and professor
of psychiatry.
Connecticut Gov. Lowell P. Weicker
Jr. is scheduled to be the keynote speaker
Sept. 21 in Yale Commons at a dinner
and ball that are part of the anniversary
events.
For further information about the
CMHC 25th anniversary celebration,
call (203)789-7290.
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Dr. (iriffith Addresses
Transracial Adoption
In a lecture he delivered at the
University of Maryland Medical Center
in Baltimore, Ezra E.H. Griffith, M,D..
associate professor of psychiatry and
African and Afro-American Studies,
presented his perspective on black
children being adopted by white
parents, lie noted that despite the 20year stand against such transracial
adoption taken by the National
Association of Black Social Workers,
"the scientific data show that black
children involved in transracial
adoptions generally adapt well, and do
not have more behavioral and .school
problems than children who are adopted
by couples of the same race.”
Dr. Griffith said that opponents of
transracial adoption who are concerned
with such issues as black children losing
their racial identity, should acknowledge
that their opinion is a political rather
than a scientific judgment. Minority
children in America have historically
been more difficult to place in adoptive
homes than have white children, and
while race cannot legally be considered
in adoptions. Dr. Griffith points out that
white couples are often discouraged
from adopting black children.
I3r. Griffith is director of Connecticut
Mental Health Center, a collaborative
program of Yale University and the
State of Connecticut. He delivered his
remarks as the Dana African-American
Visiting F^rofes.sor of Psychiatry during
Martin l.uther King Jr. Day activities at
the .Maryland medical center.

Second-hand Smoke
Tied to Infections
Two School of Medicine pediatric
researchers have produced evidence
that ties cigarette smoking in the home
with serious infections in children.
,\nne f. Berg, Ph.D., associate re.search
scientist, and ITigene 1). Shapiro, M.D.,
associate professor of pediatrics and
epidemiology, re|X)rted in a January
edition of the Anicrican Joiiniul of
l\pi(li’niiolof>y that they were looking
fur a possible association between
enrullment in a ilay-care center and the
risk of incurring a serious infection.
I hey round none. Instead, they
tlisi O', i-red that children e.xposed
postiiatally to household smoke hatl

approximately a four times-higher risk
of being hospitalized for a bacterial or
viral infection than youngsters who
were not subjected to passive smoking.

Foundation Funds
Research Equipment
The New Haven Eoundation has
awarded the department of internal
medicine, section of rheumatology,
$37,000 to further research and treat¬
ment of Lyme disease and arthritis. The
grant funds the purchase of diagnostic
laboratory equipment to aid in the
search of patients’ tissues and fluids for
evidence of the bacterium that causes
Lyme disea.se. This research will help
scientists elucidate how the disease
process comes about and hopefully aid
in diagnosis.
“Grants such as this one. to fund
equipment, are difficult to come by,
which makes it of special value,” states
Dr. Stephen E. Malawista, M.D.,
professor of medicine, whose
laboratory benefits from the grant. The
grant comes from the foundation’s
Josephine Burgess Fund, which
supports arthritis projects.

Study Questions How
Indoor Air Affects
Mothers, Children
The National Institute of Environmental
Health Sciences has awarded the John
B. Pierce Laboratory and the School of
Medicine a $3.5 million grant to study
how indoor air pollutants affect the
respiratory health of infants and their
mothers.
Brian P. Leaderer, Ph.D., an associate
fellow at the Pierce Laboratory and
associate professor of epidemiology
(environmental health) at Yale, directs
the five-year study. He also heads the
division of environmental health sciences
of the department of epidemiology and
public health.
Researchers suspf'ct that children
exposed to indoor concentrations of
gases from such sources as tobacco
smoke, cleaning chemicals, and
kerosene and gas heaters have increased
risk of acute or chronic upper and lower
respiratory symptoms.
The researchers plan to study POO
infants and their mothers from the New
Haven area in a variety of environments
to determine whether indoor pollutants

contribute to increased coughing,
wheezing, runny noses or breathing
problems. They also will test whether
pollutants affect the mothers’ lungs.
Co-investigators are Michael B.
Bracken, Ph.D., professor of epidemi¬
ology and obstetrics and gynecology;
William S. Beckett, M.D., a Pierce
Laboratory associate fellow and
associate professor of occupational
medicine and of epidemiology
(environmental health); Theodore R.
Holford, Ph.D., professor of public
health (biostatistics); and Kathleen
Belanger, Ph.D., associate research
scientist in epidemiology, obstetrics and
gynecology.

Scientists Study
Cocaine-alcohol High
A chemical formed when cocaine and
alcohol are consumed together may
contribute to both the euphoria, or
“high,” and to the sometimes fatal toxic
effects cocaine u.sers experience.
School of Medicine researchers report.
In a late autumn presentation at the
annual meeting of the Society for
Neuroscience, John D. Elsworth, Ph.D.,
research scientist in psychiatry and
pharmacology, described chemical
changes akin to a drug-induced
euphoria in laboratory rats that were
given cocaethylene, a compound
apparently formed in people who
consume cocaine and alcohol together.
“Cocaethylene appears to have
cocaine-like effects on brain chemistry,”
reports Dr. Elsworth. The findings
could aid researchers to develop drugs
to help wean addicts from cocaine.
The findings may explain why
cocaine abu.sers say they can prolong
their “high” by drinking alcohol,
suggests Robert H. Roth Jr., Ph.D.,
professor of psychiatry and
pharmacology, an author of the
research report. Half of cocaine abusers
are estimated to drink alcohol while
imbibing cocaine.
Comments co-author Peter 1. Jatlow,
M.D., professor and chaimian of
laboratory medicine and professor of
psychiatry. “Some cocaine abusers have
reported that drinking ethanol with
cocaine lessened the dysphoria,” or
“crash,” after a cocaine high. He is
quick to add, however, that despite this
salutary effect, cocaethylene also may
contribute to sudden death and the
cardiac problems that sometimes occur
in cocaine abu.sers.
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FACULTY NEWS
Donald J. Cohen, M.D., the Irving B.
Harris Professor of Child Psychiatry,
Pediatrics and Psychology, received the
27th Annual Strecker Award sponsored
by the Institute of Pennsylvania
Hospital in Philadelphia. He was
honored for his research into the
treatment of autism and Tourette’s
syndrome in children.
Evan H. Dillon, M.D., assistant
professor of diagnostic radiology,
presented a paper, entitled “Achilles
Tendon Healing: MRl Evaluation,” at
the Radiological Society of North
America annual meeting held in
November in Chicago.

by TrKn b'trsc.bbau,

What's Stopped Happening to Me? by
Dale Burg and Dr. Mary Jane Minkin,
assistant clinical professor of obstetrics
and gynecology, Lyle Stuart (New York)
1990.

NEW BOOKS
Treatment of Retinopathy of Prematurity,
ed. Dr. Joseph W. Eichenbaum, ’73,
Mosby-Year Book Co. (St. Louis) 1990.
Parent vs. Parent: How Yon and Your
Child Can Survive the Custody Battle,
by Dr. Stephen P. Herman, assistant
clinical professor of psychiatry.
Pantheon (New York) 1990.
Your Aching Back: A Doctor's Guide
to Relief, rev. edit., by Dr. Augustus A.
White, ’63-’66 HS, Simon and Schuster
Inc. (New York) 1990.
The Triune Brain in Evolution, by
Dr. Paul D. MacLean, '40, Plenum
Press (New York) 1990.
Pediatric Trauma, 2nd edit., ed. Dr.
Robert J. Touloukian, professor of
surgery and pediatrics, Mosby-Year
Book Co. (St. Louis) 1990.
A Year-Long Night: Tales of a Medical
Internship, by Dr. Robert Klitzman,
’85, Penguin Books (New York) 1989.
Assisting Pediatric Practice: A Clinical
Study, by Dr. Raymond S. Duff, ’52,
’59 M.P.H., Health Administration
Press (Ann Arbor) 1990.
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Alfred S. Evans, M.D., M.P.H., the
John Rodman Paul Professor Emeritus
of Epidemiology, was honored by the
American Public Health Association
with the 1990 Abraham Lilienfeld
Award for his contributions to the
teaching of epidemiology.
Myron Genel, M.D., associate dean
for government and community affairs
and a 1957 graduate of Moravian
College in Bethlehem, Penn., was
honored by his alma mater with the
1990 Comenius Alumni Award. The
award recognizes his outstanding
contributions to society. Dr. Genel also
is president of the newly fomied
Connecticut United for Research
Excellence (CURE), a coalition of
colleges and universities, hospitals,
voluntary health organizations,
professional health societies and
industries. CURE was established to
promote public understanding of
biomedical research.
Nicholas M. Greene, M.D.,
professor emeritus of anesthesiology,
was presented the American Society of
Anesthesiologists Distinguished
Service Award at its annual meeting in
October. The award is given for
meritorious service and achievement
during a career in anesthesiology.

1967, was cited as one of the 12 best
articles published during the journal’s
25-year history.
Robert ,1. Levine, M.D., professor
of medicine, has been lecturing on
ethical issues at several international
conferences. Over the past months, he
has spoken at the Menendez Pelayo
International University in Santander,
Spain, on ethics of research involving
human subjects; at the Pan American
Health Organization’s “Regional
Consultation on AIDS, Human Rights,
Ethics and Law,” in Santiago, Chile; at
the Council for International
Organizations of Medical Sciences’
meeting, entitled “Development of
International Ethical Guidelines for
Epidemiological Research and
Practice,” held in Geneva, Switzerland.
He also spoke on scientific integrity at
the annual meeting of the American
College of Neuropsychopharmacology
in San Juan, Puerto Rico.
James Merikangas, M.D., attending
physician at YNHH and assistant
clinical professor of psychiatry at the
School of Medicine, has been named to
the editorial board of the Annals of
Clinical Psychiatry, where he will edit
a special treatment section.
Bernard S. Siegel, M.D.. assistant
clinical professor of surgery, has been
named honorary chaimian of the newly
organized National Wellness Coalition.
The coalition works with Congress and
officials from the White House, U.S.
Department of Health and Human
Services and the National Institutes of
Health to shift the focus of national
health policy from illness to wellness.
Juan Rosai, M.D., professor of
pathology and director of anatomic
pathology, presented the 1990 Arthur
Purdy Stout Memorial Lecture in
October at the American Society of
Clinical Pathologists fall meeting. The
lecture was entitled “Head, Neck and
Mediastinal Pathology Related to
Branchial Pouch Derivatives; A New
Histogenetic and Pathogenetic
Proposal.”

Richard H. Greenspan, M.D.,
professor of diagnostic radiology and
associate dean for clinical affairs, was
honored with the Gold Medal of the
Association of University Radiologists
Society. The article he co-authored on
in vivo magnification angiography,
published in Investigative Radiology in
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Pathology, EPH
Chairmen Named
In an appointment that culminated a
national search, Jon S. Morrow, M.D.,
F^h.D., professor of pathology, has been
named chairman of the School of
Medicine's department of pathology
and chief of pathology at Yale-New
Haven Hospital. Dr. Morrow, who
received his M.D. degree from Yale in
1976 and completed his internship and
residency at YNHH, has been a faculty
member and attending pathologist since
1981. He succeeds Vincent T. Marchesi,
M.D.. Ph.D., director of the Yale
Center for Molecular Medicine.
Dr. Morrow’s pioneering work has
helped define the structure and function
of the cell cytoskeleton, the microscopic
filaments which serve as a foundation
for the outer layer of cells of all bodily
tissues, called epithelial cells. His studies
have helped scientists delve into the
molecular level to identify the origin of
several inherited blood diseases in
children. His recent research has focused
on how disorders of cytoskeleton
structure can disrupt the central nervous
system and cause epithelial diseases,
including certain forms of cancer.
EJeyond these basic science
endeavors. Dr. Morrow headed the team
that designed and installed the
pathology department’s computerized
patient information system. This system
has become a national model used by a
number of institutions.
Medical school Dean Leon E.
Rosenberg noted Dr. Morrow’s
"significant contributions" to the
School of Metlicine and added, “In his
new position as chairman of pathology,
he will lead this well-established
department to even greater
accomplishments."
Soon after Dr. Morrow’s appoint¬
ment was announced. Dr. Rosenberg
made public the reappointment of
Burton 11. Singer, Rh.D., professor of
public health and statistics, as chainnan
of the medical school’s department of
epidemiology and public health (EPH).
Dr. Singer’s three-year term will begin
at the completion of his initial, two-year
term as chairman in July 1991. He will
eontinue to serve as associate dean for
public health.
\s he announced Dr. Singer’s
r. ■ ipomtment. Dean Rosenberg said:
During the past year, under his inspired
K ..'.t Tship, the department of epidemi¬

ology and public health has reorganized
its academic program and launched
,several new initiatives that bridge
public health with foresty, law and
other disciplines and that encourage
public health, medical and nursing
students to work together. This
reappointment will allow Dr. Singer to
continue enhancing Yale’s long-standing
tradition of excellence in public
health."
An expert in tropical diseases. Dr.
Singer is chaimian of a World Health
Organization steering committee for
social and economic research in the
tropical disease program.

FACULTY NEWS

Brenda Bigland-Ritchie
Receives Humboldt Award
Dr. Brenda Bigland-Ritchie has received
an international Humboldt Research
Award for senior U.S. scholars,
recognizing her achievements in neuro¬
physiology. Dr. Bigland-Ritchie is
adjunct professor of pediatrics and
lecturer in neurology, a fellow at the
John B. Pierce Laboratory and a professor
of biology at Quinnipiac College.
The award, given since 1972 by the
Alexander von Humboldt Eoundation,
based in Bonn, Germany, is one of IOC)
presented annually to foster cooperation
between foreign and German researchers
and their institutions. Recipients are
invited to conduct research in the Eederal
Republic of Germany.
Dr. Bigland-Ritchie’s prize of 95,()()()
Deutschemarks (approximately $62,()()())
will allow her to spend 12 months
throughout the next five years with Dr.
Albrect Struppler, director of neurology
and clinical neurophysiology at the
Technical University of Munich, who
studies causes of neuromuscular diseases.
In Munich, Dr. Bigland-Ritchie will
employ microneurography to record
nerve impulses during muscle
contraction to determine how
infonnation about changing muscle
properties is transmitted to the brain
during muscular fatigue. She also will
stimulate the human brain directly with
magnetic pulses. By combining these
techniques, she hopes to gain new
insights about infonnation processing
by the brain during physical activity.

Six Yale Researchers
Win Wakeman Award
For Spinal Cord Research
Six Yale researchers were numbered
among 17 scientists who shared the
1990 Wakeman Award for Research in
the Neurosciences. The 17 won the
award, one of the highest honors in the
neurosciences, as co-authors on a study
on methylprednisolone, a steroid drug
that can help people paralyzed by spinal
cord injury recover some sensation and
movement.
The researchers received their award
at a ceremony held last fall at Duke
University in Durham, N.C. They
include: principal investigator Michael
B. Bracken, Ph.D., professor of
research in epidemiology and obstetrics
and gynecology; co-principal investigator
William F. Collins, M.D., the Harvey
and Kate Cushing Professor of Surgery
(Neurosurgery), chaimian of the surgery
department; Theodore R. Holford, Ph.D.,
professor of public health (biostatistics);
Linda Leo-Summers, M.P.H., project
manager in epidemiology and public
health; Joseph M. Piepmeier, M.D.,
associate professor of surgery
(neurosurgery); and Mary Jo Shepard,
M.P.H., associate research scientist in
epidemiology and public health.

Dr. James P. Comer
Wins McGraw Prize
James P. Comer, M.D., M.P.H.,
associate dean for student affairs and
the Maurice P. Falk Professor of
Psychiatry and in the Child Study
Center, was awarded the Harold E.
McGraw Jr. Prize in Education, which
carries a cash award of $25,000. Judges
cited Dr. Comer's contributions to
urban public education.
Two decades ago. Dr. Comer intro¬
duced a method for improving urban
public schools, an approach that
encourages parents, teachers, admini¬
strators and other school employees to
work as a team. Because of the
approach’s success in New Haven and
other cities, last year the Rockefeller
Foundation of New York City
announced a multi-million dollar
initiative to introduce Dr. Comer’s
method nationwide.
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Dean Elected
To National Post
Dean Leon E. Rosenberg has been
elected chair-elect of the Council of
Deans, part of the governing structure
of the Association of American Medical
Colleges (AAMC).
Dr. Rosenberg’s election came in
October at the council’s annual
business meeting, held as part of the
AAMC’s 101st annual meeting in San
Francisco. The dean, who will continue
to serve on the AAMC executive
council, succeeds Robert E. Tranquada,
M.D., dean of the University of
Southern California School of
Medicine, who becomes Council of
Deans chairman.
The AAMC represents the 126
U.S.accredited medical colleges, 16
accredited Canadian medical schools,
more than 400 major teaching hospitals,
including 72 Department of Veterans
Affairs medical centers; more than 90
academic and professional societies,
and the nation’s medical students.
Leading the organization of deans
of the nation’s medical schools.
Dr. Rosenberg says, strengthens his
service to Yale. “By interacting with
the leadership of the AAMC and
medical educators throughout the
country, I hope to help address the
many problems found by clinicians and
health scientists,” the dean states.

Dr. Jay Katz Named
Endowed Professor
Jay Katz, M.D., professor (adjunct) of
psychiatry, was named the first
Elizabeth K. Dollard Professor in Law,
Medicine and Psychiatry by University
President Benno C. Schmidt Jr. The
chair was recently established by the
Elizabeth K. Dollard Trust and honors
the 1939 Law School graduate.
Dr. Katz, an outspoken advocate of
patients’ rights, was among the first
researchers to explore the problems
created by experiments on human
beings and to bring about changes in
rules and procedures to protect subjects.
In 1984, he authored the book. The
Silent World of Doctor and Patient,
which documents the practice of
physicians witholding information from
their patients and omitting patients from
decision-making. He also is co-author
of The Family and the Law and
Psychoanalysis, Psychiatry and Law.
Yale Medicine
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A member of the Institute of
Medicine of the National Academy of
Sciences, Dr. Katz has been honored
for his contributions to the fields of
legal psychiatry and health law teaching
by the American Psychiatric
Association, the American College of
Physicians, and the American Society
of Law and Medicine.
Michael Marsland

Bella Z. Person, M.A.L.S., has retired
as associate university librarian and
director of the Harvey Cashing!John
Hay Whitney Medical Library. She was
a 21-year Yale library staff member.
During the past si.x years, Ms. Berson
led the medical library through an
extraordinary period of development,
culminating with a $10 million
renovation and e.xpansion which was
completed in June. R. Kenny Fryer,
M.L.S.. head of Medical Library
Reference Services, now serves as
acting director of the medical library.

Linda Mayes Named
First Gesell Professor
Yale University has named Linda C.
Mayes, M.D., the first Arnold Gesell
Associate Professor of Child Develop¬
ment at the School of Medicine. A
medical school faculty member since
1985, Dr. Mayes is a developmental
pediatrician whose work is in the
tradition of Dr. Arnold Gesell, a pioneer
in the field of child development.
Dr. Mayes’ work parallels that of Dr.
Gesell in her focus on the development
of normal infants and children. Most
recently, she has applied various
procedures and conceptual models that
she has developed to study the effects

of prenatal cocaine exposure on infants’
and young children’s development.
This fall. Dr. Mayes began a five-year
longitudinal study of children first seen
at birth who have been exposed
prenatally to cocaine. She and her
colleagues are examining the effects of
cocaine exposure on young children’s
attention and curiosity.
A native of Winchester, Tenn., Dr.
Mayes received a B.A. degree in 1973
from the University of the South and an
M.D. degree in 1977 from Vanderbilt
University School of Medicine. She
completed residency training in pediatrics
and a fellowship in neonatology at
Vanderbilt. In 1982, she came to Yale
as a Robert Wood Johnson General
Academic Pediatrics Fellow. She was
also a fellow to the National Center for
Clinical Infant Programs from Yale.
Among her professional honors, she
received the Amos Christie Award in
pediatrics from Vanderbilt University,
a research and teaching award from the
Ambulatory Pediatrics Association in
1985, the advanced pediatric research
award from the John,son & Johnson
Foundation in 1984 and 1985, and from
1986 to 1991 holds a William T. Grant
Faculty Scholars Award. In 1989,
Dr. Mayes was named the Elizabeth
Mears and Hou.se Jameson Assistant
Professor of Child Development at the
Yale Child Study Center.

Dr. Reich Receives
Diabetes Awards
Dr. Eva-Pia Reich, associate research
scientist in immunobiology, has
received the Juvenile Diabetes
Foundation International (JDF) Career
Development Award and the Greenwall
Foundation Award for her research on
insulin-dependent diabetes mellitus
(IDDM), also called juvenile diabetes
type 1.
The three-year JDF award, which
carries a $45,000 prize, will support Dr.
Reich’s project entitled “Role of T
Lymphocytes in the Pathognesis of
Diabetes.” Dr. Reich’s research focuses
on why certain white cells, T lympho¬
cytes, from patients with IDDM
selectively attack and destroy insulinproducing beta cells of the pancreas.
Her research, conducted in collabor¬
ation with Dr. Robert S. Slierwin,
professor of medicine, uses the nonobese diabetic mouse model which
spontaneously develops type I diabetes.
Dr. Reich says the researchers isolate
lymphocytes from pancreatic tissue
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ALUMNI REPORT
Seven years have passed since publica¬
tion of the School of Medicine Alumni
Directory. An update of this volume
has been a high priority for me since
my appointment as director of alumni
affairs. In spring of 1992, another, more
impressive edition of the directory will
debut. It will include more than I 1,000
medical school, public health and
physician associate alumni/ae, as well
as former house staff and post-doctoral
fellows. Also featured will be school
codes, specialty codes and specialty
sections to enhance the volume’s utility
as a professional reference.
The Bernard C. Harris Publishing
Company. Inc. will produce our directory.
Harris Publishing soon will begin
compiling data gathered from you, our
graduates, via a mailed questionnaire.
Your cooperation in providing this
infonnation will help us publish an
accurate, comprehensive directory.
Harris Publishing guarantees the
confidentiality of this database and
takes steps to safeguard against any
inappropriate use of it or the directory.
Nevertheless, if you prefer not to be
listed, and hence, not to he contacted by
Harris Publishing, please communicate
with the medical school alumni office
in writing as soon as possible at: Office
of Alumni Affairs. Yale School of
Medicine, .TTl Cedar St., P.O. Box 3333.
New Haven. CT 065 l()-S(),3.3.
We are eagerly anticipating the
alumni office's relocation to new
quarters in the former Lee High School
— now known as 100 Church Street
South — in late spring or early
summer. •'I'his space has been designed
for efficiency and comfort by Herbert
S. Newman Associates of New Haven.
We invite alumni/ae to visit us and to
see our new office. The new facilities
emphasize the importance of our
relationship with you by providing an
easily accessible and comfortable place
for us to interact.
.A continued concern for medical
school students as future alumni
occupies the attention of this office.
Nick Spinelli has volunteered to help
organize class secretaries and agents
bi’lAn' they leave the medical school for
'(.-.tgraduate training.
V.cannot rely alone on the fine
. ■. iiing of i.iiir superb faculty to
- i: - I'der student loyalty to their alma

mater. Students must know that we, the
medical .school faculty, staff and
alumni, care about them as individuals
and colleagues. This more than
anything reinforces students’ desire to
consider themselves as part of the
medical .school family after they graduate.
In this spirit, the alumni office has
agreed to student council requests for
assistance with various projects. To
mention a few, our office supported the
efforts of the annual dance,
affectionately known as the Cadaver
Ball, held in January at the Grassy Hill
Country Club in Orange. In February,
the alumni office hosted a studentfaculty tea in the Beaumont Room. We
also helped to advertise and promote
the second-year student show, which
was presented in March.
Alumni, who share an open
invitation to such events, have
responded, but the students welcome
even greater participation. This
invitation is no formality; students are
eager to talk with the alumni about their
own medical .school experiences, and to
learn from their predecessors about
their life lessons. You will be favorably
impressed with these bright, dedicated
young people, who surely will evoke
memories of your own student days.
Another chance to remini.sce and
catch up with old friends presents itself
at our annual Alumni Reunion
Weekend, to be held on June 7 and 8.
Dedication of the new Boyer Center for
Molecular Medicine will take place on
Thursday, June 6, so that returning
alumni/ae may share in the festivities.
Our related theme for the weekend:
"Clinical Medicine in an Age of
Molecular Medicine."
We encourage all alumni/ae to
attend; quinquennial reunions
(celebrated every five-years) will be
held for classes ending in the years “I"
and "6.” Medical class reunion
seminars will be followed by our
keynote speaker, Nobel laureate George
E. Palade, M.D., Sterling Professor
Emeritus of Biology at Yale and dean
of scientific affairs. University of
California, San Diego, School of
Medicine. He will discuss “The
Medical School Curriculum and the
Rapid Expansion of Biomedical
Sciences." At surgical grand rounds on
June 8, moderator William F. Collins

Jr., M.D., chairman of surgery, will
discuss recent advances in this field.
Faculty seminars include: 1) "Recent
Advances in Disorders of
Pigmentation,” moderated by Jean
Bolognia, M.D. ’80; 2) “Lyme Disease:
State of the Art,” moderated by Daniel
W. Rahn, M.D. ’76; 3) “The Pain
Experience,” moderated by Luke M.
Kitahata, M.D., Ph.D.
Dr. Vincent T. Marchesi will
moderate a panel discussion entitled
“Yale Center for Molecular Medicine
— Program for the Future.” Center
faculty members will discuss upcoming
molecular research programs in
genetics, cardiobiology, neurobiology,
and oncology and development.
The medical reunion dialogue and
tea/sherry will conclude the scientific
program. Arthur Ebbert Jr., M.D.,
professor emeritus of medicine, will
moderate a discussion between Alvan
R. Feinstein, M.D., professor of
medicine and epidemiology, and Joseph
Warshaw, M.D., professor and
chairman of pediatrics, entitled
“Fundamental Scientific Challenges in
Clinical Care.” We encourage you to
attend these thought-provoking sessions.
Finally, I would invite alumni who
have not contributed this year to the
School of Medicine Alumni Fund to do
so now. The Kresge Foundation
Challenge will provide a $1 million
donation to help complete the Center
for Molecular Medicine if Alumni Fund
participation rises from last year’s 43
percent to 55 percent in 1990-1991.
Alumni Fund giving also must reach
$450,000 before the fiscal year ends
June 30. As usual, your Alumni Fund
dollars will support medical student
financial aid unless you stipulate
otherwise.
If you did not support our Alumni
Fund last year, please help us increase
the percentage of participation with
your gift. If you did contribute last year,
it is vital for you to do so again this
year to help maintain the base of
participation on which we are building.
Remember, every contribution counts.
Arthur C. Crovatto. M.D. '54
Director of alumni aff airs
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Highlights: Alumni Weekend
June 6-8y 1991
Thursday, June 6
1:30 p.m.

Boyer Center for Molecular Medicine Dedication
“Constructing a National Agenda for Biomedical Research”

Friday, June 7
8:00 a.m.

Registration, Sterling Hall of Medicine rotunda

9:00 a.m.

Perspectives in Molecular Medicine

1:00 p.m.

Class reunion seminars (concurrent)
I. Class of 1941 — 50th reunion
II. Class of 1946 — 45th reunion
III. Class of 1951 — 40th reunion

4:00 p.m.

Special address: “The Medical School Curriculum and the Rapid
Expansion of Biomedical Sciences,” George E. Palade, M.D., dean,
scientific affairs. University of California, San Diego, School of Medicine

5:00 p.m.

Dean’s reception

Saturday, June 8
9:00 a.m.

Surgical grand rounds

9:15 a.m.

Concurrent faculty seminars: dennatology, rheumatology,
immunobiology, neuroanatomy, pharmacology, anesthesiology

10:30 a.m.

Yale School of Medicine Reunion Symposium:
“Center for Molecular Medicine — Program for the Future”

11:45 a.m.

Annual meeting of the Association of Yale Alumni in Medicine,
Distinguished Service Award presentation

1:00 p.m.

Sherry and buffet luncheon

2:45 p.m.

Guided tours: Yale Center for British Art, historic sections of New Haven,
Center for Molecular Medicine

3:15 p.m.

Yale medical reunion dialogue and tea/sherry:
“Fundamental Scientific Challenges in Clinical Care”
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Dr. Joseph S. Pagano, '57, was
elected president of the International
Association for Research on EpsteinBarr Virus and Associated Diseases.
Inc. He is the Lineberger Professor of
Cancer Research, professor of medicine
and microbiology and immunology, and
director of the Lineberger Comprehensive
Cancer Center of the University of
North Carolina at Chapel Hill.

ALUMNI NEWS
Dr. Paul D. Mad .ean,'40,senior
research scientist at the National
Institute of Mental Health, presented
the John F. Fulton Lecture on "Planning
and Remembering the Future: Frontal
Lobe Functions and John Fulton’s
Continuing Contribution" at the 296th
meeting of the Beaumont Medical Club
held in November at the medical
school.
Dr. Robert Schwartz, 47,
professor of pediatrics at Brow n
University Program in Medicine and a
member of the division of pediatric
endocrinology and metabolism at
Rhode Island Hospital, was awarded
the American Academy of Pediatrics
1990 Nutrition Award for Research.
The academy noted Dr. Schwartz's
research into the metabolism of
carbohydrates in newborns and the
mechanisms that control blood sugar
levels in infants of diabetic mothers.
Dr. Robert N. Hamburger, "51.
was named professor emeritus at the
University of California, San Diego.
School of Medicine, in July, after more
than 30 years as professor and head of
the pediatric immunology and allergy
division.
Dr. Robert (L Petersdorf, '52.
president of the Association of
.American Medical Colleges, was one of
four of this year's recipients of the
National Medical Association Scroll of
Merit. The award, which recognizes
outstanding contributions to medicine,
w as given to Dr. Petersdorf for his
efforts in support of minority medical
education and the improved health
status of minority Americans.

Dr. Joseph D. Ferrone, '62. clinical
professor of orthopedic surgery at Tufts
University School of Medicine and
senior orthopedic surgeon at Tufts-New
England Medical Center, was appointed
to the Dean Junior College board of
trustees.

Robert Zeppa. M.D. '52

Dr. Harry C. Miller Jr., '54,
professor and chairman of urology at
the George Washington University
Medical Center, was elected president
of the mid-Atlantic section of the
American Urological Association. He
also is secretary and treasurer of the
American Association of Clinical
Urologists.
Dr. Paul Calabresi, '55. professor
and chainnan of the department of
medicine at Brown University, was
elected a member of the Institute of
Medicine of the National Academy of
Sciences. Dr. Calabresi also is
physician-in-chief at Roger Williams
General Hospital and director of the
Roger Williams Center for Cancer and
Related Diseases.

Dr. Robert Zeppa, '52, was
awarded the American College of
Surgeons (ACS) Distinguished Service
Award in recognition of his clinical and
surgical research on liver and portal
circulation diseases. The award also
cited his dedication to the University of
Miami School of Medicine, where Dr.
Zeppa has been a faculty member since
1966. Dr. Zeppa. the Lucille and Dewitt
Daughtry Professor and chainnan of
surLory, is a fomier chairman of the
ACS Ciraduale Medical FTlucation
C ommitlee and a member of the ACS
( ommiiiee on I'rauma.

Helen L. Smits. M.D. '67
Dr. Helen L. Smits, '67. director of
the John Dempsey Hospital at the
University of Connecticut Health Center
and professor of community medicine
at the UCONN School of Medicine, was
elected chairman of the board of
commissioners of the Joint Commission
on Accreditation of Health Care Organi¬
zations. Her one-year term began Jan. 1.

S

Raul Calabresi. .M.D. '55

Dr. Anthony V. Proto, '71. professor
and chairman of radiology at the Medical
College of Virginia. Virginia Commonw'ealth University in Richmond, delivered
the annual oration in diagnostic radiology
on chest at the 76th Scientific As.sembly
and Annual Meeting of the Radiological
Society of North America (RSNA). His
lecture focused on understanding newer
observations seen on conventional chest
radiographs to strengthen accuracy of
diagnoses. Dr. Proto chairs the RSNA
.scientific exhibits committee and is an
associate editor for Radiology.
Yale Medicine
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Dr. Robert H. Posteraro, ’73,
professor and chairman of radiology at
Texas Tech School of Medicine, was
appointed commander of the 829th
Station Hospital U.S. Army Reserve
Unit in Lubbock.
Francis S. Collins, ’74 Ph.D., a
Howard Hughes Medical Institute
associate investigator at the University
of Michigan Medical Center, received a
Gairdner Foundation International
Award for his contributions to the
identification and analysis of the cystic
fibrosis gene. The molecular techniques
developed by Dr. Collins and his
colleagues also will facilitate the study
of other genetic diseases.
Dr. Thomas W. Smith, ’75,
recently gave his 75th lecture to
residents and practicing
ophthalmologists at the Eye and Ear
Institute of the University of Pittsburgh.
Dr. Smith, clinical associate professor
of ophthalmology at the Pittsburgh
School of Medicine, has lectured for
more than 10 years and also is a
member of Keystone Eye Surgeons in
Dubois, Penn.
Dr. Christopher PL Attinger, ’81,
was appointed assistant professor of
surgery, division of plastic surgery at
Georgetown University Medical Center
in July. He specializes in extremity
reconstruction.
Dr. David H.W. Wohns, ’81,
currently in practice at Butterworth
Hospital in Grand Rapids, Mich., was
elected a fellow in the American
College of Cardiology.
Margarita Acosta, ’82 M.P.H., is
assistant administrator at Saint Peter’s
Hospital in Olympia, Wash.
Marie Ciacco-Tsivitis, ’86 M.P.H.,
is the infection control coordinator at
Memorial-Sloan Kettering Cancer
Center in New York.
Stacey Wills, ’90 M.P.H., of
Washington, D.C., works at the
Employee Benefit Research Institute, a
private non-profit organization that
provides research and education to
business, government and the public.
She concentrates on state initiatives to
cover the uninsured and on health care
finance policy issues.
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STUDENT NEWS
Irene M. Hegeman, a fourth-year
medical student, was awarded a $2,500
Rock Sleyster Memorial Scholarship by
the American Medical Association to
encourage her interest in psychiatry.
Bill Rodriguez, a second-year
student, competed on the New York
Ultimate team in the National Ultimate
Erisbee Championship held in November
in West Palm Beach, Fla. Mr. Rodriguez’s
team is the defending U.S. national and
world ultimate frisbee champion, having
defeated teams from 13 other countries
in a July tournament in Norway.
Ultimate frisbee is akin to soccer, with
seven-member teams competing on a
70-by-40-yard field. Players pass the
flying disc among themselves and score
by whirling it into the goal, located in
the opposing team’s end zone.

Medical Students Offer
Youngsters Health Talks
Seventh-graders at Roberto Clemente
Middle School in New Haven stared
wide-eyed at the lung specimens
displayed by second-year medical
students Joe Esherick and Linda Keyes,
who explained that smoking was
responsible for the black spots evident
on one lung. Meanwhile, across town at
the Career Education Center, secondyear students Valerie Vanhoutte, Julie
Miner and Emily Davidson stood in front
of a classroom of high school students
and talked with them about AIDS.
The students are volunteering in two
programs sponsored by the American
Medical Students Association (AMSA),
based in Reston, Va. The first program.
Adolescent Substance Abuse Prevention
(ASAP) is one of 10 two-year pilot
projects sponsored by AMSA. Students
Teaching AIDS to Students (STATS),
the second program, is part of a

national high .school AIDS education
program initiated in 1988.
Approximately 35 medical students
have joined the ASAP effort, meeting
weekly with Clemente .seventh-graders
during science class. The program
includes sections on the physical
changes brought on by drugs, alcohol
and tobacco; ASAP also presents ways
to resist peer pressure to try drugs.
During the STATS program’s first
two years, Yale students have spoken
about AIDS to more than 2,()()() teen¬
agers from New Haven high schools
and middle schools. About 60 students
from the School of Medicine, the
department of epidemiology and public
health and the School of Nursing have
volunteered.

Minority Conference
Targets Health Care
Leading health professionals and
political leaders presented their views
on “Bridging the Gap in Health Care:
Availability vs. Access’’ when the New
England region of the Student National
Medical Association (SNMA) held its
annual conference Eeb. 15 and 16 at the
School of Medicine. More than 70
students from the nine medical schools
in the region and 150 undergraduate
premedical students attended.
“Our program focused on problems
encountered in health care for minorities,
and we explored ways to increase
awareness of and access to health care,”
reports Ellis L. Webster, a fourth-year
medical student who chairs the SNMA’s
Yale chapter, founded in the early 1970s.
On Saturday, the 16th, the School of
Medicine and the Yale chapter of the
SNMA hosted the annual recruitment
day conference for undergraduate
minority students interested in
attending the School of Medicine. Dr.
Woodrow A. Myers Jr., New York
City’s health commissioner, gave the
keynote address, highlighting disease
trends in the ’90s and outlining the
concerted effort needed to control these
problems. Other speakers included New
Haven Mayor John C. Daniels; Cornell
Scott, M.P.H. ’68, executive director of
the Hill Health Center; and Marie
Spizey, chief of the Connecticut Bureau
of Community Health.
Based in Washington, D.C., the
Student National Medical Association
is the nation’s oldest and largest
organization for black. Latino and
native American medical students.
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Laura Kuckes

Agnes V. Bartlett
OBITUARIES
Agnes V. Bartlett, M.D., died Aug. 7 at
Hanover Terrace Healthcare in Vermont.
She was 79.
A native of Kyoto, Japan. Dr. Bartlett
graduated from Mount Holyoke
College and in 1938 from Yale School
of .Medicine. Following residency
training in obstetrics and general
practice, she served as a medical officer
in relocation centers in .Arizona and
California during World War 11.
After the war. she moved to
Thetford Hill. Maine, and began a
general practice with Dr. William
Putnam. She later undertook specialty
training in Hanover and was in private
practice in Springfield, Vt., and
Concord, N.H. From 1964 until her
retirement in 1976, Dr. Bartlett
practiced at the Veterans .Administration
Hospital in White River Junction.
She was a director of the FJrookhaven
Home for Boys in Chelsea and a
volunteer parole officer.
Memorial contributions may be
made to the Norwich Public Library ,
Norwich. VT {)5{).35.

Daniel S. Egbert
Daniel S. Egbert. M.D., died April 28
at his home in Fort Dodge. Iowa. He
w as 84.
.A native of Nebraska, Dr. Egbert
graduated from the University of
Nebraska .Medical School in 1931 and
interned at San Diego General Hospital.
He served on the house staff from 1932
to 193-3 in pathology at Yale and later
set up practice in Atlanta. From 1940
through 1945, Dr. Egbert served as a
medical officer in the U.S. Army and as
a commanding officer of a portable
surgical hospital unit in the Chica BumiaIndia area. In. 1945. he established a
practice in Fort Dodge, where he stayed
until his retirement in 1983.
Dr. Egbert was a charter member of
the .American Society of General
Practitioners, a charter diplomate of the
American Board of Family Practice,
and served a term as president of the
Webster County Medical Society.
He leaves his wife, Helen; a daughter.
Nancy; two sons. James and Thomas;
and si.x grandchildren.
Memorials may be made to the Dr.
Daniel S. ligbert Memorial Cancer
Library established at Trinity Regional
Hospital, fhe library serves families
and friends of cancer patients.
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Charles T. Elynn Jr.
Charles T. Flynn Jr., M.D., died Sept. 11
in Fairview General Hospital. Cleveland.
He was 72.
Dr. Flynn was fonner chaimian of
the medical board and chief of staff at
Meriden-Wallingford Hospital in
Connecticut. He also was an orthopedic
surgeon in Meriden for 33 years. He
retired in 1984 but remained as director
of the hospital.
A native of Connecticut. Dr. Flynn
was a graduate of Providence College
and a 1943 graduate of Yale School of
Medicine. During World War 11. he
served in Europe as a major in the
Army Medical Corps.
He leaves his w ife. Martha; two
sons. Stephen and Thomas; seven
daughters, Barbara. Debora, Ann. Joan.
Donna. Martha and Christine; and eight
grandchildren.

Erancis J. Kenney
Erancis J. Kenney. M.D., died Aug. 13
in Cincinnati, at the age of 62.
A Connecticut native. Dr. Kenney
was a 1951 graduate of Harvard
University and a 1955 graduate of Yale
School of Medicine. He trained in
general and thoracic surgery at Harvard
and the University of Michigan and was
a diplomate of the American Board of
Surgery and the American Board of
Thoracic Surgery . Eollow ing a career in
clinical practice. Dr. Kenney worked in
the pharmaceutical industry until his
retirement in 1989.
He leaves his w ife, Jane; two
daughters. Jane and Elizabeth; and two
.sons, Francis Jr. and Edward.
Donations may be made in Dr.
Kenney's name to the Harvey
Cushing/John Hay Whitney Medical
Idbrary, P.O. Box 3333. New Haven.
CT 065 10. or to the Choir Eund at Old
St. Mary's Church. Over-the-Rhine,
123 E. 13th St., Cincinnati. OH 45210.

Laura Kuckes, M.D., died Aug. 5 in a
boating accident in Admiralty Bay,
Alaska. She was 29.
A native of New Jersey. Dr. Kuckes
was a 1982 graduate of Cornell
University and a 1988 graduate of Yale
School of Medicine. She spent one year
before entering Yale working in
Washington, D.C., for the Union of
Concerned Scientists. Dr. Kuckes
interned at the Mary Imogene Bassett
Hospital in Cooperstown, N.Y.. and
later practiced for the North Slope
Borough in Barrow. Alaska. Under a
grant from the Yale International
Student Fellowship Program, Dr.
Kuckes studied blood-brain barriers
using electron microscopy at the
Institute of Cell Biology in Romania.
At Yale. Dr. Kuckes extended her
schooling one year to pursue her thesis
work and to become associated with the
play writing program at the Yale School
of Drama. There she co-authored two
plays and wrote a musical, which were
produced at the Yale Cabaret. She also
received the medical school's
Marguerite Rush Lemer Creative
Writing Prize.
Dr. Kuckes organized the medical
school lecture series on nuclear war and
was a delegate to the International
Physicians for the Prevention of
Nuclear War congresses for three years,
during which she produced a multimedia show entitled “Snap-shots with
the Red Army."
Dr. Robert H. Gifford, associate
dean for education and student affairs,
who spoke at her memorial service,
said, “During her years as a medical
student, Laura hoped to combine her
dramatic writing skills with her medical
thesis work. . . She realized the close
relationships that could be forged
between medicine and psychiatry
through playwriting, and became
acutely aw are of how much art and
medicine infomi each other. Laura had
a natural ability to transfer enthusiasm
to those around her. . . She lived with a
zest and passion that captured our
hearts and has left us full of fire and
excitement for adventure and full of
hope for a better world."
Dr. Kuckes leaves her parents.
.Arthur and Haralyn Kuckes; a sister.
Niki; and a brother, Dylan.
Memorial contributions in Dr.
Kuckes' name may be made to
Physicians for Social Responsibility,
lOOO 16th St., NW. Suite 810.
Washington. D.C. 2(X)36.
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Bernard F. Mann Jr.
Bernard F. Mann Jr., M.D., died Nov. 4
in Fairplay, Colo. He was 76.
A native of Maine, Dr. Mann
graduated from Bates College in 1936
and from Boston University School of
Medicine in 1940. He served in the
U.S. Navy for six years in the Pacific
on the destroyer U.S.S. Case and at
naval stations in Williamsburg, Va.,
and Bremerton, Wash.
Dr. Mann was a Fulbright Professor
of Pathology in the Medical School of
the University of the Philippines in
Manila. He served as assistant clinical
professor of pathology at Yale School
of Medicine from 1904 through 1971
and also was associate pathologist at
the Hospital of St. Raphael in New
Haven. Following work in surgical
pathology and cytopathology at the
New England Deaconess Hospital,
Boston, and teaching at Harvard
University Medical School, Dr. Mann
spent five years as chief of pathology
services for the Arabian American Oil
Co. in Dhahran, Saudi Arabia.
He leaves his wife, Martha; two
daughters, Nancy and Constance; and
one son, Donald.
Contributions may be sent to the
Camden Area Y.M.C.A., Camden, ME
04843.

James W. Reed
James W. Reed, M.D., died July 10 at
the Franklin Memorial Hospital in
Farmington, Maine. He was 85.
A native of Maine, Dr. Reed
graduated from the University of Maine
and received an M.D. degree from Yale
in 1931. He interned at New Haven
Hospital and served residencies at the
Boston Dispensary and the Franklin
County Memorial Hospital.
In 1934, he established a radiology
practice in Farmington and later
affiliated with Rumford Community
Hospital. From 1942 to 1945, he served
as a radiologist for the Maine General
67th Hospital Unit in England.
Dr. Reed coached the Farmington
State Teachers College track and cross¬
country teams and the junior boys ski
team of Farmington Ski Club for
several years. He also served on the
Farmington school board and the board
of the Girl Scout Camp Kirkwold.
He leaves his wife; a daughter,
Carol; a son, James; and two grand¬
children. Memorial gifts may be made
to the Franklin Memorial Hospital, 1
Hospital Drive, Farmington, ME 04938.
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Knute Berger
Knute Berger, M.D., died Dec. 24 at
age 75.
A Seattle native. Dr. Berger
received a B.S. degree in chemistry
from the University of Washington in
1937 and an M.D. degree from Yale
in 1941.
Dr. Berger began his career as a
surgeon but later chose to meld his
passion for art with his devotion for
medicine. For many years he worked
as a medical illustrator, photographer,
sculptor and exhibit designer. He also
developed teaching models for use in
medical school classes. Dr. Berger
was the creator of the syndicated
cartoon series, “Mr. Quiddity,” for the
New York and Illinois state medical
associations and was co-author of the
children’s book, A Visit to the Doctor.
He was a captain in the U.S. Army
Air Force during World War 11, later
working at Virginia Mason Hospital
and at hospitals in South Carolina and
Peru. He served as medical director at
John Slade Ely Center for Health
Education Research in New Haven.
In 1961, he joined the research
team of Dr. Lester Sauvage at the
Hope Heart Institute at Providence
Medical Center in Seattle, where he
served for more than 20 years as head
research pathologist. He is credited

Paul H. Lavietes
Paul H. Lavietes, M.D., died Dec. 27 in
his home in New Haven. He was 83.
Dr. Lavietes, a native of New
Haven, received his bachelor’s and
medical degrees from Yale in 1927 and
1930. He completed his internship at
Sinai Hospital, Baltimore, and his
residency at New Haven Hospital. He
also was a Saxe research fellow in
metabolism at Yale from 1932 to 1933.
Dr. Lavietes served as a captain in
the U.S. Army at the Center for
Tropical Disease, Treatment and
Research in Swannanoa, N.C., for three
years. From 1933 through 1981, he was
an attending physician at Yale-New
Haven Hospital. Beginning his career at
the School of Medicine in 1933 as an
instructor. Dr. Lavietes became an
assistant professor, clinical assistant
professor and later clinical associate
professor until 1984. He also served as
a clinical associate professor of public
health from 1968 through 1981.
Dr. Lavietes was in private practice
of internal medicine in New Haven for

“Blue Embassy " ho.x art by Knute
Berger. M.D. '41.
for such advances as improved blood¬
vessel grafts and attachment
mechanisms for artificial heart valves.
He retired in 1982 and, with his
wife, Margaret Haseltine Berger,
formed Island Cupboard, a company
that marketed gift cards featuring his
photography and Mrs. Berger’s
poetry.
He is survived by his wife, two
daughters, Barbara and Kari; a son,
Knute; and two grandchildren.

25 years until he became the founding
medical director of the Community
Health Care Plan in 1971, a position he
held until his retirement in 1981.
He was a consulting physician at
Fairfield Hills Hospital, the Veterans
Administration Medical Center in West
Haven, Meriden-Wallingford Hospital
and Laurel Heights Hospital.
Dr. Lavietes was a member of the
Society for Clinical Investigation and a
founding editor of the Medical Letter of
Drugs and Therapeutics: he served on
the publication’s advisory board from
1959 through 1964. He also was a
board member of Gaylord Hospital in
Wallingford and on the medical advisory
committee of the Jewish Home for the
Aged from 1968 through 1986.
He leaves his wife, Ruth Sweedler
Lavietes; a son, Marc; a daughter,
Sylvia; and three grandchildren.
Memorial contributions may be
made to the Jewish Home for the Aged,
169 Davenport Ave., New Haven; or
the Yale School of Medicine, Develop¬
ment Office, P.O. Box 3333, New
Haven, CT 06519.
41

OBITUARIES

Author of more than 200 journal
articles and co-author of a hiatus hernia
textbools. Dr. Lam was a member of the
American Association for Thoracic
Surgery, the American Surgical
Association and the Central Surgical
Association.
He is survived by his wife, Marian;
two daughters, Marjorie and Janet; two
sons, Richard and Douglas; and nine
grandchildren.
Contributions may be made to the
Cowboy Band Foundation at HardinSimmons University in Abilene, TX
79604, or to the Franlslin Community
Church, 32473 Normanndy, Franklin,
Ml 48023.

Conrad Lam, M.D. '32

Conrad Lam
Conrad Lam. M.D., died May 14 in
F'arniington Hills, Mich. He was K4.
A native of Michigan, Dr. Lam was
a 1927 graduate of Hardin-Simmons
University, Te.xas, a 1932 graduate of
>'ale School of Medicine and a 1938
graduate of the University of Michigan,
w here he received an M.S. degree in
surgery.
Dr. Lam served as a thoracic and
cardiac surgeon for 30 years at the
Henry F-'ord FFospital until his retire¬
ment in 1983. In 1930. in collaboration
with Dr. FF.FF. Aram, F4r. Lam conducted
one of the first heart-valve transplant
surgeries. In 1936, he performed
.Michigan's first open-heart operation
using total heart-lung bypass. He also
developed methods to close holes in the
heart and to stop the heart during
intracardiac operations. In 1980, he was
recognized by Shiley Laboratories as
one of the "'F'en F^ioneers of Cardiac
Surgery."
In 1987, Dr. F,am received a
Distinguished Service Award from
Yale School of Medicine. He also was
honored by Hardin-Simmons LJniversity
with the Keeter Alumni Award, the
L'niversity's most prestigious alumni
award; a Distinguished Alumnus
■Avsard and with an honorary doctorate,
file Henry l ord Hospital has
I'stablishetl a cardiac and thoracic
ur-ers lecture series in his honor.
4.’

IN MEMORIAM
Crutcher McClure
Ben Klotz
April 25, 1990

'26 M.D.

Amy H. Hunter-Wilson
.Inly 7, 1990

'30 M.D.

Henry Brill
.Inne 17, 1990

'32 M.D.

Conrad R. Lam
May 14, 1990

'32 M.D.

Lester Q. Stewart
March 10, 1990

'33 M.D.

W. Howard Horner
September 9,1990

'33 M.D.

Emir A. Gaw
July 23,1990

'36 M.D.

Willis Thayer
March 28, 1990

'36 M.D.

Agnes V. Bartlett
August 7,1990

'38 M.D.

Dorothea H. Scoville

Grill work, historical library promenade,
Harvey Cushinf’Uohn Hay Whitney
Medical Lihrarv.

Walter L. Kulp
Walter L. Kulp, Ph.D., died July 18 in
Storrs, Conn. He was 99.
Dr. Kulp retired as chairman of the
bacteriology department at the
University of Connecticut in 1933. He
also served as director of the Windham
Hospital Laboratory, and before his
appointment at UConn, taught at Yale
School of Medicine.
A Pennsylvania native. Dr. Kulp was
a 1911 graduate of Allegheny College
and a 1923 Ph.D. graduate of Yale
University.
He leaves his wife, Lula Casler
Kulp; a daughter, Carol Beagley; three
grandchildren and five great¬
grandchildren.

'21 HS

'38 M.P.H.

Nathaniel Kenigsberg
November 22, 1989

'39 M.D.

John F. Marchand

'40 M.D.

Frederick A. Waldron
August 17,1990

'41 M.D.

David G. Decker
July 17,1990

'42 M.D.

C. Thomas Flynn Jr.
September 20, 1990

'43 M.D.

Rex P. Dannebaum
February 21,1990

'49 M.D.

'33 M.P.H

Guy W. Steuart
June 20,1990

'36 M.D.

John B. Fine
Lawrence J. Biris

'79 M.D.,
'80 M.P.H.

Gary F. Velat
August 1, 1990

'80 M.P.H.
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DEVELOPMENT REPORT
Gift of Noted Aiumnus
To Name Yale’s CMM
University President Benno C. Schmidt
Jr. has announced the largest individual
gift ever received by the School of
Medicine. A $10 million contribution
from Dr. and Mrs. Herbert W. Boyer of
Mill Valley, Calif., will provide
construction funding for the Center for
Molecular Medicine (CMM). The
center, which will be dedicated on June
6, will bear the Boyer family name.
President Schmidt said, “The
Boyers' generous gift for the center is
especially meaningful because this
marvelous new research facility is built
around an educational core; medical
students, post-doctoral fellows, graduate
students, and medical residents will
benefit from its teaching programs. It is
fitting that the Boyer name will always
be associated with this building, for it
will inspire young people to strive for
scientific excellence and for innovation
and discoveries that can benefit
mankind.”
From 1963 to 1966, Dr. Boyer
undertook a post-doctoral fellowship in
the laboratory of Edward A. Adelberg,
Ph.D., professor of genetics, today, a
deputy provost of the University. Dr.
Boyer then joined the faculty of the
University of California, San Francisco,
where he is currently professor of
biochemistry. A native of Derry,
Pennsylvania, and a graduate of Saint
Vincent’s College and the University of
Pittsburgh, Dr. Boyer ushered in a new
era of genetic science when he and Dr.
Stanley Cohen of Stanford University
invented the first recombinant DNA
technology.
After being awarded the National
Medal of Technology in 1989, Dr. Boyer
was invited to the White House in
November 1990 to receive the National
Medal of Science, thus making him one
of only three persons to receive both of
the nation’s highest research awards.
As co-founder of Genentech, Inc., in
1976, Dr. Boyer helped launch the
biotechnology industry. In less than !5
years, Genentech has grown into a
company with annual revenues of more
than $400 million from the development
of such bioengineered pharmaceuticals
Yale Medicine Spring 1991

as Protorpin, a human growth hormone,
and Activase, an anticoagulant for the
treatment of heart attack.
Over the years, the Boyers have
remained active in Yale affairs; their
son, Ethan, graduated from Yale College
in 1990. Dr. Boyer serves as chaimian
of the Dean’s Council of the School of
Medicine. The council, a volunteer
group comprising leaders from business,
science, medicine and private organiza¬
tions interested in the field of medical
science, advises Dean Leon E.
Rosenberg on matters related to the
school’s planning and development. In
commenting on this gift. Dean
Rosenberg said, “Erom the earliest days
of my deanship. Dr. Boyer has been a
source of wise counsel and
encouragement. I rejoice in this gift
from two splendid friends of Yale.”

Kresge Foundation
Challenge Update
The School of Medicine moved a
major step closer to earning the Kresge
Eoundation’s $1 million challenge grant
when Dr. and Mrs. Herbert W. Boyer
announced their magnificent gift (see
accompanying article). Dr. and Mrs.
Boyer’s gift enabled the school to
double the amount required by the first
of the challenge’s three terms: to raise
$5 million toward the construction of
the Center for Molecular Medicine.
School of Medicine Alumni Eund totals
also show impressive progress on the
second and third terms of the challenge,
which include;
• raising $450,0(X) in current-use support;
• reaching 55 percent participation.
These terms must be met before June
30, the end of the fiscal year. Because
55 percent participation requires more
alumni to support the school than in any
other year, the development office and
Kresge Challenge Chairman John B.
(Jack) Ogilvie, ’34 M.D., have
organized a series of phonathons in
which alumni and students have
contacted as many alumni as possible.
Alumni who wish to contribute
specifically to support the Center for
Molecular Medicine can join other
major donors by making a gift to name

one of the center’s rooms. In addition,
those who contribute $5,000 or more to
the alumni fund before June 30 will be
included on the dedication plaque
which will be prominently displayed in
the center. If you are interested in
naming a room in the CMM, please
contact Jay Angeletti, Office of
Development, Yale School of
Medicine, P.O. Box 3333, New Haven,
CT 06510-8055, (203) 785-5576.

Alumna Bequest Benefits
CMM and Public Health
Amy Hunter-Wilson, ’30 M.D., ’34
Dr.P.H., has made a major bequest to
support the School of Medicine’s
Center for Molecular Medicine and the
Department of epidemiology and public
health. Dr. Hunter-Wikson, who made
two significant gifts during the last two
years of her life to establish endowed
scholarships in medicine and public
health, died July 7, 1990.
Dr. Hunter-Wilson, known profes¬
sionally as Dr. Hunter, was bom in
1898 in New York City. A 1921
graduate of Vassar College, she earned
a master’s degree in nutrition from
Cornell University. Dr. Hunter then
came to New Haven where she earned
her two Yale degrees. Later, she served
her residency at the Children’s
Community Center in New Haven and
was clinical instructor in pediatrics at
the School of Medicine. In 1935 she
became the director of the Bureau of
Maternal and Child Health within the
state of Wisconsin Board of Health. She
.served in that position with great
distinction until she retired in 1961.
In recognition of Dr. Hunter-Wilson’s
bequest, the school will name for her
one of the Center for Molecular
Medicine’s state-of-the-art laboratories,
and will establish an endowed research
fund for young faculty in the
department of epidemiology and public
health. Dr. Hunter-Wilson’s husband,
Mr. Erederick Wilson, now age 103, is
the retired forestry division chief of the
state of Wisconsin agency that was
known during his tenure as the
Conservation Commission. In addition
to her husband. Dr. Hunter-Wilson is
survived by a niece and two nephews.
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CONTINUING MEDICAL
EDUCATION AT YALE

Friday
June 7, 1991
Friclay-Sunday
August 16-18, 1991

Yale Alumni in Ophthalmology

(A)

Director: Robert L. Lesser. M.D.

Thrombosis, Thromboembolism and Thrombolysis

IB)

Director: Michael D. Ezekowitz, M.D.. Ph.D.
Will provide the practicing clinician basic knowledge on the pathogenesis and treatment
of various disease processes in which the predominant pathology is thrombosis and/or
thromboembolism.

Thursday-Saturday
Sept. 26-28, 1991

Methods and Application in Molecular Medicine

(C)

Director: Stephen Reeders. M.D.
Will acquaint fellows and physician-researchers in internal medicine specialities with
new techniques in molecular biology, molecular genetics and cell biology.

Friday-Saturday
Sept. 27-28, 1991

Visiting Lecture Series in Clinical Ophthalmology

(D)

Director: David E. Silverstone. M.D.
Speaker: Melvin Riihin. M.D.
Will focus on the update of ophthalmic optics.

Friday-Saturday
Oct. 25-26, 1991

Director: Geori>e K. Aghajanian. M.D.

Thursday
Oct. 31, 1991

Director: Lawrence S. Cohen. M.D.

; II.; ' 1: 1
; ; -

Kl

Neurobiology of Affective Disorders

3rd Annual Cardiology Update

(E)

(F)

I ON THE ATTACHED POSTCARD TO OBTAIN MORE INEORMATION ON
LIE. PLEASE BE SURE TO INCLUDE YOUR NAME AND ADDRESS.
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OW being admitted to
the high calling of the
physician, I solemnly
pledge to consecrate my
life to the care of the sick, the
promotion of health, and the
service of humanity...

Commencement 1991
AIDS Research at Yale:
Shifting into High Gear
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Climbing the Himalayas: A Call to High Adventure
In an article relating how a passion for mountaineering became his
avocation, Richard Wohns, M.D. ’77, gives his answer to the call of
the wild — medical research at 21,500 feet.

^

The Physician as Citizen
Delivering the medical school commencement address, James R Comer,
M.D.,

exhorts the Class of 1991 to help build a brighter future for

America through all her children.

African-American Students: YSM’s Unfolding Legacy
Graduating physician Daryl Daniels reveals the fascinating —
though not unbroken — 137-year history of African-American medical
students at Yale.

AIDS Research at Yale: Shifting into High Gear
As the diagnosis of America’s first AIDS patients marks its
10th anniversary, the medical school has set its sights on
becoming a leader in this area of basic and clinical research.

20

1991 Lerner Award
In a series of three poems, Christopher Fey, ’93 Med., displays
why the 1991 Marguerite Rush Lerner Award was not the first
of his many honors for poetry writing.

23
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LETTERS TO THE EDITOR
Lesbian/Gay Network
To the editor:
I am writing on behalf of the Lambda
Health Alliance, a new group for les¬
bian, gay or bisexual health profession¬
als at Yale, in our attempt to form an
alumni network.
In its first semester, the group has
had much success and support, having
held numerous meetings, a rap session
and a potluck. We are looking forward
to many more activities in the coming
semesters, such as a dance, film screen¬
ings and sensitivity-raising seminars.
Graduates interested in our alumni/ae
network should write:
Lambda Health Alliance
Yale School of Medicine
c/o 1 101 Sterling Hall of Medicine
P.O. Box 3333
New Haven, CT 06510-8012.
Kyle Herhokl. '94 Med.

Living Wills
To the editor:
As a Yale College graduate (’42) and
attorney with 35 years of practice, I
would like to comment on the Spring
1991 interview with Angela R. Holder,
L.L.M., entitled “Are Living Wills Nec¬
essary?”
In the Cruzan case, the U.S. Supreme
Court held that the Constitution did not
prevent Missouri from requiring clear
and
convincing
evidence
of the
comatose patient’s wishes concerning
the withdrawal of life-sustaining treat¬
ment. In other words, it is up to the state
involved to set the standards. When the
case was returned to the Missouri court,
further evidence, though not written
documentation, was produced; the state
withdrew its case, and Nancy Cruzan
was allowed to die, although she never
had a living will.
In Hawaii, where 1 live, the 1991
state legislature passed a hill to expand
the present Hawaii living will statute to
provide that a living will could become
effective when a person was in a persis¬
tent vegetative state, even though death
was not likely to happen in a short time.
The bill also provides that artificial
Yale Medicine Summer 1991

feeding and hydration may be with¬
drawn like other medical practices.
This bill is important because it
specifically protects the doctors and
health care facilities who follow the
desires of the the patient as expres.sed in
the living will from suits by members of
the family and from criminal prosecu¬
tion. The Hawaii statute, however, does
not provide for a durable power of attor¬
ney being given to a family member or
other person to decide on medical care
when a patient is incompetent. This ren¬
ders the naming of such in a living will
or other document probably a good idea,
but of dubious legal effectiveness.
It is not clear under such a statute
that a doctor or care facility would be
protected Just because the person named
in a durable power of attorney by the
patient approved what the doctor or care
facility did. Hopefully, the statute can be
further amended, but until then, it would
appear advisable to make a living will
that will stand on its own as the expres¬
sion of the desires of the maker.
What I have said applies primarily to
Hawaii, but the principles may be appli¬
cable to other Jurisdictions.
{Mr.) Page M. Anderson
Honolulu

Ms. Holder’s reply:
I believe Mr. Anderson overreacts in his
concern about the threat of a malprac¬
tice claim from which physicians need
protection. There has never been a mal¬
practice case in the United States
involving a "Do Not Resuscitate” order,
disconnection of a respirator or ending
artificial feeding, as long as the patient’s
wishes were known or the family made
the decision. If the family agrees, there
is no one else with legal standing to sue.
(On the other hand, there have been at
least two successful suits against physi¬
cians who refu.sed to disconnect respira¬
tors.) In 1983, the California Court of
Appeals dismissed the only criminal
case ever brought against physicians for
withdrawal of life support, holding that
these decisions cannot be the basis of
prosecution.

Most Famous Alumnus?
To the editor:
If someone were to ask who is the bestknown recipient of a Yale medical
degree, the answer might come as a sur¬
prise when I mention the name of
Alfred Carlton Gilbert. ’09.
Although A.C. Gilbert never prac¬
ticed medicine, some of his accomplish¬
ments include winning an Olympic
medal, holding more than 150 U.S.
patents and, of course, inventing and
then manufacturing more than 150 mil¬
lion Erector sets, which must make his
name a household word to almost every
American male over age 40.
I wonder if Yale Medicine readers
might be interested in an article on this
remarkable 1909 graduate.
William McKean
North Haven, Conn.

Pvditor’s reply:
Thanks for this fascinating lead. Our
editors will seriously consider develop¬
ing such an article.

Corrections
Two captions require correction in the
FallAVinter 1990 edition of Yale
Medicine. On page 31, Deputy Dean
Robert M. Donaldson’s first name was
listed incorrectly. On page 37, renova¬
tion of the Morse Periodical Room at
the Harvey Cushing/John Hay Whitney
Medical Library was made possible by a
$1 million gift by Mrs. Belle Morse in
memory of her husband, Carl A. Morse,
a 1925 Sheffield Scientific School grad¬
uate, and their son, Stephen 1. Morse,
’51 M.D.,Ph.D.

Angela R. Holder, LL.M.
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CLIMBING THE HIMALAYAS:
A CALL TO HIGH ADVENTURE

Ph<»lo>iraphs cuurlcsy of Richard Wohns. M.l).

Himalayan majesty: Mount Everest and its sihs, Niiptse and Lhotse.
by Richard Wohns. M.D. ’77
My eight trips over the past 17 years to various regions in the
highest nioLiiitains of the world have transformed the
Himalayas from a distant, unfathomable, even mystical realm
into a place of comfortable familiarity. "Going high" has
become my passionate escape into the beauty, challenge and
secrets of another world.
My mountaineering career began as a hiker and scrambler
while ill Harvard College, then quickly progressed to an inter¬
est in peaks that were higher than Vermont's White Mountains.
In 197.7, Mt. Kilimanjaro in Africa introduced me to the world
of thin, cold air. Himalayan odysseys began while I was at
Yale .School of Medicine.
In 1974, 1 was fortunate to receive a Wilbur Downs fellow¬
ship to travel and study retinoblastomas in Sri Lanka, formerly
known as C'eylon. This eye tumor, relatively rare in the West¬
ern world, occurs more commonly in the Sinhale.se and Tamils
ol that now troubled land. I feel lucky to have lived in Sri
Ri( hard Wohns. M.l).. is a nenrosnryeon in private practice in
iciioma. Wash.
0

Lanka at a time when civil war did not preclude outsiders from
experiencing this wonderful country and its people.
Prior to my return to Yale from Sri Lanka, I traveled
through Kashmir. My visit to the Vale of Kashmir involved a
mountaineering excursion to the Gangabal Glacier, which pro¬
vided an exciting combination of glacier and rock climbing,
plus superb high-altitude lake trout fishing.
While on Kilimanjaro and on the Gangabal Glacier, I suf¬
fered severe headaches, insomnia, Cheyne-Stokes "tidal” res¬
pirations and nausea. It wasn't until 1 returned to Yale that I
learned 1 had experienced symptoms of acute mountain sick¬
ness (AMS). AMS. along with high-altitude physiology in
general, became pet subjects of mine, and have since devel¬
oped into serious field research interests. Initially, I was simply
interested in how to continue high-altitude sojourns without
suffering AMS symptoms. Then, as my professional interests
became focu.sed on neurosurgery, a natural inclination to study
high-altitude cerebral pathophysiology evolved.
At the School of Medicine. 1 was able to complement my
medical education with my interest in travel and mountaineer¬
ing by arranging accredited clerkships abroad. Travel time
opened up thanks to credit Yale granted me for the courses in
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neurophysiology and biochemistry I had taken at Harvard
Medical School during my undergraduate days.
I would have finished medical school in three years were it
not for my Yale advisor, Etsuro Motoyama, M.D., an associate
professor of anesthesiology, who dissuaded me from this “fast
track.” I am forever indebted to him for this sage advice. Dr.
Motoyama, today, the vice chair of anesthesiology at the Uni¬
versity of Pittsburgh medical school, not only guided me intel¬
lectually and professionally but also shared a keen interest in
the mountains.
We found common ground in other areas, as well, including
opera, flying, Japanese culture and cuisine, and skiing. Dr.
Motoyama introduced me to Marie Lauritano, the woman I
married, and is the godfather of Nicolai, my third child.
The story of my medical school climbing experiences con¬
cludes with a 1975 trip back to Kashmir, where I worked as a
medical student clerk in the outpatient clinic and emergency
room at University Hospital in Srinagar. This location allowed
me further access to the Kashmiri Himalayas. This second
Himalayan encounter continued into the Khumbu, or Everest,
region of Nepal, where I completed the classic trek to Ever¬
est’s base camp and Kala Patar, an 18,400-foot “hill” with
spectacular views of several 8,000-meter peaks, including
Everest, Lhotse and Nuptse.
Life After Yale
While in the Khumbu region, I had met a British physician
who worked at the High-Altitude Trekkers’ Aid Clinic in
Pheriche, on the route to Everest. He offered me the opportu¬
nity to work at the clinic following medical school graduation
in 1977, thus initiating my plans to return to Nepal. In antici¬
pation of this trip, my remaining days in medical school
included a self-directed training program for maximum highaltitude performance.
This exercise regimen proved to be as demanding as were
clerkships and thesis research. Warm weather workouts
involved 100-plus miles of jogging per week, bicycle com¬
mutes between the Mt. Carmel section of Hamden and New
Haven, plus weekend rides of 30 to 50 miles. Wintertime
brought cross-country skiing in Sleeping Giant State Park and
in various locations in Vermont. New Haven's East Rock Park
was my favorite place for jogging up hills. Tennis continued as
my social sport; I fondly remember my matches at the Yale
indoor courts with classmate Doug White.
Medical school and the exercise program allowed little time
to climb, except for several weekend trips to Mt. Washington
and Cannon Mountain. At the recommendation of Dr.
Motoyama, however, I did make time for a five-day ice and
snow climbing seminar on Mt. Rainier in Washington state.
This course took place at Camp Muir (10,000 feet) and
included a summit climb. In addition to ice and snow climb¬
ing, we practiced crevasse rescue, rope travel and technique,
and belaying. In the evening, the camp fire brought out “war
stories” shared between students and our instructor, the famous
mountaineer Lou Whittaker.
The leader of my rope team on our summit climb was
Gombu, the Nepalese Sherpa who had accompanied Lou’s
brother, Jim Whittaker, during the first American ascent of Mt.
Everest in 1963. Gombu humbled us all by climbing the last
200 meters up Mt. Rainier backwards while smoking a
cigarette!
Before starting my internship and neurosurgery residency at
the University of Washington, I returned to Nepal. I was
clearly at my peak physically. I also thought this trip might
mark the end of my ability to maintain adequate fitness and
Yale Medicine Summer 1991

have the opportunity to travel to the Himalayas, given the gru¬
eling nature of a neurosurgery residency.
I arranged to meet Dr. Motoyama in Nepal, as he and sev¬
eral fellow mountaineers were climbing up the Arun and
Barun Valleys to several high passes east of Everest at the
same time that I was planning to climb Island Peak — my first
20,000-foot summit. Our routes were very clo.se to each other.
On arrival in the Everest area, I hired several Sherpas and
proceeded to acclimatize myself by trekking up Gokyo Peak
(18,500 feet), then across a pass back to the Khumbu Valley,
then up the Imja Valley to Island Peak and the Amphu Lapsa
Pass. There the rendezvous with the Motoyama party was to
occur. Only, I was given a message on a match book cover
while in the Khumbu Valley that their party encountered
severe weather and treacherous climbing conditions. One of
their porters had died of a head injury.
Our meeting location was changed to Dingboche in the
Imja Valley, from which Dr. Motoyama and I trekked up
toward Island Peak. He had met representatives from Moun¬
tain Travel, Inc., in Katmandu, who had been looking for a
doctor to accompany the first commercial group permitted by
the Nepali government to circumnavigate the Annapurna
Range, over the Thorong La Pass (18,400 feet). Dr. Motoyama
could not join this group but suggested that I go with them
instead. As a “rugged individualist,” I was prejudiced against
commercial trekking or climbing groups; but luckily, I recog¬
nized this opportunity as an offer I couldn’t refuse.
The “Around Annapurna” trip has since become a classic
Himalayan voyage, world-renowned for its awesome exposure
to a wide variety of Nepali and Tibetan people, villages and
fabulous peaks, including the 8,000-meter summits of Dhauligiri, Annapurna and Manaslu, and regions of subtropical,
desert, alpine and glacial character.

Dr. Richard Wohns at the Baltoro Glacier in Pakistan.
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After leaving Dr. Motoyama in the Inija Valley, I proceeded
to climb Island Peak, return to Katmandu, then travel to
Pokhara for a few days of bird watching at Fishtail Lodge,
again with Dr. Motoyama. The Mountain Travel Around
Annapurna group convened thereafter, and we departed for our
trip together.
At the Thorong La Pass, I made a first ascent of the south
summit of Thorongtse (21,500 feet) with two of our Sherpas.
The Mountain Travel group consisted of the president and vice
presitlent of the company, plus a number of fascinating indi¬
viduals from the LInited States and England. 1 ran daily clinics
for the group members, Sherpas and porters, and also treated
the local people, since there were no medical facilities or pro¬
fessionals in the vicinity.
1 do not encourage medical treatment of indigenous people
by doctors on expeditions or trekking groups, because care can
only be offered in a cursory way. However, in this circum¬
stance I considered it to be appropriate and worthwhile. We
were, es.sentially, the first Westerners seen by most of the pop¬
ulace, and it was very difficult to withhold simple health care
and provisions.
Physician Ascending
Toward the middle of my internship, the vice president of
Mountain Travel, Dick McGowan, called and invited me to be
the doctor for an expedition to Pakistan that he and his wife
were to lead during the summer of 1978. This involved an
extremely rigorous approach up the Baltoro Glacier to K2, the
second-highest mountain in the world.
Considered by many to be the most spectacular mountains
in the world, the western-most portion of the Himalayas, the
Karakorum, proved to be the fabled "kingdom of the mountain
gods." From the confluence of the Baltoro Glacier with the
Godwen-Austin Glacier at Concordia (15.100 feet), we viewed
the Karakorum giants of K2, Broad Peak, Gasherbrum,
■Masherbrum and Chogolisa.

An emergency appendectomy at 10,000 feet.

We climbed up to 21,000 feet on K2. following the route
that Chris Bonington's British expedition had Just abandoned
due to an avalanche that killed noted climber Nick Estcoun.
We also visited the grave of Art Gilkey of Charlie Houston's
historic 1952 American K2 expedition and communed with
one of the world’s greatest climbers. Reinhold Messner, and
Japan's mountain hero, Babaguchi.
4

Dr. Ensno Motoyama (left) meets up with Dr. Wolms in Nepal’s
Imja Valley in 1977.

Baltistan and the Karakorum were exceedingly remote,
which signalled to me the need to be medically self-sufficient.
Recalling the jocular motto developed at Yale among my circle
of friends: "Always be prepared for everything," I had packed
my medical kit with sterilely packaged surgical instruments for
performing burr holes, abdominal procedures, and for treating
lacerations and orthopedic injuries. To these I had added a
multiplicity of medications, intravenous fluids, oxygen and
anesthesia equipment. Such planning proved crucial; on this
expedition, we experienced numerous medical emergencies,
including a porter with a ruptured appendix and peritonitis.
I perfomied an appendectomy on him alongside the Braldu
River, which flows down from the Baltoro Glacier. After we
ran out of antibiotics and fluids, we were fortunately aided by
Bonington's doctor, who gave us his surplus supplies and
radioed for a helicopter.
Prior to the helicopter evacuation (our “Medivac" arrived a
week later) the several doctors with Jim Whittaker's American
K2 expedition “made rounds” during the postoperative period
and provided extra help. The porter, Mohammad Ali, met me
in Scardu after our expedition returned from K2. I brought him
a hearty curry lunch, since he had lost a lot of weight!
Back at Elashman's Hotel in Rawalpindi, Pakistan, 1 men¬
tioned to our liaison officer. Capt. Zafar. that 1 was a friend and
Harvard classmate of Bena/ir "Pinkie" Bhutto, the daughter of
the imprisoned Pakistani President Zulfikar Ali Bhutto. Asking
the hotel desk clerk about Pinkie's whereabouts, we found that
she was under house arrest in our hotel.
I spent the next afternoon with Pinkie reminiscing about
Harvard, cautiously discussing Pakistani politics, and then
with true mortal fear, talking about her father's impending exe¬
cution. Under the circumstances, I never would have imagined
that Pinkie herself would become Pakistan’s president one day.
During our tete-a-tete, we were surrounded by her personal
guards, but also by several Pakistani Army detention officers. I
was surprised to find that our expedition's liaison officer, a
captain in the Army, was very pro-Bhutto.
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Everest: The Ultimate Challenge
The following years revolved around marriage, children and
my neurosurgery residency, until 1981, when an invitation
arrived to join a Mt. Everest expedition in the spring of 1984.
The team desired a climbing physician who could also direct a
high-altitude research program. I had written several papers on
mountain medicine and related subjects and had become active
in the field of high-altitude physiology, and had further contin¬
ued climbing locally in the Cascades of Washington state.
Thus, I leapt at the chance of Joining this expedition.
Our group, composed of climbers from the northwestern
United States, had been given permission to climb the north¬
east buttress and northeast ridge of Mt. Everest. The approach
required travel through China and Tibet, then up the classic
1920s British route to the summit.
This was the route where the famous British climbers,
George Mallory and Andrew Irvine, disappeared just beneath
the summit. Mallory left for posterity his famous answer to the
question: Why climb Everest? “Because it’s there.” He took to
his death the secret of whether he and Irvine ever reached the
summit.
Our expedition’s research would focus on the role of cere¬
bral dysfunction in AMS, high-altitude cerebral edema, highaltitude pulmonary edema and retinal hemorrhages. There had
never been an expedition whose research was neurologically
oriented; thus, we pioneered the use of cortical evoked poten¬
tials at extreme high altitude and demonstrated a correlation
between symptoms of AMS and increased latency of visual
evoked potentials.
We also carried out a double-blind, randomized, controlled
study on the drug Dilantin and its potential prophylactic effect
against AMS. Other research protocols involved the use of
ambulatory EEGs, pulmonary impedance plethysmography,
and retinal photography. Better treatment and prevention of
AMS and high-altitude edema resulted from our studies.
Our research was funded by grants from the U.S. Army and
the Dreyfus Foundation, plus private contributions and
involved a sophisticated base camp research station at 18,000
feet. We used a Weatherport tent to shield our computers and
other sensitive bioelectric equipment against the harsh envi¬
ronment of Everest’s north side, where winds often exceeded
60 miles per hour and temperatures plummeted well below
0 degrees Fahrenheit. A Kohler gas generator provided power.
The research tent doubled as a clinic and mini-hospital, where
I treated our climbers with AMS symptoms and several British
Everest North Face Expedition members injured in an
avalanche.
After completing the base camp research protocols, we
moved our research equipment to 21,500 feet in a tent under
the North Col, which is a saddle on the northeast ridge. Here,
we became the first to monitor climbers’ evoked potentials
before and after extreme high-altitude exposure. It also was in
this tent that another world’s record of sorts was set — the
highest altitude hemorrhoidectomy ever recorded — by an
ophthalmologist, no less, on the podiatrist in our expedition!
Our group did very well on Everest but missed reaching the
summit by 800 feet due to porter problems. We had carefully
planned our load to include enough food, tents, climbing sup¬
plies and oxygen for several summit approaches; but when the
high-altitude porters quit unexpectedly, only two of our climbers
were within reach of the summit. The climbers were without a
tent and didn’t have enough food and oxygen for a bivouac on
the descent. Lacking such support, they wisely elected not to
take the exceedingly high risks in trying to become the first
Americans to summit Everest from the north side.
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1 expended so much time and energy in preparing and exe¬
cuting the expedition, and in the subsequent data analysis, sci¬
entific paper writing and slide presentations, that I actually lost
interest in climbing for several years. 1 continued to hike and
ski extensively in the Cascades with family and friends, but 1
“retired” from high altitude until Dr. Motoyama and I traveled
to Nepal again in 1989.
At this time, we accomplished the crossing of a high-altitude pass in a remote area of Nepal near the Tibetan border.
The Ganja-La Pass connects the upper Langtang Valley with
the Helambu Valley and provided a first-class adventure for us.
Over the years, I have become an avid mountaineering book
collector and especially enjoy the classic Himalayan expedi¬
tion books. A collection of maps of the Himalayas and southcentral Asia also complements my library. My avocation of
mountain medicine has been formalized, as I am now vice
president of the International Society of Mountain Medicine.
The society was founded several years ago in Switzerland to
promote scientific research related to high-altitude physiology
and mountain rescue. For 1992, I have organized a high-alti¬
tude neuroscience research expedition. Once again, I plan to
travel far and high.
YM

Dr. Wohns and colleagues profiled against Everest's legendary
North Face.
5

THE PHYSICIAN AS CITIZEN
hy James F. Comer. M l)., M.P.H.
Editor's note: Dr. Comer delivered the commencement address
to the Class of 199! on May 27. lie dedicated his remarks to
the memory of Peter A.T. Crannnm. M.D.. associate professor
of obstetrics and yynecoloyy. for his “combined commitments
to professional excellence. social justice and citizenship."
I'd like to take just a few minutes to talk about an aspect of the
life of a physician that is given too little attention, that is. the
physician as citizen.
There is every reason to believe that you will become fine
physicians. You have had the best medical education available
in the world. And while medicine is changing, it still is and
always will be one of the most honored professions in the
world. It will bring you great personal satisfaction, and at the
same time enable you to serve an appreciative patient popula¬
tion and public.
It has a kind of inherent excitement that will command your
interest and time. Thus, there is a tendency among physicians
to feel. “My citizenship responsibilities are met through my
dedication to my profession." But while important, our profes¬
sional contribution is not enough, particularly at this point in
our history.
We live in a remarkable time, in a remarkable country...one
of the most successful and best countries in the world. But we
are in trouble — economic, educational, social, even spiritual
trouble. And whether you attend your .^O-year class reunion in
an America that is vibrant and successful, or not. depends a
great deal on whether you and other leaders of today and
tomorrow adequately address citizenship tasks beyond your
profession. But how can I suggest that we are in trouble after
two of the most exciting and promising years of the 2()th cen¬
tury — perhaps any century — a period when totalitarian gov¬
ernments fell and much of the world called for democracy.
And the democracy everyone wants has survived in large part
because America had the courage and the strength to destroy
Nazism two generations ago; and had the generosity to rebuild
the economies of its former enemies; and several months ago
hail the courage to crush the forces of a cruel dictator. Also,
America hail the know-how that launched the scientific and
technological age which created the affluence that most of us
enjoy, and which undermined the claims of Communism.
But we ignored, or didn't understand, the implications of
the post-World War II science- and technology-based economy
we pul in place. Before the I95()s. heads of households didn't
need an education to hold living wage jobs and meet their
adult responsibilities — to support themselves and their fami¬
lies. rear their children, and serve as responsible citizens. As
late as 1930, only 20 percent of all Americans over 23 years of
age had linished high school. But we will need a 90 percent
high school graduation rale by the year 2000. And almost one-

Dr. James P. Comer, the Maurice Palk Pnfessor in the Child
Study Center and in Psychiatry, is associate dean for student
affairs at the School of Medicine.
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third ot all new jobs created between now and the year 2000
will require a college degree. Fewer than 10 percent of the
nation's existing Jobs are open to low- or unskilled laborers.
A Turning Point
To develop people so that they can acquire the high level of
education needed today, a society must invest in its people —
must promote high-level family functioning, adequate health
care and good education. Most of the industrialized countries
of the world — especially Germany and Japan, those nations
we put back on their feet after World War 11 — invested in
their people.
America, by contrast, while helping others, permitted large
numbers of her own families to be closed out of the economic
mainstream, to experience debilitating poverty and stress. And
now, too many of those families are unable to give their chil¬
dren the kind of preschool experience that would enable them
to succeed in school. As school dropouts and underachievers,
they are much more likely to participate in the underground
economy of drugs and crime and to strain the nation's social
service systems. Their reactive behavior lowers the quality of
life of every one of us.
Of particular significance to medicine, poor women are
more likely than other women to deliver low birth-weight
babies, to be exposed to AIDS, and to experience prenatal drug
exposure that impairs fetal development and precipitates mis¬
carriage and premature birth. Poor children under six are more
likely than other children to have growth retardation and
anemia, lead poisoning and accidental injury — with all the
attendant social and financial costs.
At this moment, 30 percent of all poor children under age 6
have no health insurance what.soever, even though many of
their parents work every day — the working poor. And though
blacks. Latinos and native Americans have been disproportion¬
ately affected because of their more traumatic social histories,
42 percent of the five million poor children under 6 are white.
Neither have children of the aftluent escaped the effects of
our inattention to the support of family functioning and devel¬
opment. Suicide, violence and vandalism, alcohol and other
substance abuse problems are significant among our most
affluent young people. The National Governors Association
and the White House have proposed a .set of national goals for
the year 2()()(). One is to have our students rank first in mathe¬
matics and science. But in the most recent international assess¬
ment of 13-year-olds across 12 nations. American students
ranked last in mathematics and ninth in science. The average
Japanese student scored higher than the top 3 percent of Amer¬
ican students in college preparatory mathematics.
Without a healthy, better educated work force, we will not
be able to compete economically with Germany, Japan,
Sweden and the like. And, in turn, we will not be able to afford
even our present level of health and education .services. We
will be on a downhill course as a nation.
While we need a better educated worker, nearly one-third of
the work force in the year 2000 will be made up of minority
group young people, disproportionately poor and underserved
by our present educational system. Some of the people who
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look at demographics and note the high percentage of minori¬
ties feel that the nation does not have the talent needed to
remain competitive. In fact, a New York Times op-ed page arti¬
cle — couched in the argument of reducing the deficit — sug¬
gested that we must import our future work force. Not only is
that immoral and unfair to the nations that have invested in the
education of their people, it is unfair to the American children
and families in which this nation has not invested. Such a
policy would make all of our current social problems much
worse. More importantly, the argument is simply wrong. Of
course we have the talent.

Harry Bishop

A Personal History
To make my point. I’d like to tell you the story of a poor,
African-American lady named Maggie. Maggie was born in
1904 to a poor but caring, responsible sharecropper in rural
Mississippi. But he was killed by lightning when she was 6
years of age. And because there were no support systems, a
cruel stepfather came into the lives of his widow and five chil¬
dren. The stepfather was abusive in every way and would not
allow the children to go to school. As a barefoot girl working
in the cotton field, it occurred to Maggie that the way to a
better life was through education. And at 16 years of age, she
ran away to try to get an education.
She was unable to do so. When she was forced to give up
her dream, she declared that if she ever had children, she
would make certain that all of them got an education. And then
she very, very, very carefully set out to find a husband. Her
husband, Hugh, from rural Alabama had a sixth-grade educa¬
tion. Maggie worked as a domestic and Hugh worked as a steel
mill laborer. And when Hugh died early. Maggie carried on.
Eventually, the five children of Maggie and Hugh obtained a
combined total of 13 college degrees.
Hugh was my father, and Maggie is my mother...Tm
delighted to tell you that two weeks ago she received an hon¬
orary doctorate degree from Wheelock College. Our family
story, and that of many others, is the source of my conviction
that our nation has the talent needed to survive and thrive in
the 21st century. But we must clearly do some things differ¬
ently. For, while my family was succeeding in the high socio¬
economic, predominantly white school we attended, the three
black youngsters I went off to elementary school with all went
on a downhill course. One died early of alcoholism, one spent
a good part of his life in jail, and the other has been in and out
of mental institutions all of his life. And most of their children
and grandchildren have not succeeded. Yet, my three friends
were as bright as anybody in my family and anybody in our
school. No nation can sustain this kind of loss of potentially
productive people on an ongoing basis and expect to thrive.
The difference between my friends and our family was that
our parents had the ability to give us the kinds of experiences
at home that allowed us to succeed in school, and my mother
had the kind of skill that made it possible for her to interact
with school people in a way that encouraged them to be sup¬
portive of our ambitions.
Many people will say, “That’s the problem. There are too
few Hugh and Maggie Comers among the poor families in
America today.’’ Not true.
Because I was so greatly concerned about the fact that my
friends were on a downhill course at the time I finished medi¬
cal school, I decided to try to understand what the behavior
was all about. And after voluntary work in poor communities, I
decided to pursue a career in psychiatry, child psychiatry, and
preventive psychiatry in schools rather than follow my initial
plan to become a general practitioner in my hometown.
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Dr. James P. Comer

Dr. James P. Comer
Dedicated to the Children
—

Dr. James P. Comer, the Maurice Falk Professor in the Child
Study Center and Psychiatry and associate dean for student
affairs, has developed techniques for making schools in urban
communities work better for at-risk children. A member of the
Yale faculty since 1964, Dr. Comer is well-known for his work
in school improvement, some of which was pioneered in New
Haven schools.
The pathfinding work of this Yale child psychiatrist stresses
the importance of a child’s psychological preparation for
school and emphasizes the collaboration of school staff and
parents in the child’s academic and social development. More
than 150 schools use Dr. Comer’s methods, and through major
support from the Rockefeller Foundation, his approach is
being introduced to even more at-risk students nationwide.
A native of East Chicago, Indiana, Dr. Comer holds an A.B.
degree from Indiana University, an M.D. degree from Howard
University College of Medicine, and an M.P.H. degree from
the University of Michigan School of Public Health.
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With the insight from my personal experience and my train¬
ing as a psychiatrist, we eventually developed a program in
two inner-city schools of New Haven that brought student
achievement from 32nd and 33rd out of 33 schools in 1969, to
tie for third- and fourth-highest levels of achievement among
the 26 remaining schools in the city in 1984; from the worst
attendance record to first and second in attendance five of the
previous six years; from the worst behavior to good citizen¬
ship; from school staff that burned out quickly to highly suc¬
cessful professionals; from single-parent welfare recipients,
angry and alienated from the school and society, to energized,
excited parents, some of whom went back to college and
became professional people themselves; still others took
employment they previously believed they could not manage.
The approach we developed is now being used in more than
150 schools across the country.
Our work and that of others shows that our nation has the
talent. Last year, the National Commission on Children
appointed by the F^resident and the Congress and headed by
Sen. John Rockefeller visited one of our schools. They were
delighted by the success and the excitement they found among
the parents, students and staff. But they were disturbed by the
stories of drug use and abuse and related violence that the 9and lO-year-old children they talked with experienced on a
daily basis. They were rightfully concerned that many ofthe.se
parents and children who care and want to succeed are trapped
by conditions that may well prevent them from ever contribut¬
ing their talents to the gov)d of American society. They asked,
"How can we make it possible for all of our children to con¬
tribute their talents to the well-being of society rather than end
up on the social problem side of the ledger, undemiining our
nation's future?" That question brings me back to the issue of
the physician as citizen.
The danger to American democracy today is not as apparent
as swastikas and stomping boots, or bombed-out cities —
though some sections of our cities look as if they have been
devastated by war. Thus, there is no sense of urgency. Nor is
there any foreign savior for America. You and me. and the rest
of our most thoughtful, best educated and most responsible cit-

1991 Brings Dr. Comer
14 Honorary Degrees
'fhis year, 14 colleges and universities will have recog¬
nized the distinguished career of Dr. James R Comer by
presenting him honorary degrees. These institutions
include; Indiana University, Bloomington, D.Sc.; Indi¬
ana University, Gary, D.Sc.; Wabash College, Crawfordsville, Ind., D.Sc.; Wheelock College, Boston,
Ed.D.; University of Connecticut, Storrs, LL.D.; State
University of New York at Buffalo, L.H.D.; New School
for Social Research, New York City, I..H.D.; Rhode
Island College, Providence, D.Ped.; Amherst College,
Amherst. Mass., D.Sc.; John Jay College of Criminal
Justice. New York City, L.H.D.; Wesleyan University,
Midtiletown, Conn., L.H.D.; Princeton University,
Princeton.
N.J.,
D.H.;
Northwestern
University.
F-ivanston, 111., D.Sc.; and Worcester Polytechnic Fnstiuitc, Worcester, Mass., D.Sc.
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izens are America's saviors. We must call the attention of the
nation to our country’s needs and to the urgency with which
they must be met.
Wherever you go from this day forward, you will be among
the best educated, most respected leaders in the community.
Your authority, attitudes, and opinions as physicians will intJuence public policies and practices beyond your area of exper¬
tise. In fact, people listened to my school improvement ideas,
in part, because I am a physician. That gives us a great oppor¬
tunity and an even greater responsibility — again, in our pro¬
fessional areas, but also as citizens.
But to be helpful, we must be open and informed and not
burdened by the stereotypes, myths and rationalizations that
have contributed to our problems. And as individual physi¬
cians, we have the power to treat all our patients with the kind
of respect that simultaneously enhances their self-esteem and
positively influences their health and citizenship behavior. (For
those of us who have been more fortunate, it is sometimes dif¬
ficult to understand how some of our behaviors — disrespect,
disdain and abuse—add to the burden of the poor.) As a pro¬
fessional group, your generation will have an opportunity to
create a health system that is fair to physicians and patients
alike; to all patients, affluent and poor alike. And 1 don’t for
one moment hold physicians largely responsible for the
inequities in our pre.sent system. But we can help correct them.
As powerful and leading citizens we must, through the
democratic process, make it possible for all of our young
people to live in families which will give them the start that
will enable them to obtain the education needed to participate
in the mainstream of society — as successful workers, family
members, child-rearers and citizens. We must contribute some
of our time and resources to programs that will prevent serious
social problems.
Altruistic, maybe, but hardly. The families and children we
enable to function well will not over-tax our own pocketbooks,
or our education, health and social service systems. They will
produce the goods and services that will eliminate our deficit
and enable us to compete with Germany, Japan and Sweden in
such a way that the America of 2021, your 30th-anniversary
year, will be aftJuent. vibrant and strong — still the most powertul force for democracy and fair play in the world.
Let me close with an apocryphal story F appropriated from a
graduation speaker I heard recently; Several teen-agers wished
to belittle an elderly Greek philo.sopher. One youngster held a
bird behind his back in his fist, and asked, "Old man. is the
bird dead or alive?" If he had said that the bird was alive, the
youth would have crushed it to death. If he had said “dead,"’ he
would have opened his hand and allowed the bird to fly away.
The philosopher, wise in the ways of mischievous youths,
pau.sed thoughtfully, and then said, "My .sons, the decision
about the life or death of that bird is in your hands."
To the Class of 1991, 1 say to you. the future of medicine,
the future of America, and the future of democracy is in your
hands and in the hands of young men and women like your¬
selves across the country. If you carry out your professional
and citizenship responsibilities with the dedication and talent
you have demonstrated to date, America will survive and
thrive in the 2Lst century. Your 3()th-class reunion will not
only be in a vibrant and strong America, but a better America
than we have today.
I wish you — and all assembled with you — much success
in medicine, in your personal lives and as citizens. 1 am
pleased to have shared this important day with you.
YM
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AFRICAN-AMERICAN STUDENTS
YSM’S UNFOLDING LEGACY
by Daryl Daniels, M.D. ’91

Gregory R. Huth

As I walked down the aisle to receive my Yale medical
diploma on May 27, I became the 183rd African-American to
do so. I was among 12 black Americans to graduate with an
M.D. degree from the Yale School of Medicine this year, con¬
tinuing a long and fascinating history of African-American
presence at YSM. It is important to view that pre,sence in con¬
text of the times.
Chartered by the Connecticut Assembly in 1810, the Medi¬
cal Institution at Yale College awarded the M.D. degree to
Courtlandt Van Rensselaer Creed in 1857, eight years before
the end of the Civil War. On that occasion. Dr. Creed became
the first African-American to earn a degree from the institu¬
tion, and Yale became one of the the first medical schools in
the United States to admit, educate and award a degree to
people of his race.
The Town
Circumstances surrounding Dr. Creed’s admission to Yale
reveal an important period of transition in demography and race
relations in New Haven. Though a small city by today’s stan¬
dards, with just over 20,000 people. New Haven had a decid¬
edly urban character. A strong manufacturing base, mostly car¬
riage and firearms factories, was supported by the city’s
emergence as a regional transportation center, offering both a
major harbor and strategic railroad access to New England.
In spite of its industrial character. New Haven’s social
structure remained essentially as it had been in the colonial
era. Society and the city government were dominated by a few
aristocratic families with close ties to the local clergy, espe¬
cially those associated with Center Church on the Green.
Below these families on the social pyramid was a growing
middle class, mostly artisans and skilled workers, followed by
a base of unskilled manual laborers.
African-Americans in New Haven, freed by the provisions
of the state’s Gradual Emancipation Act of 1784, were num¬
bered about 1,000, and were the least privileged citizens.
While not utterly deprived of their civil rights, they were set
apart from the rest of society in undesirable parts of the city
where land was too poor for farming.
Most lived in “New Libera,” a run-down area on lower
Chapel Street between the old waterfront and factories; some
in the area surrounding Congress and Washington streets,
known then and now as the Hill; others lived on “Negro Lane”
which was that part of State Street east of the original nine
squares. Later, quite a few settled in “Poverty Square,” the area
around lower Dixwell Avenue. Living in substandard housing
and working at the most menial of jobs for which they
received the poorest wages, almost half the black population
was employed as servants; the remainder took whatever jobs
they could find. A few were highly skilled and worked as arti¬
sans in shoemaking, woodworking and other trades. Some
worked aboard ocean vessels. Service jobs, such as barber or
Yale Medicine Summer 1991
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Daryl Danielsy M.D. ’91:
Making History by Pursuing It
As a second-year student in 1989, Daryl Daniels began
his M.D. thesis research into the story of African-Ameri¬
can medical students at Yale. Among his important dis¬
coveries, he traced the history of black Yale medical stu¬
dents back to 1854; a 1970s medical school brochure
had mistakenly stated that YSM’s first African-Ameri¬
can student graduated in the Class of 1949. Dr. Daniels
was one of five fourth-year students to give oral presen¬
tations at Student Research Day, held in May. Curtis L.
Patton, Ph.D., professor of epidemiology (microbiol¬
ogy), served as his advisor.
Dr. Daniels has begun a general surgery residency at
the University of New Mexico School of Medicine.
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waiter, were the most desirable and held by members of the
"best” African-American families.
Documents show that African-Americans in New Haven
were unwilling to play the role of bystander watching a city
prosper and move ahead. They made stunning efforts to
improve their lot early in the last century. They organized
political, benevolent and religious societies.
The first clerk of a group organized in 1824 as the African
Ecclesiastical Society was Prince Duplex, a well known
African-American and Revolutionary War veteran. With the
help of Simeon Jocelyn, a member of Center Church on the
Creen. a run-down building on Temple Street between Crown
and George Streets was purchased. On Aug. 2.‘S, 1829, the
group was recognized by the Western Association of New
Haven County and became the Temple Street Congregational
Church, renamed after its move the Dixwell Avenue Congre¬
gational Church, the first African-American Church of this
denomination in the country.
With the church as their base, they opened a small day
school, the first school in the city for African-American chil¬
dren. Vashti Elizabeth Duplex, Prince Duplex’s daughter, was
the teacher, the first black school teacher in New Haven.
Although plans for a black college were .squelched by a hostile
press, cooperation, mutual and white support brought gains in
education and employment. A small and significant AfricanAmerican middle class had begun.
An Historic Turning Point
In the summer of 1839. a series of events would begin to
unfold with profound ramifications for New Haven and the
nation. The stage was set as the Aniisttul, a Spanish schooner,
was captured in Tong Island Sound. It had sailed from West
Africa for Cuba with a shipload of 54 Africans to be sold as
slaves. Led by a man who came to be known as Joseph
C’inque. the kidnaped Africans, members of the Mende tribe,
seized control of the ship and instructed the crew to return
them to Africa, fhe crew resisted by taking a zig-zag course,
steering the ship towards Africa by day and pointing it back to
America at night under overcast skies. The Amistad was inter¬
cepted off Montauk by the United States Navy and towed to
New London. The captives were transported to New Haven to
await prosecution on charges of piracy.
At first, the fate of the.se Africans seemed hopeless, espe¬
cially since they spoke no European language. But Josiah
Willard Gibbs, an intrepid abolitionist professor at Yale,
located a Mende interpreter on the docks of New York. When
details came to light of how the defendants were kidnaped, a
great outpouring of public support followed. The Amistad case
became a cause celehre for the abolitionist movement. Thanks
in part to the efforts of the people of New Haven, the captives
were eventually freed and returned home by a U.S. Supreme
('(Hirt decision.
In addition to rekindling the national abolitionist move¬
ment. the Amistad affair generated public sympathy for
African-Americans in New Haven. Indeed, in this supportive
atmosiihere, a fledgling well-to-do class developed among
New Haven blacks, d'hey bought property, saved money, provitied lor their poor and their young. Linder the leadership of
fheodore Dwight Woolsey, an abolitionist and proponent of
African-American education, who in 1846 was chosen ninth
president of Yale, the College became a hotbed of anti-slavery
sentiment. >'ale, then the largest college in the nation, was the
school ol choice for many northern and southern students.
I he Meilical Institution appears to have been caught up in
the abolitionist fervor. In 1849. it awarded an honorary M.D.
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degree to Dr. Ezekiel Skinner of Ashford, Conn., for his work
in Liberia, a new American colony in Africa for emancipated
slaves. This abolitionist sentiment, coupled with the news that
black students were being accepted at other medical schools in
the Northeast, may have provided the impetus at Yale to admit
its first African-American.
An Ideal Candidate
Courtlandt Van Rensselaer Creed was the son of John William
Creed, a middle-class African-American who worked as a
waiter and steward at Yale College and a caterer in business
for himself. Dr. Creed’s mother was Vashti Elizabeth Duplex,
the first black teacher in New Haven and a member of a highly
successful family. They named their son for Courtlandt Van
Rensselaer, B.A. 1820, a Presbyterian minister who was dedi¬
cated to helping African-Americans. There are reasons to
believe that Van Rensselaer befriended and perhaps tutored
Creed when he was at Yale.
Young Courtlandt Creed, a lifelong New Haven resident,
was qualified to attend Yale in accordance with state law. He
prepared at the Lancasterian School, located at Orange and
Wall streets, the precursor to Hillhouse High School. More¬
over, his family could afford the tuition and had connections at
Yale and in the community. Courtlandt’s namesake was a
friend and classmate of President Woolsey and Dr. Charles
Hooker, dean of the Medical Institution. They had a close rela¬
tionship with the Rev. Leonard Bacon. This politically power¬
ful rector of New Haven’s Center Church was a Yale Corpora¬
tion member who along with Woolsey was a founder of the
New Haven African Improvement Society.
In 1854, Courtlandt Creed entered the Yale Medical Institu¬
tion. Unlike at Harvard, where three African-American stu¬
dents were forced to leave four years earlier as a result of
protests from white students, there is no record of any such
negative responses to his attendance. Why this contrasting
reception? Perhaps Yale had the advantage of having a rela¬
tively small medical .school of about 30 local young men,
while the medical .school at Harvard was perhaps twice as
large and attracted students from North and South.
As was practice at the time, Courtlandt Creed entered the
Medical Institution out of secondary school and spent three
years earning his degree. His M.D. thesis, entitled “On
Blood,” was a study on the chemistry and physiology of blood
in health and disease. His oral examinations took place in Jan¬
uary 1857 before repre.sentatives of the Connecticut Medical
Society, the faculty of the Medical Institution and President
Woolsey. On Thursday evening, Jan. 16, 1857. Courtlandt van
Rensselaer Creed and 10 other members of his class received
the M.D. degree in the college chapel.
Triumph and Tragedy_
After graduation. Dr. Creed opened an office in his father’s
house on Chapel Street, and soon developed a large and pros¬
perous practice. Neither professional success, nor happy mar¬
riage, nor births of four sons would portend the difficult years
ahead for the family.
On April 12. 1861, Confederate troops fired on Fort Sumter.
At the outbreak of the Civil War, Dr. Creed wrote to the gover¬
nor of Connecticut asking for a commission to serve as a sur¬
geon in the state militia but was refused becau.se of his race.
As the war dragged on, however, it became clear that AfricanAmericans would be needed for the Union cause. In the fall of
1863, the governor issued a call to amis to Connecticut’s
African-American men. Dr. Creed wrote the governor again,
this time to thank him. declaring, "On every side we behold
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(Connecticut’s] colored sons rallying to the sound of ‘Liberty
and Union.’”
Dr. Creed enlisted on Jan. 29, 1864, and was appointed
acting surgeon of the 30th Connecticut Volunteers, a company
of African-Americans. They trained at Grapevine Point in the
Fair Haven section of New Haven during the winter and spring
of 1864. On June 4th of that year the Army deployed the vol¬
unteers to Cold Spring, Va., where they joined other compa¬
nies to form the 31st U.S. Colored Infantry.
Dr. Creed did not remain with the 31st. Toward the end of
hostilities, he was detached to the Army’s Department of the
East. Before he was mustered out on Nov. 7, 1865, Dr. Creed
also may have served with the 13th Connecticut Volunteers
and the 55th Massachusetts Colored Infantry.
During the war, the fortunes of the Creed family had begun
to deteriorate. After Dr. Creed’s father died, the family began
to deplete the resources of his estate; they auctioned off what
remained of the family’s property to pay debts following his
mother’s death in 1879. Dr. Creed eventually returned to live
in New Haven and practice medicine but never attracted the
number of patients he had before the war. Poverty and illness
dogged him during the last decade of his life. He died on Aug.
8, 1900, of Bright’s disease, a spectrum of kidney and heart
ailments, at the age of 65, and was buried in the family plot in
Grove Street Cemetery in New Haven.
Sixteen years after Dr. Creed graduated, Bayard Thomas
Smith and George Robertson Henderson transferred to Yale
from the Medical Department of Lincoln University in Penn¬
sylvania, the nation’s first historically black college. Lincoln’s
Medical Department, founded in 1869, was poorly funded and
closed after four years. It did not graduate any students; those
George Henry Jackson, M.D. 1892, documented the therapeu¬
tic value of moderate wine intake in his 1928 hook.
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who did complete their studies did so at other schools.
Although there were less expensive and less rigorous medical
schools. Smith and Henderson entered Yale in 1874.
Their decision may have been indirectly influenced by Dr.
Creed. Dr. Elmore C. Hine, M.D. 1861, a white physician and
the dean of Lincoln University’s Medical Department, studied
medicine at Yale when Dr. Creed was practicing in New
Haven. Although no record of direct communication between
Dr. Hine and Charles Lindsley, then dean of medicine at Yale
was found, it is a reasonable speculation that their relationship
helped the two students from Lincoln transfer to Yale. Dr.
Smith completed his studies in one year, graduating in 1875.
He returned to his home state of Delaware to practice. Dr.
Henderson graduated in the spring of 1876 and began a prac¬
tice in New York City; he moved to Brooklyn in 1888 where
he died of an accidental morphine overdose at the age of 45.
A Period of Leadership
The year 1888 opened a remarkable period for what had
become the Yale Medical School. During the 15 years that fol¬
lowed, Yale would graduate eight African-Americans, with at
least one present in the school during this entire period. While
perhaps not impressive by today’s expectations, their pre.sence
represented a strong commitment to African-American educa¬
tion at a time when only a few of the white northern medical
schools admitted blacks, making Yale a leader in AfricanAmerican medical education.
The first black physician to graduate during this period was
Dr. Henry Eloyd Gamble, born in slavery in North Carolina,
Jan. 16, 1862. He took his education very seriously and even
employed a tutor to ensure the quality of his early learning.
Working as a steward, he managed to save enough money by
age 20 to begin studies at Lincoln University, graduating with
honors in 1888. He entered Yale Medical School that fall and
worked long hours at night as a janitor and waiter. My com¬
mencement marks the centennial year of Dr. Gamble’s gradua¬
tion with honors.
Dr. Gamble moved to Charleston, W. Va., where he became
widely known for his skills as a surgeon. His publications
include papers on thoracic aneurysm and caesarean .section.
His contributions to medicine, medical education and civic
organizations were many and significant. He organized the
West Virginia State Medical Association and in 1912 was
elected president of the National Medical Association (NMA).
He died in September 1932.
The year after Dr. Gamble graduated. Dr. George Henry
Jackson received his M.D. degree from Yale. His remarkable
life would seem to justify the praise of his contemporary, the
Rev. A.C. Powell, who described him as an “all-round genius.”
Born in 1863, in Natick, Mass., he spent his early life working
as a Erench interpreter and as a manager in a shoe factory.
Erom there he went to Madison Seminary, now Colgate Uni¬
versity, graduating in 1887. He earned the Bachelor of Divin¬
ity degree in 1889 and an M.D. degree in 1892 from Yale. He
also earned an M.A. degree from Shaw University in Raleigh,
N.C. He was ordained and became the pastor of Immanuel
Baptist Church in New Haven.
Dr. Jackson traveled to the Congo Eree State as a medical
missionary, returning to New Haven in 1897. Two years later
he headed overseas again, this time to France as the United
States Consul to Cognac and La Rochelle. While in France, Dr.
Jackson started a successful import-export business. In 1928
he published The Medicinal Value of French Brandy. He
retired in 1935 and died eight years later from a stroke, in Los
Angeles.
Continued on page 13
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Altlioui’li this photograph has been handed down without documentation, the two African-Americans in the hack row meet the descrip¬
tion of Arthur Leslie Howard and William Fletcher Penn of the Class of 1897. The year 1895 painted on the soles of the shoes of stu¬
dents in the front row implies that this may have been an early portrait of the class.

1888-1903:15 Years of Leadership
In African-American Medical Education
At the turn of the 2()th century. Yale Medical School took a
leading role in educating African-American physicians. Num¬
bered among them were:
Isaac Napoleon Porter. '93. A native of Summit Bridge.
Del.. Dr. Porter remained in New Haven after graduation.
From a house on Dixwell Avenue, he started a practice which
soon grew into one of the largest in the city. He served on the
New' Haven Board of Aldermen, the Chamber of Commerce,
the Historical Society, the Connecticut Medical Society and
the American Medical Association.
Arthur Leslie Howard and William Fletcher Penn, '97. Dr.
Howard was the son of a wealthy New York merchant and a
favorite of his classmates. After graduation, he went to Eng¬
land where he died of an unknown illness at the age of 28. Dr.
F’enn. who claimed to be a descendent of William Penn, the
founder of Pennsylvania, had a long and distinguished career
m surgery. He practiced originally in Atlanta, but in 1926
moved to Tuskeegee. Ala., where he gained wide regard as the
chief of surgery at the Tuskeegee Veterans Administration
Hospital.
Charles William Snyder and William Houston Wright. '()().
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Dr. Snyder, of Hartford, came to Yale from Fisk University,
where he had earned a B.A. degree in 1896. After medical
school, he practiced in New Albany, Ind., and Louisville, Ky.,
where he was active in the National Association for the
Advancement of Colored People. Dr. Snyder’s classmate. Dr.
Wright, attended high school in Bridgeport, Conn. No record
of his undergraduate education was found. He interned at
Freedman's Hospital in Washington, D.C., one of only three
programs in the country open at that time to African-Ameri¬
cans. Dr. Wright practiced in the Baltimore area. In 1908 he
was elected president of the National Medical Association. He
also served as president of: the Maryland Medical. Dental and
Pharmaceutical Association; the Board of the Maryland
School for Girls; the local and national YMCA; and the local
and national Urban League. An avid sports fan. he became
chief umpire for the National Tennis Association.
Cleveland Ferris, '03. The last African-American to gradu¬
ate from Yale during this period. Dr. Ferris was born Dec. 27.
1877. in Philadelphia. He attended Peekskill Military
Academy in New York and before entering the Yale Medical
School in 1899, he attended Phillips Andover Academy. After
Yale, Dr. Ferris went to Lincoln Hospital in New York City
where he practiced urology. He was admitted to the American
Medical Association and was elected a fellow of the New York
Academy of Medicine. He died suddenly of blood poisoning in
1913, at the beginning of his career.
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Continued from page II
Cleveland Ferris, M.D. '03, graduated from what had then
become the Yale University School of Medicine; it would be
41 years before the next African-American would receive a
degree from the school. There are several reasons for this
hiatus. The decades following the end of Reconstruction gave
rise to nationwide racial intolerance, as marked by the virtual
abandonment of African-Americans by the Republican Party
and the legalization of segregation in the South. What is more,
rapid industrialization opened the doors of the country to
unprecedented numbers of Roman Catholic and Jewish immi¬
grants from Europe. As much as America would benefit from
their labors, many in the United States would have preferred
that the “wretched refuse” never left their teeming shores.
The Ku Klux Klan resurfaced in 1915 to reaffirm the supe¬
riority of white Protestants. By 1924, New Haven, once a
hotbed of abolitionism, claimed Connecticut’s largest Klavern
with some 2,000 members. This wave of intolerance had a dra¬
matic effect on Yale as well as on its host city. The College
made a deliberate and concerted effort to limit the number of
matriculants of certain ethnic and religious groups in the
1920s, a trend evident in many of the northeastern universities.
In 1920, the dean of Brown University submitted the topic
“The Limitation of Jews and Negroes” for discussion at a
meeting of deans of New England colleges.
In New Haven, the School of Medicine followed the lead of
Yale College. By 1935, the medical school’s official admission
policy stated, “the number of women is restricted...as are some
racial groups including Europeans, South Americans, Hebrews
and Orientals.” Perhaps the most blatant example of docu¬
mented racial discrimination at Yale during this time period
occurred in 1941, when School of Nursing Dean Effie J.
Taylor denied a student entry becau.se of her race.
In the ensuing controversy, it was revealed that the medical
and nursing schools had adopted an “unwritten policy” of
racial exclusion. The purported basis for this policy was the
fear that white patients at New Haven Hospital would find
black students unacceptable on the wards. When details of the
unwritten policy became public, Yale President Charles Sey¬
mour had it stopped. African-Americans were admitted once
again. Backlash from white patients never materialized. Yale,
it would seem, had been frightened by a ghost.

largest number up to that time. Since then, about 10 black stu¬
dents have enrolled in each class.
Nearly two decades later, the medical school took its next
steps toward advancing the cause of minority student enroll¬
ment and faculty recruitment. On Sept. 8, 1988, in a convoca¬
tion speech to Yale’s incoming graduate and professional stu¬
dents, Dean Leon E. Rosenberg exhorted the University to
renew its dedication to minority medical education and
advancement. (See “America’s Disadvantaged Minorities: Re¬
kindling The Torch,” Yale Medicine, FallAVinter 1988-1989. |
At the School of Medicine, the dean acted according to his
own call. Beginning in January 1989, Martin Luther King Day
celebrations have included a .school-wide forum to explore
minority social and health-care issues. The Office for Minority
Affairs was established that same year with the appointment of
Ms. Maxine Whitehead as its first director. In recent years, the
number of African-American students entering the school has
increa.sed. For example, the Class of 1993 includes 12 AfricanAmericans, the Class of 1992, 13. As the School of Medicine
looks forward to graduating its 2()()th African-American physi¬
cian, it is appropriate to reflect not only upon its historical role
in the education of black physicians, but its commitment to the
future as well. Yale can be an important beacon for the nation;
in the words of Dean Rosenberg, “to rekindle the torch.” YM

Courtesy Kdmund .S. C’relin, M.I)., .Sc.l).

Yale Returns to its Ideals
Immediately after the “unwritten policy” was discontinued,
Beatrix Anne McCleary, M.D. ’48, was admitted, becoming
the first African-American woman to graduate from the School
of Medicine.
Today, Dr. McCleary G. Hamburg practices pediatrics in
New York City. After Dr. McCleary, a black student was
admitted to the medical school every two or three years. This
trend continued until the civil rights movement rocked the
country in the mid-196()s and demands to increa.se minority
enrollment grew.
Much of the support for increased minority admissions
came from the school’s African-American faculty; Drs. James
P. Comer and Augustus White, for instance, joined the admis¬
sions committee. During this activist time, Courtland Wilson, a
re.searcher in the physics department, picketed in one-man
demonstrations to demand increased minority admissions. He
later became a lecturer in public health and coordinator of the
medical school’s Committee for the Recruitment of American
Black and Spanish-speaking Students. The School of Medicine
admitted nine African-Americans in the fall of 1969, the
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Beatrix McCleary Hamburg, M.D. '48, shown here in a firstyear portrait, was the first A frican-American to he admitted to
the medical school in 40 years and the first black woman ever
to graduate from the School of Medicine.

Editor’s note: Special thanks to Curtis L. Patton, Ph.D.,
professor of epidemiology (microbiology), for reviewing and
helping edit this article.
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AIDS RESEARCH AT YALE:
SHIFTING INTO HIGH GEAR
hy Diane E. Loupe
Eight-year-old "Bobby," dressed in Army fatigues, shoots at
imaginary enemies with his fingers as he frenetically spins
around in a swivel chair in a Yale Physicians Building waiting
room. The irony of such child's play is not lost on Bobby’s
pediatricians; they suspect that his hyperactivity is due to his
AIDS, which has begun to erode Bobby's memory and may be
giving him delusions.
I'he devastation this disease has wreaked on Bobby's
family is no delusion, however. AIDS has killed his mother,
two brothers, stepfather and uncle. His father, recently relea.sed
from prison, contracted the virus through intravenous drug use
and then transmitted it sexually to his mother. In a grim family
legacy, she passed the virus on to Bobby and two other sons at
their birth, and through sex to Bobby’s stepfather.
Although chronic pneumonia has left the child with cardiac
and respiratory problems, his grandmother, with whom he now
lives, will not allow an oxygen tank into her apartment.
Already, bullets have chipped the brick exterior of her build¬
ing; she fears that a stray shot might smash through a window,
strike the tank and trigger an explosion.
To help them cope. Bobby and his grandmother have found
an ally in Warren Andiman, M.D.. associate professor of pedi¬
atrics. epidemiology and laboratory medicine. He and his col¬
leagues in the Pediatric AIDS Program have treated Bobby
since I MS.'S, two years before the pediatric AIDS clinic opened,
freatment extends beyond Bobby's physical needs; the boy's
spirits have been bouyed by program staffers who have
arranged such outings as picnics, parties, trips to amusement
parks and summer camp.
As medical director of the AIDS Program at Yale, Dr. Andi¬
man oversees the clinical care of about 220 children born to
women infected with the human immunodeficiency virus
(HIV), the agent that causes AIDS. This number includes 6,^ or
more infected children. The adult clinic cares for approxi¬
mately 7.S() people infected by HIV.
Bobby's case illustrates the social problems that lend a
sense of urgency to the work of up to 7S researchers and clini¬
cians at Yale University and the School of Medicine who are
trying to understand and defuse the AIDS virus. Approxi¬
mately Sb.4 million in federal and private grants and contracts
support the medical school's studies, which include examining
the natural history and pathogenesis of infection in women and
children, developing and testing anti-retroviral pharmaceuti¬
cals, clinical investigations into new treatments, and studying
chemictil and cellular interactions of HIV. Other Yale physi¬
cians and scholars are focusing on ethical and social issues.
When .AID.S first appeared in the early 'SOs, no one in the
metlical establishment
including the School of Metlicine —

I nunc E !oilin’ is stajj w riter at the incilical sehool's office of
piihlii infonnation.
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had foreseen the appearance of such a destructive virus. With
mass immunization bringing the decline of polio, smallpox
and measles, it seemed as if the age of infectious diseases had
ended. That assumption proved tragically wrong.
As AIDS emerged as the next great epidemic, the medical
.school rued the day in the I96()s when it had phased out its
department of microbiology. Moreover, there was little coordi¬
nation among those Yale scientists who were doing AIDS
research.
Under the leadership of Dean Leon E. Rosenberg, M.D., the
School of Medicine is embarking on a course to strengthen its
AIDS re.search and clinical programs. Among tho.se steps are:
•

coordinating research efforts through a University-wide
consortium of faculty studying medical, psychological,
social and economic aspects of the disease;

•

recruiting a major AIDS researcher, Gerald H. Friedland,
M.D.. to lead this consortium. [See “Pioneer AIDS
Re.searcher Comes to the University,’’ page 17.|

•

moving AIDS care into expanded facilities in the Nathan
Smith Clinic and increasing the number of clinicians
treating AIDS patients;

•

establishing a section of microbiology;

•

opening a virology laboratory at the Laboratory of Epi¬
demiology and Public Health (LEPH) to serve as a core
facility providing state-of-the-art biological containment.

Comments Acting Dean Robert M. Donaldson, M.D.. “1
think that there will be more interdisciplinary research to
advance knowledge about AIDS and a greater awareness in the
University community about the challenge of AIDS. Both of
those should combine to facilitate new advances for people
with AIDS."

Quiet Crusaders
From its advent, AIDS riveted Dr. Andiman's attention
because it seemed to comprise an “encyclopedia of infectious
diseases." Patients were getting illnes.ses he had never seen
before, such as Pneumocystis carinii pneumonia (PCP), and
Kaposi's sarcoma, a sometimes aggressive skin tumor. Other
opportunistic pathogens — cytomegalovirus (CMV), a herpes
virus; Toxoplasma gondii protozoa; and the Candida fungus —
ravaged people with HIV-weakened immune systems.
As he worked with AIDS patients and their families. Dr.
Andiman discovered that he had to consider their social diffi¬
culties Just as .seriously as their medical problems.
"All of society's ills — poverty, discrimination, drug abuse
— are rellected in this disease," he asserts. "It seemed like an
extraordinary opportunity to really think about the social,
political and ethical aspects of medicine."
B. Joyce Simpson, R.N., a research nurse and coordinator
of the pediatric AIDS program, notes that discrimination
against people with AIDS .so frightens parents that they often
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will not let infected children know that they, the children,
harbor HIV. To protect the secret, some parents avoid taking
their children to AIDS clinics for care and counseling; others
decline home visits from nurses in fear of attracting the atten¬
tion of neighbors.
Brian W. Forsyth, M.D., assistant clinical professor of pedi¬
atrics, affirms; “The stigma exists and exists dramatically.
Mothers tell us stories of people crossing the street saying,
'Don’t go near them, they’ve got AIDS.’ ”
To help families cope with such problems. Dr. Forsyth and
colleagues have started the Comprehensive Support Program
for HIV-Infected Children. In the program, family support
workers offer mothers or other caregivers of HIV-infected chil¬
dren such services as delivering diapers or food, arranging a
ride to the clinic, or providing emotional support. Dr. Forsyth
serves as its medical director.
The program’s social services director, Steven F. Nagler,
M.S.W., points out that providing social support to the family
of an HIV-infected child can save money by reducing unneces¬
sary hospitalizations. Citing a 1988 study published by Dr.
Forsyth and colleague Kathy Kemper, M.D., Mr. Nagler notes
that more than 30 percent of the days HIV-infected children
spent in Yale-New Haven Hospital during 1987 were due to
such non-medical problems as not having a responsible adult
available to care for the children upon discharge.
Prenatal Challenges
Such research into social support complements basic and clini¬
cal studies being undertaken by medical school scientists.
Some pediatric AIDS researchers, for instance, are trying to
determine how and when mothers transmit the virus to their
babies during pregnancy or childbirth.
Although all babies born to HIV-infected mothers carry
antibodies to the virus, most lose the antibodies within six to
15 months after birth and never develop the disease. Dr. Andiman, Ms. Simpson and colleagues found that only about 25
percent of HIV-infected women giving birth at Yale-New
Haven Hospital transmit the virus to their children. Studies
elsewhere show rates of 15 to 40 percent.
Why some babies get the disease and others do not presents
one of the most perplexing questions facing pediatric AIDS
researchers. In the course of caring for approximately 200
HIV-infected pregnant women since 1984, Richard Viscarello,
M.D., assistant professor of obstetrics and gynecology, and
Nancy DeGennaro, R.N., M.RH. ’91, have studied 12 pairs of
twins born to infected mothers. They found three babies who
were infected when their twins were not.
Most infected babies acquire the virus before or during
birth. Dr. Viscarello says, but researchers are not sure how
often the virus is transmitted via two major routes, across the
placenta or through contact with secretions during birth. Physi¬
cians advise HIV-infected women not to breast feed, to elimi¬
nate this occasional route of infection.
To try to identify HIV-infected children early in life —
before birth if possible — Drs. Viscarello, Andiman and
George Miller, the John F. Enders Professor of Pediatric Infec¬
tious Disease, are perfecting several screening tests.
Dr. Viscarello notes that if physicians could determine ear¬
lier which babies will become sick, it might be possible to start
preventive treatments, such as prophylactic antibiotics or
antiviral drugs, sooner. Developing an accurate prenatal test of
fetal infection would also be helpful. He adds, “Women who
knew their babies would become infected could make
informed decisions about terminating their pregnancies.”
Dr. Andiman’s group has determined that when a baby’s
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Some Facts Regarding AIDS
•

An estimated 1.5 million of the world’s people have
had AIDS; half of them have died.

•

As of May I, the U.S. Centers for Disease Control
(CDC) listed 174,893 Americans who have had
AIDS; 110,530 have died.

•

The World Health Organization estimates that by the
year 2000, 40 million people will be HIV-infected,
including more than a million U.S. residents.

•

In fiscal year 1991, the U.S. government will spend
$1,152 billion on AIDS research and treatment.

•

Connecticut health officials estimate that 1 in 200
residents is infected with HIV, roughly the same as
the national rate.

•

As in other states, Connecticut’s AIDS cases are con¬
centrated in urban areas. New Haven has an esti¬
mated 2,800 residents infected with HIV and one of
the nation’s highest cumulative incidences of children
with AIDS.

Ph()((»graphs by .lames H. Anders<m

Dr. Warren Andiman and Joyce Simpson put one of their young
patients at ease.
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blood contains high levels of antibodies that prevent cells from
fusing, the infant is likely to develop a more benign fomi of
the disease, one associated with longer life. The researchers
attribute this to the fact that white blood cells infected with the
AIDS virus tend to spread infection by fusing with uninfected
cells. If scientists could develop a vaccine to elicit a similar
antibody response, it might inhibit the spread of the virus.
In another study of 31 women. Dr. Viscarello's group found
that HIV-infected women whose blood carried antigen from the
HIV core protein p24, became progressively sicker after deliv¬
ery or abortion, while women who lacked the antigen remained
clinically stable. In another study, they found that infection
appeared more often in babies born to antigen-positive women
than in babies born to HIV-infected women without this anti¬
gen. Testing for the presence of the protein might warn physi¬
cians that an HIV-infected woman is at risk and should be
observed closely, or that a newborn is more likely to develop
AIDS, he suggests. 'Hie researchers also have discovered that

The guidelines were adopted in the fall of 1990 by a group of
prominent AIDS re.searchers, patients and community activists
meeting in New York.
Dr. Levine has also worked on developing national and
international policy governing the use of human subjects in
AIDS research. He directs the World Health Organization’s
project for developing guidelines for testing of HIV drugs and
vaccines. Among other groups. Dr. Levine advises the Council
for International Organizations of Medical Sciences, the Pan
American Health Organization and the AIDS Program Advi¬
sory Committee of the U.S. Department of Health and Human
Services.
Drugs Plus Sex: A Dangerous Combination
Although homosexual men still make up the largest category of
U.S. AIDS sufferers, increased infection among heterosexual
drug abusers is amplifying sexual infection of women, the
fastest growing population of AIDS patients, and through child¬
birth, their children.
This paradigm tends
to concentrate the
spread of the disease
in poor urban areas.
[See “Public Policy
in the Age of AIDS,"
Y,.\le Medicine, FallWinter 1990-1991.]
The fact that three
of every 10 AIDS
patients
in
New
Haven are women —
triple the national
rate — reflects the
spread
of
AIDS
among drug abusers.
Nearly all of these
women either have
used
intravenous
drugs or had sexual
intercourse with an
’
iDiind in *
•
.
* 'UiKi
IV-drug
abuser,
observes Dr. Viscarello, who also
runs a program to
treat substance-abus¬
ing pregnant women.
In a study. Dr.
Viscarello's
group
has treated 32 preg¬
nant women with
zidovudine, or AZT, the first federally approved AIDS medi¬
cation. AZT slows HIV's progression by interfering with
reverse transcriptase, an enzyme crucial to the virus’ reproduc¬
tive process. [See “Making Viral Replication Crystal Clear,"
page 18.1 Dr. Viscarello's preliminary evidence suggests that
the drug usually does not adversely affect the fetus and may
improve maternal health.
To treat both male and female HIV-infected substance
abusers. Thomas R. Kosten. M.D., associate professor of psy¬
chiatry, and Marc Rosen. M.D., instructor in psychiatry, are
directing several studies of drugs to improve mental function,
riiey have conducted a small study evaluating peptide T, an
analog of a key neurotransmitter, in IV-drug users with AIDS.
The compound, by binding to the same site in brain cells
attacked by HIV, appears to relieve the dementia that can

!

Dr. Rii hard Msc arello counsels a pregnant patient.
irregular PAP smears in seropositive women progress much
faster to invasive cervical cancer than in uninfected women.
Such differences in disease progression are one reason
women, including pregnant women, should be included in
more clinical trials of AIDS medications, argues medical ethicist Robert .1. l.evine, M.D., professor of medicine and chair¬
man of the medical school's human investigation committee.
“C'linical trials should include populations which are often
excluded, such as women who could become pregnant, intra¬
venous drug users, prisoners, racial and ethnic minorities, and
patients taking other AIDS medications and with other ill¬
nesses," he says.
Dr. l.evine has co-authored national guidelines urging
researchers to involve persons with AIDS and other commu¬
nity members in the tiesign of tests of new AIDS treatments.
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afflict AIDS patients. Dr. Kosten is also testing Ritalin, a cen¬
tral nervous system stimulant that has shown promise in
improving mental functioning in HIV-infected patients.
In pursuing the source of cognitive problems, Scott W.
Woods, M.D., associate professor of psychiatry and diagnostic
radiology, and Chris van Dyck, M.D., postdoctoral fellow,
have used SPECT — single photon emission computerized
tomography — to detect increased blood flow in the brains of
infected individuals, a possible signal of neurological prob¬
lems. Dr. Kosten believes SPECT offers a valuable tool in
monitoring patients for early signs of mental dysfunction.
The Quest for New Treatments

_

While many physicians use AZT to slow the progression of
HIV, the drug harbors .serious problems. Among these are bone
marrow suppression and the tendency of patients to develop a
tolerance to the drug. Yale researchers are among the many
clinicians, pharmacologists and virologists trying to create, test
and evaluate treatments to improve on or supplement AZT.
One such promising experimental drug is didehydrodeoxythymidine, or d4T. William H. Prusofl', Ph.D., professor of
pharmacology, and Tai-shun Lin, Ph.D., senior research scientist
in the department of pharmacology, have discovered that d4T,
like AZT, blocks reverse transcriptase and effectively suppresses
some symptoms associated with HIV infection. Moreover, slight
chemical differences between the two drugs may mean that d4T
will fight the virus even after a patient has developed AZT toler¬
ance. Keith A. Joiner, M.D., professor of medicine and chief of
the infectious diseases section, and Dr. Eriedland are directing a
clinical study of d4T, in collaboration with Helen Brett-Smith,
M.D., AIDS fellow; Yung-chi Cheng, Ph.D., the Henry Bronson
Professor of Pharmacology, who is affiliated with the Yale Com¬
prehensive Cancer Center; and John W. Mellors, M.D., associate
re.search scientist in medicine.
AIDS patients at Yale-New Haven Hospital are also receiv¬
ing dideoxyinosine, ddl, another promising nucleoside analog.
Frank J. Bia, M.D., associate professor of medicine in the
infectious diseases section, and Thomas F. Patterson, M.D.,
assistant professor of medicine, have been co-directing the
Yale .segment of a 12-center study comparing ddl with AZT in
AIDS patients who are not responding well to AZT.
In still other drug research. Dr. Patterson is conducting a
clinical study of a new way to administer the antifungal drug
amphotericin B to patients with cryptococcal meningitis, an
opportunistic infection. The compound is packaged in lipo¬
somes, lipid vessicles that deliver the drug with less toxicity.
An unwelcome side effect of such analogs as dideoxycytidine (ddC) and d4T, and to a lesser extent ddl, is peripheral
neuropathy, or numbness and nerve inflammation in the legs or
arms. When these symptoms first appeared in AIDS patients
taking ddC, Samuel Broder, M.D., director of the National
Cancer Institute, turned to his colleague. Dr. Cheng, at Yale.
Becau.se of the way neurological symptoms first appeared.
Dr. Cheng suspected that the drugs were acting on target
organs to selectively inhibit the synthesis of DNA of mito¬
chondria, small bodies in the cytoplasm which produce the
cell’s energy.
Dr. Cheng and colleagues have developed a compound
closely related to ddC which they call S-ddC, for thia-dideoxycytidine. In cell cultures, the drug seems to inhibit HIV repli¬
cation but not mitochondrial DNA synthesis. Phamiaceutical
companies are now undertaking animal studies on this agent.
Other anti-HIV compounds in Dr. Cheng’s lab are likely to
come from an unorthodox source: traditional Chinese herbal
Continued on paite 19
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Dr. Gerald Friedland

Pioneer AIDS Researcher
Comes to the University
Gerald H. Friedland, M.D., professor of medicine, who will
facilitate Yale’s AIDS research and clinical programs Univer¬
sity-wide and at Yale-New Haven Hospital, is a national expert
on HIV transmission modes. Working in New York at the
Montefiore AIDS Center, which he co-directed. Dr. Friedland
was the first to document that the virus is not spread by casual
contact.
In 1982, Dr. Friedland and colleagues also were among the
first to alert the public that AIDS could be transmitted heterosexually and from mother to child. Later, they described the
importance of intravenous drug use in fueling the epidemic.
Dr. Friedland studies the complex interactions among
behavior, gender, socioeconomic status, race and HIV infec¬
tion. He has developed Montefiore’s model multi-disciplinary
AIDS program, involving physicians, nurses, social workers,
drug counselors, nutritionists, mental health workers, clergy
and others.
A Brooklyn native. Dr. Friedland earned an A.B. degree
from Columbia College in 1959 and an M.D. degree from the
New York University School of Medicine in 1964. He was
professor of medicine, and epidemiology and social medicine
at the Albert Einstein College of Medicine.
Comments Dr. Friedland, “My vision for Yale and New
Haven is to provide superior, comprehensive clinical care for
individuals with HIV infection and their families, to establish
programs to train physicians, nurses and other health care
workers in caring for HIV-infected patients, and to develop
large scale epidemiologic studies, and clinical trials of experi¬
mental therapies.”
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Making Viral Replication Crystal Clear
Basic research into cell function may lead Yale researchers to
new or improved drugs that will thwart HIV by exploiting the
peculiar way it reproduces. Nonnally, a cell’s DNA produces a
negative copy of itself called RNA, a nucleic acid which
directs the manufacture of vital proteins. But HIV, a retrovirus,
uses the enzyme reverse transcriptase to transfer genetic infor¬
mation from RNA into DNA.
Since retroviruses have reverse transcriptase but human
cells do not, researchers in the department of molecular bio¬
physics and biochemistry (MB&B) are trying to learn about
the enzyme's structure to help develop anti-retroviral chemi¬
cals. The Yale scientists are studying reverse transcriptase and
the chemical structure and function of other HIV proteins
under a 5-year, $4.6 million National Institutes of Health grant
with support from the Howard Hughes Medical Institute
(HHMl). One of the program’s early successes has been the
growth of crystals of reverse transcriptase suitable for x-ray

crystallography. Using this technique, Thomas A. Steitz,
Ph.D., professor of MB&B and an HHMI investigator, will be
able to determine the enzyme’s molecular structure by study¬
ing the patterns of x-rays scattered by the crystal.
“Nobody’s been able to get suitable crystals to solve the
structure until now,’’ explains Dr. Steitz.
If successful. Dr. Steitz and his collaborators will be the
first to determine a structure for reverse transcriptase, informa¬
tion that will help develop medications to block reverse tran¬
scriptase, thus halting HIV with minimal side effects.
His collaboration with Donald M. Crothers, Ph.D., the
Alfred E. Kemp Professor of Chemistry, has uncovered infor¬
mation about how a fragment of the HIV protein, called trans¬
activator protein, or tat, may trigger viral replication. William
C. Summers, M.D., Ph.D., professor of therapeutic radiology,
human genetics and MB&B and in the Cancer Center, made a
clone that mass produces reverse transcriptase in bacterial cell
cultures.
The coordinator of MB&B’s NIH grant, Donald M. Engelman, Ph.D., professor and chairman of the department of
MB&B and professor of biology, is collaborating with Frederic
M. Richards, Ph.D., the Sterling Professor of
MB&B, to study how the lipid membrane
enveloping HIV fuses with white blood cell mem¬
branes. This fusion allows the virus to inject
genetic particles into the cell and spread infec¬
tion.
The culprit. Dr. Engelman thinks, is glycopro¬
tein 41, which is found in the membrane envelop¬
ing the virus. Dr. Engelman and his group are
working to develop a way to screen drugs that
would block the aggregation of gp41, thereby
preventing HIV’s spread.
Outside of the MB&B projects, medical school
researchers are seeking information about HIV
genetics. For instance, I. George Miller, M.D., the
John F. Enders Professor of Pediatric Diseases,
has spliced genetic segments of two HIV strains,
one that seems to reproduce rapidly and one that
does not. Dr. Miller hopes the resulting recombi¬
nant virus will help him locate the HIV gene that
controls rapid replication.
In another project. Dr. Miller, who also has
appointments in epidemiology, MB&B and in the
Cancer Center, is working with John K. Rose,
Ph.D., professor of pathology and cell biology.
Dr. Rose’s laboratory has developed an intracellu¬
lar trap for a critical HIV surface protein. HIV
normally binds to the CD4 molecule found on the
surfaces of white blood cells called T cells. Dr.
Rose and Linda Buonocore, P.A., associate in
research pathology, have genetically crafted a T
cell that also contains a mutated CD4 molecule
retained inside the cell. In theory, this CD4 will
prevent production of infectious AIDS virus in
the.se cells by trapping the critical surface protein
of the virus inside the cell.
All these scientists are contributing to a deeper
understanding of basic virology, not just HIV,
observes Dr. Engelman. “We’ll undoubtedly learn
something about the basic structures of viral
enzymes,” he comments. Adds Dr. Steitz, “We’re
putting a lot of effort into reverse transcriptase,
however, because of its importance in HIV.”
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Continued from page 17
remedies. After screening more than 150 such remedies for
antiviral and anti-cancer properties. Dr. Cheng and colleagues
identified about two dozen plants which seem to block reverse
transcriptase. Now they are trying to identify the active sub¬
stances in three herbs with apparent anti-HIV potential.
In yet another project. Dr. Cheng is collaborating with Dr.
Mellors to learn how HIV strains become resistant to antiviral
compounds. Dr. Mellors conducts his research at the Depart¬
ment of Veterans Affairs Medical Center in West Haven.
A colleague of Dr. Mellors' at the West Haven VA, Marie
L. Landry, M.D., associate professor of laboratory medicine
and medicine, directs the Virology Reference Laboratory,
which includes a retrovirus diagnostic section directed by
Brigitte R Griffith, Ph.D., associate professor of laboratory
medicine. The section serves the VA system nationwide as a
resource for testing for the antibody, antigen and infectious
virus in clinical specimens. The laboratory of Drs. Landry and
Griffith was the second in the U.S. to recover HIV-2 from a
patient’s blood sample. Dr. Griffith and her colleagues also
actively develop new improved tests for the laboratory diagno¬
sis of retroviruses.
Also at the VA, G.D. “Edith” Hsiung, Ph.D., professor
emeritus of laboratory medicine and a research career scientist.

»

draws upon her experience developing accurate, rapid diagnos¬
tic techniques to evaluate compounds against HIV and
cytomegalovirus (CMV) infections. She uses an electron
microscope to identify new antiviral drugs that can interact at
the cellular level to prevent AIDS virus from entering and
infecting healthy cells. She afso uses guinea pigs to evaluate
new drugs for the treatment of CMV infections in humans.
Another opportunistic infection under scrutiny on the
School of Medicine campus is PCP, Pneumocystis carinii
pneumonia. Martine Y.K. Armstrong, M.D., a research scien¬
tist in epidemiology, says the organism responsible for PCP is
difficult to study because it grows poorly outside the body. Its
sticky properties also make the organism difficult to purify in
any quantity. She and her colleagues are working to develop a
short-term culture system that will facilitate the search for
better PCP medications.
These varied research projects will be enhanced by Univer¬
sity-wide efforts to coordinate work in AIDS. Says Dr. Friedland. "The broad and deep expertise at Yale in the social .sci¬
ences as well as the biologic sciences offers a special
opportunity to study the epidemic in all its varied manifesta¬
tions. We are still at the beginning of the HIV epidemic; its full
force has yet to be felt. It’s imperative to make this a central
focus of scholarly work.”
YM
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Dr. Yung-chi “Tommy” Cheng is investigating potential anti-HIV agents among traditional Chinese herbal medicines.
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1991 LERNER AWARD
The Depression Man
1931
I knew a Depression man who could
dream flavor into his soup, through iron cauldrons;
You have seen him in the newsreel breadlines:
his dreams, his dreams of cigarettes and dimes
He walked the mudfield, flowering velvet
roses from useless rosehips
And there was a tune whistled on his lips to which
marigolds would boing from the tired earth
When hunger rang in him, his spirits jangled too:
a scrap filled him like a loaf of bread
Or if it rained and he stood there a wilting rabbit
then a sunbeam would seem to gild his head
He stubs a toe and wincing
pirouettes in exquisite pain
holding it, or if it rained.
He had a luxury of thoughts, he hummed,
a rhapsody in dustbowl
He relished watery coffee and stews
He sang with bright the blues
and yellows
Hey brother hey remember his
sinewy Rockwell frame and trousers aluff
in the field, the sour circus
on a field of smiling mud when he
vacuumed sunlight into a tin cup
Tell the lost coins that call for him
he cannot wait,
1 cannot forget the Depression man
in the thirties with the hate, the hate
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Christopher Fey

Christopher Fey, ’93
Medical Student as Poet
—

Christopher Fey began writing poems in high school in Suffern, N.Y., and in his junior and senior years won his school’s
poetry prize. Majoring in English at Amherst College, he
attended the Breadloaf and Wesleyan writers conferences and
won the Rolfe Humphries poetry prize at graduation. He is
attracted to several fields of medicine, particularly cardiology.
With an interest in medical ethics, Mr. Fey is considering the
pursuit of a law degree in addition to his training in medicine.

Editor’s note: The 1991 Marguerite Rush Lerner Prize for
creative writing hy a medical student was shared by 1993
classmates Christopher Fey and Lisa./. Nelson. Because of the
outstanding quality of their entries, a selection of each submis¬
sion will be featured in Yale Medicine, with Ms. Nelson’s
work appearing in the FalllWinter 1991-1992 issue.
Yale Medicine Summer 1991
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To a Dying Man, Once Like a Tree
Merely a bed holds him now, spoiled rind of a giant;
Once my Goliath, a spectre masquerades in human flesh.
“Many things charade as truth,” he would say.
And so had taught suspicion: this a superficial
Film, that a crude veneer.
Those are pages turning before his sunken eyes;
The pastel plates of a children's book,
A giant man stitched to the ground;
A Victorian house near a giant triple-tree.
Then grasses ameliorate with their softness the
Scene and what is said;
Thickets knit to restrict what once were paths.
Trellises curl with thorns.
Paint falls away from the wood in peels.
Those are pages turning before his eyes — or only
Truth shrouded in hope — truth colored with my desire.
See what has descended — indestructible quiet;
A quilt of breezeless solitude.
The tree lush and heady has now folded.
Its iron limbs have soaked, cracked.
Fallen from the famous triple-trunk:
One sister bows, one is broken, one stands, still.
Wanting only collapse.
“You should not want melancholy here,” we say.
For the trickle of the stream is now swollen.
Its brown banks are soft as cake —
Perhaps some light glazes the wet trunk.
You should not ask for melancholy here, as if
A river would form as if
A new tree were promised rise.
As if one could want anything of a new tree.

— Christopher Fey. Med. '93
YM

Yalk Medicine Summer 199

GALLERY
Plague scene from Johannes de Ketham’s Fasciculus medicinae

Yale Medical Historical Library

In the 14th century the bubonic plague, also known as the
Black Death, destroyed from a quarter to a half of Europe’s
population. Plague epidemics continued to devastate
Europe into the 17th century.
This woodcut, which appeared in Ketham’s Fasciculus
medicinae, shows a physician attending to a plague victim
whose opulent surroundings reveal his prosperity. The
doctor holds a vinegar-soaked sponge or pomander to his
nose to ward off infection while taking the pulse of the
moribund patient. According to Robert S. Gottfried in The
Black Death (1983), plague specialists were either incom¬
petent or unestablished doctors who nonetheless earned a
respectable income because of the danger of their practice.
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Fasciculus medicinae. first published in 1491 in Venice,
was one of the earliest printed medical books and is consid¬
ered to be the first showing anatomical illustration. The
above illustration did not appear until a 1493 edition. The
book contains several full- and partial-page woodcuts, which
are lavishly hand-colored in the copy in the Yale collection.
The artist is unidentified, although attributions have been
made to Venetian painters Gentile Bellini (c. 1429-1307) and
Andrea Mantegna (1431-1306), based on the characteristic
style of the illustration.
.fanice Braun, Historical Library
Harvey Cushing!John Hay Whitney Medical Library
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STUDENT RESEARCH DAY
Photographs by Harry Bishop

Bernice Kafni (Hover explains to Dr. John M. Leventlial her findings o)i the relationship between previous benign biopsies and snbseipient malignant melanoma.

Opening Remarks
I'he health of student research at this medical school is excel¬
lent. The best evidence for this is the 52 scientific posters you
have just been viewing at the Fifth Annual Student Research
Day. 1 applaud the scientific output and the student-faculty col¬
laboration that they vividly display.
Another measure of the health of student research is the
growth in the number of students receiving competitive fund¬
ing tor their research. At the time of our first poster .session
five years ago, 92 students received stipends totalling
SIS4.0()(). I'his year, IXK students received competitive fund¬
ing totalling .S471,()(K). This entire increase has resulted from
external grants, from agencies and gifts from donors.
We now have named research fellowships in honor of FTlith
llsiung. James Hirsch, Vernon Lippard, Richard llirschfield,
Idta Chidsey and Richard Gershon. 4'he Student Research Pro¬
gram has received external grant support from the American
Ill-art .Association. National and Connecticut affiliates; the
t onnecticut Cancer Society, four grants from the National
Institutes ol Health, as v\eil as the Howard Hughes Medical
Institute and the Juvenile Diabetes [foundation.
24

1 want to acknowledge the valuable help of our thesis com¬
mittee. In addition to serving as the prize committee, these
individuals have been of major assistance to our office in rais¬
ing the external grants to support student re.search.
Finally. I want to recognize the excellent art work done by
biomedical communications, particularly by Linda Seigneur
and Gail Beamon. Dean Gifford and Betsy Winters continue to
give considerable effort and support to the program. Our spe¬
cial thanks today goes to Nancy Dometios. who. for the fifth
year, has organized this day and run our office. Every grant,
student application, poster, even every paycheck generates vol¬
umes of paper, phone calls and work, and Nancy handles it all.
1 would also like to welcome Dr. Lee Farr and Mrs. Farr, the
sponsors of the lectureship, who are with us from California.

John N. Forrest Jr.. M.D.
Professor of medicine
Director, office of student research
Yale MEDictNE Summer 1991

Abstracts
Immunology of Human Peripheral Nerve
and the Response to Nerve Transection
in a C3H/HeJ Mouse Model
hy James Edward Stanislaw
Advisor: Thomas Trumhle, M.D., associate professor
Chief, hand surgery service, department of orthopaedics
University of Washington. Seattle
Research in limb reconstruction using peripheral nerve tissue
has been hampered by tissue rejection. Animal models of
peripheral nerve transplantation have exhibited significant
rejection reactions leading to poor outcomes. The reactions
have occurred despite cross-matching the nerves for MHC
(major histocompatibility complex) Class I antigens. Other
research has shown MHC II antigens to be instrumental in
graft rejection, perhaps more important than the role of MHC
Class I antigens. Despite claims that MHC Class II antigens
are not present in peripheral nerve, this study attempted to
define the immunology of peripheral nerves with respect to the
presence of MHC II antigens. The presence of such antigens
could add to the explanation of nerve graft rejection.
The specific aims of this study are: 1) search for MHC class
II antigens on peripheral nerve; 2) determine what cell type
expresses the antigen if present; and 3) using a mouse model,
investigate changes in the antigen concentration after trauma.
In order to provide more information on the immunology of
peripheral nerves, 35 specimens (26 from seven cadavers and
nine from surgical biopsies) were analyzed for the presence of
MHC Class II antigens using monoclonal antibodies raised
against HLA-DR, HLA-DP, and HLA-DQ (human leukocyte
antigen is the human synonym for MHC) and an avidin-biotin
enzyme complex with chromogen. MHC II antigens were
noted in all human nerve specimens and the percentage area
under light microscopy of positive staining by computer ana¬
lyzed immunohistochemistry were significantly higher (3.82
percent +!- 1.01 percent) than negative controls (0.05 percent
+j- 0.02 percent) (p=0.01).
S-100 double staining techniques as well as electron micro¬
scopic tissue fixation were used to identify cell types.
A C3H/HeJ mouse model was used to evaluate the effect of
nerve transection (trauma) on the presence of MHC II anti¬
gens. Monoclonal anti-IA antibody was used in the same
method of light microscopic, computer analyzed immunohisto¬
chemistry as performed in the human study. Fifteen to 21 days
after transection of the sciatic nerve in 10 mice, there was a
statistically significant increase (p=0.05) in the presence of
MHC Class II antigens in the distal portion of the nerve (4.49
percent +!- 0.78 percent) versus samples from eleven mice
that had exposure of the nerve without transection (1.44 per¬
cent +!- 0.21 percent) or in nerves from 17 mice that had no
surgery (1.02 percent -I-/-0.21 percent) in that limb.
Clinical relevance: The presence of MHC Class II antigens
could require more complex cross-matching for tissue trans¬
plantation. Nerve grafts which have undergone Wallerian
degeneration may actually be more prone to rejection than
other peripheral nerve tissue transplants, depending upon the
length of time of degeneration.
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Paid Isenharger displays his hypermedia computer program,
designed to provide interactive instruction in cardiac magnetic
resonance imaging.
The Image of the Woman Physician
in 10 Victorian American Novels
hy Sonya S. Erickson
Advisor: John Harley Warner, Ph.D.
Associate professor of the history of medicine
Between 1871 and 1886, in the midst of sweeping changes in
the status and representation of women, at least 10 novels fea¬
turing female physicians and medical students were published
in America. Their authors were generally well-known to Victo¬
rian American readers and included Mark Twain, Henry
James, Louisa May Alcott, and Harriet Beecher Stowe.
Despite the differences among both their creators and their sto¬
ries, these heroines had a great deal in common. In general,
they were constructed as “American” figures, meaning they
were young, single, attractive, white, middle- to upper-middle
class, and blessed with a long-standing New England pedigree.
Veritable pictures of health, they followed the dictates of the
contemporary dress-refomiers and moved freely throughout
their surroundings.
Their respective career paths were similarly uniform, begin¬
ning with their mutual childhood interest in the art and science
of healing. Having received their formal medical training in
American and European universities, the heroines proved
capable of carrying out a variety of tasks, including ligating
arteries, compounding remedies, and easing a patient’s final
days.
The medical heroines’ unconventionality, however, had its
limits. While fully aware of the women’s rights movement and
grateful for its achievements, for example, they maintained a
respectable distance from the organization. Though society in
general was depicted as unsupportive of their plans, the char¬
acters who knew them best approved of their professional
goals wholeheartedly, a sign that readers and critics should
applaud the heroines’ actions as well.
Available reviews and letters indicated that many contem¬
poraries did so, often arguing that the heroines were “real” in
the process. The representation of and response to the woman
doctor in Victorian American fiction raise questions about the
impact her monolithic image had on contemporary society. As
the numbers of women doctors, both real and imaginary,
increase again, such questions remain relevant today.
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David J. Eisenman answers Dr. Joseph W’arshaw's question about his research into
chronic hypoxia in developing rats.

Steroid Hormonal Effects on
Choleeystokinin Binding in the Central Nervous System;
P(»tential Role in the Control of Appetite
h\ Jeanne B. .Acknian
.Advisors: Neil J. .MacLusky. Ph.D.
Professor of obstetrics and gynecology
Toronto (ieneral Hospital
Frederick Naftolin. M.D.
Professor and chairman of obstetrics and gynecology
Among cholecystokinin's (CCK's) multiplicity of physiologi¬
cal roles is its role as an appetite suppressant. The purpose of
this study was to detemiine the effects of two hinds of steroid
hormones known to intluence feeding behavior and body
weight, namely estrogens and glucocorticoids, or "stress hor¬
mones." on CCK receptor levels. Particular attention was
gi\en to their effect in the ventromedial nucleus of the
hypothalamus (VMN). a neural center of feeding and repro¬
ductive behavior.
Experiment 1(a) was perfomied to detemiine if the sex dif¬
ference in rat feeding behavior is borne out in a differential
response of CCK binding to estrogen treatment in males and
females. Male and female rats were gonadectomized and
adrenalectomized (.ADX) and. after 7 to 10 days of rest, were
implanted subcutaneously v\ith Silastic capsules containing
either cholesterol vehicle or 10 percent estradiol. The animals
were weighed pre-and post-treatment and sacrificed after three
days of treatment. Specific binding of 1125-1] CCK-8S was
determined in this experiment and in the ones that follow after
in vitro incubation of frozen brain sections, autoradiography,
and quantitation of the images with computer-assisted densito¬
metry. F2xperiment 1(a) revealed a sex difference in CCK find¬
ing in response to estrogen treatment — w hile estrogen caused
dow n-regulation of CCK receptors in females (p=0.()()()l), it
had no effect on CCK binding in males. The regional specilicity ol this effect in females (VMN and cingulate cortex) was
suggested by this experiment and confimied in a subsequent
study. The suggestion of higher overall levels of CCK binding
in the female cingulate cortex and VMN when compared with
males was also confimied in this subsequent study. The fact
that onl\ males showed a decrease in body weight gain on
estrogen therap) that approached statistical significance
(p=().()7) can be explained bs the typical 4 to 6 week post-cas26

tration hyperphagia that exists only in females. Both males and
females have been shown repeatedly to lose weight on estro¬
gen therapy (when unopposed by progesterone).
Experiment 1(b) was performed to detemiine if the effect of
estrogen on CCK binding is exerted locally in the VMN or
more proximally in the neural chain. Eemale rats were ovariectomized. given at least 8 days of rest, and then bilaterally
implanted by stereotactic means with 23-gauge steel guide
tubes over the VMN. Three days after intracranial surgery, the
hormonal/cholesterol treatments were begun via 30-gauge
internal cannulae. The animals served as their own controls,
receiving 1.0 percent estradiol (diluted with cholesterol) on
one side and cholesterol vehicle on the other side. After three
days of treatment, the animals were sacrificed. Cannula place¬
ment was histologically verified. No effect of local estrogen
treatment on CCK binding was noted (no difference between
left and right VMN CCK densities was observed). Hence, the
effect of estrogen on CCK binding in the VMN appears to be
indirect.
Experiment 2 was perfomied to detemiine if dexamethasone. an essentially pure glucocorticoid, also affects CCK
receptors levels. Male rats were partitioned into three groups:
the experimental group was ADX and treated with daily morn¬
ing subcutaneous dexamethasone (DEX) injections at a
"stress" dose=200 ug/kg body weight in a vehicle (10 percent
ethanol, 10 percent propylene glycol, 80 percent nomial
saline); one of the control groups was .ADX and injected with
vehicle only; and the other control group (SHAM) was ether¬
ized but not .ADX and injected with vehicle only. Each group
was caged separately and all animals were weighed pre- and
post-treatment. .After three days of treatment, the animals were
sacrificed. .All DEX-treated animals showed decreased CCK
binding (p=0.01) and decreased body weight (p=0.001) when
compared with the control groups.
In summary, the above results suggest a sexually dimorphic
distribution of CCK receptors in rat brain and a role for estro¬
gens and glucocorticoids in modulating these receptors. Sev¬
eral proposals are made w ithin this medical doctorate thesis: 1)
estrogen is proposed as a feedback signal of body adiposity to
the VMN; 2) CCK is proposed as the neural ami of both estro¬
gens and glucocorticoids in the CNS; and 3) CCK is proposed
as an instrumental neuropeptide at the interface between stress,
feeding and reproductive behavior.
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African-Americans at the Yale University
School of Medicine: 1810 to 1960
by Daryl K. Daniels
Advisor: Curtis Patton, Ph D.
Professor of epidemiology (microbiology)
African-Americans have had a long and interesting history at
the Yale School of Medicine. Through extensive researching
of primary and secondary sources, this history is documented
for the first time. The first African-American known to have
graduated from the School was Dr. Courtlandt Van Rensselaer
Creed. Because of strong abolitionist sentiment at Yale and in
New Haven during the 1850s and his family’s prominence in
New Haven, Dr. Creed was able to matriculate at the School of
Medicine in 1854. He graduated in 1857 and practiced in New
Haven. He also served as a surgeon in the Civil War.
Two more African-Americans graduated from the Yale
School of Medicine in 1875 and 1876. These students. Dr.
Bayard T. Smith and Dr. George R. Henderson, transferred to
Yale from Lincoln University.
In 1888 the School of Medicine became a leader in AfricanAmerican medical education, graduating eight African-Ameri¬
cans in 12 years. Many of these people made significant con¬
tributions to medicine and their community. This lead was lost
when a rise in intolerance caused Yale’s schools of medicine
and nursing to adopt an “unwritten policy” of racial exclusion.
The policy was disclosed in 1941 when an African-American
applicant applying to the School of Nursing was turned away
due to her race. In the controversy that followed, the policy
was rescinded and African-Americans were again allowed to
attend the medical and nursing schools. In 1948 Dr. Beatrix A.
McCleary became the first African-American woman to grad¬

uate from the School of Medicine. African-Americans contin¬
ued to graduate from the school at a rate of approximately one
every other year until 1960.
By using this history as a guide, it is thought that the Yale
School of Medicine can better recognize the contributions made
by its African-American students and take steps to regain its
leadership role in African-American medical education.
Transcriptional Regulation of
Apolipoprotein Gene Expression
by Agiisti'n Melidn
Advisor: Andrew Stewart, M.D.
Associate professor of medicine (endrocrinology)
Apolipoproteins are the polypeptide subcomponents of the
lipoprotein lipid transport system. They play a vital role in the
transport, delivery and metabolism of cholesterol and triglyc¬
erides. Variations in lipoprotein levels correlate with risks for
arteriosclerosis and heart disease. Variations in individual
apolipoproteins also are as.sociated with various disease states.
In an effort to understand the mechanisms controlling
apolipoprotein synthesis at the level of gene expression, we
examined the 5’ regulatory regions of these important hepatically expressed genes. We identified a similar cisacting
sequence element (C3P element) in the proximal promoters of
the apo cm, apo B, apo AI and apo CII genes. In each case
this element maintains a highly conserved sequence, activates
transcription in hepatic cells and hinds a common protein, AFI. We demonstrate that the C3P element activates transcription
in hepatic specific gene expression and suggests a method by
which the production of functionally related proteins might be
regulated.

Back row (from left): .James Stanisiaw, Sonya Erickson, Augustin Melidn, .Jeanne Ackman and Daryl Daniels.
Front row: Drs. Robert Gifford, Sidney Altman, Leon Rosenberg and John Forrest. Dr. Altman, the Sterling Pro¬
fessor of Biology and a 1990 Nobel laureate, delivered this year’s Lee Farr Lecture.
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RESIDENCY PLACEMENTS 1991
CALIFORNIA
Children’s Hospital, Oakland
Stacy BeWer. pediatrics
Children's Hospital of San Francisco
Ole AAssar, medicine
Janies Hicks, medicine
Community Hospital, Santa Rosa
Colleen Foy, famiiy practice
Kaiser Permanente Medical Center, Oakland
Narisse Kendrick (Daye), medicine
Naval Hospital, San Diego
Symphorosa Williams, medicine
Christopher Steevens, transitionai
University of California, Los Angeles
Daniel Geschwind, medicine, neuroiogy
Edward McNellis, ophthaimoiogy
University of California, San Diego Medical Center
David Bernard, anesthesioiogy
Elizabeth Bower, anesthesioiogy
Scott Edwards, obstetrics and gynecoiogy
University of California, San Francisco
Ole AAssar, diagnostic radioiogy
Jorge Arroyo, ophthaimoiogy
Michael Capozza, anesthesioiogy
David Chiu, medicine, neuroiogy
Steven Finkbeiner, medicine, neuroiogy
Ethan Halm, internai medicine
Marc Seltzer, nroiogy
Margaret Toth, internai medicine
University of Southern California, Los Angeles
Philip Chen, ophthaimoiogy
Paul Isenbarger, diagnostic radioiogy
Quoc Nguyen, otoiaryngoiogy
Veterans Administration Medical Center, Martinez
Bernice Glover, internai medicine

COLORADO
University of Colorado School of Medicine, Denver
Ngozi Okezie, psycinatry

CONNECTICUT
Danhury Hospital
David Bernard, medicine
(ireenwich Hospital
Jeanne Ackman, medicine
Michael Borodkin, medicine
Hospital of St. Raphael, New Haven
fdizabeth Bower, medicine
Norwalk Hospital
Christopher Hobbie, diagnostic radioiogy
St. Mary’s Hospital, Waterbury
James Hartleroad, generai surgery
Alex Ortiz, primary carelinternai medicine
St. \ incent’s Medical Center, Bridgeport
Edward McNellis, transitionai

2K

Yale-New Haven Hospital
William Andrews, internai medicine
Ercem Atillasoy, medicine
Mark Barad, medicine
Peter Bernstein, obstetrics and gynecoiogy
Mark Bianchi, surgery, otoiaryngoiogy
Donna Brezinski-Caliguri, pediatrics
Gaetane Francis, obstetrics and gynecoiogy
David Frankfurter, obstetrics and gynecoiogy
Gwendolyn Grant, internai medicine
Lawrence Hirsch, medicine
Michael Leehy, medicine!primary
Ellen Markstein, medicine
Marc Siherherg, pathoiogy
Robert Spillane, medicine
Naomi Taylor, pediatrics
Marco Verga, diagnostic radioiogy

DISTRICT OF COLUMBIA
Children’s National Medical Center
Gonzalo Paz-Soldan, pediatrics
George Washington University Hospital
Lauren Rodgers, obstetrics and gynecoiogy
Walter Reed Army Medical Center
Betty Kim. generai surgery

FLORIDA
.lackson Memorial Medical Center, Miami
Pablo Quintela, internai medicine

GEORGIA
Emory University, Atlanta
Cargill Alleyne. neurosurgery

IOWA
University of Iowa Hospital, Iowa City
Ellis Webster, surgery, otoiaryngoiogy

MASSACHUSETTS
Baystate Medical, Boston
E. Vivek David, medicine
Beth Israel Hospital, Boston
Jean Fraser, pathoiogy
Paula Watnick, internai medicine
Mindy Wiser, obstetrics and gynecoiogy
Boston City Hospital, Boston
Douglas Fleming, internai medicine
Andrea Polesky, internai medicine
Brigham and Women’s Hospital, Boston
E. Vivek David, diagnostic radioiogy
Karen Hsieh, obstetrics and gytiecoiogy
Charles Lu, internai medicine
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Agustin Melian, internal medicine
Brenda Sirovich, internal medicine
Children’s Hospital, Boston
Bruce Horwitz, pediatrics
Massachusetts Eye and Ear Hospital, Boston
Young Kwon, ophthalmology
Massachusetts General Hospital, Boston
Jeanne Ackman, diagnostic radiology
Robert Spillane, diagnostic radiology
McLean Hospital, Belmont
Marc Agronin, psychiatiy
Mount Auburn Hospital, Cambridge
Jorge Arroyo, medicine
Young Kwon, medicine
Gina Solomon, medicine
University Hospital, Boston
Jeffrey Schechner, medicine

MARYLAND
Francis Scott Key Medical Center, Baltimore
Margaret Stevens, medicine

MICHIGAN
University of Michigan Hospitals, Ann Arbor
Stephen Bell, orthopedic surgery
Funda Meric, general surgery

MINNESOTA
University of Minnesota Hospital and Clinics, Minneapolis
James Levine, internal medicine
Mayo Graduate School of Medicine, Rochester
Monica McDonald, general surgery

NEW YORK
Columbia-Presbyterian Medical Center, New York
Lawrence Hirsch, neurology
Montefiore Medical Center, Bronx
N. Ruth Harris, obstetrics and gynecology
Mount Sinai Hospital, New York
Michael Borodkin, ophthalmology
Leacroft Green, surgery, otolaryngology
Presbyterian Hospital, New York
Melanie Moses, medicine
St. Luke’s-Roosevelt Hospital Center, New York
Dale Johnson, surgery
St. Vincent’s Hospital, New York
Philip Chen, transitioned
Strong Memorial Hospital, Rochester
Irene Hegeman, medicine, neurology
Eric Richard, interned medicine
The New York Hospital, New York
Sonya Erickson, obstetrics and gynecology
Winthrop-University Hospital, Mineola
Marco Verga, medicine

OHIO
University Hospitals of Cleveland
Steven Care, orthopedic surgery
Roger Duncan, anesthesiology
James Stanislaw, orthopedic surgery

OREGON
Emanuel Hospital and Health Center, Portland
Paul Isenbarger, transitional

PENNSYLVANIA
MISSOURI
Barnes Hospital, St. Louis
Sarah Davidson, internal medicine
Larry Horesh, general surgery
Richard Ihnat, internal medicine
Robert Orlowski, internal medicine
St. Louis Children’s Hospital, St. Louis
Denise Ihnat, pediatrics
St. Louis University School School of Medicine, St. Louis
Jeffrey Carter, general surgery

NEW HAMPSHIRE
Dartmouth-Hitchcock Medical Center
Grant Shumaker, surgery, neurosurgery

NEW MEXICO
University of New Mexico School of Medicine,
Albuquerque
Daryl Daniels, general surgery
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Hospital of the University of Pennsylvania, Philadelphia
Kenneth Laughinghouse, internal medicine
Eleanor Poliak, pathology
Michael Romanelli, internal medicine
Steven Ugent, medicine

TEXAS
Wilford Hall U.S.A.F. Medical Center, San Antonio
Jonathan Cha'i, pediatrics

WASHINGTON
University of Washington Affiliated Hospitals, Seattle
K. Eric De Jonge, medicine/primary
Richard Ingber, internal medicine
Mark Price, general surgery
Ellen Rosenthal, internal medicine

CANADA
McGill Hospital, Montreal
Alain-Marc Werner, orthopedic surgery
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COMMENCEMENT 1991

W illiam H. Stew art, Ph D., as.sociate professor of
siirt’ery (yross anatomy), was presented the Charles
U. Bohnf 'alk Prize for e.xeellenee in teaehing the
hasie seienees. Sinee J9<S5. he has direeted the
anatomy course for first-year students.

In accepting the Bohmfalk Prize for excellence in
teaching in the clinical sciences, Richard S.K.
Young, M.D., M.P.H., associate professor of
pediatrics and neurology, recalled his own Yale
medical school days w hen Dr. James P. Comer
brought his children to child development lectures.
Dr. Young has continued this tradition by inviting
his own soft, John. JO. to class.

In a lighter moment, {from left) Dean Rosenberg
and faculty members Angela Holder and Drs. Robert
Gifford and Alvati Feinstein serenade the graduating
class. {To the tune of “Let It Be." with apologies to
John Lennon.)
Chorus:
So we say, now’s the day
To slate oiir hopes that all goes well.
And give you our best wishes
Hail farewell, Yale farewell.

M)
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M.P.H. graduates Richard MarottoU,
Dympha McGiiinness Egglin,
Jane Miisen and Teryl Hundley
joyfully enter into a new phase
of their professional lives.

Pamela Carter, M.P.H.,
proudly stands ne.xt to
the sign of her alma mater.

{From left) Jennifer Sancho, M.D.,
receives congratulations from a friend
as Helen Roberts, M.D., and Mitchell Pepper,
two fellow M.P.H. graduates, look on.

Yale Medicine Summer 1991

31

Epidemiology and Public Health (EPH)
commencement speaker. Iris R. Shannon,
Ph.D., R.N., a former president of the
American Public Health Association,
speaks on community and public health
nursing at ceremonies held outside the
EPH laboratory.

Graduating medical students
Donna Brezinski-Caligiiri (left)
and Elizabeth Bower recite the new
Yale Physician’s Oath, composed by
Chaplain Alan Mermann
(see facing page).

Betty 5.Vy, Kim was among the medical school
graduates who received active duty commissions
in the medical corps during ceremonies following
commencement. Col. Norman Ream of Washington,
D.C., (left) and Ms. Kim's father, Yoon Mo Kim, of
River Edge, N..f., congratulate her on becoming a cap¬
tain in the U.S. Army. She is serving a five-year
surgical residency at Walter Reed Army Medical
Center in Washington. D.C.
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A YALE PHYSICIAN’S OATH

Now being admitted to the high calling of the physician, / solemnly
pledge to consecrate my life to the care of the sick, the promotion of
health and the service of humanity.
I will practice medicine with conscience and in truth. The health
and dignity of my patients will he my first concern. I will hold in
confidence all that my patients relate to me. I will not permit
considerations of race, religion, nationality, or social standing to
influence my duty to care for those in need of my service.
I will respect the moral right of patients to participate fully in the
medical decisions that affect them. I will assist my patients to make
choices that coincide with their own values and beliefs.
I will try to increase my competence constantly and respect those
who teach and those who broaden our knowledge by research. / will
try to prevent, as well as cure, disease.
When / am qualified to instruct, / will impart my knowledge gladly,
holding my students and colleagues in affectionate though
evaluative esteem.
In the spirit of those who have inspired and taught me, I will seek
constantly to grow in knowledge, understanding, and skill and will
work with my colleagues to promote all that is worthy in the ancient
and honorable profession of medicine. 1 will maintain the honor and
the noble traditions of the medical profession. My behavior will be
honorable and thoughtful and reflect justice toward all.
If I fulfill this Oath and do not violate it, may it be granted to me to
enjoy life and the practice of the Art. This pledge I make freely and
upon my honor. May my faith strengthen my resolve.

Yale Medicine
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SCOPE
Cushing/Whitney Library
Microfilms Fulton Diaries
Dr. John F. Fiilton, Rhodes scholar,
scientist, biographer, historian — and
Yale professor of physiology at the age
of .^0 — was a co-founder of the Yale
Medical Library in 1939.
Now the Cushing/Whitney Medical
Library has microfilmed the 46 volumes
of Dr. Fulton’s diaries through support
from the National IJbrary of Medicine's
National [^re.servation Program for
Biomedical laterature. Beginning in
1920 and ending with his death in I960,
the diaries are available to researchers
worldwide, reports Janice E. Braun,
assistant medical historical librarian,
who supervised the project.
Dr. Fulton’s diaries reveal a keen
intellect and a variety of interests, and
his observations about .scholars have
made the diaries a treasure for
biographers. Dr. Fulton, a neurophysiol¬
ogist, was a respected scientific author
and prolific medical historian, writing
more than .600 books and articles. He
joined Drs. Harvey Cushing and Arnold
Klebs to pool their personal collections
of medical books and found the Yale
Medical Library, renamed for Drs.
Harvey Cushing and John Hay Whitney
following a major expansion in 1990.

Yale Journal Publishes
Cancer Symposia Papers
This autumn, the Yale Journal of
Biology and Medicine will publish for
the third time the proceedings of the
Id la Cirasso Memorial Conference on
gynecological cancer. Advanced
planning and cooperation between jour¬
nal staff and conference organizers
allows those attending the meeting to
have the text of papers in hand as they
are presented. I’he journal invites other
groups who are idanning symposia to
avail themselves of this service;
ad- anced notice of at least a year is
required.
I his year the journal will again
publish abstracts of M.D. theses submit34

ted by graduating Yale medical students.
These abstracts offer a picture of the
wide scope of research undertaken by
the students. Akso, since the journal is
indexed by all major reference bodies,
the thesis titles will be available to
scholars internationally through such
services as Index Medicus and Medlars.
A special issue of the journal in late
1991 will be dedicated to the late Arthur
J. Viseltear, Ph.D., associate professor
of the history of medicine, in
recognition of his many years of
devoted membership on the editorial
board. This issue will feature articles
reflecting Dr. Viseltear’s deep concern
with studies in the history of medicine,
his contributions to medical school life,
and his dedication to promoting equal
access to medical care for all
Americans.

Y.A.G. Program
Marks 26 Years
Twenty-six years ago, most Connecticut
patients with a complicated ulcer had to
travel to Boston or New York for
treatment. Today, these patients have
up-to-date treatment available in many
locations throughout their home state,
thanks to the Yale-Affiliated
Gastroenterology Program (YAGP),
which marked its 26th anniversary this
spring. The program was the forerunner
of many subsequent affiliations between
Yale and Connecticut hospitals.
In 1964, Howard M. Spiro, M.D.,
then chief of the gastroenterology unit at
the School of Medicine and Yale-New
Haven Hospital, entered into an
agreement with Dr. Vincent A. DeLuca
Jr., chief of medicine at Griffin Hospital
in Derby. They established an
experimental residency program in
gastroenterology.
d’heir agreement involved a tradeoff
that benefitted both the residents and the
Griffin physicians: As the residents
trained under the community
gastroenterologists, the specialists kept
up with the state of the art through their
contact with the residents. The
arrangement blossomed into a formal
jirogram in 1968 umler a U.S. Public

Health Service grant.
Today, in addition to Yale-New
Haven and Griffin, affiliated hospitals
include the Hospital of St. Raphael in
New Haven, plus Norwalk, Bridgeport,
St. Vincent’s and Waterbury hospitals,
and the Department of Veterans Affairs
Medical Center in West Haven.
Dr. Robert M. Donaldson Jr., deputy
dean of the School of Medicine, says
one of his "great joys” is interacting
with the affiliated hospitals, attending
hospital symposia and training YAGP
residents. Dr. James L. Boyer, director
of the digestive disease section and pro¬
fessor of medicine at Yale, adds he still
“learns something every time I go out to
consult at participating hospitals.”
Comments Edwin Cadman, chairman
of Yale’s department of internal
medicine. "YAGP has had an influence
on other programs around the country.
Its goal is to provide training for its
fellows in broader depth and give
experience that the fellows couldn’t
have gotten at a solely universityaffiliated program.”

Yale/VA PET Center
Opens in West Haven
Connecticut’s first positron emission
tomography (PET) center and cyclotron
made its debut in June at the
Department of Veterans Affairs Medical
Center in West Haven. The Yale Univer¬
sity/Veterans Affairs Positron Emission
Tomography Center offers the most
advanced technology in providing infor¬
mation about disease processes.
Director of the center is Robert
Soufer. M.D., associate professor of
diagnostic radiology and medicine, who
initiated and developed the $6 million
project over the past five years. As Dr.
Soufer explains. “PET offers physicians
a highly accurate, non-invasive tool for
studying metabolism and blood flow in
the heart, brain and other soft tissue.”
PET distinguishes itself from other
diagnostic imaging systems by
pre.senting metabolic data. Such data
make possible the diagnosis of various
cardiac, neurologic, psychiatric and
oncologic di.seases with unprecedented
Yale Medicine Summer 1991

to improve health-care services to
underserved populations. Dr. McCarthy
delivered the Armstrong lecture at the
APA’s annual meeting in New Orleans.

subtlety and precision.
The PET scanner, a large, donut¬
shaped instrument, gleans its data from
the decay of positron-emitting isotopes.
An on-site cyclotron prepares isotopes
with extremely short half-lives — rang¬
ing from a few minutes to
approximately two hours. PET
technicians use the isotopes to label sub¬
stances such as glucose or water, which
the body metabolizes.
A solution containing the labeled
substances is injected into the patient’s
bloodstream. A computer then translates
the resulting signals into images that
offer data about the metabolic processes
taking place within the targeted organ.

FACULTY NEWS

Michele Barry, M.D., associate profes¬
sor of medicine, and Frank J. Bia,
M.D., M.P.H., associate professor of
medicine and laboratory medicine, have
been appointed by the United States
Pharmacopeial (USP) Convention, Inc.,
to a new advisory panel of experts in
parasitic diseases. During its 1990-1995
term, the panel will help detemiine the
content of the USP data base and advise
about clinical aspects of its work in the
area of drug standards and infomiation.
Paul G. Barash, M.D., professor and
chairman of anesthesiology, was named
to the Yale-New Haven Hospital hoard
of trustees.
William F. Collins .In, M.D.,
chaimian of the department of surgery,
has been awarded the American Associ¬
ation of Neurological Surgeons’
Cushing Medal. He was presented the
medal at the association’s annual
meeting in April in New Orleans. Dr.
Collins, the Harvey and Kate Cushing
Professor of Surgery, is past chaimian of
the American Board of Neurological
Surgery, past president of the Society of
Neurological Surgeons and of the
Neurosurgical Society of America.
James P. Comer, M.D., M.P.H., the
Maurice Falk Professor in the Child
Study Center and Psychiatry, was
honored by the Community Children
and Family Services for his efforts on
behalf of children and families in educa¬
tion. The “Comer Process,” which has
been implemented in more than 100
schools throughout the country,
emphasizes parental involvement and
promotes social skills.
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Marcia Mclnerney, Ph.D., postdoc¬
toral fellow in immunobiology, has been
awarded a postdoctoral fellowship for
1991 -1992 by the Juvenile Diabetes
Foundation International. The $28,()()()
award will support Dr. Mclnerney’s
research, which identifies immune cells
(T cells) in non-obese mice. The cells
may play a role in suppressing the
development of diabetes.

Dr. Robert Soufer, associate professor of
diagnostic radiology and medicine, is
director of the new YalelVA PET Center.
Charles B. Cuono, M.D., Ph.D.,
professor of surgery and director of the
Yale Burn Center and Skin Bank, began
a two-year temi as president of the
American Association of Tissue Banks
(AATB) Board of Governors on May 1,
1991. The AATB inspects and accredits
tissue banking facilities.
Peter J. Hotez, M.D., Ph.D., instruc¬
tor of pediatrics and epidemiology and
public health, was named a Charles E.
Culpepper Foundation Scholar in Medi¬
cal Science for 1991. Dr. Hotez will
receive $100,000 annually for three
years to fund his research into the
molecular basis and prevention of hookwomt disease in children.
Stanley W. Jackson, M.D.,
professor of psychiatry and history of
medicine, will assume the editorship of
the Journal of the History of Medicine
and Allied Sciences as it returns to Yale
after 18 years.
Theodore Lidz, M.D., Sterling
Professor Emeritus of Psychiatry, has
been elected to serve a one-year tenn as
president of the American College of
Psychoanalysts. The honorary society is
composed of 250 members and fellows
in North America.
Paul McCarthy, M.D., professor
and section chief of pediatrics, has been
honored with the 1991 George
Armstrong Award of the Ambulatory
Pediatric Association (APA), of which
he is past president. The award, named
for the 18th-century Englishman consid¬
ered to he the father of modern
pediatrics, honors Dr. McCarthy’s
outstanding research, teaching and work

James G. McNamara, M.D.,
assistant professor of pediatrics, will
conduct research on HIV infection of
fetal T cells through a $78,000 grant
from the Pediatric AIDS Foundation.
Dr. McNamara seeks to learn whether
the virus’ ability to infect fetal cells dif¬
fers from the way it infects adult cells.
Ethan R. Nadel, Ph.D., director of
the John B. Pierce Laboratory and
professor of epidemiology and cellular
and molecular physiology, delivered the
26th annual Harry G. Armstrong
Lecture at the Aerospace Medical Asso
ciation’s annual meeting in May in
Cincinnati. Dr. Nadel spoke on “The
Physiological Challenges of HumanPowered Flight,” based on research he
conducted in association with Project
Daedalus, which resulted in the longest
human-powered flight in history.
William H, Prusoff, Ph.D.,
professor emeritus and senior research
scientist of phamiacology, delivered the
Paul Neumann Association for
Scientific Re,search’s annual Paul
Ehrlich Lecture in July at the 27th Inter¬
national Meeting of Medicinal
Chemistry in Caen, France.
Judith S. Rodin, Ph.D., chaimian
and the Philip R. Allen Professor of
Psychology, has been appointed dean of
the Graduate School of Arts and
Sciences effective July I, making her
the first woman in the LIniversity’s
history to serve at this post. During her
five-year tenn. Dr. Rodin will oversee
academic policies involving more than
3.000 graduate students and faculty
members.
Gordon M. Shepherd, M.D.,
D.Phil., professor of neuroscience, has
been appointed deputy provost for the
biological sciences effective July 1, and
will assume the duties in November
after a scheduled leave of absence.
Albert J. Solnit, M.D., Sterling Pro¬
fessor Emeritus of Pediatrics and
35

Psychiatry, has been named commis¬
sioner of the Department of Mental
Health by Gov. Lowell P. Weicker. With
this appointment. Dr. Solnit hopes to
find a way to improve the quality and
distribution of state .services.
.lohn T. Stitt, Ph.D., associate
professor of epidemiology and cellular
and molecular physiology and a fellow
at the John B. Pierce Laboratory, has
been awarded a $868,()()() grant by the
National Institutes of Health. The grant
enables Dr. Stitt to continue his re.search
on the mechanisms by which normal
body temperature is altered when the
body is invaded by infectious agents.
Peter K. Stys, M.D., associate
research scientist in neurology, has been
awarded the American Neurological
As.sociation's Presidential Award and the
Canadian Medical Research Council’s
Centennial Fellowship. Both awards rec¬
ognize his research on the effects of lack
of oxygen on nerve fibers in the central
nervous system and the mechanism by
which calcium, normally a vital ingredi¬
ent for cell life, .sometimes floods the
cells, damaging or killing them. This
research has implications for the treat¬
ment of stroke and spinal cord injuries.

.John H. Warner, Ph.D., associate
professor of the history of medicine,
received the American Association for
the History of Medicine’s 1991 William
H. Welch Medal for his book entitled
The Therapeutic Perspective: Medical
Practice, Knowledge, and Professional
Identity in America, 1820-1S85. The
annual award is given to the author of “a
book of outstanding scholarly merit in
the field of medical history.” Published
in 1986, the book examines medical
activity to evaluate shifts in patient care.
While underscoring regional variations,
it also provides a nationwide view of
American medical history.

FACULTY NEWS
Harry Bishop

.Samuel (). Thier, M.D., president of
the Institute of Medicine of the National
Academy of Sciences and a member of
the Dean's Council at the School of
.Medicine, has been named president of
Brandeis University in Waltham, Mass.
From 1975 through 1985, Dr. Thier
served as professor and chairman of
medicine at Yale.
Stephen (L Waxman, M.D., f^h.D.,
professor and chairman of neurology at
the School of Medicine and chief of
neurology at Yale-New Haven Hospital,
has been appointed to a three-year term
on the Institute of Medicine’s Board on
Biobehavioral Sciences and Mental Dis¬
orders. The 12-member board identifies
key issues in the fiekls of mental and
atkiictive disorders and the
biobehavioral sciences; develops
concepts for activities in these areas that
might be appropriate for the Institute of
Medicine, and responds to requests for
studies and advice from Congress and
federal agencies. Dr. Waxman also
presented the first Vivian L. .Smith
Lecture at Baylor College of Medicine
in Houston. 'Hie lecture, entitled "The
Neurobiological Basis ol Restorative
Neurology of Multiple Sclerosis.” began
a series to honor the late founder of the
Vivian 1,. Smith I'oundation for
Restorative Neurology at Baylor.
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Linda M. Bartoshnk, Ph D.

Faculty Honored
At Commencement
During the graduation ceremony at the
School of Medicine, several awards
were presented, including the Charles
W. Bohmfalk Prize for excellence in
teaching. William B. Stewart, Ph.D.,
associate professor of surgery (gross
anatomy), received the prize in the basic
sciences, while Richard S.K. Young,
M.D., M.P.H., was awarded the prize in
the clinical sciences. Each physician
receives a $5,()()() award.
Department chairmen, directors of
medical studies and medical students
nominate outstanding teachers in each
category, and a committee of students
and faculty selects recipients. The
annual awards, funded by the Bohmfalk

Family Charitable Trust, reflect a
renewed emphasis on teaching at the
School of Medicine.
Since 1985, Dr. Stewart has served as
director of the anatomy course for firstyear students. Of Dr. Stewart, students
and colleagues comment: “He truly sets
the tone of the 'Yale System’....He has
an excellent sense of students’ wants,
needs and anxieties about anatomy and
medical school in general....A
wonderful teacher, very caring and
enthusiastic.”
In 1965, Dr. Stewart received a B.S.
degree from the University of Illinois
and a Ph.D. from Emory University. He
started a post-doctoral fellowship in
physiology at Yale in 1976. Dr. Stewart
joined the medical faculty in 1982 and
has centered his research on the sense of
smell.
Dr. Young, who joined the medical
faculty in 1986, researches the effect of
oxygen deprivation on the brain as it
develops. In 1973, he received
combined M.D., M.P.H. degrees from
Yale, after earning a B.A. degree in
biology from Stanford University.
Of Dr. Young, students and
colleagues state: “He single-handedly
revitalized the pediatric component of
the Introduction to Clinical Medicine
course....He is equally adept at the
bedside as in the classroom and has
given an abundance of time to the teach¬
ing mission....Dr. Young is a gifted and
effective teacher.”
Other medical school awards and
recipients include:
Erancis Gilman Blake Award
(posthumously) to Peter A.T. Grannum,
M.B.B.S., associate professor of obstet¬
rics and gynecology. Established in
1952 by Nil Sigma Nu, the award
honors a medical faculty member whom
the senior class designates as the most
outstanding teacher of the medical
sciences.
Betsy Winters House Staff Award to
Yvonne Gollin, M.D., resident in obstet¬
rics and gynecology. The award is
presented annually to a Yale-New
Haven Medical Center house staff
member whom the senior class believes
has made the most significant
contribution toward the medical
students’ education.
Leah Lowenstein Award to Linda M.
Bartoshnk, Ph.D., professor of surgery
(otolaryngology), of epidemiology and
of psychology. The Office for Women in
Medicine pre.sents the award to a full¬
time faculty member who.se work repre¬
sents the highest degree of excellence in
non-sexist education.
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Neuroscientists Earn
Javits Research Awards
Two Yale University School of
Medicine researchers have been named
recipients of this year’s Senator Jacob
Javits Neuroscience Awards given by
the National Institute of Neurological
Disorders and Stroke (NINDS).
Pasko Rakic, M.D., Sc.D., the Dorys
McConnell Duberg Professor of Neuro¬
science and professor and chairman of
neurobiology, received a $3.5 million
award; the award to Leonard K.
Kaczmarek, Ph.D., professor of pharma¬
cology and physiology and chairman of
the department of pharmacology,
totalled $2.1 million. This is the second
Javits Award presented to Dr. Rakic,
who was among the first neuro.scientists
to receive one in 1984, when the
program was launched.
NINDS established the awards,
which support scientists for seven years,
to honor the late U.S. Sen. Javits of
New York.
Dr. Rakic, a native of Yugoslavia,
joined the Yale faculty in 1977. He is a
member of the National Academy of
Sciences, the Yugoslavian Academy of
Arts and Science, and the Serbian
Academy of Arts and Sciences.
Since the early 1970s, Dr. Rakic has
studied the basic events of how neurons
originate, move and converge to form a
“wiring diagram” in the mammalian
central nervous system. His work
attempts to unravel the individual cellu¬
lar interactions that lead to the
development of the primate brain.
“Understanding the molecular and
cellular mechanisms of brain
development is widely regarded as one
of the central issues in neurobiology,
and the field of brain development is
one of the most exciting and robust
areas of neuroscience,” says Dr. Rakic.
Dr. Kaczmarek, a native of the
United Kingdom, joined the Yale
faculty in 1981. He has co-authored the
books Neiiwmodulation and The
Neuron. His previous honors include the
Klingenstein Award in Neuroscience.
Dr. Kaczmarek studies how electrical
and secretory properties of neurons con¬
trol prolonged changes in such animal
behaviors as reproduction, eating and
sleeping. He and his colleagues work
with the nerve cells of a slug-like
mollusk, Aplysia, also called a sea hare.
Scientists can work easily with the mollusk’s large nerve cells. By studying
electrical changes in nerve cells, they
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hope to understand how they translate
into behavior changes in animals.
Dr. Kaczmarek has isolated neurons
which, when fired, stimulate the mollusk
to initiate a number of reproductive
behaviors. He is working to understand
how biochemical changes affect the
electrical properties of these cells.
“Our ultimate goal is to understand
how neurons control long-lasting
changes in an animal’s behavior,” says
Dr. Kaczmarek.
Other Yale researchers who hold
Javits awards include William S.
Agnew, Ph.D., associate professor of
cellular and molecular physiology;
William W. Douglas, M.D., M.B.Ch.B.,
professor of pharmacology; Dorothy W.
Gallager, Ph.D., associate professor of
psychiatry and neuroanatomy; Carole
M. Choate LaMotte, Ph.D., professor
(adjunct) of research in surgery
(neurosurgery) and anesthesiology;
Robert H. LaMotte, Ph.D., associate
profes.sor of anesthesiology and
neuroanatomy; and J. Murdoch Ritchie,
Ph.D., D.Sc., the Eugene Higgins
Professor of Pharmacology.

FACULTY NEWS

Dr. Siegel Awarded
Kidney Research Grant
Dr. Noiman J. Siegel, professor of pedi¬
atrics and medicine and director of the
pediatric nephrology section at the
School of Medicine, was named an
Extramural Grant Program recipient by
the Baxter Healthcare Corporation. The
award will further his research on the
treatment of acute renal failure with thy¬
roxin. a hormone produced in the
thyroid gland. Dr. Siegel’s studies
concentrate on kidney failures due to
such impairments as blood flow
obstruction or toxic substances in the
urinary tract.
Dr. Siegel joined the Yale medical
faculty in 1972 as assistant professor of
pediatrics and director of the pediatric
nephrology section. He is chairman of
the National Kidney Eoundation
Council on Pediatric Nephrology and
Urology and a member of the
foundation’s scientific advisory
committee. He also is a member of the
medical advisory committee for the
Connecticut Kidney Foundation.
Dr. Siegel was one of 11 recipients of
the Baxter grants which total $500,000.

Dean Rosenberg
Takes Sabbatical
In May, Dean Leon E. Rosenberg
announced that he would begin a sixmonth sabbatical leave on July 1. He
stated; “After seven years in this job, I
believe it is both prudent and necessary
for me to have this time for reflection,
writing, planning and ‘doing’ science. I
fully expect that such a respite will
allow me to take up the deanship again
with renewed vigor and clear vision.
“I take this leave with a sense of ease
knowing that our stellar deputy dean.
Bob Donaldson, will ably serve as
interim dean and that you will give him
the kind of loyal and dedicated support
you have always afforded me.”

Melville Corporation
Supports Comer Program
The Melville Corporation has joined
with the Rockefeller Foundation in
funding a project which will replicate
Dr. James P. Comer’s model school
development program in a number of
inner-city school systems across the
country.
A specialty retail company based in
Rye, N.Y., the Melville Corporation has
made an initial gift of $250,000 with the
expectation of providing continued sup¬
port over four years to improve urban
schools by applying Dr. Comer’s
concepts.
Dr. Comer, the Maurice Falk
Professor in the Child Study Center and
Psychiatry at the School of Medicine,
has developed educational reforms
which address the difficulties of educat¬
ing low-income and minority children
living in cities. Developed in
collaboration with the New Haven
public school system, the Comer model
is being used by 165 schools in 15
districts throughout 12 states and
Washington, D.C.
The program focuses on a child’s
preparation for school and the
collaboration between school staff and
parents in the academic and social
development of children.
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More than 20 years ago. Dr. Pearson
initiated the first comprehensive pro¬
gram for diagnosing sickle cell anemia
in newborns, which became a model for
the neonatal blood screening programs
mandated in more than 30 states and in
other countries throughout the world.
The National Heart, Lung and Blood
Institute used it as the basis for the new¬
born component of the National Coop¬
erative Study of Sickle Cell Diseases.
An AAP member since 1966. Dr.
Pearson wrote a nutrition committee
statement on iron, and its
recommendations led to the eradication
of severe iron deficiency in this country.

Three Faculty Receive
Endowed Professorships

Dr. Howard Pearson and friend.

Yale Pediatrician
To Lead Academy
Howard A. Pearson, M.D., professor of
pediatrics, has been named vice
president-elect of the American
Academy of Pediatrics (AAP), a
national organization dedicated to
promote the physical, mental and social
health of children, adolescents and
young adults.
Dr. Pearson, who also serves as
medical/executive director of Paul
Newman’s Hole-in-the Wall Gang
Camp for children with cancer and
blood diseases, will take office as the
academy’s national vice president in
October. He will serve a one-year term
as AAP president, beginning in 1992.
With 41.()()() members in the United
States, Canada and Latin America, the
academy is dedicated to advocacy for
children, research, public and profes¬
sional education, and serving as a voice
for pediatricians.
In I96S. Dr. Pearson came to New
I laven as professor and head of
pediatric hcmatology/oncology at the
School of Medicine. Between 1974 and
19X7, he chaired the department of pedi¬
atrics and organized a continuing educa¬
tion course for practicing pediatricians,
now in its IXth year. He continues to
care for children w ith blood diseases.

President Benno C. Schmidt Jr.
announced the appointment of three
School of Medicine faculty members to
endowed professorships. Carolyn W.
Slayman, Ph.D., has been named the
Sterling Professor of Genetics; Alvan R.
Feinstein, M.D.. the Sterling Professor
of Medicine; and Burton H. Singer,
Ph.D., the Ira V. Hiscock Professor of
Epidemiology and Public Health.
Dr. Slayman became the first woman
to assume a medical department chair at
Yale when she was appointed chair of
the human genetics department in 1984.
The department she leads plays an
active role in the emerging field of gene
therapy and in efforts to map and
sequence the human genome. During
her career, she has centered her research
on the proteins that transport nutrients
across cell membranes, and the genes
that code for those proteins.
Born in Portland, Maine, Dr.
Slayman graduated from Swarthmore
College in 1958 with highest honors in
biology and chemistry. She received her
Ph.D. degree in biochemical genetics
from Rockefeller Llniversity in 1963.
and spent the following year as a
National Science Foundation (NSF)
post-doctoral fellow at Cambridge
University. She joined the Yale faculty
in 1967 as an assistant professor of
microbiology and physiology. In 1972,
she was promoted to professor.
Among her numerous professional
activities. Dr. Slayman serves on the
National Advisory General Medical Sci¬
ences Council at the National Institutes
of Health. She also is a member of the
board of trustees of Bowdoin College in
Brunswick, Maine, and of Hopkins

School in New Haven.
Dr. Feinstein, a Yale medical faculty
member and an attending physician at
Yale-New Haven Hospital since 1962,
also is director of the clinical epidemiol¬
ogy unit and of the Robert Wood
Johnson Clinical Scholars Program.
Since its onset at Yale in 1975, the Clin¬
ical Scholars Program has provided a
fellowship for training post-graduate
physicians working in clinical
epidemiology, health care delivery or
health policy.
Dr. Feinstein, a Philadelphia native
who received B.S., M.S. and M.D.
degrees from the University of Chicago
in 1947, 1948 and 1952, conducted
research on rheumatic fever at
Rockefeller Institute and Irvington
House. He has developed clinical
research techniques that have improved
methods for the prognosis and treatment
of cancer. For example, he pioneered
methods to quantify such phenomena as
pain, distress and disability. Dr.
Feinstein advocates that clinical
epidemiology and clinimetrics be devel¬
oped as additional humanistic “basic
sciences” for clinical practice.
Dr. Singer, associate dean as well as
chaimian at EPH, is one of the nation’s
outstanding biostatisticians. During
much of his career, he has studied the
dynamics of infection in tropical
diseases, beginning with his work on
malaria in Nigeria. At present, he is
working on the social and economic
impact of malaria and other tropical dis¬
eases as they relate to high-technology
drug development and vector control
methods in developing countries.
As chaimian of a World Health Orga¬
nization steering committee for social
and economic research in the tropical
disease program. Dr. Singer has been
involved in the international debate con¬
cerning the extent that high-technology
drugs and vector control methods
interrupt disease and improve the health
of people in developing countries.
Before Joining the Yale faculty in
1985, Dr. Singer had chaired for two
years Columbia University’s department
of statistics. His career also includes 18
years of teaching and research at
Columbia and 12 years as an adjunct
professor at Rockefeller University.
A native of Chicago, Dr. Singer
received B.S. and M.S. degrees from
Case Institute of Technology in 1959
and 1961. In 1967, he received a Ph.D.
degree in statistics from Stanford
Lhiiversity.
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ALUMNI REPORT
Many alumni returning for their annual
reunion weekend shared in the
dedication of the new Boyer Center for
Molecular Medicine on June 6 and 7.
Symposia were presented before and
after the dedication of this fine addition
to the medical school campus.
Discussants from the academic, govern¬
mental and business communities
presented their views on “Constructing a
National Agenda for Biomedical
Research” before a reception and tour of
the center on June 6. “Perspectives in
Molecular Medicine” commemorated
the four programs in the center: molecu¬
lar genetics, molecular and developmen¬
tal neurology, molecular oncology and
development, and molecular
cardiobiology.
Following registration on June 7,
class reunion seminars met. The Class
of 1941 (50th reunion) heard Willys M.
Monroe, M.D., discuss “The U.S. Public
Health Service: A Virginia Tradition;”
Martin E. Gordon, M.D. ’46, who was
local 45th-reunion chaimian, organized
an outstanding program entitled “From
Then to Now — Panoramic Views of
Medicine: 45 Years of Personal
Observation.” Ten members of the class
read 10-minute papers about topics in
their specialty. Thomas Kugelman,
M.D. ’60, greeted attendees and Dean
Rosenberg welcomed the alumni. Nobel
laureate George E. Palade, M.D.,
Sterling Professor Emeritus of Biology
at Yale and dean of scientific affairs at
the University of California, San Diego,
School of Medicine, discussed the
“Medical School Curriculum and the
Rapid Expansion of Biomedical
Sciences.” A reception followed at
Harkness auditorium. Returning alumni
then joined class members at dinners,
parties and picnics.
At surgical grand rounds on June 8,
moderator William F. Collins Jr., M.D.,
chairman of surgery, discussed recent
advances in this field. Concurrent
faculty seminars included: “Recent
Advances in Disorders of Pigmentation”
by Jean Bolognia, M.D. ’80, and
“Genetic Control of Pigmentation” by
Ruth Halaban, Ph.D.; “Lyme Disease:
State of the Art,” moderated by Daniel
Rahn, M.D. ’76; “The Pain
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Experience,” moderated by Luke M.
Kitahata, M.D., Ph.D.
Dr. Vincent T. Marchesi moderated a
panel discussion entitled “Yale Center
for Molecular Medicine — Program for
the Future.” Center faculty members
discussed upcoming molecular research
programs and their clinical application.
The medical reunion dialogue and
tea/sherry concluded the scientific
program. Arthur Ebbert Jr., M.D.,
professor emeritus of medicine,
moderated a provocative discussion
between Alvan R. Feinstein, M.D.,
professor of medicine and
epidemiology, and Joseph Warshaw,
M.D., professor and chairman of
pediatrics, entitled “Fundamental Scien¬
tific Challenges in Clinical Care.”
Lively audience participation ensued.
Friendships were renewed,
reminiscences exchanged, family Joys
and sorrows were shared. Alumni had
matured but remain young at heart. Indi¬
vidual classes convened picnics and din¬
ners arranged by New Haven-area class¬
mates. The golden anniversary of the
graduation of the Class of 1941 was cel¬
ebrated at a dinner at the Colony Inn
hosted by the Friends of the 50th for
class members and spouses. Dr.
Gioacchino Parrella presented a paper
entitled “The Way We Were — 50 Years
Later” to rekindle memories of their
four years at Yale. Each returning
member of the class spoke briefly. The
Class of 1986 returned for their first
five-year reunion and were introduced
by Dr. John Wysolmerski, dinner chair.
Two members of the Class of 1931 and
two from the Class of 1936 were
introduced.
Dean Leon E. Rosenberg presented a
stimulating State of the School Address
at annual meeting of the Association of
Yale Alumni in Medicine (AYAM) at
Harkness auditorium on June 8. The
dean cited Dr. Kugelman for
outstanding service at the completion of
his term as president of AYAM. Muriel
Wolf will serve as president for a twoyear term. Marie-Louise T. Johnson,
M.D. ’56, will serve as vice president,
and Gilbert Hogan, M.D. ’57, as
secretary. Elected to the executive com¬
mittee to replace members who have

completed their term are Erederic K.
Cantor, M.D. ’62; R. Leonard Kemler,
M.D. ’43; Michael H. Owens, M.D. ’78;
and Barbara Ross, M.D. ’81. Nicholas
M. Passarelli, M.D. ’59, has agreed to
serve a second term.
Elected as representatives to the AYA
are W. Scott Peterson, M.D. ’71, and
Benjamin E. Lyons, M.D. ’38. Andrew
S. Wong, M.D. ’51, will fill the
unexpired term of Marie-Louise
Johnson.
We thank Thomas Kugelman for an
outstanding term in office.
Congratulations are also extended to
those members of the executive
committee and representatives to the
AYAM whose terms have expired.
A Distinguished Alumni Award was
awarded to Lowell I. Goodman, M.D.
’51, for his accomplishments as
chairman of the Yale School of
Medicine Alumni Eund. Samuel
Kushlan, M.D. ’35, a previous recipient,
presented Dr. Goodman with a Yale
chair after appropriate remarks.
Maxwell Bogin, M.D. ’26, received a
special citation commemorating 65
years in the practice of pediatrics and
long tenure as class agent for the Class
of 1926. Nicholas P.R. Spinelli, M.D.
’44, presented Dr. Bogin with a framed
certificate.
There will be .ample opportunity in
the coming year for AYAM members to
participate in student activities. Each
year there is an annual dance in Decem¬
ber or January. The association sponsors
a student-faculty tea, and we assist with
the second-year show. Alumni are
welcome to all of these activities.
Schedules will be available.
Alumni/student interaction was
further enhanced by participation in the
Kresge Challenge phonathons. Thirtytwo students and 22 alumni were joined
by Dean Rosenberg at the alumni fund
office on March 19, 20, and 26, 27. The
$33,000 collected will be used by the
alumni fund for financial aid and for
unrestricted use by the dean.

Arthur Crovatto, M.D. '54
Director of alumni affairs
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Dr. Hoyt C. Taylor, ’40-’43 HS,
worked part-time for 10 years in the
Lawnwood Regional Hospital
emergency room after retiring to Florida
in 19k). He continues 40 hours of medi¬
cal education to retain his medical
license.
Dr. John H. Grossman II, ’41 -’45
HS. has retired from the private practice
of gynecology and conducts a weekly
one-hour radio talk show in Ansonia,
Conn.

ALUMNI NEWS
Dr. Paul Calahresi, ’55, professor
and chairman of the Brown University
department of medicine, was appointed
chairman of the National Cancer
Advisory Board by President Bush. His
five-year term began in January 1991.
The 18-member board reviews grant
applications of $50,000 or more made to
the National Cancer Institute.
Dr. Joseph P. Wierzbinski, ’58. and
Susan S. Addiss, ’69 M.P.H., have been
appointed by Connecticut Gov. Lowell
P. Weicker to served in state health
service positions. Dr. Wierzbinski has
been named state surgeon general, an
appointment which makes him a
member of the governor’s military staff.
Ms. Addiss now serves as commissioner
for the Department of Health Services
after nine years as chief of the
department’s bureau of health planning
and resource allocation.
Dr. Jack N. Blechner, ’57, professor
and head of the department of obstetrics
and gynecology at the University of
Connecticut Health Center, has been
named president of the Obstetrical Soci¬
ety of Boston. Dr. Blechner also is asso¬
ciate dean for clinical affairs at the
health center's School of Medicine.

Julian Frieden, M D. '48
Dr. Julian Frieden, ’48, chief of car¬
diology at New Rochelle Hospital Med¬
ical Center, was honored in May by the
hospital for his more than 35 years of
contributions. Dr. Frieden initiated
several new programs at the medical
center, including a progressive care unit
and a cardiac telemetry unit. He also is
an attending physician and
electrocardiographer at Montefiore
Medical Center in New York City and a
clinical profes.sor of medicine at the
Albert Einstein College of Medicine.
Dr. T. Timothy Crocker, ’48-’50
HS, clinical professor of internal
medicine (occupational and
environmental) at the University of Cal¬
ifornia. San Francisco, was professor of
internal medicine (infectious diseases)
and cancer research at the University of
California. San Francisco from 1950
through 1971. From 1971 through 1990,
he served as professor and founding
chair for the department of community
and environmental medicine at the Uni¬
versity of California, Irvine.
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Jack D. Barchas, ’60. of Westwood.
Calif., serves as associate dean for
neuroscience at University of
California.
Dr. Robert L. Johnson, ’60-’64 HS,
is clinical professor of otolaryngology at
the University of California. San
Francisco, and is chief and director of
residency training in otolarygnology at
Children’s Hospital in San Francisco.
Dr. John T. Harrington, ’62, gover¬
nor for the Massachusetts chapter of the
American College of Physicians,
received an honorary fellowship in May
from the Royal College of Physicians of
Ireland for his work in renal physiology,
nephrology and as editor of Nephrology
Forum in the journal. Kidney
International.
Dr. Stephen C. Joseph, ’63, has
been appointed dean of the school of
public health and professor of public
health and pediatrics, at the University
of Minnesota.
Dr. Donald (i. Skinner, ’64,
professor and chairman of urology at the
University of Southern California
School of Medicine, has been named the

Stephen C. Joseph. M.D. '63, M.P.H.
1991 Barringer Medal recipient. The bi¬
annual award given for achievement in
cancer research was presented to Dr.
Skinner at the American Association of
Genitourinary Surgeons’ annual
meeting held in April in Naples, Fla.
Dr. David S. Fedson, ’65. professor
of internal medicine and head of the
division of general medicine at the Uni¬
versity of Virginia School of Medicine,
was appointed to a four-year term on the
National Vaccine Advisory Committee,
beginning in July. He also has served on
the U.S. Public Health Service
Immunization Practices Advisory Com¬
mittee, and chaired the American
College of Physicians’ Task Force on
Adult Immunization.
Dr. Charles R. Rosenfeld, ’66 HS,
has been on the faculty at the University
of Texas Southwestern Medical School
at Dallas since 1973 and is director of
the division of neonatal-perinatal
medicine, and professor pediatrics and
obstetrics and gynecology. He currently
is on an administrative leave, working
in the physiology department on
vascular smooth muscle alterations in
pregnancy.
Dr. Peter N. Herbert, ’67. has been
appointed chairman of medicine for at
the Hospital of St. Raphael in New
Haven.
Dr. Donald R. Coustan, ’68, has
been appointed obstetrician and
gynecologist-in-chief at Women &
Infants Hospital of Rhode Island and
chairman of the department of obstetrics
and gynecology at Brown University. In
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Dr. Warren R. Palterson, ’72-’74
HS, of Nashville, Tenn., completed a
plastic surgery residency in 1986 and
became board certified in 1990.
Dr. .John H. (Jrossman III, ’72-’75
HS, is professor of obstetrics,
gynecology and microbiology and also
director of the division of maternal-fetal
medicine at George Washington Univer¬
sity medical school in Washington, D.C.
Dr. David A. Adler, ’73, is chief of
adult psychiatry at the New England
Medical Center Hospitals and professor
of psychiatry at Tufts University School
of Medicine.
Donald R. Coustan, M.D. '68
1982, Dr. Coustan joined the hospital
staff to establish and direct the division
of maternal/fetal medicine and later
became director of obstetrics and
associate chief of obstetrics and
gynecology. He was appointed full
professor in 1986.

Dr. Mary .Jane Minkin, ’75, was
honored by the New Haven Rape Crisis
Services of the YV/CA with its first
annual Arnold Markle Award for her aid
to rape survivors. The award, named for
the late state attorney in honor of his
advocacy of sexual assault victims’
rights, was presented to Dr. Minkin at a
ceremony in January at the New Haven
District Courthouse.

Dr. Anthony V. Proto, ’71, Joined
the staff of the Medical College of
Virginia, Virginia Commonwealth
University, in 1984, as professor and
director of pulmonary radiology. He
served as chainnan of the division of
diagnostic radiology for three years, and
as interim chairman of the department
of radiology from July 1989 through
October 1990. Dr. Proto has been a con¬
sultant for the National Institutes of
Health since 1986 and also has served
as national civilian consultant in
diagnostic radiology to the Surgeon
General, U.S. Air Force, since 1980. He
was recently honored by the Annual
Oration of the Radiological Society of
North America.

Dr. David S. Weiss, ’81, was
inducted as a fellow of the American
Academy of Orthopaedic Surgeons
during the academy’s 58th annual meet¬
ing in March in Anaheim, Calif.
Dr. Aswine K. Bal, ’86 M.P.H.,
completed a residency in pediatrics at
Beth Israel Medical Center in New
Jersey and is a fellow in pediatric infec¬
tious diseases at Yale-New Haven
Hospital.
Michael Huncharek, ’86 M.P.H.,
graduated from Boston University
School of Medicine and has accepted a
resident position in radiation oncology
at Massachusetts General Hospital.

Stacey Wills, ’90 M.P.H., is a
re.searcher at the Employee Benefit
Research Institute in Washington, D.C.,
where she examines health care cost
issues, particularly insurance, and
publishes reports on current policy
agendas in Congress, state governments
and private businesses.
Christina Wypijewski, ’90 M.P.H.,
works on prevention policies and
programs for the federal Office of
Disease Prevention and Health
Promotion, Department of Health and
Human Services.

Michael H. Owens. M.D. '78
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Dr. Wayne E. Julian, ’81 HS,
foreign service medical officer for the
United States Department of State, has
been assigned as regional psychiatrist
for South America, and will be posted at
the U.S. embassy in Santiago, Chile.

I.orraine M. Almo, ’90 M.P.H., is
employed at Indian Health Service
Community Health Nursing in Fort
Defiance, Ariz.

Dr. Paul Vignola, ’71, ’71-’74 HS.
has been appointed director of the
cardiac catheterization laboratory at
Mount Sinai Medical Center in Miami
Beach.
Dr. Raymond L. Sphar, ’72 M.P.H..
has been appointed director of medical
research service for the Department of
Veterans Affairs in Washington, D.C.
He retired from the U.S. Navy, where he
headed several research units and served
as medical research advisor in the
Office of the Secretary of Defense.

.serves the Los Angeles area. Before his
appointment. Dr. Owens served as exec¬
utive vice president and chief health
officer for the Watts Health Foundation,
Inc. and United Health Plan, where he
was responsible for the organization’s
health delivery systems.

Dr. Michael H. Owens, ’78. was
appointed medical director for CIGNA
Private Practice Plan, CIGNA
Healthplans of California. Dr. Owen’s
responsibilities include physician
relations, utilization management and
quality assurance of the 12,()()0-member
health care delivery system, which

NEW BOOKS
Child and Adolescent P.sychiatr\:
A Comprehensive Te.xthook, Dr. Melvin
Lewis, profes.sor of pediatrics and
psychiatry. Williams & Wilkins
(Baltimore) 1991.
The Trehlinka Virus. Dr. Robert B.
Litman, ’72 HS, The Ivy League Press,
Inc. (New York) 1990.
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STUDENT NEWS
John B. Houston and Jonathan E.
Sears, third-year students, were selected
to participate in the Juvenile Diabetes
Foundation's lOth annual Medical
Student Workshop. The workshop, enti¬
tled "Introduction for Potential
Investigators," was held in April in
Bellevue, Wash., and introduced
students from 65 universities in the
United States and Canada to progress
made in the treatment of diabetes
complications, islet transplantation, dia¬
betic nephropathy, and insulin treat¬
ment. Mr. Houston also was selected by
the Howard Hughes Medical Institute to
participate in the Cloister Program, a
National Institutes of Health Research
Scholars program which allows him to
perform research in an NIH laboratory
of his choice for one year.
Dr. Steven Herber, who is
completing his first year of plastic
surgery residency at Yale, has been
selected as a 1991 recipient of the
American Medical Association (AMA)
Burroughs Wellcome leadership award
based on a commitment of community
service and interest in organized
medicine. He has a keen interest in
international medical service and
accompanied Dr. Gary Price to
Guatemala, where they performed
reconstructive operations for congenital
and acquired deformities. Dr. Herber
will be attending this year's national
AMA House of Delegates meetings as a
representative of the Connecticut
Medical Society.

Joanna B. Rosen and William F. King Jr.

Second-year Students
Win Elm-Ivy Awards
William F. King Jr. and Joanna B.
Rosen, two second-year medical
students, received Elm-Ivy Awards for
community service. They and 10 other
recipients were feted at the annual ElmIvy Awards luncheon held at University
Commons on May 24. Each spring, the
city of New Haven and Yale honor indi¬
viduals from the University and the
local community who make an extra¬
ordinary contribution to New Haven.

Mr. King and Ms. Rosen organized
the Adolescent Substance Abuse
Prevention (ASAP) Program, in which
35 Yale medical students educate
seventh-grade children from the
Roberto Clemente Middle School in
New Haven about the hazards of drugs,
alcohol and tobacco. Their program is
one of 10 two-year ASAP pilot projects
nationally, sponsored by the American
Medical Student Association.
Eor their efforts through ASAP, Mr.
King and Ms. Rosen were selected by
their classmates to receive the 1991
CIBA-GEIGY Award for outstanding
community service.

DIVERTICULUM
Miles Scholar Award
Recipient Selected

Divcri 'u iiluni: 799/'.v nu’dical student
literary magazine was edited hy firstyear student James Aim.
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Shalina Mahajan, a graduate student in
human genetics, is the third annual
recipient of the Miles Scholar Award
established by Miles Inc., a health care
company headquartered in Elkhart, Ind.
Two years ago. Miles Inc. created the
award at Yale to encourage graduate
study in the biomedical sciences by stu¬
dents with high potential to achieve
research excellence.
Ms. Mahajan conducts research on
oogenesis, the formation and
development of mature eggs, called
oocytes, in the fruit lly. She studies the

transport of nutrients and molecules
between cells to learn how cells
communicate with each other during
development. Molecular disruptions in
this process may result in abnomial egg
production. “This research is a genetic
approach to understanding the
molecular basis of intercellular transport
by studying specific mutations or
disruptions," states Ms. Mahajan. who
in 1989 received an A.B. degree in biol¬
ogy from Smith College.
The Miles Scholar Award provides
tuition, supplies and other costs, plus a
two-year stipend. Candidates were
selected from second-year Ph.D. and
M.D., Ph.D. students in Yale's biomedi¬
cal .sciences program and its biology
department.
Yale Medicine Summer 1991

DEVELOPMENT REPORT
Parkinson Foundation
Issues $500,000 Grant
The National Parkinson Foundation
(NPF) has awarded the School of
Medicine a $500,000 grant to establish a
basic scientific and clinical research
program to advance knowledge about
and treatments for this neurological dis¬
ease. NPF, based in Miami, cited Yale’s
interdisciplinary approach, which com¬
bines basic research with clinical care.
The NPF program will enable the
school to expand its comprehensive
research activities, especially into the
function of the neurotransmitter
dopamine. For 20 years, Yale has been a
leader in dopamine research. Dopamine,
a chemical messenger, provides the
communication link between the
neurons which degenerate in
Parkinson’s disease and the cells in the
brain which are involved in movement.
Comments Dean Leon E. Rosenberg,
“Through NPF’s generosity, our depart¬

ment of psychiatry, which conducts
extensive neuroscientific research, and
our department of neurology, which
treats patients with Parkinson’s disease,
will expand their programs.”
The National Parkinson Foundation
Research Program at Yale University,
administered by the department of
psychiatry, will be headed by Dr. Ariel
Y. Deutch, assistant professor of psychi¬
atry. Dr. Deutch is also the chairman of
the scientific advisory board of the
National Parkinson Foundation.
This basic research program will be
complemented by the National
Parkinson Foundation Clinical and
Therapeutic Service Programs at Yale
University, directed by Dr. Kenneth
Marek, assistant professor of neurology.
Under his leadership, the department
will expand state-of-the-art diagnosis
and treatment for patients with
Parkinson’s disease; physicians and sci¬
entists will advance research by
conducting clinical studies of new and
promising strategies.

Donald S. Hetzel, M.D., vice president of Becton Dickinson and Company, speaks at a
reception where he presented a check for $150,000 to the department of laboratory
medicine to help support its Molecular Diagnostics Development Laboratory.
Department chairman Peter /. Jatlow, M.D., said the gift will allow basic and clinical
scientists to intensify their efforts to clinically apply advances in molecular
biotechnology.
Yale Medicine Summer 1991

Herman Family Gift
To Benefit EPH
Samuel S. Flerman, ’48 M.P.H., ’50
Ph.D., and his wife, Liselotte, have
donated a remainder interest in their res¬
idence to the department of
epidemiology and public health (EPH).
The funds from the sale of their home
will be used to support the work and
research of EPH faculty.
Born in Boston, Mass., Dr. Herman
attended Harvard College, where he
received his A.B. degree. He then came
to study at Yale’s department of public
health, where he earned M.P.H. and
Ph.D. degrees. After graduating. Dr.
Herman joined the National Institutes of
Health (NIH) in Bethesda, Md., where
he established research training and fel¬
lowship programs for the Eye Institute
and the Environmental Health Sciences
Institute. He also served as the deputy
director for extramural affairs at the
National Cancer Institute.
Dr. Herman left the NIH to join
Temple University in Philadelphia, as
associate vice president for research and
graduate studies at the Health Sciences
Center, as well as associate dean for
research and graduate studies at Temple
Medical School. During that time, he
directed of a Congressionally mandated
study conducted by the National
Research Council for the National
Academy of Sciences to determine
national needs for biomedical and
behavioral research personnel.
Since his retirement from Temple,
Dr. Herman has established a consulting
practice for education and research
organizations. His company specializes
in Washington representation for these
institutions and in biomedical research
administration. In this capacity, he
serves as a consultant to the Lucille B.
Markey Charitable Trust.
Dr. Herman has been an active
volunteer on behalf of EPH and the
School of Medicine, serving on several
boards and as class agent.
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Peter A.T. Grannum

Joseph Axelrod
Joseph Axelrod,
died March 31
in an auto accident near Guaymas,
Sonora, Mexico. He was 74.
Before his retirement, he directed the
Yale University Health Plan and had
been executive director of the Michael
Reese Health Plan in Chicago.
A native of New Haven, Mr. Axelrod
was a 1938 graduate of the University
of North Carolina and in 1951 received
a M.P.H. degree from Yale.
He leaves his wife. Patricia; two
daughters, Carol and Janet; three grand¬
sons; four stepchildren; and five stepgrandchildren.
Contributions may be made to the
Scholarship Committee of Alamos, c/o
Elizabeth Nuzum, Calle Comeccio 2,
Alamos, Sonora, Mexico 85760.

Walter E. Barney
Walter E. Barney. M.D., a retired
general practitioner and
anesthesiologist, died Eeb. 18 at
Willows of Woodbridge Nursing Home
in Connecticut. He was 85.
Ur. Barney formerly was chief of
staff at Milford Hospital before he
retired in 1981 after 50 years in practice.
He was a 1931 graduate of the
Catholic University of America and a
1935 graduate of Yale School of
Medicine. During World War II. Dr.
Barney was a major in the Army.
He is survived by his wife, Mary; a
son, John; and two grandsons.
Contributions may be made to the
Milford Hospital Memorial Eund, 2047
Bridgeport Ave., Milford. CT.

David H. Clement
David 11. Clement. M.D., died March I
in Yale-New Haven Hospital at the age
of 81.
Dr. Clement began his pediatric prac¬
tice in New Haven in 1946. when he
also became a clinical professor of pedi¬
atrics at the School of Medicine. At
Yale-New Haven Hospital, he .served as
director of the pediatric hematology lab¬
oratory and was associate chief of
pediatrics.
I le attained the rank of major during
World War II and later served in
military hospital centers in Naples and
Vittel. Italy. He also helped establish a
research ward for the U.S.A. Typhus
Commission in the Dachau
concentration camp, I'or which he was
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awarded the Commission Medal.
A native of Buffalo, N.Y., Dr.
Clement graduated from Yale College in
1931 and received an M.D. degree in
1935 from Harvard Medical School. Eor
20 years he was official examiner for
the American Board of Pediatrics. He
leaves his wife, Constance; and a
daughter, Constance. Contributions may
be made to the Yale-New Haven Hospi¬
tal Office of Development. P.O. Box
1849, New Haven, CT 06509.

Wilbur G. Downs
Wilbur G. Downs. M.D., clinical profes¬
sor of epidemiology. died Feb. 17 in his
Branford home. He was 77.
Dr. Downs, former director of the
Yale Arbovirus Research Unit, founded
the Trinidad Regional Virus Laboratory,
now the Caribbean Epidemiology
Centre, in Port-of-Spain, in 1952. He
.served as chief of preventive medicine
for the Island Command in Okinawa
during World War II, for which he
received the Bronze Star. After the war,
he directed a malaria control program in
Mexico for the Rockefeller Foundation;
in 1963, he negotiated to move the foun¬
dation’s virus laboratory to Yale, where
it became the Arbovirus Research Unit.
He remained as its associate director.
A New Jersey native. Dr. Downs
graduated from Cornell University and
its medical school in 1935 and 1938,
respectively. In 1941, he received a
master's of public health degree from
Johns Hopkins School of Public Health
and Hygiene.
Dr. Downs was a member and
chairman of many public and private
organization advisory committees,
including those of the World Health
Organization, the United States Public
Health Service and the National
Academy of Sciences.
He leaves his wife, Dorothy; two
sons, W. Montague and Thomas; four
daughters, Helen Haller, Anne Carroll,
Isabel, and Nancy Eeedy; and 15 grand¬
children.
Contributions may be made to the
Downs Student International Travel Fel¬
lowship, c/o Elizabeth Young. Yale
Arbovirus Research Unit, P.O. Box
3333, New Haven. CT 06510.

Peter A.T. Grannum, M.D., associate
professor of obstetrics and gynecology,
died Jan. 21 at the Yale Health Service.
He was 42.
Dr. Grannum. a native of Barbados,
was a graduate of the University of West
Indies Medical School and had been
director of medical studies for the
department of obstetrics and
gynecology at Yale since 1979. He was
a two-time recipient of the medical
school's Francis Gilman Blake Award
for outstanding teaching. He akso was an
attending physician at Yale-New Haven
Hospital and a fellow of the American
College of Obstetrics and Gynecology.
He is survived by his parents. Contri¬
butions may be sent to the Peter
Grannum M.D. Fund. Department of
Obstetrics and Gynecology, Yale
University School of Medicine, P.O.
Box 3333, New Haven, CT 06510.

Leona Baumgartner
Langmuir
Leona Baumgartner Langmuir. M.D.,
New York City's commissioner of
health from 1954 to 1962, died Jan. 15
in Chilmark, Mass, at the age of 88.
Dr. Baumgartner joined the
Department of Health in 1937 and after
her appointment as first female commis¬
sioner, she was appointed assistant
administrator of the Agency for Interna¬
tional Development. One of her last
achievements as health commissioner
was to win a political battle to fluoridate
the city's water supply. In 1962,
President John F. Kennedy appointed
her to head the Office of Technical
Cooperation and Research at the United
States Agency for International
Development, where she established a
research advisory council to improve
standards in grants for health and
welfare programs worldwide. In 1966,
she was named visiting professor of
.social medicine at Harvard Medical
School, a post she held until her
retirement in 1972.
A native of Chicago, Dr.
Baumgartner received bachelor's and
master's degrees from the University of
Kansas and was a Rockefeller Research
Fellow at the Kaiser Wilhelm Institute
in Munich before winning a Sterling
Fellowship to study at Yale, where she
earned Ph.D. and M.D. degrees. Dr.
Baumgartner has been honored with 14
honorary degrees and numerous awards,
among them the Sedgwick Medal and
Yalf. Mhdicine Summer 1991

Lasker Award of the American Public
Health Association, of which she was a
past president, and the Public Welfare
Award of the National Academy of
Sciences. She was an active member of
several professional societies, including
the Institute of Medicine and the Ameri¬
can Academy of Arts and Sciences.
She leaves her husband. Dr. Alexander
Langmuir, and six stepchildren.
Memorial contributions may be sent to
the Leona Baumgartner Student Loan
Fund, Yale University School of
Medicine, New Haven, CT 06510.

Jacob Mellion
Jacob Mellion, M.D., died Feb. 23 at the
age of 93.
Dr. Mellion served as the New
Britain school system’s health director
from 1927 until he retired in 1962. He
continued as the high school’s team
physician for 12 years after his
retirement. A native of New Haven,
Dr. Mellion was a 1923 graduate of Yale
School of Medicine and a veteran of
World Wars I and II, serving in North
Africa and Italy.
He is survived by his wife, Ethel; a
daughter, Patricia Allen; and a
grandson.
Memorial donations may be made to
Hadassah, c/o Mrs. Selma Zager, 231
Lowery Place, Newington, CT 06111.
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Henry K. Silver
Henry K. Silver, M.D., a pediatrician
who developed pioneering programs in
the 1960s, died Jan. 13 at LIniversity
Hospital in Denver. He was 72.
Dr. Silver joined the faculty at the
University of Colorado School of
Medicine in 1957 after teaching at the
University of California Medical School
and Yale School of Medicine.
He was a 1942 graduate of the
University of California at Berkeley
Medical School. In 1964 he developed
the first national program for nursepractitioners and also instituted a
program at the University of Colorado
to train students as physicians’
assistants specializing in pediatrics.
Since 1978 he served as associate dean
of admissions at the University of
Colorado Medical School.
In 1985, he conducted a study of
abuse of medical students by faculty
members and supervisors and in 1990,
co-authored a study revealing that 80
percent of the students in one medical
school reported some form of verbal,
physical or sexual abuse.
He is survived by his wife, Harriet;
and a son, Andrew.

Brigitte A. Prusoff

Hoyt C. Taylor

Brigitte A. Prusoff, Ph.D., died April 4
at Yale-New Haven Hospital at the age
of 64.
A native of Berlin, Germany, Dr.
Prusoff had been a member of the Yale
faculty since 1961 and was a founder of
Yale’s Depression Research Unit. She
was a research scientist in the genetic
epidemiology research unit in the
department of psychiatry.
Dr. Prusoff received a master’s
degree in biometry from the department
of epidemiology and public health at
Yale in 1967 and a doctoral degree in
epidemiology in 1978. Dr. Prusoff was
the recipient of the American
Psychiatric Association’s Foundation
Fund Prize and the Anna Monika Foun¬
dation Prize. She was an editorial
consultant for several psychiatric
publications as well as a member of
numerous professional organizations.
She leaves her husband. Dr. Wiliam
H. Prusoff; a son, Alvin; a daughter,
Laura; and three grandchildren.

Hoyt C. Taylor, M.D., died Jan. 4 at
Martin Memorial Hospital in Palm City,
Fla. He was 79.
Dr. Taylor, a Connecticut native, was
a graduate of Norwich Academy and
received his bachelor’s and master’s
degrees from Wesleyan University. In
1938, he received an M.D. degree from
Cornell Medical School and served for
two years on the house staff at the New
York Lying-in Hospital. He transferred
to New Haven Hospital where he served
a residency and was an instructor in
obstetrics and gynecology at Yale.
During World War 11, Dr. Taylor
served with the advanced amphibious
units in England, and upon his return
was appointed head of the department of
gynecology at Chelsea Naval Hospital,
Mass. He later opened his own practice
in Meriden, Conn., which he retained
for 25 years and was chief of ob/gyn at
Meriden-Wallingford Hospital for 15
years. He was a founding fellow of the
American College of Obstetrics and
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Gynecology and American College of
Surgeons and a member of the
Connecticut Medical Society, the Amer¬
ican Medical Association and the
Marting County Medical Society.
He is survived by his wife, Dorothy;
three daughters, Deborah Gaffney,
Jacqueline Vineis and Patricia
Linthicum; two stepsons; four
stepdaughters; and 21 grandchildren.

David Weinman H
David Weinman 11, M.D., died Feb. 2 at
his home in California at age 82.
A native of New Mexico, Dr.
Weinman received a B.A. degree from
Columbia College in 1929 and an M.D.
degree from the University of Paris in
1935.
Dr. Weinman, professor emeritus of
epidemiology at the School of
Medicine, held positions at Harvard
University Schools of Medicine and
Public Health, Columbia College of
Physicians and Surgeons, and the
University of California, San Francisco,
Medical Center. He was a consultant to
the American Medical Association
council on drugs and a member of the
World Health Organization Expert Panel
on Parasitic Diseases.

Warren H. Weiswasser
Warren H. Weiswasser, M.D., M.P.H.,
died in his home in Orange, Conn, on
Eeb. 18, at age 46.
Dr. Weiswasser had been a
pediatrician associated with the
Community Health Care Plan Inc. in
New Haven since 1977. He also served
several positions with the Quality
Assurance Network Committee, includ¬
ing medical director and chaimian.
A native of Detroit, Dr. Weiswasser
graduated from Monteith College and
the University of Michigan Medical
School. He received a master’s of public
health degree from the University of
Washington.
Dr. Weiswasser held a clinical
faculty appointment at the School of
Medicine and was a member of the
Mayor’s Task Eorce on AIDS in New
Haven.
He is survived by his wife, Janet; two
sons, Charles and Michael; and a daugh¬
ter, Julie.
Contributions may be made to the
Child Development Unit, Yale Child
Study Center, P.O. Box 3333, New
Haven, CT 06510.
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IN MEMORIAM

William Cohen
December 3, 1990

'23 M.D.

Edward W. Holland
July 5,1990

'32 M.D.

Frank J. Kenney Jr.
August 13,1991

Jacob Mellion
February 23, 1991

'23 M.D.

Raymond E. Miller
December 25,1990

'33 M.D.

Charline S. Buck
December 5,1990

'55 M.P.H.

John J. Batchelor
.lanuary 8, 1991

'24 M.D.

John J. Wolfe
April 21,1990

'33 M.D.

James F Schwartz
October 1990

'56 HS

William R. Sweetman '34 M.D.
December 3,1990

Robert T. Miller
June 3,1990

'58 HS

'59 HS

Wilfred S. Clark
September 18, 1989

'25 HS

Dorence S. Cowles
December 13, 1990

'25 M.D.

Edward F. Falsey
November 3,1990

'35 M.D.

Edward H. Futterman
March 23,1991

Ernesto Icaza

'27 M.D.

Frederick A. Post
April 1990

'36 M.D.

Edward A. Janasz

'61 M.P.H.

Gary Van Galder
January 31,1990

'63 M.D.

'36 ex med

Leland S. Berger
May 4,1990

'64 M.D.

'38 HS

David R. Stewart
October 1986

'65 HS

Edward 1. Sweet
December 21,1988

'69 HS

Michael L. Stratton

'72 HS

Peter A. Grannum
January 21,1991

'76 HS

Warren H. Weiswasser
February 18,1991

'll HS

Samarjit Ghuman
August 1989

'84 HS

Sander E. Lachman
November 2, 1988

'27 HS

George C. Wilson
December 28, 1990

'28 M.D.

John W. Cass Jr.
May 10, 1990

'29 M.D.

Lydia G. Dawes
December 4, 1990

'29 M.D.

Paul H. Lavietes
December 27, 1990

'30 M.D.

Helen R. Gilmore

'31 M.D.

Carl J. Tracey
August 7,1989

Byron C. Smith
December 5,1990

Howard B. Rindge '39 ex med
December 12,1990

Knute E. Berger
December 24, 1990

James W. Reed
,luly 10, 1990

'42 M.D.

'31 M.D.
Wilson E. Hughes
June 2,1990

Winfield L. Butsch
October 24, 1989

'41 M.D.

William I. Lourie Jr. '41 M.P.H.
September 19, 1990

Samuel W. Budd Jr.
January 21, 1991
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'55 M.D.

'42 M.D.

'32 HS
Charles W. Lloyd

'45 HS

George H. Burke
June 1,1990

'50 HS
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79 YEARS OF SERVICE

(j.D. Edit!} Hsuing. Fli.D., professor enter it us of laboratory medicine, shares a
Student Research Day program with second-year student Eileen Deignan. In 1990.
Ms. Deignan received the first research fellowship named in honor of Dr. Hsuing.
a db-year faculty member.

ERH registrar Vera Wardlaw checks the commencement schedule with Eric U.
Mood. M.F.II.. who has been a lecturer in environmental health for 43 years.
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CONTINUING MEDICAL
EDUCATION AT YALE

Friday
Sept. 13, 1991

The Children’s Hospital at Yale-New Haven Hospital Annoiinees
the First Annual Conference on Congenital Heart Disease

(A)

Director: Michael Dewai'. M l).

Friday-Satlirday
Sept. 27-28, 1991

Visiting Lecture Series in Clinical Ophthalmology

(B)

Director: David E. Silverstoiie, M.D.
Speaker: Melvin Rtihi)i, M.D.
Will focus on the update of ophthalmic optics.

Friday-Saturday
Oct. 25-26, 1991

Neurobiology of Affective Disorders

(C)

Director: George K. Aghajanian. M.D.
Primary focus will be upon underlying brain mechanisms and the mechanism(s) of action
of antidepressant and antimanic drugs.

Thursday
Oct. 30, 1991

Third Annual Cardiology Update
Director: Lawrence S. Cohen. M.D.

Thursday-Friday
Dec. 5-6, 1991

Director: Michael .1. Caphin. M.D.. Ph.D.

Cell Biology and Membrane Transport Process

(D)

(E)
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Medical school researchers are learning more about the
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savor our food and warn us about fire and other dangers.
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LETTERS
Leon Rosenberg’s
Farewell to Yale
Editor’s note: As of August 31, Leon E.
Rosenberg, M.D., resigned as medical
school dean to begin his new post as
president of the Bristol-Myers Squibb
Pharmaceutical Research Institute. The
following letter, dated Aug. 28, was dis¬
tributed to the medical school commu¬
nity. For further news about Dr. Rosen¬
berg’s departure, turn to Faculty News,
page 32.

To members of the Yale School of
Medicine community:
As I prepare to depart after 26 years as a
member of the Yale faculty, the leave
taking is even more difficult than I
anticipated. The unexpected offer from
Bristol-Myers Squibb has left little time
to prepare emotionally, or even to say
goodbye to the many people at Yale
who have made these years so reward¬
ing and enjoyable. I will miss the many
talented and dedicated people of this
school — faculty, students, staff, alum¬
ni, friends — who create a richly woven
tapestry of competence, humane ideals,
and personal warmth.
During the past seven years as your
dean I have been deeply moved by the
spirit of community demonstrated by so
many people. It has enabled us together
to build on Yale’s tradition of excellence
in medicine and to enlist new friends
and partners to move this great institu¬
tion forward. I am proud of our accom¬
plishments. There have been new build¬
ings and programs, of course; even
more gratifying is the knowledge that
we have added strong new leaders in the
departments and offices, recruited
superb scientists, teachers, and clini¬
cians, and voiced loudly our support for
such values as fairness, decency, toler¬
ance, integrity, and excellence.
What first attracted me to the world
of science was the limitless challenge
that lies before us. My next assignment
will be a fresh approach to that chal¬
lenge. As president of the Bristol-Myers
Squibb Pharmaceutical Research Insti¬
tute, I will continue to pursue three
career-long themes: developing young
scientists; using medical science to
improve human health; and building a
Yale Medicine FallAVinter 1991 -92

strong, cohesive research organization.
Further, I hope to take part in creating
new avenues of cooperation among
industry, government and universities.
Our nation’s strength in biomedical
research is the envy of the world. We
must utilize our resources yet more effi¬
ciently to improve health and to reduce
suffering.
The decision to leave Yale is the
most difficult decision of my profes¬
sional life. My years as a faculty
member, department chair, and dean
have taught me over and over again
what a great center of teaching, discov¬
ering, and serving Yale is. This decision
turns a major page in my life’s book and
those of my family. It will also mean
changes and challenges for those I leave
behind at Yale. Bob Donaldson, the
associate deans, the department chairs,
and administrative directors will need
your cooperation more than ever before.
You can depend on Benno Schmidt to
lead an exemplary search for my succes¬
sor. He has always been a great advo¬
cate of the School of Medicine and he
understands well the importance of this
moment in the School’s evolution.
Although Diane, Alexa, and I will be
moving to Princeton on September 1,
we will keep our home in Guilford. That
will enable us to maintain close ties to
our many friends here. Please know that
we are grateful for the many kindnesses
you have shown us. Most of all, I thank
you for your part in making Yale the
special place it continues to be.
Leon E. Rosenberg, M.D.
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An EPH Issue
To the editor:
I am a 1951 graduate of the Department
of Public Health as it was known when I
attended. All these years I have received
and read Yale Medicine and enjoyed it.
The FallAVinter 1990-1991 issue
provokes this note. At no time in the
past, at least to my recollection, was so
much space devoted to our School of
Epidemiology and Public Health. I am
greatly pleased and so wished to
express.
Many thanks.
Leonard F. Menczer, D.D.S., M.P.H. '51
Hartford. Conn.

AIDS Statistics
To the editor:
On page 15 of the Summer 1991 Yale
Medicine “AIDS Research at Yale:
Shifting into High Gear”), the table
mentions “one in 200 Connecticut resi¬
dents is infected with HIV, roughly the
same as the national rate.” And then
above, “the [Centers for Disease Con¬
trol] listed 174,843 Americans who
have had AIDS...”
Now, 174,893 times 200 equals
approximately 35 million — not 250
million Americans. How come? Can it
be that the natural incidence of AIDS is
closer to one in 2,000?
Francis Coughlin, M.D. '52
New Canaan. Conn.
Editor’s reply: Your calculation is in¬
valid because it mistakenly equates the
HIV infection rate with the incidence of
full-blown AIDS. The CDC statistic pro¬
vided in the article listed the number of
reported cases of symptomatic AIDS in
the United States: the one-in-2()() figure
for Connecticut, quoted from the state
Department of Health's “AIDS in Con¬
necticut Annual Surveillance Report,”
estimates the number of people who
have been infected with HIV. With a
latency period of up to seven years or
longer, not every person who tests posi¬
tive for HIV antibodies e.xhibits symp¬
toms of AIDS.
As for national HIV infection statis¬
tics. the National HIV and AIDS Infor¬
mation Service of the American Social
Health
Association
estimates
that
roughly one million Americans are HIV¬
positive. Given a population of 250 mil¬
lion. that would put the estimated inci¬
dence of HIV infection at one in 250.
T

A. C. Gilbert (left) in medical school: fascinated by how things work.

Alumnus A.C. Gilbert
Recalled at Exhibit
On Sept. 22, the Eli Whitney Museum
in Hamden, Conn., opened a ninemonth exhibition, “A.C. Gilbert and the
Tools of Learning.” The museum,
located on the site of Eli Whitney’s gun
factory, is celebrating the legacy of
Alfred Carlton Gilbert, M.D. ’09, with a
display of Erector sets. American Elyer
trains, chemistry sets, magic kits and
other Gilbert inventions, which were
manufactured in New Haven.
Bom in Salem, Ore., in 1884, A.C.
Gilbert excelled in many fields. As a
Yale undergraduate, he was an accom¬
plished athlete, establishing records in
wrestling and gymnastics. In the pole
vault, he replaced the traditional hickory
pole with spineless bamboo and won an
Olympic gold medal.
No less skilled at sleight-of-hand,
Gilbert paid for his university education
by putting on magic shows. In his last
year at Yale, he received as much as
$100 per performance, a considerable
sum for the time. A few months before
he graduated with his medical degree,
he and a fellow magician formed the
Mysto Manufacturing Company to pro¬
duce and distribute magic sets. Their
modest enterprise presaged far greater
things to come.
When A.C. Gilbert earned his degree
from the School of Medicine, he
intended to start a career as a physical
education instructor. Soon after gradua¬
tion, though, he succumbed to the lure

of invention — especially toys — a pas¬
sion that dominated the rest of his life.
By age 77, when he died, he held more
than 150 patents.
In 1916, the inventor parted ways
with his partner and the company
became his namesake. By the mid1940s, the A.C. Gilbert Company could
boast that it was the world’s largest toy
manufacturer. At its peak, the company
employed 2,500 at its site in the Eair
Haven section of New Haven.
Dr. Gilbert’s most successful and
best known creation was the Erector
Set, comprising miniature steel girders
that children used to fashion buildings,
airplanes, automobiles and other struc¬
tures. This toy may have been the most
popular in history; at the company’s
50th-anniversary celebration, employ¬
ees presented its founder with a goldplated Erector Set representing the 10millionth unit sold.
A turning point came when the first
“television generation” failed to display
the affinity for A.C. Gilbert toys that
their parents and grandparents had. The
company’s sales declined throughout
the 1950s. When the great inventor died
in 1961, his company passed away with
him.
For millions of adults in their middle
years and older, however, the name A.C.
Gilbert still conjures up the nostalgic
sound of a toy train whistle and the
image of an Erector Set town diffused in
whisps of smoke from an American
Elyer locomotive.
William McKeon
Yale Medicine
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WHY YOU ARE HERE
hy Robert M. Donaldson Jr., M.D.
What a wonderful day this is for the School of Medicine. What
could be more exciting for Dean Gifford and his student affairs
office, or more rewarding for the admissions committee, than
to see all in one room this group of such marvelous individuals
whom they have worked so long and so hard to identify and
recruit to Yale.
Let me tell you something about yourselves — and I’m
most grateful to Lynne Wootton, director of admissions, for
compiling this information. You number 59 men, 41 women.
Your diversity is remarkable. There are among you 11 AfricanAmericans, one native American, four Americans of Hispanic
origin and 25 Asian-Americans. Your origins are truly interna¬
tional, with families coming from countries on every inhabited
continent of this planet.
Nine of you have already received advanced degrees — in
disciplines as different as public health, engineering and
music. Forty-five of you seriously pursued other endeavors
before entering medical school. You have worked as engineers,
photographers, bartenders, computer programmers, emergency
medical technicians, writers, instructors, security officers, edi¬
tors, truck drivers, lifeguards, cashiers, secretaries, sales repre¬
sentatives, word processors and phlebotomists. Among you are
a management consultant, a financial analyst, a genetic coun¬
selor, an architect and a dockmaster.
You have worked in all sorts of settings, from radio stations
to children’s theaters, even a planetarium. One of you ran his
own landscaping business for a decade. Another worked as a
health planner and community development specialist for the
Muscoge Creek Indian Nation. You have volunteered not only
in hospital emergency rooms, but in shelters for battered
women, soup kitchens, suicide prevention centers. Headstart
programs, and many other programs and facilities for the dis¬
advantaged and underserved. You have helped the homeless,
the handicapped and patients with AIDS. You possess a wealth
of musical talent and have played in orchestras and chamber
groups, and one of you formed a band which had three world
tours and two albums.
You have received numerous prizes and honors. One of you
was recently elected to serve on the board of trustees of your
undergraduate college. You have conducted independent stud¬
ies in the finest laboratories and research institutes in this
country. You have investigated and published on everything
from French history, to astronomy, to medical ethics.
You must be very proud of all you’ve accomplished and,
yes, we really are lucky to have you here. What all of us
should do right now is simply celebrate. But this is also the
real world, a place of hard facts, and before we celebrate, we
must get oriented.
I realize how stressful orientations can be. As you confront
stark realities that never before entered your mind, I suspect
that by now some of you may be asking yourselves, “Is this

This article is based on an address delivered on Aug. 29 hy
Acting Dean Robert M. Donaldson Jr. to the incoming School
of Medicine Class of 1995.
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where I really want to be? Why am I here at the Yale School of
Medicine?”
Let me presume to tell you why. First and foremost, you are
here because this school acknowledges your maturity. This
means that the responsibility for your education belongs to you
and to you alone. Ever since first grade, you have lived with an
educational paradigm in which you were provided with a
defined body of information and then graded on your capacity
to comprehend, retain and regurgitate that information. That
educational paradigm no longer applies.
In the first place, the biomedical sciences embrace a rapidly
changing database far beyond what even extraordinary talents
such as yours can assimilate in four short years. Moreover,
medicine is far too important a discipline to be learned merely
for the sake of grades, no matter how valid the grading system
may be. No, you are here to learn for yourselves, for your
future and for your patients.
At the Yale School of Medicine you will not spend four
years filling your brains with as many facts as possible.
Instead, you will begin a lifetime of study. You will learn how
to learn, how to find the information you need, how to judge
the quality of data and how to interpret them and, most impor¬
tant, how to challenge the many so-called “facts” you will con¬
front.
This leads me to a second reason why you are here: for the
excitement of generating new information, coming closer to
the truth and not just passively accepting what we tell you.
Most of you will gain this experience from a required doctoral
thesis completed during four years of medical school. Judging
from previous classes, I would guess that about 20 of you will
become excited enough to spend a fifth year on a major project
and that 11 of you will be so committed to academic careers
that you will invest the several years needed for the combined
M.D., Ph.D. degree.
Third, you are here because your marvelous backgrounds
and experiences will enrich each other and enrich this place.
You will work together in small groups, learning not only from
a large and talented faculty, but also from each other. There are
in fact among you several talented experienced teachers who
have been teaching in elementary schools, secondary schools,
colleges, and even in the School of Public Health at Yale.
Undoubtedly, the best way to truly master a subject is to teach
it, and you will all be teaching each other in a variety of set¬
tings from the seminar room to the clinic to the bedside.
What I have been talking about is the Yale System of medi¬
cal education, which has been with us for more than half a cen¬
tury. Our colleagues at Harvard have recently unveiled what
they proudly call “the new pathway;” we are equally proud of
our old pathway. Although long with us, the Yale System is
unquestionably alive and well.
You should understand one hazard of the Yale System,
however. Learning how to learn for a lifetime, learning at your
own pace, and being responsible for your own education does
not add up to a journey through some sort of educational lotus
land. You will, in fact, work very hard to meet very difficult
educational challenges.
After all, the fourth reason you are here is because this
3

Robert M. Donaldson Jr.
Appointed YSM Acting Dean
The trustees of the Yale Corporation have approved the
appointment of Robert M. Donaldson Jr., M.D., as acting dean
of the School of Medicine. Dr. Donaldson, the David Paige
Smith Professor of Medicine, succeeds Leon E. Rosenberg,
M.D., who resigned, effective Sept. 1, to assume the presi¬
dency of Bristol-Myers Squibb Pharmaceutical Research
Institute, based in Princeton, N.J.
Yale President Benno C. Schmidt Jr., who heads the faculty
search committee to find Dr. Rosenberg’s successor, com¬
mented; “1 am very pleased that Dr. Donaldson will ably lead
our medical school as we conduct our search for a new dean.
The 16-member search committee which I chair is hard at
work on its task, and we hope to appoint a new dean by next
July. Yale is fortunate to have an experienced and distin¬
guished physician, scientist and administrator in Bob Donald¬
son to carry forward the medical school’s tradition of excel¬
lence during this year.”
A gastroenterologist. Dr. Donaldson has served as the med¬
ical school’s deputy dean since 1987 and on the Yale faculty
since 1973. During his career, he has been chief of the medi¬
cal service at the Department of Veterans Affairs Medical
Center in West Haven and vice chairman and acting chairman
of internal medicine.
Dr. Donaldson has conducted research on the role of cer¬
tain bacteria in digestion and in diseases that cause the mal¬
absorption of nutrients. He holds a special interest in the
basic mechanisms in the absorption of vitamin B12. The
acting dean’s clinical studies relate to peptic ulcer disease,
chronic liver disease and the ways physicians use diagnostic
technology. His research is cited in more than 100 publica¬
tions.
From 1967 to 1972, Dr. Donaldson chaired the advisory
committee for National Institutes of Health (NIH) training
programs in gastroenterology and nutrition. There he devel¬

school enjoys an excellent reputation. That reputation is no
accident. We identify and recruit students like you who have
enomious potential for excellence, mix those students together
with a large, first-rate faculty, add in an outstanding library,
make available a wide array of patients, and then impose the
highest standards of excellence on the outcome. How well you
fulfill your astonishing potential for excellence will be a matter
of serious concern to you and to this school.
You cannot really learn how to evaluate data without seri¬
ously confronting those data. You cannot truly challenge
knowledge without the hard work that goes into fully compre¬
hending what it is you wish to challenge. As is true for any
enterprise, you will get out of your Yale medical education
exactly what you put into it, nothing more, nothing less. 1 urge
you to immerse yourself totally in this exciting educational
enterprise. Those who do not run the real danger of getting lost
in the shuffle.
The fifth reason you are here is to bring to this place your
diverse racial, ethnic and cultural backgrounds. They are
essential for the kind of sensitivity and compassion needed to
care for the poor and for members of disadvantaged minorities.
You will have ample opportunity not only to involve yourself
4

oped the concept of
a clinical investiga¬
tor (young scien¬
tist) award that the
NIH would spon¬
sor. For his out¬
standing contribu¬
tions to the field of
gastroenterology.
Dr. Donaldson was
awarded
the
Friedenwald Medal
by the American
Gastroenterologi¬
cal Association.
Active in scien¬
tific publishing. Dr.
Donaldson edits the
journal
Current
Opinion in Gas¬
troenterology
and
serves on the edito¬
rial board of the
New England Jour¬
nal of Medicine. He
also edited the jour¬
nal
from 1970 to 1977.
A past president of the American Gastroenterological
Association, Dr. Donaldson was elected to the American Soci¬
ety for Clinical Investigation and the Association of American
Physicians. Between 1984 and 1990, he was a member of the
American Board of Internal Medicine and served on its exec¬
utive board in 1987.
A native of Wellesley, Mass., Dr. Donaldson received a
B.S. degree from Yale College in 1948 and an M.D. degree
from Boston University School of Medicine in 1952. He
received his clinical and post-doctoral training at the Montreal
General, Boston Veterans Administration and Peter Bent
Brigham hospitals.

in the care of such patients, but to heighten everyone’s aware¬
ness of the special needs of those who are not only ill but who
are made especially vulnerable by poverty and bigotry.
Nothing elevates the quality of medical care more than this
kind of awareness. Therefore, at the very beginning of your
medical school career, you will participate actively in work¬
shops designed to promote awareness of. sensitivity to and
respect for cultural differences, attitudes which are absolutely
crucial to the credibility of this medical center as a place of
healing.
Finally, you are here because this school is situated in a
community that will challenge you to grow rapidly and well,
both personally and professionally. You will soon find your¬
selves confronting the serious and complex health needs of
New Haven and, like your predecessors, you will meet those
needs with innovative solutions.
These, then, are the reasons you are here. You are here in
essence to make a real difference — in yourselves, in this
school, in this community and ultimately in the nation. These
are also the reasons 1 am so proud to welcome you and to wish
you well as you take advantage of the most exciting challenges
and opportunities you’ve ever had.
YM
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PHYSICIAN-SCIENTISTS
A VANISHING BREED
hy Francis S. Collins, M.D., Ph.D.
“The physician-scientist is an ‘endangered species.”'
An article bearing this disturbing title appeared 12 years
ago in the New England Journal of Medicine. It was written by
Jim Wyngaarden, who subsequently became head of the
National Institutes of Health (NIH). In the intervening years,
matters have gotten even worse — a decreasing number of
physicians are playing a meaningful role in basic science.
To define my terms, I refer to a physician-scientist as some¬
one who runs a laboratory and who has funding from a grant¬
ing agency. I distinguish this activity from routine therapeutic
trials. While acknowledging the latter as crucial, I think M.D.s
carrying out such trials are less likely to disappear from our
ranks; it is difficult to imagine clinical trials being conducted
solely by Ph.D.s. The group I am concerned about are physi¬
cian-scientists who are involved in more basic research, and
who are trying to balance its challenges with the roles of
physician and teacher.
A Matter of Style_
The gap is widening between research and clinical practice, as
is the related rift between Ph.D.s and M.D.s. Although Ph.D.s
and M.D.s have traditionally approached basic research from
different perspectives, the alienation between the two camps
seems to be getting worse.
Inevitably, tensions arise from fundamental differences in
job description. By way of illustration, consider the following
two vignettes. They might unfold on any day at a leading med¬
ical center:
John Doe, M.D., a fellow in hematology!oncology, is
working late at night. He has just admitted a female patient
with chronic granulocytic leukemia who has gone into blast
crisis. She is bleeding, and has a high fever. Wasting no
time. Dr. Doe works up the patient and searches for some
source of the fever. When he fails to find one, he obtains the
appropriate cultures and administers broad spectrum
antibiotics, knowing that to wait for a precise diagnosis of
the infectious cause is tantamount to signing this patient's
death warrant.
Dr. Doe explains to the patient, and later to her anxious
family, the seriousness of the situation, the fact that even if
the crisis passes, the chances of long survival are bleak. He
discusses these issues at length with the family; they pour
out their fears and their grief.
Dr. John Doe crawls into bed about 3:00 a.m. feeling
thoroughly drained. Though the physician may not thor¬
oughly realize it, however, something important has tran¬
spired during the time he spent with the patient and her
family trying to sift through these new developments. I’ll
return to this point later.
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Dr. Francis S. Collins

Francis S. CollinSy M.D.y Ph.D.:
Award-winning Geneticist
Dr. Francis S. Collins played a leading role in the discov¬
ery of the cystic fibrosis gene, a contribution that won him
the 1990 Paul di-Sant’Agnese Distinguished Achievement
Award from the Cystic Fibrosis Foundation. A year later,
his research group identified the gene for neurofibromato¬
sis. A professor of internal medicine and human genetics
at the University of Michigan, he also is an investigator
with the Howard Hughes Medical Institute. In 1974, he
received his Ph.D. degree in physical chemistry from Yale
and in 1977, his M.D. degree from the University of North
Carolina. He returned to Yale for a post-doctoral fellow¬
ship in human genetics after completing his internship and
residency at North Carolina Memorial Hospital.

This article was based on an address Dr. Collins delivered to
University of Michigan medical school graduates at the
Honors Convocation, May 1990.
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Now let’s turn to the second vignette:
Little does Dr. Doe know that earlier in the day. in a
building adjacent to his hospital. Jane Smith. Ph D., was
hard at work in a research lab. trying to understand the
molecular basis of chronic granulocytic leukemia. Dr.
Smith is studying the peculiar protein which is produced in
this disease when chromosome 9 sequences are fused to
chromosome 22 sequences (the Philadelphia chromosome),
and a funny hybrid protein that contains part of an onco¬
gene called abl gets produced. She has deduced that this
protein works as an unrestrained tyrosine kinese. which
means it goes around adding phosphate groups to other
proteins.
Dr. Doe rolls over with a sigh and enters an uneasy
sleep. Dr. Smith returns to her apartment after having cele¬
brated the evening with her research team. After years of
tedious work, she has finally identified the mechanism that
will provide the crucial link in understanding how this
translocation, this rearrangement of chromosomes, leads to
malignancy.
While it is certainly true that society was well served by
both these professionals, I suggest that it would have benefitted even more if Drs. Doe and Smith had been the same person
in two parts of his or her daily activity. In the first story, it may
have been an extraordinary comfort for the family to know that
their physician was doing research into the possible cause of
their loved one's disease. In vignette two, I suspect that the
insights which the Ph.D. obtained in the lab would have been
more meaningful — and potentially more immediately trans¬
lated into therapeutic ideas — if she were also personally
familiar with the ravages of the di.sease.
M.D. Alienation
Our widening gulf between the M.D. physician and the Ph.D.
researcher contributes, 1 think, to the .sense that many M.D.s
have that they don't belong in basic research. They are not
always treated kindly by Ph.D.s, and are often looked down
upon in the laboratory as second class. Similarly, Ph.D.s, when
they try to understand the clinic, are often not treated kindly.
An insightful article called “Cultures in Conflict: M.D.s and
Ph.D.s.” appeared in the New York Times in April 1990. It was
written by Natalie Angier, who has since won the Pulitzer
Prize for her medical and science reporting. In the article, Ms.
Angier contrasted a Ph.D. molecular biologist, in this case
Richard Mulligan at M.I.T., and an M.D. pediatrician, Kenneth
Culver, who works in gene therapy at the NIH.
Ms. Angier writes:
Thirty years ago the British scientist and novelist C.P.
Snow wrote Two Cultures (about the philosophical gap
between the humanities and the sciences). Today another
sort of cultural rift seems to deny union or even comity, the
gap between the doctor and the scientist. In the biomedical
community, physicians and Ph.D.s alike are probing the
fundamental mechanisms that underlie human disease,
health and development. Sometimes the doctors and the sci¬
entists work side-by-side in a research laboratory or at
least on the same university floor. But by training, philoso¬
phy. motivation and research style, doctors and scientists
might as well be from different phyla. And they are forever
arguing about which is the more highly evolved.
I’hough this passage may overstate the case a bit, it does
6

effectively evoke the differences in mindset that the physician
must carry to the hospital ward versus what the scientist takes
into the laboratory. Sometimes those mindsets can get in the
way of those who are trying to be healers as well as basic
researchers.
Note that John Doe, M.D., had to make a decision about
treating his patient with antibiotics without really knowing
what was going on. The usual situation in clinical medicine, in
fact, is that the information one deals with is woefully incom¬
plete and uncertain. It is a rare circumstance indeed where doc¬
tors are absolutely sure that they are doing the right thing. Suc¬
cessful physicians eventually learn to live with this
uncertainty. It is the best that you can do.
But this is very different from the approach one must take
to carry out good science. In that setting, one must never be
satisfied with information that is incomplete, inadequate or
lacking. Physicians, however, can sometimes stumble when
they try to transfer their clinical thought processes into sci¬
ence, as they may be inadequately critical of the data. The data
have to be more solid.
Another contrast that emerges from the John Doe-Jane
Smith vignettes is the importance of defining precise causa¬
tion. A physician treating a patient with chronic granulocytic
leukemia is usually not concerned with the chromosome 9 to
chromosome 22 translocation, no matter that this is the cause
of the disease. The physician is not concerned because thera¬
peutically, there is nothing he or she can do about it.
By contrast, to a scientist, fundamental causes are what it’s
all about. A scientist is driven by the desire to understand for
understanding’s sake. If that eventually leads to a therapy, so
much the better.
The final difference between John Doe and Jane Smith pre¬
sents itself in their source of satisfaction, and that is to my
mind an enormous difference. A physician, at least as I per¬
ceive it from my own experience, gains satisfaction primarily
from interacting with patients. Even in situations like the one I
described, where what is offered therapeutically is far too inad¬
equate for the demands of the situation, the opportunity to
enter the lives of patient and family, to interact with them and
comfort them, and to explain a frightening event to them, pro¬
vides an immediate sense of gratification. It is a real gift to be
able to share that experience with other people.
Compare this with the scientist’s gratification, which is the
joy of discovery. A key attribute of this joy is that it doesn’t
come along every day. In most laboratories like mine, about 75
percent of the experiments are a complete disaster. If you’re
not prepared for that, you get frustrated rather quickly. It’s the
25 percent that partially work that keep you going. If you’re
fortunate, perhaps 1 percent actually make some new observa¬
tion, and that’s what makes it all worthwhile.
This is different from the clinic, where almost every time
that I see patients, talk with them about their diseases, and pre¬
scribe some course of treatment, I feel good about it. Physi¬
cians who try to play both the roles of healer and basic
researcher have to constantly change their mindset to deal with
those differences as they don their different hats.
Such adjustments make it difficult for an unprepared physi¬
cian to enter research. Even when M.D.s do commit them¬
selves to the dual track, the differences in approach and expec¬
tations can prove discouraging. Fortunately, most of these
problems can be avoided through proper training.
Eluding the Pitfalls_
The problem with preparing physicians for research is twofold.
First, as I just mentioned, in some ways the thought processes
Yale Medicine
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Office of Student Research
Nurtures Physician-scientists
Yale School of Medicine has a long tradition of educating
physician-scientists; its M.D. thesis requirement, involv¬
ing original research, is one of the few such requirements
in the country, and dates back to 1839. To facilitate stu¬
dents in writing the thesis, the student research office pro¬
vides monetary support which comes from private dona¬
tions and grants as well as from school and departmental
sources. More than 150 full-time faculty members serve as
mentors for student research activities and provide labora¬
tory space and equipment.
The school’s One-year Student Research Fellowship
Program, which supports students as they devote an entire
year to research, has 14 students enrolled this year. As an
added incentive to taking a fifth year, students are not
charged tuition for the extra year. Funding for this program
comes from government, charitable and private sources.
Another program that encourages students to pursue a
career in academic medicine is the M.D.-Ph.D. program,
directed by James D. Jamieson, M.D., Ph.D., professor
and chairman of cell biology. Since its inception in 1969,
enrollment has grown from 14 students to 60.

of the healer and the scientist are different. Second, physicians
who try to do bench research often devote insufficient time to
their training. No M.D. would dream of going out and practic¬
ing medicine after two years in medical school. But many
physicians try to do research with only one or two years of
experience in the laboratory, and that can be very frustrating.
The issue of adequate training brings to mind the wonderful
experience 1 had last year in meeting Dr. James Shannon, who
was the director of the NIFI from 1955 to 1969, during its time
of enormous growth. Many of the things that we look to with
pride in this country’s biomedical research stem from Dr.
Shannon’s vision and insight. He is now 86 years old.
As he reminisced about his time as an assistant professor on
a medical school faculty in the 1930s, he painted a dramati¬
cally different picture of medicine and biomedical research
than we know today. Upon finishing his internship and resi¬
dency, Dr. Shannon was offered a job in a department of physi¬
ology without any significant research training. In the course
of six years, he taught himself and published 19 papers, some
of which are classics in the study of the glomerular filtration
rate. On 17 of those papers he was the sole author.
You would never see that happening in today’s world of
complicated research. Basic scientists need more people to
help them, and the scientists themselves need a more pro¬
longed period of training. We make a mistake, 1 think, by
advising students and new physicians that they can get away
with sketchy research training and still make a success of it.
Why does all this matter? Do we really need physician-sci¬
entists anyway? Here I will cite a less enlightening experience
1 had in 1984 at the major meeting of my specialty, human
genetics. In the president’s address to the society, he asserted
that we ought to retire the concept of the physician-scientist.
It’s an idea whose time had passed, he asserted, impossible to
do well. Therefore, it was time to dig the grave and bury the
concept forever.
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His argument was a practical one, that you just can’t do it
all and do it well. 1 must disagree, based on the large number
of successful examples I see around me.
In the John Doe-Jane Smith vignettes, I have already
alluded to my philosophy on this issue. I would argue that the
familiarity that a physician has with the clinical arena is abso¬
lutely critical for advancing the course of biomedical re.search,
and brings to every problem a perspective that a basic scientist
just will not have.
If you still have doubts, 1 need only cite the example of
Brown and Goldstein, who won the Nobel prize three years
ago for their fundamentally important work on the LDL recep¬
tor. Joe Goldstein came to that problem initially from a clinical
vantage point, trying to understand a disease called familial
hypercholesterolemia. The field of receptor-mediated endocytosis and the area of lipid metabolism have been enormously
advanced because this physician’s training led him to consider
a clinical problem and then to investigate it in the laboratory
with a healer’s perspective.
I could cite many other examples. On a much smaller scale,
my own interest in genetic diseases like cystic fibrosis and neu¬
rofibromatosis was first and foremost a clinical one. I felt com¬
pelled to move into the laboratory to try to understand these
puzzling diseases that so ravaged those affected. Had I not had
the clinical training, I would have worked on something else.
Not only does clinical training lead to a new perspective in
pursuing a problem, but I firmly believe that such training
leads to an acceleration in converting new observations into
therapeutic advances, which is what biomedicine is aiming for.
Dr. Wyngaarden summarizes this point of view cogently:
“The physician-scientist has a very special role, both in posing
relevant medical questions and in applying new knowledge to
the investigation of disease and the teaching of students. These
roles cannot be adequately filled by Ph.D. scientists, however
seminal their contributions may be.”
Evidence of Crisis_
How are we physician-scientists faring? To illustrate briefly, I
will quote some statistics that reveal who is receiving federal
grant funding in biomedical science.

Financial Support for
YSM Student Research
Endowed Research Fellowships
In honor of: Edith Hsiung, James Hirsch, Vernon
Lippard, Richard Hirschfield, Etta Chidsey and Richard
Gershon.
Student Research Program External Support
American Heart Association (national and Connecticut
affiliates), Connecticut Cancer Society, National
Institutes of Health (NIH), Howard Hughes Medical
Institute (HHMI), Juvenile Diabetes Foundation.
One-year Student Research Fellowship Program
(Five-year M.D.)
American Heart Association (national and Connecticut
affiliates), the NIH, HHMI, HHMI Cloister Program,
Samoff Fellowship Award, Pathology Award, private
sources.
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In 1970, 51 percent of the grants awarded by the NIH were
to Ph.D.s, 37 percent to M.D.s, and 6 percent to M.D.-Ph.D.s.
In 1987, the proportion given to M.D.s dropped to 26 percent
while that to Ph.D.s ro.se to 66 percent. From 37 percent to 26
percent is a substantial drop, indicative of a real decline in the
grant funding that the NIH is awarding to physicians.
This really reflects a decline in submitted grants; if you
look at the success rate of M.D.s and Ph.D.s in obtaining
grants once they submit them, it has remained about the same
over the course of time. Physicians who choose this course are
in general no less successful in competing with Ph.D.s.
I should add that there is great concern about the biomedi¬
cal research enterprise in general and the decrease in the NIH
budget. We are in one of those unfortunate downward oscilla¬
tions which trouble working scientists greatly. I can only say
that such oscillations have occurred before, and people have
survived them. One of the things that 1 think we must not do is
to terrify students by making the NIH funding crisis sound
even worse than it is.
What must we do to remove physician-scientists from the
endangered species list? Medical schools need to be sure that
they provide visible role models for students to show that it is
in fact viable to be a compassionate physician involved with
patients and also to run an effective, productive, laboratory
research program.
1 am happy to report that there are in fact many such indi¬
viduals at the University of Michigan, where I now serve on
the faculty. I commend Yale and other leading medical schools
that offer a plethora of physician-scientists as role models.
1 would encourage medical students who are interested in
possible careers as physician-scientists to study carefully the
careers of such people as Joe Goldstein, who made a substan¬
tial commitment early on to learning basic research. Look at
someone like Stuart Orkin, an enormously productive molecu¬
lar biologist and hematologist at the Boston Children's Hospi¬
tal, from whom I have learned much. He took the time to learn
firsthand the “ins and outs” of molecular biology.
Secondly, I would recommend to faculty members that we
stop complaining so much about how dreadful it is to deal with
these responsibilities of being both physicians and researchers.
1 suspect that probably we enjoy it in some way, or we
wouldn't be doing it. Although the research funding situation
may seem a hit scary at the moment, it has been scary in the
past, and we have survived nicely.
Sometimes we behave like hens who fret so much that they
step on all of the eggs. We really must not do that to the next
generation of physician-researchers. We should strive to pre¬
sent a more balanced view, and to remind them also of the ben¬
efits of this life-style, which 1 perceive as substantial.
Thirdly, we need to advise students realistically about
what's involved in undertaking a career of this sort. One needs
to have some serious time protected to learn bench research up
close and personal. You can't run a lab in the future which
does things that you yourself are not really familiar with.
Many M.D. researchers never had the opportunity to learn this
lesson, and have gotten into hot water as a result.
Various tracks allow for excellent research training of
M.D.s. Certainly M.D.-Ph.D. programs such as those at Yale
and Michigan are a wonderful way to approach this problem.
To those who were not so sure at medical school application
that they wanted to do re.search, but now are tempted, plenty of
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tracks allow protected time to do research.
Although 1 myself have an M.D. and a Ph.D., I completed
my Ph.D. in physical chemistry, quantum mechanics, before
entering medical school. I haven't used that part of my training
a lot; every bit of what I know about molecular biology I
learned as a fellow at Yale in a three-year period after finishing
my residency.
As I worked with Sherman M. Weissman, M.D., that fel¬
lowship provided excellent clinical training in genetics, and
very solid training in bench research. During those three
invaluable years, I spent about 80 percent of my time in the
laboratory.
At the University of Michigan, I have joined with col¬
leagues in trying to establish a two-year residency program
followed by a research-oriented fellowship. Such programs are
an excellent way to avoid the problem of physician-scientists
finding themselves old and gray by the time they complete
their training.
Such an approach would complement a wonderful fellow¬
ship program at Michigan in which we immerse new M.D.s in
bench research. For three months, 50 to 60 hours per week,
these young physicians learn vast amounts about protein bio¬
chemistry and molecular biology, carefully overseen by some
of our best faculty members. Programs like this ought to spring
up at leading schools of medicine nationwide.
A Nurturing Environment
Finally, we in academic medicine have to develop a way to
provide better support for people who want to pursue the
career of physician-scientist. Most physician-researchers are
never going to enjoy the financial perks of someone in private
practice. Indeed, if they are going to be successful, physicianscientists must be driven by more than dollars. Nevertheless,
with educational costs skyrocketing, medical students who
have accrued heavy debts must foresee a good chance of find¬
ing employment that will enable them to pay off their loans
and live a reasonably comfortable life-style.
Other support must come in providing protected time for
physicians who wish to commit a substantial effort to research.
In my view, a physician-researcher cannot really be successful
without devoting 60 to 70 percent of his or her time to the lab¬
oratory. To do less than that is to run the risk of falling behind
and becoming frustrated. Conversely, I do think that it is possi¬
ble to maintain reasonable clinical competence with 30 percent
of your time.
We must protect junior faculty from being swamped with
clinical duties, or they will never have the chance to develop.
At the University of Michigan, this has been given a high pri¬
ority, and the fruits can be seen in the many examples of junior
M.D. faculty who are enormously productive in research.
When the combination of clinical medicine and basic
research does not work due to lack of commitment, lack of
training, or lack of support, the result can be discouraging to
everyone to behold. When it does work, the benefit to society
is spectacular. There is a cost, in dollars, in time demands on
personal life, in trying to wear both hats and sometimes feeling
as if neither one fits very well. But surely those of us who have
the opportunity to experience both the intensely personal chal¬
lenge of patient care, and the exultation of .scientific advance,
are among the luckiest of all human beings.
YM
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TASTE AND SMELL:
EXPLORING SISTER SENSES

Photographs by Harry Bishop

Dr. Linda Bartoshuk administers a taste test similar to the one that she gave to her mentor. Dr. Carl Pfaffmann.

by Diane E. Loupe
If biomedical science ever begins awarding medals for “Pro¬
fessional Valor in the Face of Personal Adversity,” an inaugu¬
ral candidate should be Carl Pfaffmann, Ph.D.
In the spring of 1988 a bout of herpes zoster oticus — a cra¬
nial nerve attack triggered by the activation of a latent chicken
pox virus — affected Dr. Pfaffmann’s hearing. Most patients
would have accepted the bad news that the hearing loss would
be permanent and left it at that. But not this professor emeritus
and former vice president at Rockefeller University. He
viewed his illness as an opportunity to learn more about the
human senses.
Having spent his life studying how people taste. Dr.
Pfaffmann knew the cranial nerve regulating hearing — the
eighth or vestibulocochlear — nestles between the seventh and
ninth cranial nerves, which regulate taste. Although he could
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still savor his favorite foods. Dr. Pfaffmann suspected that the
virus might be subtly affecting his ability to taste.
To test his hypothesis, he contacted a former student, Linda
M. Bartoshuk, Ph.D., who studies taste disorders as a professor
of surgery (otolaryngology), epidemiology and psychology at
Yale. A few weeks later, she appeared in the kitchen of Dr.
Pfaffmann’s 262-year-old home in Killingworth, Conn., and
methodically unpacked her color-coded bottles of salty, sweet,
bitter and sour solutions. Thus began a series of experiments
which were to greatly expand our knowledge about the physi¬
ology of taste.
In the first of these experiments. Dr. Bartoshuk discovered
that the left side of her mentor’s tongue, affected by the virus,
could taste nothing. But the right side remained perceptive.
Subsequent tests over the next few months revealed that as
taste returned to the left side of Dr. Pfaffmann’s tongue, per¬
ception waned on the right. This supported findings from
another study Dr. Bartoshuk had done which suggested that
taste buds on one side of the tongue normally inhibit their
counterparts on the other side.
Dr. Bartoshuk’s studies are part of a wide array of research
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undertaken by School of Medicine scientists to understand
how we taste and smell. Their work ranges from applied clini¬
cal studies, such as evaluating taste and smell perception in the
elderly, to molecular and cellular research into how odor
molecules are translated into brain signals. Among its many
applications, this research is helping physicians to diagnose
disorders of smell and taste, architects to improve indoor air
quality, and safety officials to develop more effective odorant
systems to signal the danger of a gas leak.
Tasting Life’s Banquet_
The relationship between taste and smell is no recent revela¬
tion. For centuries, the best cooks have known that a food’s
aroma enhances its flavor. Only recently, however, have scien¬
tists discovered how much more subtle our sense of smell is
than our ability to taste.
Our taste buds, tiny, onion-shaped structures embedded in
the tongue, can perceive but four flavors: sweet, salty, sour or
bitter. Were it not for our sense of smell, all taste would be lim¬
ited to relatively unsophisticated combinations of these four
sensations. We owe more subtle taste perception to our olfac¬
tory .sense, which allows us to smell thousands of aromas,
from roast beef to red wine.
Dr. Bartoshuk’s experiments with her mentor have revealed
a key interaction between taste and yet another sense, touch.
As she painted flavored solutions across Dr. Pfaffmann’s
tongue, he perceived taste even on the dysfunctional side — as
long as the painting began on the good side of his tongue. This
revealed the important tie between touch and taste.
Explains Dr. Bartoshuk, “The brain doesn’t care where taste
is coming from. It doesn’t register location in taste. All it cares
about is quality and intensity. So you perceive taste to come
from the area that’s touched. When you chew your food, your
whole mouth is filled with this touch sensation.”
That's why a person tastes food across the tongue, although
“taste receptors are located very preci.sely in an oval around
the edge of your tongue and a little bit in the middle,” Dr.
Bartoshuk says. “There are almost no taste receptors in the
center of the tongue, and there aren’t any in other areas of the
mouth. But you don't have any subjective awareness of this.”
I’hat’s because of the tactile effect.
Dr. Bartoshuk thinks that temporary, partial taste loss, such
as Dr. Pfaffmann's, may be relatively common. Because of the
tactile effect, however, most people never notice the deficit.
Other experimental subjects have helped Dr. Bartoshuk
learn more about another taste disorder: dysgeusia, a chronic
unpleasant taste in the mouth. Such di.sorders can have a rela¬
tively simple cause, such as a medication, or a more serious
and complex origin, such as a brain tumor which affects the
nerves of taste sensation.
One of Dr. Bartoshuk’s subjects was a woman who was left
with a chronic salty taste in her mouth after surgeons removed
infected bone from near her ear and severed the seventh cranial
nerve. In an attempt to relieve the dysgeusia. Dr. Bartoshuk
anesthetized the wotnan's tongue by deadening the ninth cranial
nerve, the other nerve that transmits taste signals to the brain.
'I'o Dr. Bartoshuk’s surprise, the treatment had a paradoxical
effect — the phantom taste doubled. This led her to hypothe¬
size that the ninth cranial nerve inhibits the seventh cranial
nerve, where the salty taste originated. She is now conducting
experiments to confirm this finding.
Complicating research into taste disorders is the fact that
even normal taste sensations can differ widely. “The taste
world you live in is not the same as the person who sits next to
you,” Dr. Bartoshuk explaitis. Another aspect of her re.search
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explores genetic taste differences.
An important tool in these studies is a drug called propythiouracil, or PROP, which is used to treat hyperthyroidism.
One in four people is incapable of tasting PROP. To others the
drug tastes bitter. Researchers think the trait is genetic, inher¬
ited recessively.
PROP tasters perceive saccharine both as sweeter and more
bitter than do non-tasters. Moreover, graduate student Tracy
Karrer, who works with Dr. Bartoshuk, has discovered that
tasters are more sensitive to capsaicin, the chemical that puts
the zing in chili peppers and cayenne.
Other researchers have shown that non-PROP-tasters have
fewer taste buds. Since pain fibers wrap around each taste bud,
individuals with more taste buds may have more nerve fibers
that can perceive capsaicin’s bum. Dr. Bartoshuk also is work¬
ing with Robert H. LaMotte, Ph.D., professor of anesthesiology
and neurobiology, in trying to discover why the irritant capsaicin
paradoxically relieves chronic mouth pain in some adults.
A Subtle Interaction_
Many taste and smell studies are undertaken at the John B.
Pierce Laboratory, which is affiliated with Yale and dedicated
to sensory, physiological and environmental research. One
Pierce researcher, Joseph C. Stevens, Ph.D., a senior research
scientist and lecturer in psychology at Yale, is looking at taste
and smell losses in older people.
In one test. Dr. Stevens and his colleagues prepared two
batches of carrot soup, one spiced with marjoram the other
without. A person “tastes” marjoram as the spice’s aroma
floats up through the back of the nose. While most young adult
volunteers, aged 20 to 32, were able to identify the spiced
soup, most subjects aged 35 to 55 could not. This middle-aged
group, in turn, performed better than subjects aged 66 to 89.
Such studies suggest that the sense of smell declines gradu¬
ally throughout adulthood. In similar tests using salted tomato
soup. Dr. Stevens detected a parallel decline in the sense of
taste with age. He notes the potential danger of people at risk
for high blood pressure needing to add more salt than younger
people in order to achieve the desired effect.
Dr. Stevens points out that a declining sense of smell has
ramifications that go beyond the enjoyment of one’s food.
“Smell is a warning sense as well as a pleasure sense,” he
notes. Older people are disproportionately represented among
fire victims, perhaps because they are not as good at detecting
smoke or natural gas odorants.
Dr. Stevens and William S. Cain, Ph.D., professor of epi-

Dr. Joseph C. Stevens displays a bottle he uses for tests of the
sense of smell.
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Dr. Lawrence E. Marks adjusts some equipment that he uses
for auditory experiments.

aromatic fruit oils. Although presented as a taste test, the task
also measures olfaction; people with normal smell think the
fruit-scented samples taste stronger. This helps identify people
who exaggerate their loss of smell.
Says Dr. Cain; “It’s a very powerful illusion. When I taste
that solution with the tutti-frutti odor, it seems like I have more
flavor in my mouth, even though I know the ingredients.”
Dr. Cain also is helping to develop a test of the ability to smell.
Here researchers attach electrodes to a person’s scalp to mea¬
sure electrical changes that may occur as the subject sniffs dif¬
ferent odors.
Dr. Cain’s interest in indoor air quality also has produced
some novel approaches. Surprisingly, for tests to determine
whether an airborne substance is an irritant, he recruits people
with no sense of smell. Anosmic subjects prove ideal; not dis¬
tracted by bad odors, their noses do retain what is called the
common chemical sense. Controlled by the fifth cranial nerve,
this sense perceives such sensations as stinging, irritation,
freshness, prickling, piquancy, burning and tingling
These anosmic volunteers help Dr. Cain determine the pun¬
gency of certain chemicals as part of his research into “sick
building syndrome.” Buildings can make their occupants ill
when new carpets, furnishings, paint, office machines or other
items introduce noxious fumes into the environment faster
than the circulating air can flush them out. Research by Dr.
Cain and Yale colleagues have helped improve engineering
standards for air circulation to help avoid this problem.
A Molecular Common Denominator

demiology (environmental health) and psychology, collaborate
to test the ability of people to detect odorants, such as ethyl
mercaptan, which are added to scent naturally odorless
propane (LP) gas. Forty-five percent of subjects over age 60
were unable to detect this skunky smelling chemical at levels
that met minimum federal safety standards. Ten percent of sub¬
jects under age 40 were not able to smell the chemical at this
concentration, either.
In ongoing studies, the PierceA'ale researchers are testing
the ability of volunteers of various ages to detect different mix¬
tures and concentrations of gas odorants. Their results will
prove useful to gas companies in improving the mixture of
scents they use to warn against gas leaks.
Old age and illness are not the only antagonists to our abil¬
ity to taste and smell. Every year many people lose their sense
of smell to accidents, especially head injuries.
Dr. Stevens remarks: “If you hit your head on a dashboard
or fall off the back of a truck, you’re very likely to shear the
olfactory nerve fibers,” which thread through small perfora¬
tions of bone in the skull.
Such injuries can cause anosmia, a complete lack of smell,
or hyposmia, diminished olfaction. In either case, the sense of
smell returns in about 20 percent of cases, although recovery
can take years. Dr. Cain estimates that 1 percent of the popula¬
tion will experience some prolonged loss of smell during their
lives. Besides head trauma, smell losses can be caused by
exposure to corrosive chemicals, chronic sinus infections,
nasal polyps and upper respiratory infections.
The problem is common enough for Dr. Cain to develop
clinical tests to measure possible loss of smell. Reliability is
critical; in the case of an accident, test results may be used as
evidence in lawsuits alleging negligence. How is it possible to
determine if someone is faking a loss of olfaction? Dr. Cain
meets this challenge in some ingenious ways.
In one of his tests, he asks subjects to taste a variety of
sugar solutions, some of which are enhanced with tasteless.
Yale Medicine
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Sensory perception is a psychological as well as a visceral
experience, explains Lawrence E. Marks, Ph.D., professor of
epidemiology (environmental health) and psychology. Dr.
Marks, a Pierce laboratory fellow, submits “certain principles
and processes are common to many different sensory systems,
despite fundamental differences among them.”
To illustrate his point. Dr. Marks poses the question: Which
is brighter, a cough or a sneeze? Though this may sound like a
conundrum, developmental studies he has conducted indicate
that most people, no matter what their age, will choose the
sneeze. Cross-cultural studies by other researchers confirm this.
Why? Dr. Marks thinks the nervous system may respond
similarly to the frequency of waves whether those waves be
perceived as sound or light. In other words, the brain draws
parallels between high-pitched sounds and bright colors, each
comprised of high-frequency waves, and between low-pitched
sounds and darker colors, with their lower frequencies.
“Maybe the nervous system uses the frequency of neural
impulses to some extent to encode both pitch and loudness,
although in slightly different ways,” suggests Dr. Marks.
Such considerations come under the heading of “synaesthesia,” in which one kind of sensory stimulation evokes the sen¬
sation of another. Throughout history, many artists have
reported synaesthetic experiences, observes Dr. Marks in a
1978 book. The Unity of the Senses: Interrelations Among the
Modalities. Nineteenth-century French poet Charles Baude¬
laire, in his sonnet “Correspondences,” drew analogies
between vision, taste and smell when he wrote “There are
odors as fresh as children’s skin/As sweet as oboes, as green as
prairies.”
Sir Isaac Newton proposed parallels between musical notes
and colors, leading 18th-century Jesuit priest Louis-Bertrand
Castel to build a “color organ.” This clavichord unfurled col¬
ored ribbons that corresponded to different notes; audiences
feasted on both the music and the visual display.
“It was all part and parcel of this notion of the unity of the
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senses. There were similarities and analogies and relation¬
ships,” Dr. Marks says.
To explore whether some associations between sound, light
and size are innate. Dr. Marks and his colleagues tested chil¬
dren and young adults. They found that even young children
perceived sunlight as louder than moonlight, a pebble as higher
pitched than a boulder; red was higher pitched than blue but
lower than yellow. The researchers also discovered that people
respond more quickly and accurately to .sensory combinations
that are synaesthetic complements, such as white and highpitched, than contrasting pairs, such as black and high-pitched.
Dr. Marks has constructed mathematical models to help
describe these sensory connections. His models may help pre¬
dict conditions that would maximize performance of aircraft
pilots, air traffic controllers and others who monitor complex
displays of information. Similarities between tactile perception
and hearing could enhance the development of hearing aids that
translate sound into vibrations which deaf people can interpret.
Olfactory Neurons: A Basic Analysis_
Any synaesthetic connections that the mind creates may reflect
cellular and molecular processes involved in perception.
Gordon M. Shepherd, M.D., D.Phil., professor of neuro¬
science, reports that his studies of olfaction have led him to
think that, neurologically speaking, organisms smell, see, taste
and hear in very similar ways.
He explains, “Smell is a kind of odor image, an image
evoked by the pattern of activation set up by the receptor cells
and elaborated by the smell pathway in the brain. It functions
like an image in a visual system.”
When a person sniffs a gardenia, for example, a five-stage
molecular relay race lets the brain identify the odor. As the nose
inhales the volatile molecules that comprise the flower's fra¬
grance, the race begins. The second leg occurs when molecules
dissolve in the mucus covering the cilia, tiny hair-like structures
in the nasal cavity extending from the olfactory neuron.
During leg three, protein molecules called receptors, which
line the cilia, respond to the fragrance molecules in much the
same way as a lock is opened by a particular key. The fourth
leg of the race is run as the receptor protein activates a
sequence of enzymes that amplify the odor signal. Finally, this
produces a second messenger, a protein that completes the race
by translating odor molecules into electrical impulses for
nerves to pass along to the brain.
Stuart Firestein, Ph.D., assistant professor of neurobiology,
studies the tiger salamander to discover how the home stretch of
the relay race — the .second messenger system — functions. He
and his co-workers connect a microscopic electrode to one of
the unusually large olfactory cells of the reptile. They then spray
the cell with a cocktail of banana, cinnamon and nutlike odors.
The odors trigger the opening and closing of tiny channels in the
cell's membrane, flooding the cell with ions, atoms with a posi¬
tive or negative charge. Dr. Firestein measures the resulting
electrical change, which the brain interprets as an odor.
Drs. Firestein and Shepherd believe that humans can detect
about 1,()()() "basic” odors, analogs to the mere handful of
basic taste sensations. Using these basic scents as building
blocks, the brain builds a repertoire of 10.000 or more con¬
glomerate odors that it can recognize.
“There are smells that evolution could never have put into
our noses, like new car smell,” observes Dr. Firestein. “And
yet. we can perceive that smell as a very distinctive odor.”
Dr. Firestein uses an alphabetical analogy to illustrate the
theory. Conglomerate smells, he says, correspond to English
language words, which are combinations drawn from the let¬
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ters of the alphabet. Basic smells, by contrast, are like Chinese
language ideograms; each symbol represents one concept.
Molecular genetic research is also making its contribution
to olfactory research. Earlier this year, Columbia University
researchers greatly advanced the field by cloning and decoding
the genetic sequence of olfactory receptor proteins. Dr.
Shepherd thinks that the Columbia studies confirmed the pre¬
dictions of some scientists that olfactory receptor proteins
belong to the largest family of genes known.
Olfactory proteins also belong to a group of protein recep¬
tors that respond to different types of neurotransmitters, small
hormone-like molecules used by nerve cells to communicate
with each other. Such neurotransmitters as serotonin, dopamine
and adrenaline help regulate emotional and physical states.
In recent experiments. Dr. Eirestein bathed a salamander’s
olfactory cells in beta-blocking drugs, thus suppressing the
cells’ ability to perceive odors. Physicians prescribe betablockers, which block human neurotransmitters, to control
hypertension. Dr. Firestein’s work suggests that the olfactory
receptor may resemble these neurotransmitter receptors.
Therefore, the salamander’s nose might be useful to scien¬
tists who wish to learn more about how cells translate other
chemicals into brain signals. This represents only one of many
potential contributions that olfactory research may offer to
other areas of medical research. For instance, a better under¬
standing of cellular signalling may aid cancer researchers, who
know that some forms of the disease are triggered by a signal
that tells cells to replicate without restraint.
Dr. Firestein believes that the olfactory receptor cell could
have value as a model for other sensory phenomena, such as
sensory adaptation. “When you walk into a room with an
unusual or unpleasant odor, after a couple of minutes, you no
longer sense that odor,” explains Dr. Firestein. “But if you
walk out and come back in, you smell it again. You know that
the odor is still there, but your perception of it has dimin¬
ished.” Drawing a parallel between this adaptation and the tol¬
erance patients can develop toward therapeutic drugs. Dr.
Firestein suggests that experiments with olfactory cells may
help scientists understand such tolerances and develop ways to
limit them.
Even the budding field of nerve regeneration could benefit
from research into the sense of smell. Drs. Firestein and
Shepherd are among the basic scientists who are trying to
describe how olfactory neurons regenerate over long distances.
Many nerves will not reconnect after they are severed, but
olfactory neurons can regenerate and reconnect with appropri¬
ate receptors in the brain, so that the receptor responsible for
smelling chocolate doesn’t reconnect with the brain receptor
for smelling vinegar.
Knowing how these neurons regenerate might enable
researchers to stimulate nerve regeneration in other systems,
perhaps helping in the far future to restore sight to the blind,
hearing to the deaf and feeling and movement to victims of
spinal cord injury.
What research trends should soon command the public’s
attention regarding the sense of smell?
“The olfactory sense in human behavior,” replies Dr.
Shepherd.
For example, scientists are working on identifying the elu¬
sive human pheromones, chemicals similar to those that con¬
trol mating and social behavior in some insects and animals.
Tomorrow, the allure promised by perfumes and colognes may
be more than today’s Madison Avenue hyperbole.
YM
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CMHC CELEBRATES
25 YEARS OF SERVICE

Photographs by James Anderson

At the celebration ofCHMCs 25 th anniversary, Abraham A. Ribicoff (left) speaks with chairman of psychiatry B. Stephen Bunney
and William H. Sledge, head of CHMC's clinical division.

Editor’s note: To protect confidentiality, patient names have
been changed in this article.
by Gitta Morris
Twenty-five years ago, at the dedication of the Connecticut
Mental Health Center (CMHC), Wilbur Cohen, undersecretary
of welfare in the Johnson administration, spoke of a “new era”
in the care of the mentally ill. On the same occasion Connecti¬
cut Gov. John Dempsey called the new $5 million facility a
“good investment.”
Both remarks have proven prophetic. First, CMHC has
made significant contributions to an innovative era in which
day hospitals, crisis units, specialized outpatient treatments,
and residential and vocational services have helped humanize
the mental health care system and make it more effective.
Such innovations, in turn, have proven a good investment
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by opening the system to more people while helping to control
costs. This has allowed CMHC to offer an improved quality of
life to most of the 50,000 or more patients who have received
treatment here since September 1966.
The great need for CMHC’s services became apparent
almost from the moment the center opened its doors. During
its first two months, CMHC treated 700 patients — twice as
many as expected. Last year, some 5,500 people, most of them
poor and severely disturbed, found their way into the center's
patient care programs. Many others benefit indirectly from the
research and teaching that are integral to CMHC’s mission.
A Lifelong Struggle_
Susan, a 34-year-old woman, has a history of mental illness
that is typical of many of the center’s patients. Over the past 14
years, she has been admitted 16 times to Connecticut Valley
Hospital, a state mental hospital located in Middletown. Four
times Susan has entered a private facility for treatment, and
three times, CMHC.
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Diagnosed with a schizo-affective disorder, Susan has led a
chaotic life, running away from family and from treatment,
embroiled in legal problems, arrested for larceny and judged
incompetent to stand trial. Ten years ago, she had a baby and
gave the child up for adoption.
When at the mercy of her illness, Susan can be paranoid,
suicidal and emotionally explosive, living in the streets and
involved in petty crime. When her illness is under control, how¬
ever, she is bright and does her best to live independently. She
has a certain appeal that makes people want to befriend her.
For the past year, stabilized by medication and with the
assistance of her CMHC case manager, Susan has been able to
live in an apartment that is managed by Continuum of Care, a
nonprofit provider of housing for psychiatric patients. She is
learning computer skills and, although she still must contend
with occasional bouts of paranoia, Susan is faring better than
at any time since she became ill.

CHMC's anniversary celebration featured a reunion of present
and past directors: (from left, back row) current director, Ezra
E. El. Griffith, Eritz Redlich, Boris Astrachan: (from left, front
row) Morton Reiser and Gerald Klerman.

Susan’s progress, and that of thousands of others who have
been helped at CMHC, might not have been possible were it
not for an informal meeting that took place back in the 1950s
in the office of newly elected Gov. Abraham Ribicoff There
Fredrick C. “Fritz” Redlich, M.D., Sc.D., then chairman of the
Yale department of psychiatry, and a group from the Connecti¬
cut Mental Health As.sociation frankly presented their con¬
cerns to the governor. “What do you plan to do about mental
health?" they demanded.
“I’ve only been in office for one day,” an embarrassed gov¬
ernor protested. Then the shrewd politician turned the tables
on Dr. Redlich. “What does Yale plan to do about mental
health?” he asked.
Out of this exchange was bom a collaboration between the
University and the State to create a mental health treatment,
training and research institution. Its foundation was “Action
for Mental Health.” a report produced by a nationwide coali¬
tion of mental health care advocates. The document proposed a
national program against mental illness to be fostered by statesupported training and research centers.
Further impetus came with the Community Mental Health
Centers Act spearheaded by President John F. Kennedy in the
early 196()s, which offered federal support for clinical care
within a community context. Construction was launched with
14

$4 million in state funds, $900,000 in federal money and a
contribution of $100,000 from the University.
By way of long-term support, the State maintains the
CMHC building and underwrites its overhead costs. Connecti¬
cut also pays the salaries of most of the administration and
support staff and of about 70 percent of the nurses, social
workers and other direct care providers. Finally, the State pro¬
vides the senior administration, research staff, psychiatrists
and some other professionals through a $7 million contract
with Yale.
With an annual budget of nearly $19 million and 41 inpa¬
tient beds (plus 13 beds in the research unit), CMHC is one of
the largest psychiatric facilities administered by the Yale psy¬
chiatry department. The department also is responsible for
Yale Psychiatric Institute and for psychiatric care at Yale-New
Haven Hospital and at the Department of Veterans Affairs
Medical Center in West Haven.
Only a hint of the University-State relationship manifests
itself as one approaches CMHC’s five-story brick structure at
the comer of Park Street and South Frontage Road; the center’s
brick facade is more reminiscent of a state government office
building than of the Yale buildings on the medical campus.
Appearances aside, extensive collaboration begins at the
top level of administration. On the State side, the commis¬
sioner of the Department of Mental Health and the regional
director of mental health play a major role in setting policy for
clinical services. For Yale’s part, the chairman of the psychia¬
try department serves as the designate of the medical school
dean to oversee teaching and research.
Reporting to both the State and the University, CHMC
Director Ezra E.H. Griffith, M.D., professor of psychiatry,
coordinates the center’s three areas of activity — clinical ser¬
vice, research and teaching. As he explains it, “My job is to try
and hold a sensible balance between and among these aspects
of CMHC’s mission.” He is assisted by associate directors of
the clinical, nursing and administration divisions.
Meeting the Challenge_
Eor the past two years, the clinical division has been headed by
William H. Sledge, M.D., associate professor of psychiatry. An
Alabama accent has survived his 17 years in New Haven,
dating back to his psychiatric residency at Yale. He explains
that CMHC strives “to provide patients the flexibility to move
easily among the center’s five clinical units and the many ser¬
vices they offer.”
Those units include:
Entry and Crisis. In nearly 2,700 face-to-face encounters
and more than 4,000 telephone calls per year, this unit evalu¬
ates the nature and urgency of patient concerns and arranges
help. This is the sole portal into treatment at CMHC.
Mobile outreach and crisis intervention are extensions of
this unit. In mobile outreach, CMHC clinicians go into the
community to treat acutely disturbed, sometimes dangerous
individuals; caregivers have even been called on to negotiate
the release of hostages. Crisis intervention, a short-temt outpa¬
tient program, serves as an alternative to hospitalization for distres.sed patients who can be helped by intemiittent treatment.
Inpatient service. Offering the most intensive treatment for
patients with prolonged, severe psychological disorders, this
service is located on CMHC’s secure fourth and fifth floors.
Patients may stay from a few days to several months.
Acknowledges Martha Mitchell, M.S.N., associate director
of nursing since 1982, “In this day and age, anyone admitted to
a public sector inpatient unit is impoverished and severely disYale Medicine
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turbed. There just aren’t that many beds anymore. People here
are among society’s most disadvantaged.”
In this setting, nurses play a major role in assuring that
patients receive the support and the structure they need to
reshape their lives to adapt successfully outside the institution.
“There’s a sense of trying to do your damdest to get their trust,
to be as flexible as possible, to provide the patient with some
modicum of control,” says Ms. Mitchell.
“It takes a lot of skill to relate to people who are as sick as
they can be and denying it. Often their family gives up on
them. They have no support system. You can get very attached
to these people, and you get very in touch with how chaotic
and how resourceless their lives are.”
Outpatient services. This aspect of CMHC’s treatment
program was reorganized by Dr. Sledge. In past years, patients
were assigned to an individual therapist. If this therapist hap¬
pened to be a resident or other trainee, after the rotation con¬
cluded, the subsequent caregiver had to start the therapeutic
relationship all over again.
Today, each patient is cared for by a team of some 12 to 14
professionals — psychiatrists, psychiatric social workers,
nurses, social workers, trainees and other mental health profes¬
sionals. Each group is coordinated by a team leader, usually a
social worker or nurse, who works closely with a CMHC psy¬
chiatrist. Though trainees rotate on and off the team, the other
team members provide the continuity that minimizes any dis¬
ruption of therapy.
CMHC offers outpatient services not only at its Park Street
headquarters, but also at the West Haven Mental Health Clinic

and the Hispanic Clinic at 1 Long Wharf Drive in New Haven.
The latter, explains Dr. Sledge, is to provide Hispanics “a spe¬
cial clinic that is sensitive to them, one that is really theirs.”
Day Hospital. Here patients spend six hours each weekday
in therapy designed to help them cope with the practical tasks
of life, like dressing appropriately for work, shopping for food
and clothing, and managing a checking account.
Patients also acquire the social skills that will ease their
transition back into the community. Says Dr. Sledge, “The day
hospital staff teach about normal, everyday interactions that
most of us take for granted, like making eye contact during a
conversation or how to ask the bus driver for change.”
Other patients benefit from the crisis respite program in the
homelike Brownell House. Located in a pleasant residential
neighborhood near the day hospital, Brownell House accom¬
modates four patients for an average of 15 days each. Part of a
three-year federally funded research demonstration project, the
program is a joint venture of CMHC, the State Department of
Mental Health and Continuum of Care, with Dr. Sledge as the
principal investigator.
By providing a short-term halfway house, the crisis respite
program fills the gap between inpatient and day hospital care.
The experimental project randomly assigns patient volunteers
to either the inpatient hospital or the crisis respite program;
researchers then compare for clinical effectiveness and cost
efficiency.
Substance Abuse Treatment (SATU). This fifth clinical
unit serves as a national model for substance abuse treatment
programs. Its immediate past director, Herbert D. Kleber,

Ezra E.H. Griffith —
Strengthening a Vital Institution
Dr. Ezra E.H. Griffith, CMHC’s director for the past two years,
is a brusque, outgoing man who is long on self-confidence and
comity. His assured air may have something to do with his cos¬
mopolitan past.
Bom and raised in Barbados, he came to the United States
with his family as a teen-ager. Tme to the heritage of his
homeland, he journeyed to France to earn his medical degree
before coming to New York City for residency training at
Albert Einstein University. Dr. Griffith’s research too reflects
his international background; he has studied the therapeutic
effects of African-American and Caribbean religious rituals
and the cultural aspects of psychiatry.
In 1977, Dr. Griffith came to Yale as an assistant professor
of psychiatry and to CMHC as associate director of the inpa¬
tient unit. He was named the center’s acting director in 1987,
and two years later was appointed director.
From the start. Dr. Griffith has put a heavy emphasis on
community relations. As soon as he became director, he relates,
“I met with community groups and pastors, and was quite
shocked when they said they would never come into the center.
They saw it as a distant Ivy League, Yale institution and never
thought of it as a resource for them and their constituencies. If a
member of the congregation was suffering, they would not
think to say ‘Let me call the CMHC to see if you can get help
there.’ That bothered me seriously,” he acknowledges.
To remedy the situation. Dr. Griffith began meeting with
Hispanic and African-American health and social service
providers, with pastors and city representatives. “Getting a
sense of community,” he calls it. During these encounters he
explained the mission and the wide range of services available
Yale Medicine
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Dr. Ezra E. H. Griffith

at the center.
Such efforts have had a dramatic effect. When Dr. Griffith
assumed the CMHC directorship, the center cared for 3,000
patients. Last year, that number topped 5,500.
Dr. Griffith sees CMHC’s faculty, staff and students as a
wellspring of expertise that should flow generously into the
community. Comments Dr. Griffith, “We have some powerful
brains here that reflect on a wide range of health care issues, and
their expertise should be made available to the community.”
15

CMHC Teams Row Against
Tide of Urban Poverty
“It’s very difficult to work in our community in the tradi¬
tional manner, with patients coming in here to get medica¬
tion and therapy once a week,” observes Kenneth S.
Thompson, M.D., assistant professor of psychiatry. “More
and more of our patients have a history of having had to be
hospitalized at some point in their lives. Now they’ve been
deinstitutionalized to the community. They need a lot of
care, especially as conditions in the neighborhoods they
live in have become worse and worse. Poverty there is as
bad as ever, if not worse, and it’s accompanied now with a
wave of drugs, violence and disease.”
Moreover, many CMHC patients face the challenge of
breaking an endless circle: Because they are mentally ill,
they cannot find or hold jobs; because they do not work,
they remain poor — often with no health insurance — and
with nothing constructive to occupy their time.
CMHC uses a team approach to cope with its burgeon¬
ing population of low-income, severely disturbed patients.
Dr. Thompson serves as medical attending physician for
one such team, which is responsible for some 300 outpa¬
tients.
On a recent morning, the team, comprised of 12 to 14
professionals — physicians, psychiatric social workers and
nurses, trainees and mental health workers — discussed
several patients. Jack, a musician, had made some of the
most dramatic progress.
Jack arrived at CMHC two months before, psychotic,
depressed and obsessed with his health. Having just
learned that he had diabetes, he was convinced that he was
dying.
To complicate matters, “we had a terrific time convinc¬
ing his family to let him go on medication” for his mental
illness. Dr. Thompson recalls. “They were very resistant.”
Team therapist Kate Young, a nursing student at Yale,
worked hard and long with the patient and his family. She
finally was able to persuade the family to allow Jack to
enter treatment at CMHC.
For his first few weekly medication and therapy ses¬
sions, Jack showed up overweight, disheveled and miser¬
able. Dr. Thompson is pleased to report, however, that
after two months of treatment, “1 literally did not recognize
him. Jack was clean, he felt better, and was taking care of
some issues in his life. It was really a profound change.”
Thanks to CMHC’s leading role in a statewide managed
care system, the center can help patients like Jack from the
greater New Haven area and throughout Connecticut. The
system, which divides the state into 23 catchment areas,
each coordinated by a lead agency, helps the mentally ill
make the best use of the many services — from crisis cen¬
ters to soup kitchens — that are available to them.
As lead agency in Catchment Area 7, CMHC coordi¬
nates mental health care in New Haven, Hamden, Woodbridge and Bethany. In these towns 15 agencies provide a
wide range of clinical .services, residential treatment, voca¬
tional rehabilitation and social support. CMHC also works
with other lead agencies to help place patients who need
inpatient care, but live in catchment areas with no such ser¬
vices. or with inpatient beds that arc filled.
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M.D., was named deputy director of demand reduction for the
federal Office of Drug Control Policy. Current director
Richard S. Schottenfeld, M.D., associate professor of psychia¬
try, also is a nationally known drug researcher and clinician.
To help New Haven deal with its epidemic of substance
abuse, SATU offers an evaluation and brief treatment unit, an
alcohol unit and SATU outpatient services. The cocaine clinic
is widely recognized for outpatient cocaine treatment using
psychological interventions. In addition, SATU’s award-win¬
ning research component is one of two major sites for National
Institute of Drug Abuse research in the United States.
Where Psyche Meets Soma
In the basic science laboratories, every effort is made to gear
research toward possible clinical applications. Comments
George Heninger, M.D., professor of psychiatry and director
of CMHC’s Abraham Ribicoff Research Center, “Many of our
scientists are undertaking basic re.search leading to clinical
trials. We’re always thinking how we might apply our results
to improve the treatment of our patients.”
In addition to the work done at the Ribicoff center,
CMHC’s strength in research comes to the fore at such pro¬
grams as the Center for the Studies of Prolonged Psychiatric
Disorder and the Consultation Center. Together, these pro¬
grams have advanced psychiatric re.search, especially into the
treatment of depression, schizophrenia and substance abuse.
CMHC’s Laboratory of Molecular Psychiatry also focuses
on these three areas. Typical is the research of Ronald S.
Duman, Ph.D., assistant professor of psychiatry. Dr. Duman
studies the biochemical mechanisms that underlie the thera¬
peutic action of antidepressant treatments.
As one approach, his research team is “cloning nerotransmitter receptors from the locus coeruleiis, a region of the brain
which is involved in depression,” he explains. The Laboratory
of Molecular Psychiatry has recently isolated a cDNA clone
for a neuropeptide Y receptor, a protein that has been impli¬
cated in depression. Dr. Duman says that improved medica¬
tions may result from a better understanding of the molecular
mechanisms of antidepressant treatments and characterization
of neurotransmitter receptors that play a role in depression.
George K. Aghajanian, M.D., the Foundations Fund for
Research in Psychiatry Professor of Psychiatry and Pharma¬
cology, is conducting pathfinding studies into how psychoac¬
tive drugs affect brain function at a single neuron level. His
re.search, involving lone neurons from minute slices of rat
brain, attempts to explain how neurotransmitters pass along the
Yale Medicine
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electrical impulses that are key to brain cells communicating
with each other.
Dr. Aghajanian’s studies involve two elements:
• how receptor proteins for the brain chemicals nore¬
pinephrine, serotonin and opioid peptides work at the
molecular level;
• how these receptors induce changes within brain cells
that may be relevant for schizophrenia, depressive illness
or drug dependence.
Dr. Heninger’s studies at the Clinical Neuroscience
Research Unit have been based in part on Dr. Aghajanian’s
findings. Armed with data about the role that serotonin plays
in depression. Dr. Heninger and colleagues have been able to
develop treatments that regulate this brain chemical to relieve
depressive illness. He works closely with Lawrence H. Price,
M.D., associate professor of psychiatry, and with assistant pro¬
fessors Wayne E. Goodman, M.D., and Christopher J.
McDougle, M.D.
Like Dr. Aghajanian, CMHC scientist Michael Davis,
Ph.D., professor of psychiatry and psychology, studies the
brains of laboratory rats. Dr. Davis’ research is helping to iden¬
tify the basis of panic attacks and other anxiety disorders. He is
discovering how the neural systems involved in learning and
memory are affected by fear conditioning.
His studies of the startle reflex — which causes mammals
to Jump when surprised — are revealing the pathways between
the amygdala, the brain’s fear center, and the brain centers that
control breathing and heart rate. Such reactions as rapid
breathing or increased heartbeat, useful to defend against phys¬
ical danger, are maladaptive when evoked by everyday stress.
Learning more about the neural pathways involved in the
“fight or flight’’ reaction could lead to improved drug or other
treatments for anxiety or panic disorders.
Many CMHC patients find their psychological problems
exacerbated by addiction to illegal drugs. Trying to improve
drug treatments through basic research is Eric J. Nestler, M.D.,

Ph.D., the Elizabeth Mears and House Jameson Associate Pro¬
fessor of Psychiatry and Pharmacology. His research has
revealed some of the biochemical mechanisms by which
cocaine and opiates produce addiction in laboratory animals.
Dr. Nestler notes that on an acute level, “these addictive
drugs exert very different effects and react with different pro¬
tein receptors.” Still, the various drugs have a similar func¬
tional effect — addiction.
This chronic effect may be traced to similar protein changes
in the brain’s me.solimbic dopamine system, which many sci¬
entists believe plays a key role in addictive behavior. This is
the area of the brain on which Dr. Nestler’s research team is
focusing, with the aid of a strain of rats that is more vulnerable
to drug addiction.
Dr. Nestler’s research may soon offer a direct benefit for
CMHC patients. Along with CMHC researcher Thomas R.
Kosten, M.D., associate professor of psychiatry, he has applied
to the University’s Human Investigations Committee to initiate
a clinical trial for a drug that may help reduce addicts’ craving
for cocaine.
Along with encouraging basic research that will result in
better treatments for CMHC’s patients, center director Dr.
Griffith works to insure that the teaching program serves the
needs of both patients and students. Last year, 83 professional
students were trained at the center, most of whom were psychi¬
atric residents, and predoctoral or postdoctoral fellows in psy¬
chology. Other trainees include social work interns, nursing
students and chaplaincy interns.
Dr. Griffith points out that as CMHC moves steadily toward
treating seriously ill patients with chronic disorders, the center
offers students a unique educational challenge. “How many
places can you go,” he asks, “where you can learn how to
develop a treatment program for someone who doesn’t have a
place to live and no support services?”
As CMHC moves beyond its silver anniversary, the mount¬
ing pressures of society — especially on those who are poor
and disenfranchised — will make this already difficult charge
all the more daunting.
YM

In a relaxing moment of conversation before dinner, a day-hospital patient is flanked by
associate director Edna Akiin, C.I.S.W., (left) and director Jeanne Steiner, D O.
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BRIDGING THE GAP:
PATHOLOGY AT YALE

Hh<)Ui|>raphs by Hurry Bishop

Assistant professor of pathology Brain West. M.D., (right) examines slides from an ischemic colon. With him are YNHH resident
Marc L. Silverherg, M.D. '91, (left) and Joe Esherick, a third-year medical student.

hy John Dinolfo
Early afternoon on a typical weekday: In his office on the
second floor of Yale-New Haven Hospital's Memorial Unit,
Stuart Elynn. M.D., associate professor of pathology, receives
a phone call from the operating room. A surgeon has just
removed a worrisome growth from the right breast of a 46year-old woman. Eine needle aspiration of the mass, done the
previous week, had revealed atypical cells, raising the specter
of breast cancer and necessitating today's biopsy.
By phone, the surgeon advises the pathologist that he has
discovered no evidence of a well-defined mass. Dr. Flynn
quickly assesses the possibilities: Either the lesion is benign or
a diffuse infiltrating neoplasm, a cancer that does not produce
a tumor but insidiously penetrates normal tissue.
In the OR, the biopsy, roughly the circumference of a silver
dollar, is packed in ice and rushed to a tissue processing lab in

the pathology department, where Dr. Flynn carefully examines
the sample for gross evidence of cancer, notably, discol¬
orations or hard irregular areas. Finding none, he dissects the
lesion and discovers a 2 centimeter cyst—the site that had been
previously aspirated.
He slices two small segments of tissue and quickly passes
them to a lab technician who immerses the samples in liquid
nitrogen. The frozen tissue section is deftly sliced again, by
machine, into sections thinner than a snowflake, then mounted
on slides.
Soon after, the surgeon arrives from the OR. He and Dr.
Flynn examine the slides under a micro.scope. “It's benign,”
Dr. Flynn says with a sigh of relief.
Though happy with the result—and the expected impact the
good news will have on the patient—Dr. Flynn has little time
to savor the satisfaction of the moment. He returns to his
office, where other patients’ slides await inspection.
This recent case illustrates how Yale's practicing patholo¬
gists help establish a diagnosis, thus playing a key role in

John Dinolfo is a free-lance writer based in Eairfield, Conn.
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patient care. These pathologists evaluate an average of five
breast biopsies each weekday. Elapsed time for such a frozen
tissue section assessment, from initial contact in the OR to the
clinical decision, is usually about 10 minutes. Fortunately,
most breast biopies done at Yale-New Haven are benign. Dr.
Flynn explains. When a biopsy does prove malignant, the sur¬
gical pathologist employs a battery of histopathologic and
molecular tests to try to determine cancer severity and spread.
Such tests, usually done within a week of the biopsy, typically
offer vital insights into the patient’s prognosis and likely
course of therapy.
Often unknown to the patient, the pathologist plays a key,
behind-the-scenes role as a member of the clinical team. “The
pathology report is often the most important single piece of
information in the patient’s chart,” explains Jon S. Morrow,
Ph.D.’76, M.D.’76, chairman and chief of pathology since
September 1990. “There’s often very little way to tell until that
tissue is removed whether it is benign or malignant. That deci¬
sion rests on the shoulders of the pathologist.”
In addition to assessing breast biopsies, Yale pathologists
routinely help to diagnose other potentially malignant condi¬
tions. For example, sometimes a cancerous lesion cannot be
distinguished from simple inflammation by gross examination,
or a tumor margin needs clarification so that a surgeon can tell
if all diseased tissue has been removed. In such cases, the
pathologist establishes the diagnosis in the laboratory—often
before the conclusion of surgery.
Indeed, on a typical work day, pathologists and their staff
analyze 20 to 50 frozen tissue specimens. “The rate of error for
frozen sections approaches zero,” Dr. Morrow points out. If
doubt persists as to whether a lesion is malignant, the patholo¬
gist errs on the conservative side, deferring diagnosis until
more information is available.
Although vitally important, frozen tissue sections are just a
small part of the pathology story. This year alone, Yale pathol¬
ogists will evaluate up to 35,000 scrapings, biopsy samples,
fluids or cytologic specimens. Most tissues are sent by col¬
leagues at Yale-New Haven Hospital and the Department of
Veterans Affairs Medical Center in West Haven, although
every year physicians from as far away as Brazil and Japan
turn to Yale pathologists for help in assessing difficult cases.
Autopsies also play a vital part in the work of Yale patholo¬
gists, providing a powerful tool for quality assurance and con¬
tinuing medical education. Up to 30 percent of autopsies
reveal information that would have altered clinical care, had
the information been known prior to death.
In combining varied clinical duties with research and teach¬
ing, Dr. Morrow says that each of his department’s faculty
members is faced with “a job with enormous responsibilities.”

High-technology Tools
Aid Today^s Pathologist
Among the sophisticated technologies used by School of
Medicine pathologists are:
• electron, flourescent and confocal laser microscopy;
• advanced cell-biological and biochemical techniques,
including electrophoresis, high- pressure liquid
chromatography, and in-vitro cell culture;
• molecular genetic and recombinant DNA techniques, in¬
cluding DNA cloning and sequencing. Northern and
Southern blotting, ILFLP mapping, and in-situ hybridiza¬
tion;
• specialized monoclonal and polyclonal antibodies and
protein markers;
• the preparation of recombinant proteins in bacteria;
• retroviral mediated gene transfer;
• computer-assisted image analysis;
• flow cytometry, the laser-induced flourescent analysis
of cell cycles.

Providing a Keystone
In one sense, every physician is a pathologist; pathology’s
Latin roots translate as “the study of disease.” More than most
biomedical disciplines, however, pathology serves as a nexus
between basic research and clinical medicine. “The real chal¬
lenge is to form a bridge so that new developments in the labo¬
ratory are quickly applied to clinical studies and vice versa,”
explains Dr. Morrow. He himself is an expert on the cell’s cor¬
tical cytoskeleton—the protein infrastructure that supports the
cell membrane.
Roughly half of the department’s 20 full-time faculty mem¬
bers conduct research into cell growth and differentiation
while the other half are engaged in clinical studies designed to
improve patient care. Many faculty members undertake both.
Among those engaged in both basic and applied research
Yale Medicine
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Stephen L. Warren, M.D., assistant professor of pathology,
loads a gel of cells cultured with the c-src oncogene.
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are Vincent T. Marchesi, M.D.’63, Ph.D., the Anthony N.
Brady Professor of Pathology, Cell Biology and Biology, and
Sally Marchesi, M.D., professor of laboratory medicine and
pathology. In collaboration with Dr. Morrow, this husband and
wife team have identified cellular and genetic mechanisms in
the cortical cytoskeleton that appear to cause hemolytic ane¬
mias—hereditary diseases in which red blood cells break
down. This research stems from Dr. Vincent Marchesi’s pio¬
neering work at the National Institutes of Health in 1968,
where as a Public Health Service medical officer he discovered
spectrin—the main protein comprising the red blood cell
cytoskeleton.
Dr. Vincent Marchesi, director of the new Boyer Center for
Molecular Medicine (BCMM), points out that sophisticated
molecular tools now allow scientists to study normal and
abnormal molecules in a cell at the same time—a dramatic
advance since the late 196()s. “It's like having a window
instead of trying to look through a brick wall,” he observes.
Dramatic views from the window of molecular research
have dramatically changed the way inherited anemias are diag¬
nosed. Today, Dr. Morrow explains, it’s not enough simply to
detect red blood cell shape abnormalities under a light micro¬
scope: “Increasingly, you want to know what the molecular
defect is, where the mutation is and in which protein.”
Yale clinicians have found that genetic mutations affecting
spectrin production in the cytoskeleton appear to account for
two hemolytic anemia.s—hereditary elliptocytosis and heredi¬
tary spherocytosis. Awareness of such genetic factors has led
to improved screening for hemolytic anemias, explains Dr.
Sally Marchesi. Because of Yale’s expertise in this field, pedia¬
tricians from around the nation send blood samples of anemic
patients for evaluation of difficult cases.
“If we determine that it is a cytoskeletal defect, it’s quite

Yale Pathologists Pursue
Wide Range of Research

Drs. Sally and Vincent Marchesi.

clear that splenectomy will improve the patient’s hematologic
status,” Dr. Sally Marchesi says. That alone may normalize a
patient’s blood counts.
On another front. Professor of Pathology and Biology
Michael Kashgarian, M.D.’58, employs his expertise in the
pathogenesis of kidney injury and disease. In collaboration
with Dr. Morrow, he is trying to identify molecular factors in
the renal cortical cytoskeleton that help determine kidney cell
polarity—the directional arrangement of proteins within each
cell. Dr. Kashgarian explains that restoring the proper polarity
is necessary to restore kidney function after acute ischemic
damage, in which the organ is deprived of oxygen-rich blood
due to a heart attack, traumatic injury or other such event.
“We’re also interested in the way that injury initiated in the
kidney seems to progress independently after the injury has
been removed,” Dr. Kashgarian says. “When this secondary
injury progresses to end-stage renal disease, the patient must
have a kidney transplant.” Dr. Kashgarian hopes that research
into molecular mechanisms underlying progressive renal fail¬
ure may lead to improved therapies to arrest the disea.se.
The PathologisTs Little Black Bag_

Major research areas within the pathology department
include:
• molecular oncology involving breast, skin, ovarian and
gastrointestinal cancers;
• the molecular basis of oncogene action;
• control of viral replication and infection (AIDS);
• the molecular basis of neuronal changes in several
diseases involving the brain, such as stroke, AIDS, and
Alzheimer’s disease;
• transplant rejection in heart, liver and kidney and the
immunology of the vascular system;
• cell-cycle control and mitotic structure;
• cardiovascular pathology;
• nonnal and abnormal endothelial and epithelial cell
growth and differentiation;
• gastrointestinal and immunological disorders in
neonatal, pediatric or geriatric patients.
• cellular and molecular basis of ischemic and
anoxic injury.
20

In the quest to discover the root of a disease, “any tool is fair
game if you can bring it to bear,” says Dr. Morrow. In roughly
95 percent of cases, evaluation of morbid anatomy or the use
of a light microscope provide enough information to make a
.sound therapeutic decision. Yale’s pathologists employ a wide
range of molecular tools, from electron microscopes to flow
cytometry — the laser-induced analysis of cell cycles — to
confimi other, less definitive clinical findings, or to gain a
better understanding of the underlying causes of disease. [See
“High-technology Tools Aid Today’s Pathologist.”]
One of the most dramatic of these tools is polymerase chain
reaction (PCR), a simple yet powerful biochemical technology.
PCR can replicate and harvest unlimited amounts of DNA
from the cells of any host, whether alive or dead, even the cells
of Egyptian mummies. Capable of duplicating DNA from even
a single cell, PCR offers an incomparable window on the
world of gene amplifications and rearrangements.
To maximize the u.se of its advanced investigational tools in
the clinical .setting and to facilitate disease-related research in
the University and throughout Connecticut, the pathology
department has recently consolidated many of its activities in
the Molecular Diagnostics Laboratory (MDL). The purpose of
this facility is two-fold:
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1) to make sophisticated and innovative molecular analyses of
patient tissues available on a routine basis to practicing
pathologists and clinicians;
2) to serve as a resource that can provide patient tissues, and
scientific and medical expertise to University scientists who
may be working on problems with potential medical
applications.
Key areas of focus in the MDL include immunologic and
molecular markers that identify specific tumors and the identi¬
fication of DNA alterations in solid tissue neoplasms. MDL
also offers an oligonucleotide synthesis facility, used by
researchers throughout the University.

Dr. Michael Kashgarian recently served on an NIH panel
which determined that the small amount of mercury used in
tooth fillings did not pose a health risk to dental patients.

One aim of the MDL is to serve as a principal resource for
in-state hospitals and clinics. “We anticipate that in the next
few years, we will become a much larger reference laboratory
for the state,” Dr. Morrow says. Currently, six faculty and staff
scientists participate in the MDL’s work; Dr. Morrow envi¬
sions that 10 or more faculty members will be directly
involved in the laboratory’s efforts in coming years.
In research as well as in patient care, cancer remains a pri¬
mary focus within pathology. Cancer studies illustrate the
increasingly interdisciplinary nature of biomedical research.
Take, for example, the use of flow cytometry to detect
multi-drug resistance in patients undergoing chemotherapy. Dr.
Yale Medicine
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Flynn has been using various assays to measure expression of
a molecule called P-glycoprotein. Using flow cytometry, he
has found that elevated P-glycoprotein levels often correlate
directly with multi-drug resistance—a finding helpful to col¬
leagues in oncology and pharmacology.
By administering various drugs to modulate the effects of
chemotherapy on patients with elevated P-glycoprotein levels,
Yale clinicians are attempting to re-sensitize drug-resistant
individuals to cancer therapy. Preliminary results of clinical
studies have been encouraging. “That keeps us going day after
day, because it is so exciting,” Dr. Flynn says.
Dr. Flynn is also using flow cytometry in the prognosis of
breast cancer with no lymph node involvement. Early findings
from flow cytometry studies suggest that breast cancer patients
with no evidence of chromosomal abnormalities or increased
tumor proliferation may benefit from less aggressive therapy.
A long-term follow-up study is now underway.
Other Yale pathologists are trying to improve the chances of
surviving breast cancer (the national mortality rate stands at 33
percent) by predicting early in the course of disease which
patients will be high-risk. Physicians hope to target chemother¬
apy and radiation more effectively by minimizing therapy to
low-risk patients.
That goal may be closer thanks to recent discoveries about
the neu (also called erhB-2) protein, which represents a large
family of oncogene products that are growth factor receptors.
This area of research is the purview of David Stem, Ph.D.,
assistant professor of pathology and an expert in the genetic
and molecular mechanisms that direct tumor growth.
Dr. Stem explains that neu proteins act as receivers at the
cell surface that sense the presence of growth-stimulating hor¬
mones, or growth factors, outside the cell. The receptors then
initiate a chain of events inside the cell that eventually results
in cell proliferation.
Explains Dr. Stem: “Genes encoding proteins that act along
this signalling chain are frequently altered in cancers because
excessive stimulation of these pathways leads to uncontrolled
cell division, a hallmark of cancer cells.”
Dr. Stem’s laboratory is investigating the exact means by
which the signal is transmitted across the cell membrane by
growth factor receptors, and the cascade of intracellular events
that follows. “Because the basic mechanisms of cell division
are similar in unicellular and multicellular organisms,” notes
Dr. Stern, “we are investigating these problems in yeast, which
are amenable to the powerful tools of genetic analysis, as well
as in mammalian cells.”
Potential improvements in the diagnosis of breast cancer
stem from recent findings suggesting that in 15 to 30 percent
of breast tumors, the neu gene is altered; in these tumors, the
gene is present in abnormally high numbers of copies. Drs.
Stem and Flynn are studying whether neu protein overexpres¬
sion—in itself, a weak prognostic indicator—may point the
way to a more reliable marker for breast cancer.
Toward that end, the researchers are collaborating with
Barry M. Kacinski, M.D., Ph.D., associate professor of thera¬
peutic radiology, obstetrics and gynecology. This team is test¬
ing specimens from hundreds of patients with breast or ovarian
cancer to determine if severity of disease is associated with
certain key alterations in the neu protein, known as autophos¬
phorylation. These complex biochemical changes may offer
valuable insights into the biology of breast cancer.
“There’s no doubt in my mind that either receptor autophos¬
phorylation or phosphorylation of receptor substrates will turn
out to be strong diagnostic markers,” says Dr. Stem. This
prospect offers the potential clinical application of improved
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screening and more accurate ways to determine the stage of
breast, ovarian and other cancers.
Crucial Animal Research_
Laboratory animals make a vital contribution to human health
through Yale pathology studies. Assistant Professor G. Paolo
Dotto, M.D., Ph.D., has bred a line of transgenic mice that
expresses key human oncogenes. The animals allow Dr. Dotto
to study the production of primary epithelial tumors—cancers
that closely resemble human carcinoma of the skin and cervix.
Why not simply use cell cultures to learn about such
tumors?
“It is very important to use primary cells, cells freshly pre¬
pared from the animal,” Dr. Dotto notes, “because if you use
cell lines, they probably will have undergone significant
changes already. If you don't study all the steps, you might
miss some that have already occurred.”
In fact. Dr. Dotto’s research shows how cell culturing and
animal studies complement each other: “You can genetically
manipulate the cells in culture, put them back into the animal
and study whatever your gene is doing in that situation.”
By identifying key genetic signals and protein transforma¬
tions that occur in the first few minutes of epithelial tumor
growth in mice. Dr. Dotto hopes to learn how human onco¬
genes and tumor suppressor genes, acting in concert, activate
epithelial tumors—the bulk of solid tumors seen in humans.
His team is also studying how healthy keratinocytes, the prin¬
cipal cell in the epidermis, suppress the growth of primary
tumor cells by producing a molecule called “diffusable growth
inhibitory factor.”
Yale scientists also hope to develop new cancer treatments
by studying how tumors are fed by blood vessels. On the vas¬
cular front, Joseph Madri, M.D., Ph.D., professor of pathology
and biology, is trying to identify key molecular signals that
direct the early stages of blood vessel formation in tumors. He
is focusing on the role of certain cell surface receptors—pro¬
teins that bind to extracellular proteins in lock-and-key fash¬
ion, triggering a complex series of biochemical events that
result in angiogenesis, the formation of new blood vessels.
By learning how to inhibit or even arrest this process in its
very early stages. Dr. Madri hopes to reduce or eliminate the
blood supply to tumors and thus rob them of the oxygen and
nutrients they need to survive.
“If one could effectively modulate angiogenesis,” he says,
“one would have a tremendous handle on the neoplasia prob¬
lem, on metastasis.”
Taking the opposite tack, some vascular researchers in the
Madri laboratory are learning how key cell surface receptors
act to increase blood vessel growth. Dr. Madri speculates that
such studies may one day allow scientists to develop
improved, long- tenn skin grafts for bedridden elderly patients
with decubitus ulcers and trauma patients with severe burns.
The Madri team is afso studying how the endothelial cells
that line the coronary arteries react to damage. “If we can
better understand the response of the vessel wall to injury, we
can design and execute therapies that will allow for a longer
beneficial time following injury,” Dr. Madri says. The clinical
goal; to minimi/.e the risk for blood vessels re-closing after
patients have undergone coronary artery bypass grafting or
angioplasty.
.Some of the department’s most novel research involves
viruses. Identifying and regulating factors that control viral
reproduction is a principal concern of John K. Rose, Ph.D.,
professor of pathology, cell biology and biology. “He’s doing
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very novel molecular manipulations in genes, very revolution¬
ary,” Dr. Morrow says.
Two years ago. Dr. Rose discovered that a key step in the
assembly of the human immunodeficiency virus (HIV) could
be blocked by a specifically mutated CD4 receptor molecule.
Using molecular genetic tools to alter a part of the CD4
molecule. Dr. Rose has created a soluble form of CD4 which is
retained in the cell and binds the HIV glycoprotein before it
can reach the cell surface—in effect, blocking HIV prolifera¬
tion by blocking viral exit from the cell.
Challenges remain, however, before this in vitro work can
yield an effective gene therapy for AIDS. “One would have to
deliver this molecule in some way into a patient’s T-cells, prob¬
ably into stem cells of the bone marrow,” Dr. Rose explains.
Scientists at Yale and elsewhere are attempting to design a safe
and effective delivery system for Dr. Rose’s genetically engi¬
neered AIDS-blocker, a task that could take years.
A Powerful Data Base
AIDS researchers, cancer investigators and other scientists
benefit from Yale’s pathology computerized data base, or CoPath™, which the pathology department has been assembling
since 1983. Developed at Yale by a team headed by Dr.
Morrow and now marketed nationally, Co-Path is one of the
nation’s most sophisticated and comprehensive anatomic
pathology information systems.
By September 1991, more than 750,000 patient records had
been programmed into the data base, representing every
patient specimen evaluated by the Yale pathology department
since 1915. “We never purge our data,” Dr. Morrow says with¬
out a hint of overstatement.
Information compiled during the past 50 years provides an
especially valuable basis for retrospective or prospective stud¬
ies in the diagnosis, staging and management of many dis¬
eases. The pathology information system also offers direct
clinical benefits: Its comprehensive data, when used in con¬
junction with those of the Yale Tumor Registry, enable the
physician to determine whether a patient is experiencing a pri¬
mary or recurring condition.

A Teaching Mandate
The training of current and future clinicians and medical
scientists is one of the primary missions of the pathology
department. Toward that end, the department provides:
• a required course for second-year medical students, in
which all pathology faculty members participate;
• a graduate course in cancer biology;
• a graduate program with the department of biology,
leading to a Ph.D. degree in experimental pathology, and
giving the department membership in both the medical
and graduate schools. Plans call for interdepartmental
collaboration to teach a Yale College course in the biology
of disease;
• training for 18 residents preparing for board
certification, plus six fellows;
• frequent consultations and conferences for physicians
from every major specialty—offering continuing
education for practitioners and diagnostic pathologists.
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Interdepartmental cooperation: Scott A. Weed (left), a graduate student in cell biology, discusses a sequencing gel with pathology
chairman John Morrow. Mr. Weed is conducting research into disease-causing DNA mutations in muscle spectrin.

Pathology’s place between basic research and clinical care
will again be put to good use as the department takes a leading
role in the new Boyer Center for Molecular Medicine
(BCMM). It is no coincidence that Dr. Vincent Marchesi,
former chairman of pathology, was named the first director of
the Boyer center; BCMM is dedicated to interdisciplinary
basic research that can be applied clinically.
Many of the Boyer center’s 25 full-time faculty members
and other scientists will collaborate with pathology researchers
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to evaluate molecular mechanisms underlying a range of dis¬
eases. During clinical consultations, seminars and other
instructional presentations both within and beyond the Univer¬
sity, Yale’s pathologists will discuss key research and promul¬
gate important findings made by Boyer center scientists.
“Because pathology involves every other clinical activity,”
says BCMM director Marchesi, “pathology is going to be the
unique vehicle by which the center can extend into the clinic,
particularly in the areas of oncology and vascular biology.” YM
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YM INTERVIEW:
HARRY M. ZIMMERMAN
What was neuropathology like at Yale in the 1930s?
In the early 1930s neuropathology was virtually nonexistent in
this country. 1 graduated from the medical school in 1927 and
spent the next two years with Dr. Milton C. Winternitz, dean of
the school and chairman of pathology, as a resident and then an
instructor in pathology. One day he said to me, “We ought to
have a section of neuropathology.” There was no one in the
country to learn neuropathology from. The best place was Ger¬
many, where they had a well-organized department in Munich
at the Deutsche Forschungsanstalt fur Psychiatrie. The head
of the institute was a world-famous neuropathologist, Walther
Spielmeyer. So I wrote to Spielmeyer, he accepted me and I
left in February of 1929. Dr. Winternitz provided me with a
Charles Linaus Ives fellowship to make it possible for me to
travel.
What was it like to study in Munich?
I found in Spielmeyer's laboratory a large number of foreign
students like me, who were learning neuropathology with the
intent of taking the knowledge hack to their countries. That is
where I met Ko Hirasawa of Japan. Fie became dean of the
medical school of Kyoto University and a few years later
became president of Kyoto University. Many of the fellows
whom I trained were recommended originally to me for train¬
ing by Dr. Hirasawa. Altogether, I have trained 88 Japanese
men, most of whom are professors or associate professors in
Japan. At my 9()th birthday, 77 of them signed their business
cards and presented them to me in a plaque. I came back from
Spielmeyer's laboratory to New Haven and began organizing
the section, along with my other duties in general pathology.
One day, Winternitz said to me, “You're making slow
progress. Would Spielmeyer be willing to come here and help
you get the laboratory organized? Write him, tell him we will
give him an honorarium of $10,000 if he will come to New
Haven and work with you a few months.” So I wrote to Dr.
Spielmeyer, who had never been to America before, and he
accepted the offer.
What were some of your first studies in the new section?
During the Great Depression in the 1930s, it occurred to me
that this epidemic, this crisis in funds and jobs, led to alot of
starvation and produced alot of neurological disorders like
beriberi and pellagra and should be studied experimentally.
I studied the brains of dogs with beriberi produced by a
deficiency of vitamin B1 and compared them to the human
cases that we were getting because people were dying with
these diseases all through the United States, especially in New
Haven. There was a city dump where starving people would
rummage through and eat the scraps. Eventually they deve-

I'his interview was conducted hy Rosalind D'Eugenio, media
specialist at the YSM Office of Public Information.
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Dr. Harry M. Zimmerman.

Harry M. Zimmerman, M.D. ’27
Right Man at the Right Place
Harry M. Zimmerman, M.D. '27, is the dean of American neu¬
ropathology. Bom in 1901 in Lithuania, he graduated from
Yale College in 1924 and the School of Medicine in 1927.
Serving first as a resident and then an instructor in pathology
under Dr. Milton C. Winternitz, Dr. Zimmerman studied nearly
two years in Munich, Germany, to learn the emerging specialty
of neuropathology. Upon his return to Yale in 1930, he estab¬
lished the first full-time neuropathology section in the country.
During World War II, he served in the Pacific as a Comman¬
der in the medical corps in a research unit established by Vice
Admiral Ross T. Mclntire, Surgeon General of the United
States Navy. There he became an expert in Japanese encephali¬
tis and helped develop the first vaccine against the disease.
After the war. Dr. Zimmerman was a founder of Albert Ein¬
stein Medical College in New York City, and established its
neuropathology department. In the process of founding the
school, he became a close friend of its famous namesake and
was chosen by Dr. Einstein to perform the autopsy on his brain
when the great physicist died in 1955.
Eor decades neuropathology fellows and residents from
around the world have come to New York City to study with
Dr. Zimmerman. Eor his role in teaching many of the leading
neurologists and neurosurgeons of Japan, in 1973 he was
awarded the Order of the Sacred Treasure, that country's high¬
est civilian honor. And in 1981, Dr. Zimmemian became the
first neuropathologist to receive the Gold Headed Cane Award
from the American Association of Pathologists.
Today, Dr. Zimmerman is an emeritus professor and consul¬
tant in the department of pathology at Albert Einstein Medical
College/Montefiore Medical Center.
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oped either beriberi or pellagra or both. We discovered that if
you injected these dogs with a dose of vitamin A, kerotin or
thiamine, it resulted in a response within 24 hours, so that a
paralyzed animal was able to walk again even if their lesions
were not completely healed. These experiments helped support
the therapeutic practice of thiamine injections in human
beriberi. When affluent times developed in '35, ’40, these dis¬
eases disappeared, nutrition was adequate. Then I began to
work on brain tumors. A friend of mine at the Harvard Medical
School produced a brain tumor in a mouse by injecting a
chemical carcinogenic agent like methylcolatrete and brought
me the slide of the brain to identify. I took over these experi¬
ments at Yale and wrote a series of papers which attracted
Harvey Cushing’s attention and helped bring him to Yale. We
had a neuropathology laboratory at New Haven better than any
other in America at the time. I was the right man, at the right
time, in the right place.
Did you collaborate with Dr. Cushing when he was at Yale?
Dr. Cushing arrived in New Haven with 2,000 brain specimens
from all the operations he did in Boston. And with him came a
complete transcription of all the clinical records of these 2,000
cases. 1 looked at many of the specimens and would offer my
views on the work. He had a system; on the anniversary of a
brain operation that he did, either the patient would appear on
a yearly basis or would write a letter describing his or her
progress. Many patients appeared in New Haven. Cushing’s
laboratory adjoined my own and if a patient came to see him
that he thought I’d be interested in, he’d knock on the wall.
That was a signal for me to come.
In cases that were difficult to diagnose, the patient would be
brought before the neurological study unit. The group met
weekly and included representatives from neuroanatomy, neu¬
rophysiology and neurology, among them Harvey Cushing.
Plans for treatment were outlined, and the student body was
allowed to come in and listen to what these experts were talk¬
ing about.
Harvey Cushing lived in a home where his backyard and
my backyard were separated only by a fence. Periodically I’d
get a call from him to come over and see a new rare book he
just got. So I would hop the fence and he would unpack a book
that now probably costs well over a million dollars. And he
made a world-famous collection which is now at the Harvey
Cushing/John Hay Whitney Medical Library.
You performed Dr. Cushing’s brain autopsy, didn't you?
Harvey Cushing told me about an illness he had in France in
General Pershing’s army; while doing an operation, he col¬
lapsed and was paralyzed from the hip down. He was shipped
back to Boston and was in bed for about four months until he
recovered the use of his legs so that he was able to operate
again. He always thought that he had a viral infection, a myeli¬
tis. Then one day, he said, “I feel numbness in my left hand. 1
must have a lesion up on the right side of my brain. One day
you’ll have a chance to look and see if I was right or not.” He
asked that when he died, if I would do the autopsy.
At his expressed wish I performed a postmortem examina¬
tion that revealed encephalomalaci of several gyri on the right
side. The sudden onset of paralysis while in France was caused
by a massive thrombus in the aorta that extended from below
the renal arteries to the bifurcation of the iliacs. This old blood
clot was already partly calcified. His paralysis wasn’t due to a
viral infection after all.
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While we're on the subject of autopsies, your most famous was
of Albert Einstein. How did you get to know him and how were
you selected to perform the autopsy of his brain?
I was asked in 1950 by the president of Yeshiva University
to help build a medical school. 1 told him I wouldn’t help with
a parochial school; 1 had enough of restrictions in the admis¬
sions of women, blacks and Jews, but he said they didn’t want
a restricted school either. Then I asked if we had to call it
Yeshiva University School of Medicine. And they said not if I
didn’t want to. So 1 said okay, 1 will help you build a medical
school.
After 1 had raised $2.5 million, 1 thought we had enough
money to start building the school. Now, what to call it? One
of my advisors suggested calling it the Albert Einstein College
of Medicine. 1 didn’t know Einstein, but I had a good friend in
New York, Dr. Gustave Bucky, who did and got him to arrange
a meeting for me.
That was in January of 1953, on a blustery cold day. As we
drove up to Einstein’s house, this man with disheveled gray
hair came out, no necktie, with a gray woolen sweater, with a
hole in one elbow, and no socks. He never wore stockings
except on formal occasions.
He greeted us and ushered us into the house. We talked a
little while and pretty soon he said to me, “Dr. Bucky tells me
you want to ask me something. What is it?” So I told him 1 was
raising money to build a nonsectarian medical school. He liked
the idea because he had suffered prejudice as a Jew in Ger¬
many and had to go to Switzerland when the Germans
wouldn’t give him an appointment to the university. “In what
way can I help?” he asked. I told him by letting us use his
name.
He was truly a modest man. He said, “Dr. Zimmerman, how
would it look to the public to know that a non-M.D. is being
given the name of a medical school?” So I said, “If you don’t
let us use your name, then we’ll have to call it the Joseph
Goldberger Medical School.” He said, “Who is Joseph Goldberger?” I said, “If I call this the Albert Einstein College of
Medicine, who would call me and say, ‘Who is Albert Ein¬
stein?”’ A twinkle in his eye arose and he turned to Dr. Bucky,
and said, “Over the telephone you told me Dr. Zimmerman
was an M.D. He sounds like a lawyer to me.” Then he gave us
the use of his name for the school and we became very good
friends.
How were you selected to autopsy his brain?
He asked me to. I agreed to do the autopsy and also to the con¬
dition that I didn’t write a paper on my findings. After he died
and the brain was brought to me here at Montefiore, a reporter
from the New York Times came and offered me $5,000 for a
photo of a genius cell from Einstein’s brain. I told him I
couldn’t do it. So he then offered me $10,000. I told him I
couldn’t give him a photo of a genius cell because there was
no such thing. I could have given him a photograph of Ein¬
stein’s brain, that’s not a genius cell. It’s not the way cells
look. They don’t look any different from anyone else’s. It’s
what they do that makes the difference. He was a genius
because his cells were able to do things that neither you nor I
can do. I got many letters from children saying they heard I
examined Einstein’s brain and wanted to know what 1 found.
So finally, the editor of the Book of Knowledge, a reference
book they publish for children, wrote me and said would you
write just a page explaining Einstein’s brain and other brains
and so forth? So 1 got pemiission from the executor of the Ein¬
stein estate and did write a small article.
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A 1973 photograph of Dr. Zimmerman and his wife. Miriam, at a reception in Japan after he received the Order of the Sacred
Treasure, which is visible on his suit coat.

E.xplain a little of the work you did in the North Pacific Islands
on encephalitis and amyotrophic lateral sclerosis (ALS).
In 1943, I was asked by the Navy and by the commanding offi¬
cer of Naval Medical Research to help set up a research unit in
the Far Pacific. All kinds of rumors had arisen as to what tropi¬
cal diseases our soldiers would encounter. There was no record
of what diseases were common, and many were neurological
diseases.
Tom Rivers, the chairman of that Naval Medical Research
Unit, brought me to the Mariana Islands, where we conducted
experimental work with cows, monkeys, dogs, sheep and
chickens. We would stop at various islands and the peasants
would meet the ships and we frequently gave them a couple of
chickens. We'd go back a year or two later and found that they
had built chicken coops and it changed their whole economy.
You were promoted to commander cptickly. How did that come
about'!’
After our re.search was well on its way, Tom developed a
bleeding ulcer and had to go back to the states. He recom¬
mended me to the Bureau of Personnel in Washington to suc¬
ceed him as the Commanding Officer of our unit, but Dr.
Richard ,Shope. of Princeton, was longer in the service than 1
and had a higher rank. He would be the natural choice to suc¬
ceed Tom, but the bureau in Washington solved the problem by
my early promotion to Commander.
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How did you come to investigate Japanese encephalitis?
I went to Okinawa to establish a laboratory' on the beach of
Bruckner Bay, and the Army sent in Albert Sabin, professor of
virology at New York University, who joined my unit. The
Army sent him in because an epidemic of Japanese encephali¬
tis was ravaging the island, and like polio, it involved mostly
children. But our troops were going to land on Naha, the
southern capital of Okinawa, and they were going to march up
and clean out the Japanese that occupied Okinawa to the north
end, which was several hundred miles distant. And the Army
people got worried that some of our soldiers may come down
with Japanese encephalitis.
You and Dr. Sabin developed a vaccine didn't you?
Yes. I was doing autopsies on children who had died from
Japanese encephalitis, and 1 gave Sabin a fresh piece of brain
from one such child. He injected the specimen into several
hundred white Swiss mice and made a crude vaccine. He inoc¬
ulated 200.000 American soldiers who were going to go
through the island. And not one developed Japanese encephali¬
tis. At that time, nobody really knew the pathology, so I wrote
a paper on it during the w ar and it was published.
What other diseases did you work with during the war?
While 1 was on Guam I saw patients in the native hospital in
Agana. The Japanese occupied the island and they only had
Yale Medicine
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polished rice to live on, which does away with all the thiamine
and all the vitamin A. So the natives who were eating only pol¬
ished rice came down with beriberi, which I was able to diag¬
nose and treat quickly. I also noticed some of the patients had a
fatal paralytic disease like Lou Gehrig had, namely, amy¬
otrophic lateral sclerosis. The incidence seemed unusually
high for the total population, so I confirmed the disease at
autopsy and sent a report to Washington, alerting them. But the
report was stamped “secret” and was not disclosed until after
the war.
In 1973, you received the Order of the Sacred Treasure by the
Japanese emperor, the highest civilian award bestowed in
Japan. How were you selected?
Most of the Japanese who learn neuropathology learn it from
me in America; some of the most influential neurologists and
neurosurgeons in Japan are former students of mine. So the
Japanese government, through the emperor’s office in Tokyo,
invited me to receive the Order of the Sacred Treasure.
My wife and I went to Japan, and at Hunata airport the
stewardess opened the door and a band burst into the “Star
Spangled Banner.” There was a whole committee to greet me
and two small children brought my wife and me flowers. At
the ceremony the commissioner of education made a speech
and said, “You are hereby given the Order of the Sacred Trea¬
sure, second-class.” My wife jokingly asked the secretary who
gets the first-class. He answered, “Only the emperor. General
MacArthur got the Order of the Sacred Treasure, fourth-class.
The Japanese hold teachers in higher esteem than generals or
almost anybody else.”
How has neuropathology changed during your career?
There are fewer and fewer clinicians like neurologists and neu¬
rosurgeons and psychiatrists doing neuropathology. It has
become technically so complicated with the advent of electron
microscopy especially, that if you don’t devote your whole
time to neuropathology, you don’t make any progress. Clini¬
cians have given up the study and especially the teaching and
the experimental work in neuropathology. Neuropathology
also has become a well-recognized specialty like pediatrics
and surgery and medicine. Emphasis has shifted from descrip¬
tive morphology to considerations of etiology and pathogene¬
sis of diseases of the nervous system.
What developments have most advanced the field of
neuropathology ?
Neurovirology has helped greatly in advancing neuropathol¬
ogy, especially in making it possible to work experimentally in
areas of etiology. This is also true of electron microscopy, an
instrument first employed by metallurgists and in recent years
adapted to biology. Molecular biology is another field that has
had a mutually beneficial impact on neuropathology.
What do you think currently is the most exciting work taking
place in neuropathology?
This is probably in the field of Alzheimer’s disease, where the
work of Dr. Robert Terry, whom I trained for six years and
who is now professor of neuropathology at the University of
California in San Diego, is outstanding. He has trained most of
the researchers in degenerative diseases. His most recent
research has led him to believe that amyloid has nothing to do
with Alzheimer’s.
A second field of great import is the Parkinson-DementiaALS complex that has been advanced by Dr. Asao Hirano,
who has been at Montefiore for the past 36 years. And Dr.
Yale Medicine
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Elias Manuelidies at Yale was able to transmit the human
Creutzfeldt-Jakob disease to guinea pigs, hamsters and mice.
These are just a few examples of some very important
advances.
What do you feel is your greatest professional contribution?
My training of all these people. I’ve got 39 professors in
America I’ve trained, not only Japanese. The only Western
country where 1 haven’t got a man trained in neuropathology is
in England. In the 2nd World War, much of science in Ger¬
many was destroyed, so young Germans came here to learn
neuropathology from me and to take it back to Germany.
That’s the way I paid Spielmeyer back, you see.
What other countries have your fellows come from?
The three leading professors in neuropathology in France were
trained here by me. An ambassador from Japan wrote me a
long letter of thanks on behalf of the French government for
training their neuropathologists. Some years ago, I was asked
to chair an international meeting in Budapest. I was having
lunch with Dr. Briole and my wife when a young man walked
up to me and said, “Dr. Zimmerman, I want to introduce
myself. I’m your grandson.” My wife looked at me in shock.
Then the young man realized that he had to explain himself.
He said, “You trained Dr. Hassoun and Dr. Hassoun trained
me, so I’m your neuropathological grandson!”
Three people in Israel were trained here by me. One of
them was even the dean of the medical school in Tel Aviv. I
trained two Greek neuropathologists, one Turkish neuropathol¬
ogist and several from South America, but not as many as from
Japan. I now have seven fellows in training for whom the
Japanese government supplies funds.
With all the technological advances made in the field, are you
still comfortable in neuropathology?
To be frank with you, I haven’t got time to think of anything
else. In addition to the seven fellows from Japan, I presently
have several from this country. I haven’t got the opportunity to
change my mind because I’m constantly doing more. And I get
consultations from different doctors, neurosurgeons, different
patients in different parts of the country, who send me in their
histories and slides to make the diagnosis. Even if I wanted to
get out of neuropathology, the demand on my service is such
that I couldn’t entirely get out. Unless I told people 1 am no
longer willing to help.
What direction do you think neuropathology is taking, and
what would you like to see happen in the field?
I think the concentration will be in basic chemistry, virology to
study the mechanism of brain function and nerve cell function.
Obviously the functions are different from the glia, which is
the supporting structure in the brain. We know practically
nothing of what the glial cells really do. And certainly, we
don’t know what brain ganglion cells do; and that requires
ultra-microscopic chemistry, structures that deal not with
structures that you can see with a naked eye, even with the
electron microscope. It deals with subatomic structures. And
that’s the function, molecular structure and function, that I
think is the future of neuroscience in general and neuropathol¬
ogy as part of neuroscience. YM
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GALLERY

Portrait of Milton C. Winternitz and the Yale Pathology Department
1926, photographer unknown
In this portrait taken at the peak of the Roaring ’20s, Milton
C. Winternitz, M.D., is pictured front and center. In 1926,
he was serving his ninth year as chairman of the pathology
department and his sixth year as medical school dean.
Bom in Baltimore in 1885, Dr. Winternitz worked his
way through college and medical school at Johns Hopkins
selling penny insurance. Upon graduating with his M.D.
degree in 1907, he continued his studies with Dr. William
Henry Welch, a Yale College and Columbia medical school
graduate who began the first modern pathology department
at Johns Hopkins. Dr. Winternitz came to Yale in 1917 to
establish the second such department.
Under his leadership as dean. Sterling Hall of Medicine
and Lauder Hall were built. He established the Institute of
Human Relations to encourage interdisciplinary coopera¬
tion within medicine and with the social sciences, an idea
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that proved decades ahead of its time. He initiated the Yale
System of medical education emphasizing independent
study, and in 1923, at his behest, the University founded the
Yale School of Nursing.
Among his many accomplishments in biomedical
research, in 1933, he initiated a study group on the biology
of cancer that laid the groundwork for many subsequent
discoveries in the field. In the 1940s, he collaborated with
Dr. Max Taffel and others at Yale to isolate elements in
nitrogen mustard gas that were used as the first cancer
chemotherapy.
Dr. Winternitz completed his deanship in 1935 and
retired as pathology chair in 1950. He died in 1959 having
left an indelible legacy for his department, the School of
Medicine and Yale University. YM
Gregory R. Huth, M.P.H.
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SCOPE
can be hazardous to children’s health.
According to the report, poor
children are more likely than other chil¬
dren:

Scientists Find Sunlight
Alters Cancer Gene
By studying New England and Swedish
patients, researchers have identified a
gene—p53—that they say interacts with
sunlight to lead to squamous cell car¬
cinoma, a common form of skin cancer.
In normal skin cells, gene p53 limits
cell division. However, the researchers
report in the Nov. 15 issue of the
Proceedings of the National Academy of
Sciences, that the sun’s ultraviolet (UV)
rays alter this gene.
“Our results show for the first time
how a common human carcinogen
works,” says biophysicist Douglas E.
Brash, Ph.D., assistant professor of ther¬
apeutic radiology and a member of the
Yale Comprehensive Cancer Center. He
led the eight-member, multidisciplinary
research team from Yale, Massachusetts
General Hospital, Dermatopathology
Associates of New York in New
Rochelle, and University Hospital in
Uppsala, Sweden.
“Sunlight is a carcinogen to which
everyone is exposed, and is an example
of an ’all-natural’ carcinogen,” Dr.
Brash points out.
Skin cancer, usually caused by
overexposure to sunlight, is the most
common cancer in the United States.
According to the Centers for Disease
Control, 632,000 new cases are reported
each year, and 8,500 deaths annually
result from the disease.
Of 24 patients, 72 percent from New
England and 46 percent from Sweden
showed changes in the p53 gene, identi¬
fied by sequencing the gene’s DNA.
The mutations did not appear to be
inherited and did not resemble changes
found in cancers of internal organs, such
as colon and lung. Instead, Dr. Brash
concludes that the mutations resembled
those caused by ultraviolet light, a com¬
ponent of sunlight.
The researchers chose p53, originally
discovered elsewhere in 1979, as a
candidate gene because they knew that
the mutated p53 gene causes
premalignant lesions in mouse skin. The
same gene, p53, is also altered in other
types of cancer.
Yale Medicine
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Dr. Lorraine V. Klerman

Klerman Documents
Poverty’s Effects
On Poor Children
A report authored by Lorraine V.
Klerman, Dr.P.H., professor of public
health, has documented the adverse
influence of poverty on the nation’s 5
million poor young children. “Alive
and Well?; A Research and Policy
Review of Health Programs for Poor
Young Children” was released by
Columbia University’s National Center
for Children in Poverty. The review
described the many ways that poverty

Three-Year Grant
Supports Tanaka Study
As part of its Focused Giving Program,
Johnson & Johnson has committed
$270,000 over three years to support
research that Kay Tanaka, M.D., profes¬
sor of genetics, will conduct at the Yale
University School of Medicine.
Dr. Tanaka will examine the molecu¬
lar structure of three inherited disorders

•

to be bom too early or too small;

•

to die in the first year of life;

•

to experience acute illness, injury
or lead poisoning;

•

to experience abuse or neglect;

•

to suffer from nutrition-related
problems and chronic illnesses
— many of which are
preventable.

“The reasons for higher levels of
health problems among poor infants
and children are complex and difficult
to analyze,” comments Dr. Klerman
from her office in the Laboratory of
Epidemiology and Public Health. “But
they all lead to one overriding and
disturbing indicator: that your chances
of being healthy increase with your
income.”
Among the policy strategies
suggested by the report to reverse this
situation are to expand programs such
as Special Supplemental Food Program
for Women, Infants and Children
(WIC) and Head Start, so that the
programs could serve all the poor
women and children who could benefit
from them. The Klerman report also
recommends adoption of a universal
health care system and improved
financing strategies that would offer
adequate reimbursement to private
practitioners who serve poor families.

of fatty acid metabolism. The project is
intended to contribute to the
development of new, accurate
diagnostic tests and to increase
understanding of the diseases.
Johnson & Johnson has awarded pre¬
vious awards to Yale’s department of
genetics toward the development of the
DNA Diagnostic Laboratory and to
Charles A. Janeway Jr., M.D., professor
of immunobiology, biology and in the
Cancer Center, for studying the function
of cells in the immune system.
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Lead Hazard to Bridge
Workers Studied
Construction workers involved with
bridge rehabilitation in Connecticut are
the focus of a five-year, federally
funded study and surveillance project
designed to limit lead exposure hazards.
Yale researchers in the
occupational/environniental medicine
program are conducting the study in
cooperation with other occupational
medicine clinics throughout the state,
the state departments of health and of
transportation, several labor unions and
the construction industry.
CRISP, the Connecticut Road
Industry Surveillance Project, is
supported by $849,600 from the
National Institute for Occupational
Safety and Health of the Centers for
Disease Control.
This funding comes at an auspicious
time, notes Kathleen F. Maurer, M.D.,
M.P.H., a postdoctoral associate in
occupational medicine, because the
Connecticut Department of
Transportation is midway through a 10year, $7.5 billion bridge rehabilitation
program involving 3,700 bridges, more
than 2.000 of which still are coated with
lead-based paint.
Dr. Maurer directs the project under
its principal investigator. Dr. Mark R.
Cullen, director of the occupational/
environmental medicine program and an
associate professor of medicine and epi¬
demiology at Yale.
Dr. Maurer explains, “The project
will establish a state-wide medical eval¬
uation system to identify and treat work¬
ers with lead toxicity from bridge
repair." She and her colleagues,
including industrial hygienist Irene
Smith of Groton, will “propose remedial
action for health and safety hazards
found at bridge sites, and also establish
a computer infonnation system to docu¬
ment occupational disease among
construction workers."
Concern over lead poisoning in
bridge w(vrkers was heightened in the
fall of 1989 when the occupational
health center at Lawrence and Memorial
Hospitals in New London, Conn., which
is affiliated with Yale, identified eight
construction workers from a single com¬
pany who tested positive for lead
toxicity. Subsequently, the Lawrence
and Memorial occupational health care
professionals discovered workers from
other companies who had high lead
levels.
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For bridge workers, lead exposure
generally comes when layers of old
lead-based paint are sandblasted off
steel bridges, and the workers inhale or
ingest lead dust particles.

Yale Study Disputes
Alcoholism Gene
t
'7
I
■o

Dr. Carolyn W. Slayman

YSM Renames
Human Genetics,
Neuroanatomy
The Yale Corporation has approved
changes in the names of the department
of human genetics and the section of
neuroanatomy recommended by the
School of Medicine's Board of
Permanent Officers.
To reflect more accurately its current
breadth, the department of human
genetics, chaired by Carolyn W.
Slayman. Ph.D., becomes the
department of genetics. The department
encompasses basic research, teaching,
diagnostic laboratories, patient care and
clinical research in all aspects of
genetics.
The section of neuroanatomy, headed
by Pasko Rakic, M.D., Sc.D., the Dorys
McConnell Duherg Professor of Neuro¬
science, becomes the section of neurobi¬
ology, which has this broader field as its
research and educational mission.
The name change also benefits
faculty with joint appointments in such
areas as anesthesiology, neurosurgery,
ophthalmology, otolaryngology and
psychiatry. In addition, the change will
facilitate research funding and
recruitment of faculty and students.

A gene that has been claimed to cause
alcoholism may not be related to the
disorder according to a team of Yale
researchers. Dr. Joel Gelemter, assistant
professor of psychiatry at Yale and chief
of the laboratory of psychiatric genetics
at the Department of Veterans Affairs
Medical Center in West Haven, has
shown no association between the D2
dopamine receptor gene (DRD2) and
alcoholism.
The gene in question, is really a
marker and because the original study
indicated that alcoholics have an
increased incidence of the marker,
scientists felt a link between the actual
gene, which codes for a chemical called
dopamine, and alcoholism was likely.
At issue is whether the presence of a
genetic marker known as “A1 allele” on
that gene predisposes a person to
alcoholism or other behavioral
disorders.
A new study has been unable to
repeat results indicating a genetic
association with alcoholism. “We were
not able to replicate the results pre¬
viously reported,” states Dr. Gelemter.
His data does not support an associa¬
tion between a marker for the gene
DRD2 (the dopamine D2 receptor gene)
and alcoholism.
The authors studied 44 unrelated
white subjects diagnosed as alcoholic
and a random sample of 68 white
subjects. They compared the frequency
with which A1 or A2 appeared at DRD2
in the alcoholics and the controls.
The Yale/VA team of researchers
lead by Dr. Gelemter include: Stephanie
S. O’Malley, Ph.D., associate professor
of psychiatry and director of Alcohol
and Drug Treatment Unit at the
Connecticut Mental Health Center in
New Haven; Neil J. Risch, Ph.D.,
associate professor of public health and
genetics; John H. Krystal, M.D.,
assistant professor of psychiatry and
chief of neuropsychiatric studies unite at
the VA; Kathleen R. Merikangas, Ph.D.,
associate professor of psychiatry and
epidemiology; Kenneth L. Kidd, M.D.,
professor of genetics, psychiatry and
biology; Henry R. Kranzler, assistant
professor of psychiatry and director of
the division of addictive disorders at the
University of Connecticut.
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Program Opened
For Autistic Adults
Christopher J. McDougle, M.D.,
assistant professor of psychiatry, and the
Yale Child Study Center have started
the Yale Adult Pervasive
Developmental Disorders Program, one
of the first programs dedicated solely to
studying and treating adults with autism
and related disorders.
The Yale Child Study Center has an
internationally known program to study
and treat autistic children, which
includes studies of autistic adults. In its
30-year history, the center has studied
the neurobiology of autism and autistic
adults.
Advising the adult program are Child
Study Center Director Donald J. Cohen,
M.D., the Irving B. Harris Professor of
Child Psychiatry, and Fred R. Volkmar,
M.D., the Harris Associate Professor of
Child Psychiatry in the Child Study
Center. Drs. Cohen and Volkmar are
professor and associate professor,
respectively, of pediatrics, psychiatry
and psychology.
Dr. Cohen comments: “The
knowledge about adults with autism that
will be gained from the work of Dr.
McDougle will shed important light on
underlying processes and better ways of
caring for autistic individuals as whole
people.”
To date, most autism research has
focused on children. Approximately 1 in
2,000 people suffer from autism. Dr.
McDougle estimates. But as autistics
grow into adults, their symptoms often
change, leading to misdiagnosis, he
says. Also, most governmental funding
for education and other services for
autistic people runs out when they turn

21.
Extending previous work with
autistic individuals pioneered by the
Child Study Center, Yale's new program
began last fall to study and treat adults
between the ages of 18 and 70.
Participants attend twice monthly
outings designed to enhance social
skills. A group of 25 autistic adults, all
from the New England area, participates
in such activities as bowling and
shopping. The program has begun a
support group in which parents, friends,
professionals and others meet monthly
to discuss results of ongoing research
and new ideas.
In the research program, Yale faculty
members are studying the biochemistry
of autism, especially the relationship
Yale Medicine
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between autism and serotonin, a potent
chemical in the brain that transmits
nerve impukses between cells. Serotonin
is thought to be involved in controlling
mood and social behavior. Child Study
Center researchers first noted a link
between serotonin and autistic behavior
in 1961.

I
I

Police Department’s community
policing program and the Child Study
Center’s Forum on Education and
Society, created this year in response to
concerns about children’s fears
emerging from the Persian Gulf War.
“However,” points out Dr. Donald J.
Cohen, director of the Child Study
Center, “we soon realized that the most
immediate sources of trauma for inner
city children occurred much closer to
home, in the violence they experience in
their daily lives.”
New Haven Police Chief Nicholas
Pastore observes, “The worst victims of
violence are children. They are sub¬
jected to violence directly and trauma¬
tized by their exposure to the violence
they must witness in their daily lives.
Children, especially poor children in our
society, have the fewest resources avail¬
able to protect themselves,” he adds.

Robert Venturi To Design
Clinical Science Building
Dr. Donald J. Cohen

Child Study Center Aids
Police in New Program
Leaders of the New Haven Department
of Police Services and the Yale Child
Study Center have announced an
innovative, cooperative venture to
reduce the impact of violence on the
lives of the children of New Haven.
During the past several months,
faculty members of the Child Study
Center and New Haven Police officers
have collaborated to develop:
• a graduate-level course on child
development for all police
recruits;
• a system for officers in the field to
receive consultation about, and
referrals for, clinical interventions
for at-risk youth;
• a fellowship for selected police
officers to learn about available
mental health services for
children.
The program is funded by a $50,000
Rockefeller Foundation grant and
$50,000 in private donations and is part
of a broader effort by the University,
New Haven Police, and the New Haven
public school system to coordinate their
response to the emotional needs of chil¬
dren exposed to violence.
The program developed out of the

Robert Venturi, winner of the 1991
Pritzker Prize — one of the most presti¬
gious awards in architecture — has been
commissioned to design the School of
Medicine’s Laboratory for Clinical
Science. The five-story structure will
offer the latest technology to physicianscientists and other basic researchers
from a variety of disciplines as they
conduct studies to advance clinical care.
Mr. Venturi is principal architect in
charge of design at Venturi, Scott
Brown and Associates, Inc. (VSBA),
based in Philadelphia. VSBA has
garnered 80 major design awards since
it was founded in 1966.
VSBA’s projects include two
research laboratories at Princeton
University and science buildings at the
University of Pennsylvania, Dartmouth
College and the University of California
at Los Angeles. VSBA will collaborate
with Payette Associates of Boston, a
specialist in designing laboratory
modules inside research buildings.
In announcing the selection, Yale
President Benno C. Schmidt Jr. said, “I
am tremendously pleased that Robert
Venturi will undertake a major commis¬
sion at Yale at the medical school,
where the University in recent years has
enjoyed such important and interesting
architectural contributions.”
The location of the Laboratory for
Clinical Science has yet to be
determined.
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and residency training at YNHH. He
served as associate professor of
medicine and chief of clinical
cardiology at the University of Texas
(Southwestern) Medical School in
Dallas between 1968 and 1970, after
which time he returned to Yale as a
faculty member.

Faculty
News
Dr. Lawrence S. Cohen

Lawrence S. Cohen Named
YSM Acting Deputy Dean
Lawrence S. Cohen, M.D., a worldrenowned cardiologist, research scien¬
tist and educator, has been named acting
deputy dean of the medical school. Dr.
Cohen, the Ebenezer K. Hunt Professor
of Medicine and an attending physician
at Yale-New Haven Hospital, has been a
Yale faculty member for 21 years. He
was named to his endowed professor¬
ship in 1981.
Dr. Cohen is past president of the
Connecticut Affiliate of the American
Heart Association (AHA) and has been
active nationally with the AHA's
Council on Clinical Cardiology and the
.Scientific Sessions Committee. Dr.
Cohen's early research focused on
cardiac catheterization. In the mid196()s, at the National Heart Institute, he
was one of the first investigators to
perform x-rays of the heart's arteries.
Subsequently, he developed a major
interest in coronary artery disease.
For the past eight years. Dr. Cohen
has been a principal investigator at Yale
in the area of thrombolytic, or bloodclot dissolving, therapy to treat patients
with a kind of heart attack called acute
myocardial infarction (MI). He also
directs Yale's TIMI clinic program, part
of a multicenter study on different
aspects of the most appropriate
treatment of Ml patients using
thrombolytic therapy.
A native of New York, N.Y., Dr.
C’ohen received an A.B. degree in I9.‘i4
from 1 larvard College and an M.D.
degree in 19S8 from New York
fi'niversity. He completed his internship
.12

Dr. Leon E. Rosenberg

Leon Rosenberg Resigns
To Accept Corporate Post
Leon E. Rosenberg, M.D., has resigned
as medical school dean to become presi¬
dent of Bristol-Myers Squibb
Pharmaceutical Research Institute. Dr.
Rosenberg, who had served as medical
school dean since July 1984, began his
new post on Sept 1.
Yale President Benno C. Schmidt Jr.
named fomier Deputy Dean Robert M.
Donaldson Jr., M.D., a gastroenterolo¬
gist, as acting dean. Dr. Lawrence S.
Cohen, a cardiologist who is the
Ebenezer K. Hunt Professor of Medi¬
cine, is serving as acting deputy dean.
President Schmidt will chair the search
committee for Dean Rosenberg's
successor.
Dr. Rosenberg commented.

“Throughout my career at Yale, I have
endeavored to educate young scientists
and to employ scientific methods to
understand disease mechanisms and help
patients with inherited disorders. I am
excited about the opportunity to join a
leading health care company whose mis¬
sion, similarly, is to use science to
improve human health. I will be fortu¬
nate beyond measure if my years at Bris¬
tol-Myers Squibb turn out to be as fulfill¬
ing and meaningful as my years at Yale.”
An internationally known research
geneticist, teacher and clinician. Dr.
Rosenberg began his 26-year career at
Yale in 1965 as an assistant professor of
medicine, and in 1972 was appointed
professor and the first chairman of a
new department of human genetics. In
1980, he was named C.N.H. Long
Professor of Genetics.
During his deanship. Dr. Rosenberg
advanced the school’s missions in teach¬
ing, research and patient care. He
provided leadership for the school’s
capital campaign that raised $155
million to increase endowment, help
meet research and program needs, and
provide new and renovated facilities.
Several major construction projects
were completed, including the Boyer
Center for Molecular Medicine, the Yale
Psychiatric Institute, the Yale
Physicians Building, expansion and ren¬
ovation of the Harvey Cushing/John
Hay Whitney Medical Library,
renovation of the Boardman Building
for the Yale Eye Center, and
construction of the Magnetic Resonance
Center, the latter a joint project with
Yale-New Haven Hospital.
An academic plan to chart the
school’s strategic course in the 1990s
was completed, and a department of
orthopaedics and rehabilitation, a
section of immunobiology and a center
for medical infonnatics were
established. An Office for Minority
Affairs was also set up.
Said Mr. Schmidt, “Lee Rosenberg is
an extraordinary man who has made
extraordinary contributions to Yale Uni¬
versity and its School of Medicine. His
vision, drive and inexhaustible energy
have contributed to a remarkable deanship. His years as dean have seen not
only significant growth in virtually
every critical field of medical education
at Yale, but also a great invigoration of
the school, its facilities and its program.
We will miss him, and we wish him
well.”
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Benno Schmidt Names YSM Dean Search Panel
Sixteen members of the Yale faculty serve on the committee to search for a new
dean for the School of Medicine. Yale President Benno C. Schmidt Jr., chairs
the committee. Carolyn W. Slayman, Ph.D., Sterling Professor of Genetics and
chair, department of genetics, serves as vice-chair.
Other members include;
Thomas N. Byrne, M.D., associate clinical professor of neurology:
Edwin C. Cadman, M.D., Ensign Professor of Medicine and in the Cancer
Center, and chair of the department of internal medicine:
Donald J. Cohen, M.D., director of the Child Study Center, Irving B. Harris
Professor of Child Psychiatiy, and professor of pediatrics, psychiatry, and
psychology:
Lawrence S. Cohen, Ph.D., acting deputy dean of the School of Medicine and
Ehenezer K. Hunt Professor of Medicine, ex officio:
Gerhard H. Giebisch, M.D., Sterling Professor of Cellular and Molecular Phys¬
iology: Dr. Barbara Kinder, professor of surgery and in the Cancer Center,
and chief of surgery at the Department of Veterans Affairs Medical Center:
Forrester A. Lee, M.D., assistant professor of medicine:
Vincent T. Marchesi, M.D., Ph.D., director of the Boyer Center for Molecular
Medicine and Anthony N. Brady Professor of Pathology, Cell Biology, and
Biology.
Judith Rodin, Ph.D., dean of the Graduate School of Arts and Sciences, profes¬
sor of medicine and psychiatry, and chairman of the Mac Arthur Eoundation
Center for Studies of Health and Behavior Psychology:
Frank T. Ruddle, Ph.D., Sterling Professor of Biology and Genetics and chair¬
man of the biology department:
Alan C. Sartorelli, M.D., Alfred Gilman Professor of Pharmacology and direc¬
tor of the Comprehensive Cancer Center:
Clarence T. Sasaki, M.D., Charles W. Ohse Professor of Surgery and in the
Cancer Center:
Burton H. Singer, Ph.D., associate dean for public health, Ira V. Hiscock Pro¬
fessor and chairman of the department of epidemiology and public health,
and professor of economics and statistics:
Joan A. Steitz, Ph.D., professor of molecular biophysics and biochemistry:
Joseph B. Warshaw, M.D., professor and chairman, department of pediatrics.

James D. Jamieson
Appointed M.D., Ph.D.
Program Director
James D. Jamieson, M.D., Ph.D.,
professor and chairman of the
department of cell biology, has been
appointed director of the School of
Medicine M.D., Ph.D. program.
The program enrolls a limited
number of qualified students who
complete the first four terms of the med¬
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ical school curriculum, then a doctoral
thesis and clinical clerkships in the
department in which the Ph.D. degree is
sought. Students pursue a course of
study which ultimately leads to joint
M.D., Ph.D. degrees in any of the
relevant graduate programs of the
University.
The M.D., Ph.D. program, which
began in 1968 and graduated its first
students in 1973, currently enrolls 61
students, 13 percent of students at the
medical school.

Dr. Donald M. Engelman

Donald Engelman
Named Acting Dean
Of Undergraduates
Donald M. Engelman, Ph.D., professor
and chairman of molecular biophysics
and biochemistry (MB&B), has been
named acting dean of Yale College by
Yale President Benno C. Schmidt Jr.
beginning July 1 while Dean Donald
Kagan is on a year-long leave from the
University. The Yale Corporation
confirmed the appointment at its
November meeting.
Dean Kagan, a historian of ancient
Greece, will spend the year at the
Institute for Advanced Study in the
Behavioral Sciences at Stanford Univer¬
sity, where he will work on a longplanned book about the origins of war.
Dean of the University’s 5,100
undergraduates since July 1989, Profes¬
sor Kagan plans to return to Yale July 1,
1993, to resume his post as the
College’s chief academ.ic and
administrative officer.
In announcing the selection.
President Schmidt stated: “1 am very
pleased Don Engelman has agreed to
accept the important responsibilities of
the acting dean of Yale College. He is
an outstanding scientist. He is a proven
administrator. He has a broad
understanding of the values of liberal
education. He is devoted to students and
has been deeply in the academic and
social life of Yale College.”
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Dr. Paul G. Barash

Paul Barash Named
Associate Dean
For Clinical Affairs
Paul G. Barash. M.D.. chairman and
chief of the department of
anesthesiology at the medical school
and YNHH, has been named associate
dean for clinical affairs. In his new posi¬
tion. Dr. Barash will administer the
comprehensive, specialty outpatient
care that Yale faculty physicians provide
through the Faculty Practice Plan.
Dr. Barash's appointment, effective
July 1. is concurrent with his
departmental chair. He succeeds
Richard H. Greenspan. M.D.. professor
of radiology, who will return to
teaching, research and patient care.
In announcing the appointment,
former medical school Dean Leon E.
Rosenberg stated: “Paul Barash has
demonstrated his leadership, scholarship
and organizational skills at the School
ol Medicine and Yale-New Haven
Hospital. His diverse experience will
enhance the administration of the
school's clinical programs. We can be
assured of a smooth transition from
Dick Greenspan's five years of able ser¬
vice to Paul Barash's new and exciting
vision for clinical service at Yale."
Dr. Barash came to Yale as an
34

assistant professor of anesthesiology in
1973. and a decade later was named
chairman and chief of the department of
anesthesiology. He also serves on the
YNHH board of trustees, and between
1974 and 1982 directed the surgical
intensive care unit.
His research has centered on patients
with cardiovascular disease who
undergo surgery, the use of new drugs in
aesthesiology, children's responses to
anesthesia during surgery, and the phar¬
macology of cocaine. Twelve years ago.
Dr. Barash and colleagues introduced
echocardiography to the operating
room. This technique uses ultrasound to
monitor the heart during surgery.
Dr. Barash has served as president of
the Connecticut State Society of
Anesthesiologists and president of the
Society of Cardiovascular Anesthesiolo¬
gists. A fellow of the American College
of Anesthesiology, he also serves as a
senior examiner of the American Board
of Anesthesiology, which certifies anes¬
thesiologists.
Dr. Barash is senior editor of the
textbook Clinical Anesthesia and serves
on the editorial boards of the Journal of
Clinical Monitoring and the Journal of
Clinical Anesthesia.
A Brooklyn, N.Y., native. Dr. Barash
received a B.A. degree from the City
College of New York in 1963 and an
M.D. degree from the University of
Kentucky College of Medicine in 1967.
He completed his internship at Kings
County, N.Y., Medical Center and
residency training at Yale-New Haven
Hospital, where he was chief resident.

Genetics Sponsors
Visiting Professor
As part of a National Science
Foundation initiative to encourage the
participation of women in U.S. science
and engineering research, Terry Ashley,
Ph.D., an adjunct research associate
professor at the University of
Tennessee-Knoxville, is spending two
years in Yale's genetics department. Her
research will attempt to transfer
techniques for mitotic labeling of DNA
sequences for light and electron
microscopy to both meiotic
chromosomes and nuclei.
Ms. Ashley also will develop and
coordinate a .series of guest lectures by
women in genetics, a series jointly
spon.sored by the department of genetics
and the office for women in medicine.

Ralph Horwitz Named
To Hines Professorship
Ralph Horwitz, M.D., has been named
the Harold H. Hines Jr. Professor of
Internal Medicine and of Epidemiology
and Public Health. A leading scholar in
the field of clinical epidemiology. Dr.
Horwitz came to the University in 1978
as an assistant professor of medicine
and co-director of the Robert Wood
Johnson Clinical Scholars Program at
the School of Medicine. In 1982, he was
named associate professor and chief of
the section of general internal medicine
and in 1983, associate professor of
epidemiology.
Dr. Horwitz has made major
contributions toward improving the
quality of basic data used in clinical
research, including the development of
rigorous methodologic standards for
observational case-control studies and
the development of new methods to
improve research on the efficacy of
therapeutic agents. His methods have
been used in studies on the cause-andeffect relationships of estrogen and
endometrial cancer, tampons and toxic
shock, and anticoagulants and
myocardial infarction.
Dr. Horwitz earned his B.A. degree
from Albright College in 1969 and his
M.D. degree from the Pennsylvania
State University College of Medicine in
1973. He served his internship at the
Royal Victoria Hospital of McGill
University in Montreal and was a fellow
of the Robert Wood Johnson Clinical
Scholars Program at Yale from 1975 to
1977. He was a senior assistant resident
at Massachusetts General Hospital from
1977 to 1978.
A fellow of the American College of
Physicians and the American College of
Epidemiology, Dr. Horwitz has won
several awards for his work, including
the C.V. Mosby Award for General Aca¬
demic Excellence from the
Pennsylvania State University College
of Medicine (1973) and the Henry J.
Kaiser Family Foundation Faculty
Scholar Award (1981-1986). In addition
to his teaching, research and administra¬
tive work, he also serves as a reviewer
for numerous medical journals,
including the American Journal of
Epidemiology, the American Journal of
Medicine and the Journal of the
American Medical Association.
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28 Faculty Members Appointed, Promoted
The Office of the Dean at the School of Medicine has announced the following
appointments or promotions to senior ranks, effective July 1. In recognizing fac¬
ulty members’ excellence in teaching, research and patient care, these faculty
become members of the Board of Permanent Officers (BPO), the school’s
governing board which is responsible for major academic decisions.
Five faculty members were appointed to senior ranks with tenure. They
include: Peter Cresswell, Ph.D., professor of immimohiology; Gerald H.
Friedland, M.D., professor of medicine: Jordan S. Pober, M.D., professor of
pathology: Reinhard Jahn, Ph.D., associate professor of pharmacology: and
Joseph Santos-Sacchi, Ph.D., associate professor of surgery (otolaryngology).
Eighteen faculty members in various departments were promoted to
professor, the highest academic rank. They are: William Agnew, Ph.D., cellular
and molecular physiology: Margaret J. Bia, M.D., medicine: Michael B.
Bracken, Ph.D., epidemiology: Toni Claudio, Ph.D., cellular and molecular
physiology: Gary S. Kopf, M.D., surgery (cardiothoracic): Jeffery Koscis,
Ph.D., neurology: Carole C. LaMotte, Ph.D., surgery (neurosurgery) and
anesthesiology: Robert LaMotte, Ph.D., anesthesiology and neurohiology:
Brian Leaderer, Ph.D., epidemiology (environmental health): Robert M. Liskay,
Ph.D., therapeutic radiology: Joseph Madri, yi.D., pathology: Ira Mellman,
Ph.D., cell biology: Manohar M. Panjabi, Ph.D., orthopaedics and
rehabilitation: Richard R. Pelker, M.D, orthopaedics and rehabilitation:
Richard E. Peschel, M.D., therapeutic radiology: Gary Rudnick, Ph.D.,
pharmacology: Sally E. Shaywitz, M.D., pediatrics and in the Child Study
Center: and Frederick J. Sigworth, Ph.D., cellular and molecular physiology.
Five faculty members were promoted to associate professor with tenure,
including J.G. Collins, Ph.D., anesthesiology: Daniel C. DiMaio, M.D., Ph.D.,
genetics: Susan Hockfield, Ph.D., neurobiology: Richard J. Robbins, M.D.,
medicine: and William B. Stewart, Ph.D., surgeiy (anatomy).
These faculty members may hold joint appointments with one or more of the
following institutions affiliated with the medical school: Yale-New Haven
Hospital, the Department of Veterans Affairs Medical Center in West Haven and
the John B. Pierce Laboratory.

Eleanor R. Adair, Ph.D., senior
research scientist and lecturer in
psychology and a fellow at the John B.
Pierce Laboratory, has been honored by
the Institute of Electrical and
Electronics Engineers with the United
States Activities Board Award for her
paper entitled “Currents of Death Recti¬
fied.’’ The award recognized
outstanding journalistic or other efforts
that contribute to the enhancement and
expansion of public understanding of
the engineering profession.
Edward A. Adelberg, Ph.D., professor
emeritus of genetics, was honored with
a symposium, “Bacterial Genetics: Past,
Present, Euture,’’ by the department of
human genetics in May.
Erank J. Bia, M.D., associate professor
of medicine and laboratory medicine,
was selected by the W.K. Kellogg Foun¬
dation for its National Fellowship
Program. The program, established in
Yale Medicine
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1980, increases individuals’ skills in
areas outside their chosen disciplines to
more effectively handle society’s
problems.
Edwin C. Cadman, M.D., Ensign
Professor of Medicine and chairman of
the department of internal medicine, has
been appointed to the new Scientific
Advisory Board of Argus
Pharmaceuticals, Inc. The board
consists of seven leading international
experts in the fields of immunology,
oncology, infectious disease and
biochemistry.
Patricia Goldman-Rakic, Ph.D.,
professor of neuroscience, has been
awarded the $50,000 Lieber Prize by the
National Alliance for Research on
Schizophrenia and Depression. Dr.
Goldman-Rakic is the fifth recipient of
the award, which recognizes
outstanding achievement in research on
schizophrenia.

Faculty
News
Gabor B. Huszar, M.D., research
scientist in obstetrics and gynecology
and pediatrics, is a member of the
Reproductive Biology Study Section,
Division of Research Grants at the
National Institutes of Health for a term
of three years. Study sections review
grant applications submitted to the NIH,
make recommendations to the appropri¬
ate NIH national advisory council or
board and survey the status of research
in their fields of science.
Michael Kashgarian, M.D., professor
of pathology and biology, is a member
of a National Institute of Health
committee which was formed to
examine evidence of risks or side effect
from silver amalgam, a material used
for dental fillings. They found that mer¬
cury used in the fillings had no harmful
side effects.
Lorraine V. Klerman, Dr.P.H.,
professor of public health, has been
selected to receive a CAHS Human Ser¬
vices Award by the Connecticut Associ¬
ation for Human Services. The award,
which was presented in November,
recognizes the outstanding efforts to
improve the delivery of human services
to the people of Connecticut.
Irvin M. Modlin, M.D., professor of
surgery, has received an honorary
degree of Doctor of Medicine from the
Goteborgs University in Sweden.
David E. Musto, professor in the Child
Study Center, psychiatry and the history
of medicine, has been selected to partic¬
ipate in two symposia on substance
abuse problems and prevention
measures. The symposia, entitled “Hard
Drugs, Hard Choices in Connecticut,’’
were broadcast on Connecticut Public
Television in September.
Pilar N. Ossorio, Ph.D., a postdoctoral
associate in the division of infectious
disease, was selected by the American
Association for the Advancement of
Science to participate in a workshop of
intensive study on the values and ethical
issues associated with science and tech¬
nology. The workshop, held July 28 to
Aug. 3, explored various minority
perspectives on science and technology,
how they compare to prevailing
Continued on page 36
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Faculty News
Continued from page 35
perspectives, and the different influence
that these perspectives can have on
scholarship, individual practices, and
policy decisions.

Alumni
News

Scott A. Rollins, Ph.D. a postdoctoral
fellow in the section of immunobiology,
has been awarded a 1991 Jane Coffin
Childs Fellowship. The $73,500 award
will support his research on the role of
the human anti-inflammatory protein
CD59, which protects transplanted
tissue and organs from rejection.

Albert ,1. Solnit, M.D., Sterling Profes¬
sor Emeritus of Pediatrics and
Psychiatry, was presented the American
Academy of Child and Adolescent
Psychiatry's Simon Wile Award,
recognizing his outstanding leadership
and continuous contributions to child
psychiatry. Dr. Solnit is the state of
Connecticut's Commissioner of Health.
,Iody L. Sindelar, Ph.D., associate
professor of public health and of the
Institution for Social and Policy Studies,
has been selected by the New York State
Public Health Department to serve on
the independent board (the panel of
health economics) to establish hospital
rates and trend factors in the state of
New' York.
Stephen (J. Waxman, M.D., Ph.D.,
professor and chaimian of neurology
and professor of pharmacology, was
presented the 1991 Distinguished Alum¬
nus Award by the Albert Einstein
College of Medicine of Yeshiva Univer¬
sity in June.
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Dr. David M. Raskind, '24, has
retired from orthopedics and consults
for the Hospital for Joint Diseases in
New York City. In September, he com¬
peted in the age 85 to 90 tennis tourna¬
ment at Longwood Cricket Club as the
oldest competitor in the U.S.A.
Dr. Allan J. Ryan, ’43-'45 HS, was
elected co-president of the International
Association for Dance Medicine and
Science, for whom he prepared and pre¬
sented the first annual meeting in
Baltimore in June.

Frank H. Ruddle, Ph.D., chairperson
and the Sterling Professor of Biology
and Genetics, has been appointed chair¬
person of the Genome Study Section,
Division of Research Grants by the
National Institutes of Health.
Kevin A. Sevarino, M.D., Ph.D., assis¬
tant professor of psychiatry, was named
one this year's Pfizer Scholars and Post¬
doctoral Fellows. Ten physicianscientists were honored with awards by
Pfizer to pursue clinical or basic
biomedical research at U.S. medical
.schools. Dr. Sevarino conducts research
on human psychiatric di.sorders and
focuses on the regulation of known and
unknown cellular signal transduction
proteins by cocaine.

ments in YNHH’s financial position and
in upgrading the hospital’s credit rating.

Dr. Morris A. Wessel, '43, and Uni¬
versity Secretary Sheila A. Wellington,
M.P.H.’ , were honored for their
commitment to people with disabilities
by Marrakech Inc., at its annual
founders’ dinner in May.

Joseph A. Zaccagnino

Joseph Zaccagnino
Named President, CEO
Of Yale-New Haven
In a joint session on Sept. 16, the boards
of trustees of Yale- New Haven Hospital
and its parent corporation, Yale-New
Haven Health Services, Inc. appointed
Joseph A. Zaccagnino, M.P.H. '70, as
president and chief executive officer of
both of YNHH and its parent
corporation.
Mr. Zaccagnino, who has served as
the hospital's executive vice president
and chief operating officer since 1978,
assumed the position of president and
CEO on Oct. 1, succeeding C. Thomas
Smith, who left to become president of
Voluntary Hospitals of America in
Irving, Texas.
As executive vice president, Mr.
Zaccagnino has been involved in the
recruitment and development of the
senior management team and chiefs of
clinical services. He has guided the hos¬
pital's strategic and business planning
and has been involved in restructuring
many hospital services.
Under his direction, effective man¬
agement systems and financial controls
have resulted in significant improve¬

Dr. Charles A. Hall, ’44, was
honored with a symposium by the
Department of Veterans Affairs and
Albany Medical College for his signifi¬
cant contributions to medical education,
writing chapters for books and mono¬
graphs and as a review editor for many
scientific journals.
Dr. Richard C. Thompson, ’44 HS,
inventor of the Thompson Retractor in
1960, has retired for anesthesiology and
resides in San Mateo, Calif.
Dr. Martin E. Gordon, ’46, clinical
professor of medicine and consulting
gastroenterologist at Yale-New Haven
Hospital and the Hospital of St.
Raphael, was awarded the 1991 Ameri¬
can College of Physicians’ Laureate
Award. This award honors senior physi¬
cians who are masters or fellows of the
college who have demonstrated a com¬
mitment to excellence in medical care.
Dr. Francis R. Coughlin, ’52,
received a J.D. degree in 1988 and seeks
to change a federally mandated, state
implemented, administrative law system
for medical malpractice.
Dr. William O. Minturn, ’52, retired
after 30 years of general thoracic and
vascular surgery in Sun City, Ariz. He
was one of the area’s “pioneers,”
opening a medical clinic in 1965. Dr.
Minturn was the area’s first thoracic and
vascular surgeon and the first to perfomi
vascular grafts in heart surgery.
Dr. Robert (J. Petersdorf, ’52, pres¬
ident of the Association of American
Medical Colleges, received an honorary
D.Sc. degree from Georgetown Univer¬
sity School of Medicine in May. A
Yale Medicine
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member of Georgetown University
Medical Center’s clinical faculty, he
participates in more than 40 profes¬
sional organizations and has authored
more than 400 publications.
Dr. Alan H. Covey, ’54, has a
cardiology practice in New York with
his son. Dr. Alexander G. Covey.
Dr. Eiji Yanagisawa, ’56-’59 HS,
clinical professor of otolaryngology, has
been named president-elect of the New
England Otolaryngological Society
and vice president of the American
Broncho-Esophagological Association.
Thomas P. Weil, M.P.H. ’58, Ph.D.,
has been honored by the University of
Missouri-Columbia with the creation of
the Thomas P. Weil Distinguished Pro¬
fessorship in Health Services Manage¬
ment. The professorship will honor Dr.
Weil for his contribution as an educator,
consultant and statesman in the field of
health services organization and
management.
Dr. Thomas Lau, ’60, is a pathology
consultant for seven north central
Florida medical laboratories, teaches at
art and natural history museums and is
president of the Yale Club of
Gainesville.
Dr. Melvin Dollinger, ’60 serves
with Cancer Care Associates in
Torrance, Calif., and as a clinical pro¬
fessor of medicine at the University of
Southern California School of
Medicine.
Dr. John K. Pearce, ’61, directs The
Family Center of Somerville, Mass.,
and co-edited Ethnicity and Family
Therapy and Family Therapy: Combin¬
ing Psychodynamic and Family Systems
Approaches.
Dr. David H. Groth, ’62, ’62-’64
HS, has retired after 24 years from the
U.S. Public Health Service at the
National Institute for Occupational
Safety and Health and has started as
pathology consultant in occupational
and environmental health.
Dr. John T. Harrington, ’62, chief
of medicine at Newton- Wellesley
Hospital and professor of medicine at
Tufts University School of Medicine,
was inducted into the Royal College of
Physicians of Ireland as an honorary
fellow at a Dublin ceremony. He was
cited for his excellence in patient care,
medical education, clinical research in
nephrology, basic research in acid-base
physiology and medical editing.
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Alumni
News
Dr. Glenn L. Kelly, ’ 62, associate
clinical professor of surgery at the
University of Colorado School of
Medicine, has a private vascular surgery
practice in Englewood, Colo. He also
invented the Kelly-Wick graft tunneling
device and is president of the Rocky
Mountain Vascular Surgery Society.

Dr. Lionel M. Nelson, ’69, was
elected to the board of trustees of Health
Dimensions, Inc. and continues to prac¬
tice otolaryngology in San Jose, teach at
Stanford University and serve as an
Army reservist, leading medical teams
into the Pacific and Asia.
Dr. Anthony V. Proto, ’71, became
chairman of the department of radiology
at the Medical College of Virginia,
Virginia Commonwealth University in
November 1990.
Dr. Paul A. Vignola, ’71, ’71-’74
HS, directs the cardiac catheterization
laboratory at Mount Sinai Medical
Center in Miami, Fla.

Dr. Gary L. Tischler, ’62-’65 HS,
has been appointed profes.sor and execu¬
tive chairman of the department of
psychiatry and biobehavioral sciences
and director of the Neuropsychiatric
Institute at the University of California,
Los Angeles School of Medicine.

Dr. Jesse B. Jupiter, ’73, was
appointed associate professor of ortho¬
paedic surgery at Harvard Medical
School and remains an associate ortho¬
paedic surgeon at Massachusetts
General Hospital.

Rosemary A. Stevens, ’63 M.P.H.,
Ph.D., was appointed dean and Thomas
S. Gates Professor at the University of
Pennsylvania School of Arts and
Sciences in September.

Dr. Donald L. Kent, ’72, ’73-’76
HS, has been elected vice president of
the Long Island Society of Otolaryngol¬
ogy - Head and Neck Surgery for 19911992.

Dr. David S. Fedson, ’65, professor
of medicine at the University of Virginia
Medical Center Primary Care Center, is
a member of the National Vaccine Advi¬
sory Committee, created by the U.S.
Public Health Service to coordinate gov¬
ernment and non- government activity in
vaccine research, production and use.

Arthur L. Lanckton, ’74 M.P.H., of
Sarasota, Fla., has served dual careers
over the past 50 years as an inter¬
national business executive and as a
professor, administrator and board
member in higher education at four col¬
leges and universities.

Dr. Meivyn S. Korobkin, ’67, from
Ann Arbor, Mich., was named a fellow
of the American College of Radiology
at its annual meeting in September.
Dr. Marc E. Lippman, ’68, profes¬
sor of medicine and pharmacology at
Georgetown University School of Medi¬
cine in Washington, D.C., and director
of Georgetown’s Vincent T. Lombardi
Cancer Center, has been selected by the
Endocrine Society as its 1991 Edwin B.
Astwood lecturer for his outstanding
basic and clinical contributions to the
understanding and treatment of breast
cancer. His lecture was entitled “Growth
Factor Control of Normal and Malig¬
nant Mammary Cell Growth.”
Kenneth W. Price, M.P.H. ’68, has
been named director of radiation safety
at the University of Connecticut Health
Center. Since 1974, he has served as
deputy director of radiation safety at
Yale and since 1975, as a lecturer in
radiological health. He will remain a
lecturer in environmental health at the
School of Medicine.

Dr. Mary Lake Polan, ’75, co-chaired the 10-member NIH Task Force for
Research on Women’s Health at a public
hearing in June. Testimony focused on
the leading causes of death among
women, including heart disease, breast
cancer and AIDS, and on conditions that
disproportionately affect women, such
as osteoporosis, autoimmune disea.ses,
urologic disorders and sexually trans¬
mitted diseases.
Lawrence M. Wexler, ’76 M.P.H.,
has been promoted to director of
research for the department of ortho¬
paedic surgery, and associate professor
of community and preventive medicine
at New York Medical College in
Valhalla, N.Y.
Dr. Harvey J. Berger, ’77, president
of Centocor, a biotechnology company,
spoke at a workshop in Palo Alto, Calif.,
sponsored by the National Institutes of
Health to obtain a consensus on policies
to guide the exchange of research data
among scholars.
Robert W. Buckingham, ’78
Dr.P.H., has been named dean of the
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College of Health and Human Perform¬
ance at Mankato State University,
Minnesota State University System. In
his new position, he will be responsible
for academic departments, as well as
athletics for men and women.
Dr. Michael K. Lindsay, '79,
assistant professor in the department of
obstetrics and gynecology and a mem¬
ber of the division of maternal-fetal
medicine at Emory University Medical
School of Atlanta, received an M.P.H.
degree from Emory University School
of Public Health this year.
Dr. Susan C. Schachner, '81, is an
associate attending physician in the
department of medicine at the Long
Island Jewish Medical Center Affili¬
ation at Queens Hospital Center.
Dr. Robert W. Plant, ’82-’86 HS,
serves as director for the Anxiety and
Depression Program and the Psychiatric
Partial Hospital Program at Sterling
Institute for Neuropsychiatry and
Behavioral Medicine in Stamford.
Conn. In April, Dr. Plant spoke at the
conference on Hospice Care and the
Chemically Dependent AIDS Patient
and Eamily in Norwalk, Conn.

New Books

John K. Pearce, ’61, and Leonard J.
Friedman. W.W. Norton & Co., Inc.
(New York) 1991.
Integrating Pharmacotherapy and
Psychotherapy, edited by Dr. Bernard

Coping with Grief, by Robert W.

D. Beitman, '68, and Dr. Gerald L.

Buckingham, '78 Dr. Ph.H., and Sandra
K. Huggard. Rosen Publishing (New

Klerman. American Psychiatric Press,
Inc. (Wa.shington, D.C.) 1991.

York)1991.
Everyone’s Guide to Cancer Therapy,

The Profit Motive and Patient Care: The
Changing Accountability of Doctors

by Dr. Malin Dollinger, ’60. Andrews &

and Hospitals, by Bradford H. Gray, ’73

McMeel (Kansas City, Mo.) 1991.

Ph.D. Harvard University Press
(Cambridge, Mass.) 1991.

Exiles Erom Eden: Psychotherapy Erom
an Evolutionary Perspective, by
Kalman Glantz, Ph.D., and edited by Dr.
John K. Pearce, ’61. W.W. Norton &
Co., Inc. (New York) 1989.

Treating Personality Disorders, New
Directions in Mental Health Series No.
47. by Dr. David A. Adler, ’73. JosseyBass (San Francisco, Calif.) 1990.

Eamily Therapy: Combining

What’s New in Medicine, Dr. Ludmil A.

Psychodynamic and Eamily Systems

Chotknowski, ’42. FACP Health Press

Approaches (Japanese edition), by Dr.

(Santa Fe.N.M.) 1990

Dr. .lefTrey Satinover, '82-’86 HS, is
as co-founder and executive director of
Sterling Institute, medical director of
the Temenos Institute in Westport,
Conn., and president of the C.G. Jung
Foundation of New York. He was a key¬
note speaker at the conference on Hos¬
pice Care and the Chemically
Dependent AIDS Patient and Family.
Dr. Robert A. Aronowitz, ’85, has
been named a recipient of the Charles E.
Culpepper Foundation Scholarships in
Medical Humanities for 1991. This
$.7(),()()() award will fund his research at
the University of Medicine and
Dentistry of New Jersey/Robert Wood
Johnson Medical School, where he is
assistant professor of medicine.
Michael S. Huncharek, '86 M.P.H.,
a radiation oncologist from Boston,
wrote a chapter entitled “Asbestos in
Buildings and Cancer Risks: Public
Health and Public Policy Considera¬
tions," which appeared in Sourcebook
on Public Health Diseases.
Linda V. Bergonzi, ’90 M.P.H.,
teaches health communications courses
at the department of epidemiology and
public health at Yale and works on
health documentaries with lecturer
Alberta Jacoby. She also has her own
video company, "Bella Productions.”

.78

At the annual Wilber Downs Eellowship poster presentations held in late October,
second-year student Christopher Gilligan talks with first-year students Dan Stolar
and Marjorie Rosenthal about his research into Chagas disease in Zimbabwe. Nine¬
teen Downs fellows presented posters about their overseas e.xperiences.

Student
News
Kaveh Khoshnood, a graduate student
in the department of epidemiology and
public health, is a member of AIDSBusters, a program in which volunteers

distribute bleach packets, condoms and
infonnation pamphlets about AIDS test¬
ing and drug treatment in parts of New
Haven with high concentrations of intra¬
venous drug users.
Carolyn G. Shapiro, a Ph.D.
candidate in the history of medicine, has
been awarded one of nine 1991 Albert J.
Beveridge grants for research in the his¬
tory of the western hemisphere.
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ALUMNI REPORT
Plans for the 1992 annual spring reunion
on June 5 and 6 are almost complete.
All alumni are invited to attend,
especially the quinquinnial (fifth-year)
reunion classes, those ending with num¬
bers two or seven. This year the Class of
1942 will be honored at the Friends of
the 50th festivities. We look forward to
a record attendance.
We encourage each reunion class to
consider a presentation, featuring class
members who offer short papers about
their specialities, research or about
professional issues. Connie Tolliver,
assistant to the director, is available to
advise reunion classes about these
programs. Connie and our
administrative assistant, Patty DiNatale,
also will help the local class chair to
make reunion arrangements — lodging,
class dinner and activities, meeting
facilities and so forth. Please do not hes¬
itate to contact us. (Our telephone
number and new address are listed at the
end of this article.)
Congratulations to our alumni for
exceeding the conditions of the Kresge
Challenge. Contributions by 56 percent
of alumni to the fund exceeded last
year’s rate of 43 percent. This 13
percent increase allowed us to exceed
the 55 percent alumni participation
required by the challenge.
Helping greatly in meeting the
challenge were the efforts of Leonard
Kemler, M.D., outgoing chairman of the
alumni fund. Also contributing
significantly to our success were Dean
Leon E. Rosenberg, alumni and students
who joined a series of phonathons. Your
alumni affairs director and John Foster,
M.D., the new fund chairman,
encourage you all to maintain this
record of generous giving. It represents
a vote of confidence in and expression
of loyalty to the school and all it
represents.
If you have not received your
questionnaire from the Harris
Publishing Company for the medical
school alumni directory, please contact
the alumni affairs office immediately so
that we can have one mailed to you. It is
imperative that you complete and return
the form as soon as possible. An
accurate directory depends on the
promptness of your response.
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The form has been simplified so that
only corrections of information need to
be recorded. If your biography is
unchanged, you need only return the
form. Note again that Harris Publishing
guarantees the confidentially of the data
base and takes steps to safeguard against
inappropriate use of it or the directory.
We are eagerly waiting for the
completed directory which is scheduled
for release in the spring of 1992.
This call for cooperation emphasizes
the fact that the office of alumni affairs
functions effectively only when alumni
are actively involved with their alma
mater and alumni association. Such
involvement allows us to thank our
school for what it has given us in
training and education.
Opportunities to serve include the
various boards and committees that are
open to our alumni. For example, John
Foster is actively seeking volunteers to
serve on the alumni fund board. The
executive committee of the Association
of Yale Alumni in Medicine too seeks a
working, representative board. In
addition, class agents and secretaries
play a crucial role in maintaining class
identity and in helping to organize
reunions.
Nicholas Spinelli, M.D., helps medi¬
cal students establish a class identity by
encouraging them to form into effective
class groups that will continue to
function after graduation. This process
is aided by alumni attendance at student
affairs, both academic and social, which
is welcomed by the students. We
enhance the sense of family within the
association by paying early attention to
students and continuing our interest
after their graduation. The alumni office
can provide you with the dates of
student events that alumni can attend
and benefit from. Call us for details.
Turning to news about our school.
Dr. Rosenberg has resigned after a
distinguished and outstanding tenure as
professor and dean to become president
of research at Bristol-Myers Squibb. He
leaves an improved physical plant with
many new buildings, a distinguished,
caring faculty and an institutional
concern for societal needs and the
humane practice of medicine. His
legacy will be the foundation for an ever

stronger and more influential institution.
Dr. Robert Donaldson has been
named acting dean. He has been
intimately involved in planning the
medical school’s growth and
development, and is superbly prepared
to lead YSM as a search committee
headed by Yale President Benno C.
Schmidt Jr. looks for a new dean. Dr.
Lawrence S. Cohen, the Ebenezer K.
Hunt Professor of Medicine, has been
appointed acting deputy dean.
Finally, the alumni office has
relocated to new quarters at 100 Church
St. South, the former Lee High School.
Except that we are now further removed
from the rotunda, we are pleased with
our ample, newly renovated space and
its modem decor.
Our new mailing address is
Yale University School of Medicine
Office of Alumni Affairs
P.O. Box 7613
New Haven, CT 06519-7613
This is also the mailing address for
the Association of Yale Alumni in
Medicine. Our telephone number
remains (203) 785-4674.
Arthur Crovatto, M.D. '54
Director of alumni affair
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Memorials
Deceased medical alumni and
friends may be memorialized by a
gift at any time to the Medical
School Alumni Fund endowment in
the name and class of the person so
honored. The next-of-kin of a de¬
ceased medical alumnus/a is advised
about this In Memoriam Program by
a mailing from New Haven some
weeks after the School of Medicine
receives notification of the death.
The letter of information includes a
copy of the Testament of Remem¬
brance in which the names of all per¬
sons so memorialized are listed in
the medical section by class, thus
establishing a lasting memorial. Do¬
nors receive a personally penned
note of appreciation from the In
Memoriam program director. Your
inquiries and interest are welcome.
Deceased alumni and friends so
honored in 1990-1991 were:

George Frederick Converse 1887
Jacques D. Soifer ’24
Paul H. Lavietes '30
Raymond Miller ’33
Walter E. Barney ’35
W. Howard Homer ’35
Nathan Kenigsberg ’39
Arthur Tucker ’39
Knute Berger ’41
David G. Decker ’42
Wilson E. Hughes ’42
Joseph P. Kriss ’43
Erederick Waldron ’43
Charles S. Judd, Jr. ’46
Lawrence P. Shea ’47
Haavik Arne ’56
John B. Pine ’56
John Gallagher ’58
Leland S. Berger ’64
Morris Shultz (friend)

Richard G.Jordan
Dircctiir Emeritus
In Memoriam Program
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Lester W. Burket
Lester W. Burket, M.D., former dean of
the University of Pennsylvania School
of Dental Medicine, died June 29. He
was 84.
A Bozeman, Mont., native. Dr.
Burket earned his A.B. and dental
degrees from the University of Pennsyl¬
vania and in 1932 became a Rockefeller
fellow at Yale School of Medicine,
where he received his M.D. degree in
1936.
He was an instructor in dental pathol¬
ogy at Yale for one year and later taught
at the University of Pennsylvania
School of Dental Medicine from 1937
through 1977. He served as dean of the
school from 1951 through 1972.
Dr. Burket was named a Sterling
fellow in pathology at Yale University
and in 1950 received an honorary
degree from the University of Antioquia
in Medelin, Colombia. He also was
named an honorary professor at the
National University in Bogota.
In 1948, he was decorated by Queen
Wilhemena of the Netherlands for his
assistance to Dutch dentists after World
War 11. He was a consultant to the
Army, Navy, Veterans Administration
and the U.S. Public Health Service. He
also represented the United States in
dentistry at the World Health
Organization.
Dr. Burket served as president of the
American Association of Dental
Schools and chairman of the Council on
Dental Education and authored the text¬
book Oral Medicine. He was a recipient
of the Pons Medal from the Connecticut
State Dental Society and the Pauchard
Award from the Pauchard Academy.
He is survived by his wife, Grace.

Willard A. Krehl
Willard A. Krehl, M.D., died May 11 at
his home in Sun City West, Ariz. He
was 77.
Dr. Krehl received an A.B. degree
from Cornell College in Iowa, M.S. and
Ph.D. degrees in biochemistry from the
University of Wisconsin, Madison, and
a M.D. degree from Yale School of
Medicine in 1957.
A native of Illinois, Dr. Krehl was a
fellow in biochemistry at the University
of Wisconsin and a fellow in nutrition

at Yale.
Throughout his academic career, he
served as associate professor of
nutrition and biochemistry at Yale;
director of clinical laboratories at
Milwaukee County General Hospital;
professor of internal medicine and
director of the clinical research center at
the University of Iowa College of Medi¬
cine, University Hospitals; and profes¬
sor in and chairman of the department
of community health and preventive
medicine at Jefferson Medical School in
Philadelphia.
Dr. Krehl also held positions as vice
president of development at Lenz Indus¬
trial Testing Laboratory in Kentucky
and as medical director for the Pederal
Reserve Bank in Philadelphia.
He was a member of the American
Medical Association and of the
Philadelphia College of Physicians.
Contributions may be made to the
College of Physicians Library of
Philadelphia, 19 S. 22nd St.,
Philadelphia, PA 19103.

Obituaries
Neville Kirsch
Neville Kirsch, M.D., died July 18 at
Yale-New Haven Hospital. He was 79.
Dr. Kirsch graduated from Ohio State
University and Long Island College of
Medicine. He served his internship at
Grace New Haven Hospital from 1940
through 1942.
Dr. Kirsch retired from his private
dermatology practice in West Hartford
in 1984 after 37 years. He also was a
clinical professor of dermatology at
Yale and a consultant for the Commu¬
nity Health Care Plan in New Haven.
He was a past president of the New
England Demiatology Society and the
dermatology section of the Connecticut
State Medical Society.
Contributions may be made to Yale
University School of Medicine, Depart¬
ment of Demiatology, PO. Box 3333,
New Haven, CT 06510.
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Harvey L. Young
Harvey L. Young, M.D., died May
25 at age 66.
A Washington native. Dr. Young
served with the Navy during World War
II and graduated from Washington State
University in 1948 and from Yale
School of Medicine in 1952. He in¬
terned at Deaconess Hospital and had a
private practice as a family physician in
Spokane Valley from 1953 through
1969.
Dr. Young was a founding member
and first chief of staff of the Valley Hos¬
pital and Medical Center. He also was
president of the Deaconess staff and a
clinical instructor at the University of
Washington’s Spokane Family Practice
Unit. In 1977, he was appointed medical
director of the Medical Service Corp. of
Eastern Washington and served as vice
president of the Washington State Medi-

Obituaries
Harrison F. Wood
Harrison F. Wood, M.D., died July 26 at
the Hebrew Home and Hospital in West
Hartford, Conn. He was 73.
A native of Chicago, Dr. Wood
served seven years during the 1950s as
an associate at the Rockefeller Institute
for Medical Research in New York
where he studied strep infections.
Concurrently, he was medical director
of Irvington House, a research and treat¬
ment center in New York for children
with rheumatic diseases. There he
participated in a study that found that
continuous doses of antibiotics could
ward off strep infections and thus
prevent rheumatic fever.
Dr. Wood joined the Yale faculty in
the 1970s. He taught immunology for
eight years and served on the staff of the
Veterans Administration Hospital in
West Haven.
Dr. Wood received undergraduate
and medical degrees from New York
University and served an internship at
Bellevue Hospital.
He leaves his wife, Nina, and two
sons, Stephen and Matthew.
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cal Association and as a member of the
Spokane County Medical Society’s
executive committee and board of
trustees. In 1978, he was named DoctorCitizen of the Year by the Spokane
County Medical Society.
Dr. Young was named to the
Washington State Nursing Home
Administrators Board and the State
Nursing Home Advisory Council as
the State Medical Association’s repre¬
sentative. He was director of medical
services and vice president of the Madi¬
son Convalescent Centers Inc. and
director of Spokane Visiting Nurses.
He leaves his wife, Hilda; a daughter,
Robin; two sons, Stephen and Roger;
and two grandchildren.
Memorials may be sent to Yale Uni¬
versity School of Medicine, c/o Alumni
Fund, P.O. Box 1890, New Haven, CT
06508.

In Memoriam
Israel E. Blodinger
January 24, 1991

’22, ’25 M.D.

Leonard Greenburg ’23 Ph.D., ’23
March 13, 1991
PHSP, ’30 M.D.
Davis H. Pardoll
April 8, 1991

’25 MED

Dominic J. DeU’aguilla
March 1989
Leonard F. Ciner
February 23, 1991
Edgar W. Warren

’31 HS
’32 M.D.

’32, ’36 M.D.

July 21, 1991
’34 HS

John H. Lawrence
July 7, 1991
H. Stuart Irons
February 3, 1991

’36, ’40 M.D.

Ewilym A. Edwards
January 15,1989

’39 HS

Charles L. Wood

Jarrett H. Folley
August 11, 1991

’41 HS

Charles L. Wood, M.D., pediatrician
and educator, died July 20 in Delray
Beach, Fla.
A native of New York City, Dr.
Wood graduated from New York
University and in 1930 from Yale
School of Medicine. After serving an
internship and as an instructor in
pediatrics at New Haven Hospital, and
as a resident at Babies Hospital,
Columbia Presbyterian Medical Center
in New York, Dr. Wood opened a
private practice in Manhattan.
In 1962, Dr. Wood joined the staff of
the University of Pittsburgh and served
as chairman of the department of pediat¬
rics at the Children’s Hospital where he
was recognized with several teaching
awards. He served as an associate
clinical professor of pediatrics and an
attending physician at Babies Hospital
for more than 25 years. In 1989 he was
the first recipient of the Babies Hospital
Distinguished Alumni Service Award.
Dr. Wood was a lieutenant colonel in
the Air Force During World War II.
Dr. Wood is survived his wife, Doris;
a son, Charles Jr.; and four grand¬
children. Contributions may be sent to
the Charles L. Wood J.D. Pediatric
Scholarship Fund, School of Medicine,
University of Pittsburgh, Pittsburgh, PA
15261.

Phillip H. Gates
May 31, 1991

’41 HS

Sydney E. Sinclair
May 17, 1991

’41 HS

Robert J. Schaffer
February 24, 1991

’43 HS

Hoyt C. Taylor
January 4, 1991

’43 HS

Charles A. Hall
July 27, 1991

’44 M.D.

Henry G. Brickman
June 5,1991
George A. Cohn
June 11,1991
Orman H. Glazier
April 7, 1991
Harvey L. Young
June, 1991
Harold R. Bemshock
Aprils, 1991

’50 M.P.H.
’51 HS
’51 M.P.H.
’52 M.D.
’53 M.P.H.

Daniel R. Rectanus
September 21, 1989

’55 HS

F. Brantley Scott, Jr.
July 27, 1991

’55 M.D.

Richard D. Gerlack
June 27, 1991

’58 HS

Embree H. Blackard, Jr.
January 3, 1991

’59 HS

Carmine W. Terraciano
January 18,1991

’59 HS

Norman J. Lewiston
August 6, 1991

’59 HS

Brigitte Prusoff
April 4, 1991
Jeffrey M. Nakamura
January 3, 1991

’67 M.P.H.,
’78 Ph.D.
’76 HS
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DEVELOPMENT REPORT
Alumni Fund Success
Meets Kresge Challenge
On June 7, University President
Benno C. Schmidt Jr. named the Center
tor Molecular Medicine for Dr. and Mrs.
Herbert Boyer in recognition of their
$10 million gift in support of the
facility's construction. He also
expressed his great appreciation for Dr.
and Mrs. Boyer's role in satisfying the
first term of The Kresge Foundation
Challenge — to raise the remaining $5
million needed to complete the
building's construction.
With the challenge's first term
satisfied, success then depended on
alumni support to satisfy the two
remaining terms:
R. Leonard Kemler, M.D.'43, (center) is honored for his five years of outstanding ser¬
vice as chairman of the School of Medicine Alumni Fund. Presenting his award is
Acting Dean Robert M. Donaldson Jr.. M.D., (left) and the new YSM alumni fund
chairman. John W. Foster Jr.. M.D.'Vl.

• to raise $450,000 in alumni fund
support for current operations
• to reach 55 percent in alumni fund
participation.
Under the direction of The Kresge
Foundation Challenge Chairman John
B. Ogilvie, '3 IS, '34 Med., and alumni
fund Chairman Leonard Kemler '39S.
'43 Med., School of Medicine
volunteers put in motion an
unprecedented alumni fund effort to
secure the Kresge Foundation's $1
million challenge grant. The alumni
fund board, class agents, and alumni and
student phonathon volunteers provided
additional leadership.

By June 30, the close of the alumni
fund year, alumni had soared past both
of the challenge's remaining terms.
Alumni fund giving for current
operations totalled $541,427 — a 28
percent increase over the 1989-1990
total. Alumni also exceeded the most
formidable term of the challenge, to
reach 55 percent participation in the
1990-1991 alumni fund. A total of 2,041

1989-1991 Alumni Fund Final Figures
(living for Current Use
1989-1990

The Kresge Foundation
Challenge Goal

1990-1991

$450,000

$541,427

1989-1990

The Kresge Foundation
Challenge Goal

1990-1991

45 percent

55 percent

56 percent

$421,822
Participation
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alumni, or 56 percent, did support the
fund, and in so doing secured the $1
million challenge grant.
Highlights of the alumni effort to
meet the challenge include the
generosity of Sanfurd Bluestein, '46,
who in honor of his 45th reunion offered
to match all increa.sed and new gifts up
to a maximum of $45,000. Class agent
letters and a four-night spring
phonathon helped earn all of Dr.
Bluestein's matching gift well before
the fiscal year's end on June 30. During
the phonathon, 30 callers spoke with
more than 1,000 alumni; 323 alumni
pledged nearly $33,000.
In recognition of Chairman John B.
Ogilvie's gift in support of the Boyer
Center's construction, and of his leader¬
ship throughout The Kresge Foundation
Challenge, a dining room was named
for him at the center. Finally, as the
class which achieved the highest
percentage of participation among the
10 youngest graduating classes, the
Class of 1982 won the Kresge Cup, with
38 percent participation.
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Aniyans Donate Estate
To School of Medicine
Announcing the largest gift in the
history of the School of Medicine,
University President Benno C. Schmidt
Jr. said that John Anlyan, M.D.’45, a
prominent California surgeon, and his
wife Betty Jane will donate their entire
estate to Yale — a gift valued at $25
million. Dr. Anlyan, also a member of
the Yale College Class of 1942, and
Mrs. Anlyan have named the University
as sole beneficiary of their joint estate.
Most of the funds will be applied to
the School of Medicine — the exact
designations of the gift to be determined
by the president. School of Medicine
dean, and members of the Yale Corpora¬
tion at the time the funds are received.
Some $2 million will endow a profes¬
sorship in the humanities, which is Mrs.
Anlyan’s area of academic interest.
Mr. Schmidt announced the gift at an
October 3 dinner in New Haven given
by the Yale School of Medicine Dean’s
Council in Dr. and Mrs. Anlyan’s honor.
As Mr. Schmidt awarded Dr. Anlyan
a special Yale presidential medal, he
said: “Dr. and Mrs. Anlyan’s gift is an
act of splendid generosity and vision.
By providing unrestricted general
support for the medical school, this gift
will greatly benefit future generations.

The humanities endowment symbolizes
and strengthens the close ties between
the University and the medical school
generally. Everyone at Yale owes Dr.
and Mrs. Anlyan a great debt of
gratitude.”
Said Dr. Anlyan: “This is a thankyou gesture for making my life possible.
My wife and I feel that Yale has done
very well for us. I came here on a wing
and a prayer on August 29,1939, just
days before Hitler marched into Poland,
and I could not have made it without
Yale’s help.
“We feel that all alumni should
voluntarily give as much as they can to
Yale,” continued Dr. Anlyan. “The best
thing we can do for the youth of the next
generation is to educate them.”
Dr. Anlyan was bom and raised in
Alexandria, Egypt, where he attended
Victoria College (an elementarythrough-high school level institution),
and was admitted to Yale College in
1939. He completed his undergraduate
work in three years to begin his pursuit
of a medical degree. He finished both
courses of study in just six years.
Reflecting on his medical school
education. Dr. Anlyan commended the
Yale System: “Medical school was a
pleasant surprise because of the opening
remarks of Dean Milton Wintemitz to
our class of fewer than 60 students. He
said that we were old enough to monitor
ourselves. We were not required to

attend classes and we would be treated
as adults who wanted to learn.”
After a surgical residency at the Uni¬
versity of Chicago and at Ohio State —
his wife’s alma mater and where he
received his master’s degree in surgery
— Dr. Anlyan returned to Yale, serving
as instructor in surgery from 1949 to
1951. He then spent three years as a
Damon Runyon Fellow at MemorialSloan Kettering Institute in New York
City, after which he moved to San Fran¬
cisco and established a practice in can¬
cer surgery. Dr. Anlyan’s two brothers,
William G. Anlyan, M.D. ’49, and Fred¬
erick, both attended Yale as well.
The Aniyans have consistently
supported the School of Medicine and
the Yale Alumni Fund over the years,
and have contributed generously to the
Campaign for Yale and Berkeley
College. In 1986, the Aniyans donated
$1 million to the School of Medicine for
renovation of laboratories in molecular
neurobiology. That contribution has
helped further Yale scientists’ research
on the structure and function of the
brain at the molecular level.
In expressing his appreciation to the
Aniyans, Acting Dean Robert M.
Donaldson said: “We are immensely
proud that the largest gift to Yale
University since 1967 has been made by
a Yale School of Medicine alumnus and
his wife.”

D'- J,'hn A. Anlyan (left) and his wife, Betty Jane, with Benno C. Schmidt Jr.
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REUNION REPORTS
Photographs by Harry Bishttp

1926
65th-year reunion
h\ Dr. Ma.xw ell Bogin
And now the 65th reunion is history.
Attendance was double that of the 60th
reunion. Present were Dr. Elizabeth R.
Harrison and myself, the class agent.
Dean Rosenberg’s address was very
infonnative and inspiring. He touched
on many subjects, including the new
construction of the past few years.
My personal observations, while
traversing areas that I had trodden
before, gave the illusion that the same
steps were a bit steeper and the same
distances a bit longer. But there are
always the memories.

1931
60th-year reunion
hy Dr. A.J. Schechter
.Abraham J. Schechter and James A.
Springham attended their 60th reunion,
a grand event for both.
Abe has been retired since 1979
when he left New York with his wife,
Vivian, for the more equitable climate
of Los Angeles. Their son, Robert, and
his wife, Amy, Yale School of Medicine
graduates of 1974, are responsible for
three grandchildren, while daughter
Minda (Stanford Law 1975)
contributed a pair of twins. All are in
Los Angeles, which makes this a happy
retirement for Abe and Vivian.
Jim is active in the practice of
psychiatry in Evanston, 111. He has spent
many years in India and China, combin¬
ing medical and surgical care with
Christian missionary work, aided by his
now deceased wife, a graduate of Yale
School of Nursing. Jim has seven
children who live in various parts of the
United States. He has his usual vigor,
enthusiasm and good health.

1936
55th-year reunion
hy Dr. Nicholas D' Esopo
The 55th-year reunion of the Class of
1936 w as attended by Dr. Nicholas
44

Nicholas D'Esopo, M.D.’21. and Yolande Lyon, M.P.H.’52

D’Esopo and his wife. Rose, and by Dr.
Stephen Nagyfy and his wife, Ava. Dr.
D’Esopo received communications with
three other classmates who were unable
to attend.
The two classmates and their wives
enjoyed the reunion weekend
immensely. Especially outstanding was
the molecular medicine symposium
moderated by Dr. Vincent Marchesi.
The review of Lyme disease was also
exciting, and the Eriends of the 5()th
dinner on Saturday night was also much
enjoyed. Noteworthy was the large
number of returnees for their 5()th-year
reunion, among them a remarkable
number of pediatricians. The occasion
has motivated us to attend our 6()th-year
reunion in 1996!

1941
50th-year reunion
hy Dr. Rohert W. Ollayos
One word describes the 5()th reunion
activities of 1941 YSM: great.
Seventeen members, 13 accompanied
by spouses, attended; Areson, Bell,
Carey, Diefendorf, Duncan, Fenton,
(jrilbert, (ilike, Lasell, Lih, Monroe,
Neighbor, O'Connell, Parrella,
Pecora and Walton. To attest that the
names of romance still burn brightly,
Willys Monroe provided a special extra

with the introduction of his recent bride,
the former Dr. Louise Robertson.
The consensus was that the group
overall looked fit. Evidence of the
encroachments of increasing age was
small; a few showed of what is usually
described as a “more mature figure.”
Eortunately, all seemed nimble of wit,
most have traded stethoscope for
rocking chair. Exceptions included Pete
Duncan, Sid Lasell, Ed O’Connell and
Ed Rogers, who still maintain at least
part-time medical functions.
Those attending the dedication of the
Boyer Center for Molecular Medicine
on Thursday were impressed by the
magnificence of the facilities, and
enjoyed the sociability of the hospitality
hour which followed. On Friday, at the
class reunion seminar, Willys Monroe
presented his paper, “The U.S. Public
Health Service: A Virginia Tradition.”
He represented our class very well, and
his paper received much commendation.
For Friday evening Charlie Cheney
arranged a special class dinner at The
Graduate Club. Unfortunately, because
of illness, Charlie was unable to attend
this and other events of the reunion.
Jack Parrella served ably as master of
ceremonies. Following dinner, all class
members took turns offering a variety of
personal reminiscences and
commentaries. These provided a lot of
fun and climaxed a happy day. Jack ParYale Medicine
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Mis. Esther Diefendoif and Herbert W. Diefendorf, M.D.’41
rella had prepared a brochure containing
a series of observations, reflections and
reminiscences of the past 50 years. For
those unable to attend, a copy will be
provided through the office of alumni
affairs.
The celebration ended with the
“Friends of the 50th” dinner, at which
’41M was honored. Attendance was so
large that the event had to be held at the
Colony Inn. This great dinner concluded
with appropriate and interesting
comments from representatives of YSM
and the office of alumni affairs.
My special thanks to Charles
Cheney, Willys Monroe and Jack
Parrella for their help in facilitating our
class reunion activities, and for
providing me a news-line, and to those
classmates unable to attend who
provided letters of information in
response to my inquiries. These letters
will form the basis of a more detailed
newsletter which hopefully will reach
every member of the class.

1946
46th-year reunion
by Dr. Martin E. Gordon
An enthusiastic Class of ’46 returned to
New Haven in large numbers, and the
many activities of their 45th-year
reunion earned their meritorious
support. After the dedication of the new
Boyer Center for Molecular Medicine,
an impressive scientific program
followed, replete with Nobel laureates.
The class met on the steps of 333 Cedar
St. for still another classic Hall of Fame
photomural, oblivious to the passage of
time and the sepia tone. They were then
Yale Medicine
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led to the historical library for a
nostalgic reexamination of the plates of
Vesalius and other awesome treasures of
their Yale experience, including Harvey
Cushing’s memorabilia, rekindling
images of student days.
The class then presented a seminar,
“From Then to Now — Panoramic
Views of Medicine: Personal
Observations,” that proved to be a
remarkable survey of the progress in
medicine, influencing the career
developments of 10 class
representatives of various specialties.
These included Margaret J. Albrink’s
“Triple Threats of Diet, Diabetes and
Obesity on Coronary Artery Disease”
(lipid research), Franklin C. Behrle’s
“How Small is Too Small” (neonatal
progress), Sanfurd G. Bluestein’s
“Radiology Alters the Scene” (clinical
radiology’s growth), Vincent Congo’s
“By the Way Doc” (sexual dysfunction),
Joe D. Morris’ “Cardiac Restoration: A
Half-century of Miracles” (originating
the initial ICU and extracorporeal pump
units). An additional presentation
included: Julian A. Sachs’ “From Gen¬
eral Practice to Emergency Medicine —
A Specialist in Spite of Myself’ (the
growth of hospital trauma and
emergency rooms), Donald P. Shedd’s
“Restoration of Voices Lost—Tea with
the Duchess” (advances in head and
neck surgery), Robert R. Wagner’s
“Infectious Diseases Then, Molecular
Biology Now” (the growth and research
aspects of virology), William J.
Wedemeyer’s “The Road to
Automation” (technological changes in
pathology and laboratory medicine).
Aaron T. Beck, the “Father of
Cognitive Therapy,” gave insights into

his pioneering work on depression and
suicide.
Vincent Pepe’s assessment of a prac¬
titioner’s role in obstetrics and gynecol¬
ogy and other equally cogent comments
from all attending members of the class
were followed by the summation by
Martin E. Gordon, seminar organizer
and chairman, who had presented “The
Evolution of On-Sight Viewing and
Doing—Trends from the Magenkrazer
to 3-D Imaging” (gastroenterology/
endoscopy and travel medicine).
Class members and companions
were then shuttled for dinner
overlooking Long Island Sound,
followed by a Long Wharf Theatre’s
production of “Picnic.” A specially
arranged backstage tour and
personalized discussions with the cast
completed the memorable evening.
On June 8, the morning scientific
programs and the traditional lavish Yale
luncheon were followed by an afternoon
of warm comraderie, group psychother¬
apeutic discussions and informal
lakeside relaxation at the Gordons’
home. The evening’s traditional dinner
at Mory’s conveyed the most intimate
and hilarious aspects of the class’ versa¬
tility. Letters and comments from
classmates unable to attend were shared.
The impressive accomplishments and
stellar achievements of the children of
the class were further evident when the
biographic summaries were exchanged.
Memories of the deceased class
members were evoked, in reaffirmation
of the close amalgamation of this YSM
Class of 1946. Toasts to the past and
hopes for at least matching attendance at
the 50th brought this reunion to a warm
conclusion.

1951
40th-year reunion
by Dr. John L. Sullivan
What a happy weekend. The weather
was perfect. Our medical school reunion
program concentrating on molecular
medicine was outstanding!
The old medical school atmosphere
was even better. We rubbed shoulders
with the medical students out on the
Harkness dormitory courtyard.
Frank and Dolly Allen, Tom and
Barbara Amatruda, Paul and Polly
Bruch, Sid and Ina Furst, Lowell and
lone Goodman, John and Betty Lou
Haxo, Carrold and Luanna Iverson,
Jocelyn Malkin, Wally and Pat
Morgan, Jim and Jan Riley, Bob and
Claudia Small, John and Mary
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Sullivan, and Andy and Irene Wong
were there. The old boys looked great
and the girls were lovely.
The lighter side of the program
started at Mory's on Friday evening. We
were on the upper floor for cocktails
and dinner. It was the old days all over
again, casual and spontaneous.
Everyone had a chance to take the floor
and reminisce or bring us up to date on
classmates not present. The wine
flowed, the food was great — it got
better and better as the night went on.
Saturday was notable for two events
dear to the heart of Class of ’51. At the
annual business meeting, our own
Lowell Goodman received the AYAM
Distinguished Service Award. Did you
know he was the bantam weight boxing
champion of Yale in his undergraduate
days? 1 didn’t. His acceptance speech
was a highlight of the program.
In the afternoon we went to the dedi¬
cation of the Tom Forbes study in the
historical library. He was a sincere
friend and mentor of the Class of '51.
We expressed our feeling on Dr. Forbes
to Mrs. Forbes. She remembered our
class and sent her love.
Next came the highlight of the week¬
end, cocktails at Sid and Ina Furst’s in
Woodmont. Their beach-front home is
so pleasant it’s better described by the
feeling it gives you. We were out on
their lawn with a spectacular view of
Long Island Sound. We were part of a
beautiful, peaceful scene. Nobody
wanted to leave for Scribner’s
restaurant!
But we were glad we did — one of
Connecticut’s best shore restaurants. We
were in the right place. Goodie, our

music minister, brought his tapes of the
’40s and ’50s. Nostalgia, nostalgia!
Back to Sid and Ina’s for after-dinner
drinks on the lawn. I suggested skinnydipping, but there were no takers. Forty
years will do it to you.
That was it. Let’s all make the 45th.

1956
35tb-year reunion
by Dr. John H. Gardner
The weekend of June 7 and 8, was the
35th-year reunion of the Yale School of
Medicine Class of 1956. Five of us,
mostly with wives, arrived in New
Haven early enough to attend a cocktail
buffet at my mother’s apartment on
Thursday. On Friday, many of us
attended lectures on various subjects
(the Lyme disease discussion was excel¬
lent), including the ubiquitous
discussion of molecular biology.
Friday night was one of the high
points of the reunion and probably the
best attended event. Poor Helen and
Steve Downing appeared to have set a
dangerous precedent by agreeing to
offer Friday night dinners at reunions;
we all assembled at their hospitable
house in Guilford for an appropriately
bibulous evening with catered dinner. It
was a wonderful occasion upon which
to renew acquaintances, and we are very
grateful to our hosts for the thought and
effort that they put into the occasion.
Saturday was more formal, not only
in terms of the medical school presenta¬
tions but our class dinner, which we had
at Amarante’s Restaurant on the

Mr.s. Helen l-orbes and Muriel Wolf, M.D.' 59. converse at the dedication of the
Thomas R. TOrbes Study at the medical historical library.
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“eastern shore” of New Haven harbor.
It was here that the class picture was
taken, unfortunately, without those who
came only for the Friday dinner.
Overall, those depicted do not look too
different from times before. There have
been some changes in hair and some
changes in weight, but overall, we seem
fairly hearty.
Don Nalebuff still looks vertically
somnolent, quite as in the last picture I
took of him. Although many of us form
a hard core of reunion attenders, there
were some exceptions, and it was partic¬
ularly pleasant to see Charlie Zigun
again. I hope that all of us, plus some of
those who do not come so often, can
attend the 40th reunion. This was a
great occasion to get together with very
remarkable people.
Twenty-one of us returned to New
Haven for part or all of the reunion pro¬
gram. This is 30 percent of our class,
which isn’t bad, but we hope for even
more at the next reunion. Those who
attended were the following: Al Apfel,
Leo Boyajian, John Carroll, Joe
Cerny, Jim Collias, Don Dalessio,
Steven Downing, Mitch Edson, John
Gardner, Bob Hill, Bill Hindle, Chuck
Hopper, Marie-Louise Johnson, Pres
Manning, Dwight Miller, Norman
Moon, Don Nalebuff, Fred North, Bill
O’Brien, David Page and Charlie
Zigun. Most of the above came with a
spouse, and so we had a fairly sizable as
well as very enjoyable gathering.

1961
30th-year reunion
by Dr L.T. Chiaramonte
The 30th-year reunion was quieter and
more personal than the 25th. My wife,
Ann, and I enjoyed ourselves by
catching up with what has been going
on with our classmates. Sally and
Vincent Marchesi hosted a cocktail
party Friday evening at their waterfront
home in Guilford. I, for one, was
impressed with the two of their five
children I happened to meet. Vincent,
who is in charge of developing Yale’s
new Boyer Center for Molecular
Medicine, moderated a seminar on
Saturday morning. He also graciously
gave us a private tour.
Saturday evening dinner with John
Fenn and David Brooks at our table
was stimulating. Imagine talking to the
chief of staff at Yale-New Haven Hospi¬
tal and a psychiatrist at the same time.
The quiet recollections of George Lodi,
Continued on page 48
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DISTINGUISHED SERVICE AWARDS

Dr. MaxH’ell Bogin with (from left) daughter Debbie Cohen,
his wife, Edith Bogin, and daughter Abby Kenigsburg.

Maxwell Bogin, M.D.
Class of 1926
On the 65th anniversary of his graduation, teacher of clinical
pediatrics to generations of students, beloved and conscien¬
tious physician to thousands of children, your loyal service to
Yale University School of Medicine as class agent and liaison
has been exemplary. As a faithful alumnus and son of Yale, we
salute you.
Dr. towel L Goodman (left) with Samuel D. Kushlan, M.D. '35.

Lowell I. Goodman, M.D.
Class of 1951

The Kresge Foundation Challenge
Chairman John B. Ogilvie,’34 M.D., was
cited for his leadership in helping to
secure the $1 million grant.
Yale Medicine
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Starting as a farm boy from Indiana, a fifth generation
Hoosier, your destiny took you to Yale College, Yale School of
Medicine, and to a research career in psychiatiy.
Your loyalty and love for our School of Medicine forged a
lasting connection to alumni affairs. You assumed an effective
leadership role in the exceptional Class of 1951.
Since 1975, you served as class agent for your class in its
alumni fund activities. Your efforts were so innovative and
fruitful that within five years you were selected to be the
national chairman of the Yale University School of Medicine
Alumni Fund. You brought the same creativity and energy to
this function, personalizing the relationship of the fund and its
agents with your personality and good humor.
You met the record challenge of your predecessor in this job
by doubling his achievement.
It is not for your material accomplishments, but rather the
love for your school and the service to it that you are honored
today.
As a distinguished physician, father of a physician, husband
of an educator, and loyal alumnus we salute you.
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Continued from page 46
Roy Ronke and Bob Briggs never fail
to impress me as well as their faithful
attendance at every reunion. Roy, in his
understated way. told of being one of
the first combat medical officers in Viet¬
nam. This impressed me, as one who
spent his service time as a weekend
warrior with the National Guard.
As for me, a few pounds heavier and
several hairs grayer, I have made the
mistake of editing a text on food allergy.
1 have my hands full supervising a new
practice dedicated exclusively to people
who perceive they are allergic to foods
and food additives, in addition to my
“normar’ activities. If you missed the
fun in '91, come alive for reunion 35.

1966
25th-year reunion
hy Dr. Arne Yoiingherg
The Class of 1966 25th-year reunion can
be judged a great success. On a
beautiful Friday evening on the shores
of Long Island Sound we had
champagne and a sumptuous spread of
hors d'oeuvres at Clarence and
Carolyn Sasaki’s beautiful home in
Stony Creek. Special surprise guests
were Ed and Joy Crelin. Later on, some
of us en joyed pizza, beer and laughs at
Sally’s in Wooster Square. Saturday
brought more beautiful weather,
meetings, tours of the campus, and then
a class dinner at the New Haven Lawn
Club. The highlight of the evening had
each classmate give a short biography of
his/her years since medical school, and
the response was a mixture of
admiration, pride and plenty of good
laughs. The passing of Bill Yeagley and
Bruce .lackson was sadly noted, and
news of classmates who couldn't attend
was shared by friends. After some talk
about future get togethers, we parted
with some wistful goodbyes.
A list of all those attending the week¬
end festivities includes: John and Lee
Baxter (endocrinology), Robert and
Patricia Bazemore (medicine and
psychiatry), Frank and Kathy Bell
(ophthalmology), Phil and Arlene
Bernstein (orthopedics), F.ugene and
Hollis (/assidy (pathology), Donald
and Phyllis Cohen (psychiatry). Bob
and Betsy Dragon (general surgery),
.\nthony and Olive P'appiano
(pathology), Peter and Christine
(libbons (radiology), Stanley and
Nancy (ireenspan (psychiatry), Mac
and Helle (JrifTiss (infectious disea.se).
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Stuart and Barbara Hauser
(psychiatry), Richard Howard
(surgery), Gordon and Barbara Kelly
(ophthalmology), Stuart and Sheila
Kotler (radiology), Sidney and Lynn
Lipton Levitsky (pediatric
endocrinology), Henry and Nancy
Mann (psychiatry), Caroline McCagg
(rehabilitation medicine). Bob
McRoberts (orthopedics), John and
Marian Mateyka Melish (medicine
and pediatric infectious disease), Tony
Robbins and Phyllis Freeman (public
health), James and Victoria Sansing
(dermatology), Clarence and Carolyn
Sasaki (otolaryngology), Joel and Cyn¬
thia Singer (plastic surgery), Larry and
Susan Toder (orthopedics), and Arne
and Patti Youngberg (radiology).
Special thanks to Donald Cohen and
Clarence Sasaki for putting the
weekend together. For those who
couldn’t attend, please send me a short
biography so we can put together a class
newsletter.
The most ironic part of the weekend
was that while we were partying, Stu
Kotler’s daughter, Yale Med. '93, was
studying for second-year boards....And
the beat goes on!

1971
20th-year reunion
hy Dr. Barry B. Perlman
“How time flies.” This phrase expresses
the feeling of the 26 or so members of
the Class of '71 who gathered for the
20th-reunion. The class dinner again
was held at the beautiful shoreside home
of John (now professor of neurology at
Yale) and Ellen Ebersole. Space limita¬
tions permit only brief mention of class
members but, unfortunately, not of their
family members who attended and
contributed to the pleasure of the day.
Those living either in the New Haven
area or nearby Connecticut included
pediatricians Tom Etkin, Dave Rinzier,
Semeon Tsalbins and Lenny Eisenfeld,
whose specialty is neonatology. Al
Weihl is the director of education in the
emergency department at Yale. Richard
Kaufman practices internal medicine in
nearby Branford. Barbara Kinder, who
was instrumental in making reunion
arrangements, is now the director of
surgery at the Department of Veterans
Affairs Medical Center in West Haven.
John Foster practices radiology nearby.
Several psychiatrists attended. Mike
Piercey, the medical director of Four
Winds Hospital in Katonah, N.Y., and
Dave Lippman, who lives in Great Bar¬

rington, Mass., were the parents with
the youngest children, while Barry
Rand, who practices in Brooklyn, was
the most recently married. Frank
Miller, at Cornell, and Jon Stewart, at
Columbia, are both involved in
academic research. Barry Perlman is
director at St. Joseph’s Medical Center
in Yonkers, N.Y Peggy Finston, living
in Prescott, Ariz., just returned to
practice; she authored Parenting Plus:
Raising Kids with Special Health Needs,
and is at work on a novel.
Among those travelling long
distances to attend were: Paul Vignola,
who directs the cardiac catherization lab
at Mt. Sinai Hospital in Miami, Fla., and
Bob Vranian, who practices cardiology
in Virginia. Doug Schmidt and Mike
Gallant are both plastic surgeons work¬
ing in Denver, Colo., and St. Petersburg,
Fla., respectively. Bruce Block,
unfortunately without Marian, came
from Pittsburgh, where he runs a family
practice center for a residency program.
Coming from the Midwest were Jerry
Woodhead, an academic pediatrician in
Iowa City, and Jared Gardiner, a
radiologist in Wichita, Kan. Allan
Graham cares for “New York City drug
addicts in peaceful Vermont.” Richard
Moggio is a cardiac surgeon at New
York Medical College in Valhalla, N.Y.
Judith Bader practices radiation oncol¬
ogy in Maryland after many years at the
National Cancer Institute. It was nice to
have her return to her first reunion, and
we hope others will follow suite for the
25th in 1996.

1976
15th-year reunion
hy Dr. Alfredo L. Axtmayer
Greetings from Wallingford, Conn! It’s
hard to believe that 15 years have come
and gone. 1 am pleased to say that the
reunion was attended by 15 of us. It’s
also hard to believe that those of you
who live nearby, i.e. New York and the
Boston area, could not drag your bodies
back to New Haven at this juncture. 1
am pleased to report that all of those
who did attend look well and are doing
great....
Peter Swanson continues in family
practice in Shelton, Conn., and has been
at that for 12 years. Charlie Swenson
looked great, perhaps a little less hair on
top, but the beard is still going strong.
He lives in White Plains, N.Y, and com¬
mutes between there and New York
City, running a Cornell-affiliated
Yale Medicine
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treatment program for suicidal people.
He keeps thinking of family practice.
Rich Kayne made it late to the
reunion dinner but continues to practice
endocrinology in the MeridenAVallingford/Cheshire area. He and I work
together at the newly named Veterans
Memorial Medical Center in Meriden.
His children are 12, 9 and 7. Maria is
still busy with her import/export
business.
Florence (Comite) Cabin and her
husband, Henry, were also present at our
dinner. He is an honorary class member
from the Class of ’75. Florence is back
at Yale in reproductive endocrinology.
Their children are Jonathan, age 12, and
Mikey, 7 years-old. They look like they
keep a very busy schedule.
Dan Rahn, who has been back on
the faculty at Yale University School of
Medicine since 1988 directing a clinical
program in Lyme disease, is making the
big move from the New Haven/Guilford
area to a new position as vice chairman
of the department of medicine in
Augusta, Ga. It will be a big move for
Dan, Lana, Jaron, age 9, Rebecca, age
6, and Zachary, age 4. We wish them
well!
Cindy Mann looks great, continues
to practice pediatrics in New Haven at
Connecticut Health Care Plan. Ken
Dobuler also is in New Haven,
practicing pulmonary medicine in a
group with 29 other M.D.s. Vinny
DiCola also continues in New Haven in
cardiology in a group with six others.
He has a son age 4 and a daughter age 3.
Bill Levy and Doug Mann came
from the Philadelphia area. Bill is a little
league coach who moonlights as a cardi¬
ologist, and Doug practices ear, nose
and throat surgery in Media, Penn. He
has three children and his wife, Jane, is
an ophthalmologist. He gets the award
for the most physically unchanged
appearance since graduation.
Rich Pelker is professor of
orthopaedics at Yale but aspires to be a
full-time sailor and beach bum. Norm
Kohn came all the way from Chicago
just for reunion dinner. He still lives
near the University of Chicago and
practices psychiatry there.
The prize for the longest trip for our
reunion goes to Randy Hawkins and
his wife. Penny, who came all the way
from San Diego. He is a neurologist
with a big group downtown and loves
California (as expected). He has
extended an invitation for anyone going
to San Diego to look him up while they
are there. I am sorry to report his hair is
shorter and he is playing golf!

I continue to do general orthopedics
in Wallingford and am too busy to make
it down to New Haven except every five
years for reunions!
Best wishes to one and all. Let’s
hope we can get a bigger crowd for the
“20th”!

1981
lOth-year reunion
by Dr. Barbara Ross
The lOth-year reunion dinner for the
Yale School of Medicine Class of 1981,
held at the Chart House on June 8 was a
big success, with 21 people attending.
Scott Hundahl made the longest trip,
from Honolulu, where he is a surgical
oncologist and his wife, Leilani, is an
internist. East Coast oncologists
included David Lebwohl (medical
oncology), here with his wife, Sally, an
archivist, and Yvedt Matory (surgical
oncology fellow), with husband Randy,
a law professor at Harvard. Both David
and Yvedt are at Memorial-Sloan
Kettering, along with Ines Carrasquillo
and Richard Rodman.
The three rheumatologists at reunion
were Dean Noritake, Stewart
Greisman and Barbara Roach. Dean
and Lynn came all the way from
Pasadena and have two children, Daren
and Alison. Stewart shares a practice in
Manhattan with his wife, Lisa Babitz
(geriatrics), and they have two
daughters, Laura and Jill. Barb
practices in New Haven, and she and
husband Rick have two energetic
toddlers, Matthew and Emily.

Not surprisingly, the New York area
was very well represented. David Weiss
is an orthopedist in Manhattan — his
specialty is dance medicine, .so he is at
the ballet several times a week. Dovelet
Shashou is a pediatric ophthalmologist
in New Jersey. Her husband. Jon, is a
radiologist at Einstein and they have a
2-year-old son. Donald Moore
practices family and emergency
medicine in Brooklyn; he and wife
Christine have one daughter. Robert
Kenet is an instructor in cardiology at
Cornell, and is president of Vanguard
Imaging. His interests include digital
imaging in cardiology and dermatology
as well as the harpsichord. Jane Asch
has a private psychiatry practice in New
York City, and she is in psychoanalytic
training at Columbia. Also representing
psychiatry is Marty Teicher, who is at
Harvard and divides his time between
research, clinical work, his two children
and speaking to the press about Prozac.
It was wonderful to see so many
classmates come back to New Haven for
reunion, and we are looking forward to
our 15th in 1996!

1986
5th-year reunion
Attendees: Catherine Ann Arnold,
Cristina Brunet, Amanda Dill, Daniel
Fierer, Cynthia Hall, Roberto LewisFernandez, Steven Waisbren and
John Wysolmerski.

Donald Moore. M.D.'Sl, and his wife, Christine Moore.
Yale Medicine
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1990-1991 ALUMNI FUND REPORT
From the YSM
Alumni Fund Chairman
The alumni of the Yale University
School of Medicine have much of which
to be proud. We have been blessed by
being educated in what is recognized as
one of the five best medical schools in
this country. Our faculty is known
throughout the world for its research
activities, teaching abilities, and for its
unwavering commitment to student edu¬
cation. The Yale System allows for
personal growth as well as intellectual
scientific achievement. It is no wonder,
therefore, that our alumni remain
steadfast and loyal in their support of
our school. At no time was this more
evident than in the 1990-1991 campaign
of the School of Medicine Alumni
Fund. All previous records were broken.
Faced with a $ I million dollar challenge
from the Kresge Foundation, and a
S4(),()()0 challenge from Dr. Sanfurd
Bluestein, you met them both with
resounding success.
In the 1990-1991 campaign, we
raised $69.‘S,839.37, breaking all
previous records for annual giving.
Equally as important, however, was that
our level of participating reached 56
percent. We share first place with the
Law School for the highest percentage
of participation among the graduate and
professional schools at Yale.
There are many people to thank for
this noteworthy achievement. The
professional staff, under the guidance of
alumni fund Director Monica Robinson,
were diligent in their pursuit of our
goals. Class agents responded to calls
for action promptly and with
enthusiasm.
Most of all, thanks must be given to
you, our alumni for answering the call
of our school so willingly and
generously. The board of the School of
Medicine Alumni Fund tips its
collective hat to all of you.
My term as chairman of the School
of Medicine Alumni Fund has come to a
close. Personal thanks go to Monica
Robinson and her staff, members of the
alumni fund board, and to all of the
class agents. You have made my job
easy by doing all the work, and interest-
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Dr. R. Leonard Kemler
ing by being such stimulating people. It
has been a wonderful experience.
Best wishes go to my successor. Dr.
John Foster. May you enjoy the work as
much as I have, and may you break all
the recently established records.
R. Leonard Kemler, M.D. '43
Chairman

Dean’s Message
No task plea.ses me more as acting
dean than to thank the Yale medical and
EPH alumni for generously contributing
their time, energy and talent to help pro¬
vide for the continuing needs of their
school. I truly appreciate your loyalty
and commitment to the well-being of
the Yale School of Medicine and its
Department of Epidemiology and Public
Health.
Medical alumni's total gift of
$695,830 to the School of Medicine
Alumni Eund, with 56 percent participa¬
tion, not only set new records for total
giving and percent participation, but
exceeded the requirements of the
Kresge Eoundation Challenge, thus
earning a $1 million donation to the new
Boyer Center for Molecular Medicine.
Special thanks go to R. Leonard
Kemler, M.D., the outgoing chairman of

the School of Medicine Alumni Fund,
and John Ogilvie, M.D., who
coordinated the program for meeting the
Kresge Challenge. The class agents’
work also was crucial to this success.
The highlight of the EPH Alumni Fund
was the extremely generous gift of
$300,000 over three years by Samuel S.
Herman, M.P.H., Ph.D., and his wife,
Liselotte. I hope that our alumni
continue to vigorously respond to their
school’s needs.
Because of the ongoing
accumulation of debt that medical and
EPH students accrue when acquiring
their education (medical student debt at
graduation averages more than $49,000,
while EPH students’ tops $31,000), Yale
will continue to designate your financial
contributions to student aid. Our
students greatly appreciate your
support; helping them meet their
financial needs allows the School of
Medicine to attract the outstanding
talent which we traditionally expect at
Yale University.
As we implement the newly adopted
academic plan, we intend to integrate
curriculum revisions that will enable us
to attain the plan’s goals within the
parameters of the Yale System. The
expansion of the school’s physical plant,
as well as construction of the Children’s
Hospital at Yale-New Haven, also are
essential elements in helping us meet
the goals of our academic plan.
Your generous contributions not only
represent important investments in the
academic plan, but they also support the
future clinicians, basic scientists and
public health specialists who are needed
to address the pressing medical and
public health challenges that we will
continue to face as we enter the 21st
century.
Robert M. Donaldson Jr.
Acting Dean
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Medical School Alumni Fund Class Participation
1989-1990
AGENT

CLASS
1922 and prior
1923
1924
1925
1926
1927
1928
1929
1930
1931
1932
1933
1934
1935
1936
1937
1938
1939
1940
1941
1942
1943A
1943B

Wilbur Johnston
Nelson Ordway
Rebecca Solomon
James Ferguson
Charles Cheney
Walter Burdette
Dorothea Peck
Brownlee Brinkley

1944
1945
1946
1947A
1947B

Nicholas Spinelli
Richard Breck
Thomas Whelan
George Barnes
W. Roy Breg

1948
1949
1950
1951
1952
1953
1954
1955
1956A
1956B

Anne Godley
Daniel Elliot

Vincent Gott
John Rose
Robert Kramer
John Gardner
Donald Dalessio

1957A
1957B

Harry Briggs
Howard Minners

1958A
1958B

Andrew McGowan
Paul Rudnick

1959A
1959B

Asa Barnes
Muriel Wolf

1960A
1960B

Eugene Gaenslen
Thomas Kugelman

1961A
1961B

Robert S. Briggs
Warren Widmann

1962A
1962B

A.R. Pschirrer
Frederic Cantor

1963
1964A
1964B

Craig Llewellyn
William J. Houghton
Robert Lyons

1965
1966A
1966B

David Hill
Mary Alice Houghton
Gary Townsend

1967A
1967B

James Dowaliby
Anthony Lovell

1968A

Frank Lucente

Yale Medicine

William Cohen
David Raskind
Alice Whittier
Maxwell Bogin
Harry Zimmerman
Paul McAlenney
Michael D’Amico
Franklin Foote
John Ogilvie
James Haralambie

Lowell Goodman
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TOTAL
$2,011
686
11,334
5,473
1,720
1,136
3,580
1,376
147,690
3,426
2,339
2,103
4,652
6,780
3,991
2,289
1,346
4.131
16.441
4,593
3,600
6,743
5.930
12,673
10,131
10,573
8,800
6,834
2.653
9,487
7,675
3,930
74,952
10,581
4,275
8,710
6,034
6,932
4,862
3.235
8,097
3,575
4.575
8,150
9,702
4.820
14,522
7,222
4.474
11,696
5,333
6.500
11,833
3,305
4.610
7,915
4,090
3.051
7,141
6,984
2,185
10.650
12,835
13,299
2,975
3.400
6,375
3,428
5.715
9,143
9,053

1990-1991
% PART
100
100
100
50
60
63
60
67
71
91
50
69
75
52
34
64
72
69
65
76
64
74
64
65
67
70
78
64
71
56
60
71
59
42
55
60
58
47
53
50
57
64
61
53
52
53
61
57
59
57
57
57
51
57
54
60
39
50
32
41
68
55
50
57
52
55
54
74
64
45

TOTAL
2,370
1,.546
12,214
611
841
1,710
2,191
1,553
70,425
3,256
2,514
2,303
7,028
6,975
4,361
2,040
1,488
3,869
12,070
9,776
5,369
29,174
7.092
36,266
10,297
5,806
55,973
5,191
2.444
7,635
8,644
3.864
8,886
15,324
5,634
8,737
/,435
6,085
10,262
6.855
17,117
7,275
5.485
12,760
9,746
4.955
14,701
8,859
5.051
13,910
.3,171
5.375
8,546
4,650
9.425
14,075
3,101
3.826
6,927
8,722
3,885
10.750
14,635
14,243
3,150
3.495
6,645
3,572
6.390
9,962
16,353

% PART.
100
100
100
75
75
83
100
89
67
KX)
85
113
100
100
61
83
92
90
95
90
85
100
93
97
100
94
79
93
93
93
82
84
79
69
60
72
79
68
75
74
75
73
70
65
66
66
83
70
77
59
63
61
60
77
67
66
50
58
50
48
79
64
53
59
55
57
63

71
67
58

51

1968B

Donald Lyman

4.830

58

6.188

75

13,883

52

22,541

67

1969

Adrian Schnall

7,602

52

11,307

65

1970

James Missett

5,823

46

5,403

50

197IA

John Cieply

3,468

43

5,944

66

197IB

Barbara Kinder

5.725

44

10.450

7Q

9.193

44

16,394

68

1972

Harry Malech

9,835

47

10,386

59

I973A

Lee Goldman

1,766

48

1,-599

45

1973B

John McQuade

2,015

39

2,831

48

1973C

Jerrold Rosenbaum

1.691

43

2.029

54

5.472

43

6,459

49

1974A

Amy Schechter

1,755

49

1,745

49

1974B

Robert Schechter

3.800

37

3.040

50

5,555

43

4,785

50

1,570

31

1,631

35

1.179

20

1.559

30

2,749

26

3,190

33

1975 A
1975B

Mary Jane Minkin

I976A

William Levy

3,(X)0

35

4,570

56

1976B

Glenn Gorlitsky

1.260

36

2.725

40

4,260

36

7,295

48

2,420

24

5,910

32

2.527

47

1.570

56

4.947

36

7,480

44

1,770

22

3,070

42

1977 A
I977B

Ronald Vender

1978A

Duke Cameron

I978B

Seth Powsner

325

27

350

40

1978C

Thomas Smith

115

25

200

33

2.210

25

3,620

38

685

34

1,770

51

1979A

Jeffrey Kaine

1979B

Cynthia Sherman

1.900

24

3.160

37

2.585

29

4,930

44

1980A

Eduardo Alfonso

2,375

35

1.855

40

1980B

Stevem Rosenfeld

1.056

27

1,357

46

3,431

31

3.212

43

1.645

20

3,703

37
23

1981

Anthony Urbano

1982A

Muriel Cyrus

650

12

948

1982B

Jed Gorlin

300

35

385

50

I982C

S. Wolf-Rosenblum

470

38

970

57

1,420

28

2,303

43

1983A

Michael Tom

276

9

971

27

I983B

David Schwartz

330

30

585

36

606

20

1,556

32

1984A

Hinggr Hsu

485

26

620

33

1984B

Jay Kostman

500

19

750

32

985

23

1,370

33

1985 A

Greg Sachs

695

26

807

31

I985B

Fred Santoro

190

23

700

3i

885

25

1,507

31
28

I986A

Eric Bernstein

230

16

958

1986B

Clinton Lindo

95

11

125

20

I986C

Eric Suan

35

7

700

15

1987A

Barry Weinstock

1987B

Subba Gollamudi

1987C

Mindy Schuster

1987D

Mark Widmann

360

12

1,783

21

261

20

745

39

50

17

123

32

100

14

360

41

725

20

411

17

1.953

33

57

19

237

32

145

17

168

18

20

8

215

28

1988A

Michael Mockovak

1988B

Susan Valley

1988C

Hedi Zaghi

222

15

620

26

1989A

Stephen Bharucha

no

13

250

28

1989B

Lewis Lipsey

245

24

175

39

1989C

Melissa Myers

50

11

76

33

1989D

Roger Widmann

35

13

205

50

440

15

706

38

1990A

Chander Sarny

160

36

1990B

Daniel Stryer

75

50

I990C

Jonathan Foster

88

36

1990D

Roberto Soto

I990E

Thomas Christopher

1990F

Tracy Nelson

I'AiilG

Ercem Atillasoy

30

22

199011

Betty Shin Wun Kim

80

M

588

29

52

5

10

150

36
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CONTRIBUTORS 1991-1992
The names and data included on the following pages were provided hy the
Yale School of Medicine Alumni Fund and reflect contributions made
between July 1,1990 and June 30,1991.
MEDICAL SCHOOL
ALUMNI
1858
T. Beers Townsend*

Nathan Levy*
William C. Meredith
Alfred F. Seibert
Theodore H. Sills
M. Dawson Tyson
Harry M. Zimmerman

1887
1928

George Frederick
Converse*

1906
Charles R. Mitchell*

1908
Michael A. Parlato*

1912
Walter Clark Tilden*

Max Alpert*
Sheldon A. Jacobson
Edward P J Kearney
Ralph E. Knutti
R. Harold Lockhart
Edward W. Ludwig*
Nathan E. Ross
Robert 1. Rubinstein*
John M. Russell*
Alvin A. Schaye*
George C. Wilson*

1913
Ralph Emerson Taylor*

1916
Ernest Russell*

1919
Willys M. Monroe*

1920
Oscar Brenner*

1922
Maurice Grozin*
Chester E. Hurwitz*
Helen R Langner

1923
William Cohen*
Julius Anthony Olean*
Hyman W. Weinstein*

1929
James Rae Ameill Jr.*
John M. Bailey*
John W. Cass Jr.*
Frank H. D'Andrea
Robert A. Frisch
Olive Gates
George S. Goldman
Alexander O. Haff*
John A. Hangen
Tony Liebman Rakieten*
William Frederick Roth
Jr.*
Russell B. Scobie
Robert Tennant
Newell Raymond
Washburn*
Julius G. Weiner*
Mabel Wilson

1930
1924
Donato Anthony D'Esopo*
David M. Raskind
Myron A. Sallick*
Jacques Diamond Soifer*

1925
Waldo F. Desmond*
William E. Hall
Samuel Reback
Eli Hyman Rubin*
Alice A. S. Whittier
Howard Asa Wood*

1926
Stanton T. Allison*
Maxwell Bogin
William H. Hahn*
Joseph L. Hetzel*
Morris Hinenburg
Joseph T. Matteis

1931

1927
Wallace Robert Bostwick*
Henry Irwin Fineberg*
John Martin Freiheit*
Donald F. Gibson*
Ernesto Icaza*
Albert Jablonsky*

Yale

Medicine

Daniel N. Beers*
Frederick Fitzherbert
Boyce
Charles A. Breck*
Lewis Dickar*
Vincent A. Doroszka*
Knox H. Finley
J. Roswell Gallagher
Leonard Greenburg*
Amy H. Hunter Wilson*
Paul Harold Lavietes*
Moses D. Lischner*
James Merriman Lynch*
John W. Maroney
Paul Watson*
Charles L. Wood

Henry H. Briggs Jr.
Benjamin Castleman*
Michael D'Amico
Paul A. Harper
Morris Heller*
Thomas C. Jaleski
Rhoda M. Mickey
Nelson Newmark
Abraham J. Schechter
James A. Stringham
Max Taffel
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1932
Louis K. Alpert
Reginald V. Berry
Frank Carroll
Clement C. Clarke
Hester B. Curtis
Joseph P. Donnelly
Lee E. Farr
Thomas E. Farthing*
Lewis F. Foster
Elizabeth M. Ramsey
Benjamin N. Tager
Myron E. Wegman
Roland T. Wehger*

1933
Myron J. Adams*
Fred W. Buse
Warren P. Cordes
Franklin M. Foote
Jack Greenberg
Daniel Foster Harvey*
George K. Hirst
Robert Watkinson
Huntington Jr.*
John G. Martin
Raymond Everett Miller*
Ashley Pond III*
Paul L. Saffo
Edwin B. Seelye*
Sidney Stringer*
Francis M. Woods

1934
Frederick Beck
Joseph Budnitz
Francis P. Guida*
Derick Algernon January*
Knowles B. Lawrence
Herbert C. Miller
Edward Thomas
O’Donnell*
John B. Ogilvie
Lucien M. Pascucci
Harry Sherman
Wedgwood P. Webber
William R. Willard
George Zalkan*

1935
Walter E. Barney*
George A. Carden Jr.
Edgar S. Childs
Edward F. Falsey*
H. Hoffman Groskloss
James Quintin Haralambie
W. Howard Homer*
Mildred Hartshorn January
Samuel D. Kushlan
Donald P. Morris*
Norman E. Peatfield
John D. Preece
Norman P. Rindge
Milton Rose*
Clark P. Searle
Walter A.L. Thompson

1936
Lester W. Burket
Albert W. Diddle

Margaret C. L. Gildea
George A. Hahn*
Louise G. Hutchins
Philip M. LeCompte
Donald F. Marshall
Stephen F. Nagyfy
Frederick A. Post*
Hugh Allan Smith
Margaret Sommers
Morris Tager
Rafael Amllaga Torrens

1938

1937

Roy N. Barnett
Henry L. Carideo
S. Charles Kasdon
Benjamin E. Lyons
John J. McGillicuddy
Nelson K. Ordway
Charles J. Petrillo
Edward W. Pinkham Jr.
James Radcliffe Jr.
George E. Roberge
Theodore W. Steege
Lester J. Wallntan

Edmund R. Blower
William G. Cooper Jr.
D. Crosby Greene
Wilbur D. Johnston
Alfred E. King
Dunham Kirkham
Julia Mehlman
James P. Morrill
T. Dennie Pratt
Alan A. Rozen
Morgan Sargent
Albert D. Spicer
John M. Thomas
Jean Wells
Lorande M. Woodruff

Stephen W. Collins Jr.*
Harold H. Coppersmith
Norman L. Cressy
William H. Druckemiller
Robert Goodfellow Ernst*
John P. Ferguson Jr.
Joseph B. Forman
S. Jerome Greenfield
Nathaniel Kenigsberg*
Margaret A. Lennox
Ward J. McFarland*
James Peter Murphy
Russell Nahigian*

1939

SCHOOL OF MEDICINE
ALUMNI EUND BOARD
Daniel L. Arons, M.D. '67
Sharon L. Bonney, M.D. '76
M. Felix Freshwater, M.D. '72
Harry C. Briggs. M.D. '57
James M. Dowaliby, M.D. '67
Alex R. Gaudio, M.D. '63
Herbert S. Hurwitz, M.D. '54
Sidney S. Lee, M.D. '50
Benjamin E. Lyons, M.D. '38
Andrew J. McGowan Jr., M.D. '58
John B. Ogilvie, M.D. '34
Helen L. Smits, M.D. '67
Ronald J. Vender, M.D. '77
Marcia J. Wade, M.D. '78

OFFICERS 1991-1992
John W. Foster, M.D. '71
Chairman
J. Roswell Gallagher, M.D. '30
Bequest and endowment co-chairman
Samuel D. Kushlan, M.D. '35
Bequest and endowment co-chairman
Former house staff chairman
EPH Alumni Fund
Stephen Skorcz, M.RH. '70
Chairman
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Douglas S. Riggs
Roger N, Ryley
Ernest L. Sarason
Bradford Simmons
Rebecca Z. Solomon
John D. Tobin
Arthur S. Tucker*
Darrell G. Voorhees
Douglass W. Walker
John H. Wentworth
Malvin F. White

1940
Theodore E. Allen
Joseph V. Baldwin
Ronald S. Beckett
Jack S. Blaisdell
Philip S. Brezina
David Crocker*
Wynant Dean
Richard E. Dormont
James F. Ferguson Jr.
Eugene J. Fitzpatrick Jr.
Henry D. Humphrey
H. Stuart Irons*
Donald G. Johnson
Ira D. LeFevre Jr.
John D. MacAllister
Paul D. MacLean
Edward Martin
K. Alvin A Merendino
Maurice Ross*
Lee S. Sannella
W. Norman Sears*
Joseph E. Sokai*
J. Champneys Taylor
Patricia E. Wanning
Helen H. Woods

1941
Robert H. Alway
Robert H. Areson
W. Randal Bell
Knute E. Berger*
William A. Carey
Joseph P. Carson Jr.
Charles B. Cheney
Herbert W. Diefendorf
Robert F. Dine*
Peter A. Duncan
Lloyd D. Flint
John Franklin
Robert L. Gilbert
Frederick P. Glike
Thomas S. Harvey
William Edmund Kenney
William Lee
Bjorn Lih
John R. McDermott*
Willys M. Monroe
Malcolm C. Murfitt
Jean E. Neighbor
Edward B. O'Connell
Robert W. Ollayos
Gioacchino S. Parrella
David V. Pecora
Edwin D. Rogers
Leslie Simmonds

1942
William E. Bloomer
James M. Bunce
Walter J. Burdette
Robert E. Carroll
Donald S. Childs Jr.
Ludmil A. Chotkowski
Vincent J. Collins
Eugene M. de Hostos
David G. Decker*
Hendrik DeKruif
William F'leeson
Elihu Friedmann
Allan V.N. Goodyer*
William Harrison Jr.
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Wilson E. Hughes*
Leo Kellerman
John R. Lincoln
Patrick S. Mullins*
Dean Nichols*
Samuel Ritvo
Lois Knight Rogers
Richmond W. Smith Jr.
Carter Stilson
Edgar B. Taft
Maurice Tulin
Francis P. Vose*
Anhur A. Ward Jr.
Irving Norman Wolfson
Med. memorial 1942
Classmates*

1943A
Ralph D. Alley
Anonymous
John R. Brobeck
Edward S. Brown
Lycurgus M. Davey
Donal L. Dunphy
R. M. Fasanella
Gerard Fountain
Edward Douglas Homing*
Stuart L. Joslin
R. Leonard Kemler
Joseph P. Kriss*
Jonathan Trumbull
Lanman*
Douglas Lindsey
J. Philip Loge
Henry E. Markley
Walter J.J. Nero
Dorothea R. Peck
Edward F. Rabe
Earl J. Rhoades
Henry A. Riedel
Bernard R. Rowen
Marcus E. Sanford
Robert A. Sears*
Edward Hersey Soule
Hilliard Spitz
Nicholas M. Stahl
Sophie Trent Stevens
Oliver G. Stonington
Robert G. Turner
Frederick A. Waldron*
John J. Weber
Morris A. Wessel
Robert H. Wyatt

1943B
Richard N. Abbott
John R. Almklov
David G. Borden
James L. Bradley*
Robert F. Bradley
S. Brownlee Brinkley
Henry B. Bruyn Jr.
Thomas L. Bucky
Jane B. Cadbury
Philip B. Chase
Hunter H. Comly
Norman 1. Condit
Thomas D. Cook
Ronald W. Cooke
Joseph I. Epstein
Robert H. Fumian
Victor C. Hackney
Fred M. Haddad
Frank R. Hurlbutt Jr.
Henry H. Jones
Joseph F. Kell
Sawyer E. Medbury
Hoyt B. Miles Jr.
Benjamin R. Robinson Jr.
Donald W. Seldin
Francis A. Spellman*
W. Keasley Welch

1944
Carl E. Andrews
Joseph Ciola*
Edward J. Conway
Robert E. Cooke
John C. Coolidge
George B. Corcoran Jr.
Frank W. Countryman
Lawrence S. Crispell
Charles H. Crothers
Lawrence G. Crowley
John H. Doherty
Robert W. Frelick
Carol Goldenthal
Charles A. Hall
Howard B. Hamilton
Robert 1. Hinkley
W. Raymond James
Ward S. Jenkins
Edith M. Jurka
Harvey W. Kausel
Jerome J. Kaye
John Weaver King
Frederick F. Krauskopf
Ronald E. Losee
Ellen P. MacKenzie
Elias J. Marsh
Katharine Hawley Martin
Joseph Massaro
A. Reese Matteson
Paul E. Molumphy*
Russell R. Monroe
Lawrence K. Pickett
Laurence G. Roth
Haynes W. Sheppard
Sarah P. Sherwood
Eugene Smith
Nicholas PR. Spinelli
Mrs. Gertrude Spinelli*
Priscilla Dienes Taft
Anthony Varjabedian
Calvin Watts Woodruff*
Reuben Zucker*

1945
George Howard Allison
Albert S. Atwood
Frederic M. Blodgett
Richard W. Breck
Louise H. Burr
Alice Shepard Cary
Sanford F. Cockerell
Jay B. Cohn
Richard R. Dyer
Robert S. Easton
Sidney S. Feuerstein
Alice Dershimer Friedman
James D. Gardam
Philip S. Good
Herbert S. Hamed Jr.
Isao Hirata Jr.
Paul W. Hoffert
O. Roger Hollan
John R. Howick
Hans R. Huessy
Leland W. Jones
John A. Knapp
William E. Laupus
Mark McD Lindsey
James R. Mason
Charles E. McLean
George W. Naumburg Jr.
Fitzhugh C. Pannill
Richard M. Peters
Elliot R. Reiner
Charles E. Sherwood
Joseph R. Stanton
Kenneth C. Steele

Linus W. Cave
Thomas J. Coleman
James F. Cooney*
Thomas A. Doe
Edward F. Edinger
Gregory E. Flynn
Martin E. Gordon
Charles Sheldon Judd Jr.*
Benjamin F. Kitchen Jr.
James A. Kleeman
Vincent J. Longo
Richard Hess Mann*
Thomas J. Mathieu
Hugh J. McLane
Joe D. Morris
John H. Morton
Thomas J. Murphy
John F. Neville Jr.
Laura W. Neville
Harry Dickson Patton
Vincent Pepe
Francis G. Reilly*
David H. Riege
Phillips E. Roth
Julian A. Sachs
Donald P. Shedd
Richard G. Sisson
R. Bruce Thayer
Robert R. Wagner
William P. Walsh
William J. Wedemeyer Jr.
Thomas J. Whelan Jr.
Hugh R. Williams*

Allyn G. Bridge
Arthur L. Coleman Jr.
Ruth E. Cortell
Richard H. Cote
G. Robert Downie
Victor A. Drill*
Elizabeth Euller Eisner
Albert A. Fisk
Boy Frame*
Emil Frei III
Julian Frieden
Anne Godley
Paul S. Goldstein
Allan Green*
B. Herold Griffith
Sylvia Preston Griffiths
Richard M. Hannah
Halsted R. Holman
Paul B. Koehler
Robert E. Lempke
John P. Morris
John B. Morrison
David E. Morton
James W. Needham
George P. Rostel
Lewis P. Rowland
Benjamin F. Rush Jr.
Gabriel A. Saviano*
Jerome H. Shapiro
Jessie Parkinson Spear
Paul Talalay
Wallace W. Turner
Paul Woodbury Weld

1947

1949

George R. Barnes Jr.
Albert W. Bostrom Jr.
John E. Bowers
W. Roy Breg Jr.
Richard G. Britton*
David L. Brook
Rocco A. Calandruccio
John L. Cannon
M. Richard Carlin
John C. Carpenter
Arthur Harry Chapman
Robert A. Chase
Amoz I. Chemoff
William F. Collins Jr.
Bradford S. Colwell
Robert P. Darrow
Jean H. Dougherty
Owen W. Doyle
Franklin Harold Epstein
Edward Foord*
Richard K. Friedlander
Frank L. Golbranson
Frank H. Horton
Robert J. Kerin
Don F. Kimmerling
Anton N. Lethin Jr.
Richard P. Levy
Brock Lynch
Victor A. Machcinski
William K. McClelland
Robert F. Newton
Myron K. Nobil
Lawrence C. Perry*
Philip H. Philbin
Olive E. Pitkin
Irving Rudman
Lawrence P. Shea*
Alvin Somberg
Igor Tamm
William F. Thompson
Patricia B. Tudbury
Ellis J. Van Slyck
M. Henry Williams Jr.

William G. Aniyan
Alfred E. Bacon Jr.
William D. Bevis
Jonathan S. Bishop
Mary Pucci Couchman
Phillip G. Couchman
N. Joel Ehrenkranz
Daniel W. Elliott
Gunnar O. Eng
Albert A. Fisk
Eleanora C. Gordon
Frederic W. Gray
Jackson Harris
Frederick R. Hine
Benjamin A. Johnson
Orval 1. McKay
Orlando J. Miller
Timothy F. Nolan Jr.
Julian 1. Pichel
Charles L. Rennell Jr.
Murray Z. Rosenberg
Daniel Rudman
Carl M. Russell
William H. Sewell
Martha Vaughan
Vernon T. Watley
Mary-Agnes P. Wine

1946

1948

Margaret J. Albrink
William G. Bantleld Jr.
Franklin C. Behrle
Sanfurd G. Bluestein

Russell J. Barmett*
George F. Batten
Edith M. Beck
Jonathan S. Bishop

1950
Russell N. Anderson
Lyal D. Asay
Sylvia L. Axelrod
Malcolm A. Bagshaw
John E. Borowy
William H. Bucher
Class Of 1950*
Alvin Davis
Claude W. Delia
Marie C. Duncan
Kent Ellis
Thomas J. Ferraro Jr.
Daniel Fine
Lawrence R. Freedman
David A. Frucht
Carl A. Gagliardi
Archie James Golden*
Melvin H. Kaplan
Lucian S. Lapinski
Sidney S. Lee
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Janus C. Lindner
Margaret S. Lyman
Harold March
Harry L. McClelland
Marina P, Meyers*
John H. Meyers
Orlando J. Miller
Charles A. Nugent Jr.
Robert Edward Quinn*
Robert T. Sceery
Cynia B. Shimm
Jane B. Shumway
Martin E. Smith*
John S. Strauss
Myra D. Tyler
Erederick Edward Vultee*

1951
Karel Bedrich Absolon
W. Robert Adams
Thomas T. Amatruda Jr,
Stanley D. Ardell
John W. Berg
Eleanor Clay Bigley
John J. Egan
Eerdinand H. Flick
Sidney S. Furst
Joseph M. Garland
Lowell I, Goodman
John T. Groel
Robert N. Hamburger
John V. Haxo
Carrold K. Iverson
William Kiekhofer
Robert D. King
Jocelyn S. Malkin
Francis L. Merritt
Paul D. Millikin
Walter S. Morgan
Albert R. Mowlem
Richard S. Munford
Ismail Nik Nevin
Gerard B. Odell
Alfred Owre Jr.
Jose Felix Patino
Arthur A. Pava
Majic S. Potsaid
Robert G. Small
William F. Stephenson
Harold M. Sterling
Bradley R. Straatsma
John L. Sullivan
William A. Taylor*
Andrew S. Wong

1952
John W. Arnold
Maurice L. Bogdonoff
Siegried A. Centerwall
Willard R. Centerwall
Frank R. Coughlin Jr.
Barbara B. Coughlin
Richard N. deNiord Jr.
John P. Filley
Richard D. Floyd
Robert P. Gerety
Thomas S. Kelly
James Kent Luce
N. Karle Mottet
Robert L. Nolan
Sidney Nathan Paly
Robert G. Petersdorf
Leon A. Phillips
John Macklin Roberts
Leonard Rush
Mary Wheatland Schley
Donald H. Schultz
Robert B. Schultz
John H. Wagner Jr.
Doris L. Wethers
John L. Wolff
Harvey L. Young*
Robert Zeppa

Yale Medicine

Pictured at the June 6 dedication of the Boyer Center for Molecular Medicine, are (from left) Benno C.
Schmidt Jr., Herbert W. Boyer, Ph.D., his wife, Marigrace, their son, Ethan, and Dean Leon E.
Rosenberg. This photograph and others in this section, taken at The Boyer Center dedication scientific
symposium, celebrate YSM alumni’s generosity in meeting the $1 million Kresge Eoundation Challenge.
(See the Development Report, page 42.)
1953

1954

1955

Seth F. Abramson
Jonathan Barry*
Claude Bloch
Harold D. Bomstein Jr.
William R. Chaffee
Allen Chetrick
Rex B. Conn
Louis R M Del Guercio
John Leo Doppman
James P. Dunn
Donnell Dencil Etzwiler
Vincent Lynn Gott
Robert Emanuel Hamlisch
A. Daniel Hauser
George L. Hoffmann
David Purdy Holman
Peter Biggs Hukill
Alvin Joseph Keroack
Robert Francis Kiley Jr.
Richard Robert Knowles
III
Frederick Martin Lane
Hildegard Mueller Leslie
John Dutch Lord
Robert N. Melnick
Harvey Martin Peck
Warwick Potter Jr.
Paul G. Quie
Jose Ramirez-Rivera
Irwin K. Rosenberg
Barbara F Rosenberg
Virginia C. Saft
William Lindsay Shepard
Richard Andrew Sinnott Jr.
Ora K. Smith
John Frazier Snyder III
Lynn Cortland Stoker
William Junior Vandervort
William A. Whalen Jr.
William August Wilson
James Frederic Young

Frank P. Berg
George W. Bostwick
Richard J, Bouchard
George N. Bowers Jr.
Ralph K. Campbell
John R. Cole
William D. Cone
Arthur C. Crovatto
Donald D. Davis
Walter J. Freeman
Orlando F. Gabriele
John A. Gariepy
Edward J. Gerety
Samuel T.J. Giammona
Frank L. Gruskay
Nicholas A. Halasz
Katherine H. Halloran
Robert P. Hatch
Walker R. Heap Jr.
Eva H. Henriksen
Samuel J, Hunter
Herbert S. Hurwitz
Robert F. Hustead
Robert J. T. Joy
Donald S. Komfeld
Lowell A. Kristensen
Richard Lamb
Harry C. Miller Jr.
Paul N. Neufeld
James J. Nora
Lowell E. Olson
William J. Paule
Anthony V, Piccirillo
Richard D. Pullen
Jacques M. Quen
John Keith Rose
Elihu M. Schimmel
Leonard M. Silverman
Robert L. Stein
Martin B. Vita
John W. Vosskuhler

John C. Bailar III
George E. Becker
E. Edward Bittar
Jerome Bobruff
Joseph 1. Boylan Jr.
Irwin M. Braverman
Edward Noel Brennan
Padraic Bums
Leo R. Cardillo
Nicholas A. Coassin
Edward D. Coppola*
Milton Com
Pasquale James Costa
Robert G. Crounse
John G. Daley
Fred Wendell Doyle
Leroy Engel
F. Robert Fekety Jr.
Edwin G. Fernand
Mahlon V.R. Freeman
James Conway Garlington
Barbara W. Gibson
Paul Gonick
Ion Grosser
John H. Hodge
D. Franklin Johnson Jr.
Harry O. Kendall
David R. Kessler
Robert A, Kramer
Edward A. Kmll
William E. Lattanzi
James Lum
Alexander Maitland III
Joseph S. McGuire Jr,
Robert C. Nodine
James P. Nolan Jr.
Sherwin B. Nuland
Edward J. Ottenheimer Jr.
John C. Pace Jr.
Robert H. Peters Jr.
Gregory Peterson Jr.
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Robert A. Reich
Paul J. Robinson
F Brantley Scott Jr.
Clement B. Sledge
Phillip W. Smith
Alan A. Stone
Myron P. Walzak Jr.

1956
Alan E. Apfel
Suzanne S. Becker
Alvin D. Benjamin
Peter Bios Jr.
Levon Z. Boyajian
Thomas M. Brown
Rosalie A. Bums
John F Carroll
Joseph C. Cemy
Edwin L. Child
James C. Collias
Donald J. Dalessio
Chandler Dawson
S. Evans Downing
Mitchell Edson
Gilbert M. Eisner
Thomas F. Ferris
John B. Fine*
John H. Gardner III
Sumner Gochberg
Val Shea Greenfield
Alan R. Gurwitt
Ame G. Haavik*
Armen Charles Haig
John Herd Hart
Robert L. Hill
William H. Hindle
Marie-Louise T. Johnson
George T. Kammerer
Jerome O. Klein
William V. Lewit
Leo Lutwak
Preston C. Manning
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Dwight F. Miller
Elmer T. Mitchell Jr.
Norman F. Moon
Donald J. Nalebuff
William M. Narva. MC
A. Frederick North Jr.
William M. O’Brien
David A. Page
James Richard Patrick
George W. Paulson
Stewart E. Pursel
Roben J. Rice
Robert Lee Scheig
Edward C. Senay
Benjamin A. Shaver Jr.
Donald William Sherrick
Daniel R. Silbert
TJieodore K.L. Tseu

1957
Donald Agostinelli
Joseph S. Amenta
Jane Barbara Battaglia
F. Calvin Bigler
Jack Norman Blechner
Richard 1. Breuer
Harry C. Briggs
Carl A. Brinkman
John P. Carey
Albert K. Chun-Hoon
Louis Z. Cooper
Harold Dick Cross
Thomas H. Danaher
James R. Dorr
Salvatore Falbo
Harold J. Fallon Jr.
Robert E. Fishbein
Ronald H. Fishbein
James R. Fitzgerald
Anthony L. Fons 111
Elizabeth H. Forsyth
Edward O. Fox
Gary A. Fry
Robert H. Glass
Anne H. Good
Jack Peter Green
Gilbert F. Hogan
Warren R. Johnson
Richard Lee Kahler
Stanley E. Kilty
William L. Kissick
Willard A. Krehl
Jack Levin
Edgar H. Levin
Bennett F. Markel
Mark D. Marshall
Howard A. Minners
Robert K. Modlin
Hugh Lamson Moffet
George Albert Nelson Jr.
Herbert A. Newman
Thomas Francis O'Brien Jr.
Jo.seph S. Pagano
Clittord B. Reitler
Arnold Schoolman
Stanley Simbonis
Kenneth A. Simon
Gilbert B. Solitare
Donald C. Stahl
William J. Waskowitz
Herbert Winston

1958
George K. Aghajanian
Don P. Amren
Joseph E. Angelo
John P. Amoi
(lerard N. Burrow'
Benjamin Bursten
John A. Carlston
John A. Creatura
Robert J. Donohue Jr.
Lawrence Dubin
Donald A. Duncan
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Joel C. Eberlin
Philip R. Fazzone
Michael E. Fishman
Raymond A. Gaito
John Currier Gallagher*
Marcia Kraft Goin
William M. Gould
James Greenwald
Charles A. Hall Jr.
Michael Kashgarian
Haskins K. Kashima
Jay Ward Kislak
Theodore W. Lieberman
Myron Lotz
Thomas J. Mauro Jr.
Michael J. McCabe
Leo T. McCallum
Andrew Joseph McGowan
Jr.
Albert Muggia
Robert S. Neuwirth
David W. O'Keeffe
Carol F. Phillips
David M. Pugh
William B. Radcliffe
Paul A. Rudnick
Bruce H. Sklarew
Richard E. Sledden
Edward Lloyd Socolow
Ray mond W. Turner
Margaret Smith Wenzel
Joseph P. Wierzbinski III
John Patrick Wood
Pauline B. Wood

1959
Scott Ingram Allen
Carol J. Amick
Robert M. Amick
Asa Barnes Jr.
Francis A. Beer
Jack F. Bowers
Med. Class Of 1959
Edwin M. Clayton
Sidney M. Cohen
Martin Colodzin
Lyall S. Crary Jr.
Ronald C. De Conti
William L. Donegan
Gerald Fenichel
Robert L. Fisher
Paul Jay Friedman
Robert J. Gonyea
Gerald B. Gordon
David Gowing
W. Keith Hadley
James H. Halsey Jr.
H. Rodney Hartmann
William H. Heydom
C. Richard Hinckley
Leonard Inker
William J.A. Jablonski
John J. Jasaitis
Edvardas Kaminskas
Herbert J. Kaufmann
Kristaps J. Keggi
David W. Kingsbury
Myron S.S. Lee
Kathryn Huxtable Lewis
Raymond Mark
John C. Marsh
Brian J. McGrath
Peter M. Molloy
N. Ronald Morris
James A. O'Neill Jr.
Robert H. Ostberg
Nicholas M. Passarelli
Charles A. Phillips
James D. Prokop
James R. Ralph
David Pardee Reed
Joseph D. Saccio
Constantine J. Sakles
Marc D. Schwartz

Richard M. Senfield
Owen .A. Shteir
David B. Skinner
Sanford P. Solomon
James J. Stagnone
Lisa A. Steiner
John S. Strauss
Lois W. Tice*
Leo H. Von Euler
Munel D. Wolf

1960
Alan W. Ames
Jack D. Barchas
Stuart P. Bowne
Donald P. Buebendorf
Thomas E. Carson
Stanley M. K. Chung
Gerald N. Cimmino
Francis D. Cogliano
Louis A. D'Avanzo
Malin Dollinger
David Paul Dunn*
March Enders
Warren H. Fisher
Paul Jay Friedman
Eugene C. Gaenslen Jr.
James 1. Gilman
Maxwell E. Gottesman
Sylvia D. Grant
Roland H. Ingram Jr.
Daniel M. Jones
William S. Kaden
Eric P. Kindwall
Susan T. Kleeman
Thomas P. Kugelman
Edward R. Lang
Thomas Lau
Thomas L. Lincoln
Donald L. Miller
Richard G. Morrill
Fred Palace
Jerrold M. Post
Martin L. Reite
Charles H. Robinson Jr.
Albert Matthew Ross
Daniel J. Rubin
John J. Schrogie
Ross L. Snyder Jr.
Fred Stargardter
Constantine M. Voyagis
Roben C. Wallach
May Yung-Fun Woo Wang
Ronald A. Yankee

1961
Kenneth A. Arndt
Earl L. Baker
Frank H. Baker
Albert A. Bechtoldt Jr.
Robert S. Briggs
Paul David Deiter
Ronald A. Dierwechter
Jon Dudley Dorman
T. Wayne Downey
Christopher Francis
Durham
John E. Fenn
Charles F. Gibbs
James M. Giffin
Edward C. Gilbert
David D. Griffith
J. Dale Howe
Louis D. Hunt
Richard L. Keefe
Thomas Kirsch
Robert Isaac Levy
George M. Lordi
Hugh James Lurie
Sally Lockwood Marches!
Vincent T. Marches!
David B. Matloff
Joseph W. McDaniel
Anoush Miridjanian

Richard Allen Moore
Norman 1. Moss
Roland D. Paegle
John Curtis Parker
John Pearce Jr.
Elaine Pitt
Bruce C. Robinson
William M. Rogoway
Roy E. Ronke Jr.
Shaun J. Ruddy
Thomas H. Sakoda
Stanley G. Schade
Robert R. Springer
John J. St. Andre
Robert N. Taub
Hugh C. T'hompson III
Eranklin H. Top Jr.
David E. Weaver
John V. Weil
Warren D. Widmann
John R. Woodward

1962
Jon M. Aase
Michael H. Alderman
Charles B. Anderson
Frederic P. Anderson
Dean E. Burget Jr.
Fredric K. Cantor
Thomas Newell Chase
Oliver Townsend Dann
Arnold Joel Eisenfeld
1. Bruce Elfenbein
John W. Foreman
Leroy A. Forstrom
Stephen John Fricker
Anthony V. Furano
John N. German
John A. Godley
David H. Groth
Roderick C. Haff
John H. Hageman
John T. Harrington
Patricia C. Hassakis
Gary Jacobson
Walter Watson Kamey
Glenn L. Kelly
David E. Knoop
Bernard Kosto
Allan L. Mattem
Stanley E. Matyszewski
David J. McConnell
William G. Meffert
William A. Miller
Malcolm S. Mitchell
David D. Nicholas
A. Richard Pschirrer
Joseph Ross
James A E Spencer
Nancy Ann Staley
Larry Lee Stewart
Seth Thaler
Sherwood Waldron Jr.
William Farnsworth Weber

Peter B. Livingston*
Craig H. Llewellyn
Edward G. Lund Jr.
Herbert Meltzer
Robert E. Mueller
Sheldon R. Pirmell
Jay M. Pomerantz
Gene R. Profant
Lee Bland Talner
Richard M. Thompson
Thomas W. Tillack
Peter V. Tishler
Lawrence Tremonti
Peter G. Weiner
James G. Wepsic
Jerome Allen Winer
Alfred J. Wise

1964
William A. Alonso
Berton W. Ashman
Leland S. Berger*
Robert M. Briggs
Thomas A. Cardella
Joseph E J Curi
Mary V. Digangi
Alfonso Esguerra
Anthony Eerrante
Norman C. Post
Peter A. Gross
John F.B. Haney
Christopher W. Hauge
Richard Hockman
Lawrence Horwitz
William J. Houghton
William E. Knight
Lewis Landsberg
Richard V. Lee
Thomas L. Lentz
James S. Levine
Paul R. Lightfoot Jr.
Richard Murray Linburg
Robert W. Lyons
Andrew E. MacMahon
William E. Matchett
Robert L. Mitchell
James J. Murphy
William B. Pratt
Jack S. Rice Jr.
Stanley J. Rosenberg
Jonathan J. Russ
Saul M. Schanberg
Norman Scher
Robert L. Shelton
Diane Shrier
Donald G. Skinner
A. Thomas Snoke
Lyall C. Stilp II
Sigrid L. Tishler
Lee Van Lenten
Charles Vogel
Stephen Waltman
Oscar Wand

1965
1963
Barbara Rosenthal Almond
Richard J. Almond
Miguel R. Alonso
V. Richard Back
Charles W. Carl Jr.
Theodore J. Chu
Andrew Edin
B. Allen Flaxman
David H. Fram
William T. Friedewald
David H. Fulmer
Alexander R. Gaudio
Lee D. Goldberg
Peter B. Gregory
Benjamin Keith Harris
Brian C. Judd
Constantine D. Kyropoulos
William B. Lehmann

Susan A. Aoki
Thomas T. Aoki
John H.M. Austin
Victor J. Burner
Thomas B. Caldwell III
David G. Campbell
Robert M. Cohn
Michael J. Cummings
Phyllis Hurwitz Duvdevani
Carl Ellenberger Jr.
David S. Fedson
Robert 1. Finkel
Michael P. Flynn
Christopher C. Gates
Frank J. Grady
Robert Andre Gryboski
James K. Gude
Reid R. Heffner Jr.
David A. Hill
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Carl E. Hunt
Virginia Burnham Johnson
Ronald J. Karpick
Mohandas M. Kini
Sandra Chook Levine
Mark W. Lischner
Philip D. Manfredi
Michael B. Mayor
Walter W. Noll
A. Lawrence Ossias
Robert L. Pickens
Alan N. Rachleff
William A. Renert
Gene A. Robinson
George B. Rowland
John F. Schilke
John H. Seashore
Margretta Ann Reed
Seashore
David P. Simmons
Robert T. Solis
Alan William Stone

1966
Patricia Bazemore
Robert P. Bazemore
Philip Bernstein
James Edward Brown
Eugene Patrick Cassidy
Thobum Aaron Dadisman
Jr.
Joseph A. Donadio
Robert E. Dragon
Robert N. Frank
Peter D. Gibbons
Jeffrey B. Gluckman
Stanley I. Greenspan
J. McLeod Griffiss
Robert A. Gunn
Henry G. Hanley
Stuart T. Hauser
Jay G. Hayden
Mary Alice Houghton
Richard J. Howard
Gordon R. Kelly
Stuart M. Kotler
Wilbur L. Kukes
David C. Law
Caroline O. McCagg
Robert L. McRoberts
David B. Melchinger
John Stephens Melish
John J. Mooney
Eli H. Newberger
Edward J. O’Keefe
Neil J. Peterson
William D. Peterson
James D. Slavin Jr.
Lawrence J. Toder
Gary L. Townsend
Jon S. Wayland
Joan T. Wayland
Arne S. Youngberg

1967
Daniel L. Arons

Arthur L. Beaudet
Richard S. Bockman
Daniel J. Booser
Gary C. Burget
William T. Cave Jr.
Kenneth F. Crumley
Cynthia Rapp Curry
Marian C. Davidson
James J. Dineen
James M. Dowaliby II
John A. Drews
Peter R. Egbert
Dennis Grant Egnatz
Herbert W. Felsenfeld
Richard J. Hart Jr.
Richard L. Heppner
Peter N. Herbert
George P. Herr
David L. Ingram
Mary Jurbala
Melvyn Korobkin
Anthony P. Lovell
Stephen W. Miller
Joseph L. Morris
Jennifer Robinson Niebyl
John O. Pastore
William E. Perkins
Daniel F. Phillips
Brian F. Rigney
Jonathan L. Saveli
Alfred Q. Scheuer
Stephen C. Schimpff
Sidney C. Smith Jr.
Helen L. Smits
Lewis S. Solomon
Robert S. Steinberg
Richard B. Swett
M. David Tilson III
Karen H. Toker
Robert A. Vogel
Robert A. Vollero
Joseph F. Walter
Martin Wand
Robert J. Winer
Robert S. K. Young
Peter M. Zeman

Peter JokI
William F. Keane
Jeffrey S. Lee
Marc E. Lippman
Peter A. Livingston
Frank E. Lucente
Donald O. Lyman
Stephen I. Marglin
Rodrigo Martinez
John Allen McCutchan
Maria S. McCutchan
David P. Millett
Richard P. Mills
Richard M. Morehead Jr.
John A. Ogden
James W. Ogilvie
Margot Onek
Henry F. Panek
Jackson B.E. Pickett III
Charles T. Post Jr.
Ralph Jerome Rauch
Joseph L. Renda
Gordon H. Sasaki
Jacob J. Schlesinger
Bruce Stuart Schoenberg*
Frederick C. Sherman
Elizabeth M. Short
Howard W. Siegel
Gerald L. Springer
Lee H. Strohl
Edmund C. Tortolani Jr.
James L. Weiss
Per Henrik Wickstrom
Creed W. Wood

1969
Charles S. Angell
David G. Ansel
David W. Barry
Robert E. Belliveau
David A. Berkowitz
Donald H. Buchholz
Bruce W. Burleigh
N. Roger Cooke
Leo M. Cooney Jr.
Richard J. Daly
Michael W. Dennis
Charles A. Dinarello
Douglass T. Domoto
Ralph J. Falkenstein
Gary S. Famham
Lesley Forman Fishelman
Steven A. Frankel
William H. Frazier
Royal J. Gay
David A. Geer
Sander G. Genser
Robert O. Gordon
Steven M. Herzberg
John Frederick Hiatt
Larry C. Horowitz
Thomas C. Howard
Lee M. Jampol
Joel Mark Kaufman
Lynn G. Lagerquist Jr.
Michael R. Liebowitz

1968
Julius H. Anderson
Philip L. Barry
Daniel I. Becker
Bernard D. Beitman
Stuart J. Brill*
Donald R. Coustan
Rutledge W. Currie
Robert G. Dillard
Edward M. Druy
Barbara Mayer Egbert
Alan G. Finesilver
Richard A. Getnick
Mark Gilbert Grand
Leonard Grauer
Ralph S. Greco
Kevin N. Hennessey
John R. Hill II
Harry S. Holcomb III

1970
Elissa B. Arons
Gregory W. Bartha
John W. Blanton Jr.
Richard A. Charlat
Henry Chessin
Michael J. Chusid
C. Norman Coleman
James E. De Lano Jr.
Daniel Frizell Dedrick
Margaret W. DeLano
W. Montague Downs
Jonathan Ecker
Robert Alan Epstein
Bruce A. Fabric
Steven L. Fish
Robert D. Gilbert
Thomas H. Gouge
Paul C. Hessler
Jay H. Hoofnagle
Jonathan D. Katz
Kenneth A. Khoury
Ely A. Kirschner
Thomas L. Lewis
Anne W. Lucky
Jay W. Marks
William K. Mueller
James J. O’Donnell
Lynn Whisnant Reiser
Bruce A. Reitz
Robert M. Rosa
Dennis E. Shield
Stuart S. Short
Richard A. St. Onge
Robert S. Stem
Ray W. Tripp 111
C. Bruce Wenger
Daniel Wuensch
Marc O. Yoshizumi

NUMBER
CONTRI¬
BUTED

1972
Robert D. Arbeit
Michael A. Catalano
Michael L. Chamey
Alan J. Clark
Leonard H. Cohen
Philip L. Cohen
Gloria Cummings*
Norman M. Dinerman

1971
Judith L. Bader
Laurie J. Bleicher
Bruce Block
Marian H. Block

1989-1990
NUMBER
SOLI¬
CITED

Willard Cates Jr.
John L. Cieply
Frederick L. Cohn
Edward C. Cottle
Robert B. Diasio
John S. Ebersole
Leonard I. Eisenfeld
Thomas Etkin
Daniel E. Feldman
Harvey Fembach
Fred Finkelman
Peggy A. Finston
John W. Foster Jr.
Michael C. Gallant
Jared J. Gardner
Richard Gloor
Allan W. Graham
Jerold Alan Haber
William W. Hay Jr.
N. Timothy Jette
Geoffrey P. Kane
Richard E. Kaufman
Robert M. Kessler
Barbara K. Kinder
Michael E. Klein
William L. Krinsky
Gary M. Lande
David H. Lippman
Sten B. Lofgren
Sherry W H Loo
Wallace J. Matthews Jr.
Patrick T. Minihan
Steven H. Moffic
Richard Albert Moggio
Martin Pans
Robert Park
John A. Patti
Barry Bruce Perlman
Stuart B. Phillips
Michael C. Piercey
Anthony V. Proto
Irving G. Raphael
Douglas R. Schmidt
James P. Southwick
Charles J. Sutherland
Daniel R. Synkowski
Richard D. Travers
Semeon G. Tsalbins
Yvonne E. Vaucher
Paul A. Vignola
Robert B. Vranian
Ray C. Walker
Albert Carl Weihl
Jerold C. Woodhead
Bums Woodward
Daniel G. Wright

Elliot M. Livstone
Robert L. Marier
Arnold F. Mazur
Ellen B. Milstone
Thomas F. Minehan
Bruce K. Nagle
Lionel M. Nelson
Nancy Olmsted
Timothy A. Pedley
Deborah A. Putnam
N. Burgess Record Jr.
Joseph D. Robinson
Joseph M. Rochford
Dennis J. Rudzinski
Lutz H. Schlicke
Adrian M. Schnall
David J. Schulak
Gerald J. Smallberg
David L. Upton
Robert J. Walat

1990-1991

PERCENT
PARTICI¬
PATION

TOTAL

NUMBER
SOLI¬
CITED

NUMBER
CONTRI¬
BUTED

PERCENT
PARTICI¬
PATION

TOTAL

Alumni

3,735

1,630

44

$ 607,960

3,735

1,630

44

$ 607,960

Former House Staff

2,112

221

10

28,932

2,093

207

10

71,366

432

69

16

7,946

432

39

9

10,761

—

—

—

11,337

—

—

—

13,285

6,279

1,920

31

$ 656,175

6,182

2,287

37

$695,839

Parents/ Friends
Interest/Miscellaneous
TOTAL
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William H. Druckemiller
Jr.
William F. Duke
M. Felix Freshwater
Robert B. Geehr
Robert D. Glassman
Robert F. Goodman
Andrew H. Greenhill
Bruce B. Haak
Andrew E. Hoover
Thomas L. Horn
Vernon H. Humbert Jr.
Fred Hyde
Richard J. Inwood
Anthony H. Jackson
Jesse B. Jupiter
Frank M. Kahr
David L. Kneapler
Paul A. Lucky
Harry L. Malech
Jeffrey S. Menkes
Jerome H. Meyer
David B. Moyer Jr.
John P. O'Grady
Marc B. Osias
Peter J. Panzarino Jr.
John N. Posch
Louis Reik Jr.
William L. Risser
Richard S. Robbins
David H. Romond
Philip M. Rothfeld
Carl D. Sorgen
Frederick D. Stockwell
Gary .M. Strauss
Lawrence P. Temkin
Philip J. Weyman
Brooke M. Wolf
John D. Wright Jr.
Michael W. Yogman
Steven M. Zeldis
1973
David A. Adler
David Nelson Bailey
Mary Ann BrunstetterShafer
James N. Campbell
Marvin M. Chassin
George B. Colson
Joseph M. Connors
David L. Coulter
Carolyn G. Dedrick
Christopher M. Doran
Jane H. Ferguson
Richard J. Fingeroth
Robert A. Florin
Lee Goldman
Frederick M. Henretig
Howard S. Honig
Andrew G. Kadar
Michael S. Kramer
Lynne M. Liptay
George Lister Jr.
Douglas E. Mattox
John F. McQuade, III
Jerry Nagler
John Frederick Neil*
Claes M. Nilsson
David E. Peach
David Pickar
Robert Joseph Polackwich*
Charles F. Reynolds III
James S. Robertson
Thomas J. Romano
Harry S. Rornanow itz
Jerrold F. Rosenbaum
John P. Sherck
Joseph F. Simeonc
Robert A. Sirota
John R. Stratton
Charles F Stroebel
James F. Sullivan
Robert J. Ursano
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Christine A. Walsh
Richard S.K. Young
1974
Stephen B. Arnold
Irving M. Asher
Leonard 1. Banco
Douglas A. Berv
Neil Blumberg
Ronald C. Brown
Peter J. Buchin
Bert D. Collier Jr.
Paul David
Roger H. Emerson Jr.
Gerald O. Franklin
Allan B. Friedland
Michael A. Gerber
Ary Louis Goldberger
David Grant
Robert F. Hempton
Robert C. Jimerson
Marie T. Kelly
Robert M. Kolodner
Saul Lande
Olusegun O. Lawoyin
Edward L. Marut
James R. McMonagle
Daniel A. Moros
Ronald D. Neumann
Jerome B. Orlin
Richard C. Pasternak
Andrew L. Ries
David Z. Ritvo
Daniel 1. Rosenthal
Amy S. Schechter
Robert J. Schechter
Frederick S. Shessel
Alan B. Silken
James A. Strom
George H. Talbot
Carol C. Teitz
Edward M. Wolin

Alan B. Bloch
Helen Y.Y. Chang
Pauline Y. Chao
Richard S. Childs Jr.
Ellen C. Cooper
Vincent C. Dicola
Kenneth J. Dobuler
Gary S. Dorfman
Thaddeus P. Dryja Jr.
John A. Elefteriades
Leonard Firestone
Dennis M. Fisher
Ira H. Gewolb
Rose Hannah Goldman
Glenn A. Gorlitsky
Joel Kabak
Richard D. Kayne
Norman V. Kohn
Richard E. Kremer
William J. Lederer
William K. Levy
Sidney Mandelbaum
Cynthia F. Mann
Douglas G. Mann
Jon S. Morrow
Richard L. Neubauer
O’dell M. Owens
Daniel W. Rahn
Paul R. Ramirez
Mark C. Ruchman
Susan H.K. Ryu
Lawrence E. Samelson
Richard S. Schottenfeld
John T. Sladky
Charles R. Swenson
Jacob E. Tauber

Peter M. Ting
John C. Wiles
Jerome B. Zeldis
Carol M. Ziminski

Sharon R. Weinstein
John E. Whitcomb
J. Douglas White
Daniel Wohlgelemter

1977
Michael G. Adelberg
Phyllis August
John J. Boronow
Barbara Jeanne Brin
Stuart Brian Dubin
Marybeth Ezaki
Anne H. Flitcraft
James A. Fox
Julia B. Frank
Barbara K. Gehrett
Steven R. Hahn
Robert W. Hand
Bruce L. Innis
Howard K. Koh
David J. Kreis Jr.*
Margaret S. McKenna
Robert J. Mitchell
Alan S. Penziner
Richard E. Peschel
Theodore M. Pitts
Jordan S. Pober. PhD
Leonard A. Rappaport
Rachel Z. Ritvo
Steven J. Scheinman
Susan Bromberg Schneider
Ricky M. Schneider
Simeon A, Schwartz
Kenneth M. Stallings
Ronald J. Vender
Steven L. Warsof

1978
Thomas T. Amatruda
Michael J. Anderson
Patricia Bell
Joann N. Bodurtha
Booker T. Bush Jr.
Duke E. Cameron
Paul M. Copeland
James N. Dreyfus
Emily A. Fine
Maija G. Freimanis
Arthur M. Gershkoff
George M. Golenwsky
Linda J. Hall
Jerald D. Hansing
Jeffrey Neal Hausfeld
Alexandra N. Helper
Anne A. Knowlton
Cynthia S. Kretschmar
Kendrick E. Lee
Gertrude Wilkins
Manchester
Sanford D. Markowitz
Jose Luis Martinez
Robert K. McLellan
Michael J. Mitchell
Yvette L. Piovanetti
Barbara H. Pober
Seth M. Powsner
Jeffrey David Roth
Sally Rudicel

1975
Donald S. Bairn
Robert M. Bell
Ralph E. Binder
Sharon L. Bonney
William S. Bush
Rodney J. Butch
Brendan Clifford
Stanley W. Gale
Lana L. Holstein
Carol L. Kandall
Kevin Kane
Bernhard H. Lisker*
Richard J. Loewenstein
Yvonne E. Lomax Burnett
David A. London
Mary Jane Minkin
Robert G. Nankin
Andrew B. Newman
Edwin G. Olson
George J. Pardos
Mary Lake Polan
Stirling M. Puck
Vivian Reznik
Philip J. Rich
Salvatore V. Romano Jr.
Fred P. Rosenfelt
Steven A. Schwartz
Barbara J. Stoll
David J. Taylor
Richard L. Wagner
Mark F. Wheeler
David W. Wiltse
Douglas R. Zusman
1976
Sarah S. Auchincloss
Alfredo L. Axtmayer
John C. Bartlett
William G. Bithoney
Peter B. Bitterman

Roy P. Vagelos, M.D.. chairman and CEO of Merck and Co., Inc.
Yale Medicine
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Neal D. Ryan
Donald C. Simonson
Timothy J. Swartz
Rebecca A. Taub
Caroline R. Taylor
Marcia J. Wade
John D. Wagner
David L. Wessel
Susan Wong
1979
Nancy Berliner
Guthrie S. Birkhead III
David A. Brenner
J. Kenneth Burkus
Roy D. Carlson
Paul E. Collier
Isabel Cunningham
Jeffrey Neil Dombusch
Norman L. Elliott
John A. Fox
Joel I. Franck
John Jay Gargus, Ph.D.
Phillip M. Gendelman
David E. Golan
Bruce Halperin
Edward C. Halperin
Marc Hellerstein
Jonathan H. Holt
Arthur C. Johnson III
Jeffrey L. Kaine
Leslie Jay Katz
Helen H. Kay
Jonathan Kolitz
Wing-Yin Leong
Michael K. Lindsay
Shirley McCarthy
Timothy W. McKeithan
David E. Ness
Barbara Ann Peters
Jean Rosenthal
Lynn K. Rudich
Gary L. Schaer
Cynthia Anne Sherman
Jill A. Silverman
Gary Vitale
John T. Woo
Jeffrey Work
1980
David E. Adelberg
Eduardo Alfonso
Seth Leo Alper
Frederick R. Aronson
Alan B. Astrow
David Allen August
Jay M. Baraban
Mark S. Bernhardt
Patricia Church Brown
Daryl F. Browne
Michael W. Champeau
Michael M. Chang
Thomas F. Deering
Barbara G. Fallon
Todd J. Garvin
Marc F. Glickstein
David Jay Goldberg
Gary I. Greenwald
Maria White Greenwald
Jonathan L. Jacobs
Barry M. Kacinski
Theodore W. Marcy
Mary Polly McKinstry
Eric J. Nestler
Mark J. Ratain
Neal L. Rosen*
Steven I. Rosenfeld
Alan E. Schlesinger
Gerri A. Schulman
John A. Selling
Jeffrey N. Siegel
Hille! D. Skoff
Kim R. Swartz
Phillip I. Tarr

Yale Medicine

Howard W. Telson
Walter H. Williams
Mary Hill Wise
Lawrence H. Young
Raphael Zahler
1981
Adaora A. Adimora
Lisa E. Babitz
Alicia Barela
Sherri L. Brown
Stephen Wilson Burgos
Patricia A. Burke
Chee C. Chow
Christine M. Duranceau,
Ph.D.
Paula M. Fracasso
Ramona Q. Fung
Robert L. Galli
Laurie J. Gordon
Stewart G. Greisman
Neil D. Gross
Jeffrey A. Gruskay
Stephen R. Harrison
Scott A. Hundahl
Donald Ingber, Ph.D.
Thomas Kievan
Brian K. Kobtlka
Elliot Each
Aiziz Laurent
David E. Lebwohl
Bernard Lewin
Barton N. Milestone
Robert M. Milstein
Richard L. Mogeiman
David A. Paly
Robert B. Portney
Susan Burdette Radoux
Barbara A. Roach
Dovelet Shashou
Martin H. Teicher
Anthony M. Urbano
Alan B. Wagshal
John C. Wong
Frank E. Yeomans Jr.
1982
Sylvia R. Beck
Cathleen R. Belden
Paula K. Braverman
Thomas J. Brennan
David Goldstein
Jed B. Gorlin
Jessica Herzstein
Kenneth M. Huttner
Henry Jampel
Laurie B. Komreich Katz
Michael E. Katz
Patricia Kellner
Kathleen Anne Nolan
Joyce A. O’Shaughnessy
Christopher N. Otis
Robert Pierattini
Carrie A. Redlich
Steven D. Resnick
Robert J. Rizzo
Christopher W. Roberts
Paula C. Schlesinger
Cary S. Sennett
William M. Sikov
Yuen Tat So
Don L. Stromquist
Paul E. Sylvan
Lynn T. Tanoue
Patrick Toth
Albert L. Ungricht
David A. White
Stephanie Wolf-Rosenblum
Sandra L. Wolin
Jon P. Younger
1983
John Taylor Adams*
Robert E. Bookstein
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Michael Brines
Elena Citkowitz
Nancy Kraemer Crocker
Nancy Czarkowski
Anil Mohan DeSilva
James S. Grober
Tammy C. Harris
William Kadish
Robert M. Kotloff
Ana Maria Lamas
David Lindgren
Laurie Margolies
Edouard R. Martin
Miguel A, Martinez
David P. Norton
Dan A. Oren
Victor M. Perez
Augusta S. Roth
Moshe Rubin
Daniel Paul Sabbeth
Daniel M. Sosin
Philip M. Spiro
Kenichi Takeshita
Barbara E. Tardiff
Abby S. Van Voorhees
Pamela Leslie Zeitlin
1984
Martha Ray Arden
Robert W. Arnold
John F. Babich
Leonard Bell
Jessica Berman
Barbara Ann Coda
Leon Eisikowitz
David J. Fillmore
David A. Frank
Robert John Havlik
Sabra Lynn Jones
Emilio J. Juncosa
Jeffrey N. Katz
Michel Kliot
Daniel M. Kolansky
Jay R. Kostman
John H. Krystal
John Gerhart Lane
James G. Linakis
Dominic D. Pennachio
Jill S. Ratain
Ronnie G. Rosenberg
Paul B. Rothman
Joshua D. Schor
David A. Shrier
Michael Simons
Paul M. Snyder
Mark Stein
Susan P. Tredwell
1985
Jaime I. Arroyo
Barry D. Bergquist
Jane E. Carter
Calixto E. Dimas
Guy Fried
William D. Gaillard
Richard Bruce Garber
Samuel D. Goos
Marie Hobart
Stuart Neal Isaacs
Susan Korrick
Shirley J. Lee
Ted W. Love
Jeffrey A. Lowell
Anthony Marks
John Jerome Merendino
Robert D. Needlman
Thomas Newton
Leslye C. Pennypacker
Anne Regenstein
Ellen C. Rieur
Maria Suzette Rivera-MacMurray
Greg A. Sachs
Fred Santoro

Gary L. Shapira
Timothy Alan Shapiro
Louis J. Tesoro
Kimball Woodward
1985 Classmates*
1986
Catharine Ann Arnold
David Atkins
W. Lee Bailey
Eric F. Bernstein
Cristina M. Brunet
Suzanne D. Conzen
Ian A. Cook
John A. Detre
Amanda B. Dill
Gerard M. Doherty
Daniel S. Fierer
Jay Gates
Michael Grossbard
Gary Hirshfield
Jeremy L. Holtzman
Jay D. Kranzler
Roberto Lewis-Femandez
Julia Whiteside Michel
Matthew R. Moore
Steven Waisbren
John J. Wysolmerski
1987
Andrew Bazos
Ellen Dolnansky
David M. Fujii
John Michael Gaziano
Laurence Adam
Greenbaum
Marian Lee Greenburg
Glenn A. Healey
Hugh C. Hemmings Jr.
Peter T. Ho
Amy Caroline Justice
Rebecca E. Kadish
John F. Keaney Jr.
Joseph Thomas King Jr.
Christopher King
Susan Deborah Kruger
Elliott Levy
John Harlan Meyer
Nancy D. Olson
Patricia M. Powell
Lauri R. Robertson
Seth A. Rosenthal
Patrick A. Ruwe
Mindy G. Schuster
Michael H. Solon
Lynn Street
Richard P. Tierney
Robert C. Urban Jr.
Pradeep Kumar Varma
Leslie Vogel
David H. Weingold
Barry Weinstock
Mark D. Widmann
1987 Classmates*
1988
Kenneth A. Andreoni
Joi Barrett
Susan J. Baserga
John Pieter Belzer
K. Lisa Cairns
Kathleen Camey-Godley
David P. Cheimow
Robert W. Dorns Jr.
Joshua E. Freedman
Dean Kedes
Lisa Conrad Larkin
Frederick Long
Michael E. Mahig
Lance Arlen Markbreiter
Peter Alexander Merkel
Theodore Miclau
Michael Emeric Mockovak
Jacqueline G. Pachon

Donna Richman
Michael A. Rothschild
Mitchell J. Sklar
Walter Michael Stadler
Philip Adam Stull
Brent Watson Tatum
Susan Valley
1989
Stephen Bharucha
Maura Jo Brennan
Don H. Chin
David M. Cromwell
William S. Curtis
Alexandra Flather-Morgan
James M. Ford
Susan Garetz
Anita Goodrich
Adam L. Greene
Joni H. Hansson
Kraig E. Humbaugh
Howard Kesselman
Lawrence R. Kleinberg
Zachary Klett
Gregory M. Koshkarian
Marc Levesque
Robert L. Levin
Lewis Lipsey
H. Michael Morris
Lisa Ragen
Viviann Mattson Rubin
Virginia Jordan Sink
Stephen M. Smith
David M. Stier
Andrew Thomas Walker
Dora-Linda Wang
John Thomas Whalen
Roger F. Widmann
Darryl S. Wong
1990
Susan G. Anderson
Nancy R. Angoff
Ercem S. Atillasoy
Thomas J. Christopher
Mark A. Dettelbach
Ronald Ennis
Jonathan Todd Foster
Douglas Marc Freedman
Joanna Mara Girard
Alan Sander Hilibrand
Betty Shin Wun Kim
Kathleen Alexia Kline
Toshiko F. Magnus
Ira Meisels
Erika H. Newton
Jack Parent
Jane E. Rasmussen
Chander N. Sarny
Susie K. Sharpe
Neil A. Solomon
James H. Stein
Daniel Stryer
Marko Yakovlevitch
1990 Classmates

FORMER HOUSE
OFEICERS
Phillip R. Aaron
William R. Adams
N. Erick Albert
John L. Albrigo
Arthur Ames
William F. Arndt
John P. Amot
John M. Aversa
Adel H. Ayoub
Arnold M. Baskin
Richard Bass
Carl Bennett Bean
Gerald A. Belkin
Norberto A. Belleza
Gregory Kent Bergey
Ralph Daniel Bien
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Richard A. Blasband
Gary Bloomgarden
Malcolm B. Bowers Jr.
Christine Brahney
Ronald W. Braun
David Braun
John K. Burkus
Dennis J. Card
Claudia TTiomas Cany
Richard S. Casden
J. Richard Casuccio
Whei C. Chang
Richard Allen Chase
Rys/.ard Chetkowski
Chang Song Choi
Michael Chun
Ian M. Cohen
Bunon H. Cohen
David L. Copen
Leandro Cordero
Susan Covey
Sidney L. Cramer
Roben E. Crootof
Michael Martin Deren
Alexander Deutsch
Philip Sheridan Dickey
Daniel M. Divack
Donald S. Dock
June F. Donnelly
John 1. Dortman
William R. Drucker
Paul Duray
Stephen A. Edelstein
David E. Eibling
■Malcolm Mitchell Ellison
Walter Ettinger
Robert A. Feldman
Jeffrey C. Femyhough
Louis B. Fiemian
Richard Webster Finner
Stephen V. Flagg
Morris A. Flaum
Bruce T. Fletcher
John V. Forrest
Julia B. Frank
Daniel J. Friedenson
Josephine Fuhrmann
Norman H. Gahm
Phillip H. Gates*
David M. Gershenson
V. Philip Glassman
Barry Goldberg
Neal Benjamin Goldberg
Joel S. Golden
John W. Goldkrand
Isaac Goodrich
Richard Reed Gramse
Willard F. Greenwald
Mary Gregg
Gordon W. Grundy
Jo.seph Guaraldo
Kenneth Gwirt/
Hedda Ann Litowitz
llaning
Ray V. Haning Jr.
Richard B. Harvey
Mary .M. Hennan
Karen Hermansen
Philip D. Herrick
Douglas P. Hobson
Robert J. Holmes
Gregory L. Holmes
David Smith Hubbell
Eric A. Hyson
Robert M. Johnston
Clifford Joseph
Juliana Haeng-Cha Kang
Neil B. Kappelman
Jill P. Karpel
Falward Kent
Stephen King
Samuel ('. Klagshrun
Arthur H. Knowlton
Alexander Sandor Koleszar

W)

Thomas J. Koontz
Boonsri Kosarussavadi
Eugene Kuchner
Joel C. Labow
Sheri J. Lagin
Pritchard T.C. Lam
Emmanuel Landau
Robert Jan Lerer
Vincent Leung
Douglas M. Levin
Arthur L. Levy
John D. Lewis
Luke K. Licalzi
Deborah Lightner
Walter S. Lockhart
Dean Lohse
Kim Margolin
Stephen Mariani
Frank Masino
Richard J. Maunder
Robert McDonnell
John P. McGovern
Janet Meegan
Thalia Mesologites
William Metcalf
John H. Monroe
Yasmeen A. Moody
Patrick E. Moriarty
Sheila M. Moriber Katz
Lewis B. Morrow
John Moses
Hirotsugu Munechika
Seymour Cy Nash
Ethel H. O'Brien
Edgardo Ortiz
Robert L. Paltzik
George W. Paschal Ill
Lawrence Pass
Samuel J. Potolicchio Jr.
Edward W. Powers
Geoffrey R. Priest
Robert Princenthal
Shubhinder Puri
Edward L. Racek
Donald C. Rankin
Gilbert A. Ratcliff
Ranjit Rath
Robert R. Rickert
James A. Robb
Jeffrey P. Robbins
Robert L. Rowley
James R. Sabetta
Julia Sabetta
Michael Saruk
A.S. Hasan Sarwar
Mark Scharf
Fred Schiffman
Anton Schittek
Ronnie G. Schlesinger
Jonathan Schreiber
Doug Schulman
James Thomas Sehn
Howard Senter
Edwin C. Severinghaus
Thomas E. Shaffer
Daniel W. Shapiro
David H. Shapiro
Irving Sherman
Gary R. Siegel
Joel Silidker
Frederic N. Silverman
Earl J. Simburg
Daniel Simon
Ethan A H Sims
Thomas J. Spackman
Stephanie S. Spangler
Richard I. Staiman
Phillip Stark
John G. Steciw
Sturla Stefans.son
Judit Stenn
Elsa L. Stone
Barry S. Strauch
Fred Leslie Strieker

Nobel laureate George E. Palade, M.D., Sterling Professor Emeritus of Cell
Biology and dean of scientific affairs, the University of California San Diego
School of Medicine.

Herbert Tabor
Imad F. Tabry
James P. Taitsman
Marc J. Taylor
Lee Lawrence Thibodeau
Troy L. Thompson II
Carol Touloukian
James S. Touloukian
Kenneth Towbin
L. Newton Turk III
Daniel W. VanHeeckeren
Romulo L. Villar
Robert S. Waldman
Gary R. Wanerka
Thomas A. Warthin
Lionelle Wells
Herbert Allan Wenner
George Wharton
Benjamin B. Whitcomb
Princess Williams
Robert J. Williamson
Philip Witorsch
Eiji 'Yanagisawa
Robert C. Young
Marvin Paul Zimmerman

FORMER HOUSE
OEEICERS
Richard Walter
Zimmerman

PARENTS AND
FRIENDS
Yvonne and Badri Aghassi
Mrs. Bieggi
Bryan Birch
Harriet Farnsworth Brown
Mr. and Mrs. Abe Cazen
Mr. Howard Chin
Willibald H. Conzen
Mrs. Judy Coppola
Carolina Anca De Hostos
Anthony Delica
Mr. Arthur E. Dolnansky
Mr. and Mrs. Kenneth T.
Doran
Mrs. Vincent A. Doroszka
Dorothy Marie Ference
Philip Arthur Fey
Mr. Max Finkelman
William J. German*
Gideon Goldstein

Hans Graichen
Dr. Earl Hellerstein
Frederick W. Heilman
Mrs. Gloria F. Holmes
Guenther August Kaiser
Chang-Wuk Kang
Jacob Byung Kim
Andrew S. Kim
Kenneth P. Kinney
Leighmin James Lu
Mrs. Virginia G. Mannick
Mr. Shizuo Matsui
Mr. and Mrs. Victor M.
Newman
Mr. and Mrs. Louis Parent
D. Helaine Patterson
Dr. and Mrs. Levi V. Perry
Henri Peyre*
Ann D'Esopo Phillips
Mr. Leonard Portney
R. Donald Reich
Harold and Frances
Sampson
Henry S. Sanematsu
Mrs. Duangduen Schulick
Kenneth Alan Stein
David Donaldson Strachan
Prof, and Mr. Lubert Stryer
Mrs. Leo Teitz
Thomas M. Tierney
Mark Tyma
Jack Weingold
James Wells
Lloyd and Margo Zbar

* Deceased
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STERLING ASSOCIATION
LIFETIME
BENEFACTOR
Myron A. Sallick '24*
Berthold M. Comeau ’28*
Nathan E. Ross ’28
J. Roswell Gallagher ’30
Amy H. Hunter Wilson
’30*
Robert R. Wagner ’46
Myra D. Tyler ’50

SPONSOR
Myron A. Sallick ’24*
Leonard Greenburg ’30*
John B. Ogilvie ’34
H. Stuart Irons ’40*
David V. Pecora ’41
Anonymous ’43 March
Sanfurd G. Bluestein ’46
Lowell 1. Goodman ’51
Warren D. Widmann ’61
Mohandas M. Kini ’65
Stuart J, Brill ’68*
M. Felix Freshwater ’72
Michael G. Adelberg 'll

FORMER HOUSE
OFFICERS
Richard Allen Chase

PATRON
Donald P. Morris ’35*
Theodore E. Allen ’40
Robert H. Furman ’43
December
Martin E. Gordon ’46
Thomas T. Amatruda, Jr.
’51
Harold D. Bomstein Jr. ’53
William H. Hindle ’56
Edward O. Fox ’57
John A. Carlston ’58
Philip R. Fazzone ’58
A. Thomas Snoke ’64
Leonard Grauer ’68
James W. Ogilvie ’68

FORMER HOUSE
OFFICERS
Ronald W. Braun
Walter S. Lockhart
Dean Lohse

PARENTS AND
FRIENDS
Gideon Goldstein

FELLOW
William Cohen ’23*
Nathan E. Ross ’28
Henry H. Briggs Jr. ’31
Nelson Newmark ’31
Harry Sherman ’34
Margaret C. L. Gildea ’36
Alfred E. King ’37
Willys M. Monroe ’41
William Fleeson ’42
William Harrison Jr. ’42
Ralph D. Alley ’43 March
Lawrence G. Crowley ’44
Frederick F. Krauskopf ’44
A. Reese Matteson ’44
Nicholas PR. Spinelli ’44
Jay B. Cohn ’45

Yale Medicine

Franklin C. Behrle ’46
Thomas J. Coleman ’46
Owen W. Doyle ’47
Allyn G. Bridge ’48
Anne Godley ’48
Paul B. Koehler ’48
Jerome H. Shapiro ’48
Claude W. Delia ’50
Kent Ellis ’50
Harry L. McClelland ’50
Gerard B. Odell ’51
Arthur A. Pava ’51
Mary Wheatland Schley
’52
Ora K. Smith ’53
Arthur C. Crovatto ’54
James J. Nora ’54
John F. Carroll ’56
Mitchell Edson ’56
Marie-Louise T. Johnson
’56
Preston C. Manning ’56
F. Calvin Bigler ’57
William L. Kissick ’57
Donald C. Stahl ’57
Gerard N. Burrow ’58
Robert J. Donohue Jr. ’58
Paul A. Rudnick ’58
Raymond W. Turner ’58
Carol J. Amick ’59
Robert M. Amick ’59
Kiistaps J. Keggi ’59
Leo H. Von Euler ’59
John J. Schrogie ’60
Constantine M. Voyagis
’60
John E. Fenn ’61
Anoush Miridjanian ’61
Seth Thaler ’62
Alexander R. Gaudio ’63
Robert E. Mueller ’63
Peter G. Weiner ’63
Alfonso Esguerra ’64
Peter A. Gross ’64
Richard Murray Linburg
’64
Robert W. Lyons ’64
Robert L. Mitchell ’64
Donald G. Skinner ’64
Michael J. Cummings ’65
Philip D. Manfredi ’65
Jay G. Hayden ’66
Gary L. Townsend ’66
Kenneth F. Crumley ’67
M. David Tilson, III ’67
Joseph F. Walter ’67
Ralph J. Falkenstein ’69
David A. Geer ’69
Joseph M. Rochford ’69
Dennis J. Rudzinski ’69
Laurie J. Bleicher ’71
John W. Foster Jr. ’71
Michael C. Gallant ’71
Barbara K. Kinder ’71
Richard Albert Moggio ’71
Lynne M. Liptay ’73
Jacob E. Tauber’76
Marcia J. Wade ’78
Michael K. Lindsay ’79
Scott A. Hundahl '81

FORMER HOUSE
OFFICERS
Samuel C. Klagsbrun
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PARENTS AND
FRIENDS
Mrs. Vincent A. Doroszka
Frederick W. Heilman
Jacob Byung Kim

ASSOCIATE
Michael A. Parlato ’08*
Walter Clark Tilden ’12*
Julius Anthony Olean ’23*
David M. Raskind ’24
Maxwell Bogin ’26
John Martin Freiheit ’27*
Ernesto Icaza ’27*
Ralph E. Knutti ’28
Knox H. Finley ’30
J. Roswell Gallagher ’30
Lee E. Farr ’32
Myron E. Wegman ’32
Jack Greenberg ’33
Edgar S. Childs ’35
Samuel D. Kushlan ’35
Norman E. Peatfield ’35
Philip M. LeCompte ’36
Frederick A. Post ’36*
Rafael Arrillaga Torrens
’36
Stephen W. Collins Jr. ’39*
William H. Druckemiller
’39
John P. Ferguson Jr. ’39
Richard E. Dormont ’40
Patricia E. Wanning ’40
Peter A. Duncan ’41
Robert W. Ollayos ’41
Hendrik DeKruif ’42
R. Leonard Kemler ’43
March
Jonathan Trumbull Lanman
’43 March*
Hunter H. Comly ’43
December
Henry H. Jones ’43
December
Hoyt B. Miles Jr. ’43
December
Carol Goldenthal ’44
Elias J. Marsh ’44
Benjamin F. Kitchen Jr. ’46
Joe D. Morris ’46
Vincent Pepe ’46
William J. Wedemeyer Jr.
’46
George R. Barnes Jr. ’47
David L. Brook ’47
William F. Collins Jr. ’47
Robert J. Kerin ’47
Igor Tamm ’47
Edith M. Beck ’48
G. Robert Downie ’48
N. Joel Ehrenkranz ’49
Malcolm A. Bagshaw ’50
Sidney S. Lee ’50
Margaret S. Lyman ’50
John L. Sullivan ’51
Sidney Nathan Paly ’52
Robert G. Petersdorf ’52
John Macklin Roberts ’52
Robert Zeppa ’52
Seth F. Abramson ’53
Richard Andrew Sinnott Jr.

’53
James Frederic Young ’53
Lowell E. Olson ’54

Leonard M. Silverman ’54
Leroy Engel ’55
James Lum ’55
Rosalie A. Bums ’56
James C. Collias ’56
Sumner Gochberg ’56
William V. Lewit ’56
William M. Narva, MC ’56
George W. Paulson ’56
Stewart E. Pursel ’56
Theodore K.L. Tseu ’56
Donald Agostinelli ’57
Albert K. Chun-Hoon ’57
Robert K. Modlin ’57
Clifford B. ReitJer ’57
John Currier Gallagher
’58*
William M. Gould ’58
Paul Jay Friedman ’59
Herbert J. Kaufmann ’59
James A. O’Neill Jr. ’59
James R. Ralph ’59
David B. Skinner ’59
Paul Jay Friedman ’60
Eugene C. Gaenslen Jr. ’60
Thomas P. Kugelman ’60
Albert A. Bechtoldt Jr. ’61
Ronald A. Dierwechter ’61
Jon Dudley Dorman ’61
Thomas H. Sakoda ’61
Nancy Ann Staley ’62
Peter B. Gregory ’63
Edward G. Lund Jr. ’63
Lawrence Tremonti ’63
Stephen Waltman ’64
Michael P. Flynn ’65
David A. Hill ’65
Robert L. Pickens ’65
Robert T. Solis ’65
Wilbur L. Kukes ’66
David B. Melchinger ’66
John A. Drews ’67
Helen L. Smits ’67
Rutledge W. Currie ’68
Ralph S. Greco ’68
Kevin N. Hennessey ’68
Jeffrey S. Lee ’68
Margot Onek ’68
Charles T. Post Jr. ’68
Frederick C. Shemtan ’68
Per Henrik Wickstrom ’68
Leo M. Cooney Jr. ’69
Larry C. Horowitz ’69
Adrian M. Schnall ’69
Robert M. Rosa ’70
Bruce Block ’71
Frederick L. Cohn ’71
Daniel E. Feldman ’71
Sten B. Lofgren ’71
Patrick T. Minihan ’71
Martin Paris ’71
Robert Park ’71
John A. Patti ’71
Michael C. Piercey ’71
Charles J. Sutherland ’71
Albert Carl Weihl ’71
William H. Druckemiller
Jr. ’72
Jerome H. Meyer ’72
John F. McQuade. Ill ’73
Saul Lande ’74
Olusegun O. Lawoyin ’74
Edward L. Marut ’74
Douglas R. Zusman ’75

Gary S. Dorfman ’76
John A. Elefteriades ’76
Leonard Firestone ’76
O’dell M. Owens ’76
Gary Vitale ’79
David Atkins ’86
Amanda B. Dill ’86
Michael H. Solon ’87

FORMER HOUSE
OFFICERS
John L. Albrigo
John M. Aversa
Christine Brahney
John V. Forrest
John P. McGovern
Robert L. Rowley*
Daniel Simon
Carol Touloukian
James S. Touloukian
George Wharton

PARENTS AND
FRIENDS
Andrew S. Kim
R. Donald Reich
Prof, and Mr. Lubert Stryer

MEMBER
Charles R. Mitchell ’06*
Alice A. S. Whittier ’25
Tony Liebman Rakieten

29+

‘

Robert Tennant ’29
Frederick Fitzherbert
Boyce ’30
Michael D’Amico ’31
Paul A. Harper ’31
Thomas C. Jaleski ’31
Joseph P. Donnelly ’32
Elizabeth M. Ramsey ’32
John G. Martin ’33
Ashley Pond, 111 ’33*
Sidney Stringer ’33*
James Quintin Haralambie
’35
Stephen F. Nagyfy ’36
Hugh Allan Smith ’36
Margaret Sommers ’36
Alan A. Rozen ’37
Benjamin E. Lyons ’38
John J. McGillicuddy ’38
Edward W. Pinkham Jr.,
Ret ’38
Rebecca Z. Solomon ’39
Malvin F, White ’39
Henry D. Humphrey ’40
Edward Martin ’40
Robert H. Areson ’41
Knute E. Berger ’41*
Herbert W. Diefendorf 41
Robert L. Gilbert ’41
Robert E. Carroll '42
Leo Kellerman ’42
Dean Nichols ’42*
Lois Knight Rogers ’42
Maurice Tulin ’42
Irving Norman Wolfson
’42
Lycurgus M. Davey ’43
March
J. Philip Loge ’43 March
Edward F. Rabe ’43 March
Henry A. Riedel ’43 March
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Edward Hersey Soule ’43
March
John J. Weber '43 March
Norman I. Condit ’43
December
Victor C. Hackney ’43
December
Sawyer E. Medbury ’43
December
W. Keasley Welch ’43
December
Edward J. Conway ’44
John C. Coolidge ’44
Robert W. Frelick ’44
Charles A. Hall ’44
W. Raymond James ’44
Edith M. Jurka ’44
Jerome J. Kaye ’44
Laurence G. Roth ’44
George Howard Allison
’45
Albert S. Atwood ’45
Alice Shepard Cary ’45
Richard R. Dyer ’45
Robert S. Easton ’45
Alice Dershimer Friedman
’45
James D. Gardam ’45
O. Roger Hollan ’45
George W. Naumburg Jr.
’45
Richard M. Peters ’45
Gregory E. Flynn ’46
Charles Sheldon Judd Jr.
’46*
Robert R. Wagner ’46
William P. Walsh ’46
W. Roy Breg Jr. ’47
John L. Cannon ’47
Robert A. Chase ’47
Franklin Harold Epstein
’47
Richard K. Friedlander ’47
Brock Lynch ’47
William K. McClelland ’47
Myron K. Nobil ’47
Olive E. Pitkin ’47
Jonathan S. Bishop ’48
Ruth E. Cortell ’48
Richard H. Cote ’48
Elizabeth Fuller Eisner ’48
James W. Needham ’48
George P. Rostel ’48
Benjamin F. Rush Jr. ’48
Paul Talalay ’48
William G. Anlyan ’49
Jonathan S. Bishop ’49
Eleanora C. Gordon ’49
Jackson Harris ’49
Benjamin A. Johnson ’49
Timothy F. Nolan Jr. ’49
Julian I. Pichel ’49
Charles L. Rennell Jr. ’49
Carl M. Russell ’49
Martha Vaughan ’49
John E. Borowy ’50
Alvin Davis ’50
Lucian S. Lapinski '50
Janus C. Lindner’50
Harold March ’50
Jane B. Shumway ’50
John S. Strauss ’50
Stanley D. Ardell ’51
Eleanor Clay Bigley ’51
John J. Egan ’51
Sidney S. Furst ’51
Joseph M. Garland ’51
John T. Groel ’51
Carrold K. Iverson ’51
Robert D. King ’51
Jocelyn S. Malkin ’51
Paul D. Millikin ’51
Albert R. Mowlem ’51
Richard S. Munford ’51

Majic S. Potsaid ’51
Andrew S. Wong ’51
Thomas S. Kelly ’52
Leon A. Phillips '52
John H. Wagner Jr. ’52
Doris L, Wethers ’52
John L. Wolff ’52
William R. Chaffee ’53
Rex B. Conn ’53
John Leo Doppman ’53
A. Daniel Hauser ’53
Peter Biggs Hukill ’53
Richard Robert Knowles
III ’53
Paul G. Quie ’53
Jose Ramirez-Rivera ’53
Irwin K. Rosenberg ’53
Barbara F. Rosenberg ’53
William A. Whalen Jr. ’53
Richard J. Bouchard ’54
Herbert S. Hurwitz ’54
Robert J. T. Joy ’54
Paul N. Neufeld ’54
Anthony V. Piccirillo ’54
Richard D. Pullen ’54
John Keith Rose ’54
Robert L. Stein ’54
John W. Vosskuhler '54
Padraic Bums ’55
Edward D. Coppola ’55*
Milton Com ’55
David R. Kessler ’55
Robert A. Kramer ’55
John C. Pace Jr. ’55
Robert H. Peters Jr. ’55
Phillip W. Smith ’55
Peter Bios Jr. ’56
Levon Z. Boyajian ’56
Thomas M. Brown ’56
Joseph C. Cemy ’56
Donald J. Dalessio ’56
Thomas F. Ferris ’56
John H. Gardner, III ’56
Val Shea Greenfield ’56
John Herd Hart ’56
George T. Kammerer ’56
Jerome O. Klein ’56
Donald J. Nalebuff ’56
Robert Lee Scheig ’56
John P. Carey ’57
James R. Dorr ’57
Anthony L. Fons III ’57
Anne H. Good ’57
Richard Lee Kahler ’57
Jack Levin ’57
George K. Aghajanian ’58
Joseph E. Angelo ’58
Lawrence Dubin ’58
James Greenwald ’58
Michael Kashgarian ’58
Jay Ward Kislak ’58
Thomas J. Mauro Jr. ’58
William B. Radcliffe ’58
Edward Lloyd Socolow ’58
Joseph P. Wierzbinski III
’58
Asa Barnes Jr. ’59
Francis A. Beer ’59
Sidney M. Cohen ’59
Robert L. Fisher ’59
Robert J. Gonyea ’59
H. Rodney Hartmann ’59
William H. Heydom ’59
C. Richard Hinckley ’59
Leonard Inker ’59
John J. Jasaitis ’59
Myron S.S. Lee ’59
James D. Prokop ’59
Sanford P. Solomon ’59
Lisa A. Steiner ’59
Muriel D. Wolf ’59
Stuart P. Bowne ’60
Roland H. Ingram Jr. ’60
Daniel M. Jones ’60
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Edward R. Lang ’60
Donald L. Miller ’60
Jerrold M. Post ’60
Daniel J. Rubin ’60
Fred Stargardter ’60
May Yung-Fun Woo Wang
’60
Ronald A. Yankee ’60
Earl L. Baker ’61
Robert S. Briggs ’61
Edward C. Gilbert ’61
Richard L. Keefe ’61
Robert Isaac Levy ’61
George M. Lordi ’61
John Curtis Parker ’61
Elaine Pitt ’61
Shaun J. Ruddy ’61
Stanley G. Schade ’61
Hugh C. TTiompson, Ill "61
John V. Weil ’61
Charles B. Anderson ’62
Fredric K. Cantor ’62
Thomas Newell Chase ’62
Oliver Townsend Dann ’62
I. Bruce Elfenbein ’62
Anthony V. Furano ’62
John N. German ’62
David H. Groth ’62
David E. Knoop ’62
Allan L. Mattem ’62
Stanley E. Matyszewski
’62
William A. Miller ’62
Larry Lee Stewart ’62
Miguel R. Alonso ’63
Charles W. Carl Jr. ’63
Andrew Edin ’63
B. Allen Flaxman ’63
Benjamin Keith Harris ’63
William B. Lehmann '63
Peter B. Livingston ’63*
Lee Bland Talner ’63
Peter V. Tishler ’63
William A. Alonso ’64
Berton W. Ashman '64
Thomas A. Cardella ’64
Anthony Ferrante '64
Christopher W. Hauge ’64
William J. Houghton ’64
Lewis Landsberg ’64
James S. Levine ’64
William F. Matchett ’64
William B. Pratt ’64
Stanley J. Rosenberg ’64
Robert L. Shelton ’64
Sigrid L. Tishler ’64
Oscar Wand ’64
Thomas B. Caldwell, III
’65
Robert M. Cohn ’65
Phyllis Hurwitz Duvdevani
’65
Carl Ellenberger Jr. ’65
Robert I. Finkel ’65
James K. Gude ’65
Carl E. Hunt ’65
Virginia Burnham Johnson
’65
Ronald J. Karpick ’65
Sandra Chook Levine ’65
Mark W. Lischner ’65
A. Lawrence Ossias ’65
Gene A. Robinson ’65
John H. Seashore ’65
Margretta Ann Reed
Seashore ’65
Robert N. Frank ’66
J. McLeod Griffiss ’66
Stuart T. Hauser ’66
Caroline O. McCagg ’66
John J. Mooney ’66
Daniel L. Arons ’67
Herbert W. Felsenfeld ’67
Richard J. Hart Jr. ’67

Peter N. Herbert ’67
Anthony P. Lovell ’67
Joseph L. Morris ’67
John O. Pastore ’67
Jonathan L. Saveli ’67
Alfred Q. Scheuer ’67
Sidney C. Smith Jr. ’67
Robert S. Steinberg ’67
Richard B. Swett ’67
Robert A. Vogel '67
Martin Wand ’67
Robert J. Winer ’67
Daniel I. Becker ’68
Alan G. Finesilver ’68
Richard A. Getnick ’68
William F. Keane '68
Peter A. Livingston ’68
John A. Ogden ’68
Gordon H. Sasaki ’68
Lee H. Strohl ’68
David G. Ansel ’69
Bruce W. Burleigh ’69
Richard J. Daly ’69
Michael W. Dennis ’69
Lesley Forman Fishelman
’69
Royal J. Gay ’69
Sander G. Genser ’69
Thomas C. Howard ’69
Nancy Olmsted ’69
Timothy A. Pedley ’69
Joseph D. Robinson ’69
Lutz H. Schlicke ’69
Gerald J. Smallberg ’69
Gregory W. Bartha ’70
James E. De Lano Jr. ’70
Jonathan Ecker ’70
Thomas H. Gouge ’70
Jay H. Hoofnagle ’70
Ely A. Kirschner ’70
Jay W. Marks ’70
Bruce A. Reitz ’70
Richard A. St. Onge ’70
C. Bruce Wenger '70
Marc O. Yoshizumi ’70
Judith L. Bader ’71
Marian H. Block ’71
Edward C. Cottle ’71
Richard E. Kaufman ’71
Wallace J. Matthews Jr. '71
Stuart B. Phillips ’71
Irving G. Raphael ’71
Douglas R. Schmidt ’71
Richard D. Travers ’71
Semeon G. Tsalbins ’71
Yvonne E. Vaucher’71
Paul A. Vignola ’71
Robert B. Vranian '71
Jerold C. Woodhead '71
Bruce B. Haak '72
Thomas L. Horn '12
Vernon H. Humbert Jr. ’72
Fred Hyde ’72
Jesse B. Jupiter ’72
David L. Kneapler ’72
Richard S. Robbins ’72
David Nelson Bailey ’73
David L. Coulter "73
Richard J. Fingeroth ’73
Andrew G. Kadar ’73
David Pickar ’73
James S. Robertson ’73
Harry S. Romanowitz ’73
Joseph F. Simeone ’73
Charles F. Stroebel ’73
Irving M. Asher '74
Amy S. Schechter ’74
Robert J. Schechter ’74
Carol C. Teitz ’74
Edward M. Wolin ’74
Sharon L. Bonney ’75
William S. Bush ’75
Rodney J. Butch ’75
Mary Jane Minkin ’75

Alfredo L. Axtmayer ’76
John C. Bartlett ’76
Pauline Y. Chao ’76
Vincent C. Dicola ’76
Glenn A. Gorlitsky ’76
Norman V. Kohn ’76
William K. Levy ’76
Sidney Mandelbaum ’76
Mark C. Ruchman '76
Susan H.K. Ryu ’76
Ronald J. Vender 'll
Duke E. Cameron ’78
Cynthia S. Kretschmar ’78
Isabel Cunningham ’79
Phillip M. Gendelman ’79
David E. Ness ’79
Barbara Ann Peters ’79
Cynthia Anne Shennan ’79
David E. Adelberg ’80
Michael W. Champeau ’80
Todd J. Garvin ’80
Hillel D. Skoff ’80
Ramona Q. Fung ’81
Thomas Kievan ’81
Martin H. Teicher ’81
John C. Wong ’81
Cathleen R. Belden ’82
Thomas J. Brennan ’82
Don L. Stromquist ’82
Michael Brines ’83
Ellen C. Rieur '85
FORMER HOUSE
OEFICERS
Adel H. Ayoub
Norberto A. Belleza
Dennis J. Card
Whei C. Chang
Michael Chun
Stephen A. Edelstein
Richard Webster Finner
John W. Goldkrand
Isaac Goodrich
Karen Hermansen
Robert J. Holmes
Eric A. Hyson
Clifford Joseph
Eugene Kuchner
Hirotsugu Munechika
Ranjit Rath
Robert R. Rickert
James R. Sabetta
Daniel W. Shapiro
Ethan A H Sims
Barry S. Strauch
James P. Taitsman
PARENTS AND
FRIENDS
Willibald H. Conzen
Chang-Wuk Kang
Leighmin James Lu
Henry S. Sanematsu

* Deceased
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PUBLIC HEALTH ALUMNI FUND
1921
Ira V. Hiscock*
1923
Leonard Greenburg*
1927
Alice S. Baldwin
1930
Ruth E. Grout
1933
Miriam M. Campbell
Eunice Nickerson Tyler
1934
Amy 11. Hunter Wilson*
Iwao M. Moriyama
1935
Franklin M. Foote
Almeda King
1937
Howard West
William R. Willard
1938
Willard H. Boynton
Richard K C Lee
1939
Carl I. Cohen
1941
Roslyn L. MacNish
Margaret Hyde Moore
Marion Redmond
Alexander Witkow*

From the EPH Alumni Fund Chairman

I am pleased to acknowledge a $30(),()00
donation (over three years) to the department of
epidemiology and public health (EPH) from
Samuel S. Herman, M.P.H. ’48, Ph.D. '50 and
his wife, Liselotte.
Born in Boston, Mass., Dr. Herman attended
Harvard College, where he received his A.B.
degree. He then came to study at Yale’s
department of public health, where he earned
M.P.H. and Ph.D. degrees. After graduating. Dr.
Herman joined the National Institutes of Health
in Bethesda, where he established research
training and fellowship programs for the Eye
Institute and the Environmental Health Sciences
Institute. He also served as the deputy director
for extramural affairs at the National Cancer
Institute.
Dr. Herman left the NIH to join Temple Uni¬
versity in Philadelphia as associate vice
president for research and graduate studies at
the health sciences center, as well as associate
dean for research and graduate studies at
Temple Medical School. During that time, he
directed a congressionally mandated study con-

ducted by the National Research Council for the
National Academy of Sciences to determine
national needs for biomedical and behavioral
research personnel.
Since his retirement from Temple, Dr.
Herman has established a consulting practice
for education and research organizations. His
company specializes in Washington, D.C.,
representation for these institutions and in
biomedical research administration. In this
capacity, he serves as a consultant to the Lucille
B. Markey Charitable Trust.
The funds from a remainder interest in their
home will support EPH faculty research.
Besides thanking Sam Herman, I thank those
classes that passed the $ 1,000 per class goal.
This helped us reach 97 percent of our goal for
$140,247 from 654 donors.
Thanks to all of you.
Stephen Skorcz, M.P.H. ’70
Chairman

Amount

1942
Henry F. Canby
Leonard Parente
Charles D. Spangler

Class

Agent(s)

1948

Samuel S. Herman

1943
Richard F. Clapp
Eric W. Mood
Miriam 11. Rohde

1959

Dorothy M. Wilson

2.200

1969

Robert L. Young

2.097

1971

John Bihldorff

1.719

1976

Elaine P. Anderson

1.685

1967

James M. Malloy

1.650

1975

Linda K. Broker

1.568

1970

Susan W. Balter

1,350

1980

Christina P. Quinn

1,320

1978

Ann T. Freedman

1.145

1952

Yolande F. Lyon

1,100

1973

Gary Dean Sax

1.085

1986

Indu B. Ahluwalia

1943
Muriel Bliss Wilbur*
1944
Massimo Calabresi*
Jean F. Heston
Jane Y. Parker
1945
Roslyn R. Bill'ord
Naomi Barer Golden
Joe Bales Graber
Lois M. Jund
Ha/el M. Whitesel
1946
Dorothy B. Hamilton
1947
Sidney S. Chipman
Edna Miller Finberg
Anne 11. Pulton
Lillian L. Konick
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Stephen Skorcz

1977

$100,575

Aric T. Wilt

1,085

Dorothy A. Rice

1,050
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Raymond W. Leonard
Cecil G. Sheps
Oscar Sussman, D.V.M.

1948
John B. Dibeler
Mary L. Ellis
Joseph Hanford Gerber
Samuel S. Herman. Ph.D.
Dorothy S, Hoffmeyer
Richard E. Johnson
Beatrice H. Kaasch
Dorothea S. LaBelle
Hiram Sibley

1949
Edgar L. Geibel
Eleanor R Kostant
Hilda H. Kroeger
Christine R. Owre
William B. Parsons
Elizabeth D. Robinton
Matilda Rudnick

1950
Dorothy Reese Bloomfdd
Henry G. Brickman*
Ida M. Bucher
Helen P. Cleary
Austin J. Evans
Jerome M. Glassman
Dorothy R. Granoff
Martha P. Jayne
Frances K. Reynolds
Elizabeth M. Scully
Nathan M. Simon

1951
Clarissa E. Boyd
Norton G. Chaucer
Joanne E. Finley
Homer P. Hopkins Jr.,
Ph.D.
Robert L. Johnson
Leonard F. Menczer
Jessie Parkinson Spear
James M A Weiss
Walter Wenkert
John J. Zugich

1952
Cahit H. Corbacioglu
Howard Dunphy
Mary O. Gabrielson
Joanna Adele Henry
Malcolm C. Hope
Charles Holway Lawrance
Sidney S. Lee
Helen Kardys Loria
Yolande F. Lyon
Hannah Eileen MacHenry
Jeanne Ellen Paty
Brena B. Wolff

1956
David D. Boyd
Marvin H. Burton
Kathleen H. Howe
John E. Ives
Paul I. Kaufman
John F. Mullett
Julia R. Nole
Alice M. Wagner

1966
1957
Anne Anzola
Janet Beach
William A, Clermont
Edward R. DeLouise
Gaston Jules Deslouches
Sheldon Selig King
Edna May Klutas
Shirley T. Steidel
Paul W. Stemlof
Patricia A. Viscosi

1958
Eduardo Anzola
Josephine Blanchett
Edward Bronstein
Helen H. Davenport
Normand E. Girard
Patricia P. Grimaila
E. Field Horine Jr.
Edward H. Noroian
Mary K. Spiker

1959
William L. Kissick
Marvin A. Lavenhar. Ph.D.
Lee J. Podolin
John S. Pullman
Ellwyn D. Spiker
Mattie Lee D. Wade

1960
Bruce A. Barron
Gyla E. Brooks
Kathryn L. D’Amico
Wouter Ekker
Maxine Geeslin
Rose A. lannotta
Katharine Anna Keppel
John J. Kwasnowski
R. John C Pearson
Hannah Clark Russell
Else Niebuhr Schulze

1961
Gordon R. Beem
Martin Donabedian
Helen M. O’Connell
Margaret P. Parker
Angela M. Russo
William R. Slivka

1962
Thomas A. Biumenthal
Thomas R. Mayhugh

1953
Jeanette Averill
Abraham Cutcher
Laurence K. Rainsford
Milton H. Sisselman
Constance B. Thomas

1954
Ruth M. Taber

1963
Raul R. Cuadrado
David Dolins
C. DuVe Florey
Edward M. Kenney
Jean M. Maynard
Samuel B. Webb Jr.

1955

1964

Amy L. Cawley
Evelyn S. Farnsworth
Morris London
Mary Me C. Mogan
Frances R. Ogasawara
Gerald Rosenblatt
Daniel E. Ross

Katherine Maria Detre
Neal L. Maslan
Estelle Siker
Monroe W. Spero
Claudewell Sidney Thomas

Yale Medicine

James F. Jekel
Michael E. Kove
Peter J. Levin
Charlotte Miller
Francia M. Pagano
Elliot A. Segal
Viola J. Spinelli
David S. Weiner

Allen Cohen
Anne B. Collart
Richard H. Ferraro

1967
Carlos E. Alvarez Herrera
Caroline Fong-Cheng
Ann Gomez
Joel Kavet, Sc.D.
Patricia D. Mail
Charles J. Petrillo Jr..
Dr. PH.
Nancy Ruth Phillips, Ph.D.
Brigitte Prusoff*
Bruce J. Steinhardt
Beth M. Whelan
Irma Willner. R.N.
Robert L. Woodward
Peter T. Wotton

1968
Richard W. Ashton
Sonia M. Colon
Joseph L. Dorsey
Elizabeth Schwartz Elliot
Robert R. Everett
Carl R. Fischer
Francis J. Greaney
William D. Harkins
Susan F. Klein
R. Elizabeth Leif
Margaret J. Lindsay
Jean C. MacCorison
Richard L. Petrelli
Arnold R. Saslow
Sheila W. Wellington

1972
David P. Barone
Frances L. Bushnell
Catherine A. Connolly
Daphne deJ. Gemmill
Susanne Harris
Dorothy N. Lewis
Sergio Ruschel
Jo Ann K. Silverstein
Laurence A. Tanner
Frederick A. Vago
Joyce R. Waksman

1973
Emily M. Barclay
Eva Danielsson Cohen
Ellen B. Doft

1969
Susan S. Addiss
Janet A. Albrecht
Victor Crown
James M. Dawson Jr.
Beryl 1. Ford
Sharon A. Garcia
Catherine E. Hanley
Gerald R. Harpel
Sylvia N. Holtzberg
Charles C. Jeffrey
Samuel P. Korper
Marva Serotkin
Wanda Vierthaler
Carolyn K. Wells
Chester W. Zamoch Jr.

1970
Susan W. Balter
Katherine Benesch
Michael B. Bracken. Ph.D.
Hamilton B. Brown Jr.
Walter M. Gawlak
Robert S. Gureasko
Shirley O. Labrum
Scott W. Lite
C. P. Noel McCarthy
Andrea W. Nevins
Anthony M. Orlando
Peter Orris
William L. Pedersen
Nancy Norton Reitz
Charlotte F. Schwartz

1971

Robert M. Edwards
Edgar W. Francisco III

J. David Amundson
John Bihldorff

Gerard R. Goulet
William J. Grego Jr.
Donna Brown Grossman
Anne H, Hall
Barbara R. Unterman Jones
Philip D. Kennedy
Amy P. Kentera
Kathy S. Keuning
James E. Knoben
Marion Lee
Stuart L. Lefkowich
Hillary Demby Malafronte
Laurence F. McMahon Jr.
Lois S. Michaels
Edward J. O’Neill
Mary W. Palshaw
Dale P. Sandler, Ph.D.
Edward V. Sargent
Audrey Weiner Solomon
Raymond Chiu-Ping Tang
Franziska U. Ulrich

1976
Elaine P. Anderson
William F. Appicelli
Rochelle Arcus-Ting
Cheryl F. Austein
Joanna M, Erikson
Paul H. Etkind
Robert H. Frazier
Wendy Com Friedman
Annette B. Garofalo
Karen A. Gordon
Robert T. Kauer, Ph.D.
Cleve Lee Killingsworth
Robert A. Knauf
Eric Malz
Robert C. Marquardt
Gino A. Nalli
James B. Rokos
Robert Risdon Schwarz
Mary Jo Shepard
Gladys A. Williams
Thomas S. Wingardner Jr.

1977
1973

1965
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Evelyn J. Bromet
William F. Carey Jr.
Willard Cates Jr.
Katrina H. Clark
Dale A. Culp
John A. Daeley
Harvey Fembach
Anne-Marie A. Foltz
Dennis R. Hamilton
Sara P. Hartman
Mohamed Ismail Johnson
William P. Koughan
Mark J. Magenheim.
M.P.H.
Joan L. Martinez
Eugene S. Mayer
Nancy P. Mogielnicki
William C. Okulicz
Wan Hin Ooi
David A. Osgood
Carol L. Paul
Marcia Russell. Ph.D.
Jane Silver
Walter O. Spitzer
Robert E. Steele
Barbara R. Stoloff
Judith Whitcomb

Jerone A. Gamble
Marilyn S. Halper
Dennis P. May
George A. Million
Marjorie E. Nelson
Gary Dean Sax
Janet B. Schoenberg
Alice S. Stark
Thomas J. Stranova
Irene Trowell-Harris
Bonnie C. Yankaskas.
Ph.D.
Carl J. Zack

1974
Thomas A. Benoit
Ian B. Berger
Carl A. Cappello
Beth G. Crocker
J. Breckenridge Eagle
Elizabeth M. Helming
Roberta Lawrence
Heather Maycock Ogilvy
Nils R. Richardson
Abigail L. Smith
Myma M. Weissman,
Ph.D.
Bienvenido G. Yangco

1975
Edith N. Baum
Ralph E. Binder
Linda K. Broker
Ann C. Cunningham
Linda K. Demlo
Jack A. Eiferman
Joyce H. Glazer

Richard B. Burford Jr.
Patrick F. Carone
Steven R. Cohen
Bruce D. Cummings
Annette T. Eichenbaum
Gerard J. Foley
Henry C. Gift
Travis K. Hedrick, Ph.D.
Rhona Kantor Kershnar
Teri J. Klein
Thorsten Kruse
Ronald F. LaPensee
Wendy K. Lefkowich
Polly W. Marvin
Harris Pastides
Linda Mendelsohn Pottem
Dorothy A. Rice
Abby Rothschild
Carroll Schilling
Young S. Shin
Gail M. Sullivan
Virginia R. Towle

1978
Vijaya V. Bapat
Kathleen M. Berman
Alan B. Bloch
Robert W. Buckingham
Ann T. Freedman
Janice F. Gold
Cynthia R. Gross
David W. Houck
Jean Crum Jones
Margaret Long Karis
Rosalyn I. Liss
H. James Myers
Marguerite Nelligan
Patricia Lynn Noeker
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Peter F. O'Connor
David W. Osborne
Ellen J. Reitler
Ellen D. Rothberg
Irene Schapiro
Karen C. Schneider
Robert E. Schwartz
Alan J. Siniscalchi
Lucy Ellen Weiger

1979
Bruce S. Anderson
Virginia P. Bainbridge
Gertrud S. Berkowitz
Mananne Berwick
Mania P. Borgstrom
Christopher M. Cannon
James F. Consedine II
Susan De Renzo
Elizabeth Feuer
Lynn Fielden-Smith
Judith B. Gancher
Debra Haffner
Karen G. Hellenbrand
Joseph D. Henn-DeMayo
Lucinda H. Hogarty
Geoffrey P. Kane
Loren R. Kantor
Phillip S. Katz. Ph.D.
Karen Kmetzo
Paul Anthony Kowalski
Benjamin Krevsky
Renee S. Leary
Mary Elisabeth Lorenzi
Osvaldo Marrero
Patricia J. Moore-Pastides
Dolores Peneet
Marcia C. Richardson
Lisa Klar Rosenfeld
George B. Rowland
William E. Schweizer
Ralph Tartaglione Jr.
Elizabeth Tedder
Mary Jane A. Teta
Jane P. Watkins
Louise Wise
Jonas Zucker

Samuel S. Hamilton
Virginia S. Humphrey
Helen E. Kelly
Yee-Lean Lee
Robert V. Levine
LeRoy F. Ludwig
Kristina Obom Maldarelli
James S. Marks
Steven Morrow
Jane Ungate O'Connor
Ann L. Prestipino
Nancy Maguire Rhodes
Jeri Ann Rose
Norman M. Schlossberger
Lydia A. Selling
Marsha L. Silverman
Benita J. Sticca-O'Colmain
R. Blake Whitaker Jr.
Philip A. Witman
Mane L. Zanotti

1981

1980

Christopher J. Bevan
Harold J. Burdo Jr.
Carlos Ceballos
Patricia J. Checko
Rollin C. Chew
Angelo J. Devita
Alfred P. Dufour
Peggy A. Gallup
Judy E. Garber
Marie F. Gavula
Joan Urquhart Goodman
Diane E. Goren
Gerlinde B. Kehlenbach
Cindy F. Kleinian
TTiomas J. Krause
Katherine M. McCormack
Blackford Middleton, M.D.
Marlee D. Mooney
Mary' E. Papke
Ellen Gallagher Parsons
Barbara Gaugler
Pennebaker
Elizabeth N. Shapiro
Susan M. Stoecker
Karin Swanson
Keith D. Tait
Kathleen R. Yager

Phillip R. Aaron
Gary J. Aboff
Frederick R. Aronson
Diane Denis Aye
Curtis S. Breslin
Antoinette M. Brooke
Richtud L. Buck
Gary L. Busack
Martha G. Dale
Alfred E. Fasulo Jr.
Barbara H. Granger
Ellen B. Greif
Irwin J. Halperin

Margarita Acosta
Jamie L. Amaral
Martha Livingston Bruce
Francis L. Crowley
Doris Gordon
Denise Heinemann
Susan Eberle Levy
Linda F. McCaig
William F. McKeon
David L. Mork
Susan G. Rice

1982

NUMBER
SOLlClTEl)
EPll Alumni
Interest Miscellaneous
TOIAL
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Sally R. Rinaldi
Lisa E. Stone
Carol L. Vander Wal
Michele T. Visconti
Sandra Michaelson Warren
Maud Helen White
Alvin C. White
Amy B. Wilson
Jill Okrent Zaheer

Fitzpatrick
Shirley J. Lee
P. Douglas McConatha
Mara Natkins
Donna ITierese Perla
Adrian J. Pinsince
James V. Soscia
Priscilla A. West
Terry Martin Zingman

1983

1986

Barbara W. Abraham
Dean S. Archibald, M.D.
Mark L. Dembert
Lorraine DeNicola
Eileen McDonald Egan
Susan Earis
James N. Gaito
Ellen M. Ginzier, M.D.
Daniel A. Graybill
Wendy L. McGill
Cynthia M. Meyer
Scott K. Mock
Shinsuke Morio
Judith F. Nelson
Suzanne Nutt
Jeannee Parker-Martin
Barbra G. Rabson
Keith A. Radcliffe
Nano G. Rush
Lynn Marie Saphire
Paul M. Schur
Elizabeth C.H. Stevenson
Patricia C. Weber
Vicki L. Wilson
Nancy K. Wright

Clare F. Averbach
Andrea Lee Boissevain
Lewis P. Bower Jr.
Louise M. Brenner
Marijane L. Carey
Katherine H. Ciacco
Reid M. Davis
Joe Tom Easley
Susan Anne Egerter
Nancy E. Eithian
Stephen B. Gruber
Michael S. Huncharek
Roxanne Kapikian
Wendy Lee
Amy June Lippmann
David C. Lowy
Adrienne Marks
Monica Ann O'Neill
Philip O. Renzullo
Denise Amy Riedel
Eric Triffin
Virginia M. Westra
Katherine Burdick Wilson
Lynn D. Wilson
Aric T. Wilt

1984

1987

Laura D. Gibowski
Alexandra H. Giraud
Carolyn H. GranthamMillman
Kim S. Griswold
Penny H. Hausser
Marcia Lipkind Hirsch
Sarah M. Horwitz
Gregory R. Huth
Mehrdad Jalali
Georgia Jennings
Jean G. Larson
Andrea C. McCrenskyKremer
Grael M. O'Brien, Ph.D
Mitchell A. Portnoy
Jessica L. Richer
Julie A. Russem
Gerald L. Springer
Marie Ann Tobin

Hilda C. Chaski
Margaret D. Corbae
Deirdre A. Darsh
Nicolas N. Doan Van
Meg B. Domino
Robin N. Eastman
Jolie H. Eries
Bridgid M. Garrison
Carol Guardiano
Charlotte Hitchcock
Sara A. Holdcroft
Timothy A. Jacobs
Kastytis V. Kaleda
Michael T. Koff Jr.
Catherine A. Leda
Mary Ann Lillie
Peter James Malloy
Barbara J. Moggio
Maureen Brady Moran
Joseph J. Napolitano
Judith Ann Natale Sabino
Pamela Fitzgerald
Pomputius
Anita A. Roth

1985
Rene S. Cabral
Katherine Santella

1989-1990
NUMBER
PERCENT
CONTRI¬
PARTICI¬
PATION
BUTORS

TOTAL

NUMBER
SOLI¬
CITED

Michael J. Testa
Joel A. Wasserman
Elizabeth A. White

1988
Barbara Ellen Andrews
Robert Joseph Anthony
Ellen Elizateth Banach
Elaine P. Berger
Giselle Charlotte Bleecker
Lydia Jeanne Landis
Mark William Legnini
Paul Alan Lindia
Saifuddin Taiyeb Mama
Carrie A. Redlich
Lawrence Vincent Silvia
Bnan A. Triplett
Darlene Uten Zimmermann

1989
Judy Gardner Audette
John K. Cantelmo
Daniella Duke
Michael Joseph Gillespie
Eddie Sim Go
Elizabeth Harrison Hadley
Wen Hsiao
Marcella Perez Jones
Clifton Ping L,ee
Angela A. Mattie
Joanne Susan Mosca
Deena Beth Myers
Elizabeth Ann Platz
Robert P. Sbriglio
Nipon Sermpanich
Joy Misako St. Germain
Sophie Helene Tworkowski
Maureen McBride
Whitehurst

1990
Sylvia Elaine Bailey
Linda V. Bergonzi
Nicholas A. Daniels
Amy Margaret Davis
Cheryl Lynn Eattibene
Mark Steven Lachs
Lucie Langeler-Wilkins
Janet McCann
Angela B. Miller
Jennifer Jennings Miller
Karyn J. Nair
Charles W. Tomatore
Julie Ann Utroska

FACULTY
U. Robert Merikangas
Arthur J. Viseltear*

* Deceased

1990-1991
NUMBER
PERCENT
CONTRIPARTICIBUTORS
RATION

TOTAL

2,267

597

26

$135,523

2,353

654

28

$140,248

~

—

—

869

—

—

—

940

2,267

597

26

$136,392

2,353

654

28

$141,188
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EPH Alumni Fund Class Participation
1989-1990
CLASS

AGENT

TOTAL

1990-1991
% PART.

TOTAL

% PART.

1941 and prior

Eric Mood

$ 2,499

62

2,330

62

1942

Eric Mood

525

80

750

60

1943

Eric Mood

301

18

176

30

1944

Eric Mood

226

33

180

3

1945

Stephen Skorcz

125

33

160

42

1946

Stephen Skorcz

75

29

25

14

1947

Stephen Skorcz

145

30

325

37

1948

Samuel Herman

100,885

56

100,575

56

1949

Edgar Geibel

480

35

450

35

1950

Eric Mood

590

43

750

52

1951

Robert Johnson

590

40

595

42

1952

Yolande Lyon

445

33

1,100

44

1953

Milton Sisselman

185

25

195

26

1954

Eric Mood

45

14

25

7

1955

Frances Ogasawara

370

47

340

50

1956

David Boyd

520

42

390

42

1957

Edward DeLouise

520

45

570

50

1958

Philip Hallen

350

22

620

33

1959

Dorothy Wilson

1,250

22

2,200

22

1960

Gyla Brooks

350

39

625

48

1961

Joseph Prekup

425

41

210

5

1962

Thomas Mayhugh

250

20

1963

David Dolins

650

30

49

32

1964

Estelle Siker

760

36

625

23

725

41

675

34

1965
1966

Allen Cohen

135

23

160

12

1967

James Malloy

1,680

38

1,650

34

1968

Francis Greaney

1,185

36

960

36

1969

Robert Young

1,340

33

2,097

38

1970

Susan Balter

1,235

32

1.350

31

1971

John Bihidorff

1,540

44

1,719

52

1972

Dorothy Lewis

1973

Gary Sax

1974A

Thomas Benoit

1974B

395

21

525

26

1,330

30

1,085

27

350

30

390

23

275

20

450

26

625

25

840

25

1975

Linda Broker

1,178

27

1.568

35

1976

Elaine Anderson

1,670

30

1,685

31

1977

Dorothy Rice

740

24

1,050

25

1978

Ann Freedman

1,210

24

1,145

26

1979A

Catherine Norton

1,010

34

670

34

1979B

Ralph Tartaglione

560

36

875

43

1,570

35

1,545

39

1980

Christina Quinn

820

22

1,320

32

1981A

Angelo DeVita

485

21

565

25

1981B

Barbara Pennebaker

255

33

350

43

740

27

915

34

1982A

Constance Garowey

265

12

255

12

1982B

Jean Milton

470

26

560

35

735

19

815

24

1983A

Jeffrey Hughes

475

22

315

17

1983B

Marybeth McNemey

245

20

570

43

720

21

885

30

1984A

Anthony Alberg

235

18

405

22

1984B

Leslie Balch

205

330

16

440

12
18

735

19

1985A

Joan Cleary

205

13

40

4

1985B

Katherine Fitzpatrick

305

21

233

21

1986A

Indu Ahluwalia

1986B

Aric Wilt

510

17

273

13

625

25

655

24

510

24

430

28

1,135

25

1,085

26

1987A

Hilda Chaski

458

15

740

29

1987B

Elizabeth Wennar

300

8

225

10

758

12

965

20

1988

Joseph Della Puca

425

15

370

14

1989

Joy St. Germain

370

16

455

18

1990

Jennifer Miller

415

12
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TRANSITIONS
95
C
■O

At of his last functions as president and CEO of Yale- New
Haven Hospital, C. Thomas Smith (left) attended the June 6
dedication of the Boyer Center for Molecular Medicine.
With him are center Director Vincent T. Marchesi and Mr.
Smith's successor. Joseph A. Zaccagnino.

At the fall meeting of the Association of
Yale Alumni in Medicine, Thomas P.
Kugelman, M.D.’bO, passed the
president's gavel to Muriel Wolf, M.D.'59.

Hundreds of friends and colleagues attended a Nov. 16
reception honoring former Dean Leon E. Rosenberg. He is
pictured with (from left) Drs. Robert M. Donaldson Jr. and
Donald J. Cohen and Dr. Rosenberg's wife. Diane.
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CONTINUING MEDICAL
EDUCATION AT YALE

Saturday-Sunday
March 14-21, 1992

Imniunocytochemistry & Cryosections: A Practical Course

(A)

Direclor: Paul Webster, Ph.D.
For academic, governmental and industrial researchers involved in biological and medical
research who want to familiarize themselves with all aspects of the ultrastructnral
immnnolocalization of antigens and gain practical experience of cryosectioning.

Friday
March 20,1992

Bone Up On Osteoporosis

(B)

Director: Karl lusogna, M.D.
A state of the art approach to diagnosis and management of osteoporosis.

Friday-Saturday
April 3-4, 1992

Advances in Transfusion Medicine and linmunoheniatology

(C)

Director: Edward Snyder, M.D.
Fourth Annual Yale-Flarvard Symposium on advances in transfusion medicine
and immunohematology.

Friday-Saturday
April 24-25,1992

Visiting Lecture Series in Clinical Ophthalmology

(D)

Director: David Silverstone, M.D.
Guest Speaker: George Spaeth, M.D.
Glaucoma management in the 1990s.

Friday-Saturday
May 1-2,1992

Visiting Lecture Series in Clinical Ophthalmology

(Fj

Director: David Silverstone, M.D.
Guest Speaker: James Gills, M.D.
Cataract and lOL surgery update.

Wednesday
May 27, 1992

Fifth Annual Rheumatology Symposium - Lyme Disease

(F)

Director: Robert Schoen, M.D.
Will provide a focused update on all aspects of Lyme disease.
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International Health:
A Sleeping Giant Rouses
A Tribute to Wilbur G. Downs

Yale Medicine
Alumni Bulletin of the School of Medicine

Spring 1992; Volume 26, Number 2

President’s Message
As political changes across the globe continue at an astonishing
pace. University President Benno C. Schmidt Jr. outlines Yale's
commitment to leadership as a world university.

The Gift of Sight: India’s Cataract Camps
Medical alumni Mohandas M. Kini and Alexander R. Gaudio relate
their experiences as surgeons in one of India's cataract camps, part of
a system that saves the sight of thousands of people every year.

International Health: A Sleeping Giant Rouses

7

As Yale University unites its efforts in international health, eco¬
nomic development and the ecology, the School of Medicine builds
on more than a century of experience abroad.

A Renaissance Man in the Developing World
Dr. Herbert S. Sacks. ’52-'55 HS, recalls his relationship with the
late Wilbur G. Downs, and how this citizen of the world laid the
groundw'ork for an international health program at Yale.

East Meets West: The Yale-China Bond
Sherwin B. Nuland. '55 M.D., a medical advisor to the Yale-China
Association, reflects on the challenges of helping this Asian nation meet
its goal of an advanced approach to medicine.
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PRESIDENT’S MESSAGE
Michiic! Marslund

Henry Luce III and Benno C. Schmidt Jr. discuss the site of Henry R. Luce Hall, which will house the Yale University Center
for International and Area Studies. The Henry Luce Foundation Inc. donated $10 million to the project, to he completed in 1994.
hy Betino C. Schnudt Jr.
The world continues to change, and those changes pose special

Third, they will treat international studies as a distinct disci¬

challenges and unprecedented opportunities for American edu¬
cational institutions, particularly those—like Yale—which are

pline that cuts across traditional academic and professional
fields. They will therefore approach international studies from

“world universities.” Our institutions of higher education face

an interdisciplinary perspective, which will encourage not only

special challenges because they stand at the leading edge of

the comparative study of the languages, arts, culture, history, and
contemporary circumstances of all major regions of the world but

America’s international competitiveness and as a prime example
of the benefits of freedom and institutional pluralism. If America
is to maintain its global leadership role into the 2l.st century, the

also of such distinctively global fields as international health care
delivery, international human rights, international political

continued excellence and vibrancy of American universities will

economy, international law and the biosphere.

be an important reason why.

Fourth, the world universities will place high priority on
maintaining libraries, art collections, natural history and anthro¬

But our universities have a far more important role to play
internationally than simply keeping America competitive. Yale,
together with a relatively small number of true "world universi¬
ties.” will help forge both the intellectual alliances and the

pological collections, and other materials significant to all major

strategies that will guide leaders in every country and region.

by their close and extensive personal and institutional links with
students, faculty, alumni, and administrators from the world's

These “world universities” will be characterized by five
features. First, they will stand out for their ability to attract the
most distinguished students and scholars from all over the world

regions and international subjects.
Fifth and finally, the world universities will be distinguished

other leading universities and research entities, as well as govern¬
ments, foundations, corporations, and intergovernmental orga¬

to their undergraduate and postgradtiate programs and profes¬
sional schools. Second, they will demonstrate special ability to
send their faculty and students to study, teach and pursue re¬
search throughout the world and particularly to assist in the

nizations.
Yale is committed to playing a special role in forging and

intellectual reconstruction of universities, governments and the
private sector in developing and newly democratized countries.

in helping to shape responses to the problems and possibilities of
the emerging world order.
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maintaining such international educational and intellectual net¬
works and is well-positioned tocontinue playing an essential role

ii;irr> Hishdp

LETTERS

Dr. Martin Gordon
reacts to a question
posed to a student
presenter at the
annual Wilhur
Downs Overseas
Travel Fellowship
symposium and
poster session, held
in November 1991 in
the Jane Ellen Hope
Building.

Remembering
Wilbur Downs
l o the editor:

He became a fascinated student and

international travel fellowships, which of¬

then masterofcoLintless creatures and sub¬

fer the opportunity to study in a scientific

jects of nature. The world of Downs

endeavor abroad.

stretched from the sea to the skies while he

named for him because of the profound

snatched a flying arthropod, an as yet un¬

respect for his vigorous planning and in¬
tuitive sensing where the prepared mind

This fellowship was

I understand that the Spring 1992 edition

classified species, soon to be meticulously

of Y \i 1-. MedicinI: will feature interna¬

labelled, magnified and categorized.

A

w ill solve worthy problems. The synthesis

tional health. No discussion ofthis topic as

feisty fish was patiently awaited and suc¬

of the best in a kind, consummate scientist

it relates to the medical school would be

cessfully hooked by a lure of secret con¬

and insightful individual seems to be the

complete without a tribute to Wilbur C.

coction, itself springing from a little-known

persona of Will Dow ns. Chaucer's obser¬

Downs. M.D.. founder of the overseas

bird, feathers extracted and hung in the

vation best expressed this:

travel fellowship program that bears his

basement for years, waiting its turn for the

name.

endowed opportunity. This too was of his

"He taughte and first he folwed it

Will Dow ns' commanding presence w as

disposition, the constant defense of deli¬

himselve..."

immediately felt by all. not by an over¬

cate ecosystems' balance, expressed by

bearing nature, but by his carefully chosen

bringing sense to the nonsense of seem¬

Martin E. Gordon. M.D. '46

statements that flowed freely of wisdom

ingly glorious solutions to water supplies,

New Haven

based on experience. His adroit responses

the diverting of rivers, and glib changes by

to problems posed by both students, fac¬

the "experts," soon to affect the health and

ulty and friends were measuretl. impres¬

way of life of these hungry, native people.

sively profound anil invariably convinc¬

The feeling of being fortunate to be part

Editor's note: Dr. Gordon, clinical pro¬

ing. This characteristic was conveyed by

of this master's class was shared by stu¬

fessor of medicine, a long-tinw supporter

his totally frank, perceptixe observations,

dents as well as colleagues, imbibing the

of international health at the Yale Univer-

'fhose w ho were fortunate enough to know

many personal events of a lifetime of ad¬

sitv School of Medicine, serves on the

this giant came to realize that nothing

venturous science, a man of extensive re¬

niedical school's committee on interna¬

escaped his keen scientific grasp, surpris¬

flection on the universal status, warmly

tional health.

Eor further coverage of

ingly. in spite of the lifetime narcolepsy

discussing a better path to problem-solv¬

\\ ilhiir Downs, see ". \ Renais.sance Man

that never handicapped his intuitive prob-

ing. His passion for "learning by doing"

in the Developing World" by Herbert

inu.

became exemplified by developing the

Sacks. M.D.. on page 16.
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A Daughter’s Tribute
To the editor:
1 write in response to the notes on the 5()thyear reunion in

Yale Medicine

ter 1991-1992).

(FallAVin-

1 am David Pecora's

daughter, and I’d like to point out that my
dad still works "full time." We are grate¬
ful for his good health, which has enabled
him to purse his passion for practicing
medicine.

Up until October when he

turned 75. he was taking calls, working on
a trauma team, putting in long hours every
day, seven days a week.

Now he only

takes surgical emergency calls.
My only regret is that our "system”
does not recognize and allow individuals
like my dad, who are gifted, competent,
and devoted physicians to continue to
practice as long as they can. More and

Dr. Green during a recent trip to Munyara, Tanzania

more, recently, he has been under pres¬

Emeritus in Name Only

sure to retire. The impetus for this has not
been a concern for him or his patients, but

To the editor:

recruited from the United States and

rather an effort to lessen the competition
he represents to his younger colleagues,

Readers

who often are not so well trained and

interested in learning that one of the
medical schooFsfaculty, though emeri¬

experienced.
Although I cannot speak for my dad, I

of Yale Medicine

nia. The programs at both sites are
based on volunteer physician teachers

might be

tus. keeps himself professionally busy
in other ways. Most recently, for ex¬

Canada to teach, one at a time, in these
two pre-existing, structured teaching
programs for 12 months a year for four
years at Lusaka and for three years at
Moshi. Working in, with and for these

of the reasons medicine is not the re¬
spected profession it once was, is that too

ample, I completed a one-month stint

two programs involves a great deal of
time in East Africa and an equally great

of teaching in Lusaka at the University

deal of time recruiting back in the States.

many of its younger members no longer

of Zambia Medical School where I am

The ultimate goal is to improve the

share the value of dedication to the ser¬
vice of their fellow human beings that the

Professor of Anaesthetics. The 1400bed University Teaching Hospital is

quality and quantity of medical care in
an area where anesthesia personnel are

older members took for granted. Medi¬

one of two locations at which I have

so scarce that only 15 to 20 percent of

cine today has become a business. As I
watch my dad's career drawing to a close,

established Overseas Teaching Pro¬

the amount of surgery that should be

grams sponsored by the American So¬

done can be done.

I share his sense of loss, because I think
we as a society will never know the likes
of him and his generation of doctor.
I

ciety of Anesthesiologists. The other is
at the non-sectarian Kilimanjaro Chris¬
tian Medical Center in Moshi, Tanza¬

Nicholas M. Greene. M.D.
New Haven

can say that it is my impression that one

attribute this sad situation, in large part to
a lack of willingness of this profession to
hold its own members accountable when

Corrections

they are unethical or greedy.

dollars per procedure, does not always
produce a sterile culture, and is poten¬

1 also want to register my frustration
with the waste that occurs when our soci¬

tially dangerous to patients. Yet. on both
counts we ignore the timeliness of our

Yale Medicine,

ety does not allow all of its citizens to be
productive. My father is a world-class
expert on the treatment and cure of tuber¬
culosis. In addition, transtracheal aspira¬

heritage.
The world is facing a rise in the inci¬

tant professor of pathology, was mis¬

dence of tuberculosis, and everyone is
concerned about lowering the costs of

spelled. as was the first name of Jon
Morrow, professor and chairman of pa¬

tion was developed by him (New E)i-

health care. Instead of looking at what we

gland Journal of Medicine. 1985, Vol.
71, page 285). At $35 per procedure,

already have, we are going to ransom the
next generation's well-being in order to
reinvent what the last generation already

thology, on page 23. To correct an error
on page 44, Nicholas D'Esopo is M.D.

transtracheal aspiration is less expensive,
more accurate, and safer than the much
more
commonly
prescribed
bronchoscopy that costs thousands of

in the caption on page
18, the first name of Brian West, assis¬

Class of 1936. Our apologies.

discovered.

Y,\le Medicine welcomes letters from its
readers. Letters will he published at the

Ann Pecora Diamond

discretion of the editors and may he ed¬
ited for length, style and content.

New Haven
Yale Medicine Spring 1992

In the FallAVinter 1991-1992 edition of
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THE GIFT OF SIGHT:
INDIA’S CATARACT CAMPS

Hiimi

Siir<^ei>ns opcrale in </ convcrtcil c la.ssrooiii in Main^alore. India.

h\ Mohandas M. Kuu. M.D.. Fh.D. '65
and Alexander R. Gandio, M.D. '65

cataract surgery is out of the question. The problem of limited
funds is. compounded by a lack of supplies and a minuscule
ophthalmologist-to-patient ratio.

World Health Organi/ation (WHO) data from 19S7 estimate

d'his makes it imperative that programs intended to assist

that worldwide. 3.^1 million people are blind, of which 6.S per¬

developing lands be designed with such limitations in mind.

cent live in Asia and 20 percent in Africa. That number is
rajiidly increasing with the population explosion in developing

operations in a short period of time and at a price that the

nations. By far. the leading cause of blindness is cataracts,

national health care system, private and governmental, can
sustain. During each of the past several years one of us (MMK),

affecting an estimated 20 million people, most living in rural
areas of rieveloping countries.
As to cataract treatment, health professionals bear both
good new's and bad news, d’he good news is that, unlike some of
the other causes of blindness, cataracts can be surgically treated.
■Such operatir)ns. with or without intra-ocular lens (lOL) implantation. have proven a safe and effective method r)f restoring
\ision in those patients who can be accessed. In the United
.States, w ith 100.000 ophthalmologists per person, approximately
I million cataract operations, most involving lOLs, are per-

Effective approaches provide for a high volume of cataract

has volunteered in one such successful system—the cataract
camps of India. In 1987, both of us participated in a camp in
Mangalore, organized by Professor C.R. Kamath, M.D.. chair¬
man of the ophthalmology department at Mangalore's medical
school. For both of us. the experience was emotionally and
spiritually exhilarating
The conceiit of "ambulatory" cataract surgery that is the
current norm in the U..S. has been long prevalent in cataract
camps in India, dictated by financial exigencies. W'ith limited

formetl yearly at a cost of .S3 to 4 billion.
The bail news reflects the status of health care in the world
at large. Namely, in ileveloiiing nations such as those of Asia

resources, a population of 8.30 million and a ratio of one oph¬

and sub-Saharan Africa, where the per capita annual health
expenditure is only a few dollars, high-technology, high-cost

cataract-related blindness. Local Indian Rotary Clubs and Li¬
ons Clubs and a large cadre of community health workers

4

thalmologist for every million people, this subcontinent relies
heavily on community involvement in its campaign against
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contribute magnanimously of their time and effort to the camps
which offer, at least to some, the hope of sight.

each convenient patient "bedrooms," each accommodating ap¬

One can liken a cataract camp to a wheel, the ancient

proximately 10 patients and 10 relatives, dheir shared bed
consists of a blanket on the floor, d’he operating room has four

symbol of India which is featured prominently on its national
flag. Each camp serves as a wheel's hub. connected to several

to six operating tables, so that several ophthalmologists can
simultaneously perform surgery.

mobile clinics, which are the spokes. These clinics screen
patients and channel candidates for cataract surgery to “the

operations, mostly for cataracts, but also for dacryocystitis,

center,” in our case the city of Mangalore on the beautiful
Malabar coast facing the Arabian Sea.
The Malabar coast has been a thriving trading area for

A typical morning of surgery includes approximately l.'^O
pterygia, glaucoma and trachoma. Patients are prepared in an
anteroom with dilating drops, lid and retrobulbar anesthetic
blocks, and a subconjunctival prophylactic antibiotic injection

2,000 years, with Arab ships, called dhows, plying the Indian

to supplement antibiotic drops administered several times the

Ocean to carry on the spice trade with the Middle East and

day before surgery.

Europe. Vasco Da Gama, the Portuguese explorer, discovered
the sea route to India five centuries ago and founded the first
Portuguese colony on the western coast of India. Jesuit mis¬
sionaries soon came and established a successful system of
education. The Portuguese influence is still evident in the
region, as is the influence of Jesuit schools.
Vegetation here is lush and verdant, a result of the mon¬
soons which bring close to 100 inches of rainfall per year.
Agriculture and related industries, the mainstays of the economy,
provide a greater level of prosperity than is seen in many other
parts of India. In fact, Mangalore is known as the cashew nut
capital of the world.
In keeping with this city’s relative "prosperity," a wellestablished medical school offers postgraduate residency pro¬
grams in all major fields, including ophthalmology. We came
to the cataract camp in response to an invitation by Dr. Kamath.
He and his colleagues apply themselves indefatigably to the
planning and successful operation of camps throughout the
area. Their enthusiasm and hospitality made our experience all
the more memorable.

Front left, Drs. Gaiidio, Kamath and Kitn.

Mangalore's approach for the past 17 years has been to
send teams of ophthalmologists and technicians to surrounding
villages to examine patients for eye pathology, especially cata¬
racts. The team's impending arrival is well-publicized; every¬
one with ocular or visual problems is encouraged to attend the

Drs. Gaiidio and Kini:
Partners in Humanitarian Service

local clinic. Careful scheduling makes it easy for people to
attend; clinics are offered twice a year, at times chosen not to
conlJict with the planting or harvesting seasons.

Alexander R. Gaudio, M.D. '63. and Mohandas M. Kini.

Since India has a well-established optical industry, inex¬
pensive spectacles are available to patients who need only

clinical projects since 1959. when they were research

corrective lenses. Eor cataract patients, those who are judged

in ophthalmology at the Massachusetts Eye and Ear Infir¬
mary in Boston, and subsequently did fellowships in reti¬

healthy enough are scheduled for surgery in the camp. Patients
with a history of hypertension, diabetes, anemia or other signifi¬
cant problems are operated on in the hospital proper.
Camps are under the medical supervision of a faculty mem¬
ber from each of the departments of cardiology and anesthesiol¬

M.D. '65. have collaborated on various academic and
fellows in pharmacology at Yale. They were co-residents

nal diseases and surgery. Today, Dr. Gaudio practices in
Hartford, Dr. Kini in Boston. At the Mangalore School of
Medicine in 1987, the authors served as volunteer eye
surgeons for the cataract camp and taught postgraduate

ogy. A cataract camp operations manual sets strict guidelines
that emphasize service and high quality. In Mangalore, the
cataract camp is scheduled during school vacation, so that

students and practicing ophthalmologists. As part of their

schools can be temporarily converted into operating theaters

and ophthalmic medicines. Reports Dr. Kini. "Numerous
U.S. companies have been extremely generous in the

volunteer work. Drs. Gaudio and Kini garnered easily
transportable supplies, such as fine sutures, instruments

and hospital rooms. Some children returning from break sit
down to desks that were used as an operating table only a few
days before.

donation of supplies, in particular Alcon Labs of Fort
Worth. Texas, and Johnson & Johnson of Princeton, N.J.

Converting a school into an ambulatory surgical unit is a
fascinating process that testifies to Indian ingenuity. After

In addition, our own hospital, the Massachusetts Eye and
Ear Infirmary, has been an extraordinarily generous source

appropriate decontamination procedures, the main classroom
serves as the operating room, and satellite classrooms provide

of valuable supplies over the past 15 years."
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Operations consist of an intracapsiilar cataract extraction
(ICCE) performed with the aid of magnifying loupes; illumina¬

While the "hub-and-spoke” system has been effective in
channelling patients to the eye camps, much work remains;

tion is provided by a single bulb suspended from the ceiling.

though the field clinic and cataract camp attract more than

Prohibitive cost precludes intraocular lens implantation and the

2.000 patients per session, less than 25 percent of those in the

microscopic surgery taken for granted in the United States.

area needing cataract operations receive them. Moreover, the

Paramedical personnel assist in patient traffic, handling
supplies and equipment, and recoridng the operation.

modern era of cataract surgery in the villages surrounding

Rotary

Mangalore awaits the availability of low-cost lOL’s and cheaper

Club and Lions Club volunteers serve as medical aides, bring¬

portable microscopes. For now. the overriding hope of Dr.

ing patients to and from the operating table. These local civic

Kamath and his colleagues, which we share, is the attainment of
a “cataract-free" zone in Mangalore and its environs.

groups also help patients with transportation, board and lodging
for their stay at the camp.

What makes this hope seem achievable is the extreme cost-

Patients are admitted on a Saturday, have their surgery

effectiveness of the cataract camp system. The total cost per

performed on Sunday, and are discharged by the following

patient, including surgical and post-operative care, amounts to

weekend. As is the usual custom in developing nations, close

less than $20 (U.S.). less than 1 percent of the cost in the United

relatives often room with patients during their hospital stay,

States. The.se expenses are covered by financial support from

providing emotional support and custodial care. At each cata¬

local and outside philanthropic agencies.

ract camp, approximately 150 patients receive free surgical and
post-operative care.

Non-governmental organizations (NGOs) such as Sight
Savers (U.K.) and Operation Eye Sight Universal (Canada)

Daily post-operative checkups are done for five to seven
days, followed after one month by checks in the rural villages,

have been extremely important supporters of our cataract camp.
Other NGOs that are active in blindness prevention programs

where spectacles are irrovided through the generosity of local

both in India and throughout the world are Helen Keller Inter¬

opticians. Complication rates have been acceptably low.

most of these surgical patients are blind from “white’' mature

national and the International Eye Foundation (U.S.A.). Fore¬
sight (Australia). Chiistoffel BUudenmission (Germany), and

cataracts, they are grateful for the restoration of vision and

Organization pour la prevention de la cecite (France).

happily tolerate the aphakic spectacle correction with their
attendant magnification and distortion problems—found un¬

To the credit of U.S. ophthalmologists and ophthalmolo¬
gists in advanced nations, many are volunteering their services

bearable by most patients in the U.S.

in developing nations at their own expense.

As

The American

Academy of Ophthalmology, under the able guidance of Presi¬
dent George E. Garcia. M.D.. and Executive Secretary Bruce
Spivey. M.D.. have started a section on international ophthal¬
mology. emphasizing the commitment of organized American
ophthalmology to problems in developing nations.
Does this burgeoning international awareness and the suc¬

Geographic Location
Can Contribute to Blindness

cess of India's cataract camps offer a realistic hope of eliminat¬
ing preventable blindness altogether? In countries such as
China and India, which have a reasonable number of skilled

coma. diabetic retinopathy and age-related maculopathy

personnel, the answer is yes.
In sub-Saharan Africa, however, where the health care

are chiefly responsible for legal blindness, in the develop¬

challenges can best be described as staggering, prospects are

In contrast to the United States, where cataracts, glau¬

ing world, the major causes of blindness are cataracts and
ocular diseases peculiar to geography. These diseases
include; onchocerciasis (river blindness), trachoma and
xerophthalmia, with the latter two conditions attributable
to poor hygiene and poverty. Onchocerciasis, which oc¬
curs mostly in West Africa and in small pockets of Cen¬

not as bright. In sub-Saharan Africa, despite an annual inci¬
dence of 5()0.()()0 newly blind people, only 5().()00 cataract
operations are performed each year, leaving an estimated “cata¬
ract backlog” of 3 million. Whereas the challenge in China and
India is how to distribute manpower, in sub-Saharan Africa the
crisis is the lack of manpower. What is more, the rapid spread

tral and .South America, is treated by oral ivermectin.
Vector control is achieved by spraying the breeding sites

of HIV infection, along with ocular complications of AIDS,

of the Simulium black fly with larvicide.

treating trachoma wdth tetracycline ointment, commu¬

in these nations.
To end on a hopeful note, perhaps part of the worldwide

nity-based health education programs emphasize simple
hygiene to prevent intrafamily transmission.

peace dividend promised by the end of the Cold War will be
directed toward improving health care in the developing world.

Xerophthalmia and keratomalacia are caused by vitamin

In the meantime, developing countries will continue to rely on
the critical contribution of skilled Western volunteers. There

Along with

A deficiency, a major cause of measles-associated blind¬
ness of Africa, t reatment consists of oral vitamin A

introduces a menacing new factor in providing ophthalmic care

capsules, 2()(),()()() ILL for two consecutive days, along
w'ith maintenance supplements. Recent studies have also
shown that vitamin A supplements increase childhood

is much to recommend the volunteer experience. Our feelings
upon seeing the quiet, tearful smile that comes to a patient's
face when the eye patch w'as removed for a post-operative
check were a mixture of exhilaration, our ow n tearfulness and

sLiiA'ival significantly.

gratitude to God.
think about it.
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The “goose bumps” still appear when we
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INTERNATIONAL HEALTH:
A SLEEPING GIANT ROUSES

Robert Liu. M.P.H. '92. a 1991 Downs Iiitenuitional Travel Fellow, assists a couuuiuiity health worker in Patau. Nepal.

by Gregouy R. Huth, M.P.H. '84

Although his response rings true for the Yale School of
Medicine (YSM) as well, growing efforts at the school promise

Outside, the plate glass windows of the University Art Gallery
lecture hall impassively defied the cold October rain. Inside,

to help launch the University into international leadership.
Ever since 1834. when medical missionary Peter Parker

wami and dry. sevei'al score graduates who had returned for the

graduated with his M.D. and M.Div. degrees and trekked to

Association of Yale Alumni's 39th Assembly listened in rapt
attention as Gaddis Smith. Ph.D.. led a faculty panel discussing

Canton to establish the first Western hospital in China [see
"Gallery." page 27]. generations of YSM faculty and graduates

Yale's future as an international university.
As Dr. Smith, director of Yale's Center for International and

have produced leaders in international health. Some of these
efforts have been the result of University-affiliated programs,

Area Studies, invited questions from the audience, a venerable,
tweed-jacketed alumnus rose and asked whether Yale could be

such as the Yale-China Association's founding of Chang-Sha
Hospital in 19Us by Yale College alumnus Edward Hume. M.D..

considered an international university even today.
'if you're asking if we should be." said Dr. Smith, "my reply
is a definite yes. If you're asking ’are we.' the answer is a

and Fu-Chen Yen. M.D. '04.
Historically, other Yale contributions in international health
have resulted from federal government initiatives, such as YSM's

qualified yes."
Gregory R. Huth is publications editor at the Yale University
School of Medicine Office of Public Infonuatiou.
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involvement with the Atomic Bomb Casualty Commission, which
began ongoing epidemiological studies in Japan at the end of
World War II. Individual efforts too have played a role. For
example, since his retirement in 1989. Nicholas M. Greene.
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M.D.. professor emeritus of anesthesiology, has been making
regular trips to East Africa to train physicians in his specialty.
This academic year should prove a hallmark, however, for
the international efforts of Yale and its medical school as they
cr)ordinate their hurgettning—though heretofore disparate—edu¬
cational anri research resources in this field.
On the education front. 1991-1992 is witnessing the third
side of what Gaddis .Smith calls, the "Yale Triangle" falling into
place. Sides one and two. he e.xplains. were created in 1990 with
two joint graduate degree progratiis. The first was in epidetiiiology and public health (EPH) and international relations; the
second, internatiotial relations anil forestry/environmental stud¬
ies.

This academic year should complete the triangle with ex¬

pected faculty apprmal of a joint program in forestry/environ¬
mental studies and EPH. Thus, the Lhiiversity will have laid the
groundwork for interdisci|ilinary cooperation in the areas of
health, econotnic development and the ecology.
Building on this foundation, the international relations cen¬
ter. forestry/environmental studies and EPH have received fund¬
ing from Yale's new Bass Center for Biospheric Studies to fomi
a Center for Human Ecology. Environmental Change and Infec¬
tious Diseases. This cooperative venture will focus on Brazil,
especially the destruction of its rain forest.
Refen ing to the three crucial, related areas of development,
ecology and human health. Dr. Smith observes. "Through 40
years of the Cold War. policy makers were so obsessed with the
military balance that they ignored other aspects of the interna¬
tional political equation. Erom now on. universities have to train
people w ho know what the real problems are."
Erom all indications. Yale and its School of Medicine are
rapidly mew ing to assume their share of that responsibility.
Curtis Patton. Ph.D.
I he Big Picture
In recent years. YS.M's strength in international health has been
growing in all three aspects of its mission: research, education
and patient care.

Research has been particularly strong, with

much of It undertaken at the EPH Laboratory (LEPH).
Department Chairman Burton H. Singer. Ph.D.. the Ira

Health and other donors, funded construction of the nine-story
EPH Laboratory, which included space for YARLf Eor years,

Vaughan Hiscock Professor of Public Health and Statistics, has

the Rockefeller Foundation also contributed program funds to
YARU. which serves as the World Health Organization (WHO)

brought to bear his own extensive research experience abroad—

Reference Centre for Arboviruses.

particularly in South America—as he shapes and expands the
department's international role.

As chair of the Steering Com¬

Directed since 1971 by Robert E. Shope. M.D.. professor of
epidemiology. YARU comprises 10 faculty members and other

mittee on Social and Economic Research for the World Health

researchers who study diseases such as leishmaniasis, dengue

Organi/ation (WHO) Tropical Disease Research Program.

and encephalitis, which are transmitted by biting insects and
ticks. Such diseases affect millions of people and their domestic

Dr.

Singer advocates an interdisciplinary approach. He has led EPH
111

developing joint degree programs and in forming Yale's new

Center for Human Ecology. Environmental Change and Infec¬
tious Diseases.
Dr. Singer sa\s. "Countries can still do well economically
without destroying the ecology."

He adds that it's acadetnia's

job "to de\ clop a rigorous scientific basis for land-use and health
policies in iiartnership with developing countries."

animals throughout the world.
Scientists from many countries come to study at "I'ARU.
furthering their graduate and post-graduate education.

Cur¬

rent students come from lands as diverse as Egypt and Australia.
Japan and Peru. Thailatid and Brazil. Much of the basic research
the scientists learn to perform relates to the inteiplay of ecology,

Dr. Singer is continuing a three decade-old tradition of

economic development and human health.
Take, for instance, the groundbreaking work of Rebeca

leadership in international health at EPH which began in 1964.
when Wilbur Downs. M.D.. and his research team movetl to the

Rico-Hesse. Ph.D.. assistant professor of epidemiology. In De¬
cember 1990. a colleague from Venezuela pre.sented her with a

department Irom the Rockefeller Eoundation.
fhey came to
found the ^’ale .\rbo\irus Research Unit (\'.‘\Rl ). The

other '^'ARL> researchers confirmed that the virus had never been

Rockeleller Eoundation, along with the National Institutes of

reported in humans.

\ irus that neither had encountered before.

Dr. Rico-Hesse and
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Another YARD researcher. Robert B. Tesh. M.D., professor
of epidemiology, explains how cutting down the rain forest in
tropical areas of South Amei ica has brought about malaria epi¬
demics. "Anopheles dorlinpi. the species of mosquito that carries
Lalciparnin malaria, requires open pools of water in which to
breed. Clearing the rain forest and its dense canopy increases the
luimber of unshaded pocds. This offers new breeding areas for
the insects," says Dr. Tesh. even as the number of non-immune
human targets in the area increases dramatically with new settle¬
ments.
For years. Dr. Tesh has been conducting reseairh on another
tiny insect that wreaks major havoc in tropical and subtropical
areas—the sand fly.

Sand flies spread viral diseases, such as

sand fly fever and parasitic diseases, such as leishmaniasis. The
latter disease appears in several forms. In cutaneous and muco¬
cutaneous leishmaniasis, the di.sease can cause severely disfigur¬
ing lesions on the nose, mouth and in other mucous membranes.
Visceral fonns can cause severe anemia and other symptoms
which can be fatal.
Dr. TeslTs research into sand fly-borne diseases has taken
him to Venezuela. Brazil, other nations in South America and the
Middle East.

A leishmaniasis sttidy that he has undertaken in

Colombia since 1984 has revealed a new organism, Leishniunia
colonihiensis, which causes a kind of cutaneous leishmaniasis in
northern South America. His current work also is focused on
how to control the sand fly vector.
A Neglected Branch of Medicine
As a carrier of parasitic as well as viral diseases, sand flies also
command the attention of a second major YSM basic research
group, the MacArthur Center for Molecular Parasitology, di¬
rected by Frank F. Richards. M.D., professor of medicine. Pail

Lowell Levin. Etl.D.

of the depailment of internal medicine, the center includes 44
faculty and other researchers who have appointments in various
Scientists determined that the infectious agent was an

departments, ranging from medicine to EPH, chemistry, pediat¬
rics, and molecular biophysics and biochemistry.

arenavirus, and named it Giianarito, after the town near which it
was discovered. The disease the virus caused was named Ven¬

Dr. Richards explains that the center's name comes from the
John T. and Catherine D. MacAilhur Foundation, which pro¬

ezuelan hemorrhagic fever, because it is related to Argentine and
Bolivian hemorrhagic fevers.

vided start-up funds eight years ago. While the foundation offers
continuing financial support under a 10-year agreement, today,
major funding comes from the National Institutes of Health, for

How does the appearance of Guanarito virus in hu¬
mans relate to the ecology?

Dr. Rico-Hesse notes that

which the center serves as one of two Tropical Disease Research

the disease has arisen in “an area where settlers have been
clearing the rain forest for the sake of raising corn and other cash

Units in the United States. The MacArthur Center is one of the
largest of a woi ldwide consortium of 10 research centers on the

crops.”

biology of parasitic di.seases.

Dr. Rico-Hesse’s studies have led her to conclude that clear¬
ing the forest displaced hoards of rats, which moved into the
human dwellings that were built on the new cane plantations.
Rats cany the virus and shed it in their urine. Sometimes the
rodents come in contact with food stored on open bins; simply
sweeping a floor tainted by dried rat urine can aerosolize the
virus and expose humans to it.
Dr. Rico-Hesse and her YARD colleagues have recently
received grants from the National Institutes of Health and the Pan
American Health Organization to identify the species of rodent
that carries the Guanai ito virus. The scientists want to detennine
ways to control the rats or at least to limit human contact with
them.
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Dr. Richards observes that while most tropical diseases
occur in less-developed countries, most medical research is con¬
ducted on the diseases of the First World. Dr. Richards sees
hope, however, in research centers such as the MacArthur. which
are applying new techniques to solve biological mysteries at the
cellular and molecular levels.
Having thrown down the high-technology gauntlet, center
scientists must employ every bit of their knowledge and insight
to overcome the subtleties of parasitic organisms. Among their
most challenging foes are trypanosomes, which are cariied by the
tsetse (which means "fly” in Swahili). These microorganisms,
which cause sleeping sickness in man and widespread disease in
cattle and other animals, have adapted against host immune
responses in an insidious way.
9

The immune systems of mammals are able to kill off almost

Molecular Parasitology Searches
For ‘'Silver Bullet'' in RNA Evolution

all—perhaps more than 99 percent—of the invading typanosomes
by making antibodies to the glycoproteins that serve as an over¬
coat to each microorganism. UnfoUunately for the host animal,
the remaining I percent of trypanosomes sure ive by shedding

Researchers applying molecular technology to study such

their protective coating, revealing a new. slightly altered protein

single-celled parasites as Leishmania and tr\ panosomes

overcoat. The antibodies custom-made to the old overcoat can¬

have produced dramatic results which give scientists hope

not attack the new one. and while the immune system busies

for discovering new. safer methods of treating parasitic

itself manufacturing new antibodies that can destroy the new

diseases. A key discovery has been the wa}’ host organisms

coat, a window of opponunity opens, providing time for the
microorganisms to reproduce.

have evolved in their use of RNA for protein manufacture,
as opposed to parasites, which are lesser evolved.

However, when the immune system finally does produce a

Explains Dr. Frank F. Richards, director of the

set ot antibodies to destroy microt)rganisms with the new over¬

■MacArthur Center for Molecular Parasitology. "Organisms

coat. 1 percent of this generation of typanosomes survives, and

that live inside larger organisms are often spared the evolu¬

the destructive cycle continues. Typanosomes can produce up to

tionary pressures to which most living things are exposed.

1.000 generations of progeny with altered overcoats, more than

There is no drought, cold or excess heat inside the body.

enough to exhaust the immune system.

Parasites have, as a consequence, sometimes held onto

immune exhaustion leads to the death of the host animal.

Without medication,

ancient biological mechanisms since they have not felt the

Alan C. Sartorelli. Ph.D.. director of the Yale Comprehen¬

competition to replace them by newer, more efficient mecha¬
nisms."

sive Cancer Center, and Curtis F. Patton. M.D., professor of

These archaic mechanisms may offer scientists the

epidemiology (microbiology), are two Yale researchers who are
leading teams to develop new drugs against trypanosomes.

".Achilles heel" they look for that would allow medications

Explains Dr. Sailorelli. "Trypanosomiasis represents a seri¬

to destroy the invading organisms without harming their

ous threat to the health of man and domestic animals. We have

hosts.

By way of illustration, in the cells of parasites and

developed a new class of methylating agents that can cure labora¬

higher species alike, the formation of proteins—a critical
process on which all life is based—takes place in three
stages:

tory mice bearing African trypanosomes. The drug that we have
selected for funher development, called TSM. is orally active,
has a high therapeutic index and is inexpensive to produce.

In

addition, it has a unique mechanism of action causing differentia¬
tion of the parasite to a fomi which cannot survive in the blood¬
stream."

1)

First. DNA is transcribed, or copied, into RNA.

2)

Next, certain amino acids move along the RNA
strand, creating messenger RNA (mRNA). In a

antitrypanosomal efficacy of TS.M in African livestock

process called splicing, the amino acids create an

to determine its potential in agricultural use.

information template, selecting and assembling the
genes that the cell will need to make the needed
protein.
.M

Drs. Patton and Sartorelli hope to evaluate the

EPH's tradition of foreign sendee goes beyond basic medi¬
cal and epidemiological research.

Since the mid-l94()s, for

example. EPll lecturer Eric W. Mood. M.P.H. "43. has travelled
the globe on behalf of WHO. offering his expeilise on environ¬

Finally, the mRNA template produces the coding

mental health projects.

information that allows the cell's ribosomes, en¬

WHO Collaborating Centre for Health Promotion Policy and

zymes and other "biosynthetic machinery" to manu¬

Research has been providing educational and public health con¬
sultations.

facture the required protein.

And since November 1989. the Yale-

Directed by Fowell S. Fevin. Ed.D., M.P.H.. professor of
senger RNA in a different way. using cell machinery that is

public health, this WHO centre has played a role in supporting
the newly emerging nations of Eastern Europe. As Dr. Fevin

not present in the host.

Some of these organisms make

explains. "WHO asked us to gather data on leading health educa¬

mRNA by stitching together more than one piece ot RNA. a

tion programs in the Ldiited States for the Czech and Slovak

Dr. Richards explains that trypanosomes assemble mes¬

process called trans-splicing; others employ "RNA edit¬

Republic. Hungary. Albania and other countries who were devel¬

ing." using one piece of RNA to transmit more than one
message.

oping new health promotion curricula for their schools."

"'rhese differences can be exploited." Dr. Richards
says, "by using drugs which affect the parasite cell mecha¬
nism. but lea\e the host unharmed."
Both biologists and disease experts, including some at
Yale. ha\'c joined in the pursuit of such a therapeutic "silver
bullet." Dr. Riehards hopes that "it w ill not be long before
the results begin to improve health in the developing coun¬
tries of the world. "

Dr. Fevin and centre associates contacted health educators
throughout the L'nited States and asked them to recommend w hat
they thought were America's best programs in the field. He then
refined the resulting list and provided descriptive summaries to
WIK) so that the nations requesting assistance could apply the
information in ways that would best suit their own cultures.
WHO also has assigned shorter-tenn projects to the centre.
For instance, w ithin 24 hours of an urgent telephone call from the
French Ministrv of Health, the centre was able to furnish exten¬
sive data about the impact of .American anti-smoking regula-

1(1
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tions. This information helped tlie French government in their
deliberations on anti-smoking legislation.

Patton.
As Dr. Patton explains. "Downs fellowships pay for trans¬

Hands-on Experience

developing countries, where students assist the permanent stalf

portation to and from health-related projects, most of them in

One cannot discuss the medical school's involvement with inter¬
national health in any depth without returning to the legacy left
by Wilbur Downs. In addition to his role in establishing the
Arbovirus Research Unit—in the very construction of LEPH—
Dr. Downs' influence continues in the International Health Stu¬
dent Travel Fellowship program named in his honor in I9S4.
Dr. Downs began the Comtnittee on International Health in
1966 with a small grant from the Rockefeller Foundation.

He

served on the committee for the rest of his life, raising funds and
building an endowment.

More than 233 medical and EPH

students have benefited from the travel fellowships, 21 in 1991
alone. Since the late 197()s (except for a brief sabbatical)
the

and gather data for research."

Room and board are usually

arranged by a Yale or overseas sponsor, in addition to a modest
stipend provided by the committee.
Prospective fellows submit proposals for overseas research
projects in late winter to the committee.

The committee's 24

faculty members evaluate the proposals and award fellowships
oti merit, based on the amount of funds available for the year. In
the autumn following their overseas experience, students present
their research in poster sessions: in addition to poster displays,
five fellows, whose research represents a cross section of studies
undertaken din ing the year, make oral presentations.
(ContiniieJfrom po<^e II)

committee has been chaired by Dr. Downs' colleague, Curtis

{Conrinucil on

IS)

Ms. Strachan proudly reports that during its first year, the

Student Involvement Grows
In International Health

task force has organized a series of four lectures which have been

Many international specialists note the similar health challenges

University of New York Medical School, who is renowned for
having set up more than 500 community-based health clinics

facing the people of developing nations and underserved people
in the United States—especially low-income minorities—the socalled Third World within our borders. This linkage also is
rellected in the makeup of the Task Force on International Health,
a new medical student organization at Yale.
The task force is an outgrowth of YSM's Student National

well attended by both students and faculty.

Speakers have

included experts in international health, tropical medicine and
primary care, including H. Jack Geiger, M.D.. a professor at City

worldwide.
“Our goal for 1992 is to raise $10,000 so that two or three
medical students from developing countries can visit the School
of Medicine as part of a clinical exchange program," reports Ms.
Strachan.

Medical Association (SNMA) chapter, an organization of minor¬

In recent years, several foreign student exchanges have been

ity students. Cunently, the task force is comprised of its chair,

arranged through the YSM chapter of Physicians for Social

Dina Strachan, an African-American; Sylvia Garcia, a HispanicAmerican; and Rajen Naidoo, a black South African of Indian

Responsibility.

descent.

All three second-year medical students were 1991

This group has sponsored such exchanges be¬

tween Yale and medical schools in the Czech and Slovak Repub¬
lic and other Eastern European lands.

Wilbur Downs fellows.

Dina Strachan. M.D. '93. ex¬
plains her Doxns Overseas
Travel Fellowship research to
Dr. Robert Shope at the 1991
poster session in the Jane Ellen
Hope Biiiltling.
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Drs. Marie-Loiiise and Kenneth
Johnson and friends in front of
the
Peace
Cathedral in
Hiroshima, Japan, following a
memorial service they attended
there in 1966.

Since leaving Japan in 1967. the Johnsons have often returned

Maiie-Loiiise and Kenneth Johnson:
30 Years in International Health

to ABCC, now the Radiation Effects Research Eoundation. In

Marie-Louise T. Johnson. M.D.Yi.'S. Ph.D.'54. vice president of

School of Medicine and director of medical education at

1990. Marie-Louise made her 25th trip to Japan to consult on a
repeat study of skin cancer in atomic bomb survivors.
Today, Marie-Louise Johnson is a clinical professor at the

the Association of Yale Alumni in Medicine, and her husband.

Benedictine Hospital in King.ston, N.Y.

Kenneth. M.IJ.. HS

professor of community medicine at Mount Sinai Medical Cen¬

are among the YSM alumni/ae who

Kenneth is adjunct

have been leaders in the field of international health.

ter in New York City and senior program consultant with the

fhey begtin their overseas activities in 1962 as associate
professors at the School of Medicine. At that time, the husband-

Robert Wood Johnson Foundation in Princeton, N.J.

and-wifc team travelled to the Bahamas island of Eleuthera,
where they helped to establish an ambulatory care facility. In
196.^ they implemented a serologic suiwey of the island's 3,()()()
inhabitants for the WHO Reference Serum Bank, then directed
by noted Yale faculty member, the late John R. Paul. M.D.
In 1964. the Johnsons left New Haven to become the founh
generation of Yale faculty members to work in the department of
medicine at the Atomic Bomb Casualty Commission (ABCC) in
Hiroshima and Nagasaki, Japan.

As ABCC chief of medicine,

Kenneth completed several epidemiologic studies on the late
effects of radiation in atomic bomb survivors, Marie-Louise, as
the first dermatologist assigned to the ABCC, completed the first
clinical study on the prevalence of skin conditions in the study
population.
In 1968. Kenneth, as director of epidemiologic research at
Cornell University, worked with the Jamaica. West Indies, min¬
ister of health to establish a primary health care system in cetitral
Jamaica. The program eliminated the Kwashiorkor/Marasmus
and neonatiil tetanus which were endemic among the 17,0()()
rural residents.
•Marie-Louise. then director of dermatology at Belle\ ue Hos¬
pital in New \'ork, helpeil train Jamaica’s first group of commu¬
nity health aides. The Johnsons' continuing interest in interna¬
tional medicine has taken them as consultants to Guam, Micronesia
and Ecuador.

Drs. .Marie-Louise and Kenneth Johnson
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Those who delivered oral presentations at the November

A similar educational philosophy underlies the International
Health Program (IMP) in the department of internal medicine, co¬

1991 poster session include:
Heather Christian, M.D.’94, Jamaica, three months, sickle¬

directed by Drs. Michele Barry, associate professor of medicine,
and Frank J. Bia, associate professor of medicine (infectious

cell anemia (thalassemia). “The aim of my study was to
examine patients for hematological and clinical indices in

diseases) and laboratory medicine. Over the past decade, these

sickle cell-beta thalas.semia syndromes," Ms. Christian re¬

Third World and in domestic disadvantaged communities for
elective rotations for second- or third-year house officers. Wilbur

ports.

She searched for subpopulations that may represent

different molecular bases.

Downs fellows also conduct research at these sites.

Aniiika M. Brown, M.D. '94, Zimbabwe, three months. She
gathered infomiation about the attitudes and knowledge on
tobacco use in preadolescent children.
Syhia Garcia, M.D. '94, Venezuela. 10 weeks.

two faculty members have been e,stablishing sites throughout the

Ms. Garcia

collected epidemiologic data about the newly discovered strain
of hemonhagic fever virus being studied by YARU.
Christopher ./. Gilligan, M.D. '94, Brazil. 10 weeks.

This

second-year student studied vacuole membrane disruption in
host cells infected with Trypanosonia caitzi, transmitted by
“kissing bugs” which are displaced from the rain forest by
human settlements.
Mickey R. and Jay Riggs, both M.D. '92, Southern Africa, 10

More than 120 residents and faculty have taken part in the
program, which offers training sites in Haiti in the West Indies;
Tanzania and Zimbabwe in Africa; the Fiji School of Medicine in
the South Pacific; and at Zuni and Navajo reservations in the
southwestern United States.
Drs. Barry and Bia echo their colleague. Dr. Patton, in
pointing out that most residents who do an overseas rotation do
not pursue a careei' in international health.

Dr. Barry adds,

however, “The program does r)ffer house officers some imiiortant new perspectives.”
Both doctors say that IHP house officers, like Downs fel¬
lows, learn:
• Cost containment in an atmosphere of minimal resources;

weeks. This husband-and-wife team conducted a field evalu¬
ation of water quality around Malamulo Hospital, Malawi.

Although other 1991 Downs fellows travelled as far afield
as New Guinea, Thailand and India, one student, George R.
Bruno, M.D. '94, stayed virtually in Yale's own backyard. Mr.
Bruno travelled to St. Kitts in the Virgin Islands to survey the
incidence of filovirus infection in a colony of African green
monkeys, which are bred there for biomedical research.
Dr. Patton acknowledges that most Downs fellows will not
pursue careers in international health. He reminds us, however,
that recruiting physicians to overseas service is not the primary

• The importance of preventive medicine;
• Humanistic approaches to healing in lieu of high-cost, hightechnology treatments;
• Community-based health care;
• Peifonning physical examinations without the aid of hightechnology diagnostic tools. In the words of one recent IHP
resident, “It's amazing how much you can learn about a
patient Just using a stethoscope.”

purpose of the program.
“Downs fellows learn self-reliance, independent thinking
and often must assume great responsibility under extremely chal¬

Continiieil on page 14

lenging conditions,” Dr. Patton says.
Thus, the program provides a vital complement to the Yale
System of medical education.

At the 1991 Downs International Travel
Fellowship poster session. Sylvia Garcia,
M.D. '94, reports on her epidemiological
research into newly discovered Venezuelan
hemorrhagic fever.
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Foreign Students Bring their Unique
Perspective to Medical School, EPH

Just as importantly. Dr. Bia adds. IHP rotations teach “a
healthy respect for cultural diversity and the value systems of

Students from outside the United States add to the rich mosaic of
the medical school and its department of epidemiology and
public health.

While most of the 16 foreign students at the

medical school and 37 foreign students at EPH come from

other cultures." Such awareness is key for physicians who work in
urban, teiliary-care hospitals such as Yale-New Haven, where pa¬
tients come from a variety of backgrounds. That is one of the
reasons that YNHH continues paying residents their stipends
even while they are away on an IHP rotation.

industrialized nations

Drs. Bairy and Bia also have brought cross-cultural learning

as diverse as Canada,

oppoilLinities home for YNHH residents by developing several
innovative patient care programs.

Turkey. Korea and
Taiwan, an increas¬
ing number come
from the developing
world,

They include the Southeast

Asia Refugee Clinic and the Tropical Medicine and International
Traveller's Clinic at the Primary Care Center.
Eurthermore. Dr. Barry received funding from the W.K.
Kellogg Eoundation to train residents in working with the area’s

including

China. Iran and vari¬

homeless population.

ous countries in Af¬

Health Center, residents help staff a mobile van and work in area

In this rotation, undertaken wdth the Hill

rica.

soup kitchens.
While some for¬

As Dr. Ban'y reminds us, referring to New Haven's home¬

eign Students will

less and underserved people, "It is our moral imperative to care

succumb to the lure

for the Third World that lives in our own backyard."

and

Still other signs of life in the form of new' or planned

high-technology

programs, and even new construction, indicate that Yale's

medicine and stay in

giant of international affairs is rousing indeed. This academic

the flnited States
upon graduation, two

year. EPH plans to debut its international health track, devel¬

students.

"With this program, for the first time. M.P.H. and doctoral

of affluence

oped by a committee that Dr. Shope chairs.

Rajen

As he explains,

Naidoo, M.D. '94.

students will have a fomial cun'iculum—complete with field

and his brother. Pat.
i^ai'en Naidoo
Dr.P.Il. '94. are ea¬
ger to return and work in their home country.

experience—to prepare them for an international career.”
They are black

Meanwhile, at the medical school. Drs. Bia and Barry are
hard at work raising the funds that would allow Yale to launch

South Africans with Indian heritage and members of the recently

the nation's first physician certification program in tropical dis¬

legalized African National Congress (ANC); Pat serves on the

eases and international health.

ANC's health secretariat.
Last year the brothers returned to South Africa after 10 years

will be Jointly administered by the medical school. EPH and the
Center for International and Area Studies.

This interdisciplinary program

In summer 1991. as a Wilbur Downs fellow. Rajen

Yale University's contribution—and long-term commit¬

Naidoo had a glimpse of the challenge that awaits him and his
brothel' upon graduation. His fellowship took him near his

ment—to the global village will manifest itself in bricks and
mortar as the $10-million Henry R. Luce Jr. Hall is dedicated in

of exile.

hometown of Durban. At the ANC's request, he undertook an

1994 as the pemianent home for the Center for International and

epidemiological evaluation of a primary care clinic in a squatter's

Area Studies. The three-story. 30,000-square foot building, to be

community.
"Although by and ku'ge the clinic functioned effectively.” com¬

built between Hillhouse Avenue and Prospect Street, will bring

ments Mr. Naidoo, "most of the problems 1 .saw couldn't te solved

expansion into the 21st century.
What is the University's stake in the future of international

metlically." He cites, for extunple. inadequate housing lutd sanita¬
tion. luid a pit latrine system that polluted the water supply.
Rajen Naidoo sees such conditions as "based in the apart¬
heid system." and foresees no easy or inexpensive solutions to
relieving them even as apartheid is phased out in coming years.
Pat Naidoo agrees: "Health care providers in South Africa

under one roof all of the center's programs and provide space for

studies? Comments President Benno C. Schmidt Jr.:
The world continues to change, and those changes pose
special challenges and unprecedented opportunities for
American educational instituti^ms. particularly those—like

face the initial task of overcoming the systemic inadequacies ot

Yale—which are ‘world universities....’

apartheid," he says. Emphasizing the need lor international
cooperation, he adtis, "Developing a non-racial. democratic and

to jdaving a special role in forging and tnaintaining interna¬

equal health care system for South Africa is a challenging task

positioned to continue playing an essential role in helping to

that will require the collective experience of health care systems

shape responses to the problems ami possibilities of the

throughout the world. "
foward that end. the brothers are working with EPH Chair¬

e)nerging world order."

man Burton Singer to cotrrdinate a seniinar in developing poli¬

Yale is committed

tional educational and intellectual networks and is well-

YM

cies for AIDS and for health care in general for South .Al'rica.
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1991 LERNER AWARD
a cry for comfort
by Lisa J. Nelson
I am sure thal the "yiiuyua'' is nol good for one's health. Can you
say stressful? Tension? Adventure in the most disastrous and
diabolical sense of the word. I can’t decide which aspect of this
transportation system from hell is the most amusing.

Is it the

unpredictable nature of the yuayiia, whereby it may arrive at any
time within a wonderfully specific window of an hour and fortyfive minutes followed by at least a 30-minute ride to the closest
of sites. Or perhaps my daily 50-minute morning ride to the
Medical Center from Isla Verde. That is. if there is no need to
change guagiias. Out the back of one guagua and into the gaping
mouth of another (when it arrives, if ever)... oh boy. a whopping
two hours, same trip, ilos guaguus. And burning all the while in
the pit of my stomach, pounding in my brain behind my eyes, is
the knowledge that this could be a 20-minute trip in traffic at rush

Lisa ,/. Nidsoii with Aaron B. Lenier, M.D.. Pli.D..

hour. But time is not my major worry. No. I could deal with a long
trip, especially if it were at all regular. If I took the same giiagiia

professor emeritus and senior research scientist in
dermatology. In 1981, Dr. Lerner established the

route on the return trip two days in a row. If there were such a

creative writing award for medical students in memory

thing as a "direct” or "best” route. If you could go back on any

of his late wife. Marguerite Rush Lerner.

given voyage the same way that you came. But these are still not
major worries.

Major worries are really fears.

Fear for my

personal safety on random guagiia stops where a change may he
necessary. Feai' that my uncertainty may show on my face
followed by conversation with men Fd rather not talk to who
make rude sucking noise with their tongues and their teeth that I
hear are meant to be some .sort of vulgar kiss. Everywhere there

Lisa J. Nelson, YSM ’93:
Muse among the Children

is talk of attacks, assaults, whispered warnings from women

During the summer of 1990, Lisa Nelson received a
Wilbur G. Downs International Health Travel Fellow¬

while waiting.

"jCuidado!

ship to conduct research in Puerto Rico on the relation¬

Don't wear any jewelry...” and I don't. A bulky blue plastic watch

ship between migration and psychiatric disorders in
children. Her essay, "a cry for comfort,” illustrates the

Open mouths that I travel alone.

is all. (A feeble attempt to find order or patterns in arrival times
at the g;^t/g/w-stop.) "No gold. A woman, just last week, right
around the corner...She was wearing a gold watch." Guagiia by
night is to be avoided at all cost unless it is from one bright spot
in front of the apartment building to another, like the Fine Arts
Center, with no change of guagiia. I am almost constantly tense,
anxious, frozen in an atypical expressionless and silent state,
attempting to be invisible in my Anne Rice novel while keeping
a careful eye on the surroundings and my proximity to my
destination from a small space on the guagiia seat. The 25-cent
recurring nightmare that does not dispel in immediate relief once
a particular episode is over. The tension remains behind the eyes
and within the stomach.
YM

fears that can be evoked by being a young, single
woman alone in foreign land. It is part of a collection of
poetry and prose, written in Spanish and English, which
Ms. Nelson composed in Puerto Rico. As an under¬
graduate at Yale College. Ms. Nelson majored in psy¬
chology and graduated magna cum laude with special
distinction in her major. She has w-'orked in projects
concerningchildren and theirmental health during both
her undergraduate and medical studies. In May 1991, as
an American Psychiatric Association mini-fellow, Ms.
Nelson attended the APA annual meeting in New Or¬
leans. She is considering a career in child psychiatry.

Lisa J. Nelson, a third-year medical student, shared the 1991
Marguerite Rush Lerner Award for creative writing by a medical
student for a collection (f poetry and prose written in Spanish and
English. Her essay “a cry for comfort" is part of that collection.
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A RENAISSANCE MAN
IN THE DEVELOPING WORLD
Really haw life yels on is a secret. You only know your memorx and it makes its own time. The real
time leads yon alony and yon never know when it happens. The best that can he is come and gone.
E.L. Doctorow. Welcome to Hard Times

I’holoiiriiphs l)\

h\ Herbert S. Sacks, M.D., I IS '52-'55
I'he mind ol Wilhiir George Downs (WGD), relentlessly search¬
ing. excited by new challenges and fresh discovery, is very
much part of us who loved him. lived with him. worked with

S. S;iks

him. and learned from him. IIis professional identity as com¬
passionate physician-researcher was not limited to disease en¬
tities but had ramifications in his muted anger at political and
socio-economic conditions which denied a person's indepen¬
dence and autonomy.

He believed that such conditions bred

dliteracy, poverty and disease.
Wil was a complicated, versatile man with extraordinary
talents, sensitivities and competencies.

A brilliant scientist,

his reputation as virologist, entomologist, malariologist. epi¬
demiologist. parasitologist, mammalogist and ornithologist
brought him many rewards and outstanding professional hon¬
ors. He was an outdoorsman. expert competitive marksman
with rifle and pistol, saltwater and freshwater fisherman with
admirable trout fly tying skills. (Fora lyrical story of Wil's last
fly-fishing expedition, see ''Fishing: .Stupendous Vulgarities.
Delicate Subjects." by rin)mas McGuane. Esepdre. October
1991. pp. 74-77.)
.A superb bookbinder, he was also the consummate biblio¬
phile. reading in French. Spanish and Russian. WGD had an
insatiable hunger for books scientific and for fiction with
themes and plot locations pertinent to his own peripatetic life
experience.

Dr. \\ iihur Downs with a train porter in Africa in 1976.

and accidental career-shaping events which occurred while
liv ing overseas much of his life.
Roots of a Legend

And to lift his spirits and the spirits of those

around him. he played great guitar.
He was. most of all. a mentor for the young—available,

Wil. the boy growing up in Saranac Lake. New >’ork. located
snapping turtles by dangling his toes in the mud.

Harrv

patient and motivating, always communicating his passion for
new learning. His elective courses and tutorials have inspired

Fowler, his high school friend, taught him fly-fishing and the
mysteries of nature, lessons that would have a lifelong influ¬

a sizable cohort of young people to pursue careers in interna¬

ence.

tional health and tiavpical medicine. Wil was retired at 60 in
1972. but continued, without compensation, to teach, advise,
atlminister projects and conduct research from his office and

entomologist.
FAnhaps the reader may want to know Wil. the medical
studetit at Corttell. the Rockefeller Foundation fellow, the

hiboratory at the Yale .Arbov irus Research Lhiit until he died
on Fch. 17. 1991.

Pacific Theater malarial control officer who was awarded the
Bronze Star? How about Wil. the Rockefeller Foundation

I'he etiitors of ) \// Mioicist asked me to write about WiFs

In high school. WGD was determined to become an

malarial control researcher in Mexico?

Who will describe

role in developing international health at Yale, emphasizing
his .African experience. His leadership was not a spontaneous

him in Trinidad founding the 4'rinidad Region Virus Labora¬
tory. isolating .Vs new viruses and training many of the impor¬

event liLit flovvcil from a confluence of early-life events, the
powerful connection he had with his chemist father, his rela¬
tionships w ith mcilical school teachers/investigators at ('ornell

tant arbovirologists of that era?
Why not explore his move to New Haven in I96.V relocat¬
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ing the Rockefeller Foundation's Virus Laboratory to Yale?
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John Fuller's book. Fever (New York, Reader's Digest, 1974),
depicts Wil as the team catalyst playing a crucial role with
fellow scientists in isolating and characterizing the Lassa Fe¬
ver virus from Nigerian patients. The importance of the
dynamics of Wil's family life over the years of remarkable
scientific productivity would be an engaging saga in itself.
My relationship with this Renaissance man began in 1965.
As a senior psychiatric consultant to the Peace Corps since its

Herbert S. Sacks, M.D.—
International Psychiatrist
Dr. Herbert S. Sacks, clinical professor in the Child
Study Center and psychiatry, practices child, adolescent

inception, and then as policy advisor for the agency's North

and adult psychiatry in Westport, Conn. He began his
involvement in international health in 1961, as a senior

Africa, Near East and South Asia division. 1 was recruited by

consultant to the Vermont-based student-exchange pro¬

the Yale College five-year B.A. program to develop its selec¬
tion, orientation, evaluation and assessment components. Presi¬

gram, Experiment in International Living, and to the

dent Kingman Brewster proposed a radical idea for its time: to

Peace Corps.
“My long consulting experience in the pediatrics out¬

send Yale College students to contrasting cultures for a year to

patient department was invaluable in Africa." Dr. Sacks

engage in a broad range of projects under the aegis of respon¬

says, referring to an United States Aid to International
Development assignment in 1974 to research the drought

sible researchers and administrators.
The conflation of my experience brought me to medical

in the Sahel.

Working with USAID and host govern¬

school Dean Vernon Lippard to argue for an international

ment officials. Dr. Sacks sorted through the maze of

health committee whose charge would be to pursue overseas
research opportunities for medical students and to monitor

international and non-governmental organization projects
in his operational sector. He sub-contracted with the

international health projects independently contracted by medi¬

psychiatry departments of medical schools in Dakar and

cal school faculty. It was an idea whose time had come;
indeed, Wil had beaten me to it! With the support of Bob
McCollum, then chairman of the department of epidemiology
and public health (EPH), Wil had approached Dean Lippard
two weeks earlier. And so a faculty committee was estab¬
lished, including George Silver, Albert Evans, Lowell Levin,

Abidjan for studies regarding forced internal migration
due to governmental planning. He also arranged studies
of the consequences of drought-compelled population
movements.
Dr. Sacks adds, “I was a member of the research
team, deeply involved in and fascinated by the complex

Byron Waksman, Dorothy Horstmann and myself.
The early years of the Committee on International Health

group dynamics associated with work-driven profes¬
sional colleagues and friends. We were given little relief

were full of dedication and frustration as we sought funds
under Wil’s optimistic chairmanship. The Rockefeller Eoun-

from one another in an unforgiving culture, separated
from family and for the most part possessing limited

dation came through with $5,000, and later, Wil’s private
campaign began to generate contributions with medical school

language facility.
“As a psychiatrist designing research and recasting

matching funds. He ran the committee meetings, encouraging

health policy, in a brief moment I could affect the lives
of more people in desperate straits than I could in a

debate in a climate of comity with a readiness to entertain
ideas presented by accomplished, strong-willed proponents
even when his philosophic reservations were substantive.
In 1971, I was approached by a former Peace Corps admin¬
istrator who had become director of the West and Central

therapeutic lifetime in my office."
Dr. Sacks is a trustee of the American Psychiatric
Association and serves on its Council for International
Affairs.

Africa desk of the U.S. Agency for International Development
(ireporv R. Huth

(USAID) of the Department of State. The John E. Kennedy
Medical Center in Monrovia, built and sponsored by USAID,
needed a long-term training, service and research relationship
with a respected American medical school. Dean Eritz Redlich
declined the opportunity, concerned that students' intense antiVietnam war sentiments—combined with suspect USAID ac¬
tivities in Vietnam and with Latin American dictatorships—
might disrupt the medical school's educational mission. The
medical school had been narrowly spared in the May Day
1970 campus turmoil following upon our incursion into Cam¬
bodia and Laos.
Despite this disappointment, Wil’s encouragement sent me
across town to attempt to weave together an international
proposal incorporating health, law, economics and African
studies. The provost aborted this early endeavor, citing Presi¬
dent Brewster’s reluctance to give his imprimatur to Yaleidentified overseas projects. As a result, our later projects
were not Yale-sponsored, only Yale-based: The principal
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investigator was WGD; I was co-investigator.

Nonetheless,

overseas, we were known as the "Yale Group."
During this era. an increasing number of medical and EPH

to photograph migrant birds, his specimen bottles prepared to
collect insects for viral studies, his ever-present notebook in
hand. Wil swept through the villages.

He felt children’s

students were sent abroad on summer travel fellowships. (In

spleens, assessed with dismay the inadequate and expired

fact, more than 2.‘i() fellows have been sent

medicaments in deteriorated and fly-specked health posts; he

overseas during the past 27 years.)

Mentors

with special expertise reviewed and critiqued
student proposals. The selection process was
refined, and a brief orientation program was
created to address potential health and emo¬
tional problems. Reports and papers were sub¬
mitted upon the fellows' return; in the late fall,
formal presentations and poster sessions were
given by the fellows based upon their modest
research in the developing world. Wil assigned
the involved staff work to the tactful and de¬
voted Yale Arbovirus Research Unit adminis¬
trative assistant. Betty Young.
Crisis in the Sahel
In 1974. my USAID friend called with some
urgency, asking that I constitute a health team
to v isit the Sahel, the sub-Saharan nations be¬
sieged by the effects of the cyclical drought
emergency. The agency sutfered from a limited
health presence and questioned the reliability of
massive requests from the stricken sub-Saharan

Making friends during a 1976 trip to the Sahel.

nations for medicaments and equipment.
Our team's charge was to provide USAID field representa¬

queried infirniiers about their training and then read the entries

tives in Senegal. Niger. Upper Volta and USAlDAVashington

in the infirniiers' registers. In his Danish schoolbag, we had

with back-up expert assistance.

gathered a limited supply of pharmaceuticals to repay the
infirniiers for their exposure to our questions.

We were to assess general

health and nutrition proposals under the Sahel Recovery and
Rehabilitation Program and to recommend what measures

During the long, hot drives across Senegal and Mauritania.

were needed to assure effective delivery of health, medical
and nutrition services. Despite the daunting task of mastering

and nodding off. He told us of his long history of narcolepsy,

the idiosyncratic health care delivery systems of each nation,

a condition exacerbated by the rocking and pitching of the

primarily based on the French colonial model, our study com¬

four-wheel drive vehicle.

mitted USAID to major actions.

ings. only to awaken and make the most salient comments of

Wil. George Silver and 1 departed for a month's Journey to

Wil would frequently cycle between periods of wakefulness

Eater I found him asleep at meet¬

Senegal. Mali. Mauritania. Niger and Upper Volta with side

the group.
During the hours of travel and at mealtime, we often re¬

trips to Abidjan and to the World Health Organization (WHO)

called our experiences during World War II.

in Geneva. The trip was enervating, with hours of interview¬

marvelous raconteur.

ing health workers: health-post iiifiniiiers. regional hospital
doctors and government ministers.

Shope (father of Dr. Robert Shope, director of the Yale Arbo¬

During our IS-hour days, we journeyed to nomadic
camps. We consulted with USAID officers and dealt
with Wllf) and the United Nations Children Fund. We

WGD was a

Wil and his good friend. Dr. Richard

virus Research Unit), conv inced the militarv to send them into
Okinawa after the first waves of American soldiers and Ma¬
rines landed. Wil’s interest was to make a quick survey of the

exhumed voluminous collections of health and health-

anopheline mosquito population. He wanted to make rough
estimates of the combat effectiveness of Japanese troops and

related data, collaborated with Institut Pasteur research¬
ers. reviewed the efforts of myriad European medical

of the exposure of our own men to malaria. Dick's parallel
task was to undertake a snail survey and gather evidence of

and relief organizations, and conferred with hospital of¬

infection referent to schistosomiasis.
Landing under cover of night, they accomplished their
work, and as light came up. they drove their jeep in the

ficials ami colleagues at the University of Dakar and
University of Abidjan faculties of medicine.
In our
hurried c|uest for information, we drove through dust
storms, coloring our hair and clothing carmine. Splash¬
ing through rivers,
schistosomiasis.

we

worried

faintly

about

Wil was at his physical peak, at b I. an imposing figure over
six-feet tall, beaixlevl and handsome. His camera at the ready
IS

direction of the American bridgehead.

Their mission, how¬

ever. would not go without incident: Kamikaze pilots looking
for targets of opportunity strafed them as Wil's helmeted head
bowed in sleep. This encounter only added to Wil's legend;
His narcoleptic nap made him a heroic figure, oblivious to
enemy fire!
Yale Medicine
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The intimacy of our drouglit-emergeiicy journey was repeated
a decade later, when a series of projects was undeilaken by Yale
teams in the West African Sahel. For several of us, these
weeks became times of self-revelation. Early life memories

WGD and I entrained at Gare Treichville. Cheniin de FerAhidjan-Ongadongoii. with onr getting off'at BohodDioulasso
796kni.and 18112 honrsaway. Price—$42 for compartment
with climatise. The OCCGE, a French West and Central

came to light, often poignant and predictive of the adult char-

A frican epidennologic snrveillance organization,
possessed 6,()()() documents of historic and current
iniportance we were charged to review...
The railroad transects the Ivory Coast from
Abidjan's green coastland north to Bobo's Sahel.
WGD c/uietly mused upon the ecological
, ■

' J

ti'ansformations in the region: heavy rai)} forest,
the forest, the guinea savannah (baobab and
acacia), then Sahel and desert. This ecological
profile on a rainfall gradient would infold itself
through the night. He was fascinated with the

i.

y

changing human disease patterns reflective of the
rapid ecological alterations over the 796 km.
train route.
The train doesn't roar: it pussycats through
the forest, gives a muted bellow as it charges into
a short tunnel emerging into darkened Dinibroko
Station with a neon RAN sign mounted on a
yellow' brick wall. Three hundred people crowd
the platform. In the throng are Ivorian women
toting orange, pineapple and banana baskets,

A train station along the route to Boho-Dlionlasso.
acters of the storytellers.

Family issues, conflicts and deep

babies astraddle their backs. Chaos took on a
semblance of order as second- and third-class carriages

concerns emerged, provoked by the disastrous climate of

filled.

drought, and human and animal death. We were dejected by
evidences of rampant parasitic and bacterial disease, by scenes
of marasmic children clutching at emaciated mothers with no

thrusting packages, food and chickens through open windows.

From the train platform, many secured seats by

WGD comes to life, leaps off the train followed by me. "Wil.
don't get left behind!" I shout at hi))}. He a)iimatedly speaks

breast milk and by the thousands of displaced nomadic people
without their animal Hocks but not without their Toureg dig¬

to a w'0))}an ve)jdor who sells him four stnall ora)}ges for

nity and pride. But there were moments of high spirits, as
well; I can hear Wil leading us in wonderfully obscene World

is asking cjuestio)is about cerebral ))ialaria.

War II songs as we drove over pot-holed dirt roads to our next
destination.
A Human Touch
Wilbur Downs had a great capacity to approach people
Linthreateningly; his warmth and gentleness let him elicit a
wealth of impressions and information. He duly noted the

eight ce)its. As the conductor urges everyo)ie O)) board, he

As a result of our recommendations from that trip to the
Sahel. C-1.^0 Hercules aircraft were dispatched with medica¬
ments, field hospitals, insecticides and fogging machines. What
followed was a continuing, promising relationship with USAID
which resulted in the agency supporting other institutional
research undertakings and culminating in the Senegal River

names, addresses and phone numbers of his acquaintances in

Pilot Health Research Program of 1976 to 1978. In the next
six years, our group became the health sector design team of

his journal, which he kept from his days as a school boy.

this massive, integrated development project in the Senegal

Often these connections became networks, invaluable in deal¬
ing with large questions emerging from our scientific projects.
New alliances spared us the time and pain inherent in clearing

River Basin.
The project's aim was to construct two dams, one at St.
Louis in Senegal and the other at Manantali in Mali: the

scientific equipment through customs, getting liquid nitrogen
aboard a jet, banking (hire w functionnaire to stand in line for

intended outcome was a series of irrigated agricultural perim¬
eters growing three crops a year on both sides of the Senegal

you for three hours), competing in the motor pool for USAID
vehicles for field trips, reserving space in hostelries, and ac¬

River. The project also was to promote livestock, improve
farm-to-market transportation infrastructure, and increase river

quiring camping equipment. Wil's spontaneity crossed social
class, occupational and racial boundaries.
An example springs from the pages of my journal, dated
Nov. 4, 1976:

navigability to Kayes in Mali. The relocation of villages and
the retraining of fishermen whose forebears had fished for 7()()
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years were project imperatives.

Finally, establishing hydro-
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electric power would bring with it light industry and, with

In 1981. we submitted a major $6 million, six-year proposal

careful controls, general improvement of the population's health

to USAID to help minimize the potential deleterious health

and nutrition.
The development project was funded by the World Bank.

effects of the massive dam project. Our plan depended on a

USAID, the European Economic Community, the African

huge, multinational investment wherein the United States was
to contribute $53 million. The proposal included an American

Development Bank, and the Erench and British development

base in a West African university, medical school or other institu¬

agencies.

tion with laboratory facilities and experience in public health,

Also included were the host countries, the Saudis

(enriched by huge oil price increases), the Germans and Cana¬

parasitology, medical entomology and virology.

dian AID. As Wil prudently pointed out. each of the partici¬

Implicit in our proposal was that Yale would be the pref¬
erential bidder based upon our prior achievements under Wilbur

pants had its own national self-interest to pursue, which tem¬
pered the declared altruistic motives in assisting this drought-

Downs’ leadership.

stricken region.
To emphasize the importance of careful health planning,

contract, related research opportunities would have opened to

we repoi ted:

Had the School of Medicine gained the

Yale's Law School, and the departments of anthropology,
economics and African studies.
After a tw'o-year bureaucratic struggle within USAID, how¬

The proposed dam and irrigation projeets in the Senegal
River Basin will produce niajor ecological changes in the

ever, deeply held personal and policy differences led the agency
to decide upon only minor American participation in the

affected regions of Senegal. Mali and Mauritania. Expe¬

Senegal project. The resignation of a senior USAID officer,

rience with similar welter projects in other African coun¬

the one who conceptualized this grand scheme, ended Yale's

tries suggest that the newly created lakes and irrigation

decade-long involvement with the agency. This story bears a
disturbing footnote; Without the strong health component

sYstems will cpuckly become infested with acpiatic snails,
mosciultoes ami black flies. As these vector species be¬
come more abundant, the prevalence of the diseases that

recommended in the Yale proposal, the dramatic increase in
water-borne diseases and illnesses caused by arthropod vec¬
tors did accompany the development project, problems that

the\ transmit (schistosomiasis, malaria, onchocerciasis

continue today. Ten years after our prediction of a Rift Valley

and certain arthropod-borne viral illness) will also in¬

Lever epidemic, in 1987 our worst fears were realized.

crease. Unless appropriate control measures are insti¬

Despite this setback, Wilbur Downs continued to consult with

tuted. these iliseases could easily become the major health
problems in the region, inhibiting both agricultural and

international health agencies for the rest of his life. He also
w'orked detemiinedly at Yale to build the endowment for the

economic development.

Committee on International Health, which funds the Downs

Fast Yale studies in the Senegal River Basin indicate
the following general pattern of human disease: A high
prevalence of malaria, schistosomiasis and onchocerciasis
in the upper valley: a somewhat lower prevalence of
malaria and schistosomiasis and no onchocerciasis in the
lower vallev.

The proposed water development projects

will probablx adversely affect this pattern, particularly in
the middle and lower portions of the valley.

International Travel Eellowships.

Thus, he continued—and

continues today—to enrich the lives of Yale students and
improve the health of people in developing nations.
Wil’s ongoing influence also is felt personally among those
of us who knew him well.

On a bookshelf in my study, I

recently came across a half-dozen books he had given me.
And my "WGD Correspondence" folders bear witness that
nary a w'eek passed since 1984 when Wil didn't send me a
letter enclosing a clipping from New Scientist. The Guardian.
Nature or Science, or a copy of a recent letter from his daugh¬
ter. who cared for Rumanian orphans after Ceascesau's down¬

lldll'lll l.l.ll-ll

fall. And. of course, there were the thoughtful critiques of
African political evolution w-hich would have health sequelae.
Often we'd talk of our frustrations w ith the American bureau¬
cracy and the lack of political will of health professional in
government service to foster international health progress.
Even a year after Wil's death, my dream-life, provoked by
this writing assignment, reconstitutes vi\id African scenes
and fragments of WGD conversations. Such is the strength of
character of this extraordinary man for all seasons. His legacy
lies not in his glow ing scientific achievements alone, but even
more in his abiding friendships, his gifted leadership in inter¬
national health, and his remarkable mentorship of students and
young faculty.

VM

Members of the Committee on International Health carry on
the prom! trmlition of Hr. \\ ilbur (1. Downs.
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EAST MEETS WEST:
THE YALE-CHINA BOND

Fred S. Kantor. M.D., (he Paul B. Beeson Professor of Medicine, views a tissue sample with Chinese colleagues.

by Shenvin B. Niiland, M.D. '55, HS '55-'6J
It is difficult to escape the conclusion that forces of consider¬
able magnitude will retard efforts by the People's Republic of
China to develop a scientifically based system of health care.
The single most important obstacle appears to be the belief
system of a society that has no tradition of science.
Here I must point out several implicit characteristics in any
reasonable description of that often misunderstood concept that
we call science. The word itself is abstract. Attempts to define
it in any absolute sense are fraught with the threat of confusion.
If you don't believe that, try looking up science in an un¬
abridged dictionary.

The science that I have in mind has allowed Western
medicine to achieve its present accomplishments. This science
relies on the experimental method and inductive reasoning. It
implies a certain rigor with which observations are made, veri¬
fied and interpreted. Such are the foundation stones upon
which we have built the extraordinary discoveries of the last
250 years, since the scientific method was first propounded in
the 17th century.
Chinese culture is imbued with the concept that sickness is
part of an inevitable cycle of nature, against w-hich man is
foolish to struggle. It is the old story of the fragile reed that
survives by bending with the wind, while the great oak resists
and falls. Traditional Chinese medicine is. in fact, the medicine
of harmonies. The two cosmic forces of Yin and Yang form the

Dr. Sherwin B. Nuland, associate clinical professor of surgery,
is a member the Yale-China Association board of trustees and is

material basis of all creation, and its soul as well; their interac¬
tion determines whether the universe is to be disordered or

a 24-year member aiid former president of the Beaumont Medi¬

ordered, wiiether sickness or health is to be the lot of any

cal Club. An earlier version of this article appeared in China
Update, a publication of the Yale-Ciuna Association.

individual within it. The tw'o forces generate the five elements
of Metal. Wood. Water, Fire and Earth, of which all other
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things, including the hiinian organs, are made. Everything is
related to everything else, is acted upon by everything else, in

deductive reasoning process rather than relying in the intuitive

ways that are both physical and spiritual.
In such a system, it would be self-defeating to separate

nese] medicine." The caveat provides a discriminating insight.
The reasoning process by which a Chinese researcher or clini¬

natural phenomena into their component elements in order to

cian arrives at his conclusions is often quite at variance with the

microinvestigate each contributing factor individually and with¬

method used by his Western colleague. This fact, well known
to those even slightly familiar with China, is often disregarded,

out prejudgment. The Western scientist divides and then subdiN'ides his studies into ever more scrutable parts, attempting to

rea.-<oning that seems to characterize much of the current [Chi¬

as if ancient patterns could be discarded merely by wishing

remoxe them from outside influences that might change the

them away.

course of the events he is trying to observe in their pure state.
Ilis ultimate purpose is to understand nature so that he may

the evidence of our five senses is determined by a cultural bias

The way in which most inhabitants of our planet evaluate

influence it wherever he can. in order to make life better. But it

so strongly ingrained that it takes a conscious re-training to

is a fundamental teaching of Chinese thought that such separa¬

change it. What a faculty member of a school like HMU view's

tion is senseless, because it frustrates the very principle upon

as proof of a proposition is often independent of what his

w hich nature must be understood, the principle that interdepen¬

Western colleague would call rigorous logic.

dence. harmony and bowing to nature's inexorable will are the

presents a major obstacle to the development of modern medi¬

true paths to making life better.

The Chinese physician has

cal .science in China. What is more, the all-too-frequent failure

been taught from childhood that mankind does not influence

of Americans to acknowledge this lack of rigor only adds to the
obstruction.

nature — mankind lives w'ith nature's unremitting rhythms.

This in itself

I do not argue that the Western way is right and the
Chinese way is wrong, simply that they are different. And so

Outside Influences

different are they, that a culture imbued with the spirit of one
has difficulty, no matter the purity of its motivation, in adapting

We have failed to take other matters into account, as well.

to the other.

Even the modern education of a Western-style

program in today's China is affected by the subtle authority of
4.()()() years of contemplative philosophy.
Although I had been to the People's Republic before, my
first visit to the Hunan Medical Lhiiversity (IIMLI) took place in
March of 19(S9. three months before the Tiananmen Square
uprising. I had reviewed the report of the delegation of Yale
professors who travelled to China to renew the Yale-China
affiliation in 19S(). The report is suffused w ith their enthusiasm
about the possibilities that lay ahead.

Although it contains a

soberly realistic evaluation of the disabilities of the Chinese
system and of some factors that might inhibit development, the
prospects for a successful exchange program are excellent. An
air of optimism runs through the report like a pleasingly recur¬
rent theme.
Perhaps this optimism reflects the rc/>gc/.s7 that characteri/ed much of American thinking about the People's Republic in
that yeasty post-Mao period.

Emergence from the stultifying

ef fects of the Cultural Revolution seemed certain to bring about
not only a political and economic rapprochement with the West,
but also to foster an intellectual openness in which partnerships
might thrive in such supposedly culture-independent areas as
science and health care.
Comments of delegation members convey their excitement
about the proposed joint undertaking, an excitement which,
seen with the benefit of hindsight, seems to arise less from real
cwidence than it did from the hopefulness of that period. The
generosity of spirit found in the report mirrors. 1 will guess, the

Among them is the Chinese emphasis on appearances, and on
the honors that accrue to seniority. Although the 1980 report
refers to "the pro\ ision of a period of edtication for the leaders,
hut most importantly, the younger members of the Chinese
medical establishment", in practice it has been the fomier. and
rarely the latter, who have come to New' Haven.
Policy conferences between Americans and representa¬
tives of the People's Republic confront a dilemma that has
existed ever since China decided that the West has some things
that might be of value to its national development.

The di¬

lemma concerns not only how to adapt Western concepts to
Chinese society, but also how traditional Chinese cultural pat¬
terns might benefit from improvements in modern technology,
and actually contribute to them as well.
In the past, two great impediments blocked the accomplish¬
ment of such a goal. Eirst is the understandable Chinese resis¬
tance to the West's historical attitude of "cultural imperialism;"
second is its polar opposite, our own equally understandable
reluctance to be so forthcoming with Western notions that we
risk being accused of cultural imperialism. The mix of old and
new apprehensions has resulted in a bit of a stand-off. in w hich
neither side is accomplishing as much as it should. In being
overly sensitive to each viewpoint, we may have been too
insensitive to the job that both sides acknow ledge must be done.
I believe in the universality of psychological responses; to
me. cultural differences are only the outer layers of a mental
machinery driven by the same subconscious forces in Changsha
as in New Haven. Cultural differences. I believe, grow' out of
choices made by societies at various periods in their history.

generosity of spirit with w hich the delegation was welcomed by
Its Chinese hosts, fhe pervading atmosphere of genuine amity

They should not be allowed to obscure psychological dy namics

so characteristic of relationshi|is developed with Chinese col¬
leagues is frequently an unacknowledged influence in decisions

This is a roundabout way of saying that I am convinced, perhaps

that shoukl be made on more substantive grounds.
One ol the most realistic cautionary notes in the 1980
report stresses ''the need to tleveloii approaches to science and
medicine which stress the orderly collection of facts and the

that are the common heritage of all members of our species.
simplistically. that people are the same everywhere; each of us
responds to the same unspoken messages that underlie all ver¬
bal communication.

On some not-quite conscious level we

di\'ine the truth about each other.
Y.ale
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During our visit to Beijing on the 1989 trip, John Bryan
Starr, president of the Yale-China Association, and I met with
Dr. Cao Ziyi, at that time the PRC's vice minister of public
health. The meeting had been arranged at my request, because I
wanted some sense of the central government's priorities in
relation to health and medical education. Cao's office is located
in the building in which the deposed Emperor Pu Yi lived after
he was forced to leave the Forbidden City. It was the perfect
setting in which to discuss transitions.
Cao was at the door to greet us. A short, full-faced, rather
wholesome looking man of about 45, he wore a neatly tailored
navy-blue business suit.

The first thing that struck me about

him was the golden smoothness of his skin, a quality that made
his face appear to beam when he smiled. I watched those smiles
carefully throughout our hour-long discussion. Although in
general they appeared in response to something John Starr or I
was saying, there seemed to be a deeper source as well. I had a
vague perception that our conversation was setting off brief

Dr. Slierwiii B. Niiland

trains of thought in his mind, and his smile was sometimes the
result of his own inner musings. He struck me as a person who
not only listens, but has the ability to analyze and synthesize
what he is hearing as he is hearing it. I felt as though we were in

Sherwin B, Nuland, M.D. ’55:
Encountering China

the presence of a man whose power comes from an intimidating
ability to out-think everyone around him.
Dr. Sherwin B. Nuland joined the medical advisory com¬

Three other officials attended the meeting: Dr. Liu Bingxun,
director of China's department of medical education; Dr. Liu

mittee of the board of trustees of the Yale-China Associa¬

Yinsheng, chief of that department's division of science and

tion in 1986 and assumed the committee chair in 1988. In

technology exchange; and Mr. Tan Sui, deputy director of the

that capacity. Dr. Nuland is responsible for shaping the

national medical examination center.

association's work in the field of medicine in China—

Joining John Starr and

me was Mrs. Geraldine Kunstadter. who was in Beijing as a

work that began with the opening of Xiangya Hospital in

member of the Yale-China hoard of trustees. Geri Kunstadter,

Changsha in 1906.
Under Dr. Nuland's direction, the association has

who has a degree in electrical engineering from M.I.T., is
chairman of the Albert Kunstadter Family Foundation, a philan¬
thropic trust that has long devoted much of its advisory and
financial resources to the assistance of developing nations.
Our discussion with the vice minister covered a wide range

launched two new collaborative research and training
programs that link Yale School of Medicine faculty mem¬
bers with colleagues in

two medical schools in China.

The focus of the first project, based at Hunan Medical

of areas that relate to health policy and medical education. Of

University in Changsha, is pediatric cardiology. The fo¬

the 133 medical schools in China, 13 have been designated as

cus of the second project, located at Shanghai Medical
University, is the treatment of breast and liver cancer.

what are called “key" schools. Five of these are in a category
that might be called “superkey." because they are given special
funding and other kinds of support.

These selections were

made in the I95()s and have never been changed. They include
two institutions in Bei jing, and one each in Shanghai. Guangzhou
and Chengdu in West China. A look at the map confimis that
geography played a major role in the choice of schools, as did
historical development and the quality of the institution at the
time of selection.
Obviously, this status of superkey was of considerable

Dr. Nuland recently took a leave of absence from his
private surgery practice in New Haven to devote more
time to his vocation as author and medical historian. His
critically acclaimed first book: Doctors: The Biography
of Medicine (Alfred A. Knopf, 1988) was a Book-of-theMonth Club alternate selection and has been translated
into three languages. He is currently at work on a book
about the physiology and history of disease and dying, to
be published by Alfred A. Knopf. He recently has com¬
pleted the text for a pictorial history of military medicine.

concern to us because it does not include HMU, which is merely
a “key" school. As we discussed the matter, there occurred one
of those brief bits of talk that sometimes provide clues to an
entire philosophy.

Wanting to know whether there was any

possibility that other .schools might rise to the category of
superkey, 1 turned to Liu Bingxun, who had not changed his
stolid expression even once, and asked if the present designa¬
tions were meant to continue forever. He delivered up his reply
with a face of stone; “Yes, it is forever," he said very firmly,
“For now."
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That small statement exemplifies what I can only think of
as a vast undercurrent of pragmatism that runs through all
official Chinese policy, and even through areas where there is
less policy than Westerners believe. Behind the obdurate pos¬
ture that government leaders often display to public view lies
hidden an unspoken promise to yield just a bit, should there be
some visible advantages for China. The apparent inflexibility is
more a bargaining position than a fixed reality.
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We spoke of many other things—delivering health care to
proxincial farmers (farmers make up 80 percent of China's
population), retraining China's 7(K).00() "barefoot doctors." pro¬

the lack of institutional support required for them to use what¬
ever knoxvledge they have gained. Researchers come home to
inadequate laboratories; clinicians find none of the diagnostic

viding specialty education for surgeons and internists, enhanc¬
ing the financial and social status of Chinese physicians. Of

and therapeutic equipment they have become familiar with in
the West. Based on the statements made by Vice Minister Cao,

course, we also discussed the priority that an overpopulated
nation's central government places on medical education and

as xvell as xvhat the two Lius xvere now saying. I am not
optimistic about a quick fix for this issue.

the health care of individual citizens.
Cao took ad\ antage of this part of our discussion to make
an obviously political statement:

"The first problem to be

.\ Job. Not a Profession
After our meeting xvith the ministry officials ended that mid¬
afternoon. John Starr. Geri Kunstadter and I sat down in the
hotel lounge to discuss the day's events, over coffee. Listening
to these two articulate people, both of them so much better
acquainted w ith China than 1. helped to crystallize some of my
own emerging ideas.
Perhaps the greatest clarifx ing element xxas a single remark
of Geri's based on her experiences with medical treatment in
China—"They don't seem to care about their patients the xvax
American doctors do." That sentence affimrs an obsen ation so
readily verified that it is virtually axiomatic.

It cannot be ex¬

plained by invoking the difference in xalue our txxo cultures
place on indixidual human lixes.

And it certainly cannot be

explained by any intrinsic character differences betxxeen Chinese
and American doctors, because everx' piece of ex idence indicates
that inteipersonal relationships betxx een strangers are distinguished
Sur'^eons pciforni their art at I liman MeJica! University.

by greater kindness in their countrx’ than in ours.

solved is population control. Without it. all other reforms and

is determined by complex factors. The outcome of those factors

The amount of caring that a healer exhibits toward the sick
constructions are nonsense."

He believes, he told us. that if

is xvhat xve in America call the doctor-patient relationship, a

population control can be achieved, every other problem—the

bond that develops for as long as a patient considers a physician

economy, agriculture, transportation, energy, population, edu¬
cation—will be easily overcome. Until then, these other areas

to be his or her doctor. In this transaction, two individuals relate
to each other on two distinct levels of understanding. The first is

must remain at a higher level of priority than the health of the

personal, and involxes the same considerations that determine

people.

the tone of transactions between any txvo people who begin a
partnership xvith certain preconceptions about each other's role.

The one couple-one child solution has been difficult for
many American experts to accept. Not only simplistic, it also
risks tearing at the fabric of a culture so dependent on the

The second level is societal. The Western physician occu¬
pies an elex ated position. Call it parental, or authoritatixe or

consanguineal and extended family. Although 1 was not hesi¬

even magisterial. Call it anything that implies respect for those

tant to disagree with several other of Cao's view s, it would have

xx ho. by X irtue of their superior knoxvledge. society allows to

been senseless to debate a principle that has become such an

make pronouncements and decisions about our lives.

idee fi.xe of national policy. This is one area of domestic affairs

West, medicine is one of the learned professions.
In the classical sense, a profession has a contract xvith

where immoxability is as real as it appears.
As the meeting concluded, the two Lius, both Mao-suited

In the

men in their mid-bOs. asked us xvhether they might meet again

society. Society prox ides it with status, privilege, good income,
and permission to choose, train and discipline its members

w ith the three of us that afternoon, at the Sheraton Great Wall

without outside interference.

Hotel at 2 p.m.

society asks in return only for a guaranteed constant supply of
health care; in effect, a kind of beneficent noblesse oblige.

that meeting xve reviexved our relationship

with H.MC and described the new plan of affiliation.
Liu 't’unsheng again brought up the old refrain to xvhich we
had been exposed so many times—the x oimg are too inexperi¬
enced in science to make optimal use of their studies in the
West. This time I did dig in my heels and insisted that all the
science in the xxoiid is of no use to a visiting scholar xxho is
handicapped by poor linglish. I had by this time concluded that
officials xxho insist on describing their young people as scien¬
tifically naive are i.|uite axvare of the error of that position. What
the> are realix insisting on is the yai inianzi. the prix ilege due
senior people.
We eoneluiled our meeting by discussing one of the most
serious problems lacetl by returning Chinese medical scholars.
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Of the profession of medicine,

Hence, doctors in the West assume a great moral responsibility
in return for the special status granted them by society. Upon
this basis medicine is a profession—a calling and not a craft.
With no such special contract in communist China, medi¬
cine is not. in either the societal or the moral sense, a profession.
It is simply a job. The mere fact that it requires more education
than most other jobs does not increase its xalue. There is little
prix ilege, and therefore little assumption by doctor or patient of
the healer's xx illingness to accept extraordinarx obligation.
This simple truth, once recognized, explained a great deal
of xvhat 1 had seen in China, and xvhat had been described to me
by colleagues xxho had visited there. Doctors in the People's
'I'.-xLE Medicine Spring 1992

Republic work at vvhal is essentially a low-esteem Job. Particu¬
larly in present-day China, where farmers and factory workers
are far better remunerated than healers, the inadequate financial

1 have spoken has .seen evidence of this in China. Doctors are
workers. The value of workers is proportional to an output that

rewards of physicians rellect their inadequate image in society.

can be measured in units of money. For doctors, that figure is
very low. and for this reason, medicine does not attract nearly as

They do not produce what current Chinese society values most—

great a proportion of highly motivated, ambitious young people

goods and money.
1 was not shy, either in Changsha or Beijing, about asking

as it does here at home.

people what they earn. Having had the question put to me a few
times on my previous visit, once by a young man who walked
up to me on a Guangzhou street. 1 did not consider it personal or
rude. I found out that the average physician earns less than $30
a month; the highest paid doctor to whom 1 spoke did not earn

And then, there is the other obstacle to modernizing the
health care system—neither it nor medical research are very
high among the central government's priorities, and they are
not likely to rise higher during our lifetime, d’he United States'
recognition of individual health as a basic right simply does not

$1,200 in his best year, and yet his rank and title are at a level

equate in China. What appears to be the same game is played
by different rules in the two countries.

that is stratospheric compared to his colleagues.
Regardless of differences in purchasing power, such sala¬

Science Confronts Harmony

ries mean that China's highest ranking physicians live in very
small hospital-based apartments without regular hot water; they
do not own cars; their vacations, if they can afford to go away,
are simple and cheap; they do not have funds to visit foreign
countries; the expense of books and Journals is beyond them; a
translator whose English is no better than theirs earns, at a
conservative estimate, five times their salary.
But most countries provide doctors with better rewards
than money alone can buy. They include recognition, esteem
and trust, with the understanding that doctors, in the words of
Robert Louis Stevenson, “stand above the common herd." Nei¬
ther I nor any American medical or diplomatic visitor to whom

Having come to this conclusion, what should the medical repre¬
sentatives of a friendly nation consider to be their role? It has
been the received wisdom that Americans cannot set goals for
other countries, and especially for a country with problems as
complex and cultural characteristics as inconsonant with our
own as are China's. And yet, our Chinese colleagues seek out
exchanges, point with pride to those few medical advances they
have managed to make, and in numerous other ways indicate
that they want what we perceive them to need—a science-based
system of medical education and health care.
Does any kind of assistance fall outside that category of
“cultural imperialism" against which we tell each other to be
constantly on guard? Perhaps clues present themselves all over
the landscape, not only from China, in its history and present
situation, but also from the West.
Whether foreign or native, those who wish to modernize
China must understand and deal with the traditional belief in
totality and harmony. But in their sensitivity to this belief, they
cannot ignore that the People's Republic has decided to bring
the strengths of modern science to bear on their nation's prob¬
lems. Although it is no longer fashionable to quote Mao Tsetung,
he was articulating his country's fundamental approach to mod¬
ernization when he said, "Make the past serve the present and
foreign things serve China."
What has not served China, at least in the eyes of the West,
are the ineradicable memories of the Tiananmen massacre that
occurred a few months after our visit. The cruelties of that
unforeseeable event and its aftermath have influenced every
aspect of our relationship with the People's Republic. Support
for cultural and scientific exchanges has waned, and there has
been a marked diminution of the optimistic enthusiasm with
which Americans approach collaborative efforts with Chinese
colleagues. In fact, some of those colleagues have been dis¬
placed. Cao Ziyi, for example, was seen as too supportive of
the students, and someone else now occupies his office. These
are the political facts of life in present-day China.
But the work of the Yale-China Association, though slowed
for a time, remains unchanged. In a new mission statement
ratified last year, the board of trustees reaffirmed its nearly
century-old commitment to “changing lives: Chinese lives and
American lives. Teaching and learning are the heart of this
endeavor." In order to teach and to learn, it is necessary to make

Young physicians: the future of Chinese medicine.
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use of every experience we have had since Yale-China founder
Dr. Edward Hume first set foot in China in the earlv IPOOs, and
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especially the new insights of the years since we resumed our
collaborative efforts in 1980.

With this in mind, the medical

program of Yale-China has been allowed a rapid evolution of
perspective, to incorporate the requirements of a relationship
that is not only bilateral but symmetrical and mutually benefi¬
cial. in a way that circumstances have not previously permitted.
Both sides have now agreed that the focus of Yale-China's
attention should he young medical scholars, those most likely to
benefit by a program whose mission is to change lives.

It is

realistic to expect that, in addition to its other virtues, such a
policy is likely to result in the forging of long-standing relation¬
ships between individuals w ith similar academic interests in our
two countries. We have insisted that the Chinese participants
demonstrate English-language ability by achieving a high grade
on a standardized examination, so that they make the most
effective use of their fellowship time.

We have replaced our

previous, rather general approach to the character of the visits
back and forth. Now we offer a highl\ organized program in
which specific departmental sections are chosen, and the mem¬
bers of those sections plan the objectives of their exchange.
Hunan Medical University leaders have chosen pediatric
cardiology as a specialty that particularly needs strengthening
at their institution.

Dr. Charles Kleinman. director of that

section at Yale, will fashion, in meetings with his Chinese
counterpart, a program of affiliation in which young scholars
come to New Haven for var\ing periods of time to learn the
methods of their specialty as they are practiced at the Yale-New
Haven Hospital.
Senior Chinese doctors, even those who have no familiarity
with English, are not excluded from participation, but they will
fulfill a supeiA isor_\ role. Visits they may make to New Haven
w ill be relatively brief, and for the purpose of seeing to it that
things are proceeding to their satisfaction, as well as to learn
about American clinical and research methods.
During the course of a visit to the Shanghai Medical Uni¬
versity m 1990. John Starr and I discussed with the leaders of
their faculty a new affiliation with that "superkey” school. Eor
reasons of both history and economics. Shanghai is more West¬
ernized than any other city in the Peoples' Republic, and its
major medical school is much more advanced in scientific
medicine than is our sister school at Changsha. A few months
later. Ii)r. Tang Zhaoyou. the university's president, came to
New Haven to set up groundwork for an exchange in oncology.
Meeting w ith T.S. Ravikumar. M.D.. Yale's chief of surgi¬
cal oncology, and Dr. William Hait. clinical director of the Yale
Comprehensive Cancer Center. Dr. Tang outlined the ways in
which our tw'o schools might mutually benefit by such a pro¬
gram. and work together on major research projects. On return¬
ing from an exploratory visit to the Shanghai Medical Univer¬
sity last spring. Drs. Ravikumar and Hait drew up proposals for
clinical and research affiliations in breast and liver cancer. By
the lime this article reaches print, x isiting scholars from Shang¬
hai and Changsha will he planning their arrival in New Haven
to begin work.

PassingtheTorch
One of the lessons of the past 150 years of Western medicine
derives from the way in which various medically underdevel¬
oped countries have sent their young physicians off to study in
leading foreign centers so that they could return home and
develop a form of health care and research that is most suitable
to their own culture and national characteristics.

Not only

knowledge, but ascendancy in medical leadership passed by
this process from Erance to the German-speaking countries to
the United States. In each case, a form of biomedical science
developed that was indigenous to conditions and precedents in
the home country. This is a lesson for China too. and it reflects
the pragmatic w isdom of Mao's dictum.
In a classic canon of traditional Chinese medicine called
the Nei Ching. its alleged author, the mythical Yellow Emperor
Huang Ti. conducts a dialogue with a learned physician. Chi Po.
At the beginning of Book V. the Yellow Emperor asks Chi Po.
"What is the way of medical treatment?" The first sentence of
the physician's answer is a classic in itself:

"The way of

medical treatment is to be consistent."
Perhaps those words convey part of the answer to develop¬
ing scientific medicine in China—an answer that must accom¬
modate 4.000 years of tradition, as well as the country's need
for the most advanced form of biomedicine. This means modi¬
fication and compromise, and the compromises will have to be
made not only in the rigorous applications of Western scientific
thinking but also in the rigorous adherence to a tradition that is
no longer consistent with China's emerging role in the society
of nations. It is not within the pow'er of well-meaning American
friends to design the structure of this second kind of compro¬
mise; by having signified their wish to modernize. Chinese
authorities have made a commitment to go much further than
they yet have, to make tradition bend in the interest of their
people's well-being.
This commitment will require a significant re-ordering of
national priorities.

A nation's productivity depends in large

part on the health of its people. Not only that, but a government's
investment in its individual citizens brings with it a return that is
incalculable: the strengthened resolve and solidarity that the
citizenry feel when their leaders demonstrate an empathetic
understanding of basic daily life.
And there is more. It will be necessary (and here compro¬
mise guarantees failure) to elevate the societal status of physi¬
cians. It is not merely a matter of better salaries: It is a matter of
recognition that the nation values the health of its individual
citizens enough to put great value also on those who provide
their care. There must be found within the cultural framework
of Communist society, the ground rules of the social contract
that makes medicine a profession.
^'oung people w ill have to be giv en reason to dedicate their
lives to healing. In the West, that dedication has always come
from society's recognition that medicine is not a job. but a
calling. When more of the best youth of China feels itself called
and privileged, it will respond to that call and that privilege with
the same enthusiastic sense of obligation that has brought a
century of medical progress to the United States.
VM
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Portraits of Peter Parker, M.D., and a Tumor Patient; Lam-Qiia, Late-1830s
In the mid-1800s. Chinese artist Lani-Qua painted nearly
200
portraits of Dr. Peter Parker's tumor patients. Lam-Qua did so
at no charge, in gratitude for the free medical services

residents that they formed the Medical Missionary Society to
continue funding the hospital.

Dr.

Dr. Parker devoted more than 20 years introducing progres¬

A

sive medicine and surgery into the Orient. He was the first to

graduate of the Britain Royal Academy. Lam-Qua captured the

train native surgeons, including artist Lam-Qua's nephew, in

most intricate medical details of Dr. Parker's patients before and

lithotomy, amputation, cataract removal and other surgical pro¬
cedures. Dr. Parker also introduced sulphuric ether as China’s

Parker (1834 M.D.) peiformed for the people of China.

after surgery, often including delicate Cantonese landscapes as
backgrounds. Lam-Qua created the images first as sketches on
rice-paper and then as a .series of Western-style oil portraits.
The portraits were used by Dr. Parker on his trips to England
and the United States to raise funds for his missionary work.
More than 80 of Lam-Qua’s portraits are part of a permanent
collection in the Harvey Cushing/John Hay Whitney Medical
Library at Yale.
Dr. Parker, who graduated with degrees from the medical

first anesthetic.
In addition to his medical duties. Dr. Parker served as secre¬
tary and interpreter to the Mission of the United States to
China. For several years, he served as acting U.S. commis¬
sioner to China and in 1855 was named commissioner to the
Chinese Empire.
During the Opium War between Great Britain and China, all
foreigners were expelled from Canton, and Dr. Parker's hospital

and divinity schools at Yale, amved in China in 1834 to estab¬

was forced to close. A few years later, however, he returned to

lish that country’s first Western hospital. With little clinical
training. Dr. Parker founded Canton's Ophthalmic Hospital in

Canton and reopened the hospital. Dr. Parker stayed until ill
health forced him to leave in 1857. He died in 1888 at age 83,

1835, and within its first year treated more than 2,000 patients.
Although many Chinese did not embrace Dr. Parker's Christian
religious teachings, his medical “miracles” so impressed Canton

after treating more than 52.000 patients in China.
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Rosalind D'Eugenio, media specialist
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SCOPE
Comments Yale President Benno C.

American Cyanamid
Supports BCMM
Carcliobiology Program

Schmidt Jr.. "Because of the contribu¬

Molecular cardiobiology. directed by

tions to the biomedical sciences that the

Jordan S. Pober. M.D.. Ph.D.. is one of

agreement will make possible. Yale's
teaching and research programs will

four programs in the Boyer Center

advance the frontiers of knowledge and

programmatic, rather than departmental
lines to encourage interdisciplinary
collaboration.

American Cyanamid Co. lias av\ arded a

enhance patient care. 1 am most grateful

five-year. $6 million grant to Yale

that our commitment to scientific

University to support basic scientific

inquiry and education in the 21st

research in the School of Medicine's

century has received such generous
support."

new Boyer Center for Molecular

vascular disease."

which have been established along

Other BCMM programs include
molecular genetics, headed by Joan A.
Steitz. Ph.D.; molecular and develop¬

.Medicine (BCMM). With the agree¬

Lederle Laboratories is a research¬

ment. which represents one of Yale's

intensive organization that has produced

Spyridon Artavanis-Tsakonas, Ph.D.;

largest corporate collaborations.

important therapeutic agents for heart

and molecular oncology and develop¬

Cyanamid and its Lederle Laboratories

disease, psychiatric illness, infection and
cancer. In addition to ethical pharma¬

ment. headed by Sherman M.

will provide basic support for the
endothelial cell program in molecular

ceuticals. Lederle manufactures child¬

basic researchers will play key roles in

cardiobiology.

hood and adult vaccines.

each program to speed the discoveries of

Vascular endothelium, the single

Vincent T. Marchesi. M.D.. Ph.D..

layer of cells lining the heart, blood

BCMM director, established the

vessels and lymphatic vessels, is thought

program in molecular cardiobiology.

to play a major role in heart disease. As

He has conducted path-breaking studies

Cyanamid E.xecutive Vice President
Frank V. AtLee explains, the grant

into the structure of membrane proteins

"imobes Yale's scientists and Lederle's

observes that "Interest in endothelial

best research talent to produce basic

cells' immune properties and inflamma¬
tory reactions is increasing as more

science that may lead to novel therapies
for the major medical threat posed by
atherosclerotic disease."

in red blood cells. Dr. Marchesi

scientists work to determine the role
these cells play in thrombosis and

mental neurobiology, headed by

Weissman. M.D. Clinically oriented

basic science to the bedside.

Study Finds Dyslexia
Occurs in Continuum
A School of Medicine study has
challenged the conventional understand¬
ing of dyslexia. That view suggests that
dyslexia is a specific disorder in which
the reading abilities of affected children
differ fundamentally from those of other
poor readers and do not change over
time.
"Dyslexia is not an all or none
phenomenon." said the study's principal
investigator. Sally E. Shaywitz. M.D..
professor of pediatrics. "Dyslexia is
much more like hypertension and occurs
along a continuum with gradations or
degrees."
She reported her results in the Jan. 16
issue of the New Engkuid Journal of
Medici)te. Dyslexia, a specific difficulty
in learning to read, is believed to be
biologically based and can be experi¬
enced by people of average to aboveaverage intelligence.
Although estimates vary, some
experts believe it affects as many as 12
percent of the nation's students. In the

IF//// a ,S'b million i’rcin! from American Cyanamid Co., all four programs of
I he Boxer Ceiiler for Molecular Medicine are fully operational.
2<S

stud). which currently is funded by the
National Institute of Child Health and
Y.ale Medicine Spring 1992

Human Development, the researchers
charted the reading development of 414
randomly selected Connecticut children
from first through sixth grade. They
found that in any given year, as well as
from year to year, the children's reading
ability varied predictably, fitting a

infants' lungs," Dr. Warshaw

New Center To Research
Infant Lung Diseases

explains. “Lung injuries are common
complications of premature infants;
the incidence may be as high as 25
percent,” he notes.

The National Heart, Lung and Blood

Among the fundamental ques¬

Institute has awarded the University
a five-year, $4.3 million grant for an

tions Yale physicians and scientists
will consider; How do lungs respond

bell-shaped curve.

interdisciplinary team of physicians

Dr. Shaywitz said the importance of
the finding for dyslexia is that it

and biomedical scientists to study
neonatal lung injury and its long¬

to injury? What process repairs the
injury? How do lungs develop and
function in children? How do lungs

recognizes that reading ability is not

term clinical consequences.
“Through our pediatric lung

normal distribution curve—a distribu¬
tion of values that appear on a graph as a

constant over time, but rather that there

expand and contract? What kind of
energy is required to breathe? In
addition, researchers will advance

is a predictable variability in reading
ability in all children from year to year.

center, we hope to generate knowl¬
edge that will lead to a better under¬

our understanding of lung illnesses

"Current policies for the identifica¬
tion of dyslexic children are based on

standing of the events underlying lung
injury,” says Dr. Joseph B. Warshaw,

caused by alterations in gene expres¬
sion.

the belief that dyslexia is invariant over

program director. “This knowledge

time, that a small group of children can

will be essential before prevention

Others will study the regulation
of surfactant—a wet substance the

be identified as dyslexic in the early

strategies can be rigorously eleveloped

body produces to reduce surface

school years and that this group will not

and tested.”
Dr. Warshaw. chairman and chief

tension—in both injured adult and

change from year to year," said Dr.
Shaywitz. She added that educators
may need to idenitfy a larger number of
children who are “at risk” for reading
difficulties.

of the department of pediatrics, notes
that the center will involve nine or
more faculty members in the
departments of pediatrics, cell
biology, epidemiology and public
health, and pathology.

Unique Art Show Comes
To School of Medicine

“We plan to study both normal
and abnormal lung development and
to address major questions about

developing lungs. If immature lungs
of premature babies have no surfac¬
tant. the lungs may collapse.
Lung injuries may occur in
premature babies because their
lungs, though fragile, need aggres¬
sive treatment, often requiring
prolonged hospitalization. Children
who survive lung injuries often have
chronic infections.

In December, more than six talented
artists from across the nation exhibited
their paintings and sketches in New
Haven. Only, some of them might not
be able to draw a straight line.
How to account for this paradox?

Pneumococcal Vaccine
Proves To Be Effective

Mental Health Center (CMHC),
featured pen and ink sketches, oil
paintings, wood carvings and bronze
sculptures.
Susan T. Naylor, R.N., M.S.N.,
arranged the exhibit as coordinator of
the Adult Pervasive Developmental
Disorders Clinic. She explains that the
show represents the collaborative
efforts of adult autistic in- and out¬
patients at the CMHC.
"We involved the CMHC patients in
planning and presenting this art show,"
Ms. Naylor says, "to help them normal¬
ize their illness and see what it means
to be part of society."
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of pneumococcal vaccine.
The researchers, in collaboration with
colleagues at the University of Pennsyl¬

These adult artists are autistic savants.
Their exhibit, held at the Connecticut

may explain some conflicting informa¬
tion previously reported on the efficacy

With a recently completed study, Yale
re.searchers hope to end some of the

vania and the National Institutes of

controversy about the effectiveness of the

Health, proved that the vaccine worked
against infections caused by the 23 types

pneumococcal vaccine that has been used

of pneumococcal bacteria included in it

in the United States since 1978. Eugene
D. Shapiro, M.D., associate professor of

and did not work against types of the
bacteria which were not part of the

pediatrics and of epidemiology, led the

vaccine.
The vaccine protects against more
than 90 percent of pneumococcal

six-year Connecticut study.
“The main purpose of this research,"
he states, “is to assess the vaccine’s
effectiveness in a large-scale study. We
found that the vaccine has a 61 per cent
efficacy in patients with healthy immune
systems. We designed this study with
internal controls specifically to assure its
validity."
The study was published in the Nov.
21 issue of the New En^laiul Journal of
Medicine. Results from the Yale study

infections that produce serious diseases.
Vaccination is especially recommended
for adults with chronic renal and
pulmonary diseases, chronic alcoholism
and congestive heart failure. And due to
increased risk to serious pneumococcal
disease among the elderly. Dr. Shapiro
recommends the vaccine be used as a
preventative measure for them, as well.
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Martin Luther King Jr. Day 1992
Cornell Scott. M.P.H. '('>8, pictured here with
Maxitic Whitehead, director ofniinority affair.s.
moderated a .sympo.siimt entitled. "New Haven:
,4 Community Fii’ht.s Back." which was also the
theme of this year's Martin Luther King Jr. Day

l*hi»t(»^ruphs li\ Hnrr\ Hishop

events. (See photo cm facing page.)

Rita ,/. Louard. M D.. associate research
scientist in medicine, (foreground) attends
one of several luuchtiuie seminars. Iti this
seminar. Mustafta Ahdul-Salaam. director
of the New Haven Fauuly Alliance,
discussed how his organization works to
support and maintain the health and
structural integrity of families.

John Kirk, pictured here with fellow second-year student Karen Broder. presents
Adolescent Substance Abuse Prevention program (ASAP) t-shirts to Roberto
Clemente Middle School sttidents. Mr. Kirk and Ms. Broder co-direct a\SAP with
Christopher Gilligan. also '9J M.D.. and were among F^ medical school and EPH
students who were presented awards for commtmity service.
(See "Student News." page Jb.)
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lliis year's syniposiiini panel featured (from left):
Edward H. Kaplan, an associate professor in the
schools of organization and nianagcnient and
medicine. He spoke of New Haven's snccessfid needle
e.vchange program, which is slowing the spread of
AIDS among IV drug ahnsers. Gerald Friedland,
M .D., professor of medicine, disciisseil the University¬
wide AIDS Consortium which he heads. New Haven
Police Chief Nicholas Pastore and Donald .1. Cohen,
director of the Child Study Center, described a new
initiative between the medical school and the police
department to aid children and families who have
suffered from violence.

William //. Gray III, president and chief e.vecntive officer of
the United Negro College Fund (left), receives the key to the
city from New Haven Mayor John Dainels as Acting Dean
Robert M. Donalds(m Jr. looks on. Mr. Gray delivered this
year's Martin Luther King Jr. Day keynote address.

Entertainment by the Yale University Gospel
Choir is becoming a tradition at the School of
Medicine's Martin Luther King Jr. Day.
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Faculty
News
Neuroscientists Earn
Javits Research Awards
Two School of Medicine researchers
have been presented Javits
Neuroscience Investigator Awards by the
National Institute of Neurological
Disorders and Stroke (NINDS).
Robert 11. LaMotte. Ph.D.. professor
of anesthesiology and neurobiology, and
Bruce R. Ransom. M.D.. Ph.D.. associate
professor of neurology and of cellular

Marion Morra: Longtime crusader against cancer.

and molecular physiology, were selected
for the award, which recognizes out¬
responsible for the many communica¬

standing contributions to neurological
sciences. They are among 12 Javits
award recipients at Yale.

NCI Award Named
For Marion Morra

NINDS established the awards, which

tions and outreach activities of the
Yale Comprehensive Cancer Center.
She also serves as a liaison to local,
state and national organizations

support scientists for seven years, to

The first annual award for

honor the late Li.S. Sen. Jacob Javits of

involved in cancer control and

outstanding leadership of the

research.

New York.
Dr. La.Vlotte. a native of Washington.

National Cancer Institute's (NCI)

Ms. Morra. associate clinical

Cancer Information Service (CIS)

professor at the School of Nursing,

D.C.. joined the Yale medical faculty in

was presented to Marion Morra.

ld77. With the award, he will conduct

teaches graduate level courses in

associate director of the Yale

communications and health market¬

research on the nerve function of pain

Comprehensive Cancer Center, by

and itch and the sensation response that

ing. She is also associate research

Marilyn Quayle. wife of Vice

occurs after a skin tissue injury. He also

scientist in the department of

President Daniel Quayle, and Samuel

will continue to stud_\ the conditions

epidemiology and public health,

Broder, M.D.. director of the NCI.

under which changes in the spinal cord

where she teaches about advances in

who announced the award henceforth

neuron can become prolonged and

cancer prevention and control.

will be named after Ms. Morra.

possibly contribute to the suffering of

Following the presentation, the

patients with chronic pain that persists

committees of the NCI and the

Marion Morra Award was also given

long after a tissue injury has healed.

American Cancer Society and has

to Kate Duffy, head of the CIS

written numerous articles, pamphlets

section at NCI in Bethesda, Md. The

N.M.. joined the Yale medical faculty in

and self-help booklets for cancer

presentations were part of a

ldK7 and was named director of the

patients and their families. With her

ceremony marking the 15th

school's outpatient neurology clinic a

sister, the medical writer Eve Potts,

anniversary of the CIS.

Dr. Ransom, a native of Santa Fe.

year later. With the award, he will

The CIS. through its toll-free

Ms. Moira serves on several major

she co-authored CHOICES: Realistic
.Alternatives in Cancer Treatment

expand his notable work on the physiol¬

number. I-800-4-CANCER, annually

ogy of neuroglial cells, the non-neuronal

responds to more than 500.000

cells in the brain, and their relationship

1987); Understanding Yonr Immune

inquiries about cancer from the

to neurons. Dr. Ransom is focusing on

Svstem (Avon Books. 1986); and

American public. It is the largest

the effects that glial cells have on ions,

TRIUMPH: Getting Back To Normal

service of its kind in the world.

W'heti You Have Cancer (.Avon

positively or negatively charges atoms
that play a key role in intercellular

In addition to her duties directing

(Avon Books, 1980; revised edition,

Books. 1990).

the CIS at Yale. Ms. Morra is

communication.

}2
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Yale Child Study Center
Faculty Named to
Endowed Professorships

and adolescence. She also researches
problems in linking children and

Rosemary H. Balsam. M.D..

families who need treatment with

associate clinical professor of psychiatry
and staff psychiatrist at the Yale Health

appropriate psychiatric services.
Mr. Marans focirses his research on

supervising analyst at the Western New

Plan, was appointed training and

the role of aggression in children and on

England Institute for Psychoanalysis by

Two faculty members at the Child Study

methods for studying observations

Center have been named to endowed

derived from psychoanalytic interviews.
He is program coordinator for the Child

the American Psychoanalytic Associa¬
tion in December.

professorships. Mary E. Schwab-Stone,
M.D., assistant professor of psychiatry,

Study Center/New Haven Department of

Professor of Child Psychiatry, and

Police Service Project, a program that
arranges counseling for children

was named the Harris Assistant
Steven Marans, M,S,W., assistant

exposed to violence. This Joint venture,

clinical professor of social work, was

initiated last fall, includes a course on

appointed the Harris Assistant Professor

child development for all police recruits;
a consultation for field officers regard¬

of Child Psychoanalysis.
Dr. Schwab-Stone, who Joined the

ing services for children who are victims

Alexander Baumgarten. M.B.B.S.,
Ph.D.. professor of laboratory medicine,
was appointed to the U.S. Food and
Drug Administration general and plastic
surgery devices advisory panel. The
panel met in February to offer advice on
the continued use of silicone gel breast
implants.

Child Study Center in 1987, is the

or witnesses of violence; and a fellow¬

principal investigator for the Yale Child

ship for selected police officers to learn

Maurice Falk Professor in the Child

and Adolescent Psychiatric

about available mental health services
for children.

Study Center and Child Psychiatry,

Epidemiologic Study and the RuralUrban Study of Child Psychiatric

In 1986. Irving and Neison Harris,

.lames P. Comer. M.D., M.P.H.. the

received a $50,600 Charles A. Dana

Di.sorders. Concerned with the prob¬
lems of inner-city youth, she concen¬

brothers who graduated from Yale in

Award for using psychiatry's insights
into child development to forge a

1931 and 1936 respectively, donated $5

pioneering model of collaboration

trates her research on the relationship
between a child’s .social environment

million to the Yale Child Study Center

between parents and teachers in public

to establish these endowed fellowships.

.schools.

and psychiatric conditions of childhood

Alvaii R. Feinstein, M.D., Sterling
Professor of Medicine and Epidemiology
and co-director of the Robeil Wood Johnson
Clinical Scholais Program, and .Ioann G.
Elmore, M.D., a Robert Wood Johnson
Clinical Scholar, have been awarded a
pi'ogram development grruit of $38,000 by
the Ameiican Cancer Society to support
research on the efficacy of m;immography
for breast cancel' screening.
(Jary E. Friedlaender. M.D.,
professor and chairman of orthopaedics
and rehabilitation, will serve a four-year
term on the National Advisory Board for
Arthritis and Musculoskeletal and Skin
Diseases for the National Institutes of
Health.
R. Kenny Fryer. M.L.S.. head of
reference services in the Harvey
Cushing/John Hay Whitney Medical
Library, was named a distinguished
member of the Academy of Health

Executives from Boehriiiger-Ingelheim Pharmaceuticals. Inc. (BIPI) meet the first
recipient of the Boehringer-lugelheim Young Investigator Awai'cl. Carl flashimoto,
Ph.D., assistant professor of cell biology, received the award for his research into the
development of the fruit fly embryo. He studies how the Drosophila embryo
differentiates into front and back, a process that has molecular ec/uivalents in other
organisms, including humans. (Front row. from left) Alan Rosenthal, M.D.. senior
vice president scientific affairs. BIPI: Dr. Hashimoto: Acting Dean Dr. Robert M.
Donaldson .Jr. (Back row. from left) Richard Asch. district sales manger. BIPI: Victor
Hartmann. M.D., vice president, medical. BIPI: and Gordon Letts. Ph.D.. director of
pharmacology. BIPI.
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Information Professionals of the
Medical Library Association.
(Jerhard H. Giebisch, M.D..
Sterling Professor of Cellular and
Molecular Physiology, was granted the
degree of Docteur Honoris Causa in
October by the University of Lausanne.
Switzerland. Dr. Giebisch studies the
cellular mechanism of dissolved
substance transport to the kidney. In
33

Edward F. Zigler. Ph.D.. Sterling

particular, he and his associates have
investigated the mechanisms of renal

Professor of Psychology, was pre.sented

potassium transport. Dr. Giebisch spent

the Loyola-Mellon Social Science

a sabbatical year in Lausanne from 1974

Award in October, for his contributions

to 1975.

to the scientific study of human behav¬

University, but continues as a professor
of surgery.
Asa Barnes, M.D.'59, '63-'65 HS.
clinical professor of pathology at the

ior and the nature of social institutions.

University of California. Irvine. College
of Medicine, has been elected president

neurobiology, will serve a four-year

Howard V. Zonana, M.D., associate
professor of psychiatry, received the

of the California Blood Bank. He is also
president of the boards of directors of

term as a member of the Sensory

Outstanding Service Award from the

the American Red Cross Los Angeles

Disorders and Language Study Section.

American Academy of Psychiatry and

and Orange Counties Regional Blood

Division of Research Grants, at the

the Law (A.APL) at its national meeting

Charles

\.

(ireer. Ph.D.. associate

professor of surgery (neurosurgery) and

National Institutes of Health.
(Jeorge R. Heninger. M.D.. profes¬
sor of psychiatry, summarized the latest
knowledge about affective disorders at
the third annual Bristol-Myers Squibb
Symposium on Neuroscience Research
held at Yale in October.
Charles A. .laneway .Ir.. M.D..
professor of immunobiology and a

in Orlando, Fla., in October, and was

Center and the greater Long Beach
chapter of the American Red Cross. In

elected AAPL president for 1992-1993.

the latter capacity, he traveled to

Dr. Zonana also spoke at the third

Cambodia to coordinate medical

International Congress on Psychiatry

assistance projects with the Cambodian

Law and Ethics held in Jerusalem in

Red Cross and other agencies.

November. His address was titled
"Voluntary Psychiatric Hospitalization
and the Growing Conllict with Patient
Rights."

Alan Lieberson, M.D.'62. serves on
the Norwalk Bioethics Committee as a
patient advocate, and advises clients
troubled by the health-care system.
David M. Holden, M.D.'63. has

Howard Hughes Medical Institute
investigator, was awarded a Doctor of

been appointed to the Accreditation

Medicine Honoris Causa degree in

Council for Graduate Medical Education

(October by the Nicholas Copernicus

Residency Review Committee for

School of Medicine in Krakow. Poland,

Family Practice as a representative of
the American Academy of Family

for his studies on the activation of T
lymphocytes.

Alumni

Ira S. .Mellman. Ph.D.. professor of
cell biology, will serve a four-year term
as a member of the Cellular Biology and

Physicians. He has been professor and
chairman of the department of family
medicine at the State University of New

News

Physiology Study Section. Division of

York at Buffalo School of Medicine and
Biomedical Sciences since 1983.

Research Grants, for the National
Institutes of Health.
Fasko Rakic. M.D.. Sc.D.. Dorys
.McConnell Duberg Professor of
Neuroscience and chairman of neurobi¬
ology. was granted the degree of Doctor

Samuel D. Kushlan, M.D.'35, was
honored by the School of Medicine's
di\'ision of digestive diseases w ith the
23rd annual Kushlan Lecture, "AIDS

Gyorgyi University in Szeged. Hungary,

and the GI Tract." delivered by Marvin
H. Sleisenger. M.D.. professor of

for his studies on the mechanisms of

medicine at the University of California

brain development.

at San Francisco.

Honoris Causa by the Albert Szent-

Robert E. Shope. M.D.. professor of
epidemiology, director of medical
studies for epidemiology and public
health, and director of the Yale Arlx)virus Research Unit, was named an
hoiK)rary diplomate by the American
College of Veterinary Microbiologists
tor his contributions to this field.
■loan A. Steitz. Ph.D.. professor of
molecular biophysics and biochemistry,
has been avs arded the Christcipher
Columbus .Award in Biomedical
Research b\ the National Institutes of
Health Christopher Columbus Medical
.Sciences Committee.
.■^4

Rocko M. Fasanella, M.D.'43. was
honored by the Italian-American
Historical Societv of Greater New
Haven at its annual distinguished award
dinner in December for his more than 40
years of service to the greater New
Haven area as an eye surgeon, educator
and humanitarian. Dr. Fasanella was a
founder of the Caribbean Ophthalmological Society and is also a member of
professional societies in the United
States, France. Spain and Peru.
B. HerokI (Jriftlth, M.D.'4,S. '48'49 HS. has retired after 21 years as
chief of idastic surgery at Northv\ estern

Ian C. MacLeu)]. M.D.
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Ian C. Mac-Lean, M.D.. '63-’65 HS,

Bernard H. Selin, M.D.’8I. while

was installed as the 33rd president of the
American Academy of Physical Medi¬

completing his residency in emergency

cine and Rehabilitation at its annual
assembly held in Washington. D.C. in

the Shock- Trauma Center in Baltimore.

October. A member since 1967. Dr.

several weeks as part of an earthquake

medicine in Pittsburgh, spent a month at
1 le also traveled to Costa Rica for

MacLean served on the academy's

analysis team after a large tremor in

board of governors since 1986. He is

April. In October, he presented a two-

also a director of the American Board of

day workshop in Korea on emergency

Electrodiagnostic Medicine and is the

medical service development.

American Medical Associations’s House
of Delegates representative for the

.1. Mark Blue, M.D., '84 P.A., who

American Association of

received his M.D. degree in May 1991

Electrodiagnostic Medicine.

from East Carolina University in
Greenville. N.C., has begun his resi¬

Diane K. Shrier, M.D.'64. has
accepted a position as vice chair and

dency training in orthopedic surgery at

director of clinical psychiatric services
of the department of psychiatry at

the University of Missouri.
W. I>ee Bailey, M.D.'86. presented

Children's National Medical Center in

research findings on the molecular

Washington. D.C. She concurrently has
been appointed professor of psychiatry
and pediatrics at George Washington

mechanisms of restenosis after coronary
Richard B. Biuford. '77 M.P.H

University Medical School.
Richard B. Burlorcl, 'll M.P.H.,
Morris B. Mellion, M.D.'70. was
elected president of the American
Academy of Eamily Physicians, which
represents 71,000 family physicians and
medical students. In addition to his
private medical practice. Dr. Mellion
teaches at the University of Nebraska
Medical Center and in the School of

artery angioplasty at the European Heail
Congress in Amsterdam and at the
American Heart Association meetings in

vice president for administration at

Anaheim, Calif. He has accepted a

Yale-New Haven Hospital (YNHH)

position as the Interventional Cardiology

since 1988, joined the medical school's

Eel low with Dr. Geoffrey Hartzler at the

Eaculty Practice Plan as executive

Mid-America Heart Institute in Kansas

director in Eebruary. Eor the past 14

City, Mo., beginning in June.

years, Mr. Burford has worked in
hospital operations at YNHH. He is a

Leslie Vogel, M.D.'87. is serving as

Health, Public Education and Recreation

past president of the Yale University

an instructor in clinical psychiatry at

at the University of Nebraska, Omaha.

Hospital Administration Alumni

Columbia College of Physicians and

Association. Mr. Burford also is a

Surgeons in New York.

Henry R. Black, M.D.. '71- 74 HS,
has been named Roberts Professor and

lecturer in the department of epidemiol¬

chainnan of the department of preven¬

ogy and public health, teaching hospital

tive medicine and professor of medicine
at Rush Medical College in Chicago,
effective April 30.

organization and management.

Albert C. Pottash, M.D.'74, was the
recipient of the 1991 Distinguished

head of the molecular cardiobiology

Alumnus Award from Eriends' Central

Molecular Medicine.

.James .J. Cullen, 88 M.P.H., has
been appointed chief executive officer
for the Hospital of St. Raphael in New

.Jordan S. I^ober, M.D.'77. fomierly

Haven.

of Harvard University, has been named
program at Yale’s Boyer Center for

School, Wynnewood, Penn., recognizing
Mark .J. Rataiii, M.D.'KO, director

Marcia D. Morris, M.D. 89. a
psychiatric resident at New York
Hospital-Cornell Medical Center in
White Plains, has been selected as one
of the 10 American Psychiatric Asso¬

his unique contributions to medicine and
psychiatry. He is the executive director

of clinical pharmacology and associate

ciation/Burroughs Wellcome Eellows

of seven psychiatric hospitals located in

professor of medicine for the department

New York, New Jersey and Elorida, and
also serves as a clinical professor at

of hematology/oncology at the Univer¬

for a two-year term. Her husband.
Michael Morris, M.D.'89, is a resident

sity of Chicago Medical Center, has

in ophthalmology at Manhattan Eye. Ear

New York University Medical School.

been awarded the American Cancer

and Throat Hospital.

Alan M. Levine, M.D.’74, ’75-’80
HS, was promoted to professor of

Society’s Clinical Oncology Career

orthopedic surgery and oncology at the
University of Maryland.

financial support for three years to

Development Award, which provides
individuals who have demonstrated a
.serious commitment to an academic

Stacey H. Wills, M.D.. '90 M.P.H..
has begun a new position as a clinical
research analyst for a consulting firm in
Virginia, serving more than 80 pharma¬
ceutical companies worldwide.

career in clinical oncology.
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New Books

The Liviipy Will Handbook, by Alan

serx es on the school's Minority .Affairs

Lieberson. '62 .M.D.. J.D. Hastings

Committee, the Student National
Medical .Association and w as co¬

House (New Vork) 1992.
The New .\mericanism: How the
Democratic Party Can Win the
Presidency, by Steven Jonas. M.D.. '67
M.P.H.. w ith a forw ard b>' George
McGovern. Thomas Jefferson Press
(New "^'ork) 1992.

Glenn'S
Thoracic and
Cardiovascular
_Surgery

coordinator of the Summer Minority
High School Student Research program;
\ ictoria L. Holloxvay, president of the
Student National Medical .Association
chapter at A'ale. xx ho also serx es on the
Minority .Affairs Committee, xvas co¬
coordinator of the Summer Minority

\\ hat's a \ irus Anywavi^ The Kids'

High School Student Research program

Book .About .AIDS, by Da\ id Lassler. '82

and dex eloped the nexv "Cross Culture"

M.D.. and Kelly McQueen. Waterfront

program for high school students;

Books (Burlington. Vt.) 1990.

Vamilee O. Berminghani and Karen
Rosewater, xvho established and serx e
as coordinators of a central student
X olunteer office, lead a new student tour
program for students at Hill Central

Student

News

Elementary School and are dex eloping a
community group to provide serx ices to
pregnant xxomen from the Women's
Center at Yale-Nexv Haven Hospital and
the Hill Health Center.
M.D.-Ph.D. student: Suresh Karne.

Marlene Coriijo. a fourth-year medical
(llenn's Thoracic and Curdiovascitlar

student, received the 1991 William and

Surgery, fifth edition, edited h> .Arthur

Charlotte Cadbury .Award from the

E. Baue. M.D.. with .Alexander S. Geha.

National Medical Lellowships. Inc. The

M.D.. Graeme L. Hammond. .M.D..

honor includes a certificate of merit and

Hillel Laks and Keith S. Naunheim.

$2,000.

■Appleton and Lange (Norwalk. Conn.)

students to the medical sciences.
Second-year EPH students: Luoluo
Hong. XX ho xvorked xvith the Nexv Hax en
"^'WC.A. Rape Crisis Center. Rape
Hotline; serx ed as co-facilitator for a

1991. (Renamed by the editors in honor
of senior editor of the fourth edition.

xx'ho xx'orks xvith the Hillhouse High
School .Macy program, xvhich introduces

support group for x ictims of incest and

13 YSM, EPH Students
Earn Service Awards

sexual assault; and is involved in .AIDSrelated community outreach. Elizabeth

Singer. '70 M.D.. and Stuart Copans.
Elijim F^ublication (Mill Valley. Calif.)
1991.

The School of Medicine presented the

Committee and is developing a student

first Distinguished Community Service

tutorial program on community service.

Medicine: The Art of Healinii. by
Sherwin B. Nuland. '55 M.D.. associate

community ser\ ice in the city of New
Ha\ en. These new aw ards are to be

clinical professor of surgerw Macmillan
Publishing Co. (New ATirk) 1991.

given annually on Martin Luther King

\\ illiam W.L. Glenn. M.D.)
. \ Fan's (iitidc to Baseball Fever; The

Chiao. xx ho xx orked xvith the EPH
Student Organization A'olunteer

(official Medical Reference, by Thomas

.Awards to 1.7 of its students,
recognizing their outstanding

Jr. Day. This \ear's recipients are:

Skeletal Traiinia by Alan M. Levine. '74
M.D.. co-edited by Drs. Browner.

Second-year medical students:

Jupiter and Trafton. W'.B. Saunders

Karen R. Broder. Christopher ,J.

(Philadelphia. Penn.) 1991.

(iilligan and .lohn H. Kirk, leaders of

'/'//(' Biochemical Basis of

the .Adolescent Substance .Abuse
Prexention program; .Alexandra F.

.S'enropharmacoloyy- by Jack R.
Cooper. Ph.D.. Lloyd E. Bloom. M.D..
and Robert H, Roth. Ph.D. Oxford
L'niversity Press (New '^'ork. Oxford)
1991.

Boer. (i. Richard Bruno and Karen
Rosewater, leaders of the Students
Teaching .AIDS to Students program:
Lauren L. Plawner. a trained rapecrisis counselor also working w ith
\ ictims of sexual abuse and incest; Paul
Santiago, co-president of his class, w ho

.V.
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HUMAN RELATIONS
CODE OE CONDUCT
Editor’s note: Last fall, the School of Medicine broadened its Race Relatunis Code of Conduct
by adopting a Human Relations Code of Conduct, recommended by the Minority A ffairs Com¬
mittee and discussed at length by the committee, departmental chairs. Medical School Council
and the Schoohs Board <f Permanent O fficers. We are proud to feature the complete te.xt fm
the readers of Yale Medicine:

Yale University School of Medicine is

or physical handicap. This commitment

committed to the promotion of personal and

remains consonant with the obligation to

professional development of all individuals

protect open and wide-ranging public

in its community, and encourages dialogue

discourse.

that will foster the growth, well being and

The principle of freedom of expression

dignity of all its members. In pursuit of

that might otheixvise protect even the most

these goals, the school is dedicated to main¬

offensive public speech does not protect, nor

taining an environment which places the

does it even encompass, a right to threaten

highest priority on collegial relationships,

the dignity and privacy of an individual.

mutual respect, and sensitivity among its

Such personally directed behavior will not be

students faculty and patients.

tolerated; it is antithetical to academic values,

An educational community functions best

debilitates its victims, compromises the

when there is civility and respect for the

offenders, and undennines the University's

dignity and worth of each individual. It must

fundamental commitment to individual

be ensured that our school is free from

freedom and respect for all its members.

discrimination and acts of intolerance such

Furthemiore, acts of intolerance may desti oy the

as those based on race, gender, sexual orien¬

veiy atmosphere wherein freedom of expression

tation, religion, national origin, ancestiy, age

is otheiw'ise tolerated and cherished.
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DEVELOPMENT REPORT
Dr. and Mrs. Atkins Endow
Paul Beeson Professorship
Two distinguished former faculty
members. Dr. and Mrs. Elisha Atkins,
have funded a professorship in the
department of internal medicine to honor
Fkiul B. Beeson. M.D. Fred S. Kantor.
.\I.D. "62. was named the Paul B. Beeson
Professor of Medicine.
Drs. Atkins and Beeson were col¬
leagues at Yale for nearb 10 years. In
19.^.^. Dr. Beeson brought Dr. Atkins, a
specialist in infectious diseases, to Yale
from Washington University. Dr. Atkins
earned the rank of professor in 1967.
Mrs. Atkins was a teacher in Lee
High School, where she taught in a
special enrichment and remedial pro¬
gram. Her extensive volunteer work
earned her the citizen's award by the
Cornerstone Organization in 1985.
From 1975 to 1985. upon Dr. Atkins'
retirement. Dr. Atkins was the master of
Saybrook College at Yale. Upon his
retirement, the college established a
Saybrook lectureship in their name.
Since 1985. Dr. and Mrs. Atkins have

Infectious Diseases Society of America
and in 197.7 the Kober Medal, the
highest medal conferred by the Associa¬
tion of American Physicians. He has
received honorar\ doctor of sciences
degrees from Emory. McGill. Yale and
Albany universities and in 1973 was
made an honorary knight commander of
the British Empire.
He and his wife live in Redmond.
Wash, where he continues to write and
edit medical articles and journals that
address a range of critical issues
affecting the current future role of
medicine in society.
In commenting on the Beeson
professorship. Acting Dean Robert M.
Donaldson Jr. referred to both its donor
and its namesake: "These outstanding
physician-scholars are unassuming,
straightforward men who maintain the
highest standards of integrity, dignity,
and decency. It's no wonder that both
of them have successfully served as
teachers and mentors for so many young
people who themselves have become
successful clinical investigators and
teachers. This chair is a wonderful
tribute to both the donor and the
honoree."

Dr. Spinelli Donates Estate
To School of Medicine
Nicholas P. R. Spinelli. '41. '45 M.D..
has established his second charitable
remainder trust to benefit the Yale
School of Medicine. Through his two
trusts. Dr. Spinelli will receive an
income for life and has ensured that,
should he predecease his sister. Viola J.
Spinelli '65 M.P.H.. she. in turn, will
receive the income stream throughout
her life. Afterward, the trust's assets
will pass to Yale.
A strong advocate of charitable trusts
and other life-income gifts. Dr. Spinelli
encourages other alumni to investigate
such charitable vehicles: "These gifts
can provide donors with important up¬
front tax deductions, significant income
for life and. most importantly, enable
alumni to leave Yale much more
significant gifts than they can make
during their lives." Dr. Spinelli said.
When added to the charitable trust
Dr. Spinelli created in 1985. this gift
w ill establish an endowed professorship
to be aw'arded at the discretion of the

de\oted their time to the Habitat Institute

medical school dean. Called the

for the PaiN iix)nment in Belmont. Mass.,

Nicholas P. R. and Viola J. Spinelli

a non-profit organization to promote

Professorship, it is Dr. Spinelli's wish
that the dean award the professorship to

environmental awareness and education
which was founded in 1971 on the site of

a distinguished faculty member in the

Dr. Atkins' family iKMiie.

department that most urgently needs
such funding at the time the professor¬

In 1952. Dr. Beeson became chairman

ship becomes available.
A charitable trust can be funded w ith

of the department of medicine at Yale.
He left Yale in 1965 for Oxford Univer¬
sity. as the Nuffield Professor of Clinical

stocks, bonds or cash. The donor then

Medicine. In 1974. he returned tt) the

chooses a payout rate w hich, in conjunc¬

Unitetl States and accepterl an appoint¬

tion w ith actuarial tables, determines the
up-front tax deduction and income

ment as Distinguished Physician of the
United States Veterans Administration in

stream the donor w ill receive. The
income generated b>' the trust can be
paid to one or more beneficiaries for as

Seattle. Wash.
Dr. Beeson is a fellow of the .Vmerican .Academy of Arts and Sciences and a

long as they live or for a specified

member of the National Academy of
Sciences. He is a master of the Ameri¬

period up to 20 years.
Dr. Spinelli. a longtime supporter of

can College of Physicians and received
the .lohn Phillips Memorial .Award of

4'ale College and the School of Medi¬
cine. served the medical school as
director of alumni affairs from 1985 to
1990. He has made many other gifts to

that organization in 1976. In 1972. he
recei\cd the Bristol .Award of the

All iisfrolahc Jroin the Streeter Colleetion
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Dr. Nicholas Spinelli consults with secoiul-year medical students Emil En^^els (left) and Constantino Pena
during a recent fundraising telethon.

the school, including one which estab¬
lished an endowment in support of
student social well-being.
Dr. Spinelli's legacy of support far
exceeds his charitable remainder trusts,
his ongoing financial and volunteer
support for the alumni fund, and even
his support for student social well-being.
When former patients asked Dr. Spinelli
how they could repay him for his
extraordinary, compassionate care, he
often suggested that they make gifts to
the School of Medicine: in addition to
several other gifts, one donor, Mrs.
Charles E. Nixdorff, astonished Dr.
Spinelli by leaving a bequest to Yale of
more than $500,000.
In expressing his appreciation to Dr.
Spinelli, Yale President Benno C.
Schmidt Jr. said. “I remain deeply
grateful for your outstanding personal
and financial commitment to the mission
of the school. Your loyal support has
done much to nourish the school and
University, and I thank you for your
continuing interest and involvement."

Yale Medicine
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My Gift to Yale, Yale’s Gift to Me
Fifty-five years ago. at age 16. I began

the support of our alumni in unprec¬

an 11-year journey through my
undergraduate, graduate, and post¬
graduate (medical residency) educa¬

edented forms and dimensions. We
all have received so much.
It has been, in addition, my God-

tion at Yale. As a self-suppoiling

given privilege to live a lifetime just

student, the generosity and financial
support of Yale University made this

20 miles from New Haven. This has
afforded me the gift of continued
education and stimulation at our

education possible. A lifetime later, I
can objectively state that the quality of

medical school, through the tenures of

the education 1 received and observed

many deans and many University

was unexcelled anywhere in this
country or the world. This is a debt

administrations. Throughout, the
discipline of excellence has been a

that I can never repay materially.
At the twilight of life. I rank

gift that Yale has continuously
bestowed. It has been a privilege to
witness excellence defined in all areas

education as among the most vital
social values to be preserved for our
posterity. It is one of the treasured
gifts we can bestow upon the future

of Yale education and functions, be
they music, drama, art. Renaissance
literature: in a word, university.

generations of our country. In these
sober times, extraordinary efforts and
means must be expended to preserve
the excellence of Yale; this means

Nicholas P.R. Spinelli. M.D. ’44
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Russell N. Anderson

Obituaries

Russell N. Anderson. M.D.. died Sept. 18
while vacationing in the San Juan
Islands. He was 69.
A native of Tacoma. Wash., Dr.
Anderson was a graduate of Willamette
University and a 1950 graduate of Yale
University School of Medicine. He was
a World War II physician, and later
practiced at Northgate Hospital in
Seattle, where he served as chief of
staff, a member of the board of gover¬
nors and president of the board of
trustees. Fie also served on the board of
trustees for the King County Medical
Society. He was a diplomate of the

Charles 4. Hull

American Board of Family Practice.
\\ illtelni S. Alhriiik

In 1972, Dr. Anderson Joined the

Charles A. Hall

Joint Commission for Accreditation of

Wilhelm S. Albrink

Health Care Organizations. He was
past-president of Seattle Preschool for

Wilhelm S. Albrink died July 28 at Alta

the Blind and was avidly involved with

Bates Hospital in Berkeley. Calif. He

environmental organizations.

was 75.
A native of Napoleon. Ohio. Dr.
Albrink graduated from Oberlin
College, reeeived a Ph.D. from Yale
University in 1941 and an M.D. from
^'ale University School of Medicine in
1947. Following a residency in pathol¬
ogy at Yale-New Haven Hospital from
1947 to 1950. he served on the faculty at

He is survived by his wife, Jo Ann;
three daughters. Margaret, Judith and

in Loudonville, N.Y., on July 27. He
was 71.
A native of Maine, Dr. Hall gradu¬
ated from the University of Maine and.
in 1944, from Yale University School of

Elizabeth; three sons. Stephen. Carl and

Medicine. During World War II. he

Mark; two stepchildren, Debra and

served as a troop physician on Army

Randall; and nine grandchildren.

transport ships.

Contributions may be made to the Dr.

For 20 years. Dr. Hall was principal

Russell N. Anderson Scholarship Fund,

medical investigator for the Veterans

c/o Liniversity Congregational Church.

Affairs Medical Center in Albany and

Seattle.

also was the director of the center's
Nutrition Laboratory for Clinical

Yale as associate professor.

Assessment and Research. He held

In 1961. Dr. Albrink was appointed
professor and chairman of the depart¬

Charles A. Hall. M.D., died at his home

Samuel Alpert

positions as chief of hematology and
radioisotope serv ice departments at the
medical center and w as responsible for

ment of pathology at the West Virginia
University .Medical Center. He was

Samuel Alpen. M.D.. died Sept. 4 at his

the de.scription of Transcobalamin II and

instrumental in establishing a bioethics

home in Riverdale. N.Y. He was 84.

other discoveries in enzymatic defects in
cobalamin (vitamin B12) metabolism.

program and the History of Medicine
Society and later served on the Institu¬
tional Review Board for Research on
Human Subjects.
He is survived by his wife. Margaret
J. Albrink. M.D.'46. who retired as
emeritus professor of medicine at West
Virginia University, three sons.

Dr. Alpert specialized in endocrinol¬
ogy and diabetes. He served as chief of
medicine and of the diabetes clinic at the
Veterans Administration Outpatient
Clinic in Manhattan.
A fellow' of the American College of
Physicians and a diplomate of the
American Board of Internal Medicine.

Fretlerick. John and TYter; two brothers;

Dr. Alpert was a major and a flight
surgeon in the Army Air Corps during

and two grandchikiren.

World War 11. serving in North Africa

Ccaitributions may be sent to the
Wilhelm S. Albrink Lectureship in
Bioethics. WVU School of Medicine
De\elopment Office. 0-106 HSN.
Moruantow II. WV 26505.
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and Italy.
Dr. Alpert attended Yale College
and, in 19.70. graduated from the School
of Medicine.
He is survived by his wife. Dorothy,
anti a son. Robert.

In May, Dr. Hall was named the VA
Medical Center's Physician of the Year.
He was a member of the American
Federation for Clinical Research, the
American Institute of Nutrition, the
Society for Experimental Biology and
Medicine, and the International Com¬
mittee for Standardization in Hematol¬
ogy B12 Panel.
He leaves his wife. Mary; two
daughters. Nancy and Christine; three
sons. Peter. Andrew and Dominic; and
six grandchildren.
Contributions may be sent to the
Farano Center, 25 N. Main St.. Albany,
NY 1220,7.
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Robert H. Areson
Robert H. Areson, M.D.. died Oct. 12 on
an annual liike at Baxter State Park. Me.
He was 75.
A native of Montclair, N.J., Dr.
Areson was a co-founder of the
Montclair Medical Group, where he
specialized in diabetes for 32 years, until
his retirement in 1981.
Dr. Areson was a past-president and
chairman of the hoard of Camp Nejeda,

Haven Medical Society and the New

finilei' in American Science: and Harvey

England Roentgen Ray Society. A
native of Baltimore, Dr. Lowman

Cn.sliiny, Snryean. Antlior. Artist.

graduated from Harvard University and

chief of the Journal of the History of
Medicine and Allied Sciences. She was

the University of Maryland Medical
School.
He is survived by a daughter. Gail; a

Ms. Thomson served as editor-in-

a member of the board of officers and
trustees of the Harvey Cushing/John

son. George; and two grandchildren.

Hay Whitney Medical Library, and a

Memorial contributions may be made
to the Yale Alumni Radiology Research

member of the Beaumont Medical Club
and the Nathan Smith Club at Yale.

Fund, c/o Dr. Robert White. Yale
School of Medicine, 333 Cedar St., New
Haven, CT 06510.

to the John F. Fulton Book Fund,
Harvey Cushing/John Hay Whitney

Memorial contributions may be made

a camp for diabetic children in

Medical Library, 333 Cedar St., New

Stillwater, N.J. He also was past-

Haven, CT 06510.

president of the New Jersey Diabetes

Charles L. Mache Jr.

Association.
He served as corporate medical
director for Union Camp Corp., a paper
company in Wayne, N.J., from 1969 to
1989. where he developed the
company’s industrial hygiene depart¬

Charles L. Mache Jr. died Feb. 3 in
Buffalo General Hospital at age 67.
Dr. Mache received a B.S. degree in
1945 from Yale College and an M.D.
degree in 1947 from the Yale University

ment and. in 1975, established an

School of Medicine. Dr. Mache began

employee alcohol and drug dependency

his private pediatric practice in 1953 in

rehabi I itation program.

Snyder, N.Y., and also served on the

Dr. Areson received his B.A. degree
in 1937 from Dartmouth College and his

staff at Children's Hospital.

M.D. degree in 1941 from Yale. He was

Dr. Mache was a member of the
American Academy of Pediatricians, the

a diplomate of the American Board of

American Medical Association and the

Internal Medicine. During World War

Buffalo Pediatricians Society.

II, he was a lieutenant commander in the
U.S. Navy, serving in the Aleutian

He leaves his wife. Mary; and two
daughters, Cynthia and Cathryn.

Willis J. Snow

He also was past-president of the

Samuel Alpert

Elizabeth Thomson

Charles L. Wood
July 20, 1991

Edward V. Carvey

He leaves his wife, Lois: three

Elizabeth Thomson died Dec. 29 at Yale-

daughters, Nancy. Sally and Susan;

New Haven Hospital. She was 84.
A native of Holland Patent, N.Y.. she

Jean H. Nelbach

Robeit M. Dunlap

Robert M. Lowman

from Mount Holyoke College.
She was an editorial assistant for

October 12. 1991

Robert M. Lowman, M.D.. professor

Mount Holyoke College and the
National League of Nursing Education

emeritus at the School of Medicine, died
Dec. 4 in Yale-New Haven Hospital. He

before joining Yale in 1945 as an

was 78.

Historical Library. Between 1951 and
1972, she served as a research assistant

10 years he directed the radiology

of a mammography service.
He was past-president of the New

Yale Medicine Spring 1992

'38 M.P.H.

September 2S, 1991

October 27. 1991

department at the former Grace Hospi¬
tal, where he specialized in gastrointesti¬
nal radiology and initiated development

'36 M.D.

was a 1931 graduate of Simmons
College and received a master's degree

radiology at the School of Medicine for
40 years before he retired in 1983. For

'35 M.D.

June 29, 1991

November 27, 1991

Dr. Lowman was professor of

'30 M.D.

D. Crosby Greene'37 M.D.

County Medical Society.

eight grandchildren.

'30 M.D.

September 4, 1991

Dean Lester W. Burket

medical staff at Mountainside Hospital

three sons. David. Peter and Paul; and

'26 M.P.H.

September 16, 1991

October 17,1991

Islands and the South Pacific.

in Glen Ridge. N.J.. and of the Essex

In Memoiiam

assistant in research at the Medical

Robert H. Areson

Albert W. Bostrom Jr.

'40 M.D.

'41 M.D.

'47 M.D.

April 19, 1991

Russell N. Anderson

'50 M.D.

September IS. 1991

and, later, associate in history of
medicine.
At the time of her death, she was
writing a biography of Dr. John F.
Fulton, one of the three founders of the
medical historical library at Yale. She
co-authored two books with Dr. Fulton:
Beiijantin Sillinuin, I779-1S64. Fath-

Bruce W. Jackson'66 M.D.
June IS. 1991

Laura Kuckes

'88 M.D.

August 5, 1991

Peter A. Grannum

M.D.

January 21, 1991
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ALUMNI REPORT
Meaningful communication with

Returning alumni/ae will share the

alumni/ae is the most important function

oppoilLinity to reminisce and catch up

been designed especially for use by our
alumni volunteers, and plenty of free

of the Office of Alumni Affairs. We

with old friends at our annual Alumni

off-street parking is available. You are

design our various projects to achieve
this goal. At times communication is

Reunion Weekend held on June 5 and 6.

welcome to drop by for a visit and tour.

All alumni/ae are encouraged to attend.

Our new mailing address is Office of

difficult, however, because of the wide

Quinquinnial reunions (celebrated every

Alumni Affairs, Yale University School

geographic dispersion of our classmates

five years) will be held for classes ending

of Medicine. P.O. Box 7613. New

and friends. Class secretaries transfer
available information about their peers

in the years "2" and "7." For a prelimi¬
nary schedule of events, see page 43.

Haven, CT 06519-7613. The telephone
number is unchanged at (203) 785-4674.

but busy alumni/ae don't always inform

Completion of the 1992 School of
Medicine alumni directory is expected

We expect to hear from you.

their class secretaries of professional
achievements and developments in their

in June. Questionnaires and verification

have not contributed to the alumni fund

personal lives.
The Alumni Office welcomes your

of data by telephone are being effi¬
ciently completed by the Harris Publish¬

to do so. The need for student financial
aid and for the dean’s unrestricted fund

letters. We also solicit your ideas on

ing Company. Inc. We look forward to

is real. Your response to the Kresge

improving the school and the Associa¬
tion of Yale Alumni in Medicine. Are

the directory's completion and inclusion
in our library. The Harris Company will

Challenge was superb; our 1992 goal is

there programs that would make the

solicit your subscription after confirm¬

rate of 56 percent and a total gift of

association more pertinent to you?

ing the questionnaire data to save you a

$700,000. Remember, every contribu¬

Inclusion of your suggestions in the
plans for the coming year will

second call.

tion counts.

strengthen our association and help us to

located in the former Lee High School

represent all of you. Communication
can avoid disappointments and misun¬

(100 Church Street, South, Suite 213), is

Finally. 1 would encourage all who

to maintain or exceed the participation

The new Office of Alumni Affairs,

spacious and attractive. An area has

Artluir C. Crovatto. '54 M.D.
Director of Alunuii Affairs

derstanding.
Our office continues to offer help
Hiirry

and expertise in establishing medical
student class groups; our goal is to fonn
the structure of a class organization that

Kishop

will be effective immediately after
graduation. As part of this process, we
encourage the appointment of class
secretaries and agents before graduation.
This process of nurturing students
as "future alumni/ae" is aided by alumni
attendance at students affairs, both
academic and social, which is welcomed
by the students and enjoyed by the
alumni. Increasing numbers of our
graduates are attending annual events
such as the Cadaver Ball and the
Second-year Show. Furthermore, the
Medical Student Council has applied for
and received a gift from the Yale
Alumni Association of (jreenwich.
Conn., to enhance the quality of student
lil'e. The project, named "Recovery
Room." w ill supirort the badly needed
rchabilitalion of the basement lounge
tirca m llarkness dormitory.

Dr. Arthur Crovatto. director of alunvu affairs, and Connie Tolliver, assistant to the
director, in their new 100 Church Street South offices.
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Highlights: Alumni Weekend
June 5 and 6
Friday, June 5
8:00 a.m.

Registration

1:00 p.m.

Class reunion seminars (concurrent)

4:00

Special presentation
“Changing the curriculum within the Yale System”
Moderator: Robert H. Gifford, M.D.
Associate dean, education and student affairs

5:00

Dean’s reception

Saturday, June 6
8:00 a.m.

Registration

9:00

Surgical grand rounds
Introduction: William F. Collins, M.D., chairman, department of surgery

9:15

Faculty seminars
I.

“How We Construct a Representative First-Year Class”
Moderator: Robert H. Gifford, M.D.
Associate dean, education and .student affairs

II.

“The Who and the How—The Care of Your Now-Dependent Parents
Moderators: Leo M. Cooney Jr., M.D.
Humana Foundation Professor of Geriatric Medicine
Ronald Miller, M.D., associate clinical professor of medicine

III.

“The Second Decade of the AIDS Epidemic”
Moderator: Gerald H. Friedland, M.D., director, AIDS program
Professor of medicine and of epidemiology and public health
Elizabeth Cooney, M.D.
Director of HIV care. West Haven Veterans A ffairs Medical Center

10:45

Annual meeting of the Association of Yale Alumni in Medicine

12:30 p.m.

Sherry and buffet luncheon

2:45

Guided tours: Yale Center for British Art, historic sections of New Haven

Yale Medicine Spring 1992
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CONTINUING MEDICAL
EDUCATION AT YALE

Saturday
May 16, 1992

The Journey of the Contemporary American Family:
New Frontiers

(A)

Directors: Jane Gross and Jatiet Stork

This conference will bring together leading authorities in the areas
of marriage, child development, parenting and family systems.

Wednesday
May 20, 1992

Comprehensive Care of the Pediatric Patient:
The Acute Abdomen

(Bi

Director: Robert J. Tonlonkian, M.D.

Wednesday
May 20, 1992

Clinical Controversies in Infectious Diseases 1992

tC)

Director: Vincott Qiiagliarello, M.D.

This symposium commemorates the 5()th anniversary of the clinical use of
penicillin in the United States at Yale-New Haven Hospital.

Wednesday
May 27, 1992

Fifth Annual Rheumatology Symposium - Lyme Disease

(P)

Director: Robert Schoen. M.D.

This symposium will provide a focused update on all aspects of Lyme disease.

Friday
June 5, 1992

Yale Alumni/ae in Ophthalmology Symposium

(E)

Pres idem: Robert L. Lesser. M.D.

This symposium will deal with the latest advances in excimer laser, glaucoma,
retina and ophthalmic plastic surgery.

Friday-Sunday
August 21-23, 1992

Thrombosis, Thromboembolism and Thrombolysis
Director: Michael D. Ezekowitz, M.D.. Ph.D.

'fhis course is designed for physicians and other health care professionals faced
with treating patients with thromboembolic disease.
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America the Beautiful: Who are You Beautiful for?
In his coniniencement address. Dr. Frank J. Bia asks 1992 Yale medical
graduates to prepare themselves for the pressures of a medical system that
often devalues the most vulnerable members of society.

Yale Orthopaedics: Just Short of Miraculous
Orthopaedists have harnessed the human body’s natural healing
power to offer new hope to patients with once fatal bone di.seases.
Discover the latest in orthopaedics and rehabilitation.

Emerging from the Shadows
Dr. P.H. candidate Linda Schwartz, a former Air Force nurse,
highlights the rich history of women in the United States Armed
Forces—much of it in medical service.

A Partnership Renewed
A $9()-million capital renewal project at the Veterans Affairs
Medical Center in West Haven serves as the backdrop for
cooperation with Yale in patient care, education and research.

A Career in Military Medicine
Raymond L. Sphar, M.D.. M.P.H. '72, recalls more than 30 years
as a physician and research scientist in the Navy, a career that
grew up with America’s nuclear fleet.
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GERARD BURROW NAMED DEAN
Gerard N. Burrow, M.D., previously vice chancellor lor health
sciences and dean of the University of California, San Diego

delighted to be back at Yale and look forward to working with
the outstanding faculty and students."

School of Medicine, was named dean of the Yale University

At the San Diego medical school, where Dr. Burrow has
served as vice chancellor and dean since 1988, he guided a

School of Medicine, effective July I. Former Yale President
Benno C. Schmidt Jr. made the announcement at a press confer¬
ence in Harkness auditorium on April 15.
Dr. Burrow, a 1958

.I:'»■ ^

major construction program and has helped recruit an out¬
standing faculty.
In addition to his
leadership
in

’I'

YSM graduate and a

American

member of its faculty

demic medicine.
Dr. Burrow brings

for 10 years, was se¬
lected after an interna¬

aca¬

to Yale extensive
experience in the
Canadian health¬

tional search involving
more than 140 candi¬
dates. Fie succeeds Dr.
Leon E. Rosenberg,

care system.

who last September was

Toronto, Canada.
From
1981
to

named president of

1987, he was physician-in-chief at

Bristol-Myers Squibb
Pharmaceutical

He

spent I 1 years in

Re¬

Robert M. Donaldson

Toronto General
Hospital, and the
Sir John and Lady

Jr., now on sabbatical,
served as acting dean.

Eaton Professor
and chairman of

In announcing Dr.

the department of

Burrow’s appointment,

medicine at the

Mr. Schmidt said: "We
are fortunate indeed that

University
of
Toronto. Prior to

Gerard Burrow is re¬

that, he was direc¬
tor of the division
of endocrinology

search Institute, based
in Princeton, N.J. Dr.

turning to Yale to lead
the School of Medicine
at this important time.

and metabolism at
Toronto General

Dr. Burrow will bring
to the deanship extraor¬
administrative capacity.

Hospital and pro¬
fessor of medicine
at the University of

He is a superb and car¬
ing physician who has

Toronto. He akso
was professor of

carried forward impor¬
tant research in endo¬

obstetrics and gy¬
necology at the

crinology and other
Dr. Gerard N. Barrow
medical areas.
He
brings unparalleled ad¬
ministrative experience in managing the development of contem¬

Toronto between
1978 and 1987.
Dr. Burrow, a Boston native, earned a B.A. degree in 1954

porary medical institutions."
Commented Dr. Burrow: "These are the best of times, and

at Brown University and completed his internship and resi¬
dency training at Yale-New Haven Hospital between 1958 and

these are the worst of times for medicine in the United States.
Advances in molecular and cellular biology are causing a revolu¬
tion in clinical medicine. At the same time, 35 million Americans

1966. He served as chief resident from 1965 to 1966. Dr.
Burrow is a member of the Institute of Medicine of the Na¬
tional Academy of Sciences, Society for Clinical Investiga¬

have no health insurance. This is a historical moment for leader¬
ship that can come from a great university medical school. I am

tion, Association of American Physicians, and Sigma Xi. the

dinary academic and

Yale Medicine
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University

national scientific honor society.

of

EDITOR’S MESSAGE
care. It calls for a rapid transfer of seienee and technology from

A New Dean, a New Dawn

the laboratory to the clinic. It must emphasize ambulatory care
and preventive medicine rather than hospitalization. It must be
It takes more to imike one soi’e today than it did to make seven of

productive and efficient at the same time that it is compassion¬

Greeee... Ballasar Gracian

ate and earing.

It must use the skilled practitioners of the

community as well as the clinician-scientists of the academy to
It is not often that I take advantage of my position as editor to write

educate our students. Our institution must lead in charting new

for

ways for health-eare education and delivery which embody all
of these aspects.

't ALi; Medicink.

hut tlie appointment of a new dean deserves

eomment. Medieine is faeing eritieal times. Health-eare delivery
modern of diagnosis and treatment but is also aeutely concerned

is on everyone's mind.

The piiblie desires aeeess to the most

This is the challenge that our new dean faces. Gerard N.
Burrow. M.D.. Class of 1958. is well equipped to meet it. The

with the quality of the care they receive. The benefits of drugs,

national search for a dean has succeeded in identifying an

prosthetic devices, diagnostic procedures and treatments must I'ar

individual whose talents and experience are uniquely qualified
for the task. Dr. Burrow is a product of the Yale system of

v)utweigh any potential risk. Indeed, our patients expect the very
best in results and do not expect adverse effects or misadventures.

medical education. He is both a clinician and a medical scien¬

Whereas our patients must weigh risk against benefit, employ¬

tist. His career has led him through the wilds of the Canadian

ers, insurers and third-party payers are more concerned with cost

health system, and he has already tasted the rewards and ago¬

and efficiency. Health-eare costs are escalating, and business and

nies of being a dean at the University of California at San

industry are advocating managed health-eare systems as a form of

Diego. He combines the talents of the medical scientist, skilled

medical rationing. Physicians are under constant surveillance with
pattern-of-praetiee review and pre-admission eeilifieation. In re-

clinician, effective educator and experienced health science
administrator. His leadership will ensure a prominent role for

^ponse to these eoneerns as well as the constant threat of litigation,

Yale in medieine of the 21 st century.

they are practicing a brand id' defensive medicine which often
over-utili/es expensive resources, and ignores the art of medicine.

Welcome home. Gerry! We. the alumni of this .school, .stand
ready to support you in every way we can.

Biomedical science is also under siege. Basie scientists are no

Miehael Kashgarian, Mdl. '5H

longer viewed as altruistic explorers of nature. The Baltimore and
Ciallo incidents have raised questions, not only about the validity of
new seienee. but also about the self-serving motives of scientists
with inflated egos. The ideas and discoveries of investigators are
no longer part of the public domain. Seienee and scientists are now
a commercial commodity.
capitalists.

Welcome Dean Burrow

They are the resources for venture

New offerings are made on Wall Street merely by

Editor’s note: The following editorial appeared in the

assembling a scientific advisory board of Nobel prize winners and
members of the National Academy. Rven the stuff we are made of.

April 26, 1992 edition of the New' Haven Register. It is
reprinted with pernnssion.

our genome, is being patented.
The allocation of the

New Haven should be heartened by the words of the new

indirect costs of sponsored research has embarrassed the previ¬
ously hallowed halls of ivy. New forms of resource generation are

Universities are also under scrutiny.

dean of the Yale School of Medicine, Dr. Gerard N.

being sought by medical schools, ranging from expansion of clini¬

Burrow. He takes over July I. At a press conference last
week. Dr. Burrow made special mention of the city,

cal practice to patronage from the biomedical industry.

These

saying he intends to have the medical school under his

efforts have raiseel eoneern that the true mission of the medical
school, education, is being subjugated to more mercenary goals.

leadership play an important role in inner-city New
Haven. Heaven knows New Haven, particularly its poor

I bis is the unsettled, even hostile en\ ironment that w'c in medi¬

and ill, can use all the help and attention it can get.

eine face toilay. Our traditional mission here at Yale has been to
prepare young men and women to enter the profession of medieine

Infant mortality, AIDS infection, drug abuse and gun¬
shot wounds are just a few of the crises here that can

anti to give them the knowledge anti technical skills essential to
clinical practice, teaching anti research in biological and medical

challenge the Yale School of Medieine. can inspire the
institution to look for ways it can help arrest those
problems. A dean w ho makes it clear he’s interested in

sciences. Our educational gtials must be modified to directly face
the problems anti eoneerns of modern medicine in the 'dOs and in
the century to come. The major challenge to metlieal etiueation
now is the integration of a rapidly increasing fund of basic bio■tlieal know ledge into a new pattern t)f the tlelivery of metlieal

inner-city problems here, before he even starts the job, is
a promising signal for New Haven.
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LETTERS
Sterling Associates
To the editor:
In the FallAVinter 1991-1992 edition of
Yale Medicine, two alumni were omit¬
ted from the list of Sterling Assoeiation

members. Sheldon A. Jacobson, M.D.
’28, and Jacob E. Tauber, M.D. ’76, are
both 1990-1991 Sterling Assoeiation Fel¬
lows. Their commitment does mean a
great deal to the School of Medicine and
its alumni fund, and I would like to thank
Drs. Tauber and Jacobsen again for their
gifts.

profession do not do justice to a large

The welding together of the Univer¬

number of nascent doctors who repre¬
sent the very best of our young caregivers.

sity through common concerns for our
world’s health and welfare is Just in time

Let me also say that I graduated from
medical school .J4 years ago. In my
class and in the classes of other medical
schools of that year, there were a range
of individuals. Some r)f them were very

more interested in the monetary gains in
medicine and looked at the profession as
a business. Perhaps doctors of a previ¬
from current ones.

Director
School of Medicine Alinnni Fund

So. I think that the issue is not .so clear
cut as Ms. Diamond makes it to be. Again,
I applaud her admiration for her father, but 1
do feel she has done an injustiee to many
wonderful young doctors.

Future Physicians
Still Dedicated

Lawrence S. Cohen, M.D.
Deputy dean

Editor’s comment:

Daughter’s Tribute,” which appeared in
Yale Medicine Spring 1992, was very

physicians who can combine the utmost

touching. 1 am certain that her father is
an extraordinary individual and has been

practice. The same educational philoso¬

years. Ms. Diamond’s respect for his
work and her admiration of him is very

Yale continues to take pride in prodncing

skill with the special art of caring in their

phy which produced Dr. Pecora is still in
place today. Although onr current gradu¬
ates enter an enviroijinent more suspi¬
cious, even hostile to niedicine than in

heartwarming.
However, I must take exception to
some comments in her letter, as I think
that they are somewhat unfair. She indi¬
cates . . . “that one of the reasons medi¬
cine is not the respected profession it

recent memory. I ani sure that they are
prepared to exemplify the combination of
personal integrity ami acadennc achieve¬
ment essential for the idea! compassion¬

During World War 11, while in the
Army, 1 commanded the 133rd Malaria
Control Unit. At the end of hostilities in
Europe 1 was in Rome, Italy, where I
was serving as the public health officer
malaria in the Pontine Marshes and co¬
operating with the Rockefeller Loundation on the use of DDT.
With the war over in Europe, 1 was
.sent to the Pacific with my unit for the
invasion of Japan. I arrived in Okinawa,
where my unit was assigned to work with
Maj. Wilbur Downs, who was the
malariologist for Okinawa. Malaria was
not a major problem there, but Japanese
B encephalitis was, and Wil Downs as¬
signed me and my unit to work on this
problem with him. A great experience!

International Progress

say that I have had the privilege of teach¬
ing Yale medical students for the past .^2
years. I continue to be in awe of their

tion of Yale Medicine. What a splendid
tribute to Yale’s growing tradition of
commitment to global concerns. The
diversity and depth of university inter¬
ests and talents that focus on matters
international is a surprise, even to those
of us involved. Sometimes being close
to the trees. . . .

Suninier 1992

I particularly enjoyed the article about
Wilbur G. Downs. Let me share a little
.story about my relationship to Dr. Downs.

Lecturer in public health

To the editor:
Congratulations on the Spring 1992 edi¬

Yale Medicine

To the editor:
Congratulations on the Spring 1992 is¬
sue of Yale Medicine. It is a great issue.

Eric W. Mood. M.P.H.

took for granted. Medicine today has
become a business.” Let me respectfully

dedication, sense of earing for the poor
and underprivileged, and high .scn.se of
ethics and morals. Ms. Diamond’s com¬
ments about the younger members of the

More Warm Memories
Of Wilbur G. Downs

ate physicia)}.

once was, is that too many of its younger
members no longer share the value of
dedication to the service of their fellow
human beings that the older members

Professor of public health

for the U. S. Army in Rome, controlling

To the editor:
Ann Pecora Diamond’s letter, “A

a model practitioner for these past .SO

Lowell S. Levin. Ed.D.. M.P.H.

idealistic, and like her father have con¬
tinued to provide the best of medical
care for all of their careers. Others were

ous generation were not very different

Monica C. Robinson

to enter the 21 st century!

Corrections
In the .Spring 1992

Yale Medicine,

the

name of Nicholas M. Greene, M.D.. was
misspelled on page 3. On page 12. the
medical school class year of MarieLoui.se Johnson, M.D. ’56, was listed
ineorreetly. as was the class year of Ni¬
cholas P.R. Spinelli, ’41, M.D. ’44.
3

AMERICA THE BEAUTIFUL,
WHO ARE YOU BEAUTIFUL FOR?
hy Frank J. Bia, M.I).. M.P.H.

Will you continue to care? The answer. I am afraid, could
be “no" if you are not aware of the tide now moving against

Dr. Donaldson, ladies and gentlemen, I'aeiilty, students, new phy-

your very best intentions.

sieians and proud families. Weleome to this joyous eelebration of

and status in this society can become a potent narcotic, and

Firstly, even your future comfort

so many dreams fulfilled. Today that feeling is electric, and it
charges the air around us with fresh hopes and expectations. This

you into the next century.

is as it should be, so I offer congratulations to all who have been
privileged to participate in bringing these dreams to fruition.

reversion to 19th-century medical economics has occurred.
An increasing proportion of medical care is now being pro¬

Ha\ ing said that 1 must ask you to reHect for a few moments

vided by for-profit hospitals and business ventures which,

on how immeasurably sad it would be if the visions which en¬

frankly, must make their profits from illness in our society.

under such intluences one cannot envy your mission as it takes
Secondly, for better or worse, a

gaged your minds and spirits were not allowed to reach your

How long would you expect such enterprises to remain in an

horizons and beyond.

Our species does not tlourish when its

environment serving an economically stressed inner city, or

individual and collective dreams go wanting. Langston Hughes,

fragile families that are no longer “profitable" but increasingly
in need. “But doctor," you will hear, “this market is no longer

the African-American poet, asked us this same question:

viable."
WJnit happens to a dream deferred?
Does it dry up
like a raisin in the sun?

Translation: Your patient population became an

economic liability to the very institution or practice in which
you work. What will you do?
To make matters more difficult, an increasing number of

Or Jester like a sore

health professionals now own parts of the,se new and useful

and then run?

entrepreneurial ventures, such as home intravenous services

Does it stitik like rotten meat?

and centers for specialized care.

Or crust and sugar over—

financial resources fit into such a system? You w ill become a

like a syrupy sweet?
Maybe it just sags

part of these decisions. It begins next month when you recei\'e
your first call from an insurance company representative who

like a heavy load.

considers a patient admission unwarranted, or subject to se¬

Or does it e.xplode?

vere restrictions. Welcome to managed care—and you are not

Where do those without

necessarily considered the manager.
Recent events in Los Angeles, once again, have answered
Hughes' (.|uestion and point to several converging forces which
will, most certainly, soon touch your lives. As new physicians
you will labor at the interface between the biomedical sciences
and this diverse society with which you have formed a social
contract today. In so doing you Join the fellowship of men and
women who have aided the sick for several millennia. In that
relationship an unspoken pledge exists, a pledge to do our best for
those under our care, regardless of ability to compensate on the
part of either the patient or siK'iety. Our profession has a tradition
of doing this, even under the most adverse circumstances, be our

The dangers of such an environment become clearer when
the subtle shifts of our own professional mind .set. or ulterior
milieu, are understood. The .social contract that underlies our

respected positions in society erodes when our time and efforts
become tied up with institutional profits. Our role in society
has clearly been a privileged one based upon a real trust in our
advocacy for the patient, who has primacy in all our efforts,
regardless of economics.
Twenty-five years ago. .Sen. Robert Kennedy spoke rather
hopefully in the Bronx at my own college graduation. It was
June 1967. That July, the Kerner Commission was convened

patients refugees from foreign wars or from urban blight.

by President Lyndon Johnson, but it concluded that we ran the

Many of ycni have already contributed tr) the community. I
have seen it-medical students teaching about AIDS to high
school students, or introducing the biological sciences at Hillhouse

risk of becoming two societies “one black, one white—separate
but unequal." Senator Kennedy and Dr. Martin Luther King

High School under Dean Ri)bert Gifford, and a multitude of
indi\ idual efforts to make this city a better place.

Jr. were both dead before I had e\en completed my first year
of medical school. The '6()s were over, but I need not apolo¬
gize for the aspirations. Since that time our society has be¬
come increasingly di\ ided along those very lines which many

lahoratorv medicine, delivered the FJ92 Vide IJniversitv School

then hoped to obliterate.
Today we applaud encouraging events in the former So\ iet
republics and South Africa, as if we are ob.ser\ ing from the
moral high ground. In fact, our own society slips increasingly

of .Medicine conmiencement address.

into apartheid itself.

Irank.l. Bia. M.D.. M.B.U.. associate professor of inedicine and
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nets—into alTIuent suburban and pooier urban citizens based
upon unequal educational opportunities, and disparate techno¬

The harder you try to answer that question, the better physicians

logical competence in a very complex and demanding world.
What makes it so sinister is that we fracture along persistent

has said it all.

you will become. You have my word on it, but I think she really
YIVl

racial and ethnic fault lines.
So here you are, ready to launch your career into a tempest of
intersecting storms. How do you maintain your empathy and
compassion in the face of institutional demands to maximize
your productivity and minimize that which does not generate
profit? Incidentally, teaching, be it in grammar school or medi¬
cal school, often falls into that same category: No profit, no
gain.
Well, it has been said that your best opportunities may come
to you disguised as unsolvable problems. What do you do in the
meantime?

You remember your original goals, and seek a

balance. The philosopher. Hillel, asked us;
If I am not for myself, who will he for me?
If I am only for myself, what am I?
If not now, when?

What is your real social contract? In essence, to strive to
always make a difference for the better. By contributing your
gifts equally to all members of this society, you begin to fulfill
that vision. Do not simply accept—or even worse—tolerate our
ethnic, racial and cultural diversity in your professional lives.
This society is not a melting pot, nor should it ever become one.
It is a multicultural mosaic, with many diverse pieces, interlock¬
ing relationships, all in living colors, which are never static.

Dr. Frank J. Bia

Frank J. Bia:
Leader in International Health

Revel in it—more importantly, be a constant part of it, and teach
your children to do the same.
Societies must be built upon an equal access to that which is

Frank J. Bia was horn in the Bronx and attended Fordham

good—and that includes you. Remind your health-care institu¬
tions. group practices, and even the dreaded third-party payers,

received his medical degree from Cornell in 1971. and
spent the next year in South America and at the Harvard

that you answer to yourself and to the society which gave them

School of Public Health obtaining his M.P.H. degree in

University, the Jesuit university in New York City. He

life, along with the freedom to succeed. If you do not do so, you

microbiology and tropical public health. Following four

run the risk of also becoming part of the problem, not part of the
solution. If, during these expectant days between graduation

years of medical residency at the University of Pennsyl¬
vania, he came to Yale as a fellow in infectious diseases in

and internship, you can neither recall what was said here, nor
who even said it (as sometimes occurred in medical microbiol¬
ogy), then just hold this single thought.
A child at what passes for an elementary school in today’s
South Bronx was asked to write a poem to present to Jonathan
Kozol. the author of Savage Inequalities, during his visit there.
No longer wide-eyed and innocent, she lives a life that does not
quite match our manufactured television sit-com images of
reality. She is rightfully bitter and resentful about her leaking
school roof, rotting plumbing, emphysematous heating systems,
dangerous environment and poor health care.

For they all

1976, ultimately joining the medical faculty headed by
Dr. Samuel Thier.
His initial laboratory investigations centered on the
pathogenesis of viral infections. While working with Dr.
Edith Hsiung, he isolated and characterized a new herpes¬
virus of animals while engaged in .studies of human cyto¬
megalovirus infections. His career gradually moved him
into tropical medicine and international health, while work¬
ing in Haiti, China and Thailand. He is committed to
bringing young physicians into the developing world as
part of their clinical training, and he has a particular

punctuate the egregious process already beginning to condemn

concern for the Albert Schweitzer Hospital of Haiti.

her to the lowest rungs on our social ladder.
Her two-line poem is worth committing to memory for the

In 1991, he was one of 45 individuals in the United
States chosen by the W.K. Kellogg Foundation of Battle

rest of your professional lives. 1 offer you her poem and her
question as my parting thought for the Class of 1992. She

Creek, Mich., as Kellogg National Leadership Fellows for
three years. These fellows are felt to have high potential
for future leadership in their fields. He lives with his wife,

writes:

Peggy, who is also a member of the Yale medical faculty,
America, the beautiful.

and their two young boys, Jesse and Joshua.

Who are you beautiful for?
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ORTHOPEDICS AT YALE:
JUST SHORT OF MIRACULOUS
hy John Dinolfo
To inimduce the uninitiated to his specialty, Gary E. Friedlaender.
M.D.. chairnian and chief of orthopaedics and rehabilitation,
engages them in a small ritual. Turning to his desk, which is
buried under a snowdrift of papers, he pulls out a side drawer
and produces a framed print that depicts two gaunt, bearded
saints named Cosmos and Damian. In the Brueghel-like paint¬
ing, filled with images of revival and divine light, the thirdcentury physicians perform an entire leg transplant on a dying
nobleman.
■■'I'hey're orthopaedic surgeons,” Dr. Friedlaender suggests
with a wry smile. "You can tell by the halos.”
All Jesting aside, as recently as two decades ago, it would
have taken a miracle of similar magnitude to save the leg of 14year-old "Christy.” Her X-rays revealed a tumor forming at the
distal end of the femur, the thigh bone near the knee. With a
diagnosis of osteosarcoma—bone cancer—the best chance at
extending the teen-ager’s life would have required amputation
above the knee. Even with this drastic treatment, the odds that
Christy would live to celebrate her 2()th birthday would have
been only one in five.
Contrast the .scenario today. Because of a range of clinical
advances, amputation in Christy's case is unlikely. For in¬
stance, improvements in chemotherapy, bone banking and bone
transplantation now provide the teen-ager with at least a 70 to
80 percent chance to walk down the aisle at her college
graduation—on tw'o healthy legs.
In the orthopaedic surgical unit at Yale-New Haven Hospital
(YNllH), Christy's surgeon replaces her distal femur with an
allogeneic bone transplant, a frozen femur altruistically donated
by another person at the time of death and made available
through a national bone bank system. Although her immune
system recognizes the dead tissue as foreign and reacts to it,
unlike with h\ ing, solid organ transplant.s—such as the kidney,
heart or liver—the response is not severe enough to require
immunosuppression.
Before Christy leaves the hospital a week later, her blood
vessels have begun to grow into the graft and living bone cells
are replacing those of the donated tissue, which serves as a kind
of template. Implantation of the cadaver-derived allograft not
only allows Christy to keep her lower leg; with rehabilitation
o\er the next year, she will regain a remarkable range of func¬
tion. including up to 90 degrees of flexion of her knee. Within
the next five years—thanks to the skeleton's natural selfmaintenance—Christy's li\ ing bone cells will replace much of
the (.lead tissue of the allograft.

With such results, even saints Cosmos and Damian would
have been pleased. For Just short of miraculous is the human
body’s viiluosity in transforming dead, frozen bone into live,
viable tissue. This healing ability has been a welcome discovery
for the estimated 2.000 Americans affected annually by osteosarcotna, most of whom are between ages 10 and 25.
Many of these young people will Join thousands of other
Americans who will receive bone transplants to repair defects
caused by major trauma or surgery for various cancers or other
di.seases. This year in the United States, an estimated 200.000
bone transplants or implants of various sizes will be
performed—more than 100 of them at YNHH. “The national
number is expected to increase fivefold by the end of the de¬
cade,” notes Dr. Friedlaender.
A former president of the American Council on Transplanta¬
tion. Dr. Friedlaender performs 10 to 12 large bone transplants
each year and scores of other transplants and implants. The vast
majority of allografts are done in young or middle-aged
patients—those most suited to endure surgery’s rigors and many
months of rehabilitation. The dramatic increase in bone trans¬
plants nationwide in the past decade has followed major ad¬
vances in bone banking approaches and in chemotherapy to
prevent cancer spread or recurrence.
“Our group at Yale has helped to pioneer the bone-banking
methodology,” explains Dr. Friedlaender, “from the technical
aspects of removing the bone to the ethical issues involved in
approaching the public.”
Bone transplants, however, represent only one aspect of the
clinical care provided by the department. Indeed, the faculty has
advanced several areas in musculoskeletal medicine.
“It’s an exciting time to be in orthopaedics,” says Dr.
Friedlaender. Medical students from around the world appear
to agree. Each year. 400 to 500 apply for five available resi¬
dency positions offered by Yale-New Haven Hospital.
Dr. Friedlaender himself came to Yale as a resident in
orthopaedic surgery in 1971 and progressed through the ranks to
become .section chief in 1984. When orthopaedics and rehabili¬
tation became a department in 1986, he was appointed chair¬
man.
As a resident physician. Dr. Friedlaender received his pri¬
mary training in orthopaedic surgery from Wayne O. Southwick,
M.D., professor of orthopaedics and rehabilitation, a major
force in this field for more than 30 years and Yale .section chief
from 1958 to 1979 and 1983 to 1984. Currently, Dr. Southwick
is director of spine surgery at Yale-New Haven Hospital.
Dr. Friedlaender credits his mentor with laying the ground¬
work for today’s department: “Dr. Southwick taught us to be

John Dinolfo. o frcc-loncc writer, is o frequent eontrilnitor to

y\tt Mtotdst..
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Friedlaender explains. These data have been used to measure
spinal instability in patients who suffer severe vehicular acci¬

generalists with areas of interest." he explains. That ongoing
tradition has allowed Yale orthopaedies and rehabilitation to

dents or sports injuries and in the many people who suffer from
chronic low-back pain.

eontribute to the astonishingly rapid developments that have
oeeurred in the field in the past deeade—as retleeted in the

"It's now possible to reliably replace the hip joint and the knee

department's eurrent elinieal and research strengths.

Total joint replacement is also a major clinical focus at Yale.
joint." Dr. Friedlaender points out. “Ninety-five percent of
these patients do well."

Taking the Spine in for Repairs

Part of this remarkable success rate is due to advances in
biomaterials—such as porous metals into which bone can grow

"()\er the years, we've been an international leader in the

and which extend the life of synthetic joints. Better techniques to

mechanics of the spine," Dr. Friedlaender notes. “We spend a
great deal of effort learning how to hold the spine together once

cement metallic prostheses to bone also have advanced the field.
In the past decade, Richard R. Pelker. M.D.. Ph.D.. a professor in

it's injured so that neurologic function will be protected or

the department and director of Yale's total joint replacement

recover and the bone will heal and restore stability."

services, has made major contributions to the development and

In this area, as well, the influence of Dr. Southwiek comes to
the fore. Since the late 19.S()s. he and his colleagues have

evaluation of total knee replacement systems.

developed a wide range of procedures and spinal fixation de-

and rehabilitation, heads the joint replacement service at

Kristaps Keggi, M.D., clinical professor of orthopaedics

\iees. including screws, rods, plates and other biofixtures to

Waterbury Hospital, illustrating the department's commitment

stabilize the spine during and after reconstruction.

to statewide cooperation in patient care, education and research.

For some

patients, these devices eliminate the need for a body cast.
Dr. Southwiek often collaborates with hioengineer Manohar
Panjabi. Ph.D.. professor of orthopaedics and rehabilitation and

Colleagues at Yale, Waterbury and elsewhere are trying to
improve the success rate for joint reconstruction of the shoulder,
elbow and wrist.

director of orthopaedic biomechanics, whose innovative labora¬

Yale is advancing the management of other skeletal abnor¬

tory tests of cadaver spines have produced a wealth of new

malities, as well. "We are learning how to stabilize fractures

inlormation about the types and amount of traumatic force the

very rapidly and effectively, for example, complex pelvic frac¬

spine can endure.

tures, to mobilize patients so they don't develop complications

■'Dr. Panjabi has developed the data to understand how the
spine is put together, what happens when it gets injured, and

due to bed rest." Dr, Friedlaender says. Such clinical care and
research is the purview of Michael R. Baumgaertner, M.D..

what degree of injury warrants surgical treatment,"

assistant professor of orthopaedics and rehabilitation.

Dr.

Disorders of the foot and ankle are also important to the
department, and these responsibilities are shared by Elly
Trepman. M.D., assistant professor of orthopaedics and reha¬
bilitation and chief of orthopaedics at Yale University Health

University Provides Leadership
In National Bone Banking System

Service, and Enzo Sella. M.D., clinical associate profes.sor of
orthopaedics and rehabilitation.
A Rapidly Emerging Specialty

Yale University is part of a nationwide system of bone
banks which involves several universities and medical
centers. Participating institutions preserve, catalog and

Sports medicine, a rising star among orthopaedics and rehabili¬

store cadaver bones for grafting.

High school and recreational athletes compri.se the largest num¬
ber of sports medicine patients at Yale, though a growing num¬

This supply of donor

bones is matched with potential recipients according to
anatomical size and shape.

tation specialties, also shines brightly at the School of Medicine.

ber are professional and college athletes, including some Olym¬

The medical history of the donor is carefully reviewed
tt) rule out cancer or infectious diseases, such as hepatitis,

pic hopefuls.
Located at New Haven's Long Wharf, the Sports Medicine

AID.S or venereal diseases. Unlike solid organ transplants

Center is a collaborative program with Yale-New Haven Hospi¬

or blood transfusions, however, which involve living tis¬
sue. matching the donor's tissue or blood type is not

tal. The center offers the full range of state of the art rehabilitati\e services, from the care of badly pulled muscles and the

required.

fitting of orthopaedic appliances, to advanced arthroscopic
surgery—the most important clinical development in sports

With a bone allograft, the skeleton uses the

donated tissue as a template which the body breaks down
and replaces with the patient's own cells.
Dr. (iarv I:. Friedlaender, chairman of orthopaedics
and rehabilitation, has been a leader in the bone banking
system for nearly 20 years. In the early I98()s, Dr.
I riedlaenderwas principal investigator for an NIH-funded
multi-center study into storage methodology, logistics
and clinical applications of massive bone grafts.

medieine in the past 10 years.
"At one time we used arthroscopy just to look." explains
Peter .1. Jokl. .M.D.. professor of orthopaedics and rehabilitation
and president of the American Academy of Sports Medieine.
"Now we both look and do big operations using that technique.
We can perform arthroseopie procedures within almost any
joint, thus dramatically reducing morbidity" as compared to
other surtzieal methods.

s
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Arthroscopic surgery at Yale is also commonly done to
repair damage to the shoulder, elbow, hip and ankle.
“We’re even learning to put arthroscopes into the wrists
and small joints of the hand to correct problems,” says
Dr. Friedlaender, referring to the innovative approaches
being developed by Scott Wolfe, M.D., assistant profes¬
sor of orthopaedics and rehabilitation and director of the
hand and upper extremity service.
The Hip Bone’s Connected to the...[mniune System
In an era of interdisciplinary cooperation, orthopaedists
have discovered that their field overlaps with immunol¬
ogy. In recent years, for example, biomedical researchers
have uncovered key links between bone cells and im¬
mune cells, which both arise from common stem cells of
the bone marrow. “We have also learned that many of the
signals that direct bone remodeling come from immune
cells,” says Dr. Friedlaender. “So the immune system not
only regulates potential bone graft rejection; it also ap¬
pears to maintain normal bone homeostasis.”
Trying to throw light on these dual features of the im¬
mune system is Mark C. Horowitz, Ph.D., associate
professor of orthopaedics and rehabilitation and a noted

Dr. Gaiy Friedkiender answers residents ’ questions about a 5-year-old
boy’s recurrent tumor revealed by a CT scan of the pro.ximal femur.

immunologist. Such research is crucial, he points out,
because patients develop a detectable immune response
to 60 to 80 percent of bone transplants, especially large
allografts.

Yale is a major regional site for arthroscopic repairs to
knee ligaments. During the last two years. Dr. Jokl and
Photographs hy James .\ndcrson

his colleagues have even used arthroscopy to repair tears
to the medial meniscus, the gristle-like substance at the
end of the tibia that allows the knee and leg bone to work
together with a minimum of friction.
In the past, during knee surgery, menisci were usually
removed. That practice, however, produced a high rate of
premature arthritis. Today, as Dr. Jokl explains, “We try
to save the meniscus. If we have to remove any of it, we
take out as little as possible to maintain as much function
as possible.”
In fact, the meniscus has proved so important that
Marc T. Galloway, M.D., assistant professor of
orthopaedics and rehabilitation, is performing successful
meniscal and ligament transplants in animals and in se¬
lected human patients.

He hopes that these pioneering

procedures will soon lead to improved surgical care of
athletes whose damaged ligaments or tendons have been
removed.
Additional .staff at the Sports Medicine Center include
John Daigneault. M.D., assistant professor of orthopaedics
and rehabilitation, an expert in shoulder injuries. The
center also offers the services of clinical faculty members
J. Kevin Lynch, M.D., clinical associate professor, and
Joseph Wu. M.D., clinical assistant professor.
Comments Dr. Friedlaender: “The Sports Medicine Cen¬
ter has been a model for collaboration of full-time .staff
and talented community-based clinicians.”
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Dr. Wayne Southwick explains the workings of a bone drill to Dieter
Lindskog. a Yale undergraduate who is conducting a hip fracture study.
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"We can demonstrate that there is a real T-cell mediated
response directed at the graft," Dr. Horowitz states. In other

"There appears to be a critical balance," Dr. Horowitz says.
"Too much cytokine production may induce graft rejection."

words, T-eells direct an immune system attack on the foreign
cells in the graft as if transplants were foreign instead of self.

ing to identify what level of cytokines are made by T-cells

What distinguishes grafts that are rejected?

To try and prove this contention, he and his team are attempt¬

In a word,

during bone transplantation. Once the researchers accomplish

In cell culture e.xperiments. Dr. Horowitz and

this, they will use advanced biomolecular techniques to deter¬

colleagues have found that certain cytokines, specialized pro¬
teins made by T-cells, aetix ate osteoblasts—bone-forming cells.

mine the appropriate range of cytokine production for success¬
ful bone remodeling—and bone graft incorporation.

cytokines.

Osteoblasts, in turn, stimulate another kind of bone cell called
osteoclasts to begin the process of removing dead or decaying
bone. This process, called resorption, is a key first step in the
remodeling of normal or transplanted bone.

The Molecular Mechanisms of Bone Resorption
Roland Baron, D.D.S.. Ph.D., professor of orthopaedics and of
cell biology and director of biological research in the depart¬
ment of orthopaedics and rehabilitation, has been working with
a team of 10 investigators on elucidating the molecular mecha¬
nisms by which osteoclasts resorb bone.
"The process of bone resorption is not restricted to diseases,

Orthopaedics and Rehabilitation
Offers a Cornucopia of Services

such as osteoporosis, cancers or Paget’s disease," explains Dr.

Begun in 1958 as a .section in the department of surgery,

both the quality and the quantity of bone.

Baron, "but is a normal process involved in bone growth, bone
repair and bone turnover, replacing 20 to 30 percent of the
skeletal bone mass every year."

Hence, resorption maintains

orthopaedics and rehabilitation graduated to full depart¬

A key observation made by this group was published in

mental .status in 1986, in keeping with the medical school's

1985. demonstrating that osteoclasts secrete acid in order to

.Strategic Plan to expand services in musculoskeletal medi¬

digest the matrix of bone. Following up on this observation. Dr.

cine. The department currently offers expertise in eight
clinical subspeeialties:

sible for this acidification is different in osteoclasts than in other

Baron's group has now demonstrated that the molecule respon¬
cells, opening new avenues for specific therapeutic intervention

•

spinal disorders, Drs. Wayne Soiitinvick, Thomas
Roishaw, Manohar Panjabi and Trey Crisco;

•

joint reconstruction, Drs. Richard Peiker, Gaiy
Friediaender and Krislaps Keggi;

•

•

He hopes insights gained in this

research will lead to highly specific treatments for diseases of

bone cancer, osteoporosis, osteoarthritis and other

excessive bone resorption—especially osteoporosis. More than
15 million Americans are affected by this disea.se. most of them

Friediaender, Caren Gimdherg, Mark Horowitz

post-menopausal women.

and Agnes Vigneiy:

critical to understanding how' to improve the treatment of these

sports medicine, Drs. Peter .Joki, Joim Daigneaidt,

patients." Dr. Friediaender notes.
Agnes Vignery. D.D.S.. Ph.D., associate professor of

"Dr. Baron's information could be

orthopaedics and rehabilitation and cell biology, is discovering

acquired deformities, Drs. James Marsit and

how bone cells develop and differentiate to become functional.
Dr. Vignery and her colleagues have identified molecules that

Ihomas Reitsiiaw;

govern the formation of osteoclasts, and they hope to use ge¬

disorders of childhood, including congenital and

repair of traumatic defects and fractures.

Dr.

Miciiaei Hanmgaertner;

netic engineering to monitor the differentiation of these bone
resorbing cells. By so doing, they think that it will be possible
to control the number and activity of bone cells and therefore

•

abnormalities of the hand and upper extremity. Dr.
Scott VT. Woife:

prevent bone loss.
Recently. Dr. Vignery and colleagues have identified mol¬

•

foot and ankle disorders, Drs. Eiiy Trepman and

ecules that not only inhibit bone resorption, but stimulate bone
formation and have potent immunosuppressive effects. They

Jjizo Seiia.

The tieparlment includes 17 full-time faculty; 1 1 focus
primarily on clinical research and patient care and also
staff a surgical division at the Veterans Affairs Medical
Center in West Haven. Six faculty members focus exclu¬
sively on basic science—an unusually large contingent for
an /\merican orthopaedics department.
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tion by hormones, growth factors and new ly developed drugs, in

molecular, genetic and cellular factors related to

Marc T. Gaiioway, Kevin Lyncii and Joseph Wn:

•

other ion transporting systems in osteoclasts and their regula¬
collaboration with industry.

disorders of the skeleton, Drs. Roiand Baron. Gary

•

in diseases where bone resorption is increased.
Dr. Baron's research also involves the characterization of

think that these molecules may be the ideal candidates to facili¬
tate not only bone grafts, but organ transplants in general. They
are now investigating the role of these molecules in animal
models.
In collaboration with Dr. Florence Comite, associate profes¬
sor of medicine. Dr. Vignery is applying her re.seareh to investi¬
gate the mechanism by which bone is lost in women suffering
from endometriosis. Endometriosis is a widespread and debili-
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lating disorder that occurs most com¬
monly in women who are in their 2()s
and 3()s. Dr. Comite discovered that
endometriosis is associated with a loss
of bone. Drs. Vignery and Comitc hope
to prevent the further bone loss that
may be associated with osteoporosis in
these young patients.
Yet another aspect of bone resoiption is being pursued in the laboratory
of Caren Giindberg. Ph.D., an assistant
professor in the department.

She is

refining ways to gauge .serum levels of
the bone protein osteocalcin, which is
made by the osteoblasts.
“A small amount is excreted directly
into the blood, where it can be mea¬
sured directly,” Dr. Gundberg explains.
As such, osteocalcin is an important
marker for increased bone turnover, a
sign that too much bone resorption is
occiniing.
i^y Peter Jokl checks
Dr. Gundberg believes a newly avail¬
able blood test for osteocalcin will help primary care physicians
to diagnose osteoporosis before debilitating fractures occur.

the progress of a patient with a broken foot.

cedures to a large extent is directly related to how effectively we

The test should also help orthopaedists monitor bone response

devise rehabilitation programs that suit the needs of patients.”
he says, adding, "We also look forward to working with our

to drug therapy for osteoporosis, thus eliminating the need for

strong alumni group headed by Dr. Robert N. Margoiis, clinical

biopsies.

associate professor of orthopaedics and rehabilitation. These
physicians play a key role in our educational programs.” YM

On the Horizon
Dr. Friedlaender’s plans for the department include recruiting
additional faculty, especially in the areas of spine surgery, hand
and upper extremity surgery, as well as
physical medicine and rehabilitation.
“Dr. Thomas Renshaw, a pediatric
orthopaedist and formerly the director
of orthopaedics at Newington Children’s
Hospital, joined our faculty in July to
help us expand our commitments to the
pediatric population in anticipation of
the opening of the new Children’s Hos¬
pital at Yale-New Haven,” he says. Dr.
Renshaw will be working with James
March, M.D., assistant professor of
orthopaedics and rehabilitation.
Dr. Friedlaender envisions a full
range of orthopaedic pediatric .services,
from the correction of minor gait prob¬
lems to the management of complex
multisystem disorders. Such di.sorders
require
the
collaboration
of

t

\

orthopaedists, pediatricians, neurolo¬
gists, neurosurgeons and other special¬
ists that only a major center such as
Yale can offer.
Dr. Friedlaender also foresees a
stronger emphasis on non-surgical .ser¬
vices. “The success of our surgical proYale Medicine
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Dr. Ag)ies Vigneny in her laboratory.
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OUR UNKNOWN VETERANS
EMERGE FROM THE SHADOWS

Dd Niin^. Victiuiin. March 1970: U. Gen. Lain awards a medal to a Navy nurse servini> aboard the hospital ship USS Repose. Women
served in all branches of the Armed Forces during the Vietnam War.

bv Linda Spoonstcr Schwartz. R.N.. M.S.N.

Beyond Molly Pitcher

No one can say if il was planned t)r a quirk of fate that the 1980
census was the first to ask Anterican women if they had served in

messengers and effective defenders of lonely, isolated settle¬

In the Revolutionary War, women served as nurses, scouts,

the Armed I 'orees; records on the veteran status of men have been

ments when men were away fighting. One early reconnais¬

kept since Revolutionary War times. To the surprise of many,
more than 1.2 million women told the census yes, they were

sance report advised British forces that “a raid into Connecti¬
cut was expected to encounter only rebellions women and

veterans. Where had these veterans been hiding?
Despite endless references to “our fighting men” during the

formidable hosts of boys and girls." When colonial soldiers
caring for their wounded comrades depleted the ranks of fight¬

two centuries and more of U..S. military history, until Operation
Desert .Storm, one heard little about women in uniform. Women

ing men, the .Second Continental Congress authorized Gen.
George Washington to hire women to nurse the sick.
Legend may have immortalized Molly Pitcher, heroine of

are rarely ilepieted in the scores of paintings, statues and memori¬
als commemorating America's military. Nor are they generally
seen in the parades and ceremonies that honor veterans. “Vet¬
eran" is not a word Lisually associated with women. Some say it is
America's best kept secret that women have served in and with
t)ur Armed b'orees since the time the nation began.

the Battle of Monmouth (N.J.) Courthouse, who took over
firing her husband's cannon as he lay too badly wounded to
continue. But have you ever heard of Debra Sampson? Dis¬
guised as a man. her battlefield heroics earned her decorations
for bravery at the Battle of Tarrytow n (N.Y.)
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How about Lucy Brewer? She served three years as a Marine

nurses before her, she was bui'ied at government expense with

aboard the USS Constitution during the War of 1812, at the

full military honors. In 1976, the United States issued a postage
stamp in her honor, the only stamp ever to commemorate an
individual nurse.

same time women nurses served on the warship United States
with Commodore Stephen Decanter.
Women, North and South, played crucial roles in the Civil
War. Soon after the outbreak of hostilities, a physician named

The War To End All Wars

Dr. Elizabeth Blackwell organized women in towns all over the
North to collect much needed medicines, bandages and sup¬
plies. These community groups formed the Women’s Central
Relief Organization, modeled after the Sanitary Commission,
which supported Florence Nightingale’s efforts in the Crimea.
The first such group appeared in Bridgeport, Conn., the day

Women’s status in the Armed Forces made progress of a sort
with the Army Reorganization Act of 1901, which led to the
founding of a permanent Nurse Corps. However, the 202
“charter members” of the corps and their sisters in the Navy

after Fort Sumter suiTendered.

Nurse Corps, begun in 1908, found themselves with neither
clearly defined roles, nor rank, nor military grade.

Forbidden to engage in combat, at least 400 women dis¬
guised themselves as men and fought in battle anyway. Women

When the “war to end all wars” broke out in August 1914, the
largest organized group of nurses available for duty were 8,000

also served as spies, couriers and military strategists. In a more

Red Cross nurses, who supplemented the mere 400 Army nurses
and 160 Navy nurses then on duty. This first cadre of nurses

traditional vein. Superintendent of Female Nurses Dorthea Dix,
a Boston school teacher, recruited and supervised 3,200 nurses,
several of whom served with distinction.

was immediately dispatched to serve with the British Expedi¬

Clara Barton, founder of the American Red Cross, often used

Recruitment and training of nurses at last became a govern¬
ment priority when America entered the war in 1917. Annie

her own supplies and food to care for Union soldiers. After the
war. Barton was responsible for establishing the first National

tionary Forces in Europe.

Barton’s contemporary, author

Goodrich, first dean of the Yale School of Nursing, founded
the Army School of Nursing to educate the required numbers

Louisa May Alcott, served as a volunteer nurse in Lhiion hospi¬

of nurses. Many of these women saw duty on the front lines

tals, describing her work in letters that were later published as
the book Hospital Sketches.

and were wounded or gassed. Some were imprisoned by the
Germans.

Cemetery in Arlington, Va.

During the war between the states, Mary Ann Bickerdyke
fought so hard for the rights and comforts of the common
soldier that she was given the name “Mother” by the men. Gen.

Continued on page 15

William Tecumseh Sherman conceded that she outranked even
him when it came to caring for the sick and injured. It took the
government 80 years to recognize her devotion by commission¬
ing the hospital ship SS M.A. Bickerdyke.
Soldiering wasn’t the only role denied women during the
Civil War. Female doctors were not allowed to serve the
military, either. Mary Walker. M.D., gave up her medical
practice to serve with the Union Army as a nurse.

Going

beyond the call of duty, she volunteered to he a spy, was
captured by the South and later exchanged.
Awarded the Congressional Medal of Honor, Dr. Walker
became the only woman ever accorded the nation’s highest
military honor. Ironically, her medal, along with those of
several male recipients, was withdrawn in 1917 when the
criteria changed. A special act of Congress restored the medal
in 1976.
By 1898, as America fought the Spanish-AmericanWar, the
government began recruiting women nurses to care for the
troops. Hired only on a contractual basis, however, Washington
did not officially recognize them as part of the military and
hence did not provide insurance, pension or emergency assis¬
tance, even if a nurse was injured in the line of duty. More than
1,500 such contract nurses served in Latin America, the Pacific
and on the hospital ship Relief.
Such treatment did not deter many nurses from risking their
lives. Clara Maass, for example, assisted with research into
yellow fever transmission, studies which paved the way to the
development of a vaccine. In volunteering to be bitten by an
infected mosquito, she was the last human subject to be used in
these experiments, and the only one to die. Unlike the women
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Lai Khe, Vietnam. September 1969: Capt. Bernice Scott. Army
Nurse Corps, aids a mediccd team treating a wounded soldier.
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Harry Hishop

1986, she became CNF president, and the following year was
elected to the board of directors of the American Nurses Asso¬
ciation.
Ms. Schwartz, an advocate on behalf of all veterans, has
testified before both houses of Congress seven times. In 1985.
she was appointed to the Connecticut Governor’s Advisory
Committee on Women Veterans and in 1989 to the board of
trustees of the state Veterans Home and Hospital. In 1989, U.S.
Secretary of Veterans Affairs Edward J. Derwinski appointed
her to the VA Advisory Committee of the Readjustment of
Vietnam and Other Wars Veterans. Two years later, she was
appointed vice chairman of the committee.
In 1990, Ms. Schwartz was elected to the national board of
directors of Vietnam Veterans of America, Inc. (VVA), the only
federally chartered veterans service organization which focuses
on the needs of the nation’s 9.2 million Vietnam era veterans. In
1991, she was elected VVA’s regional director for the New
England states. She was also elected president of the Vietnam
Veterans Assistance Fund, a non-profit organization that pro¬
vides financial, educational and research support to improve the
status of Vietnam veterans and their families.
Linda Schwartz resides in Pawcatuck. Conn, with her hus¬
band, Stanley, a restaurateur, and her 16-year-old daughter,
Loiraine.

l.inda Spoonster Schwartz

Linda Spoonster Schwartz:
A Voice for America’s Veterans
Linda Schwartz, a Dr.P.H. candidate at the department of epide¬
miology and public health, is writing her doctoral dissertation
on the physical health problems of women veterans of the
Vietnam War. She received her diploma in nursing from St.
Thomas Hospital School of Nursing in Akron. Ohio, is a B.A.
graduate of the University of Maryland and received a master’s
degree in psychiatric nursing from Yale University School of
Nursing in 1984.
While in the Air Force, Ms. Schwartz .served both on active
duty and in the reserves. She earned her senior Bight nurse
rating while on duty with the 69th and 58th Aeromedical Evacu¬
ation Squadron at McGuire Air Force Base, N.J.. and the 2nd
Aeromedical Evacuation Group at Rhein Main Air Base, Ger¬
many. A graduate of the Air Force School of Aerospace Medi¬
cine. Brooks Air Force Base, Texas, Ms. Schwartz created the
position of Senior Flight Nurse Clinical Coordinator in the
European Command. She retired from active duty in 1986 with
the rank of Major. Nurse Corps.
In 1985, she was elected president of the Connecticut Nurses
Association. During her tenure, the as.sociation founded the
Connecticut Nurses Foundation (CNF) and secured third-party

Ms. Schwartz as an Air Force nurse aboard a medical evacua¬

ri‘imbursement in the state for nurses in advanced practice. In

tion flight to the United States during the Vietnam War.
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Continued from page Id

Despite plaeing their lives in such danger, the nurses, in the
eyes of their government, were of les,ser status because unlike
soldiers, they were not engaged in combat. Therefore, the
government docked the pay of the nurses for the time they spent
as prisoners of war.
World War I also saw women outside the nursing corps
officially in uniform for the first time. Enlisted women, 12,()()()
Navy Yeomanettes and 305 Marine Corps Marinettes, were
assigned mostly as clerks or drivers. Gen. John “Black Jack”

This is well illustrated by the short-lived Women’s Army
Auxiliary Corps (WAAC).
Founded in 1942, WAAC was
authorized with the understanding that it would not be part of
the Army “but shall be the only women’s organization autho¬
rized to .service the Army exclusive of the Nurse Corps.” Out¬
raged by this double standard, a year later, Edith Norse Rogers,
who was serving the remainder of her deceased husband’s
Congressional term from Massachusetts, spon.sored legislation
to disband the auxiliary and create the Women’s Army Corps
(WAC) as a permanent part of the regular Army.

Pershing requested telephone operators fluent in French, who

In a curious bureaucratic twist, however, when the auxiliary
disbanded, 15,()()() to Ib.OOO women left the .service and did not

were dubbed “Hello Girls.” While these women were autho¬
rized stylish uniforms and rank, no one was required to salute

join the WACs. Hence, women who served only in the auxiliary
were not “in the military” and did not qualify for any of the

them because the Army considered them civilians. Despite the

generous veteran entitlements authorized after the war. It was
not until 1980. long after the post-war G1 Bill had expired, that a

fact that these operators served near the front lines, they re¬
ceived none of the insurance or benefits accorded the soldiers
with whom they served.

special act of Congress corrected this long-standing omission.
Reverse discrimination against men also reared its ugly head

After the close of the Great War, although women had served
honorably in Belgium. England, Italy and Russia, their contri¬

during and after World War II. Men in nursing were not eligible
to serve in any nurse corps until August 1955, when they were

butions seemed unnoticed and unrewarded.

finally authorized commissions in the Army Reserve.

Only the Marine

Corps extended servicemen's benefits to women. Most women,
especially Army nurses, had difficulty proving eligibility to
benefits and care, even when disabled in the line of duty.
Women were not even called veterans; they were referred to as
“ex-military members.”
Inequities were not limited to benefits and care. The 1920
Army Reorganization Act gave nurses “relative rank.” a kind of
shadow recognition which meant they could wear the insignia
but could not enjoy the privileges of that rank. They could not
eat with the other officers, did not receive pay equal to men of

These

men were not offered regular Armed Forces commissions until
the Vietnam War.
Soon after the WAC legislation, the Navy bit the bullet and
organized the Women Accepted for Volunteer Emergency Ser¬
vice (WAVES) as part of the Naval Reserve. In an unprec¬
edented move, the Navy turned to academia for help in design¬
ing the training program. Mildred McAffee, then president of
Wellesley College, was .selected the first director and given the
highest rank permitted a woman under the law.
Lt. Cmdr. McAffee was at firsi unwilling to use the acronym

the same rank, and could not live in the officer’s quarters.
Such practices persisted through the early years of World War

for the rather elongated official title of the group. But a Wash¬
ington newspaper headline declaring “Gobletts Come to Town”

II.

convinced her that calling the women WAVES was preferable.
Sailors soon developed their own translation of the letters:
“Women Are Very Essential Sometimes.”

Not until 1942 would women receive pay and allowances

commensurate with men. Unequal treatment wasn’t limited to
privileges and pay, either; it extended to the way the Armed
Forces treated manned women as opposed to men who were
maiTied. It wasn’t enough for the Army to make married women
ineligible to join its nurse corps; until World War II, maniage
was grounds for dishonorable discharge from the Coips—a pun¬
ishment usually reserved for convicted criminals.
When marriage was finally permitted, nurses were not autho¬
rized to be stationed with their husbands. Although marriage
for women in the enlisted ranks was tolerated, pregnancy was
unthinkable. For any woman, married or unmarried, pregnancy
was also grounds for a dishonorable discharge.
Serving in a Popular War
With the Japanese attack on Pearl Harbor and America’s entry
into World War II, demands for military personnel were tem¬
pered by the need to maintain production of war materials at
home. To free men up for combat duty, women were put to
work in factories and at construction sites. They were once
again called on as the unofficial national reserve force. While
the need was great, the Armed Forces remained reluctant to
allow women into military service or to accord them status

In 1942, the Coast Guard, which had taken heavy casualties
in the South Pacific, North Atlantic and Aleutian Islands, in¬
ducted women as SPARs (Semper Paratns—Always Ready).
Throughout this period and in succeeding years, the Coast Guard
would be the leader in accepting women and offering them
equal opportunity for advancement.
At the other end of the spectrum during World War II were
the 900 women of the Women’s Air Force Service Pilots
(WASPs). Organized in 1942 at the request of Army Air Corps
Gen. “Hap” Arnold, these women logged more than 60 million
air miles. They served as flight instructors and ferried 12.640
airplanes, including high-speed fighters, bombers and P-47
“Thunderbolts.” to overseas bases. They also had the dubious
privilege of towing targets so fighter pilots using live ammuni¬
tion could practice on something nun ing.
Other than their pay, these women garnered no military
support and had to pay for their own meals and lodgings even on
military bases. Although their duties were directed by the
military, the women were not even eligible for medical care or
insurance in case of on-the-job injury.

when they did serve.
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Of the 38 WASPs who were killed in crashes or while towing

provide reliable data on the number of women stationed in

targets, not one received death or burial benefits. They were

Vietnam, their estimates range from 7.300 to 10.000.

buried with no semblance of military honors. Not even a Hag to
drape on their coffins. Often, their female comrades would
have to "p^iss the hat" to bury them or ship their belongings

Others worked as physicians or in intelligence, supply, adminis¬
tration. air support and additional areas. Many Americans did

home. Finally, in 1977. Congress ended this shame by extend¬
ing veteran status to these valiant women.

In Vietnam, most of these women served as military nurses.

not even realize that women were stationed in Vietnam; at
times, even the government .seemed oblivious.

During World War II. more than 384.()()() women served in

A tragic example of government insensitivity was visited

the military. Women were injured, wounded, imprisoned and

upon the Orlowski family of Detroit. Mich, in 1967. When they

killed in action at Anzio and in the South China Sea. In a
seldom told story r)f heroism. 81 military women were interned

received a telegram informing them of the death of their son in

for 37 months at the camps o\'SciiUo Tomas and Los Banos in the

Vietnam, they were confused. They had no son in Vietnam.
They did have a daughter, 1 st Lt. Hedwig Orlowski, who had in

Philippines. They struggled with primitive conditions to care

fact been killed in a helicopter crash. Lieutenant Orlowski and

for the injured, sick and dying.

Along with the men. they

seven other women, all military nurses, died in Vietnam. Their

suffered and starved during their long imprisonment at the

names are engraved on the Vietnam Veterans Memorial in
Washington, D.C.

hands of the Japanese.
A March 18. 1992. “Salute to American Women Prisoners of
War” in Washington. D.C., included a woman who had been
imprisoned by the Japanese when she was 10 years old.

Vietnam redefined war. There were no front lines, no safe
places, no rules. Even American hospitals were raided by the

She

Viet Cong, who machine-gunned patients in their beds and

recalled the nurses vividly, and said that even the terrors of

threw satchel charges throughout the wards. Caring for casual¬

contending with the enemy, starvation and poor conditions of

ties presented a special emotional challenge because they were

the camps were not enough to overcome their strength and

so young, the average age of the Vietnam soldier being 19 as
compared to the 26-year-old World War II soldier.

determination.

As long as the nurses were there, the woman

said, she had faith that everything would be all right.

Exposure to enemy fire, primitive living conditions and the

Peacetime Recognition, Peacetime Conflicts

endless streams of casualties did take an emotional toll on
military nurses and other medical caregivers. Yet their proxim¬

Such tales of heroism from World War II led President Harry S

record numbers of lives to be saved.

Truman to sign into law the Women's Armed Services Act on

percent of treated casualties died of their wounds.

ity to battle—sometimes in the midst of the action—allowed for
In Vietnam, less than 2

June 12. 1948. Truman's pen finally established a permanent
place for women in the military.

Despite lingering inequities

with regard to rank and assignments, this landmark law prof¬
fered official recognition to the nearly two centuries of military
service women had given the nation. For the very first time,
women had reason to envision a military career.
During the Korean War—or as President Truman called it,
the "F^eacetime Coiinict”—the nation once more turned to its
women as an untapped military reserve. With .so few women in
the military. Secretary of Defense Gen. George Marshall formed
the Defense Ad\isory Committee on Women in the Armed
Forces to encourage women to join the service. Over the years
the committee, which still meets, has evolved into a vigorous
advocate for change and innovations for women in the military.
Korea also saw the first combat missions for the IJedgling
U.S. Air F'orce and its Nurse Corps and Women's Air Force
(WAF) contingents.

This was the first time Air Force flight

nurses and a structured aeromedical evacuation system were
used to airlift casualties from the battlefield to facilities outside
the combat area. In a major test of the system, 3,92.3 patients
were airlilfed in one day from Korea to hospitals in Japan. .Such
elliciency virtually eliminated the need for hospital ships to be
stationcrl in waters adjacent to combat areas.
fhis system also saved countless American lives in the
nation's next undeclared war—Vietnam—which dragged on to
becomr the longest war in United States' history. From the Gulf
ol lonkin in 1964 to the fall of Saigon in 197.3. more than
263.()()() women served in the military. While neither the de¬
partments of defense (DOD) nor veterans affairs (VA) can

Loii}^ Binli, VieDuim: Capt. Elizabeth Finn, staff' mirse, 93rd
Evacuation Hospital, instructs a nun from a local orphanage.
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For all its horrors, the Vietnam War furthered the cause of

Sadly, this remarkable accomplishment did not boost morale
for military nurses. The unpopularity of the war, the devastat¬

women in the military.

ing nature of the injuries they treated and the empty welcome
home left many women disheartened when they returned to

movement, the war stimulated such changes as 1967 legislation
lifting the ceiling on promotions for women. As a result, the

Combined with a growing feminist

America. My own return for a surprise visit in early May 1970

Army saw its first woman general. In 1970, pregnant women

offers a dramatic example.
I had tlown home from Japan with a planeload of casualties

were permitted to stay in the military, though, curiously, their
condition remained a “service-connected disability” until 1975.

from Vietnam so that I could attend my sister’s college gradua¬
tion. I arrived in northern Ohio on a beautiful spring day. My

During the Vietnam era. the Armed Forces disbanded the
WAC, the WAF and—in tacit admission that women were not

father greeted me at the door, expressing the shocked delight I'd

just sometimes essential—even the WAVE, and integrated their
members into military units. When the draft ended in 1973, the

hoped for; after all, I hadn’t seen my family in 18 months.
When I explained why I’d come home, however, his face
fell. There would be no graduation, he said. There had been

2 percent limit on the number of women on active duty also

trouble at my sister’s university, Kent State, the day before.

came to an end. At that time, women comprised 1.6 percent of
the military; by 1991, this increased to 11 percent of the active

Three students had been killed by the National Guard during

duty force and 13 percent of the reserves.

anti-war demonstrations. The campus was closed.
Still dressed in my uniform, I entered the kitchen where my

In the late 1970s, women doctors began to serve in military
hospitals. They were the only women to do so since Mary

sister was sitting at the kitchen table with my mother and 8-

Walker became the first officially recognized woman military
physician during the Civil War.

year-old brother. It was so wonderful to see them. But to my
amazement, my sister abruptly stood up, slammed me against
the wall and started screaming about the war.

It wasn’t the

homecoming I’d dreamed about.
My sister was not part of the demonstration but had been near
the green when the shooting started. Shooting. I knew too well
what bullets did to human flesh. I thought about the boys I had
come home with—missing arms and legs, missing eyes, missing
faces. I thought about how close my sister had come to harm. I
thought about American civilians dying at the hands of Ameri¬
can soldiers. And I wondered where the war really was.

The last bastion to fall came in 1980. when women were
finally admitted to the service academies. These changes brought
expanded roles for military women. By 1990, 100 percent of
Coast Guard, 98 percent of Air Force. 59 percent of Navy and
52 percent of Army positions were open to women.
Navy and Coast Guard women who command vessels at sea
are living proof of the progress made in these branches of the
Armed Forces. Navy, Air Force and Army women are rated as
test pilots and flight instructors. Some have even been assigned
as commanders of aircraft squadrons.
Army women participated in the invasion of Grenada and
commanded Army companies in “Operation Just Cause” in
Panama. Americans thought they were hearing things when
CNN broadcast that a unit of the 988th Military Police Com¬
pany commanded by Capt. Linda Bray was engaged in a vigor¬
ous firefight with 40 members of the Panamanian Defense
Forces. Captain Bray is thought to be the first servicewoman to
command in combat.
While such responsibilities reveal dramatic progress, they
only heralded the dawn of equality. Take, for instance, the Air
Force women who flew missions in Grenada and in the action
against Libya.

Although these women undertook the same

missions, performed the same duties—with just as much valor
as the men. they were not awarded the same medals because
such decorations can only be given in combat situations.
But they did engage in combat, you object? In a classic
application of Catch-22, these women were denied equal recog¬
nition because the law states that they cannot serve in combat.
Never mind that the heat of battle brought the hostilities to
where the women served; because of the combat law. they could
not receive the same medals as the men.
In many respects, military women came into their own dur¬
ing the Persian Gulf War, the first large-scale military operation
since the all-volunteer force was established. More than 33.300
women served in key combat support positions, commanding
battalions, manning Patriot missile placements, flying recon¬
naissance and tactical transport missions. Army Lt. Phoebe
Jeter distinguished herself as the first woman to “engage the
Long Binh, Vietnam, June 1967: Capt. Faye Ferrington helps a
patient of the 93rd Evacuation Hospital feed himself
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enemy,” by directing Patriot missile launches that destroyed
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two Scud missiles. Several women were wounded in Operation
Desert Storm, six were killed in action, seven others died in the
line of duty and three were taken prisoner of war.
Women's difficult path toward equality in the Armed Forces
is paralleled by the struggle of women veterans. For many
years, a bronze plaque at the entrance to the Veterans Affairs
Central Office in W'ashington. D.C., expressed the perceived
mission of the department.

•

Insufficient provisions for privacy;

•

Incomplete physical examinations;

•

Little or no gynecological care;

•

No systematic effort to inform women about their
entitlements.

Taken from Abraham Lincoln’s

In 1983, the VA established an Advisory Committee on

second inaugural address, the solemn words read; “To care for

Women Veterans to help revise policies and adapt services to

him who shall have borne the battle.”
If the results of the 1980 census raised many questions about

the growing number of women veterans. The VA also directed
that all future research of veterans include women. Later that

this new found entity—women veterans—one conclusion was

year, in a long overdue tribute, women POWs held by the

inescapable. The system was failing the million-plus women

Japanese during World War II were finally recognized at a
Washington reception.

veterans who were not utilizing VA benefits.
Along with the census, other dynamics were emerging to
awaken the public and Congress to the fact that the VA should
be providing better medical care to women veterans. Even as
legislation was being proposed to extend benefits to the WASPs

Congressional hearings on women veterans held in 1983
opened many eyes.

Women veterans reported that they were

expected to use communal showers while being treated in VA
hospitals. Some witnesses recounted how they had been exam¬

and WAACs of World War II. thousands of women were return¬

ined in full view of male patients; others that they had been

ing from Vietnam.

denied care altogether because of their gender.

.Many of this new generation of women veterans displayed

Rising interest in women veterans prompted the VA to com¬

symptoms of post-traumatic stress disorder (PTSD), yet the VA
denied them treatment. To begin with, they were not considered

mission a 1985 study, “The Survey of Female Veterans." which
reported that more than half the women interviewed were un¬

combat veterans; a diagnosis of PT,SD was reserved for men

aware of their VA benefits. The study also found that women

w ho carried guns, not for the women who cared for them when

veterans had twice the rate of cancers than in the general adult
female population. Especially disturbing were the high rates of

they became the carnage of war.
.Such official resistance did not sway these women from their
conviction that Vietnam was responsible for their terrifying

cervical, uterine and ovarian cancers (45 percent).

Though

memories and readjustment problems. They were having mul¬
tiple miscarriages, stillborns and giving birth to children with

department nonetheless began a vigorous campaign to acquaint

initially the VA took exception to some of the.se findings, the
women veterans with their benefits.

cancer. They wanted answers. And they would not be ignored.

Coincident with the belated recognition of World War II

Soon after the 1980 census. Congress finally granted veter¬
ans' status to the women who had .served in the Women's Army

POWs. WASPs and WAACs came efforts to create memorials
to servicewomen. Once again, the Vietnam servicewomen led

ALixiliary Corp (W'AAC).

Ffecause the G1 Bill had expired,

the way by establishing the Vietnam Women’s Memorial Project

some in Congress tried to extend comparable benefits to these
women. Although these attempts failed, the controversy only

in 1984. The Women in Military Service of America Founda¬
tion debuted in 1987 to raise funds for a memorial to honor all

heightened the resolve of the Vietnam veteran women.

American women who had served in uniform. After making its

One out of five women who served in Vietnam left with a

way through nine years of governmental delays and red tape, the

permanent service-connected disability. Although the.se dis¬
abilities qualified them for care in the VA. when they sought

former memorial will break ground on Nov. 11, 1992; the latter

sLich care, they were either turned away or received substandard
treatment,

d'he Women's Pixqect of Vietnam Veterans of

America (VVA)—funded, ironically, by the Playboy
Foundation -lobbied for a General Accounting Office (GAO)
study about the matter.

is far from that point.
Most recently, 1991 Congressional hearings on VA services
to women veterans reported some improvements. Many wit¬
nesses, however, repeated complaints voiced during the 1982
hearings.

A later GAO report substantiated many of the.se

.Advling to this momentum. Lynda Van Devanter. an Army

claims. In short, the struggle continues.
The saga of each succeeding generation of women veterans

nurse who had served in Vietnam, published Home Before
Morning, a book about her years of struggle to overcome her

unfolds like a rich tapestry woven with the finest fibers of
American traditions and values. Marvelous stories tell of cour¬

emotional and physical wounds of war. This book helped other

age in the midst of the enemy, determination in the face of
overwhelming adversity and great devotion and caring for the

women veterans see that they were not alone with their terrify¬
ing memories and illnesses.
A 1982 GAO report. “Actions Needed to Insure that Female
Veterans Have Equal Access to VA Benefits." noted:
•

A woeful lack of treatment facilities L)r women veter¬
ans;

•

Lnequal access to treatment programs and medical
ser\ ices;

casualties of war. The spirit and .service of these forgotten
daughters of America have written some of the most heroic
chapters in the history of the nation. These women have con¬
tributed to the time-honored tradition of sacrifice made by all
American patriots.
It's time that we gave them their due.
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WEST HAVEN VA AND YSM:
A PARTNERSHIP RENEWED

Norman E. Browne, executive director of the Department of Veterans Affairs Medical Center.

by Robert A. Hamilton

YSM dean, warned that further deterioration threatened the
VA’s affiliations with leading universities such as Yale.

Visitors to the Department of Veterans Affairs Medical Center in
West Haven, Conn., are as likely to hear the high-pitched whine

Three years after those hearings, while the national VA
system still struggles with quality issues related to federal

of a power saw as they are the beeping of a doctor's pager, as

cutbacks, the West Haven medical center has blossomed. To¬
day, Mr. Browne notes, the average patient census is 370. with

engineers and contractors scnrry around the grounds to complete
a six-year, $90 million capital project.
“Last year we had more than $22 million worth of construction
underway at one time, the largest amount in the VA system,”
boasts Jeremiah P. Clay, chief of building management.
Modernizing and expanding the 39-year-old facility is adding
to the upbeat mood at the West Haven VA, in growing recogni¬
tion that the medical center is again a leader in the national VA
system. This feeling represents a dramatic turnaround.
Only four years ago, when the West Haven VA brought in
Norman E. Browne as its director, the institution reflected the
distressed state of the national VA system. The physical plant,
both inside and out, was crumbling. Only 270 of 456 acute-care
beds were in use. The surgical residency program was in danger
of losing its accreditation because of low workload.
In fact, so serious was the national VA system’s health that in
1988 Congressional hearings, Leon E. Rosenberg, M.D., then
Yale Medicine
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many units running near capacity. And in the last three years,
the West Haven VA has seen the largest increase in workload
of any facility in the VA system.
What is more, the West Haven VA began several new
national programs, and improved others already in operation.
Pay scales for physicians, nurses and health professionals have
been improved. As a result, the campus that overlooks New
Haven from the west is back on the cutting edge of medical
science. What brought about the change?
Mr. Browne credits the School of Medicine, especially the
leadership of former Dean Rosenberg and Acting Dean Robert
M. Donaldson Jr., who for many years has been active at the
West Haven VA. "Drs. Rosenberg and Donaldson breathed
new life into the system,” Mr. Browne says.
Robert A. Hamilton is a free-lance writer.
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A 3()-year Partnership

How much time a doctor might spend at the University
versus the VA depends on a number of factors. “Some Yale

The School of Medicine's affiliation with the West Haven VA

faculty members spend almost all their time out here.

dates from when the latter opened its doors in 1953. This debtil
came seven years after Gen. Omar Bradley, administrator of the

research is centered here, they supervise patient care here," says

VA system after World War 11. matched the VA's critical need

five hours a week” as attending physicians.

for physicians with medical schools' needs for hospitals in

Although many people think of the VA system simply as a
vast patient care network, education and research also play

which their students and residents could train.
Nationally, although 103 out of the country's 126 medical
.schools are affiliated with a VA hospital or medical center, the

Their

Dr. Atterbury. “There are others who may only spend four or

important roles, says Robert H. Gifford. M.D.. associate dean

degree of cooperation varies w idely. At one e.xtreme, the affili¬

for medical education and student affairs at Yale. For 10 years.
Dr. Gifford has served at the West Haven VA, first as associate

ation can consist of .sending a lone ophthalmology resident for a

chief of staff and then as chief of medicine. He points out that

rotation every semester to a VA hospital 150 miles away. At

more than half the nation’s doctors received at least some
training in the VA system.

Yale, by contrast, the affiliation is comprehensive, with the two
institutions sharing responsibilities in patient care, education

“The VA nationally is an extremely important part of medi¬

and research.
In fact, all YSM clinical departments except obstetrics and

cal education, and it’s never received the credit it should." Dr.

gynecology and pediatrics have VA counterparts to which they
are linked. With an increasingly vocal population of more than
a million women veterans clamoring for better health care from

Gifford says. Each year more than 3(),00() medical residents and
22,000 students get some training in a VA facility.
In West Haven, both Yale and the VA gain from the partner¬
ship. On one hand, the West Haven VA benefits from the

the VA nationally |see “Our Unknown Veterans Emerge from

services of Yale medical students and residents who bring with

the Shadows," page 12|, a possible program in ob/gyn is under

them state-of-the-art medical practice. On the other hand. Dr.

discussion as well.

Gifford notes, the VA offers “one of the most critical parts of

Perhaps the most obvious example of the close Yale/VA

our teaching program. The students and house staff have a great

relationship is the fact that West Haven VA staff physicians

deal of responsibility to make decisions, under supervision.

have Yale faculty appointments.

There's no way you can learn medicine unless you do it yourself

For example, Colin E.

Atterbury. M.D.. chief of staff at the West Haven VA. is also

with the proper guidance, and that's what you get at the VA."

professor of medicine at Yale and associate dean for veterans

Furthermore, the physicians-in-training gain exposure to a

affairs. He explains that of 300 physicians contributing to care

different patient mix than they do at other Yale-affiliated hospi¬
tals. such as Yale-New Haven Hospital (YNHH). For instance,

at the medical center, 80 are paid by the VA, the rest by Yale.

approximately 60 percent of West Haven VA patients have a
I

chemical dependency, compared to 25 percent at YNHH. Half
the beds at the West Haven VA serve rehabilitation patients,

,

i

compared to one-third at Yale, and more patients at the VA have

-v-

1

multiple diseases, due in part to a higher average patient age.

7
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Notes Dr. Donaldson. “Not only is the West Haven VA
facility the home of some of Yale's finest physicians and clini¬
cal teachers, but the good will and collegiality of its veteran
patients make it a wonderfully positive environment in which
our students and residents can learn. By offering the best pos¬
sible supervision, the West Haven VA teaches how to care for
and serve disabled people in the best possible ways."
Finally. Yale students and residents learn the hard lessons of
cost control on the West Haven campus. Due to federal budget
constraints, especially during the 198()s when medical inllation
was running at 10 percent or more a year, the VA system was
making do with 2 percent annual increases, despite a rapidly
growing patient load. Today, as a result, the West Haven VA,
with 450 acute-care beds and 90 long-term care beds, has a $ 102
million annual budget, less than some non-profit v oluntary hos¬
pitals in Connecticut that are half its size.
Dr. Donaldson emphasizes that despite such constraints, the
West Haven VA Medical Center .serves as a “model of excel¬
lence" in veterans' care, including service to those of modest
means: “In an era when everyone—physicians, patients and
healthy people alike—woiry about the frightening costs of mediContinned on page 24

/)/' Colin
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PET Offers VA, School of Medicine
Most Advanced Imaging Technology
Overthe entrance to the Yale University/West Haven VA Positron
Emission Tomography (PET) Center stands the seal of the De¬
partment of Veterans Affairs on the left. On the right rests the
School of Medicine's coat of arms. Of equal size, the emblems
symbolize the partnership that has brought the latest diagnostic
imaging technology to Connecticut. The PET center is the only
facility of its kind between New York and Boston.

Yale technical cxperti.se helped the We.st Haven VA become
one of the first medical centers in the VA system to obtain PET
technology. At the same time, the VA grant helped Yale obtain
its own PET device sooner than would have been possible other¬
wise. because the state Commission on Hospitals and Health
Care had not approved the technology for clinical use.
State permission to collect from third-party payers began in
July 1992, in part because of the many clinical applications that
PET offers, including:
•

measuring the metabolic activity of a tumor to predict
how quickly it might spread;

"The PET center is going to benefit not only veterans, but all

•

pinpointing tumor location for surgery;

the people of Connecticut,” says Robert Soufer, M.D., center
director, chief of general and cardiovascular nuclear medicine

•

measuring ammonia IJow and sugar metabolism in the
heart to determine the extent of cardiovascular disease;

service at the VA and an associate professor at Yale.
Dr. Soufer explains that while traditional imaging
techniques—from X-ray to magnetic resonance imaging
(MRl)—provide anatomical information, PET yields metabolic
data. Here’s how PET works at the Yale/VA center:
•

An on-site cyclotron prepares isotopes with extremely
short half-lives, ranging from a few minutes to approxi¬
mately two hours. PET technicians use the isotopes to
label substances such a glucose or water, which the body
metabolizes.

•

predicting the recovery potential of a stroke patient based
on glucose uptake in the brain;

•

locating the foci of epilepsy in the brain as a prelude to
surgery.

A testament to Dr. Soufer's commitment and drive, the Yale/
VA PET center’s early patient statistics are impressive. During
its first eight months, the center .served 1 15 patients. The
facility can accommodate six patients a day.

As the patient lies comfortably on a table attached to the
scanner, a solution containing the labeled substances is
injected into the patient's bloodstream.
•

The table is passed through the opening of the donut¬
shaped scanner, and the PET device’s 1,320 crystals
monitor the gamma ray signals.

•

A computer translates these signals into images that offer
data about the metabolic processes taking place within
the targeted organ.

Most PET procedures last from 45 minutes to an hour; total
radiation exposure is equivalent to approximately two X-rays.
PET offers physicians an effective tool for early intervention
because it can detect metabolic events that precede anatomic
changes in many diseases, including cancer. In addition. Dr.
Soufer notes, “PET is a tool to ensure the appropriateness of
care. PET might not tell you a tumor is cancer. You still need a
biopsy to do that. But it can tell you how well the patient will
respond to an intervention.”
PET also offers data that can avoid unnecessary surgery. Eor
instance, a PET scan can allow a surgeon to detennine when not
to operate on a patient’s heart, because the tissue in question is
dead. The first papers from the PET center reporting new
findings in myocardial metabolism were presented by Dr. Soufer
at the International Society of Nuclear Medicine in June in Los
Angeles.
How did the VA and the University manage to bring such
sophisticated technology to the New Haven area in a time of
belt-tightening both within the national VA and at Yale? The
two institutions pooled financial resources. The VA authorized
a grant of almost $3 million for the center, says Dr. Soufer, the
principal investigator for the VA grant, and Yale raised a similiar

Dr. Robert Soufer e.xcunine.s a patient before performing a

amount through corporate sponsors.

PET scan at the YaleA'A center.

Yale Medicine

Summer 1992

Charney. M.D.. neuroscience division director and professor of
psychiatry at Yale; Steven M. Southwick, M.D., director of

PTSD Sufferers Offered Hope
Through West Haven VA Center

PTSD programs at West Haven and associate professor of p.sychiatry at Yale; and John H. Krystal, M.D., chief of the center’s
Laboratory of Clinical Psychopharmacology and assistant pro¬

Although the Persian Gulf War ended more than a year ago, for

fessor of psychiatry.

"Tom," a 28-year-old veteran, the war still rages.

yohimbine triggered panic attacks in about 50 percent of more
than 100 PTSD patients who volunteered as subjects.

A combat

veteran, he guarded a compound that was attacked by Iraqi Scud
missiles.

Daily, he e.xperienced the screaming sirens which

warned that the deadly missiles would soon follow.
Now. when Tom is awakened at home by an ambulance
siren, he still waits in dread of incoming missiles: Tom suffers

This team has discovered that the drug

Yohimbine blocks the action of the alpha 2 receptor, a pro¬
tein embedded in brain cell membranes, and which helps to
regulate activity in the sympathetic nervous system. Yohimbine
can boost heart rate and blood pressure and induce feelings of

from PTSD—post-traumatic stress disorder, a condition in which

anxiety and panic.

certain sounds, smells or images evoke traumatic events from

indicates that trauma may alter the brain chemistry in veterans

the past.

with PTSD by sensitizing them to adreneline surges.

Tom is a patient at the Department of Veterans Affairs
National Center for PTSD in West Haven.

Dr. Charney says the Yale/VA research

In other medical school laboratories, and at Connecticut

Several hundred

Mental Health Center (CMHC)—a joint program of Yale and

\ eterans. from World War II to the Persian Gulf War. are served

the State Department of Mental Health—researchers have iden¬

by the center, where treatment includes psychotherapy, group

tified a brain structure that reduces fear. In studies of mice and
rats, scienti,sts have reduced the intensity of fear by activating

counseling and medication. In an effort to improve treatment of
clinical research involving animal and human subjects in col¬

PTSD. the center also conducts a broad spectrum of basic and

cells in the amygdala—a part of the midbrain that regulates
emotion and memory.

laboration with scientists at the medical school and its affiliated
institutions.

and phobias—as well as

In one of those studies, scientists have discovered that trau¬

“Clinical disorders such as obsessive compulsive disorder
PTSD—don’t allow people to dis¬

criminate fearful from non-fearful situations,’’ explains Michael

matic events may substantially alter the chemistry of the brain,

Davis, Ph.D., professor of psychiatry and psychology at Yale

sensitizing PTSD sufferers to adrenaline surges decades later.
These surges may account for symptoms of PTSD and panic

and head of the study. “This research illustrates that reduction
or extinction of learned fear is brought about through an active

disorder. Pinpointing how those events change brain chemistry
will help therapists develop drug and psychotherapeutic treat¬

process. We hope that our studies will lead to insights into how
PTSD comes about and how physicians may more effectively

ments for PTSD sufferers, say the Yale/VA researchers, who

treat this and other types of anxiety disorders.’’

work at the Clinical Neuroscience Division of the National
Center for PTSD.

Neurological Communicative Disorders and Stroke, was con¬

Dr. Davis' research, funded by the National In,stitute of

system devoted to studying the biology and psychopharmacol¬

ducted with colleagues William Falls, a graduate student, and
Mindy Miserendino, a postdoctoral fellow.

ogy of PTSD. One such study is being conducted by Dennis S.

—Rosalind D'Eugenio and Diane Loupe

The West Haven PTSD center is the only center in the VA

Dr. Dennis Charney in an ob¬
servation room at the West
Haven VA PTSD Center.
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Addition of a new steel and glass exterior continues at Buildings I and 2.

West Haven VA Construction
Advances at Rapid Pace

A $ 12 million project to cover the brick with a new metal and
glass exterior is underway on Building 1, and a like amount
soon will be spent on Building 2. Meanwhile, work is proceed¬
ing on:
•

renovation of the surgical intensive care unit (ICU), to
support the VA’s open-heart surgery program;

•

renovation of the cardiac ICU;

•

a new Eastern Blind Rehabilitation Center;

•

construction of a new 10.OOO-square-foot outpatient psy¬
chiatry building;

•

creation of a new laboratory for cancer research.

“The patient perception of the quality of care." In commenting
on the West Haven VA's six-year, $90 million capital project.
Medical Center Director Norman E. Browne coins the phrase to
explain that a well-maintained facility is vital to patients’ sense
of well-being. He cites studies which show that patients “judge
medical centers based on how long they have to wait, how well
they believe nurses have treated them, and the appearance of the
physical plant."
West Haven VA construction goes far beyond appearances,
however; among the first construction efforts to get underway
was a $7.5 million project to bring the buildings up to fire and
safety codes, including a quick-response .sprinkler system. A
new $1.4 million telephone system ushered the VA into the
modern telecommunications era, doubling the old sy.stem's ca¬
pacity. Other projects include improved or increased clinical
and research space, such as the new audiology and speech
pathology unit, a new outpatient pharmacy and air conditioning
in the virology lab.
One of the most difficult problems posed by the aging build¬
ings was the brick exterior of Buildings I and 2, the .seven- and
nine-story towers. Interior brick was mistakenly used by the
original contractors, leaving the outer shell vulnerable to

A $48-million clinical addition will give the West Haven VA
its first building designed for ambulatory care—when the hospi¬
tal towers were built in 1953, the VA was prohibited from
caring for veterans on an outpatient basis. Also underway are
renovation and expansion of the operating room suite, a new
clinical diagnostic laboratory and a canteen.
Other projects will improve the environment by removing
contaminated soils near fuel tanks, and by replacing an incinera¬
tor built more than 20 years ago. An electrical reliability project
will upgrade the backup power supply, including in.stallation of a
.second power line, and will bring wiring up to code.
To minimize logistical problems, Jeremiah P. Clay, chief of

Connecticut’s extremes of weather. Water seeped between the
brick and the structure underneath, and in some cases, freeze-

building management, works with the clinical and research staff
to make sure no patient unit is shut down, even for a few hours.
“We keep the patient load up. we keep the clinical groups going,

and-thaw cycles caused bricks to dislodge.

and cause as little disruption as possible," Mr. Clay says.
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Continued from pui’e 20
cal care, it is very important that oiir students and physicians-intraining learn all that they can about the health-care needs of the
poor and how we can pro\ ide that care in the most cost-effective
manner.

In this complex arena, the West Haven VA Medical

Center continues to lead the way with the strong support of the
.School of Medicine. That support is one of Yale's best in\ estments and we should ne\ er forget that fact."
Cutting-edge Programs
Cooperation in biomedical research between Yale and the West
Haven VA is assured because of the Joint appointment arrange¬
ment between the two institutions. .As medical school faculty
members, the VA scientists engage in a wide range of basic and
clinical studies. Such research helps assure that V.A

patients benefit from the latest technology and developments in
clinical care.
“Research at West Haven adds an important dimension to the
care of patients," says Fred S. Wright. M.D. Dr. Wright is
associate chief of staff for research at the VA and professor of
medicine and cellular and molecular physiology at Yale.

He

notes that currently 75 principal investigators are working on
more than 300 projects at the VA. Studies range from labora¬
tory investigation in cell and molecular biology to trials of new
therapeutic drugs.
In pulmonary medicine, for example, a laboratory group is
studying the regulation of genes that code for mediators of lung
intlammation. Another group in this section is testing a new
treatment for chronic bronchitis: aerosol administration of re¬
combinant human DNase, a product of genetic engineering.
Nearly all of the research actixity is directed at solving
problems related to disease and disability. Hence, a number of
programs that directly support patient care either were started as
research projects, or currently ha\ e an important research com¬
ponent. Among these are:
•

the Virology Diagnostic Laboratory, the only national
\ irology reference laboratory in the VA system;

•

the .Mycobacteria Diagnostic Laboratory. a reference labo¬
ratory for tuberculosis and other mycobacterial diseases;

•

the Schizophrenia Biological Research Center, one of
three in the VA;

•

the National Center for Post Traumatic Stress Disorder
clinical neuroscience component;

•

the Alcohol and Substance .Abuse Center, one of two in
the VA;

•

the West Haven V.A Comprehensive Cancer Center, re¬
cently funded and now being staffed;

•

the Neuropsychology Laboratory , a diagnostic facility in
w hich electrophysiological techniques are used to locate
regions of the brain that are causing seizures.

So close is the relationship between Yale and V.A in neurol¬
ogy and neurosurgery , that the distinctions between the two
institutions blur. Take, for instance, the Neurological Research
Center.

In a sharing agreement pioneered two decades ago.

cix ilian epilepsy patients from Yale-New Ha\en Hospital are
eligible for referral to the V.A. as well as VA patients from the
West Haven campus to A'NHH. says Richard H. .Mattson. M.D.
I 'or years. Dr. Robert M. Donaldson Jr. has been a keyplayer in the Yale-West Haven V'A Medical Center rela¬

Dr. Mattson is a professor of neurology at '^'ale and the principal
inxestigator on a S3.5 million, five-year National Institutes of

He emphasizes that the collaboration adds an

Health multidepartmental grant to study epilepsy at \ ale and

important dimension to the school's community service,
especially to low-income people. Says Dr. Donaldson:

the \',A.
He explains. ".An MRI (magnetic resonance imaging) or

"Yale School of Medicine takes seriously its responsibil¬
ity to provide first-rate medical care for the poor. This is
an inleyral part of our overall mission to discover and

other test might be done at "^’ale. as well as placing electrodes
before brain surgery . The resources at the V.A. on the other

tionship.

disseminate biomedical knowledge while establishhiit the
hiyhesi standards of clinical excellence. Our partnership
with the West Haven \'A Medical Center is crucial to
meeting these responsibilities and objectives. "

hand, allow us to provide services patients couldn't get at ^'ale.
either because of oxeiioad or because they don't have the spe¬
cialized equipment such as PET (positron emission
tomography)." an adxanced diagnostic imaging technology.
Dr. Mattson says the epilepsy program presents the '^'aleWest Ha\en V.A affiliation in microcosm.
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Uuiversit}’ Secretaiy Sheila Wellington and Dr. Stephen G. Wa.xinan honor James Peters, e.xeciitive director of
EPVA, the Eastern Paralyzed Veterans Association, for his orgainzation 's support of neurological research at Yale
and the West Haven VA, The Paralyzed Veterans of America (PVA) also has provided major support.
Susan S. Spencer. M.D., professor of neurology and director of
the Yale-New Haven Hospital epilepsy unit, conducts rounds at

Jeffery Kocsis, Ph.D., profes.sor of neurology. “We can’t prom¬

the VA; John S. Ebersole, M.D., professor of neurology, is not

ise to make wheelchair patients walk. But that exciting prospect
is always in the back of our minds.”

only director of the VA unit but also head of the clinical neuro¬
physiology laboratory at Yale. Together, the two units see

Drug Research Partnership

approximately 400 patients a year from across the country.
“It’s evolved to the point where we are one big program,” Dr.
Mattson said. “There are always logistical problems, because of

The West Haven VA pioneered the concept of multi-center
studies, now called cooperative studies. One of these early

the nuisance of being four miles apart, but we’ve been doing it

studies, in the 194()s, led to effective drug therapy for tuberculo¬
sis. The VA system, because of its network of 172 hospitals and

for two decades now and the problems are not insurmountable.
It’s a model of how two institutions can collaborate to the
advantage of patient care and research.”
Collaboration in research does not stop at the YaleAVest
Haven VA partnership. A private, charitable organization sup¬
ports leading neurological research at the West Haven VA. In
1988, the Paralyzed Veterans of America/Eastern Paralyzed
Veterans of America (PVA/EPVA) Center for Neuroscience
and Regeneration Research of Yale University opened, thanks
to a $1.5 million PVA/EPVA grant. The center, which also
receives ongoing funding from the veterans groups, the VA
national research program and other sources, is directed by
Stephen G. Waxman, M.D., Ph.D., professor and chairman of
neurology.
Dr. Waxman and his colleagues are advancing knowledge
about the basic mechanisms of central nervous system develop¬
ment, function, injury and recovery. The center’s scientists are
not so lost in the minutiae of research, however, that they lose
sight of their dreams. “We’re doing basic science,” comments
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its large, homogeneous patient population, is ideally suited to
large multi-center studies. VA researchers have studied, for
example, the efficacy of open-heart surgery over and against
more conservative treatment in angina patients and the lowest
effective dose of AZT in the treatment of AIDS.
Michael D. Ezekowitz, M.D.. Ph.D., the West Haven VA’s
chief of cardiology, is principal investigator for the cooperative
study on the efficacy of low-dose warfarin in preventing strokes
in patients with atrial fibrilliation (AF). The study’s prelimi¬
nary results were made available when President Bush experi¬
enced an episode of AF in the spring of 1991. Dr. Ezekowitz is
professor of medicine at Yale.
West Haven VA researchers are also conducting studies into
clozapine, an anti-psychotic drug for schizophrenics. Dennis S.
Charney, M.D., chief of the psychiatry service at the West
Haven VA, and Robert A. Rosenheck, M.D., deputy chief, are
the principal investigators for a $5.2 million VA study to deter¬
mine the full therapeutic efficacy of the drug. Dr. Charney is
25

the VA system away from high-technology interventions and
towards primary care.
Meanwhile, the national VA's “Mission Commission” has
recommended a two-thirds reduction in the number of acutecare beds, and only a one-third increase in the number of long¬
term beds, over the next two decades.
"It’s clear that we can’t count on any additional money in the
system.” Dr. Atterbury says. “There is going to be an increasing
emphasis on long-term care, ambulatory care, primary care.”
Dr. Atterbury notes that this direction contrasts with Yale’s
increasing emphasis on high-technology medicine, and adds
that programs like the PET Center “will learn to live side by
side” with increasing primary care programs.

“There’s not

going to be room for too many more high-technology programs,
unless we can prove they’re both medically effective, and costeffective.”
Acknowledging the need to control expenses. Robert Soufer.
M.D.. associate professor of diagnostic radiology and of medi¬
cine at Yale, and chief of general and cardiovascular nuclear
medicine at the West Haven VA. emphasizes PET’s cost effec¬
tiveness. He points out. for instance, that PET can save money
by reducing unnecessary surgery.
“A physician can be more certain with regard to the appropri¬
ateness of coronary artery bypass surgery w ith metabolic PET
imaging,” Dr. Soufer says.
In other words, because PET
provides data about myocardiac metabolic activity, when com¬
pared to traditional clinical anatomic imaging such as X-rays
and MRI. a PET scan can help physicians avoid operating when
heart tissue is dead.
Despite the laudable goal of efficiency, streamlining opera¬
tions can only go so far before the quality of care begins to
professor of psychiatry at Yale; Dr. Rosenheek, clinical profes¬
sor of psychiatry.

suffer, warns YSM alumnus Robert G. Petersdorf. M.D. ’52.
president of the Association of American Medical Colleges. In

.More than 600 participants in the study will be given either
clo/,apine or haloperidol. a standard anti-psychotic treatment.

testimony this spring before the Congressional Subcommittee
on Human Resources and Intergovernmental Relations, he

This double-blind study will last 3-1/2 years, compared to six or
eight weeks for previous studies. Of the estimated 20.000

on the VA system and on medical education nationwide.

patients in the VA system who could possibly benefit from
clo/.apine. less than 100 receive the medication, principally

“Indi\ iduals across the country express grave concern that
inadequate resources are a noticeable threat to VA medical

because of its high cost—$4,000 per patient per year.

centers,” Dr. Petersdorf said.

For the same reason, up to 500.000 patients in the United
•States could be helped by clozapine, but only 13.000 receive it.

becoming a less suitable environment for medical education and
training.

painted a grim picture of the effect that proposed cuts will have

“This could result in the VA

fhe study is expected to guide policy about who should receive

“1 understand that education and training are primarily medi¬

the drug. Other laboratory research at the West Haven VA is
seeking new drugs that will have the beneficial effects of

cal school matters, but our joint concern is quality.” Dr.
Petersdorf continued. “Foremost among our concerns is the

clozapine without potential side effects, which include
agranulocytosis, a lowering of the w hite blood cell count.

recurring shortfall in Veterans Health Administration appro¬
priations, which each year Congress has been cailed upon to

FA'cn as the School of Medicine and the West Haven VA
strengthen their bonds, the relationship continues to evohe.

correct. The funding shortfalls have a direct impact on patient

One of the greatest changes the VA must face nationally during
the next 20 years will be caring for an aging patient population

care. If I had to identify the greatest menace to delivering
quality health care in the VA, it would surely be lack of fiscal
resources.”
Dr. Donaldson concurs: “The West Haven VA Medical Cen¬

in the face of continuing federal budget cuts. Despite the lower
per patient cost vis a vis the private hospital system, the national
V/\'s current annual biulget stands at $14 billion.

ter clearly exemplifies the need for this nation to face up to its
responsibilities with respect to the Department of Veterans

Of the 27 million veterans eligible for treatment now. about
one-c|uarter of them—^^just under 7 million—are 65 or older.

Affairs and its health-care system. Yale’s partnership with the
West Haven VA Medical Center is crucial to the School of

Although the number of eligible veterans is expected to decline
tu- 17 million by 2002. the population 65 or older w ill increase to
more than X million. I'his demographic shift will tend to pull

Medicine’s commitment to excellence.”
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REFLECTIONS ON A CAREER
IN MILITARY MEDICINE
by Raymond L. Spluir, M.D., M.P.H. '72
The first U.S. Navy ship in which I went to sea was a small
destroyer equipped for radar patrol duty in the North Atlantic.
Fortunately for its crew, on this occasion the ship headed south¬
ward from Newport, R.I., its homeport, for the Caribbean and
spring exercises. The ship’s captain, a salty guy from New
Bedford. Mass., took it as his task to indoctrinate this fresh doctor
into Navy customs.
“The Navy isn't a job, it’s a way of life," he said, words which
he would often repeat. His statement proved cogent for the
ensuing 28 years of my naval career.
My service began in 1956. during my first year at Jefferson
Medical College, during the Korean conflict. Not wanting to
have my medical studies interrupted, I joined the Navy’s reserve
program for medical students.

It offered summer clerkships in

research and clinical medicine and a chance for me to wear the
uniform of naval officer. My reserve status even permitted me an
experience I shall always treasure—a ride in a blimp out of
Lakehurst, N.J., shortly before the Navy pha.sed out lighter-thanair craft.
By then I was in a civilian internship, at a time when the
Nautilus and other nuclear-powered vessels had captured the
public’s imagination.

My own interest soared as I read of the

Dr. Raymond L. Sphar

Navy’s daring journeys beneath the polar icecap. Nuclear power
was a revolutionary advance for submarines. The earlier "boats”
had changed little in decades.

They had limited submergence

capability using electrical propulsion from batteries, and diesel
engines on the surface.
Nuclear fission, the source of energy in a nuclear ship, sup¬
plies heat to generators which provide propulsive and electrical
power. Other devices produce oxygen, purify the ship’s air and

Raymond L. Sphar:
Three Decades of Military Service

convert seawater to fresh water, making the ship a true submers¬

Raymond L. Sphar. a native of Charleroi, Pa., and a
graduate of Westminster College, received an M.D. de¬
gree from Jefferson Medical College in 1961 and an

ible. Going to sea in this craft worthy of Jules Verne .seemed to
me the ultimate in adventure. Since these vessels all carried

M.P.H. degree from Yale in 1972. He served as medical
officer on two nuclear submarines, commanded two

medical officers, the Navy was exerting a powerful pull on me. I
signed on.

Navy research facilities, and held a variety of staff as¬
signments in Washington, D.C., including duty in the

Preparing for Life under the Sea

Navy Surgeon General’s office as director, undersea and
radiation medicine, and director, research and develop¬

At the time, a fully qualified submarine medical officer received
instruction in three areas: diving medicine; submarine medicine—a
subspecialty of occupational medicine that focuses on habitabil¬
ity of the submarine environment—and nuclear power. Training
took nearly a year and was divided among the Deep Sea Diving
School, Washington, D.C., Submarine School. Groton, Conn.,
and for those who survived an interview with Adm. Hyman

ment. He also served as military assistant to the Secre¬
tary of Defense for medical and life sciences research.
Dr. Sphar’s military decorations include the Navy
Legion of Merit and the Department of Defense Supe¬
rior Service medal. He retired from the Navy in 1990
and was appointed director. Medical Research Service,
in the Department of Veterans Affairs in 1991.

He

resides in Washington, D.C.

Rickover, father of the nuclear navy, one of the land-based nuclear
prototypes.
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Training at the diving school was physically demanding,
particularly for medical personnel who were not built like the

Keeping Armageddon on a Leash

typical Navy diver, who often resembles Mr. Universe.

West Milton. N.Y.: Of all the unexpected places for naval
nuclear power training, our group traveled to Ballston Spa. N.Y.

My

class of 40 .M.D.s began each day with calisthenics and then
pursued a series of familiarization dives using various diving

a sleepy, land-locked village upstate, near Saratoga Springs where

equipment ranging from SCUBA (self-contained underwater

for security reasons, the Navy operates several full-scale, opera¬

breathing apparatus), which was fun. to the helium/oxygen
hard-hat diving suit, which was torture. Outfitted in the latter,

tional nuclear submarine power plants. Wandering the innards of

with its copper helmet, lead weight belt and enormous boots. I

riveting and daunting. Not only did we have to learn how it
worked—we had to qualify as power plant operators!

gained a profound appreciation for those who had to work with
such an encumbering suit.

this enormously complex assemblage of technology was both

Admiral Rickover's staff, who directed the training, left no

.My class next faced the challenge of submarine training at

room for foolishness. Worldly activity such as television was

Croton. Conn., a naval base shrouded with mystique, its subma¬

firmly di.scouraged. Keeping up with the course material pre¬

rines dark and sleek, sliding silently down the Thames River

cluded recreation anyway—there was hardly time for meals—and

and out to sea. Nuclear power made these vessels all the more

I kept reminding myself what a unique opportunity I enjoyed.

intriguing.
After weeks of lectures on submarine systems and opera¬

the stress and finished the course. Having earned the white belt

tions. my class finally boarded a submarine, a World War II

of the qualified plant operator, my eight classmates and I were

diesel boat used exclusixely for training. Surrounded by in¬
structors. each of us got a chance to try our skill at sea, diving

more eager than ever for assignment to a "nuke boat." Sea duty
remained a distant dream, however; nuclear-trained physicians

Despite the challenging workload, we all managed to survive

and surfacing until we could accomplish this with some compe¬

were .scarce, so the Navy assigned the members of my class to

tence; in an emergency, the entire crew needed to know how to

ships that were still being built as Admiral Rickover wanted

surface the boat.
Lectures on atmosphere control, personnel selection, emer¬

"nuke docs” on the ships in construction and shakedown.

gencies at sea, radiation protection and toxicology comprised

New York Shipbuilding Co. in Camden, N.J. It would be the

the medical part of the course.

An cxscape training exercise

second of three that the yard would build. My ship was chris¬

foll(.)wed at the lOO-foot tank of watei'. although we made our

tened the Haclclo after a World War II boat whose namesake,

I received orders to an attack submarine in construction at

"escapes” from the .SO-foot level; our instructors knew well the

following Navy custom, was a fish, the variety of which I had

danger of air embolism that stalks anyone who is not able to

not heard before or since.

continuously exhale all the way to the surface. No one had to

Although it could not offer the adventure of the sea. the

iid'orm us that this training, while helpful to a submarine crew in

shipyard did provide much opportunity for on-the-job learning

shallow water. v\as moot in deep-depth operations.

in occupational medicine. This vast industrial complex posed
all the hazards attendant with heavy industry; for the only lime

Upon graduating from the submarine course, many of us
received orders to report directly to operational nuclear subma¬

in my naval career. 1 wore a hardhat and safety shoes.

rines. Nine of us proceeded to nuclear power training, some¬
what envious of those who were now going to sea.

My assignment—to establish the ship's medical department,
to keep the crew healthy, and to monitor the crew's radiation

Before any t)f us could commence, however, we had to
endure yet one more trial: an interview with Admiral Rickover

exposure once the nuclear reactor came on-line—was all quite
manageable, though the focus on perfection and timeliness could

himself. .Stories about these legendary exchanges, well-re¬
counted in books about Rickover and the nuclear navy, are often

prove stressful. Admiral Rickover was in constant touch with
the ship’s prospective commanding officer, Cmdr. Jack Wil¬

bizarre but probably not apocryphal.

liams. demanding attention to the tiniest detail of ship construc¬

.My interv iew took place in a purposely remote section of the
old "Main Navy” buildings on Constitution Avenue in Wash¬

tion.

dious, the time would come when we would learn firsthand just

ington. I).C. ,Mter a pre-brief by a staff officer on "dos and
ilon'ts”—do sit down, don't speak until he speaks to you—I was

how crucial the details are to a vessel capable of deep dives.
This lesson came soon after Haddo lumbered into Delaxx are

ushered into a small, spartan r)ffice, sat down and saw for the
first lime the famous man. about 6.S. slender and wiry, with

Bay and then the Atlantic to make its maiden voyage. Admiral
Rickover, as was his custom, conducted the sea trials person¬

close-cropped w hite hair and a prominent nose. He was scowl¬

ally. W'e knew' that Rickover expected a few amenities in his

ing. and I immediately doubted that I would be able to utter a
single intelligent answer to his questions.

stateroom—a fresh set of khakis, lemon hard-candy, white grapes
and a copy of the New York Times. Being just the right size. I
provided the khaki uniform, which was returned to me after we

'file only unifying thread to the admiral's line of bru.sque
questioning seems to be the monumental stress that it placed on
the person inlerx iewed—who was often seated in a chair with
two shortened legs. This w'as a favorite way of interviewing
miiishipmen. Perhaps because the admiral dirin't deem it neces¬
sary to dexote a lot of lime to grilling medical officers, my
intcrx ii-xx xx a^ intense but mercifully brief. 1 even got to sit in a
> hair XX ith good leg’s. I lax ing thus passed muster. I could finally
!v-gin nui'k’ar |ioxxer training.

Although this dogged pursuit of excellence seemed te¬

ived the admiral's trial by water.
.Sea trials proved downright scary, with Admiral Rickover
repeatedly giving orders for fast dives to considerable depths.
sLirx

As the admiral barked out his orders in a Bat, rasping monotone
all eyes in the control room were fixed on the depth gauges.
Dix ing a new submarine with an inexperienced crew is risky
despite safety tests done before the trials, and as we approached
the ship's alloxvable lest depth at a steep angle. I stood riveted in
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place, the occasional creaking of the hull reminding me of the
sinking of the Thresher, a submarine of the same class, just 18

remained at the homeport, engaged in refresher training and
spending time with their families; one month was used for

months earlier off the coast of Cape Cod. If the Hciddo had even
a minor flaw in hull construction, neither ship nor crew would

"turnover” between crews and for leave.

have survived.
Although such maneuvers were far from popular with crews

My duty aboard

Thomas Edison cjualified me for the unofficial title of “Blue
Nose" for having crossed beneath the ice of the Arctic Circle.
Under the best of circumstances, patrols were medically
uneventful, the crew being young and healthy. We could usu¬

and even with some of the top Navy brass, over the years the
admiral stared fate in the eye with fast dives of each nuclear

ally count on an outbreak of upper respiratory illness early in the

submarine he tested. Each time, fate blinked; thanks to superb
design and construction, he never lost a submarine in sea trials.

patrol, probably attributable to naive exposure to "Scottish vi¬
ruses” after three months in the U.S. Under the worst of

The practice of fast diving, however, did contribute to the

circumstances, an acute illness or .serious injury could Jeopar¬
dize the ship's mission by diverting it from its intended course

admiral's forced retirement in 1982, four years before he died.
Soon after Hciddo was commissioned in December 1964, I
received orders to report for duty with the Thomas Edison, a

to effect a medical evacuation.
During the earlier 36,()()()-mile submerged circumnavigation

Polaris ballistic missile submarine operating out of Scotland.

by the mammoth submarine Triton, a crew member had devel¬

As the primary naval deterrent against the Soviets, each Polaris
submarine poised beneath the North Atlantic, its 16 nuclear

oped severe pain from kidney stones about halfway through the
voyage. The trip was to remain top secret until completion and

missiles helping to keep the peace by the threat of horrific

the necessity to evacuate the patient was potentially compro¬
mising to the secrecy and to the record of submergence. Capt.

retaliation.
To maximize the sea time of these expensive instruments of
force, each submarine had two crews, designated Blue and

Edward Beach, Triton's skipper, arranged a secret rendezvous
with a navy cruiser, broached only the conning tower of the

Gold.

submarine, the rest of the vessel remaining submerged, and the

As one crew patrolled the seas for 60 days, the other

unfortunate man was transferred to the cruiser off the coast of
Montevideo. The historic voyage was completed successfully
with the ship surfacing off the coast of Delaware, where Captain
Beach was picked up by helicopter and flown to the White
House lawn to receive the Presidential Unit Citation for the
ship’s crew from President Dwight D. Eisenhower.
Fresh from the Colonies
In the late 1960s, the British pha.sed out the Royal Navy's air
fleet with a view to enlarging their nuclear submarine fleet and
sharing patrol responsibilities with the United States; the U.S.
provided Polaris missiles for these ships. The Royal Navy’s
enlarged fleet would require medical officers to be trained,
specifically in medical aspects of operating nuclear submarines
on lengthy patrols.
By then the U.S. Navy had substantial experience with radia¬
tion dose measurement, nuclear plant coolant analysis, and with
problems of prolonged submergence, including treatment of
medical emergencies at .sea. The U.S. agreed to assist in train¬
ing Royal Navy doctors for similar duty.
I was selected as the first of a series of exchange officers who
would serve with the Royal Navy in an unbroken chain for 25
years. My wife Jean and .seven-month-old daughter Christina
accompanied me to HMS Dolphin, the British submarine base in
Portsmouth harbor on the south coast of England. This compact
facility, offering a mix of old and modern architecture, housed
various naval functions including the headquarters of Elag Offi¬
cer, Submarines—the admiral who commanded the U.K. sub¬
marine fleet. I was assigned to his staff.
The admiral, a tall man of about 50 with salt and pepper hair
and steel-blue eyes, was most welcoming and gave me many
opportunities to go to sea in both diesel-electric boats and
nuclear vessels. By the end of my first cruise aboard a British
diesel, 1 was feeling quite at home, having shared the tiny
wardroom with the other officers and now wearing the white
A fleet ballistic missile submarine.
Yale Medicine
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wool turtleneck sweater exclusive to the submarine fleet.
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The hyperbaric coaiplex at the Naval Medical Research lastitute. Bethesda. Md.. pictured in the above schematic diagram, is among
the most teclmiccdly sophisticated diving research facilities in the world. When the “wet pot, " which projects downward from the
center of the comple.x, is flooded with water, it becomes the work site for Navy divers who use the other parts of the habitat for
sleeping, eating, e.xercise e.xperiments and recreation.

Each chamber has its own .system of pressure vcilves and gauges for

cotnpression and decotnpression as well as extensive means of monitoring the human subjects. Steel doors between chambers permit
isolation of a portion of the cotnple.x for treatmettt of a diving medical problem or for “excursions” to different depth levels. The
institute's chamber cotnple.x can simuhite ocean dives of up to 3,000 feet, but most saturation diving experiments are conducted at the
1.000-foot level.
Located at a site adjacent to Bethesda Naval Hospital, sometimes the hyperbaric coniplex is used to treat medical emergencies
such as carbon monoxide poisoning, bone infections and “the bends. " or decompression sickness in civilian divers.

riie Royal Navy Medical School, close hy HMS Dolphin.
was the locus for training physicians in submarine medicine.
My job was to provide information on LhS. submarine medical
practice and coordinate research between the navies. Research
issues at the time focused on long-term health effects of pro¬
longed e.xposure to the submarine environment with its artificial
atmosphere and inevitable atmospheric contaminants. In fact,
the technology for atmosphere control was remarkably advanced

ings complete with splendid maritime paintings and panelled
mess halls, and the Dolphin mess was no exception. Formal
dinners were frequent, with black tie uniform mandatory .
Each dinner was governed by a protocol of toasts, and as an
American who was a full member of the mess, one of the toasts
included the President. I only wished that the President might
ha\'e shared my hangovers, because after the formal proceed¬
ings we adjourned to the bar for more drinks and rowdy games.
Leaving England wasn't easy. I had grown accustomed to

in both nax ies, keeping carbon monoxide, carbon dioxide, hy¬
drocarbons and freon within permissible limits with relative
ease. I also shared in teaching radiation monitoring, air purifi-

riding a hor.se and to sailing, to drinking Port and even to
hearing British English. At least I could look forw'ard to a

valion and other facets of environmental medicine.
I’crhaps the most memorable aspect of the Royal Navy way
; : H were the social events. Officer messes in England are

residency in epidemiology at Yale.
The Navy arranged this residency so that afterwards I could
woi k at the .Submarine Medical Research Laboratory at Groton.

uwanably housed in impressive surroundings—historic build¬

I chose Yale knowing that the faculty at the department of
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epidemiology and public health (EPH) was excellent. More¬
over, I hoped to build bridges between EPH and the laboratory
in Groton. This seemed logical, given the Navy's interest in

diving in which divers can spend extended lengths of time in

long-term well-being of submarine personnel and EPH's exper¬
tise in epidemiological research, both for acute and chronic

Genesis, extended over six years and led to the Sea Lab project

pressurized chambers at depths even beyond the limits of a
submarine. The,se multi-phased experiments, entitled Project
in which divers lived in a seabed habitat and worked in the sea
around them, demonstrating the practicality of Bond’s concepts.

di.seases.
The Groton lab was responding to the advent of nuclearpowered submarines, ships that could function underwater for

In 1981, using technology pioneered by Captain Bond, three
divers at Duke University breached the 2,()()()-foot barrier for 50

several years—far longer than the human beings who operated

days in {\\e AtlcDitis III dive. Although record-breaking dives of

them. Early research in this field studied human tolerance to
carbon dioxide and hypoxia, reduced oxygen levels.

this type are, in a sense, technological stunts, they also yield
important .scientific information. Today, Navy divers conduct

Groton quickly had established a reputation as the leader in

routine work at greater depths and for longer periods than was

nuclear submarine environmental and behavioral research. Eor

ever thought possible 30 years ago, thanks to Captain Bond’s
pioneering vision of saturation diving.

example, the lab had determined that prolonged exposure to 1.5
percent carbon dioxide levels, previously accepted as safe, caused
undesirable physiological effects such as increased respiratory
rate and a feeling of breathlessness. So the Navy designed
carbon dioxide scrubbers capable of maintaining levels below I
percent. Scientists studying motivation and effects of stress and
fatigue recommended that patrol length be limited to approxi¬
mately 60 days, which became the standard for Polaris patrols.
Prom the beginning, the Navy recognized that the closed

Such was the milieu of applied research I entered after
completing my courses at EPH. Drs. Alfred Evans and Adrian
Ostfeld, my EPH mentors, had trained me well for this assign¬
ment, and they both served as consultants to the lab on numer¬
ous occasions. I soon became involved with a longitudinal
study of submariners’ health and a seroepidemiological investi¬
gation of respiratory illness in submarine crews.

space of a submerged submarine threatened its crew with poten¬

About one year after my assignment to the lab, I was named
its commanding officer. While gratified by this appointment, I

tial atmospheric contamination.

New studies monitored con¬

quickly learned that command did not come without its hazards.

tinuous exposure for prolonged periods and took into account

My initiation came by way of a Time magazine reporter, who
upon interviewing a young medical officer and a psychologist

the interactions of contaminants—studies which were to have a
bearing on “sick building syndrome” in the budding age of
sealed office buildings. The lab undertook vision and hearing
studies as well, establishing “international orange” as the color
that offered maximum visibility at sea.
Finally, the Groton lab had made its mark in diving research.
Capt. George Bond conducted early experiments in saturation

from our staff, published a story that infuriated Admiral Rickover.
Painting the worst possible picture of life aboard submarines,
the article falsely suggested that crews suffered severe paranoia
and often reached the limits of endurance on patrol. The article
predicted similarly dire problems for astronauts in the new
space program—developments which never occuiTed. In my

“International orange” became
the standard color for emergency
equipment, including the inflat¬
able life preserver affectionately
named for Mae West. In this
photo, circa 1950, the legendary
movie star, ever the good sport,
visited the lab to thank Grotonbased sailors for their tribute.
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daily coinersations with members of Rickover's staff, the storm
subsided. The admiral made it clear, however, that there were to

About this time 1 encountered Admiral Rickover again. Hav¬
ing learned that he was a patient in Bethesda Naval Hospital, I

be no more interviews with newsmagazines.
During my second year in Groton. 1973. we began develop¬

paid a courtesy call. As I entered the room 1 wondered what his

ing a plan to resume di\ ing experiments, the large hyperbaric
chamber used by Captain Bond still being fully operational.

reading. He looked a bit older, but no less feisty. As he greeted
me. he actually managed a smile.

Despite their depth limitation. 350 feet of seawater, the tanks
could still help the Navy understand some important questions.

The radiation incident at Three Mile Island had occurred a
short time before and I opined, “Admiral, if you were in charge

•So our interdisciplinary team of scientists embarked on a

of civilian nuclear power that accident would never have hap¬

series of experiments that sought to determine whether plain air
had utility as a breathing gas in .saturation diving; the success of

mood would be.

pened."

He was in bed, propped up with pillows,

With typical modesty he replied without hesitation,

“You are ab.solutely right, Sphar."

dives at greater depths depending on carefully balanced mixtures

In our exchange, the admiral took for granted the exacting

of oxygen and inert gases. Most diving work is done at shallow

standards demanded by the Navy—particularly the nuclear navy.

depths, and our team was able to show that saturation diving

In fact, this vignette illustrates what is common to the naval

could be done at those depths using air. The lab has remained in

officer who spends months at a time cruising beneath the sea

the forefront of this research, advancing di\ ing technology for
shallow depths as well as our understanding of the human re¬

and a .scientist who drives to the laboratory every workday.
Selected for independence, intelligence, objectivity and leader¬

sponse tt) the deep-diving environment.

ship, submarine personnel display qualities that are vital to the
research setting. Hence, the discipline I learned from Admiral

.V New Challenge

Rickover’s pursuit of excellence served me well in my later
assignments in medical research.

In 19S3. the Navy .Surgeon General invited me to lead the Naval

After my tour of duty in Bethesda, I served in the Office of

Medical Research Institute at Bethesda. Md., as its commanding

the Secretary of Defense, where 1 had oversight of medical

officer. Bethesda is the Navy’s flagship laboratory for basic and

research in all of the military services. This meant participating

applied medical research regarding combat casualty care, hy¬

in NATO meetings in Brus.sels, London and Paris, where I

perbaric medicine, infectious diseases. en\ironmental stress,

enjoyed renewing old international friendships. By now, though,

transplantation immunology and toxicology. The institute be¬

almost 30 years had passed since I Joined the Navy; I decided it

gan the world's first tissue bank. Navy scientists having pio¬

was time to put my uniform in mothballs, as they do the ships of
an earlier day.

neered techniques of harvesting and storage.
.Moreover, the institute offers a highly sophisticated complex

Today, as a civilian, 1 continue my career in military-related

of chambers, allowing for experimental saturation dives at much

biomedical science as director. Medical Research Service in the

greater depth—routinely to 1.000 feet—than the dives con¬
ducted in Groton. The basic science program focuses on the

Department of Veterans Affairs. The VA has been one of the

effects of pressure on mammalian systems, particularly the

leading biomedical re.search organizations in the world for more
than 60 years. The current program is addressing important

pulmonary and nervous systems.

In applied research. Navy

clinical problems in the veteran population—aging, AIDS, alco¬

divers serve as experimental subjects for testing diving gas
mixtures and decompression schedules, which the Navy con¬

der. schizophrenia, spinal cord and brain injury and the health of

tinually seeks to improve.

female veterans, to name but a few areas of research.

Infectious disease research has focused in recent years on
malaria prevention and treatment, developing rapid diagnostic

hol/drug dependency, heart disease, post-traumatic .stress disor¬
All of

these represent important challenges, and successful results will
benefit the general population as well as veterans. The VA has

tests for field use. and on AID.S. In 1983. a new detachment of
Navy scientists in Peru expanded research into a number of
tropical diseases.

a superb team of intramural investigators, three-quarters of
them physicians, and a highly regarded peer-review system, so I
am confident that these challenges will be met effectively.

.As in Groton, my initiation at Bethesda came quickly. After
only a week in command, animal activists broke into a research

by improving people’s quality of life through biomedical re¬

lacility and stole several dogs which had beeti used in experi¬

search. The adventure goes on.

It has been most gratifying to serve my country and the world
YM

ments. As the second such incident, the break-in affirmed that
upgrading security would be my first priority. A sad testatnent
to the times, we installed elaborate security systems at the
expense of our research budget, earmarked to protect and save
human lives.
Despite this distraction, during this period the institute expe¬
rienced rapid growth in the team conducting transplantation
immunology research, having maintained a strong capability for
diiiiiu histo-compatibility research over the years. These scien¬
tist . v.iiv among the first to isolate the hematopoietic stem
sell
ih. iiri'cursor of white blood cells before they differentiitc into cell tv pcs— ami related growth factors.
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GALLERY
»iile Medical Historical Library

Dr. Harvey Cushing and Aviator

Grave Marker, 1918

As a surgeon and professor at Harvard Medical School during
World War I, Harvey Cushing, M.D., later professor of

abandoned arms and equipment slowly sink in the mud as do

neurosurgery at Yale, organized Base Hospital Unit Number 5,

the crosses which mark where heroes lie: the derelict skeletons
of man and man-made machines—riddled tanks and fallen

one of several units of American medical volunteers that served

aeroplanes, demolished gun carriages and upheaved blocks of

on the front lines. Dr. Cushing led Unit Number 5 from May
1917 through the Armistice in November 1918.

concrete and rails which once were Boche "pill-boxes"—will
slowly disappear in the winter nnre of Flanders and in another

During these years, he composed a million-word journal,

season or two will he covered with soil, grass-grown and
flower-bedecked.

complete with photographs, which is housed today in the Yale
Medical Historical Library. The photograph on the left serves as
the frontis piece for an edited version of these writings: From a

Thus the corpse of the battlefields disintegrates, leaving its
rusting and contorted bones of iron and sinews (f wire, and

Surgeon's Journal (Boston: Little, Brown, and Co., 1936). The
second photograph shows an aviator’s grave in a makeshift

even these relics are being eaten away by a swarm of coolies
and German prisoners and salvage corps people, like beetles

cemetery in France near Belgium, his tombstone fashioned from

busy over a carcass.

a shattered airplane propeller.
In the aftermath of the war, January 1919, Dr. Cushing re-

There are many front lines and front lines in many places,
but there can he none more appalling—more beggaring of

llected on a former battlefield near the Somme in France:

description than...that disconsolate and desolate strip ofcountiy which lies between Ypres and the ridge stretching from

Januaiy 2nd.

Hotel Bellevue, Lille, 9 p.m.

One must cross the old .strip of No Man's Land and see for

Paschendaele through Gheluveldt and beyond to Messines.
A riot of demoralization—the fair earth which for centuries

himself..the complete annihilation of towns, villages, and the
lands between. No description could suffice—the thing itself

had been under the harrow, drenched in the blood of hundreds
of thousands, fi.xed in an agony of despair, abandoned to soli¬

beggars it, staggers it,,.
Sand bags rot and rains wash away their contents, leveling
the parapets...trenches and shell holes gradually fill in: the
openings of ahris and dugouts get choked and obliterated: the
tangles of wire, bent sheets of corrugated iron, the litter of

tude, torn, beaten, pounded, seared, upheaved, till no man can
possibly recognize the acre he has once tilled.
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STUDENT RESEARCH DAY

Eric Rdshhci. M.D. '92. (rii^lilj e.xplains lo third-year student Ed Gunther how cloned T-cells can prevent insulin
dei>endent diabetes niellitns in experimental ainnials.

Opening Remarks
Student research, by all medical students and M.D./Ph.D. stu¬
dents. plays a central role in the Yale System of medical educa¬
tion and it is the accomplishments of student research that we
celebrate today. The ret|uirement of an M.D. thesis at Yale is
unique among American medical schools, and today we cele¬
brate the I.S.Td year of that tradition.
This year the office of student research will fund over 200
students for short-term re.search and IS students who are receiv¬
ing one-year student research fellowships. This expanded pro¬
gram requires a growth in our funding, and 1 am very pleased to
announce today the establishment of the Paul Lavietes .Student
Research bellowship. given in honor of Dr. Lavietes. a beloved

for honors by the individual departments. These people are
listed in the accompanying table, and w'e are grateful for their
work.
We also want to thank Linda Seigneur. Gail Beamon and
Virginia Simon from the office of biomedical communica¬
tions. who worked .so hard on the posters you've just seen.
Laura McDonald, who joined us recently as the .senior admin¬
istrative assistant in the office of student research, has done a
remarkable job coordinating the events ot this day.
Our special thanks this year goes to Dr. Robert Gifford,
associate dean for education and student affairs. In addition to
all the other things that he does for students. Dr. Gifford has

clinician and superb diagnostician and teacher in the department
ol' medicine lor many years. Funds for the Paid Lavietes Fellow¬

supported the student research program in every possible way,
in raising special funds, in providing us space, and in coming

ship are gi\en to the school by the Lavietes family, specifically
Mrs. Ruth Ltivietes. Dr. I.avietes' daughter. Syhia Lavietes.
M S.W .. assistant clinical professor of pediatrics, and his cousin.

to all of our meetings.

Ra\ m.ind 1 .avietes of Stratford. Conn.
file pri/e-w inning theses that will be presented today, and
eii .-I ivsearch prizes awardeil at graduation, are selected by the
1 hesic \w ards Committee, w Inch reviews all theses recommended

.John N. Forrest Jr.. M.D.
I^ro fessor of medicine
Director, office of student research
'i
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Abstracts
A Prospective Study Assessing Patients
after Anterior Cruciate Ligament Reconstruction
with Serial Magnetic Resonance Imaging, Genucom,
KINCOM and Clinical Evaluations

There were a number of significant clinical findings in this
study. Twenty-four months after ACL reconstruction, all pa¬
tients had improved from their preoperative state as measured
by ability to return to sports (p=().()()()l). One patient developed
significant ligamentous laxity 24 months after reconstruction.
Changes in laxity did not correspond with changes in the clini¬
cal outcome. KINCOM testing at each of three different speeds,

by Ann M. Smith
Faculty’ advisor: Peter JokI, M.D.
Professor of orthopaedics and rehabilitation
Faculty discussants: J. Kevin Lynch, M.D.
Associate clinical professor of orthopaedics and rehabilitation
Chris F. Pope. M.D.
Department of radiology, Maine Medical Center

showed the involved quadriceps’ strength increased over the
follow-up period. A statistically significant quadriceps deficit
persisted even 12 months after reconstruction (p<().05). No
statistically significant relationship existed between the quadri¬
ceps and hamstring strength and the patients’ ability to return to
athletic activities (p<().05).

This prospective study was performed to follow changes in
anterior cruciate ligament (ACL) grafts after reconstruction and

There were also a number of significant radiographic find¬
ings. All grafts were identified on MR as intact at 24 months.

to judge what role various instrument parameters might have in

Graft signal intensity was most like normal tendon early after
reconstructive surgery while little change in the ACL graft

assessing the success of patellar tendon ACL reconstruction.
Thirteen patients were followed after ACL reconstruction with

occurred between 6 and 24 months. The clinical outcome could

KINCOM (muscle strength testing), magnetic resonance imag¬

not be predicted either on magnetic resonance signal or overall
appearance of the graft. Changes in the patellar tendon (the

ing (MRI) and clinical evaluations. Muscle strength testing was
performed preoperatively and 6 and 12 months postoperatively.

harvest site) and menisci were detectable on MR.
Although parameters from MRI, Genucom, and KINCOM

Clinical and ligament laxity evaluations were obtained

devices can be used to detect changes after ACL reconstruction;

preoperatively, and 6, 12 and 24 months postoperatively. MRI

these changes were not predictive of clinical outcome. Further
work is still needed to determine their exact roles in manage¬

serial testing that included Genucom (ligament laxity testing),

evaluations were performed preoperatively, and 1.5, 6, 12 and
24 months postoperatively. Data from these evaluations were
analyzed with multiple regression analysis of variance (ANOVA)

ment of patients following ACL reconstruction.

and paired T-tests.

Student Research Day ora! presenters and colleagues: (front row, from left): Ann M. Smith, Dr.
Lawrence S. Cohen, deputy’ dean, Sydney Brenner, F.R.S., Kelsey Martin. Back row: Dr. Robert H.
Gifford, associate dean for education and .student affairs. Michael Girardi, Daniel Fitzgerald. John
Phillips and Dr. John N. Forrest Jr. Dr. Brenner, director, MRC Molecular Genetics Unit,
Cambridge, England, delivered the fifth annual Lee E. Farr, M.D., Lecture.
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Thesis Subcommittee
(Awards Committee)

Tran.sport of Influenza Virus Ribonucleoproteins
into and out of the Nucleus
by Kelsey Catherine Martin

Edward J. Benz Jr., M.D.

Faculty advisor: Ari H. Helenius. Ph.D.

Emile L.Boulpaep, M.D.
Miehael Caplan. M.D.

Professor of cell biology, biology and iu the Cancer Center

Dennis L. Cooper. M.D.

Faculty discussant: IraS. Mellman. Ph.D.
Associate professor of cell biology

John N. Forrest, Jr.. M.D. (Chairman)
Robert H. Gifford, M.D.

Intluenza is an RNA virus which replicates in the nucleus and

Robert E. Handsehumaeher, Ph.D.

buds from the plasma membrane. As such, its ribonucleopro¬

James D. Jamieson. Ph.D.

teins (RNPs) must undergo bidirectional transport across the

Barry Kaeinski, M.D.

nuclear envelope. This thesis examines the transport of incom¬

M. Stephen Meyn. M.D.

ing intluenza viral RNPs into the nucleus during viral entry and

I. George Miller Jr.. M.D.

the export of newly synthesized viral RNPs out of the nucleus
towards the end of infection.

lr\ in M. Modlin. M.D.
Coralie Shaw. M.D.
Andrew Stewart. M.D.
Frederick J. Suchy, M.D.
r^ichard S. K. Young. M.D.

Upon penetration of the intluenza virus nucleocapsid into the
host cell cytoplasm, the viral RNA and associated proteins are
transported to the nucleus, where viral transcription and replica¬
tion occur.

Using quantitative confocal microscopy, I found

that over half of cell-associated nucleoprotein (NP) entered the
nucleus with a half-time of 10 minutes after penetration into
CHO cells.

Microinjection and immunoelectron microscopy

experiments indicated that the NP entered the nucleus through
the nuclear pore as part of an intaet RNP structure and that its
transport was an aetive process.

Transport of the incoming

RNPs into the nucleus was not dependent on an intact microfila¬
ment, microtubule, or intermediate filament network. Subse¬
quent to penetration, the matrix (Ml) protein appeared to disso¬
ciate from the RNP structure and to enter the nucleus indepen¬
dently of the RNP. I found that 50 percent of penetrated M I
entered the nucleus with a halftime of 25 minutes after penetra¬
tion into CHO cells. Nuclear transport of M1 appeared to occur
by passive diffusion. While the entry of incoming M1 into the
nucleus was not a prerequisite for infection, the separation of
M 1 from the incoming viral RNPs was. Amantadine, an antivi¬
ral agent which induces an early block in intluenza infection,
was found to block the dissociation e\ent. and to thereby pre¬
vent import of incoming RNPs into the nucleus.
In contrast. I found that export of newly synthesized viral
RNPs depended on association w ith M I. During infection, the
export of newly synthesized NP from the nucleus coincided
with the onset of Ml synthesis. In cells in which Ml was not
expressed, NP remained confined to the nucleus. When the
transport of new ly synthesized M1 into the nucleus was blocked
by cytoplasmically microinjected anti-Ml antibodies, NP re¬
mained in the nucleus. By double-label immunocytochemistry,
M I was found associated with new ly assembled viral RNPs in
the nucleus, at the nuclear pore, and in the cytoplasm. Thus. MI
appeared to bind to the viral RNPs in the nucleus and to escort
them through the nuclear pore to their site of budding at the
plasma membrane.
Together, the results of this thesis show that Ml modulates
the directionality of intluenza \ iral RNP transport into and out
.IdIii] /.. Phillips (111(1 his faculty advisor. .Arthur B. Dubois.
M l)., projcssor oj cpidcuiioloyy and phvsioloitv.

of the nucleus.
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Third-year student Robert Icninone looks on as fellow students ponder Ins data about a rabbit model for hitman T-cell Ismphotropic
virus type I (HTLV-1) infection.

Extracorporeal Photocheniotherapy
in a Murine Graft-Versus-Host Model
of Systemic Lupus Erythematosus:

third group of B6D2F| recipients were vaccinated weekly x 6
before disease initiation using 8-MOP/UVA-attenuated B6D2F|primed D2 cells further stimulated and expanded in vitro in the

Testing the Anti-Idiotypic T-Cell Vaccination Hypothesis

presence of B6D2F| targets and lL-2.

by Michael Girardi

were vaccinated with 8-MOP/UVA-treated D2 cells primed in
vitro and/or in vivo with C3D2F| (H-2''''') cells.

Control B6D2F| mice

Only mice vaccinated with 8-MOP/UVA-attenuated D2-antiFaciilt}’ advisor: Robert E. Tigelaar. M.D.
Professor of dermatology
Faciiln discussant: Charles A. Janeway Jr., M.D.
Professor of immunobiology, biology and in the Cancer Center
Inoculation of'B6D2F|

mice with D2 (H-2‘'^"') splenocytes

results in a chronic stimulatory gral't-versus-host reaction
(GVHR) with the clinical manifestations of systemic lupus
erythematosus (SEE). This investigation tested the ability of 8methoxypsoralen (8-MOP) and ultraviolet A light (UVA)-attenuated D2 cells, primed to contain an expanded population of
T-cells with idiotypic receptors directed against MHC-II(1-A‘’),
to treat and/or prevent such SLE-like disease. Vaccination of
B6D2E| mice with the extracorporeal Iy photochemo-attenuated
idiotypic cells was postulated to induce an anti-idiotypic T
suppressor response capable of mediating disease protection.
Photochemically attenuated calls from B6D2F|-primed D2 do¬
nors were inoculated into B6D2F| recipients weekly (x6-l())
either before or after GVHR initiation with normal D2 cells. A
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B6 cells, secondarily stimulated and expanded in vitro exhibited
differences from controls when measured by the clinical param¬
eters of ascites formation (0 percent of experimental, 67 percent
of control) and mean survival (29.2 ± 1.2 weeks in experimen¬
tal, 17.0 ± 2.4 weeks in control; p<().()25). Histologic evidence
of SLE-like kidney di.sea.se was found only in the control group.
The groups also differed in mean ANA titer [calculated as
log,(titer/40) -i- 11 measured 14 weeks after disease initiation
(2.6 ± 0.4 in experimental, 5.3 ± 1.7 in control; p<0.()5). Fur¬
thermore. in mixed lymphocyte reactions cells from experimen¬
tal mice suppressed the proliferative response of a CD4-enriched D2-anti-B6 line (idiotypic) to B6 targets by I 1.4 percent
when compared to the proliferative response of the same re¬
sponder/target combination in the presence of cells from control
mice (p<0.05). These results indicate photochemo-attenuated
D2-anti-B6 cells primed in vivo and secondarily stimulated and
expanded in vitro are capable of preventing progression of
GVHR-initiated SLE-like disease via a mechanism consistent
with generation of anti-idiotypic T suppressor cells.
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S(ini E. Dolilis explains her findings about intergenerational patterns of child nuiltreatnient to fellow 1992 classmates Michael
(iirardi and Nancy Dingotl Girardi.

HIV I Nufleocapsid Protein:

protein containing 2 gm atoms Cd/mole protein is obtained.

Zinc Binding and Functional Assays

The Cd( 11) ions can be exchanged with Zn(ll), Co(ll) or "’Cd(II).

by Daniel VV. Fitzgerald

The CodH^NC protein shows d-d electronic transitions at 69S
nm (£=675 M ' cm ' per Cot 11)) and 640 nm (e=825 M ' cm ' per
Cot 11)) compatible with regular tetrahedral geometry around

l-'acidty advisor: Joseph K. Coleman. M.D.. Ph.D.
Professor oj niolecniar biophysics and biochemistry
I'acnltx discnssant: William Konigsberg. Ph.D.

both Co(ll) ions. The Co(ll). and Cd(ll),NC proteins show
intense charge transfer bands in the near UV. 355 nm (£=-8000

Professor ofmolecniar biophysics and biochemistiy and genetics

M ' cm ') for the Co(ll) protein and 255 nm (£=~I0'* M ' cm ')
for the Cd(ll),NC protein, compatible with -S coordination.

The luieleoeapsid (NC) protein (pi5) of the human immuno-

signals at 659 and 640 ppm respectively, each integrating to

defieieney virus. IIIV. is a small RNA binding protein which
coats the HIV genome. NC has been cloned and overproduced

-one Cd(ll) ion. The downfield chemical shifts suggest coordi¬
nation of each "’Cd(ll) ion to 3 sulfur donor atoms. The
spectroscopic data fully support the prediction that the NC

"^Cd NMR of the "’Cd(ll),NC protein shows two "’Cd NMR

(under the control of a phage T7 promoter) in soluble form in an
cob host. The soluble NC protein is a fusion protein contain¬
ing l.'i AA from the T7 gene 10 and 7AA from the HIV p24

protein binds metal ions to each of the tandem repeats of the -

i he plasmid containing the fusion gene is tiesignated pl.SDF.

Cys-X,-Cys-Xj-His-X^-Cy.s- sequence contained in the N-terminal half of the molecule. While it is known that the NC
nonspeeifieally coats the HIV genome, a number of other func¬

Based upon the primary sequence of NC. it has been postulated
that the NC coordinates two /ine ions and is thus a member of

tions have been postulated. Functional assays pre.sented here
show that NC increases reverse transcriptase acti\ity by 2.5

tlu' ‘Vine fingei" proteins. A homogeneous product has been
isi dated Irom the indueerl cells, aiul when isolated umler aerobic
■ i)iKlitions contains ()..T()..‘S gm atoms of Zn/mole protein and

fold. Preliminary data also support the hypothesis that NC
binds specifically to the psi .sequence of HIV and is thus essen¬

protein at the N-terminus to make a protein ol I 7 I amino acids,

tial for specific packaging of viral RNA into virions.

only 2 titratable .SI I groups. On (he other hand, if the cells
• -I u alcd in 2 inM CdCI anil purified at pl I .‘s.O. an unoxidi/.ed
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Regulation of Cytokine Production
in the Rat Osteoblast
by Transforming Growth Factor-Beta

transformation in normal fibroblasts but has since been impli¬
cated in matrix homeostasis, immunomodulation, development
and hematopoesis. Bone is the body’s largest source of TGF-6
and the protein becomes activated after osteoclast bone resorp¬

by John L. Phillips

tion.

No definitive role for TGF-6 in bone remodeling is

known.
Facult}' advisor: Mark C. Horowitz, Ph.D.
Assistant professor of orthopaedics and rehcdtilitation

This thesis pre.sents experiments which tested the effect of
TGF-6 on osteoblast cytokine production and release. Data

and dermatology
Faculty discussant: Karl L. Insonga, M.D.

TGF-6 upregulates IL-6 and GM-CSF secretion through a novel

Associate professor of medicine

synergistic interaction with other low concentration molecules

Osteoblast activities include bone formation, osteoclast regula¬
tion, and the secretion of a class of hormones called cytokines.

group referred to here as synergens. M-CSF secretion was
unaffected by TGF-6 alone or in combination with any synergen.

Osteoblast-derived cytokines include Inteiieiikin-6 (IL-6) and

90 percent of the GM-CSF and IL-6 release observed is achieved

two colony stimulating factors (CSFs): Granulocyte-Macroph¬

between 2.5 and 6 hours after exposure to TGF-6 and a given
synergen. Furthermore, the synergy between TGF-6 and a

from in vitro cytokine assays of conditioned media suggest that

including LPS, IL-1, and parathyroid hormone (PTH), as a

age CSF (GM-CSF), and Macrophage-CSF (M-CSF). Osteo¬
blasts secrete cytokines after exposure to ,several well-charac¬
terized mitogens such as lipopolysaccharide (LPS),

given molecule is TGF-6-dependent. The osteoblast response

phytohemafflutinin (PHA), and Interleukin-1. What roles os¬

suggested that the synergy between TGF-6 and IL-1 may in¬

was not altered by exposure to indomethacin.

RNA analysis

teoblast-derived cytokines play in normal bone remodeling is

volve TGF-6 upregulation of the IL-1 cell surface receptor.

unknown.
Transforming Growth Factor-Beta (TGF-6) is a ubiquitous

These observations are the first to implicate TGF-B as a stimula¬

23-25 kDa homodimeric protein stored in platelets and bone.

tory molecule for cytokine release from osteoblasts and suggest
new a,spects of bone remodeling as well as a possible role for the

TGF-6 was originally discovered as an inducer of neoplastic

osteoblast in hematopoesis.

Dr. Robert Gifford (right) shows his affection for G. Edith Hsiui2g, Ph.D., professor emeritus of lahoixitoiy medicine, for whom a
student research fellowship is named. At left is Warren A. Andiman, M.D., associate professor of pediatrics, epidemiology and
lahoraton’ medicine.
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RESIDENCY PLACEMENTS 1992
CALIFORNIA

DISTRICT OF COLUMBIA

Kaiser Rermanente, Santa Clara

Georgetown University Hospital

Da\ id Lilli, medicine
St. Mary’s Medical Center, Long Beach
KcMit Min. medicine
Stanford Affiliate Hospital
James Reese, neurosurgery
Ping Wang, general surgery
L niversity of California, Los Angeles
I iowaid Cheng, internal medicine
Joanna Jen. neurology
Da\ id Lilli, diagnostic radiology
University of California, San Francisco
Jonallian Barash. /(//inVy practice
Sara Dobbs, pediatrics
Yuly Kipervarg, medicine
Samuel Myers, internal medicine
Lawr Randall, orthopedics
Steven Simon, internal medicitie

Ted Lin, surgery, netirostirgen'
Ann Smith, diagnostic radiology
(ieorge Washington University Hospital
Nathan Schmiechen, emergency medicine
FLORIDA
University of Miami/Bascom Palmer
Ivan Suner. ophthalmology
ILLINOIS
University of Chicago Hospitals
Peter Marcus, obstetrics and gynecology
Elizabeth Roth, medicine
Mitch Saltzberg, internal medicine
West Suburban Hospital-Illinois, Oak Park
Karen Antell, /d/i;//v practice

University of Southern California, Los Angeles
L.auren Krieger. orthopedics
Andrew Phillips, ophthalmology
CONNKCTICUT
(ireenwich Hospital
Joseph LaRocca. niedicine
Santiago Villazon. medicine
Hospital of St. Raphael, New Haven
Nahum Goldberg, medicine
William Sharpe, medicine
Norwalk Hospital
h ail Sillier, medicine
\ ale-New Haven Hospital
Darrick Alainio. medicine

INDIANA
Indiana University Medical Center, Indianapolis
Gregory Engel, general stirgeiy
IOWA
University of Iowa, Iowa City
Ross Zbar, otoUtniigology
MARYLAND
Johns Hopkins Hospital, Baltimore
James Blaugrund, sttrgery. otolaiyngology
Marcus Butler, internal medicine
James Yeh, surgeiy. otoletryngology

Madeleine Blauroek, interna! medicine
Samuel Colin, medicine
•Marlene Corujo. general surgery
Jodi Dashe, obstetrics and gynecology
Deborah Dillon, pathology
Nancy Dingott. pediatrics
•Michael Girardi. medicine
Robert Johnson, interned medicine
•Alan Jotkow itz. interned medicine
l a ic Krakauer, internal meeUcine
I rancis Lobo. interned medicine
Daniel Idiilbin. internal tneelicine
John Phillips. .vn/g('/T. urology
Mickey Riggs, psye hieitry
Mar\ Lllen SuMige:, psye hieitry
Jonathan Sears, medicine, eiphthetlmologx
i dward Weiss, internal medicine

MASSACHUSETTS
Beth Israel Hospital, Boston
Kent Min. diagnostic radiology
Ken Rosenzweig. medicine
Boston City Hospital
Kathryn Ryder, internal medicine
Daniel Solomon, internal medicine
Boston University
Santiago Villazon. ophthalmology
Brigham & Women's Hospital, Boston
Douglas Dahl, surgery, urology
Jeiinifer O'Brien, anesthesiology
Frederick Welt, internal medicine
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Children's Hospital, Boston
Elizabeth Mullen, pediatrics
Anne Wolf, pediatrics
.Joint Center for Radiation Therapy, Boston
Ken Rosenzweig, radiation oncology
I.ahey Clinic Foundation, Burlington
Mat Massicotte, urology
Massachusetts (Jeneral Hospital, Boston
Stacey Berg, pediatrics
Laura Drabkin, pediatrics
Dan Fitzgerald, priinaiy care/inedicine
Nahum Goldberg, diagnostic radiology
Karen Loechner, pediatrics
Julie Lund, internal medicine
Mat Massicotte. siirgeiy
John Schulz, general siirgeiy
Claudia Showalter, diagnostic radiology
John Walsh, anesthesiology
McLean Hospital, Belmont
Karen Loechner. psychiatry
Mt. Auburn Hospital, Cambridge
Claudia Showalter. medicine
New England Deaconess Hospital, Boston
Jennifer O’Brien, medicine
Robin Perlmutter, general surgery
Sean Roddy, siirgeiy
New England Medical Center, Boston
Evan Fischer, orthopedics
MICHIGAN

Strong Memorial Hospital, Rochester
Eric Rashba, internal medicine
The New York Hospital
David Eisenman, surgery
Joseph LaRocca, anesthesiology
NORTH CAROLINA
Duke University Medical Center, Durham
William Dwyer, niedicine/pediatrics
Doris larovici, psychiatry
University of North Carolina, Chapel Hill
Ada Cheung, orthopedics
Teresa Wooten, pediatrics
OREGON
Emanuel Hospital/Health Center, Portland
Andrew Phillips, transitional
Jivin Tantisira, transitional
Oregon Health Science University, Portland
Ahmed Abou-Zamzam, general surgery
Joanna Jen. medicine
PENNSYLVANIA
Altoona Hospital
Kurt Kubicka, /d/n//v practice
Thomas Jefferson University, Philadelphia
Robin Smith, siirgeiy, urology
University Health Center/Pittsburgh
Jivin Tantisira, ophthalmology

University of Michigan Hospitals, Ann Arbor
Andrew Griffith, surgery, otolaiyngology

Neely Anne Towe Egan, pediatrics
University of Pennsylvania Hospital, Philadelphia
Darrick Alaimo. neurology

MINNESOTA
University of Minnesota Hospital & Clinics, Minneapolis
M. Wallen-Friedman, general snrgeiy

Scott Kasner, neurology
Nabil Rizk. general siirgeiy
Chloe Thio. internal medicine
RHODE ISLAND

NEW JERSEY
St. Barnabas Medical Center, Livingston
Ann Smith, transitional
NEW MEXICO
University of New Mexico School of Medicine,
Albuquerque
Mark Epstein, emergency medicine
NEW YORK

Miriam Hospital, Providence
Helena Kwakwa, internal medicine
Rhode Island Hospital, Providence
Kelly McGarry, primary care/niedicine
VIRGINIA
University of Virginia, Charlottesville
Nancy Harthun, general surgery
WASHINGTON

Columbia University
Barry Birch, neiirosnrgeiy
Lenox Hill Hospital, New York
Ross Zbar, siirgeiy
Manhattan Eye & Ear
David Eisenman, otolaiyngology
St. Luke’s/Roosevelt Hospital, New York
Tobenna Okezie, orthopedics

University Washington Affiliate Hospitals, Seattle
Charles Charman, primary care/niedicine
William Sharpe, diagnostic radiology
John Walsh, medicine

Residency placement information is provided by the Yale
versity School of Medicine Office of Education and

Uni¬

Student

Affairs.
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COMMENCEMENT 1992

Medical graduates take the Yale Physician’s Oath.

All in fun: RolfTowe. .l.D. '64,
straightens the cap of his daughter.
Neely Anne Ton e Egan. M.l). '92.

Robin Perl unit ter invites the photography to begin.

'ill ■ Wolf (left) and Jennifer O'Brien
till- class photo.

Yale Medicine
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M.P.H. graduate Linda Marc discusses post-coinniencenient plans.
Robert Randall. M.D. '92, celebrates
with his family.

IMu)t«»^raphs by Harry Bishop

Jean Flatley McGuire. M.S.P.H.. a
Pew Foundation Doctoral Fellow at
Brandeis University, fonierly with the
AIDS Action Council. Washington. D.C.,
delivered the 1992 EPH
connnenceinent address.

M.P.H. candidate Carrie McFadden
receives word that the EPH
connnenceinent is about to begin.

Yale Medicine
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M.P.H. graduate Sean Buckley
promenades with a proud supporter.
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Needle Exchange
Slows HIV Spread
Yale researchers report new findings
consistent with earlier reports that a New
Haven needle exchange-program which
began two years ago is slow ing the
spread of HIV among drug users
participating in the program.
Robert Heimer. Ph.D.. associate
research scientist in medicine, presented
the results in Baltimore at the annual
joint meeting of the Association of
American Physicians, the American
Society for Clinical Investigation and
the American Federation for Clinical
Research.
Edward H. Kaplan, Ph.D., an
associate professor in the Yale schools
of organization and management and of
medicine, led the research team. He
developed a new needle tracking system
to evaluate the effects of the program, in
which IV drug abusers anonymously

In Vitro Program
Celebrates 10 Years
This summer, the School of Medicine
and Yale-New Haven Hospital

cians, endocrinologists, nurses and

exchange used syringes for sterile

social workers who address the needs

needles on a one-to-one basis. The

of participating infertile couples. On

tracking system uses polymerase chain

May 25, 1983. the first IVF baby in
New England was born at YNHH

reaction, a .sophisticated molecular

through this program.
In 1986, Yale became one of the

for the presence of HIV.
Other Yale colleagues involved in the

technology, to analyze returned needles

celebrated the lOth anniversary of the
In Vitro b'ertilization Program

first IVF centers to use the

study include Bini Jariwala of the

cryopreservation process, allowing

department of internal medicine, and

through which approximately 220

couples to save embryos for use in

babies have been born.

subsec|uent cycles. In 1987. Yale
began a donor egg program to enable

Edwin C. Cadman. M.D.. the Ensign
Professor of Medicine and chairman of

Parents and children returned to
New Haven in .lune for anni\'ersary

women without functioning ovaries

festivities complete with picnic fare,
a clown, balloons, a puppet show,

to become pregnant. More recently,
Yale opened a center for microma¬

Babar the elephant and more.

nipulation, a process that injects
sperm cells directly under the egg
covering, offering an e\’en better

"Through this sophisticated
program, we have been able to assist
hundreds of couples w ho otherwise
would have had to consider adoption
or remain childless," explains Dr.
I iw in P,. Jones, associate professor of

chance for conception to couples
with male-factor infertility.
Recently Joining the Yale IVF

obstetrics and gynecology.

team is Dr. David L. Olive, associate
professor of obstetrics and gynecol¬

Initiated in 1982. the Yale IVF
luogram includes a team of obstetri¬

ogy and chief of the division of
reproductive endocrinology.

the department of internal medicine.
The study not only pro\ ides e\ idence
that the New Haven needle exchange
program reduces the spread of HIV. but
also indicates that offering clean needles
does not create a new generation of
addicts.
Comments Dr. Kaplan, "Introducing
this system has allowed us to pro\ ide the
first definitixe link between the opera¬
tions of a needle-exchange program and
the course of the AIDS epidemic among
IV drug users in a gi\ en locale. This
had yet to be established using tradi¬
tional evaluation approaches."

5'ale
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Epilepsy Center Receives
$3.5 Million NIH Grant
The National Institute of Neurological
ConiniLinicative Disorders and Stroke
(NINCDS) has awarded the School of
Medicine's department of neurology a
five-year, $3.5 million grant to support
research into the causes and treatments
of epilepsy.
The award marks the 25th year of
continuous NINCDS funding for the
Yale Epilepsy Research Program.
Twenty-three scientists participate in
this program to study the factors
responsible for the occurrence, fre¬
quency and effects of epileptic seizures
and how they can be controlled.
“Our research enables us to pinpoint
the exact location in the brain where
seizures begin," explains Dr. Richard H.
Matt.son. professor of neurology at Yale
and director of the program since 1985.
“This ultimately will allow us to provide
better treatment and, perhaps, to prevent
epilepsy."

out to disadvantaged people who may

which usually stay in dark concealed

otherwise not be receiving care. At the
same time, we are preparing future

places, increased their .social interaction
in open, bright areas," explains Dr.

physicians to treat homeless people in
settings beyond health care centers,”
says Dr. Barry.

Wayne F. Goodman, assistant professor
of psychiatry and principal investigator

The program is suppr)rted by a oneyear, $5(),7()() grant from the W.K.
Kellogg Foundation of Battle Creek,

Working with Dr. Goodman on this
study are Andrew W. Goddard. M.D..

Mich. The APT Foundation of New
Haven has donated a van which Dr.

director of the Yale Anxiety Disorders
Research Clinic; Diane E. Sholomskas,
Ph.D., co-director of the clinic; and

Barry and her team have stocked with
over-the-counter medications and
supplies provided free by several
pharmaceutical companies.

Medicine, the Department of Veterans

counselor from the APT Foundation,
and a Hill Health Center social worker.
Once a week, the van stops for two

School of Medicine researchers have

sees an average of 15 patients, with
medical problems ranging from nutri¬

developed a synthetic bone substitute
cement that can repair and replace facial

tional and vitamin deficiencies, to

bone defects incurred from surgery,

tuberculosis, AIDS, and mental health
problems.

trauma or infection. The cement,
developed in collaboration with re¬

The program comprises several
projects in which scientists use micro¬
scopic, biochemical and neurophysi¬
ological examinations to study where
and how basic abnormalities occur in

composed of calcium and phosphate,

of their training.

which make up 75 percent of healthy
bone.
In September, Yale was the first of
three centers in the world to begin using

Scientists Seek to Advance
Social Phobia Treatment

the cement after the U.S. Food and Drug
Administration approved it for clinical
trials.

A new study underway at the School of

Hydroxyapatite cement (HAG) will
be used in a variety of craniofacial

Medicine could help reveal the basis of
.social phobia and its relationship to
other anxiety disorders.
More than 2.4 million Americans
suffer from social phobia, finding
themselves involuntarily blushing,
shaking, and even having heart palpita¬

epilepsy.

Medical Van Treats
New Haven Homeless

searchers at the American Dental
Association Health Foundation, is

required to take a four-week rotation
with the new program as a standard part

consortium of scientists from more than

neuroanatomy, pathology, pharmacol¬
ogy, medicine and diagnostic imaging.

Researchers Develop
New Bone Cement

hours at each soup kitchen. The team

Affairs Medical Center in West Haven
and Yale-New Haven Hospital, is a
10 departments and sections, including
neurology, neurosurgery, psychiatry,

Karen L. Carrieri, R.N., clinical nurse
coordinator.

On the van, an attending physician
supervises two medical residents, a
pediatric nurse, a substance abuse

YNHH medical residents are now

The Yale Epilepsy Research Pro¬
gram, jointly based at the School of

of the study at the Yale Psychiatric
Specialty Center.

tions in reaction to everyday social
interactions. The phobia can .severely
impair people’s work and social lives,

Drs. Michele Barry, associate professor

and leave them feeling ashamed,
frustrated and overwhelmed.
In the study, researchers compare the

of medicine at the School of Medicine
and Jeanne Marrazzo, chief resident at
Yale-New Haven Hospital (YNHH),

effectiveness of a medication versus a
placebo for people impaired by social
phobia. The non-addictive drug,

have developed a mobile medical
community outreach program to provide
free medical care to homeless persons at
four New Haven soup kitchens.

currently used to treat nausea, previously
had been tested on laboratory animals to
gauge changes in social interaction.
"Administration of this drug to rodents.

procedures, such as reconstruction of
bone to correct congenital deformities;
repairing bone loss due to periodontal
disease, and filling holes made during
brain surgery.
“When tumors are removed from the
skull, there may be leakage of spinal
fluid which can be fatal," states Dr.
Craig D. Friedman, assistant professor
of surgery. “We used to put fat or
muscle grafts in the gap. but there were
still severe problems. With the HAG
mixture there is no leakage at all."
Dr. Friedman and his colleagues have
found that the body replaces the artifi¬
cial substance with natural bone as part
of the skeleton's ongoing maintenance
process.

“We are taking urgent medical care

Yai.h Medicine
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Yale Heart Book
Makes its Debut
Twenty-eight Yale School of Medicine
and Yale-New Haven Hospital faculty
and staff members, from more than 10
departments and sections, have helped
write the 429-page Yale University
School of Medicine Heart Book.
Published by William Morrow Co. of
New York, the book’s 29 chapters offer
state-of-the-art information to the public
on the prevention, diagnosis and
treatment of heart disease, including
easy to understand explanations of the
heart and circulatory systems, and of
interventional cardiology, including
coronary angioplasty. Drs. Barry L.
Zaret, Lawrence S. Cohen and Marvin
Moser are the book's medical editors.

Progress Made toward
Lyme Disease Vaccine
Yale School of Medicine and Harvard
School of F^ublie Health researchers
have genetically engineered a vaccine
for tick-borne Lyme disease that protects
mice from being infected. The agent
also works as a therapeutic drug, ridding
the tick vector—and the animal host—of
the disease-causing bacterium.
These results, which offer hope for a
Coiistniction proceeds on ihe new Children's Hospital at Yale-New Haven.

Children’s Hospital
Rises at YNHH

vaccine for humans, were published in
the June 14 Proceedings of the National

and the Newborn Special Care Unit. "It
will be specially designed for ehildren.”

Academy of Science.

slates YNHH Senior Vice President

infected with Lyme disease bacterium
fed on a vaccinated mouse, the mouse
was protected from infection and that

Mama Borgslrom. “There will be a

The team discovered that when a tick

renewal projeel—a $lf>6 million

separate entrance, and dedicated
emergency, diagnostic imaging and
operating room areas for ehildren. The

the bacteria living inside the tick was
killed by the mouse's antibodies. This

undertaking whieh involves eonstruelion
ol the ('hikiren's Hospital and renova¬
tion ol the Memorial Unit

I I-story building will also house .some

finding also provided the researchers

adult units, and will have a helipad on
the roof.

with new knowdedge of the body's
infection-protection mechanism.

Yalc-Ncvv Haven Ilosiiilal's faeililies

(MU)-

eontinues on sehedule.

('onstruetion began on the hospital
July 20, 1001. w ith the frame and (he
walls eompleted by May 1002. Seherlali'd to open in the summer of 100.^. the
Ulnldren's Hospital w ill eonsoliilate
ul \ ale-New 1 la\en's peilialrie
M : r,fs as well as house labor and
' I

■ '■>' aiul maternity and newborn
-

. nil hiding high-risk maternity

Building for Health, a major capital
campaign directed by I-. Patrick
Melkulden Jr., president ol the Bank of
New Haven, is helping to fund the
faeililies renewal project. Seeking gifts
from several sectors--hospital employ¬
ees. trustees, the merlieal staff, corpora¬
tions aiul foundations, and the eomnninily, the campaign has raised .$6..S
million—>1 iK'ieent of its goal.

The Yale/Harvard team includes
Richard A. Fdavell. Ph.D., profes.sor and
chairman of immunobiology and
investigator at the Howard Hughes
Medical Institute, director of the Yale
study; Erol I'ikiig, M.D., Stephen W.
Barthold, D.V.M., Ph.D., and Fred S.
Kantor, M.D.. also at Yale, with Sam
Telford. Se.D., and Andrew Spielman,
Se.n., at Harvard.
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Two Faculty Named
Endowed Professors

News

obstetrics and gynecology and in the

Peter E. Schwartz, M.D., professor of
Cancer Center, has been named the John
Slade Ely Professoi' of Obstetrics and
Gynecology, and Joan A. Steitz, Ph.D.,

Dr. Roberts Awarded
Postdoctoral Fellowship
William L. Roberts. M.D., an instructor
in laboratory medicine at the School of

professor of molecular biophysics and
biochemistry, has been named the Henry
Ford 11 Professor of Molecular Biophys¬
ics and Biochemistry.
Dr. Schwartz, who joined the faculty

Medicine and chief resident at Yale-New

in 1970, is acting chairman of obstetrics
and gynecology, and chief of gyneco¬

Haven Hospital, has been presented a
Merck/Arnerican Federation for Clinical

logical oncology at Yale-New Haven
Hospital. He also serves on the execu¬

Research Foundation (AFCR) M.D.-

tive committee of the Yale Comprehen¬
sive Cancer Center. In an effort to

Ph.D. Postdoctoral Fellowship Award.
Dr. Roberts will receive $50,000

diagnose and treat ovarian cancer at

annually for three years to support his
research on compounds used to treat

earlier stages. Dr. Schwartz founded the
Yale Ovarian Cancer Early Detection

leishmaniasis, a parasitic disease

Program in 1990.

transmitted by the sandfly vector. In
collaboration with colleagues in the

Dr. Steitz, also a faculty member since
1970. leads the molecular genetics
program in the Boyer Center for Molecu¬

department of epidemiology and public
health, he is also studying the mecha¬
nisms of parasite resistance, in hopes of
developing new treatments.

the Howard Hughes Medical Institute.
She has conducted studies that defined

mammals. Through this process, the
information in genes (DNA) is expressed
in protein molecules.

Scholars Program. The program,

Faculty Members
Brief U.S. Senate
Richard J. Robbins, M.D., as.sociate
professor of medicine and of obstetrics
and gynecology, was one of four
speakers to address 60 U.S. Senate staff
members at a briefing hosted by the
Association of American Medical
Colleges, the Association of American
Universities, the National Association of
State Universities and Land Grant

Martina Brueckner, M.D., assistant
professor of pediatrics (cardiology), has
been named a scholar in the 1992 Syntex

the U.S. Senate.

lar Medicine, and is an investigator with

the roles of small nuclear ribonucleoprotein particles in RNA processing in

Martina Brueckner
Named Syntex Scholar

Dr. Richard J. Rohhins testifying before

Paul Sigler Named to
National Academy

Colleges, and other members of the
Coalition for Research Freedom. The

tional health-care company based in

Paul B. Sigler, M.D., Ph.D., professor of

briefing focused on the ethical and
scientific issues of fetal tissue transplan¬
tation research.

Palo Alto. Calif., recognizes scientists
who have demonstrated outstanding

molecular biophysics and biochemistry
and an investigator with the Howard

D. Eugene Redmond Jr., M.D.,
professor of psychiatry and director of

potential for independent contributions
in cardiovascular research. Her award is

Hughes Medical Institute, has been

the Yale Neural Transplant Program,
and Myron Genel, M.D.. associate dean

sponsored by Syntex Corp., an interna¬

one of two $ 150,000 awards over three
years that Syntex Corp. makes to two
U.S. academic institutions on behalf of
the scholars.
Dr. Brueckner is studying the mouse
mutation inversus viscerum. The
mutation results in an inherited abnor¬
mality of left-right asymmetry associated
with congenital heart defects. She uses a
positional cloning approach similar to
that which led to the recent cloning of
the cystic fibrosis gene.

Yale Medicine
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elected to the National Academy of
Sciences, one of the highest honors
given to an American scientist.
Dr. Sigler, who joined the faculty in
1989, is a specialist on the chemical
interactions of proteins and nucleic
acids. He u.ses X-ray crystallography to
determine the three-dimensional

for government and community affairs,
also outlined aspects of the Yale
program to key Senate staff before the
Senate debate on legislation, which
called for restoring federal funds for
research in this area. The Senate later

structure of molecules and how they link
with one another. His research focuses

approved the legislation, 87 to 10.
The House of Representatives also
pas.sed the legislation by a wide margin,

on how genetic code is transcribed
through selective binding of regulatory

but on a vote taken on June 24. could not
override a veto issued by President

proteins to target DNA sequences.

George Bush.
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Culpeper Foundation
Scholarship Awarded
To Peter M. Glazer
Peter M. Glazer, M.D., Ph.D.. assistant
prol'essor of therapeutic radiology, has
received a Charles E. Culpeper Founda¬
tion Scholarship in Medical Science for
1992. These .scholarships support young
physicians of high potential achievement
who are committed to careers in
academic medicine.
Through this award. Dr. Glazer will

Fibroblasts and their Phenotypic

committee since 1983. he has also

Modulation.”

served on the health systems planning

Jack A. Elia.s, M.D.. professor of
medicine (pulmonary) and section chief
of pulmonary and critical care medicine,
has been appointed to the following

of directors of the American Thoracic
Society, the editorial hoards of the

geons at the annual meeting in Chicago
in May. Dr. Lorber also was reap¬

American Journal of Physiology, Lung,

pointed to a tw'o-year term on the

Cellular and Molecular Physiology, and

scientific advisory committee of the
United Network for Organ Sharing,

the Journal of Laboratory and Cliidcal
Medicine.
Francis P. Gasparro, Ph D..

the possible causes of cancer by examin¬

been elected to a four-year term as a

ing the damage produced in the heredi¬

councilor for the American Society for

tary material of mice by exposure to
potential carcinogens.

Photobiology, beginning in July. He
afso will .serve as the editor of the
society's newsletter.
Myron Genel. M.D.. associate dean

surgery at the Annual World Congress
on Intensive Care held at the Lhiiversity
of Brussels in March. In April, he was
inducted into the American .Surgical
.Associatit)!!.
Pravin N. Bhatt. M.D.. senior
research virologist in comparative
medicine, has been elected as an
honorary member of the American
Cidlege of Laboratory Animal Medicine
for his contributions to laboratory
animal science.
.Joseph R. Bove. M.D.. professor and
vice chairman of laboratory medicine,
has been appointed to the national board
of directors of the American Red Cross,
lie will serve on the biomedical services
committee which ad\ ises the board on
issues concerning blood trtinsl'usion and
tissue transplantation.
Malihouheh Eghbali. Ph D..
tissociatc professor of anesthesiology,
was the keynote spetiker at the Cardio¬
vascular .Sciences Seminar in Canaila in
April. She also spoke at the interna¬
tional sMiiposium; "Myocartlitis—
Dilated Cardiomyopathy I’athogenesis
and Clinical Implications" in Germany
111 .\lav. Both ttilks I'ocused on "RegulaM 'li ;>f (icnc f’xprcssion in Cardiac

(transplantation), was elected to a threeyear term on the executive council of the

research scientist in dermatology, has

and chief of cardiothoracic surgery,
presented a lecture on the future of heart

Marc I. Lorher, M.D.. associate
professor and director of surgery

organizations: the American Society for
Clinical Investigation (honorary), board

receive $ I ()().()()() a year for up to three
years to fund his research investigating

.)ohn C. Baldwin. M.D.. professor

and long-range planning committees.

for government and community affairs
and professor of pediatrics (endocrinol¬
ogy), was re-elected to the House of
Delegates of the New Haven County
.Medical Association (NHCMA) board
of governors and will .serve as a

American Society of Transplant Sur¬

which oversees national transplantrelated activities through a contract with
U.S. Department of Health and Human
Services.
Adrian M. Ostfeld, M.D., the Anna
M.R. Lauder Professor of Epidemiology
and Public Health and Medicine, has
been elected a fellow of the Royal
Society of Medicine in London. Recog¬
nized for distinguished contributions to
biomedical science. Dr. Ostfeld is one of
230 professionals in geriatrics and
gerontology worldwide who is a society
member.

NHCMA delegate to the Connecticut

Gerald I. Shulman, M.D.. as.sociate
professor of medicine (endocrinology),

State Medical Society's House of

and lecturer in molecular biophysics and

Delegates.

biochemistry, w'as selected as a member
of the Metabolism Study Section,

Thomas J. Godar, M.D., associate
clinical professor of medicine, was
awarded the Will Ross Medal for
distinguished volunteer services by the
American Lung Association in Miami
Beach. Fla., in May.
C. Carl Jaffe. M.D.. professor of
diagnostic radiology and medicine, was
appointed chairman of the Biomedical
Library Research Committee of the
National Library of Medicine. Dr. Jaffe
was also named (he 1992 Samson
Feldman Visiting Scholar in ,Ai1 as
Applied to Medicine by the Johns
Hopkins University School of Medicine.
.Michael Kashgarian. M.D. '58,
professor of pathology, was elected
secretary of the New Haven County
.Medical .Association (NHCMA) in
April, Dr, Kashgarian. a member since
1967. continues to .serve as a NHCMA
delegate to the Connecticut State
Medical Society's House of Delegates
and as a member of its board of gover¬
nors. C'hairman of the membership

Division of Research Grants, Depart¬
ment of Health and Human Services of
the National Institutes of Health, for a
three-year term.
Alan P. Siegal, M.D., assistant
clinical professor of psychiatry, was
installed as national president of the
American Association of Geriatric
Psychiatry in May. He is also president
of the Alzheimer's Re.source Center of
Connecticut, scheduled to open in
October in Southington.
John I). Thompson. M.S.. professor
emeritus and lecturer in public health,
w as aw aided the Baxter Health Services
Research Prize, the highest honor in
health-care services research, for
developing the diagnosis-related group
(DRG) .system, which dramatically
changed how the government reimburses
LfS. hospitals.

'l
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Dr. Robert M. Donaldson Jr. presided as acting dean at the
1992 Yale School of Medicine Commencement.

Thomas P. Duffy, M.D., professor of medicine and in the
Cancer Center, 1992 Bohmfalk Charitable Trust Award winner
for outstanding teaching in the clinical sciences, with Michele
Bariy, M.D., associate professor o f medicine, who won the
Leah Lowenstein Award for the full-time faculp’ member who
represents the highest degree of excellence in non-sexist
education.

Peter P. Stein, M.D., assistant professor of medicine, and Maiy
Jane Minkin, M.D., associate clinical professor of obstetrics
and gynecology, shared the 1992 Francis Gilman Blake Award
as the most outstanding teachers of the medical sciences, as
designated by the graduating class.

Yale Medicine
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Shanta E. Kapadia, M.B.B.S., lecturer in surgeiy (anatojiiy),
won the Bohmfalk Charitable Trust Award as the outstand¬
ing teacher in the basic sciences.
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Alumni

News
Hunter College Honors
Dr. Helen Langner

Hunter College, the college alma mater
ol Helen Parthenay Langner. M.D. '22.
obser\'ed her centennary year by
granting her an honorary Doctor of
.Science degree. Her citation, excerpted
bektw. said much of the life and times of
Dr. l.angner:
■■^'ou came to Hunter College in 1910
to pursue your interest in the natural

Dr. Helen Langner with Merle Wa.xnian. director of the YSM office for women in
medicine, at the 1992 Alumni Reunion Weekend, held in June.

sciences, a course of study that was not
open to you. as a woman, in your home

reunion weekend at the School of

Allan J. Ryan. M.D., '44-'46 HS,

state of Connecticut. After receiving a

Medicine, drawn by the scientific

was program chairman for the second

degree from Hunter in 1914. you taught

symposia and lectures which keep her

annual meeting of the International

biology in the public schools and then

abreast of current issues in medicine.
In addition to her professional

Association for Dance Medicine and

entered Yale Medical School. In 1922,
you were the fourth woman ever to

acti\ ities. Dr. Eangner maintains her
lifelong dedication to wildlife and

receive a medical degree from Yale.
You went on to a residency in the then-

environmental preservation. She is

new field of psychiatry, and. later, to an

active in many conservation groups,

Science, held in June in Durham. N.C.
Jerome M. Classman, '50 PHSP.
'50 Ph.D., who retired in 1988 as
director of clinical investigations for
Caiter-Wallace, Inc., is a pharmaceutical
industry consultant.

active practice.

including the Milford Land Conserva¬

■'Highlights of your career included
working with children in community

tion Trust, the Nature Conservancy

clinics, substitution for psychiatrists

Institute and Nature Center, and Con¬

of the Connecticut Right-to-Life Corp.

called to military ser\'ice, ser\ ing as a

since its formation in 1973, has been its

school psychiatrist for the New York

necticut Eund for the En\ ironment.
When asked about all the attention

City Department of Education, teaching

that she is receiving during her lOOth-

president since 1988. The educational
organization's aim is to amend the U.S.

clinical psychiatry at Cornell University
.Medical School, and serving as resident

birthday year. Dr. Langner replied. ''It's

Constitution to protect all life from

pretty overwhelming. Em just glad that

conception to natural death.

psychiatrist at Vassar College. You also

1 still have the wit to appreciate every¬
thing that's going on."

enjoyed an active pri\ate practice in
New York City and filled important

Connecticut chapter, the Milford Marine

Paul R. Bruch. M.D. '51, a member

Robert P. Hatch. M.D. '54, who
retired in 1984 from his obstetrics and

Maxwell J. Wolff, M.D., '25 Med., who

gynecology practice, has become active
in town planning, budget acti\ ities and
\olunteer work in his hometown of

of your time and money to help patients

will celebrate his 9.Sth birthday in
November, is praeticing dermatology

Alfred. Me. He is also a weather
obser\ er for WESH-TV in Portland.

who could not otherwise afford psychi¬
atric care.

part-time, in Los Angeles.

psychiatric posts in several agencies in
Milford. Conn. During your long and
\ aried career, you have gi\'en generously

"East month, you celebrated your
lOOth birthday. 4'he oklest li\ ing
member of the Hunter College Hall of
fame, you continue to practice psychiat¬
ric medicine, and ser\e as an atteinling
psychiatrist at .Milford Hospital."
\l her other alma mater. \'ale. Dr.
Eaii-.’iu-r annually attends alumni

Eugenio .M. de Hostos. M.D. 42,
was granted an honorary Doctor of

William H. Hindle. M.D. 56.
profes.sor of clinical obstetrics and
gynecology at the University of South¬

Medical Sciences degree by the
Uni\ersidad Eugenio Maria de Hostos in

ern California School of Medicine and
director of the Breast Diagnostic Center.

Santo Domingo, Dominican Republic.
In a January 1992 ceremony. Dr. de
Hostos tleli\’ered the eommencement

Women's Hospital. Los .Angeles
County-University of Southern Califor¬

address to 2.^0 graduate and postizraduate students.

nia Medical Center, has been elected
president of the National Consortium of
Breast Centers.
Yaliz Medici.n-k
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Robert I. Levy, M.D. '61. '61-'63
HS. has been appointed president of
Wyeth-Ayerst Research, a division of
American Home Products Corp., and is
responsible for worldwide research and
development.
Stephen C. .Joseph, M.D. '63, dean
of the School of Public Health and
professor of public health and pediatrics
at the University of Minnesota, has been
inducted into the Society of Scholars at
the Johns Hopkins University. Created
in 1967, the society honors distinguished
researchers who were at Johns Hopkins
as postdoctoral fellows, junior faculty or

at the George Washington University
Medical Center and Medical School in
Washington. D.C.
.Fan Wallace, M.D.. '69-’72 HS, was
appointed vice president of clinical and
regulatory affairs at Athena Neuro¬
sciences Inc. in South San Francisco.
Frederick L. Greene, M.D., '7()-’76
HS, professor of surgery at the Univer¬
sity of South Carolina School of
Medicine, has been elected president of
the Society of American Gastrointestinal
Endoscopic Surgeons.
Peter J. Panzarino, M.D. '72, has

visiting faculty. Dr. Joseph was a

been named chief clinical officer of

postdoctoral fellow at Johns Hopkins.

Vista Health Plans, a not-for-profit
Southern California health maintenance
organization and employee assistance
program specializing in mental health
and substance abuse. He will also serve
as medical director of Vista Hill
Foundation, which owns and operates
Vista Health Plans.
William T. Choctaw. M.D. 73. '73'75 HS. was elected mayor pro tern for
the City of Walnut. Calif., and continues
to practice surgery full-time.
Francis S. Collins, Ph.D.’74,
professor of internal medicine at the
University of Michigan and a Howard
Hughes Medical Institute investigator,
received an honorary Doctor of Science
degree from Yale in May.

.John I). Schrnmpf, M.D. '74. was
elected president of the San Francisco
Radiological Society and a fellow of the
American College of Radiology. Dr.
Schrumpf, who practices at California
Pacific Medical Center, is an associate
clinical professor at the University of
California, San Francisco.
Harvey J. Berger, M.D. 77, is
chairman and chief executive officer of
Ariad Pharmaceuticals, Inc., a biotech¬
nology company in Cambridge. Mass.,
which he established in 1991.
FYlwarcl C. Halperin, M.D. '79.
associate professor of radiation oncology
at Duke University School of Medicine,
has been named a 1991-1993 fellow of
the American Council on Education. He
will concentrate on academic adminis¬
tration and policy.
Mark L. Demhert. M.D., 83
M.P.H., is a captain in the U.S. Navy
Medical Corps and a staff psychiatrist at
the National Naval Medical Center in
Bethesda, Md.
Valerie E. Stone, M.D. '84. has been
named medical director for ambulatory
care services in the Boston Department
of Health and Hospitals (DH&H). She
.serves as the senior administrative
physician for ambulatory clinical care at
all DH&H sites, including the Ambula¬
tory Care Center (ACC) at Boston City
Hospital. The ACC's 72 specialty
clinics average 178.000 patient visits per
year.

Dr. Stephen C. Joseph

Harry A. Lebowitz, M.D.. '86- 89
HS. a Wilmington. Del., ophthalmolo¬
gist. and a member of Surgical Eye

Neal L. Maslan, M.P.H. '64.
managing director for Ward Howell

Expeditions Inc., a charitable organiza¬
tion. traveled to El Salvador in April. In

International, a national recruiting firm,

three days, his team of five volunteer
physicians performed 120 operations,

was profiled as one of America’s top
150 executive recruiters in The Career
Makers, a book recently released by

mostly on people blind from cataracts.
Robert C. Urban Jr.. M.D. 87, a

Harper/Collins Publishers. Mr. Maslan
specializes in medical, health care,

fellow in glaucoma at the Massachusetts
Eye and Ear Infiiniary. Harvard Medical

product and technology, and venture
capital search assignments.

School, has been named assistant
professor of ophthalmology at the

David H. Shapiro, M.D., '67- 71

University of South Florida. Tampa.

HS. was elected president of Morton
Plant Hospital, Clearwater. Fla. He has

Amy V. Kindrick. M.D. 89, a
fellow in the Harvard Combined
Infectious Diseases Training Program,

been on the medical staff for 18 years.
.John J. Kelly .Jr., M.D. '69, '69- 71
HS, is professor of neurology and
chairman of the department of neurology

Yale Medicine

Summer 1992

has completed an internal medicine
residency at Brigham and Women’s
Dr. Francis S. Collins

Hospital in Boston.
51

New Books

Medical Care of the Cardiac Surgical
Patient, edited by Stephen C. 'Vlay.
M.D. '75. Blackwell Scientific Publica¬
tions (Boston, Mass.) 1992.
The Patient: Biological. P.sychological,
and Social Dimensions of Medical
Practice. .Jrd edition, by Hoyle Leigh,

|1XI\'KI!SITV
ScIk )()I of .M(m licit k'

Robinson, M.D.. Memorial Prize in
Surgery by the National Medical

Plenum Publishing (New York) 1992.

edges outstanding performance in the
surgical disciplines coupled with good

When Home is No Haven: Child

Nordhaus. M.S.W., assistant clinical
professor of social work in the Child
Study Center; and Ruth D. Lord, M.A..
associate research .scientist in the Child
Study Center. Yale University Press
(New Haven and London) 1992.

Mnvrr. \L|i. I.iiwiviin-S. (inlim. \1 I).
< iriicll .1. Slll)illv-S||;!| |M', \1.S

A Window to Heaven: How Children
See Life in Death, by Diane M. Komp.
M.D., profes.sor of pediatrics (hematol-

)'(ilc University School ol Medicine

ogy/oneology). Zondervan Publishing

Heart Book, edited by Barry L. Zuret,
M.I).. the Rirberl W. Berliner Brol'essor

Flousc (Grand Rapids, Mich.) 1992.

ol Medieine (eardiology), seelion ehief
eardiovaseidar medieine; Marvin Moser,

social responsibility.
Belinda J. Chan, a third-year
student, volunteers her time to the Big
Brother/Big Sister program.
Kirk R. Essenmacher. a third-year
student, established the SMARTS
program, in which medical students go
into high school classrooms to talk with
students about careers and college.
Second-year students Barbara M.
Garcia and Walter O. Jackson
coordinated a weekly lecture series for
the medical school's 13th annual
Summer Research Apprenticeship

in medicine and the biomedical sciences.

libene/er K. Hunt I’rol'essor of Medieine
(eardiology) and deputy dean. William

Christopher G. Goring, a second-

Student

year student, .serves as the student
coordinator of the Minority Undergradu¬
ate Summer Training Program, which is
funded by the National Heart, Lung and

Study, by Raymond .S. Duff, M.I). '52.
Health Administration Press (Ann
Arbor. Mieli.) 199 I.

academic performance, leadership and

Program, which is designed to interest

M.I)., elinieal profes.sor of medieine;

Assessini^ Pediatric Practice: A Critical

Fellowships. Inc. The prize acknowl¬

minority high .school students in careers

and laiw renee .S. Cohen, M.I)., the

.Morrow & Co. (New York) 092.

Marlene Corujo, M.D. '92, is one of
two recipients of the 1992 James H.

M.I)., leeturer in psychiatry, and Morton

Pediatrics and Psychiatry; Barbara F.

I. /.livl, \1 I),

predoctoral fellowships from the
National Science Foundation.

F, Reiser, M.D.. the Albert E. Kent
Professor Emeritus of Psychiatry.

Placement Issues, by Albert J. Solnit.
M.D., Sterling Professor Emeritus of

M-.l:. tl.lli...

Second-year student Tamer
Bourslian and Eric Hoffman, a thirdyear student, have been awarded

News

Blood Institute of the National Institutes
of Health.

Pile Balinese People: A Reinvestipation oj Character, by Cordon I). Jensen.
■M l). '49. O.xiord University Press
(Asia) 1992.

Third-year students Yamilee

Criu k: Phe Broken Promise, by David F.
Allen, leeturer in publie healib, and
James F. Jekel. M.I).. 'b5 M.P.H.. the

(heir work as the first medical students

Charles FkA. Winslow Professor of

Bermingham and Karen Rosewater
were presented Elm-Ivy Awards for
serving as student volunteer coordinators

Publie I lealth and direetor of the

for (he Medical School Council. Kaveh
Khoshnood. a third-year Ph.D. student

pre\enli\e meilieine resideney program,
•St, .Martin's Press (New York) 1991.

in the department of epidemiology and
publie health, was presented an Elm-Ivy

Ill relive Care of the Newborn Infant, by
lolin C. Sinclair and Michael B.
Bracken. '70 M.P.H., Ph.D,. |irotessor
and vice chairman, department of
a|iidcmiology and publie health. Oxford
I nivcisity Press (New ')'ork aiul
;)\l->id) Pt92.

Award for his work in educational
outreach programs to curb the spread of
AIDS. The annual awards are presented
by the University and the city of New
Haven to recognize pet)ple who help
build a positive relationship between
')’ale and its host ei(y.

This Slimmer, second-year students
(from left) Chris (lilligan, Greg
Licholai and Armen Khachatryan are
bicycling the 3.400 miles from Washing¬
ton State to New Jersey to raise money
for the Leukemia Society of America.
They hope to raise $20,000.
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ALUMNI REPORT
Alumni returning for their annual
reunion weekend on June 5 and 6

Yale Alumni in Medicine (AYAM).
Sherwin B. Nuland, M.D. '55, associate

enjoyed the opportunity to renew

clinical professor of surgery, was joined

friendships with classmates and to share

by Eerenc Gyorgyey, historical librarian,
and R. Kenny Eryer. head of the medical

fond memories.
On Friday. Marie-Louise Johnson,
M.D. '56, and vice president of the
Association of Yale Alumni in Medicine,

library reference services, in a presenta¬
tion entitled “The Yale Medical Library:

Plans are already in progress for the
spring of 1993. Reunion classes ending
in 3 and 8 will be hearing from us soon.
Our office will be contacting the class
secretaries for a list of people interested
in helping to plan class .seminars and
social events. A planning meeting will
be scheduled for September. The office

Yesterday. Today, and Tomorrow.” A
guided tour of the library followed.

of alumni affairs encourages you to

Muriel Wolf, M.D. '59, will continue
as AYAM president and Gilbert Hogan,

communicate with us. We want and
need you to be in touch so that we can

within the Yale System” was moderated

M.D. '57. has agreed to serve another

by Robert H. Gifford, M.D., associate

term as secretary. The 1992 slate
elected to replace retiring members of

best represent your interests.
Alumni/student interaction was

greeted attendees with Acting Dean
Robert M. Donaldson Jr. A seminar
entitled “Changing the Curriculum

dean for education and student affairs.
Participants included Emile L. Boulpaep,
M.D., professor of cellular and molecular
physiology; Timothy L. Vollmer, M.D.,

the executive committee includes:
Harold D. Bornstein. M.D. '53, Leo M.
Cooney Jr., M.D. '69, Lycurgus M.

assistant professor of neurology; and

Davey, M.D. '43. Michael Kashgarian,

Charles A. Janeway Jr., M.D., professor

M.D. '58, Gioacchino S. Parrella, M.D.

of immunobiology and biology, and
investigator, fJoward Hughes Medical

'71, and Barbara A. Ross, M.D. '81.

Institute. All panel members serve on
the CLiiTiculum committee. A reception

Elected as representatives to the Asso¬
ciation of Yale Alumni (AYA): John N.

enhanced by joint participation in
phonathons held on March 24, 25 and
April I. Twenty-six students from all
classes of the school joined with 10
alumni and alumni fund staff in solicit¬
ing pledges for the annual campaign.
This wonderful opportunity for students
to talk to alumni about financial aid and
to compare “then and now” at the school
resulted in pledges exceeding $20,000,

followed. Returning alumni met with

German, M.D. '62, and Robert M. Rosa.
M.D. '70.

classmates at dinners, parties and picnics.
William F. Collins, M.D., chairman of

We at the office of alumni affairs
thank Dr. Muriel Wolf for her conscien¬

non-pledged donations. Einancial aid
for our dedicated students continues to

surgery, discussed recent advances in

tious leadership as president. Congratu¬

this field at surgical grand rounds on
June 6. Concurrent faculty seminars

lations and a warm thank you for a job
well done are extended to those mem¬

be the principal beneficiary of fund
contributions. If you haven't pledged,

included; “How We Construct a

bers of the AYAM executive committee

Representative First-year Class,”
moderated by Dr. Gifford; “The Who

and representatives to the AYA whose

and the How—The Care of Your Now
Dependent Parents” moderated by Leo
M. Cooney Jr.. M.D.. Humana Founda¬
tion Professor of Geriatric Medicine, and
Ronald Miller. M.D., associate clinical
professor of medicine (geriatrics); “The
Second Decade of the AIDS Epidemic,”
presented by Gerald H. Eriedland, M.D.,
professor of medicine and epidemiology
and public health, director of the AIDS
program; and Elizabeth Cooney, M.D..
assistant professor of medicine, director
of HIV care. Veterans Affairs Medical
Center. West Haven. The medical
reunion dialogue and tea concluded the
scientific program.
Acting Dean Donaldson presented a
stimulating state of the school address at
the annual meeting of the Association of

Yale Medicine
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terms have expired.
Distinguished Alumni Service
Awards were presented to George A.

with an equal amount anticipated from

plea.se do so. It is important to maintain
our high percentage of contribution.
The Yale Corporation appointed
Gerard N. Bunow. M.D. '58. medical
school dean starting July I. During his
previous stay in New Haven as a

his 50th reunion. Both were honored for

medical student, house officer and
faculty member, he forged a strong
constituency within this community.

meritorious service to the school.
Remarks were delivered by Samuel

We welcome back this son of YSM with
the expectation that our school will

Kushlan. M.D. '35, and Nicholas
Spinelli, M.D. '44. after they presented

increase in strength and remain a leader
in teaching, research and the practice of

Yale chairs to the honorees.
Helen Langner. M.D. '22, was
honored with a citation and a bouquet of

humane medicine responsive to the

Carden Jr., M.D. '35, and Walter J.
Burdette, M.D. '42, who was celebrating

needs of society as a whole.

roses as our oldest alumna; she just
celebrated her 100th birthday. She
attends our yearly meeting regularly and
still counsels psychiatry patients in her
community.
The success of this year's reunion
challenges us to improve on our record.

Arthur C. Crovcitto. M.D. '53
Director ofaluutni ajfair.s

33

He founded and was past president of
the Ambulatory Pediatric Association
and was a long-time fellow of the

Obituaries

American Association of Pediatrics. He
was the 1984 recipient of the AAP Job
Lewis Smith Award for his work in lead
poisoning.

John J. Weber

Dr. Blodgett is survived by his wife,
Phyllis, four daughters and a son.
John J. Weber. M.D.. emeritus professor

Donations may be made to: Frederic M.

t)f clinical psychiatry at the College of
Physicians and Surgeons, Columbia

Blodgett Memorial Fund. Department of

University, died April 1 1. He suffered a

Medical College of Wisconsin, 8701
Watertown Plank Rd., Wauwatosa, WI
53226.

Pediatrics. Account Number 3-35138,

heart attack while fishing near his home
in Deep River, Conn. He was 72.
Dr. Weber received international
recognition for his “outcome studies" at

David C. Cavicke

Columbia from the 195()s through the
19S()s. in which he followed the
progress of psychoanalysis patients to

David C. Cavicke, M.D., died May 26 in

determine the effectiveness of their
therapies.

Lawrence and Memorial Hospital, New
London, Conn. He was 65.

Dr. Weber recei\ed his certificate of

Frederic M. Blodgett

A native of Somerville, Mass.. Dr.

psychoanalytic medicine in 1950 from

Cavicke .served as chief resident of

the Columbia University Center for
Psychoanalytic Training and Research in

neurosurgery at Yale from 1955 to 1958.

1950. 1 le .served as the center's director

Frederic M. Blodgett

Irom 1976 to 1981. Dr. Weber was a

He then established the neurosurgical
practice at Lawrence and Memorial
Hospital, a service which he headed

director of the Visiting Nurse Service of

Frederic M. Blodgett. M.D., died March

until his death. He took a sabbatical in

New York and helped create its Mental
Health .Advisory Cr)mmittee in 1985.

12 at age 71.

1967 to teach neurosurgery in India.

Medicine. Dr. Blodgett served his

In 1948, Dr. Cavicke received a
bachelor's degree from Harvard Llniver-

practice in .Manhattan, taught and

internship and pediatric residency at

sity and in 1952 received his medical

continued his research at Columbia until
his death.

Massachusetts General Hospital in
Boston.

degree from Tufts University School of

Dr. Weber spent 10 years securing
the United States publication of

During the I96()s, Dr. Blodgett spent
much of his research time identifying

1944 to 1945.

"lead belts"—areas with a high preva¬

Dr. Weber, wIk) also was in private

Johannes Weyer's l)e Pniesti^ils

A 1945 graduate of the School of

Medicine. He served in the Navy from
Dr. Cavicke was medical staff

Dcicinoiiuiii, a seminal study published

lence of lead poisoning—in cities

in I 56.^ of witchcraft and a rejection of
the superstitions sLirrounding it.

throughout the nation. In 1972, he

president at Lawrence and Memorial
Hospital in 1972 and chief of
neurrrsurgery for many years. He also

helped develop free erythrocyte
protoporphrin (FEP), the blood screen¬

was assistant clinical profes.sor of
neurosurgery at Yale School of Medi¬

ated from Duke University and. in 1943,
from Yale School of Medicine. He was

ing test for lead poisoning.
Before his retirement after 41 years in

cine and a consultant in neurosurgery at

a resident in psychiatry at the PayncWhitney Clinic, New York University-

medicine. Dr. Bhulgett spent 19 years at

A Newark native. f)r. Weber gradu¬

Cornel I Medical Center. During World
W ar II. he was a captain in the U.S.
.Army Medical Corps.
He is survived by his wife, Helen,
and two daughters. Vanessa and
■Melissa.

Westerly Hospital. Norwich State
Hospital. Day-Kimball Hospital, the

the Children's Hospital of Wisconsin in

U.S. Naval Hospital and the U.S. Coast

Milwaukee. In 1967, he joined the
Medical College of Wisconsin faculty

Guard Hospital.
He was past-president of the Con¬
necticut Society of Neurosurgery and the

where he was a professor emeritus of
pediatrics and .served as chairman of the
department from 1978 to 1983. He was

New England Neurosurgical Society.
He leaves his wife. Mary Agnes, and

honored with the college's Distinguished
Service Award, the highest honor given
to its faculty. In 1960, Dr. Blodgett

three sons. David. Dana and Matthew.
Contributions may be made to the
D.C. Cavicke M.D. Neurosurgical Fund

receivetl the laancis Gilman Blake
Award for Outstanding Teaching at Yale

at Law rence and Memorial Hospital. 365
Montauk Ave., New London, CT

Uni\ersitv School of Medicine.

06320.
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Robert E. Kaufman
Robert E. Kaufman. M.S., died March

Medical Society, Dr. Kaufman served on

21 at the Cabrini Medical Center

the public relations board for more than
20 years and was chairman of the

Hospice. He was 83.
Dr. Kaufman, a 1929 graduate of
Yale College and a 1933 graduate of the
School of Medicine, had been in private
practice and on the staff of Lenox Hill
Hospital for 58 years.
During World War II. he served as
battalion surgeon with the 4th Infantry
Division for five years. He was awarded
both the Bronze and Silver stars for
valor in combat in Normandy on D-Day.
A member of the New York County

society’s Doctor's Emergency Service
for more than 15 years.
Dr. Kaufman appeared in the
Guinness Book of World Records with
the world's largest cigarette collection.

III Meiiwriam

Lewis L. Loster
November 17, 1991

'32 M.D

Robert E. Kaufman

'33 M.D.

March 19, 1992

He is survived by his wife, Naida; two
sons, Colin and Chris; and two granddaugh¬
ters, Elizabeth and Molly. Donations may

Joseph A. Bliss
January 1, 1992

'38 M.D.

be sent to Lenox Hill Hospital, 100 East
77th St., New York, NY.

W. Sterry Branning

'39 M.D.

June 8, 1991
Carl I. Cohen

'39 M.P.H.

April 25, 1992
John J. Weber

Robert M. Lowman
Robert M. Lowman. M.D., died Dec. 4
at Yale-New Haven Hospital at age 79.
A native of Baltimore. Dr. Lowman
received his M.D. degree from the

'43 M.D.

April 12, 1992
'47 M.D.

publications and was active in several
national, regional and local medical and

Charles L. Mache Jr.
February 3, 1992
Goffredo Accetta

'51 M.D.

radiological societies. Dr. Lowman was

January 15, 1992

He was the author of more than 120

University of Maryland in 1936. He

a counsellor for the American College of

spent several years as an instructor in
radiology at the Graduate School of

Radiology and the Radiological Society
of North America, and served as

Medicine of the University of Pennsyl¬

president of the New Haven Medical

Kenneth A. Simon

vania and later accepted the position of

Society and of the New England

Febrnaiy 13, 1992

director of the department of radiology
at Grace Hospital in 1942, commencing

Roentgen Ray Society.

a 49-year career with Yale. In 1943, he

Dr. Lowman .served as a consultant in
radiology at the Veterans Affairs

was appointed assistant professor at the

Medical Center in West Haven, where

School of Medicine and in 1962, became
professor of radiology.

residents until his death.

John J. Zugich

'51 M.P.H.

March 24, 1992

Stephen T. Baker
May 8, 1991

'57 M.D.

'72 M.D.
'73 M.P.H.

he continued to teach students and

"'Those holding torches will
pass them on to one another. ”
Plato, Republic, 328a
Inscription over the entrance of
Sterling Hall of Medicine
Yale University
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DEVELOPMENT REPORT
IMiotouniph hy Harn Kish<t|)

Dr. Carroll Establishes
Annuity to Mark Reunion
Robert E. Carroll. '38. M.D. '42. has
established a eharitable gift annuity to
benefit the School of Medicine. This
gift, which marks Dr. Carroll's 5()th
reunion year, will support student
scholarship aid and research and training
in hand surgery in the department of
orthopaedics and rehabilitation, and will
pro\ ide Dr. Carroll and his wife with an
income for life.
Dr. Carroll, a prominent hand surgeon
and longtime supporter of Yale College
and the School of Medicine, was horn in
f all River. Mass. After graduating from
YSM. he received training in general
surgery and orthopaedic surgery at the
•Massachusetts General Hospital. For a
brief time he taught at Mar\'ard Medical
School.
Following service in World War II in
the Pacific, he moved to New York City.
Dr. Carroll established the division of
hand surgery at the New York
Orthopaedic Hospital. ColumbiaPresbyterian Medical Center. He
remained there as chief until 1986. The
hand ser\ ice is renowned for its work
v\ ith congenital hand deformities, as well
as ttimors and muscle transplantation;
during his tenure there. Dr. Carroll
helped de\ elop the use of silicone
tendons for hand surgery reconstruction.

Dr. Robert E. Carroll

.•\t Columbia, he established one of
the early formal training programs for
hand surgery in the United States. Dr.

the Veterans Administration and the

Hand Surgery (Orthopaedics) at the

Public Health Service. He has been
president of the Association of Bone

Columbia-Presbyterian Medical Center.
He and his wife live in New York City.

Carroll is known as a leading teacher of
hand surgery not only in the United
States, hut throughout the world, as well.
He uas honored recently in Paris by
membership in the Hand Societies of 16
countries.
In addition to his military service.
Dr. Carroll ser\ed his country as a
'Hisultant to the U.S. Na\y. Air Force.

and Joint Surgeons and was a founder

In appreciation for Dr. Carroll's gift.

and president of the New York Society
for Surgery of the Hand, as well as a

Acting Dean Robert M. Donaldson Jr.
wrote: "On behalf of the entire school, 1
am delighted to send you an e.xpression of

vice president of the American Society
for Surgery of the Hand.

our gratitude for your loyalty and for your

Today. Dr. Carroll serves as professor
of clinical orthopaedic surgery emeritus,

\ aluable and important assistance."
Jay Aiigeletri

at Columbia University and consultant in

Senior development officer

Y.vle Medicine

Summer 1992

CONTINUING MEDICAL
EDUCATION AT YALE

Monday
September 14

2nd Annual Symposium in Congenital Heart Disease

(A)

Direclor: Michael Dewar, M.D.
This miilli-disciplinary symposium will focus atlenlion on innovative diagnostic
and therapeutic technitiues in fetal, neonatal and adolescent cardiology, neonatal
cardiac surgery and pediatric intensive care.

F riday-Saturday
September 18-19

Topics in Neuro-Opbthabnology

Wednesday-Thursday
October 9-10

8tb National Conference on Perinatal Bereavement
Fall from the Tree: Perinatal Loss

(H)

Direclor: David Silverstone, M.D.
Guest Speaker: Neil Miller, M.D.

(C)

Director: Richard ViscareUo
This symposium will enhance the scope of comprehensive care given by a multi¬
disciplinary team for families in crisis, experiencing pregnancy losses from
infertility, prematurity, anomalies and stillbirth.

Wednesday
October 21

Cardiology Update 1992

(D)

Director: Lawrence Cohen, M.D.
This symposium will present the current status of cardiologic frontiers including
silent ischemia, interventional cardiology techniciues, thrombolysis, sudden death
and heart disease in women.

Friday
November 6

Friday-Saturday
December 18-19

Recent Findings from the Neuroscience Revolution

(E)

Implications for autism, schizophrenia, affective disorders, and more in young
children and adults.
Director: Enid Peschel, Ph.D.

Topics in the Management of Retinal Disease

(E)

Director: David Silverstone, M.D.
Guest Speaker: Stuart Fine. M.D.

CIRCLE THE APPROPRIATE LETTER(S) ON THE ATTACHED POSTCARD TO OBTAIN MORE INEORMATION ON
CONEERENCES DISCUSSED IN THIS ISSUE. PEEASE BE SURE TO INCLUDE YOUR NAME AND ADDRESS.
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